<SEC-DOCUMENT>0001022079-21-000144.txt : 20211022
<SEC-HEADER>0001022079-21-000144.hdr.sgml : 20211022
<ACCEPTANCE-DATETIME>20211022162321
ACCESSION NUMBER:		0001022079-21-000144
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		68
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211022
DATE AS OF CHANGE:		20211022

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		211340775

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dgx-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:3dfc3e15-f0aa-46bd-8aee-40e417fed44b,g:988a0070-0eae-4f69-89e4-5f07a4cdd401,d:daf6b320c3f54d66937b4b767300a7e4--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dgx="http://questdiagnostics.com/20210930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dgx-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV8xLTEtMS0xLTA_7d9929f1-247e-491f-8acf-e6aa139b43ed">0001022079</ix:nonNumeric><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV8yLTEtMS0xLTA_a901812e-d7d7-4f6b-815d-a975c82e8786">12/31</ix:nonNumeric><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV8zLTEtMS0xLTA_4f54c29c-9e16-4c4e-b77a-898633c4c973">2021</ix:nonNumeric><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV80LTEtMS0xLTA_b015879c-2502-4679-ab2f-8b3ee56e1a23">Q3</ix:nonNumeric><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV81LTEtMS0xLTA_6da6c1e6-0200-4929-badc-34544961aa1d">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dgx-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="idb6102b3487f457aa5e512c514af4c6c_I20211015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i240ccb0d73a24cda883d17698d2669f7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44797d3e9c614839926a9c2f3bb5be17_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f627c3af5db4299b234650d220eee56_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2e684a75e28400dbbfc768d86f47ec7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia69f34e8c6f742d4a439c6a90e6dbb84_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60818a25d0774d728fc8875bec533fcb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30536b78fd3e41639c5a631d6df42e38_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c26a3bcfeb74909a10ba5fbcc6ec947_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf447d1f13b744eca3e676fb375b1f08_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c9436c528694ee1ac54e6f8ce941854_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bcf39ba3ca3490ba9b723f846d97a93_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d322c01404548d7bc8bcc50e7fc7e90_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6b3aa2d9a704d3890aa1d3b20c761cd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61a8b1a97ea54a2cb0efda370034cf33_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c9526dd81d14acbb165fbdb21bc7d5b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5469e4b199e4f6bba9dd760df124408_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1082d06815c4d1cbcdd4183ef7a7054_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90a31327e6d4444faef566d46a5e0076_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b159649f77f410ebe5d069195864be4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39fbe907b9a04ba88fd377e9c3ee0c5b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2de9bd88816b4b76a24f2e5e45391d53_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a7da46099a44378da1a233e2933299_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bc8004207f6457d8e91cab661dc9d7d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530936cdd95443c38a6ee1dac2f95b5d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd797ff06d5347448e67d12d0a112a21_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ba8ee8faa74b07aa6d9f1fe6d24c42_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6efac86a7154479b5393be974cf5b8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1ebeea55bd143e7a34428dfb1cb8d7b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i462380c5fb3941a2be00f2507dfe4337_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9be3cd77042747cfacd90361f64c7ca8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf43e9ec0f474249909c8e64ca28aa9e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e728b108435425ca56aae502185c623_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44095c144c7847d1864cff543b26d594_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb2c2ba8e2984a5ebf8b1e80612267d0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2877089917b44598af747bd1c932cea2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaec86bf908d1470cb320f0f36f8501f6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5469af2e4e646ff9485e5ea6fe72b27_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4291d6d468a544eda0577ac487a2c725_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a95a06eb0f94af39dece3892ff96d29_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2db14ecc4974269854d7acb2c998846_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eb4acc4683141d68c6b2262176ea057_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i496e5c6bce0145338271871a4b19a534_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c7076b530f6444a947bc2cada186634_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c4d3b899b3a4c27920b9a7a1c4341f5_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i854a56aad60640659955246cba8db3d1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ead955e97d24ea98107e5fdafbb5933_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26471b06607740b18133552b7813a289_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81dfabce71384a93b5d745045e2c2b24_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1284835d8c794866b627a0391c20a3d7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e7ae5dc9104f20a5ce0b4a9350ec65_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied656b411f5c494fa95a8a47cdf2ea4b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87c9e74f17947c78a11adfcb138af02_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib217db8b923647049bb39b949b84c79e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if16bcecb1e6d4dd9afec8d10d7899999_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16a5de19f2d549a9a4351e241b197e97_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb4bcbff08f44cdbccc42febe3b29cb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b4c9dc3e1504cc5ad275c05e942afdc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib05a9b6900b545f2b5c4580d8153e641_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib54bc123a8304d1b95560ab37cf81299_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3f89fd967647879e6f70cc4eced07a_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc6b1efe84f4f65907f66036143af31_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i666d9c35a6194943a43fbcf1f9c9b1df_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53b9c62c8412401893a2366a618ab917_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafd5f573146f490584b2d02d1a275200_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i246ee08978dd4f9281e49cde4052adb5_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f8b2bbcf7b442d5b60c4726c660f0b2_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62dc4fadac874b26b838080327833f3a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id467bea9a9a042bd95d6970a12d3be15_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:ForeignCurrencyTranslationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86982bd9508a4400a05b7e7954cd17e4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19c606c4a927487086b61b79e8c8374b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6717324b738441d5b2882980e7f96534_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36fc1b4d87cc4ef59463dc14ae3e0809_I20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i259a5f13f5bc45e7813aca65d4056271_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i285e961758554fd5ac030b44fe9867ff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id248109e93494be5ab0649ef082cb608_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibba5357fd8bf4d2f8cb494c4ee189328_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8117f4bb2f54d20ae84cf958f833fc9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a5dcd0ab13e41d480cf6fd05837a2dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c1dfb7b00dd40caa23f7b20aa962872_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b6c581188914f048902746e4d6c62a5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53fde28f195345cdaa042f2d8f3d61df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8125b809d77340e4a919837e287c04be_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aafd4a99f5b40e9855fa6aef485af35_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50c50c6fa9d5420593a7df593fbfd4b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id699393e5c1e405cb9e349542a08565d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i437864783a7b4db19f1011b84e670b30_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75d51148780249248ddb2e605bbe8abd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i748efa01b96341229310868eca941647_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb316df1367442cc90e4c2c5326acd80_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i723c339a06ce4cf38176085ba130077e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3d6d052e08a40f3aeb61f740e03dac2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i944e0f14985441db988806dbbf0e1725_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa71f4cff13142c783bc54345c97e1b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i386a526647e54047ad6392d22e224a8c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7399b9274664c749e91f89957ec71bc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34cc7bf29a7c44409c7e67bcd16c4a18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia59678286edb47a683efe4ca31c9d152_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2cfcef6577746beaf2fc395bc84e9f4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i091b01bda5c84720a769c37a5b845045_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec15589bf02e47779ded2be278cfe21a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c9fb4948c0446498ff2b9b1edc0349b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93cec6591e0847ad8a42544b505883d4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia65a33d49c0b41508f0b15bc06443452_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib938d748462e4324a82c390775ef95f0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id96bc77fc8eb4e8e88dc16ca93868148_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55bf2898a19d4ec4ada12d71732989e7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e7d971b76454263a15f1169e211c2a2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ea29ec2e2ea47a79288bb5eb1c001b0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5288d887a86f42969ff785028080679b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i868f8637411d4f61887501630bc811b0_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d06b6e3f9dd4f56a49b29e3deefc334_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfda32ff821e42f7b4ed59c5648a0dd6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfcf88539a60445eb9be5a8700c50fb6_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f600b81db564760a3990025b8fe7516_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf76d19dc0f440e89a7ca4bf2b2f2383_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib80fc1942e984fd5a7949043c3093362_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7542d9b6daf04822b7c7295e9573a8a3_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie051564f2e734da28d818b7a4efcf77c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id858b57b1f134c328d0f3870aff86791_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01995b0930f44ae494baf9f00606c1be_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71dae6d523044c6e86141e159ada5f54_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23930df4ff5e47acbd2af40147c8310f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fa4a1c7a8cf4bde9e060da17dd6138d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dgx:claim</xbrli:measure></xbrli:unit><xbrli:context id="i27f9acec26b840b1a223ab39e755c0aa_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i182a2b075333465998d6cc5c986d8320_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ddab4100a944fea58ae374a6ff4845_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58a1a67d34d240d7b603eb953adc9835_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1952efe7be544fe591e6315daee82f95_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida9a845517b14f2d85f82da38a53f275_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia12055ea11a54f1890616da76bad2b80_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad4b891b3a584530a9cf508df0670b51_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88caa1b81b364b9fa199959abd7ed0d2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf2cd09b04849daae0be004f7617d14_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i537235110c194ee082108ce9a9ecc879_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9565fe343ad34611897d8c50225762c8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3be9f0b477af42a4a4c10b096f57639b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i813b3cfd78584fa288cbfee1b07eba3a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a59539f511c449187290980e118ba4d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5acd767ddc8241cf9dfb969b29565a40_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9fa386f73d4e2e82d8ed5c274ecabf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d8c3304c5b24c6698ca6cf99acb40f8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17915cdcfe1c4db0a3f41d20dcfb007b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d583a2157a4461d84a68397c4aa9749_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida3b6e41b6d84008a6bbdb8a925027f4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i534453e984bd4a6185b2140d89a55c40_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02fec1695bc94fb4b799f16df36a277a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e86467c36344bbf941f4c24f2436504_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe9af73476c6465093764838622b5110_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2828a531f0ab4def88e14f6e27424f8c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2adc13627b04c52868f7d8eaae852b7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1864ddab8bfd440b964803911e9124ec_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd315ce487f94328842945669408cac6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5e43ad9212f4e578d1fb6094dc932e7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15f86920b99e47a8acf4dd4cfafd0615_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id771c1175b884bbca27eafcc9a648410_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6af7c6063aec42389819aab63062e23e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i048fe873cef04ee19ea2b9317513136c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id44bc581e9ad4e67838ca4c123d65f5d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b5cbcbc73384532a5dd309d11856852_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a06c98f38fb4642a99ba9b0eeb69e85_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5df9bb39dd94d1da9a87c3331dd1fc4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b8ec4029e44a988d269c3126940283_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3acee20262b40d6b10903fb4afbe132_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0e31adde43d46de97147148481af848_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia72c419b8ec64dba8571eec8d685eec3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a3d767b7d0c47bc9a4b5019b47e5bd9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d3091cfcdc640a6a96229526a63c9f3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee01dc9e07e243b99354760cac0d4d32_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3598a5751c24825831703722082a2cb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i850f59cbde9f4344a88ebab6b1fc075b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87cba5d430f245a68bd0315c18e62086_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42802853a4a454699bda9d6dbae93ab_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb27e7850474298b896873be1ac713d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98c4699f13a94272b16b1d74570e68fc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1213d16766764ac4b9e354347e502602_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90fe5caa0f59404680b57eb172b7feb0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if617a3f687c7470babc0347a121c9e4d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6c8d850bc0b470f9ed7d27f080d7d3e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5bda4a72cc2448eb1edd6aaf8e616da_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aa4bbd4b0f842faa92582711d35880e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f839de76b0f434eb190d581d2836010_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f651cc6ea1b471f8b7f8940efacc318_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78617df876924999b6673b596d4ec4bc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7fa9139c7bb4f4499a1a4264ac05a1f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37b7a8a12d95433386c13963200412ff_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b51a1e39a2f490fa85b27203276ef0c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86a46fb310654cc4b552d2896fa0e4ce_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1e1c8f2d240445c9b8dcf6436139569_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40e0c746fc364568aca78621cf9fa220_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea67ec5cbe4542ba8a94aa5c96aa362d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieea0bd6309b146afa41000f43a995747_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if642e1ad2c084744ab7670f7a6352dfa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i104ac329ccf749b18a18c82c37f79955_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b2258e70f904ecc8314266db2b2b0f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6bb57ee8aae4e0bb388398be620f121_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ec3dd09cf4437ea06fcdec19d1d6fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iead44cad5e60407b9beab7d6f4ff0009_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68612d24937c4836b820313794721e70_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2caebe9557194cc5b637ac04007df5c4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i826e2caf620945adb4857cc3ca809c61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if655a31fafc740b5b2318f68e86b82a3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if312089fa21e46d6b6f06ec4ba94bd10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fb7b07b086a4309b9d46148ab2e12c2_I20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6f992896609491290214875ab35a9d6_I20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47405452b21d4961b150a63aba4933d5_I20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3263481a80b4afdbad8e84b720b498c_I20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8f19a89fa884900aca21d4657c555f7_D20211022-20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialPaperOrLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-22</xbrli:startDate><xbrli:endDate>2021-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f807339735446ff8d0868243f7b30d8_D20211022-20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialPaperOrLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-22</xbrli:startDate><xbrli:endDate>2021-10-22</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="idaf6b320c3f54d66937b4b767300a7e4_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WASHINGTON, DC 20549</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI4_44dfe980-5f06-4a3b-b1a1-6189b5456352">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One) </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI5_3325cb90-aba8-4d8e-b6e2-8bb5b92dd543">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8zODQ4MjkwNjk5MTcx_57e6f6f6-0457-4682-b78f-cace2bba435f">September 30, 2021</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Or</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTIy_c1e61d99-ef19-4726-9f62-2934ea87f22f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from          to</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTIz_4f18ef91-2a77-4603-9de1-c133afae2c2b">001-12215</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI0_d031ec93-914b-4dca-83ba-833be84fb49d">Quest Diagnostics Inc</ix:nonNumeric>orporated</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:519.00pt"><tr><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:201.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8wLTAtMS0xLTA_e04409ea-efea-4ad1-9104-31cf18b9fe37">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8wLTUtMS0xLTA_1d145290-2848-4132-993e-411f1cf6985a">16-1387862</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8yLTAtMS0xLTA_96d6c888-a562-4111-bc79-e2da43d6febc">500 Plaza Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8zLTAtMS0xLTA_de9c930f-b0a3-46b4-882e-edeed9eea63c">Secaucus,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8zLTEtMS0xLTA_e51569d9-be28-4546-bd0b-4cc888254341">NJ</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8zLTItMS0xLTA_ef5c4f58-0ee4-4f03-9957-cd94aed8dae1">07094</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV80LTAtMS0xLTA_b8c2f583-3a24-47e1-8821-7f3219b0fbb7">(973)</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV80LTEtMS0xLTA_c11276ea-94ec-4a58-82a6-81560000765a">520-2700</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.055%"><tr><td style="width:1.0%"></td><td style="width:30.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6YWE2YTEwNWYzNzA5NDExY2FkNTNhZmU4NDRlZTgyNTUvdGFibGVyYW5nZTphYTZhMTA1ZjM3MDk0MTFjYWQ1M2FmZTg0NGVlODI1NV8xLTAtMS0xLTA_b6785615-75ec-4cc0-b625-b8a45a94c069">Common Stock, $0.01 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6YWE2YTEwNWYzNzA5NDExY2FkNTNhZmU4NDRlZTgyNTUvdGFibGVyYW5nZTphYTZhMTA1ZjM3MDk0MTFjYWQ1M2FmZTg0NGVlODI1NV8xLTEtMS0xLTA_a0a045b3-5215-4fe2-9912-afccc347491e">DGX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6YWE2YTEwNWYzNzA5NDExY2FkNTNhZmU4NDRlZTgyNTUvdGFibGVyYW5nZTphYTZhMTA1ZjM3MDk0MTFjYWQ1M2FmZTg0NGVlODI1NV8xLTItMS0xLTA_e733a5c5-36bd-43d0-b6d7-0b47553aa64e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI1_81adb1ce-485d-4331-82bc-b4bbeb62c04a">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI2_3e92f0fb-1096-4bad-8582-0540ed06fb6a">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.166%"><tr><td style="width:1.0%"></td><td style="width:42.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6NmQxZWMwNjEyMzlkNGJkYThkZDhiYzJlNGJmZDllNmQvdGFibGVyYW5nZTo2ZDFlYzA2MTIzOWQ0YmRhOGRkOGJjMmU0YmZkOWU2ZF8wLTAtMS0xLTA_44504869-e816-41b1-ac90-030f20324c9e">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6NmQxZWMwNjEyMzlkNGJkYThkZDhiYzJlNGJmZDllNmQvdGFibGVyYW5nZTo2ZDFlYzA2MTIzOWQ0YmRhOGRkOGJjMmU0YmZkOWU2ZF8xLTMtMS0xLTA_50f8ea9c-6c83-4baa-b13e-89e2a8c370cc">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6NmQxZWMwNjEyMzlkNGJkYThkZDhiYzJlNGJmZDllNmQvdGFibGVyYW5nZTo2ZDFlYzA2MTIzOWQ0YmRhOGRkOGJjMmU0YmZkOWU2ZF8yLTMtMS0xLTA_141d91d6-ff45-49de-a540-51f526a95a43">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI3_01cdec58-9f93-4d3e-8b99-1d70af6dc536">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;15, 2021, there were outstanding <ix:nonFraction unitRef="shares" contextRef="idb6102b3487f457aa5e512c514af4c6c_I20211015" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xODYz_2790642f-42e4-4ac3-86f8-e39056c32da0">122,674,771</ix:nonFraction>  shares of the registrant&#8217;s common stock, $.01 par value.</span></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1. Financial Statements (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Index to unaudited consolidated financial statements filed as part of this report:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_13">Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_16">Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_19">Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_22">Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_25">Consolidated Statements of Stockholders&#8217; Equity for the Three and Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_28">Notes to Consolidated Financial Statements</a> (unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_73">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_73">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_88">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_73">See Item 2. &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_88">39</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_91">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_91">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_91">39</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_13"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMi0xLTEtMS0w_2c24fee6-36e6-4aa4-9c2c-13e30f25bfe2">2,774</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMi0zLTEtMS0w_d94ca49b-7efd-4d2c-9948-f04aee135448">2,786</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMi01LTEtMS0w_59412367-7f32-4c22-b10f-6bd566db20f8">8,044</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMi03LTEtMS0w_a4c1b6f1-10d1-4a62-8143-3ef195c2dc55">6,435</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNS0xLTEtMS0w_c507e104-b459-4a42-9b73-70df727a702b">1,670</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNS0zLTEtMS0w_06e44c05-325f-4a72-b444-0551bcf4ace8">1,580</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNS01LTEtMS0w_a4052aa0-0877-4b85-81e5-2048a47ea75c">4,861</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNS03LTEtMS0w_7338ff8f-c844-4322-b674-18c51fab2d75">4,071</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNi0xLTEtMS0w_6344d714-bb9e-4e78-b624-5a9b8945ab9f">427</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNi0zLTEtMS0w_d396f0ac-deb9-4cd9-877f-1a53d0f6e30c">396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNi01LTEtMS0w_2b070055-8810-4301-bb15-b8936894f28f">1,263</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNi03LTEtMS0w_cf460c37-ef7e-4850-b267-3b8fd6297a0c">1,103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNy0xLTEtMS0w_b0647898-4f1c-4161-a597-370ffced1845">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNy0zLTEtMS0w_7334b98f-d913-4f79-92ef-5b2467875ff3">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNy01LTEtMS0w_40ed1f04-f0e3-4b0d-aaa3-df68fba7120e">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNy03LTEtMS0w_43729272-f16f-4624-b617-0da5e4c65a6b">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfOS0xLTEtMS0w_7df482e6-fd7d-4e4b-a4ce-6aa63f6d06f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfOS0zLTEtMS0w_b245c082-0c40-4bcc-939b-a8b95df241df">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfOS01LTEtMS0w_d5c6c799-2e99-45c4-86c8-5bc9cd9ef197">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfOS03LTEtMS0w_b004a498-d5b4-48a3-8115-cdc8f8bd4e17">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTAtMS0xLTEtMA_e6934736-ff71-44f0-a794-0b36b2dcec49">2,122</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTAtMy0xLTEtMA_05806e05-3ba6-4e87-8ec4-f0e2887c6d5b">2,068</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTAtNS0xLTEtMA_db9faa50-f9e0-42da-b415-26790307e9fd">6,199</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTAtNy0xLTEtMA_e374a0c4-bec5-45a3-9f25-f79556eff645">5,259</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTItMS0xLTEtMA_1068cab5-4ebb-4468-a031-992f021bbd2e">652</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTItMy0xLTEtMA_384c4402-1f4d-441f-9719-d9baf9b4ef7a">718</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTItNS0xLTEtMA_9d1ae501-aaad-439a-8ada-23c45b51bc46">1,845</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTItNy0xLTEtMA_2bf9f21d-4053-4789-9642-ae2d0ab2af81">1,176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTUtMS0xLTEtMA_6a97e41a-d16f-46d1-8a1f-40c5053b7d94">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTUtMy0xLTEtMA_59e03dee-8d01-45d2-8bbe-c180edeafd1a">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTUtNS0xLTEtMA_5c101fd1-8ff8-45b7-bed6-f9274951df1a">114</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTUtNy0xLTEtMA_8287f2b1-bf33-417d-8ece-185478db01cc">124</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTYtMS0xLTEtMA_a4a41410-d761-4624-b2e5-738e9e3d1eb6">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTYtMy0xLTEtMA_3e9c486a-b434-4919-92b7-fd25131bc2a1">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTYtNS0xLTEtMA_164375a8-30c1-425e-bab3-fef0b62aeb50">366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTYtNy0xLTEtMA_ae973255-2f1a-4eff-bb3e-ee07e1240c52">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income (expense), net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTctMS0xLTEtMA_0b4330d0-328d-4ed6-8df7-0d5fe5c5c019">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTctMy0xLTEtMA_44b7ce3f-13e5-40f5-8f34-1673879923aa">35</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTctNS0xLTEtMA_5a604094-5eff-4222-9d14-d4badc17e310">252</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTctNy0xLTEtMA_2c2be0a4-9cd0-4699-a69a-f7d04e212a1a">50</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTktMS0xLTEtMA_61d538f1-4d8b-4e94-a27c-09bdc6e26bdd">654</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTktMy0xLTEtMA_3f48ecd9-bb56-4c01-88f0-f1a3dbee98db">753</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTktNS0xLTEtMA_6cd654b2-dbbe-4e2b-9c06-884591cca488">2,097</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTktNy0xLTEtMA_fe8ea494-fbd4-458a-a4cc-8e3da19a6e51">1,126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjAtMS0xLTEtMA_6a1ecee3-7bbf-4e31-81c2-4b694c2de61e">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjAtMy0xLTEtMA_7720c57a-1179-4bff-aa97-15df814d6367">177</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjAtNS0xLTEtMA_b31e6faa-26d7-4ec9-a623-04a2e13c2834">483</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjAtNy0xLTEtMA_d4f6832f-631d-4ca9-a631-e5a1e69ea675">269</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjEtMS0xLTEtMA_b4c8fd4a-c792-49d3-83e1-ed17cac15463">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjEtMy0xLTEtMA_7345adb9-3e31-4b7b-9213-c2ab6edb7e46">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjEtNS0xLTEtMA_07c66ae7-6954-451d-a306-210e81822f04">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjEtNy0xLTEtMA_96aee7be-7c7b-4f5c-b4a4-b3664143bd20">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjQtMS0xLTEtMA_9ce9442b-2cdf-4313-ac90-336178aea0cf">527</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjQtMy0xLTEtMA_52f6252d-c216-42d3-a9c3-4665155c5a0c">591</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjQtNS0xLTEtMA_2cc4cf4d-79b0-43ad-bedd-3f75c3242264">1,667</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjQtNy0xLTEtMA_86083ccd-022c-42b4-8d21-6afa95583b8e">890</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjUtMS0xLTEtMA_bafb0a19-5bcd-4fbc-a47e-79fbb1fc64be">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjUtMy0xLTEtMA_78df581f-3fcd-49e4-8814-1b2e29cb9ae3">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjUtNS0xLTEtMA_796ead94-7b39-406b-9979-7c31214e4294">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjUtNy0xLTEtMA_110eba59-8d09-48d7-bdd4-4c3c32eb2e99">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjYtMS0xLTEtMA_796b8d7b-7529-4c6b-b870-76449e8d78a8">505</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjYtMy0xLTEtMA_03e4f191-a790-480e-bb4a-0c3b2d48cacb">568</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjYtNS0xLTEtMA_20365183-f8ad-4c01-898a-ac221495dde7">1,605</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjYtNy0xLTEtMA_b4b0ac81-e8df-4d00-ad93-4dd2b67dec04">852</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMzYtMS0xLTEtMA_7e005735-f261-4374-9993-caad80b0d8fa">4.11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMzYtMy0xLTEtMA_e7ef52ac-3cf6-414b-9e6c-d61ec8ffc529">4.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMzYtNS0xLTEtMA_aaadb5de-b42d-4799-a728-c4c19683268d">12.63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMzYtNy0xLTEtMA_d86e0dca-a7ab-4c30-9567-61052f05470d">6.33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDEtMS0xLTEtMA_1ec819eb-01fa-486e-82fb-41c76b1546d5">4.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDEtMy0xLTEtMA_0ead1d89-d362-4c24-9a50-030b9af3311a">4.14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDEtNS0xLTEtMA_6dea6946-1663-40ac-9819-0c2feac69f89">12.41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDEtNy0xLTEtMA_0cb64d9b-d511-47a9-8715-fd3478550ff5">6.25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDQtMS0xLTEtMA_b2f3161d-9f21-41c8-8dd3-0abf0eb00ab9">123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDQtMy0xLTEtMA_fd15d5ad-d272-46bc-ab9a-aaf5578fee1e">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDQtNS0xLTEtMA_5d08dc81-58c6-45dc-9772-7cdbdfef14d0">127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDQtNy0xLTEtMA_c697f6a5-e0dd-45a1-872b-b3d62bd74c69">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDYtMS0xLTEtMA_6db951db-f7d0-477d-ac49-0d12bd87d4b1">125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDYtMy0xLTEtMA_931f7e2e-9deb-4741-86cd-3d3d6c8f5ad5">137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDYtNS0xLTEtMA_5505b0f7-fb2a-4a9e-89df-121e14865a65">129</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDYtNy0xLTEtMA_c3d97b24-605f-41fa-aaa9-e74527e58e90">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2021 AND 2020</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMi0xLTEtMS0w_9ce9442b-2cdf-4313-ac90-336178aea0cf">527</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMi0zLTEtMS0w_52f6252d-c216-42d3-a9c3-4665155c5a0c">591</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMi01LTEtMS0w_2cc4cf4d-79b0-43ad-bedd-3f75c3242264">1,667</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMi03LTEtMS0w_86083ccd-022c-42b4-8d21-6afa95583b8e">890</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNS0xLTEtMS0w_9850eafe-d324-41fb-acd5-ac03326ec738">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNS0zLTEtMS0w_51884c60-3633-4b72-855c-d15fc6c3f7a7">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNS01LTEtMS0w_266dd706-7951-4fc1-b8e2-cc7613fe10e5">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNS03LTEtMS0w_8ca1d5a5-d667-49c4-8543-10debc613430">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in available-for-sale debt securities, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNi0xLTEtMS0w_96a38151-7d26-42d2-90a2-583056f3d34f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNi0zLTEtMS0w_2f4e2216-6901-4ad5-ba21-b00ab867a6ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNi01LTEtMS0w_cd509de7-c608-4543-b32f-e9d4f745f322">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNi03LTEtMS0w_fbf30a90-b1c8-4571-817f-96cb176c35ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred gain on cash flow hedges, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNy0xLTEtMS0w_c64ad11b-d043-407e-81ae-e08515ea4132">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNy0zLTEtMS0w_3feca964-4dd9-4b3d-914d-17383a152031">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNy01LTEtMS0w_191ba2c0-d0a7-4082-9f9e-554c10d36a5d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNy03LTEtMS0w_f8c1b4e8-d67c-4ab1-933f-fd00e576fd2b">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfOS0xLTEtMS0w_cd3ae2d9-06ca-44f8-9082-bbf8d393933e">3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfOS0zLTEtMS0w_fee3b2cd-4efc-4a4d-a364-e01b5af8954c">13</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfOS01LTEtMS0w_93599d6f-f09a-406c-bca5-7fe6bc1266b4">8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfOS03LTEtMS0w_fe6c20a6-a679-4039-9f8e-e29c72387b65">3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTEtMS0xLTEtMA_83bd1294-206d-4260-92f5-898c77ab9253">524</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTEtMy0xLTEtMA_3e37a10b-9d37-4db0-9541-fc2e195ac667">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTEtNS0xLTEtMA_962072e2-f358-489d-b53d-e245553d3f1f">1,675</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTEtNy0xLTEtMA_105c6743-6e4e-4a82-af8c-f94d04440bfa">887</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTItMS0xLTEtMA_1e1b5a42-4df8-4b6d-ae31-3b5ae7f7ce8b">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTItMy0xLTEtMA_4f3136c4-84ba-4699-abbf-611015dc4e15">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTItNS0xLTEtMA_a0d42623-de2e-4350-9ea8-413d2f8736f5">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTItNy0xLTEtMA_5148985b-0880-4fb1-b2bf-3f86169e21cb">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTMtMS0xLTEtMA_6abc4792-3d8b-455e-aec4-698bc2cdd2b2">502</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTMtMy0xLTEtMA_852702d3-e6ad-4bc1-ba0d-fd798cade5a6">581</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTMtNS0xLTEtMA_28d78c5d-6c4a-410d-a828-2f0d27f99135">1,613</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTMtNy0xLTEtMA_96ddac5e-44c1-4f26-9250-4256a494ca5a">849</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_19"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEPTEMBER&#160;30, 2021 AND DECEMBER&#160;31, 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMy0xLTEtMS0w_5b0b4267-2575-47c9-9f01-5ff786d58678">987</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMy0zLTEtMS0w_3535c4da-1c48-412e-b9e9-da23a24c3297">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNC0wLTEtMS0wL3RleHRyZWdpb246NDMxMjE0Zjc1YTRjNDNkMmJjZWRmODI4N2RjYmQ3ZjFfNjM_8ee24f22-d2ce-4573-bc5c-3b8907deec04">29</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNC0wLTEtMS0wL3RleHRyZWdpb246NDMxMjE0Zjc1YTRjNDNkMmJjZWRmODI4N2RjYmQ3ZjFfNzA_274ba934-ddd0-43f6-a3a3-dcc0eff89da0">28</ix:nonFraction> as of September&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNC0xLTEtMS0w_096dc231-bb55-49b0-a009-834d30340207">1,473</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNC0zLTEtMS0w_f6230797-8d90-4cba-b039-7b4d12f62902">1,520</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNS0xLTEtMS0w_516bd3f6-ad64-481e-8374-a171ab1af047">205</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNS0zLTEtMS0w_4b1bae83-c8a4-4ed0-8e2c-57e51af048c1">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNi0xLTEtMS0w_c2ccf9c6-6163-4758-aca3-8bcd6001a310">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNi0zLTEtMS0w_ed4463f8-459f-4e35-a47a-628084c51c3b">157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfOC0xLTEtMS0w_49bd26aa-f776-40ff-9622-de907de103ed">2,854</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfOC0zLTEtMS0w_c7ac50a8-72ec-48ef-bd6f-505e0c7fe1a3">3,058</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfOS0xLTEtMS0w_d29589a1-f79c-44b3-b9cd-30a2a9a38695">1,634</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfOS0zLTEtMS0w_9799c803-133d-4e47-b2f9-c932dddc02b6">1,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTAtMS0xLTEtMA_301dbebf-38f9-4fc1-baad-83e603ad718b">596</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTAtMy0xLTEtMA_742440ab-1769-49c2-ac1b-77c2ad3de9e0">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTEtMS0xLTEtMA_9873946d-55ce-4d47-8e34-4c7bf1dfa255">7,057</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTEtMy0xLTEtMA_a6422eaa-109d-4598-9cb9-fdbc49784f82">6,873</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTItMS0xLTEtMA_4eba30f6-bdc8-4408-8d30-f504c6c35acc">1,152</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTItMy0xLTEtMA_d39411c7-7c85-4c37-8e90-e14a76595329">1,167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments in equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTMtMS0xLTEtMA_68e3b12a-86c3-43de-aa84-5ca074635509">124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTMtMy0xLTEtMA_c4f2325a-b0e1-47bb-aed2-d8962fbc105e">521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTQtMS0xLTEtMA_c49df8df-585d-4e10-9cc0-31363886f71b">155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTQtMy0xLTEtMA_73f794f6-1d19-43d9-99bd-25a0cd78902a">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTYtMS0xLTEtMA_276cb83c-cb8a-40c7-a887-7afbb50ab1ea">13,572</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTYtMy0xLTEtMA_fe1c133d-7a0c-48b7-8627-1b10a8274335">14,026</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjAtMS0xLTEtMA_a95f55cd-d868-429b-9dc5-af5fecdbc554">1,610</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjAtMy0xLTEtMA_fd53ab66-105e-44ba-a9c3-d816394999fc">1,633</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjEtMS0xLTEtMA_cc658200-4cbf-4e49-a687-ff9c8eb0d1a0">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjEtMy0xLTEtMA_d6b504ef-b613-4ac2-8aba-f4762c8d3f3f">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjItMS0xLTEtMA_442fb733-3291-44bd-a27a-a90c27b6acbd">148</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjItMy0xLTEtMA_ef9e4911-b7f5-438a-b9ab-37ba47f76b26">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjQtMS0xLTEtMA_13ccc3fc-58e8-44ee-b532-8b25cdf47707">1,759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjQtMy0xLTEtMA_869a33b4-50cf-4567-a16d-64f0f6d13a1a">1,776</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjUtMS0xLTEtMA_d806fe30-ab2b-4194-97b7-05a8bc1b8568">4,006</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjUtMy0xLTEtMA_a510edd8-f1a8-431c-ade1-5158074785ac">4,013</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjYtMS0xLTEtMA_73e0c837-662f-44d6-9841-fecc19573e63">495</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjYtMy0xLTEtMA_2b9b6576-9524-4d14-b10e-9d5a1466658d">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjctMS0xLTEtMA_26e17297-96c0-440b-ad35-043d35008289">801</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjctMy0xLTEtMA_1c353ed1-d46c-42c3-8691-5bb550a4dcab">847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjktMS0xLTEtMA_baf0e933-ae5b-4f2b-8121-445be347cc17"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjktMy0xLTEtMA_688baa9a-63b1-4228-b375-0ed107c6d4fb"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzAtMS0xLTEtMA_627ff0c5-4e9b-46c0-b608-901b92c547df">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzAtMy0xLTEtMA_9522bef0-920f-4838-8f70-4ff4dfb751d1">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0Mjc_56baa32a-4bfe-4b65-a446-8137767ea44d"><ix:nonFraction unitRef="usdPerShare" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0Mjc_5d0b21ae-8751-4488-b078-192c0a4ecd30">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0MzM_1a4321f0-e8ce-422b-890f-9729931494ee"><ix:nonFraction unitRef="shares" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0MzM_e3ce4843-8d9f-4d19-9d4a-62f2be6af859">600</ix:nonFraction></ix:nonFraction> shares authorized as of both September 30, 2021 and December 31, 2020; <ix:nonFraction unitRef="shares" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0NDU_e4492107-b5d8-47df-8e9c-22c7669d88e6">162</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0Mzk_5112bbc5-4583-4b6d-95f0-328f55165a84">217</ix:nonFraction> shares issued as of September 30, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMS0xLTEtMA_9d442212-4565-4f58-8e26-1953537a6eb0">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMy0xLTEtMA_8e46f839-8e7d-41ac-82cd-ef06b11bdc16">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzQtMS0xLTEtMA_2fc4ef99-d1a9-420c-b2c3-fa7afe709e3d">1,936</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzQtMy0xLTEtMA_364e546b-0e7a-42e9-ab8a-be8dafdc5f28">2,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzUtMS0xLTEtMA_62d71a63-3362-4a3e-8f2e-c3513e2adbae">7,333</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzUtMy0xLTEtMA_10fd6a17-88cc-4943-9bae-6825b768face">9,303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzYtMS0xLTEtMA_8d6b5c09-6ad0-4243-a885-4dee20a61b58">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzYtMy0xLTEtMA_b43a3067-afe6-4ccb-9d55-b1ab99fd7254">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmE0MmZmY2E5OTFhYjQzZmRhN2RjZDhhODJmZWJmZDI2XzI5_2a1cb216-bc3f-49ba-b484-5c5dd3fea5d5">39</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmE0MmZmY2E5OTFhYjQzZmRhN2RjZDhhODJmZWJmZDI2XzM2_c47c143c-8482-405e-91b1-00a6ec52d626">84</ix:nonFraction> shares as of September&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzctMS0xLTEtMA_af8acaa1-5b26-4988-b49f-bb2704e08853">2,866</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzctMy0xLTEtMA_7d39487c-d178-46e8-9cbb-14f708bf87dc">5,366</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Quest Diagnostics stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzgtMS0xLTEtMA_c61da7a1-55d8-40ae-8ea7-5cacc3475581">6,392</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzgtMy0xLTEtMA_47a6d582-0a2d-4265-bc44-24f744c87644">6,759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzktMS0xLTEtMA_844fea1a-6dbd-48ef-81ba-7685506fdfab">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzktMy0xLTEtMA_d7d2433f-c34b-494c-8736-c6b67aad8ee2">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNDAtMS0xLTEtMA_bb13e832-6e94-4b88-9698-65fd3e20343f">6,432</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNDAtMy0xLTEtMA_5668008b-f26b-4888-83c6-6d49c32f005a">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNDEtMS0xLTEtMA_d0136345-8ba0-4a82-ab52-739719ba962c">13,572</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNDEtMy0xLTEtMA_a5289411-be5e-4546-86d0-5f09123b239a">14,026</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE NINE MONTHS ENDED SEPTEMBER&#160;30, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions) </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMy0xLTEtMS0w_2cc4cf4d-79b0-43ad-bedd-3f75c3242264">1,667</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMy0zLTEtMS0w_86083ccd-022c-42b4-8d21-6afa95583b8e">890</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNS0xLTEtMS0w_cfa364c6-f749-4dfb-b99c-fc879bc7cde3">302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNS0zLTEtMS0w_5821094e-a0b7-4768-96f5-8b6f6a37b29c">263</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNi0xLTEtMS0w_5ef8f964-60f4-43c1-bfb3-fcaada062701">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNi0zLTEtMS0w_e648b290-4b05-4433-bb08-c57bf3d8bcb6">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (benefit) provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNy0xLTEtMS0w_7ff374be-7c80-4505-986e-6116d8a681a9">87</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNy0zLTEtMS0w_4d274e00-05a3-49d2-8eb6-4126297a231c">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfOC0xLTEtMS0w_243ebcbe-82ef-436a-a028-47d5674bb732">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfOC0zLTEtMS0w_cf3a4314-5fea-469f-8905-241f8111e3fc">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposition of joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="dgx:GainLossOnDispositionOfJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTAtMS0xLTEtMA_2736c910-9f0e-4cb2-8044-d6108738d63f">314</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="dgx:GainLossOnDispositionOfJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTAtMy0xLTEtMA_5bf9cbb5-10d2-40a5-87a9-1c22b63df89b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTEtMS0xLTEtMA_a0d1376f-c06d-496e-a5f3-6633086a89ee">48</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTEtMy0xLTEtMA_07d31dc9-1f1e-4e99-a9b7-8927ba74232a">60</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTMtMS0xLTEtMA_a8308d2b-85d1-4d67-b58d-91c73f8dd979">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTMtMy0xLTEtMA_d45ffb61-fa90-4241-909e-238ca337f517">355</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTQtMS0xLTEtMA_61b8fd3c-ad43-4d3b-a9a4-718012abd331">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTQtMy0xLTEtMA_f5eed82c-3acc-41cd-90a4-bf485318bd72">514</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTUtMS0xLTEtMA_ad829ce1-f3aa-4ab3-8549-c40265fafb33">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTUtMy0xLTEtMA_2a9ac30f-022e-40a9-b1ca-779c09637c89">95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination of interest rate swap agreements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="dgx:TerminationOfInterestRateSwapAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTYtMS0xLTEtMA_742c2a7f-c140-44b8-a7f8-26a0a6e034a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="dgx:TerminationOfInterestRateSwapAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTYtMy0xLTEtMA_185c1a4f-7638-414f-a372-c1fce7093cd2">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTctMS0xLTEtMA_abebe853-bc13-4071-ae3e-b5d8a277a674">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTctMy0xLTEtMA_bd3d0142-422e-45cf-83a6-c55911060928">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTgtMS0xLTEtMA_f9c8a371-4502-464d-8e72-84834139a5ee">1,752</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTgtMy0xLTEtMA_115cd2d3-958f-4506-b8fe-b9e7b6cafde2">1,464</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjEtMS0xLTEtMA_77a62b9d-7ff8-4177-a13c-876d70f1ab81">251</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjEtMy0xLTEtMA_962f0425-4caa-4a20-b318-eb9ef208c349">329</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjQtMS0xLTEtMA_61844536-aece-4442-bbd1-09d8c84061b0">259</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjQtMy0xLTEtMA_d2ee482b-a73d-4138-8c56-85db5fed5c79">256</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from disposition of joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjYtMS0xLTEtMA_10e69b57-4e99-4562-ac80-eb680bb7b41c">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjYtMy0xLTEtMA_35bfb8b5-30f5-487c-9480-0c3fd6bf12d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in investments and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjctMS0xLTEtMA_eed4d28d-8024-4f81-a0c8-bf37b094a42c">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjctMy0xLTEtMA_92ce98a6-6c74-490e-8605-27b404f0cc87">19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjgtMS0xLTEtMA_e1104aca-a6a2-4b6a-8b17-4e63d3d8ea4a">248</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjgtMy0xLTEtMA_56637a5b-0345-41cc-bae0-beca06b1d15f">604</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzEtMS0xLTEtMA_5c9766c8-8881-4c8e-9693-e1e126b2375b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzEtMy0xLTEtMA_0b2e5022-d0e9-4993-b350-551fc57153f3">749</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzItMS0xLTEtMA_f4ca9201-48b1-420c-b09e-b598233c7526">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzItMy0xLTEtMA_497d2d0c-5c6a-4d37-b366-a0c32a52962f">1,002</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzMtMS0xLTEtMA_318f0e19-bb65-4bfa-a1c0-65b938a798f1">1,910</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzMtMy0xLTEtMA_38682c16-ecdc-4e8b-afea-6a4c06c33606">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzQtMS0xLTEtMA_04ddf071-d61c-44e9-96ce-1a18a17176f5">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzQtMy0xLTEtMA_80157ed7-8c6a-4804-8075-693b69348cb7">144</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzUtMS0xLTEtMA_f0a63ccb-f180-4b14-90d2-733d2304b8c3">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzUtMy0xLTEtMA_079d0ddb-2d82-4e73-ae4f-7fd9a2ee27a5">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzYtMS0xLTEtMA_5c8c362c-81a2-4caa-8dca-c184a4fd22d4">232</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzYtMy0xLTEtMA_54a28bcd-ee65-4ad5-be5d-ab39fe495c53">222</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzctMS0xLTEtMA_315dbfcf-c3d1-4222-a856-efde05eff9a3">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzctMy0xLTEtMA_3d5e7a6b-ceab-4950-8958-3ca5519e6119">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDAtMS0xLTEtMA_97425a00-ef54-4282-9c09-8d40a385af20">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDAtMy0xLTEtMA_df7dd2ad-93ae-4c31-bb7c-2f65952dd0e4">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDEtMS0xLTEtMA_18f3a5a7-9d49-4302-a71f-c90e00fb7b0c">2,171</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDEtMy0xLTEtMA_029c87f1-6480-4c79-8bb5-83288e14b0dd">447</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDMtMS0xLTEtMA_95aa486f-3634-474e-922e-447c0317a1cd">171</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDMtMy0xLTEtMA_89cad99b-c55f-486c-b08b-c1ec96451113">413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDUtMS0xLTEtMA_aee7ce01-3a7b-4516-9d34-20163b48dbca">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44797d3e9c614839926a9c2f3bb5be17_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDUtMy0xLTEtMA_5e185880-f443-4bef-a3b6-21adadb2db42">1,192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDYtMS0xLTEtMA_50af33cc-c818-4d70-9da7-34c29d75c955">987</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f627c3af5db4299b234650d220eee56_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDYtMy0xLTEtMA_fc76e28a-0d71-402e-9c1b-b73eb0591dd7">1,605</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2e684a75e28400dbbfc768d86f47ec7_I20210630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xLTEtMS0w_afcdc8dc-af3d-4448-820b-3323a2fa8746">122</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e684a75e28400dbbfc768d86f47ec7_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0zLTEtMS0w_86f91302-963d-4de0-9bbd-42ce82d513e5">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69f34e8c6f742d4a439c6a90e6dbb84_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi01LTEtMS0w_22940d76-d044-4639-8d10-16562b063650">2,555</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60818a25d0774d728fc8875bec533fcb_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi03LTEtMS0w_93537086-cfc0-4201-8948-99312ada67c3">10,246</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30536b78fd3e41639c5a631d6df42e38_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi05LTEtMS0w_fff974d3-50c4-4be1-a90b-8dea2f8631f1">10</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c26a3bcfeb74909a10ba5fbcc6ec947_I20210630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xMS0xLTEtMA_3616b30f-405f-4f12-b9c5-280e9947a16a">6,894</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf447d1f13b744eca3e676fb375b1f08_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xMy0xLTEtMA_f66b514e-78d2-4dbc-aa13-c0a00ad406ee">41</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9436c528694ee1ac54e6f8ce941854_I20210630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xNS0xLTEtMA_dd84c7b4-8b2d-4b8c-b3b2-136d4deb0744">5,940</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9436c528694ee1ac54e6f8ce941854_I20210630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xOC0xLTEtMA_a064ce5e-7461-4028-9d10-51dc1785a354">78</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bcf39ba3ca3490ba9b723f846d97a93_D20210701-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMy03LTEtMS0w_fef78ba1-7c56-4c57-9162-85eb152f9ce2">505</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d322c01404548d7bc8bcc50e7fc7e90_D20210701-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMy0xMy0xLTEtMA_afdb15b1-b69f-4c6b-8fca-c74a0aa95d7f">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMy0xNS0xLTEtMA_76625519-af6a-4ac3-941b-7d2946fc9a0e">524</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMy0xOC0xLTEtMA_c10360e2-8ec9-4942-a8c7-245d5962bebe">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6b3aa2d9a704d3890aa1d3b20c761cd_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNC05LTEtMS0w_0b83e23f-66d3-40be-9e61-f5251c4bd8dc">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNC0xNS0xLTEtMA_90bca51d-edf3-4b21-b151-adfaecfdacf0">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bcf39ba3ca3490ba9b723f846d97a93_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNS03LTEtMS0w_5a858b1a-0149-479b-a136-a8fafefaf8da">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNS0xNS0xLTEtMA_bd7a5783-4ccb-4193-8b38-1424a3c7b892">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d322c01404548d7bc8bcc50e7fc7e90_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNi0xMy0xLTEtMA_faa8245c-07f7-41d0-8278-ae3d9dede66b">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNi0xNS0xLTEtMA_0ee157e0-37ab-4280-aafb-dc51bd58974a">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNi0xOC0xLTEtMA_82d26123-79c1-4bcc-80db-16f76a7c6b00">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNy01LTEtMS0w_f30cf2fa-e921-4f4d-9171-1eee79f67eb6">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a8b1a97ea54a2cb0efda370034cf33_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNy0xMS0xLTEtMA_a1416fda-0dd8-4113-9fb6-4afdabc730fe">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNy0xNS0xLTEtMA_23ff2d8d-dccf-4a9a-9b87-33614d4e79d6">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOC01LTEtMS0w_10ab8cf8-dfd0-4dab-9a8f-8b2d50f406b3">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOC0xNS0xLTEtMA_2915577a-fc26-43fb-8dee-3b9549a6ab81">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c9526dd81d14acbb165fbdb21bc7d5b_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOS0xLTEtMS0w_8b55fe96-afed-4ace-b58e-a98bfc535b84">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOS01LTEtMS0w_452a7674-4113-4e2a-bd32-9fa116aae06b">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a8b1a97ea54a2cb0efda370034cf33_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOS0xMS0xLTEtMA_884d961d-07d7-4586-b04e-5ef98522fe69">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOS0xNS0xLTEtMA_24efd35d-8a66-4890-b995-4510e7bf7352">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItNS0xLTEtMTc4NTM_9f35ce41-e2bb-45ef-bfef-7604b5e0afcd">649</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bcf39ba3ca3490ba9b723f846d97a93_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItNy0xLTEtMTc4NjE_4280cce2-82c7-48f6-8a43-22f16152b797">3,342</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a8b1a97ea54a2cb0efda370034cf33_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTEtMS0xLTE3ODcx_e80e671f-30fa-4208-8267-c9e37191a466">3,991</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTUtMS0xLTE4ODc1_4be7a5e2-2fdb-47bb-b8c8-e3f2de5cc0d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, September 30, 2021</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5469e4b199e4f6bba9dd760df124408_I20210930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMS0xLTEtMA_5aea562e-0ed8-4cde-af10-b754f3b6273e">123</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5469e4b199e4f6bba9dd760df124408_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMy0xLTEtMA_4d3d27e8-cd0c-4093-8c00-181dfa60a4b2">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1082d06815c4d1cbcdd4183ef7a7054_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItNS0xLTEtMA_8358e4fb-0811-4396-8276-259adf9e7ad9">1,936</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90a31327e6d4444faef566d46a5e0076_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItNy0xLTEtMA_5e68d7f6-5f4b-473a-b20c-584ef30129d5">7,333</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b159649f77f410ebe5d069195864be4_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItOS0xLTEtMA_34ce62a8-eb83-45fc-a2c2-e112e39322b3">13</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39fbe907b9a04ba88fd377e9c3ee0c5b_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTEtMS0xLTA_aec4192c-a8ca-4cd8-ab5f-15bd3ea7b085">2,866</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de9bd88816b4b76a24f2e5e45391d53_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTMtMS0xLTA_bb17749c-603d-42fa-9033-470ec821c2fc">40</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTUtMS0xLTA_355968c5-2935-4292-8e42-86e168740359">6,432</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTgtMS0xLTA_be2a915d-858f-448b-bb0d-7a018ac54f62">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7a7da46099a44378da1a233e2933299_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMS0xLTEtMA_3ff940a4-c10b-42ea-9f11-ecf491464a39">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a7da46099a44378da1a233e2933299_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMy0xLTEtMA_1b2aea89-141f-4bc2-bc11-1335d09185cf">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bc8004207f6457d8e91cab661dc9d7d_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtNS0xLTEtMA_c64f6da2-8011-4276-9bce-cefbe5892090">2,841</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530936cdd95443c38a6ee1dac2f95b5d_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtNy0xLTEtMA_4701ccd2-d361-407d-aef6-8078b0ba16fe">9,303</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd797ff06d5347448e67d12d0a112a21_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtOS0xLTEtMA_e4221de0-028b-4601-91b6-f285582ec5ea">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28ba8ee8faa74b07aa6d9f1fe6d24c42_I20201231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMTEtMS0xLTA_d7dd27f2-da6f-411f-9479-91eb3ad200ea">5,366</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6efac86a7154479b5393be974cf5b8e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMTMtMS0xLTA_88b0187b-3b87-4193-96bf-c6ed8276da53">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMTUtMS0xLTA_31851f9d-70da-4e0e-b6f0-63f227b7c42a">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMTgtMS0xLTA_67027ecc-9733-49ae-8944-2187d67ea57f">82</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ebeea55bd143e7a34428dfb1cb8d7b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTctNy0xLTEtMA_d994aa2e-39a6-4907-a9cd-f68c87af2db1">1,605</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i462380c5fb3941a2be00f2507dfe4337_D20210101-20210930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTctMTMtMS0xLTA_1aa1eac0-5b3f-473c-80e6-fedcf09a41cb">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTctMTUtMS0xLTA_c5457694-ca1b-44c6-b61d-b94a235cdf5d">1,658</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTctMTgtMS0xLTA_f33e949b-c3cf-4f16-8ece-87bfe220852c">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be3cd77042747cfacd90361f64c7ca8_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTgtOS0xLTEtMA_c02fe4ec-d87e-4166-82ec-1035058dd01e">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTgtMTUtMS0xLTA_57dcd666-edd3-4f8e-b2db-48ed67ac9fd8">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ebeea55bd143e7a34428dfb1cb8d7b_D20210101-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTktNy0xLTEtMA_8ff157de-57e5-4feb-be6a-f00e9046bad0">233</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTktMTUtMS0xLTA_f8cc488f-4a10-4cb7-840f-a29b0720f0c6">233</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i462380c5fb3941a2be00f2507dfe4337_D20210101-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjAtMTMtMS0xLTA_f294cbaa-fff7-401b-91f4-a92c68ca2c6f">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjAtMTUtMS0xLTA_d196f931-a724-4106-9809-9a43b23ba42f">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjAtMTgtMS0xLTA_f1e6b4e5-51ab-4750-81f4-31232903f930">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjEtNS0xLTEtMA_c2aa8b61-d64e-491e-a67e-ccd1db1ab0da">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjEtMTEtMS0xLTA_50f9d7f2-6c4e-480f-bea2-c11266615985">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjEtMTUtMS0xLTA_fd8f99ea-b9e6-4775-9a9f-3b1614539744">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjItNS0xLTEtMA_047fa0ca-bf69-420d-bb73-062a79d9f877">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjItMTUtMS0xLTA_9ca25cd1-967b-410b-8b04-6785fbb3e5b7">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf43e9ec0f474249909c8e64ca28aa9e_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjMtMS0xLTEtMA_a0172a9a-659c-4ebf-92a7-79cb723954ef">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjMtNS0xLTEtMA_585d6e96-adce-40a8-bbef-c4cf4ac48a3e">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjMtMTEtMS0xLTA_32d319f0-2434-4c31-acdc-ad26f906a3e4">89</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjMtMTUtMS0xLTA_d8da1769-847e-45ae-b832-6b61c4b5b89b">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjQtNS0xLTEtMA_a59a944e-6187-4538-94bb-05ff58dacd32">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjQtMTEtMS0xLTA_62f5a387-dd5f-47ba-bd0b-dba3126ce97d">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjQtMTUtMS0xLTA_223c06b7-6ddd-4939-b66c-231cbc245430">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idf43e9ec0f474249909c8e64ca28aa9e_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjUtMS0xLTEtMA_5c0b1dcc-ae53-455a-872e-01d331504414">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjUtNS0xLTEtMA_4aea671e-8ea8-4906-8d9b-7c7b9b7208cf">300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjUtMTEtMS0xLTA_20dc3b1b-a076-431b-9e23-aa93d6ed0c11">1,610</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjUtMTUtMS0xLTA_39579d33-dd5a-4b54-b44b-dc491af667a2">1,910</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930" decimals="-6" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjctNS0xLTEtMTc4Nzg_fe83390e-8918-4248-b32a-7aa10a360be9">649</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ebeea55bd143e7a34428dfb1cb8d7b_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjctNy0xLTEtMTc4OTI_03771cfa-d111-4027-a9ba-b721e045fab7">3,342</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjctMTEtMS0xLTE3ODk5_9f45baa9-7a95-4abc-a538-bcfc0ca8d748">3,991</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjctMTUtMS0xLTE5MjEw_ed51dd76-2a2a-446a-b11b-fac1b757b95a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, September 30, 2021</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5469e4b199e4f6bba9dd760df124408_I20210930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMS0xLTEtMA_82081f4d-38d7-4a83-bc58-ab1d119528fb">123</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5469e4b199e4f6bba9dd760df124408_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMy0xLTEtMA_adb17ec2-4cf1-4a72-8893-557f47021d74">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1082d06815c4d1cbcdd4183ef7a7054_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtNS0xLTEtMA_003c9ad4-6b43-48bc-be72-8ee3e849fbce">1,936</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90a31327e6d4444faef566d46a5e0076_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtNy0xLTEtMA_d7781159-a09b-4637-ad8d-78cf49b58b8f">7,333</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b159649f77f410ebe5d069195864be4_I20210930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtOS0xLTEtMA_717b4cb0-f953-47d5-9024-3ab96480cd48">13</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39fbe907b9a04ba88fd377e9c3ee0c5b_I20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMTEtMS0xLTA_7a01a6f1-ed11-4531-8b90-d6dfe58cc4df">2,866</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2de9bd88816b4b76a24f2e5e45391d53_I20210930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMTMtMS0xLTA_2ca0374c-de42-42e3-99b6-d0842b15bd24">40</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMTUtMS0xLTA_153efc08-aee4-45b6-b19e-5c36ac53b627">6,432</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMTgtMS0xLTA_b03eeffa-1d6c-4262-b190-bda113191f0b">79</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.025%"><tr><td style="width:1.0%"></td><td style="width:28.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER&#160;30, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e728b108435425ca56aae502185c623_I20200630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xLTEtMS0w_9b9981de-7c16-4b75-ae68-23c7514ef877">134</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e728b108435425ca56aae502185c623_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0zLTEtMS0w_0b5b3536-a3f8-4fdc-99b1-33f8a73ecb91">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44095c144c7847d1864cff543b26d594_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi01LTEtMS0w_c9a90890-bf8b-4e46-a91c-4dd0f6e06925">2,764</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb2c2ba8e2984a5ebf8b1e80612267d0_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi03LTEtMS0w_15a2b2d9-898f-41ab-9017-8accb53b62d7">8,307</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2877089917b44598af747bd1c932cea2_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi05LTEtMS0w_e0be0a7c-20b2-444f-b761-3d02daeb7551">55</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaec86bf908d1470cb320f0f36f8501f6_I20200630" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xMS0xLTEtMA_bc24966d-adad-4833-83ef-705c6d96b089">5,187</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5469af2e4e646ff9485e5ea6fe72b27_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xMy0xLTEtMA_17e1df40-2e52-4bf2-b2be-00701ef9892f">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4291d6d468a544eda0577ac487a2c725_I20200630" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xNS0xLTEtMA_b654d2f9-1adb-487d-90a4-9b3b28d698a6">5,881</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4291d6d468a544eda0577ac487a2c725_I20200630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xOC0xLTEtMA_6850ffc7-4185-4ee9-8d50-be2d8a455880">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a95a06eb0f94af39dece3892ff96d29_D20200701-20200930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMy03LTEtMS0w_56dd2aed-dbcd-4946-a2d6-3c0a3c9aac4f">568</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2db14ecc4974269854d7acb2c998846_D20200701-20200930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMy0xMy0xLTEtMA_2e5ed972-b5f4-47e7-94af-83f7ab0cf575">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMy0xNS0xLTEtMA_514da99a-9713-4bbe-bfa9-0528a7c70356">586</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMy0xOC0xLTEtMA_1da50d86-d6ed-406a-b3ce-751fe5dfff94">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eb4acc4683141d68c6b2262176ea057_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNC05LTEtMS0w_c6ed9364-7823-4357-91f2-78870bff2039">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNC0xNS0xLTEtMA_9efc9ae1-f1ee-4811-8f46-6bf8894da7ee">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a95a06eb0f94af39dece3892ff96d29_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNS03LTEtMS0w_0beabbc5-116a-47dc-b541-d6b4d723c34c">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNS0xNS0xLTEtMA_a5a77923-7649-44c9-b9ca-d29fcf2cfa8a">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2db14ecc4974269854d7acb2c998846_D20200701-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNi0xMy0xLTEtMA_c428f93e-7cf1-43ea-85a2-3b0debeb657d">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNi0xNS0xLTEtMA_07436d6b-0bd8-411a-b65b-381da4560d61">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNi0xOC0xLTEtMTY4_804bbc71-dade-40a7-8029-d41e0386c3be">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i496e5c6bce0145338271871a4b19a534_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNy0xLTEtMS0zNQ_895e2d04-36ea-4e60-8507-1f786804e32c">1</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7076b530f6444a947bc2cada186634_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNy01LTEtMS0w_a554311b-4ad5-4292-9c44-0d3f6dad6746">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c4d3b899b3a4c27920b9a7a1c4341f5_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNy0xMS0xLTEtMA_93d38f18-bd93-4b9e-81ee-7fb3641f4c6b">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNy0xNS0xLTEtMA_7e2feb9b-4c50-4eef-a6d1-12b47edbd114">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7076b530f6444a947bc2cada186634_D20200701-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOC01LTEtMS0w_9307926d-2b04-4c45-8b38-a05c927af537">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOC0xNS0xLTEtMA_68a80ff3-513e-4f3d-a714-a477b4d76eac">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7076b530f6444a947bc2cada186634_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOS01LTEtMS0w_855d7f37-f8e9-4fa0-aad8-27faa67fe5b6">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c4d3b899b3a4c27920b9a7a1c4341f5_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOS0xMS0xLTEtMA_fe78a69a-b6c2-4715-bbc8-b34f3578e813">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOS0xNS0xLTEtMA_485949c5-6049-4682-a456-43d3d6e253db">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMS0xLTEtMA_bc8e4fc6-3943-4e7e-94d8-47eeb963835a">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMy0xLTEtMA_0411ad32-de84-45da-9f01-ec5520fc6f55">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854a56aad60640659955246cba8db3d1_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItNS0xLTEtMA_6eb0d2aa-2f5b-4030-8a3d-c5f381cccdfd">2,801</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ead955e97d24ea98107e5fdafbb5933_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItNy0xLTEtMA_490fc248-a808-4855-9bef-53d57ddd2db4">8,800</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26471b06607740b18133552b7813a289_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItOS0xLTEtMA_fb8176dd-668a-4cce-a4c3-9aa6246d6d2b">42</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81dfabce71384a93b5d745045e2c2b24_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMTEtMS0xLTA_c90fc230-54ea-4cd5-a3b9-dfd05c06c190">5,161</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1284835d8c794866b627a0391c20a3d7_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMTMtMS0xLTA_480ef4d0-d927-47ad-a409-81559def530a">46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f627c3af5db4299b234650d220eee56_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMTUtMS0xLTA_a6fa5e93-edb3-4d5e-8d2b-d451b1e66f5d">6,446</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f627c3af5db4299b234650d220eee56_I20200930" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMTgtMS0xLTA_5d9c902f-46ce-4da1-bc3c-ebb7f4d96270">80</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Nine Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2e7ae5dc9104f20a5ce0b4a9350ec65_I20191231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMS0xLTEtMA_7b5cf981-4f61-4614-918f-15ef78157e6b">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e7ae5dc9104f20a5ce0b4a9350ec65_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMy0xLTEtMA_b8142176-1283-412c-ad62-ba94ccbbc18a">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied656b411f5c494fa95a8a47cdf2ea4b_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtNS0xLTEtMA_6b07717f-3ba5-40aa-8b71-623d3d8e2d8a">2,722</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87c9e74f17947c78a11adfcb138af02_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtNy0xLTEtMA_7cac4ded-d195-431c-b415-5a49cc96c411">8,174</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib217db8b923647049bb39b949b84c79e_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtOS0xLTEtMA_c54aff99-46b5-4d8a-b8ba-93374db93e23">39</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if16bcecb1e6d4dd9afec8d10d7899999_I20191231" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMTEtMS0xLTA_7860a44d-1acb-4691-913e-9bc7cb9dc1c5">5,218</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a5de19f2d549a9a4351e241b197e97_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMTMtMS0xLTA_e5b462be-01a5-4cd6-a933-f5c805924ccd">46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44797d3e9c614839926a9c2f3bb5be17_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMTUtMS0xLTA_ca19b8e0-15fa-4944-a9a0-1494a83a246e">5,687</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44797d3e9c614839926a9c2f3bb5be17_I20191231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMTgtMS0xLTA_43da6386-0beb-428a-a5ea-426ebc86e93a">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb4bcbff08f44cdbccc42febe3b29cb_D20200101-20200930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTctNy0xLTEtMA_3fd04836-232d-4cca-a6dd-efede4b567f0">852</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4c9dc3e1504cc5ad275c05e942afdc_D20200101-20200930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTctMTMtMS0xLTA_0334269c-77e9-4960-992e-80c06dfb9938">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTctMTUtMS0xLTA_9ace39c6-f9de-437b-8594-8c10c4aee390">883</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTctMTgtMS0xLTA_1ec59446-5421-4a10-a3ef-65523ffb66fa">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib05a9b6900b545f2b5c4580d8153e641_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTgtOS0xLTEtMA_c0f5bec9-085b-4431-83a2-90308eda3f82">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTgtMTUtMS0xLTA_8333bc2b-24d3-4ac8-a9ef-efd45e80c8e3">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cb4bcbff08f44cdbccc42febe3b29cb_D20200101-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTktNy0xLTEtMA_35e9c0b4-2078-4088-b730-3ab50c4e8fb7">226</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTktMTUtMS0xLTA_5d75c0f9-726a-4477-88c5-f5086f8c89fa">226</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b4c9dc3e1504cc5ad275c05e942afdc_D20200101-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjAtMTMtMS0xLTA_e0b6bef6-4b64-4a61-b3b2-b3e608f5c11a">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjAtMTUtMS0xLTA_9b219d34-3105-41de-9234-7d1a61bc797a">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjAtMTgtMS0xLTA_d2e80422-d201-42b2-9f0d-fd1cb4c092e0">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib54bc123a8304d1b95560ab37cf81299_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjEtMS0xLTEtNDQ_3f2ecc6d-3144-4f38-a723-78d90fc1a01d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjEtNS0xLTEtMA_928781dd-d183-4762-8b4b-0689d72ce6bc">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjEtMTEtMS0xLTA_c47d7b6f-3eb4-4fdb-951f-4f99d0ed0c44">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjEtMTUtMS0xLTA_712929a0-fc11-482f-a674-38d2664c9b2a">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjItNS0xLTEtMA_8bccec9e-6df9-48aa-acdd-acf95f9e9979">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjItMTUtMS0xLTA_a862f0e4-a107-44e8-83db-b93a5eec7995">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib54bc123a8304d1b95560ab37cf81299_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjMtMS0xLTEtMA_1024e6b3-2982-4746-bccc-5b69f22131d5">2</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjMtNS0xLTEtMA_9613efee-446c-4e14-b054-44dde5d173d7">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjMtMTEtMS0xLTA_b85c10d5-db30-4c05-8e2b-096ac3a531fa">122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjMtMTUtMS0xLTA_887b34e2-0458-41f5-a318-924e8af552db">144</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjQtNS0xLTEtMA_c058a074-70ae-44a4-8f9b-276d95eeafe0">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjQtMTUtMS0xLTA_b1f4d14f-93d9-4c78-beec-498b8fc06ddd">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib54bc123a8304d1b95560ab37cf81299_D20200101-20200930" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjUtMS0xLTEtMA_f7a8e67c-4010-41ca-acf8-73792d457385">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjUtMTEtMS0xLTA_4b9b2203-5d5e-4f0e-9b09-3cdb50d85113">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjUtMTUtMS0xLTA_8a424df9-0dde-4100-9c20-f7719a5040b4">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, September 30, 2020</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMS0xLTEtMA_0d98cda8-cf9d-40a6-a23c-5cd3e3269dc0">135</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMy0xLTEtMA_c89e05c1-fb37-421d-a954-2eaf1ece6423">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854a56aad60640659955246cba8db3d1_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtNS0xLTEtMA_9d63af52-a0b5-4ea8-8e92-fad68fdfc388">2,801</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ead955e97d24ea98107e5fdafbb5933_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtNy0xLTEtMA_11dc6ee7-e76b-4d66-98d5-1ba08de85620">8,800</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26471b06607740b18133552b7813a289_I20200930" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtOS0xLTEtMA_f3ea3331-cbdb-4aa7-9b0a-1bfef5f44e3d">42</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81dfabce71384a93b5d745045e2c2b24_I20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMTEtMS0xLTA_1e3f594b-77d8-43d3-9990-b3e4d8f9c2c2">5,161</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1284835d8c794866b627a0391c20a3d7_I20200930" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMTMtMS0xLTA_f08f1013-741f-412e-aef4-a13bf42a88f4">46</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f627c3af5db4299b234650d220eee56_I20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMTUtMS0xLTA_9f65edc7-4906-463d-9ae9-a5598ffb25f1">6,446</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f627c3af5db4299b234650d220eee56_I20200930" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMTgtMS0xLTA_5e8dfc81-026e-47f3-96f6-c26b4483645f">80</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_28"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zMS9mcmFnOmJkZTUwZjVmNTBiYTQ1Zjc4ZmNkYTRjMmJlMjc2NmQ1L3RleHRyZWdpb246YmRlNTBmNWY1MGJhNDVmNzhmY2RhNGMyYmUyNzY2ZDVfMTcwMg_1b36d651-e371-444d-aa36-6ce57311350d" continuedAt="i8a940940055d4c6e893dd1c64a7a1701" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i8a940940055d4c6e893dd1c64a7a1701" continuedAt="i756fbd787cf243bd9e84e1121226055d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i756fbd787cf243bd9e84e1121226055d">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</ix:continuation>  </span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDMzNg_2199a326-0c8a-46d2-b018-7630b0b88b7a" continuedAt="iab02b2f26b0a469cb0b712174133a9ed" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div style="text-indent:29.25pt"><span><br/></span></div><ix:continuation id="iab02b2f26b0a469cb0b712174133a9ed" continuedAt="i221918ff7a9f4e80adbecf719e2300e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDMzOQ_d468e629-1795-4706-ba8e-654ddafd81e4" escape="true">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#8220;COVID-19&#8221;) continues to impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three and nine months ended September&#160;30, 2021 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDMzMw_6976fb9d-2721-43e6-924f-b4981910a8fa" escape="true">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDM0Mg_ce588c24-1b9a-47c7-ba9e-a4a04afdc8cb" continuedAt="ieb288e260b8d4a32b0e6eb23b3381100" escape="true">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i221918ff7a9f4e80adbecf719e2300e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieb288e260b8d4a32b0e6eb23b3381100">common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDM1Mg_d55da54e-9f05-4e51-8243-391e72551562" escape="true">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RleHRyZWdpb246MTM5OTg5ZjVkNzQyNDZlN2I1ZjRiOThkY2U3N2E4YjJfODgx_8fda14fb-b74c-491a-bc08-4e2881e80732" continuedAt="ifee1ef08f4524b1986406191718f7e38" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifee1ef08f4524b1986406191718f7e38" continuedAt="i1eaae87302f848dc91782558d56fb065"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RleHRyZWdpb246MTM5OTg5ZjVkNzQyNDZlN2I1ZjRiOThkY2U3N2E4YjJfODcz_acb2c679-f950-4bd9-9832-20b0d1625378" continuedAt="i96f8c48f603a44b2a806a9289f3a42db" escape="true">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i96f8c48f603a44b2a806a9289f3a42db"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfNy0xLTEtMS0w_b7244234-2ab1-49b4-b667-09528b61a1e9">505</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfNy0zLTEtMS0w_d0e39749-ee47-4d95-86f0-d789c6281a85">568</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfNy01LTEtMS0w_adbd9bd0-2464-4be0-8dbf-3d2ac7eae949">1,605</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfNy03LTEtMS0w_5a75b1b5-54db-4569-9668-64e2ee588e86">852</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOC0xLTEtMS0w_4d9a7aba-dc39-4198-9ac4-81db188841ad">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOC0zLTEtMS0w_011a3913-347d-4fad-a9d4-8be3448a80eb">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOC01LTEtMS0w_19af6867-2fae-4e54-8124-4475cfcaffea">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOC03LTEtMS0w_63a2aba2-d666-42d6-a2f5-91621c7770a7">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOS0xLTEtMS0w_cd95f6ce-9ef9-4377-bda4-660ecd6dc0a9">503</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOS0zLTEtMS0w_19daa1c3-951d-4249-bc9f-ea2dcbda8b5c">566</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOS01LTEtMS0w_c921dbae-2d44-4624-9bf3-260520da5dd8">1,599</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOS03LTEtMS0w_01030027-9ee4-4723-9a08-4455e4e07b8b">849</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTEtMS0xLTEtMA_b2f3161d-9f21-41c8-8dd3-0abf0eb00ab9">123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTEtMy0xLTEtMA_fd15d5ad-d272-46bc-ab9a-aaf5578fee1e">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTEtNS0xLTEtMA_5d08dc81-58c6-45dc-9772-7cdbdfef14d0">127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTEtNy0xLTEtMA_c697f6a5-e0dd-45a1-872b-b3d62bd74c69">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTMtMS0xLTEtMA_1be65da8-ac5b-419b-9cf3-a3f824480f81">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTMtMy0xLTEtMA_9aa90059-23bb-4ddc-a1a4-f29a8e2f4ae9">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTMtNS0xLTEtMA_cc7df161-9a3b-49bf-8884-2319f01b2cd7">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTMtNy0xLTEtMA_30f80c51-922f-45a3-aab6-f47aa6216255">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTQtMS0xLTEtMA_6db951db-f7d0-477d-ac49-0d12bd87d4b1">125</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTQtMy0xLTEtMA_931f7e2e-9deb-4741-86cd-3d3d6c8f5ad5">137</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTQtNS0xLTEtMA_5505b0f7-fb2a-4a9e-89df-121e14865a65">129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTQtNy0xLTEtMA_c3d97b24-605f-41fa-aaa9-e74527e58e90">136</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTctMS0xLTEtMA_f9bf49f4-6879-4909-b377-eceff3ecbe2c">4.11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTctMy0xLTEtMA_e6375ddc-d352-456f-a32b-dccc183be50a">4.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTctNS0xLTEtMA_c1b9a385-e2c2-41eb-9b10-faa1858e448d">12.63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTctNy0xLTEtMA_d24b1cec-ca69-405e-9c77-158b9de2e9c5">6.33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMjItMS0xLTEtMA_0d6896e9-4b4c-4496-8565-c4dc90f5b212">4.02</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMjItMy0xLTEtMA_4f2ace29-f8b5-478a-be32-31fe87882795">4.14</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMjItNS0xLTEtMA_981ffd2a-ca14-4f22-8b65-bf07379ebd73">12.41</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMjItNy0xLTEtMA_c24d52b4-93b2-48dc-9224-fb0e34e1cab8">6.25</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RleHRyZWdpb246MTM5OTg5ZjVkNzQyNDZlN2I1ZjRiOThkY2U3N2E4YjJfODcx_d4ef4108-4a3f-4226-9d8c-ea6b064eac00" continuedAt="ic95f1a99548540c58f3b0ccd3468c37c" escape="true">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ic95f1a99548540c58f3b0ccd3468c37c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOmY5ZDM2NzNiNGJlOTQ4YzU4YmY4OGM0NWIzZjdiODNhL3RhYmxlcmFuZ2U6ZjlkMzY3M2I0YmU5NDhjNThiZjg4YzQ1YjNmN2I4M2FfMi0xLTEtMS0w_4076991c-f703-492a-a2a4-8690d5020691">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOmY5ZDM2NzNiNGJlOTQ4YzU4YmY4OGM0NWIzZjdiODNhL3RhYmxlcmFuZ2U6ZjlkMzY3M2I0YmU5NDhjNThiZjg4YzQ1YjNmN2I4M2FfMi0zLTEtMS0w_af0f0b1b-7518-4775-8a8d-1e89137f30aa">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOmY5ZDM2NzNiNGJlOTQ4YzU4YmY4OGM0NWIzZjdiODNhL3RhYmxlcmFuZ2U6ZjlkMzY3M2I0YmU5NDhjNThiZjg4YzQ1YjNmN2I4M2FfMi01LTEtMS0w_579df7f1-9c45-4d14-8e95-919151840d04">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOmY5ZDM2NzNiNGJlOTQ4YzU4YmY4OGM0NWIzZjdiODNhL3RhYmxlcmFuZ2U6ZjlkMzY3M2I0YmU5NDhjNThiZjg4YzQ1YjNmN2I4M2FfMi03LTEtMS0w_6e47869a-09a3-47e5-9ebb-2cbf820ea518">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i1eaae87302f848dc91782558d56fb065"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $<ix:nonFraction unitRef="usd" contextRef="i7a3f89fd967647879e6f70cc4eced07a_D20210401-20210430" decimals="-8" format="ixt:num-dot-decimal" name="dgx:AcceleratedShareRepurchasesInitialPricePaid" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RleHRyZWdpb246MTM5OTg5ZjVkNzQyNDZlN2I1ZjRiOThkY2U3N2E4YjJfMzc2_add968ec-a6e8-45dd-aabe-2bec1338bc7e">1.5</ix:nonFraction>&#160;billion of the Company's common stock as part of the Company's share repurchase program.  See Note 9 for further details.  The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first three quarters of 2021 did not equal the total for the nine months ended September 30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of the ASRs.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfMTYxNg_8e02efae-9a65-4f6e-aad4-10bbb7430ae5" continuedAt="if07cb67a3dc54cc7bec15d96d7275a40" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if07cb67a3dc54cc7bec15d96d7275a40" continuedAt="i8629905f7ec24b2c85303e99c9ff20a8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i5cc6b1efe84f4f65907f66036143af31_D20210601-20210601" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfMjYx_895f715c-cbfd-43a5-8d97-d75580f8b7f8">225</ix:nonFraction>&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $<ix:nonFraction unitRef="usd" contextRef="i666d9c35a6194943a43fbcf1f9c9b1df_I20210601" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfNDU1_acf2a0de-d460-41d2-8939-8bbaff29d884">54</ix:nonFraction>&#160;million of customer-related intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i53b9c62c8412401893a2366a618ab917_I20210601" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfNTAw_705ac188-c9c8-41da-a427-e6966ad2e8c0"><ix:nonFraction unitRef="usd" contextRef="i53b9c62c8412401893a2366a618ab917_I20210601" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfNTAw_d09771df-c035-430f-94fd-d74b84ab9a8b">171</ix:nonFraction></ix:nonFraction>&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of <ix:nonNumeric contextRef="iafd5f573146f490584b2d02d1a275200_D20210601-20210601" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfNTk2_7d59ace5-9a29-4ec0-8ba6-14a25cdbfe49">15</ix:nonNumeric> years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8629905f7ec24b2c85303e99c9ff20a8">&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfMTMyMA_5c159baa-253b-4f12-bd20-cd711d228186" continuedAt="ie1dcb9843b0b41419c973c3187890282" escape="true">DISPOSITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie1dcb9843b0b41419c973c3187890282"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its <ix:nonFraction unitRef="number" contextRef="i246ee08978dd4f9281e49cde4052adb5_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfNjE_d45f96b1-535d-4ddb-8dc8-bbff0c77336d">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $<ix:nonFraction unitRef="usd" contextRef="i1f8b2bbcf7b442d5b60c4726c660f0b2_D20210401-20210401" decimals="-6" format="ixt:num-dot-decimal" name="dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfMjQ3_feb1d3a4-9da7-4f6d-9f44-880f7709492b">760</ix:nonFraction>&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the nine months ended September 30, 2021, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i62dc4fadac874b26b838080327833f3a_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfNTUz_1c4914e6-6e21-4e8c-980b-9209dd737025">314</ix:nonFraction>&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $<ix:nonFraction unitRef="usd" contextRef="id467bea9a9a042bd95d6970a12d3be15_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfNzI2_16da7478-8f61-4bcc-b04b-548457210858">20</ix:nonFraction>&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the nine months ended September 30, 2021, the Company also recorded $<ix:nonFraction unitRef="usd" contextRef="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfOTA2_4bb0b0c0-3f04-4a5b-a043-718ed471e78f">55</ix:nonFraction>&#160;million of income tax expense related to the gain, consisting of $<ix:nonFraction unitRef="usd" contextRef="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfOTY2_9b35e8cd-d986-4caf-a7bc-bc0fc8152643">127</ix:nonFraction>&#160;million of current income tax expense, partially offset by $<ix:nonFraction unitRef="usd" contextRef="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfMTAyMA_eb5bae41-3efb-4f50-98f3-1e151fadc362">72</ix:nonFraction>&#160;million of deferred income tax benefit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_46"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDgxOQ_03623b8c-3bd3-48e2-92f7-5e72e551ea7b" continuedAt="ic153ba25e71340d5bc99e697c4bf5315" escape="true">FAIR VALUE MEASUREMENTS  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic153ba25e71340d5bc99e697c4bf5315" continuedAt="ife77a8794f42440fa8fcf20596664710"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDgyMw_077fcb10-a5bc-4bfa-a197-94f3987364ec" continuedAt="ib77e7ffd4184467e94427d4c813adca8" escape="true">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</ix:nonNumeric></span></div><ix:continuation id="ib77e7ffd4184467e94427d4c813adca8"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNi0xLTEtMS0w_3bbb8cf6-40e3-4b95-848a-8052a6584b7a">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNi0zLTEtMS0w_7f396c89-068b-4959-96ad-f646fe0209d5">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNi01LTEtMS0w_6b479aa6-4eb6-4370-9fb1-f6125fc3646a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNi03LTEtMS0w_f1addbe2-239f-4049-b262-c5d03e14a8a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNy0xLTEtMS0w_95f43da5-65d6-4103-b166-50db51202637">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNy0zLTEtMS0w_75cf5310-0ed5-4573-852c-ab223780ab6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNy01LTEtMS0w_d0a82985-ca27-49db-a536-f7a5db41158a">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNy03LTEtMS0w_2ea503be-2467-437d-bcf1-0b7b1be053db">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOC0xLTEtMS0w_42755918-11cb-488e-a100-ee6501ac5373">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930" decimals="-6" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOC0zLTEtMS0w_e79985ea-ee4d-4f31-b8e2-84460fa79db2">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930" decimals="-6" format="ixt:fixed-zero" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOC01LTEtMS0w_8b22f759-1960-4d98-9d23-78e369711ddd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930" decimals="-6" format="ixt:fixed-zero" name="dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOC03LTEtMS0w_c6d142fd-ffcf-47f9-8dce-ab1dfde607ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOS0xLTEtMS0w_c13cc623-556b-41e7-9a44-d2ff5e2e85ca">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOS0zLTEtMS0w_4fa19bc5-5f06-4c50-a917-c1c10b2d1329">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOS01LTEtMS0w_9c36ae38-af72-48b3-b52e-8281a8647536">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOS03LTEtMS0w_579794d0-efb2-47a0-8d3f-4dfdefcf9a54">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTItMS0xLTEtMA_3e2943ff-013b-4384-962d-0ec10531bb76">179</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTItMy0xLTEtMA_554ee431-4bf4-4783-8e46-799a7fcbf9ec">124</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTItNS0xLTEtMA_3a969568-0a95-446a-9ad3-0a2d9b8703a7">54</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTItNy0xLTEtMA_e82b1a0f-2cf9-478e-8a8d-b63235d0ee09">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTUtMS0xLTEtMA_3b8f640b-a11d-446d-977d-703402ade9b4">139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTUtMy0xLTEtMA_e39f6ab7-bc8d-4c34-8d15-37ebe82d89c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTUtNS0xLTEtMA_bb1d3c6f-9335-47a2-9816-8db9ddaaf231">139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTUtNy0xLTEtMA_d295a7c1-150e-4304-aa8f-6f133bd4facc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMjItMS0xLTEtMA_4c83f1fe-55d4-4b25-b381-a6d43df228ae">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMjItMy0xLTEtMA_fb2a4e31-405e-4b74-b5d0-6ec06b045700">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMjItNy0xLTEtMA_3d163950-b1c5-42f0-9510-3b63a8fe9d2d">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMy0xLTEtMS0w_25fa838e-ad9c-4961-aa76-695bef7399d3">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6717324b738441d5b2882980e7f96534_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMy0zLTEtMS0w_67b0e206-0bd2-47fd-8402-d95c09b7322f">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMy01LTEtMS0w_1d8850ea-c19a-4add-91e6-2640c17e329e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMy03LTEtMS0w_cfc3f5d6-4338-436f-b600-4e585734ef59">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNC0xLTEtMS0w_ddf5bd1a-49ac-444a-ae65-45c2a5d33fef">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6717324b738441d5b2882980e7f96534_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNC0zLTEtMS0w_90dea4a3-e9c9-4260-939e-838c9ebc6343">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNC01LTEtMS0w_d0d2ab83-6d7c-4958-b157-08d660a8decc">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNC03LTEtMS0w_03dfc24c-fb67-4945-a714-f2d15d925147">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNS0xLTEtMS0w_3d5624be-0c91-4b93-81c6-49a4c97ae75b">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6717324b738441d5b2882980e7f96534_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNS0zLTEtMS0w_fe688ddc-0414-4ca8-ba34-e15c53b609d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNS01LTEtMS0w_4fa8d23d-7e5b-48b1-9831-644ae091810b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNS03LTEtMS0w_70e7253e-858e-4786-bbeb-95ad9da588e5">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTAtMS0xLTEtMA_bea919a2-992b-47d6-8e87-709b8a8bd8cf">129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6717324b738441d5b2882980e7f96534_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTAtMy0xLTEtMA_10915984-38f1-470b-b43d-296c9e530d13">67</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTAtNS0xLTEtMA_e97c58e9-e5d5-4708-a6a3-8a54e5f5d226">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTAtNy0xLTEtMA_2723b50a-382a-4b7c-9780-3b249a6229c8">12</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTMtMS0xLTEtMA_1ce96c34-28aa-41ac-8b45-d7943f1eb0f7">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6717324b738441d5b2882980e7f96534_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTMtMy0xLTEtMA_471bdae9-785a-4ee0-bd5d-5850e2e22469">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTMtNS0xLTEtMA_67ddf948-6c2a-4d04-bdfe-a1f38c10847f">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTMtNy0xLTEtMA_b14d8f3b-3199-42c3-8801-8aa1174183fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMjEtMS0xLTEtMA_2c46c3f4-4859-4d8a-af50-cb2725675fbb">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6717324b738441d5b2882980e7f96534_I20201231" decimals="-6" format="ixt:fixed-zero" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMjEtMy0xLTEtMA_49fb57a3-9cdc-414b-a307-e1ca5ab30456">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMjEtNy0xLTEtMA_64ecb53b-fcd2-477e-8049-ac639d72aa54">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed investment options that are classified as trading securities.  These trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><ix:continuation id="ife77a8794f42440fa8fcf20596664710"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  During the three months ended September 30, 2021, certain of the Company's equity investments became publicly-traded and, based on the readily determinable fair values, the Company recognized gains of $<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDk0NzgwMjMzNTUxMA_07e4efaf-ef18-40c6-9220-c00fd4a3d76d">42</ix:nonFraction>&#160;million in other income, net in the Company's consolidated statement of operations.  Such equity investments are now classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i36fc1b4d87cc4ef59463dc14ae3e0809_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfMjk0OQ_9391b487-0529-46ce-9df6-fa5dfa907156">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of September&#160;30, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the nine months ended September&#160;30, 2021, the Company recorded an $<ix:nonFraction unitRef="usd" contextRef="i259a5f13f5bc45e7813aca65d4056271_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfMzcwMw_d29a31f1-08d9-49de-9c03-e01eb8ad050a">8</ix:nonFraction>&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of September&#160;30, 2021 and December&#160;31, 2020, the fair value of the Company&#8217;s debt was estimated at $<ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDQ0OQ_d6047920-160e-4606-a9b6-d95f8d0eddaf">4.5</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDQ1Ng_838a904c-ed6d-4e24-9a44-d9d632c498ab">4.6</ix:nonFraction> billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_49"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfMTIxOQ_cfe60267-45b4-41f1-b272-0f825f302af3" continuedAt="ibd8ac9b7f7924e2f9bf27dc03e15fba8" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibd8ac9b7f7924e2f9bf27dc03e15fba8" continuedAt="ia522c4b01de94e0997a6f20d025285f4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfMTIyOQ_83f87be7-77bf-46a2-bbee-6dc5d798f737" continuedAt="ib35a9b7825b84ee592ed7799c1349ae8" escape="true">The changes in goodwill for the nine months ended September&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ib35a9b7825b84ee592ed7799c1349ae8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:57.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMS0xLTEtMS0w_811ac4b0-7564-4114-a544-eea29d652569">6,873</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44797d3e9c614839926a9c2f3bb5be17_I20191231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMS0zLTEtMS0w_25fd348f-c34b-4056-91a5-c4a4f35594a3">6,619</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMi0xLTEtMS0w_036ed037-8456-4ed4-b9bd-7f7b18f314f9">188</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285e961758554fd5ac030b44fe9867ff_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMi0zLTEtMS0w_6d102805-8ff3-4fae-8e5b-ae38db09c34e">247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMy0xLTEtMS0w_7e4cfada-8143-4f4b-96e5-93b9f8dea851">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285e961758554fd5ac030b44fe9867ff_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMy0zLTEtMS0w_d3a53b2e-937d-435f-bf2d-3d01cebc7a62">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfNy0xLTEtMS0w_362729a7-2b5b-46f5-919e-4c03f525c048">7,057</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfNy0zLTEtMS0w_fe44a621-11cd-4e8f-8bf4-63b292fee78a">6,873</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of September&#160;30, 2021 and December&#160;31, 2020 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, goodwill acquired was principally associated with the acquisition of the outreach laboratory services businesses of Mercy Health and adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy; Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining <ix:nonFraction unitRef="number" contextRef="id248109e93494be5ab0649ef082cb608_I20201231" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfNzE5_95dcb249-4755-4a24-a1d2-ec1bcb93dbc0">56</ix:nonFraction>% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfMTI0MA_2d9c10ac-d0d5-4fb3-a0c6-d4c41f7139d2" continuedAt="if7b000b8d7cc432ba05d16cd0778e55c" escape="true">Intangible assets as of September&#160;30, 2021 and December&#160;31, 2020 consisted of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="if7b000b8d7cc432ba05d16cd0778e55c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.727%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibba5357fd8bf4d2f8cb494c4ee189328_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy0xLTEtMS0w_ca131be3-06a7-48cf-9924-40483e194b57">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8117f4bb2f54d20ae84cf958f833fc9_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy0zLTEtMS0w_ff3194ef-0b1d-4cb2-93bf-fd59eadfc285">1,541</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8117f4bb2f54d20ae84cf958f833fc9_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy01LTEtMS0w_bb915713-66ca-4a75-b66c-091becf9b79f">704</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8117f4bb2f54d20ae84cf958f833fc9_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy03LTEtMS0w_dfb52fcb-a4f0-485c-aaec-9828259cfd00">837</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5dcd0ab13e41d480cf6fd05837a2dc_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy05LTEtMS0w_1f3538d6-0c28-4a9f-9375-23de0c7844d1">1,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a5dcd0ab13e41d480cf6fd05837a2dc_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy0xMS0xLTEtMA_1e118b9a-d2eb-4d84-8a2b-6446a8cd1451">638</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5dcd0ab13e41d480cf6fd05837a2dc_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy0xMy0xLTEtMA_10ccb0b2-2f7a-481a-a48d-9e844533591c">841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8c1dfb7b00dd40caa23f7b20aa962872_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC0xLTEtMS0w_3856ab7b-a908-45c2-bc14-2a5107399fa8">9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6c581188914f048902746e4d6c62a5_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC0zLTEtMS0w_7bed5325-ef02-4490-bb88-4a3b2f718f65">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b6c581188914f048902746e4d6c62a5_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC01LTEtMS0w_f71ffbcb-f936-4917-b93b-8ea54b408d1d">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6c581188914f048902746e4d6c62a5_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC03LTEtMS0w_2e428f4a-fb50-48d0-a328-c5755721a715">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fde28f195345cdaa042f2d8f3d61df_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC05LTEtMS0w_474929c8-700a-49e5-92c5-722421f098b9">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53fde28f195345cdaa042f2d8f3d61df_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC0xMS0xLTEtMA_c3085b8f-e69e-4937-a154-fb7537d01eb9">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fde28f195345cdaa042f2d8f3d61df_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC0xMy0xLTEtMA_86267090-edec-4658-96b3-1f8b490b84cd">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8125b809d77340e4a919837e287c04be_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS0xLTEtMS0w_255d2987-5807-45c7-8771-c51c5b74a8e6">14</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aafd4a99f5b40e9855fa6aef485af35_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS0zLTEtMS0w_d3df4439-0128-4fe9-a915-fdbb50e47a73">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1aafd4a99f5b40e9855fa6aef485af35_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS01LTEtMS0w_fbec6dc9-b4f1-4ede-ac84-67a5b8fb9182">72</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aafd4a99f5b40e9855fa6aef485af35_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS03LTEtMS0w_ee9721f5-fa6f-4ece-940b-f488c5ef5fe8">70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c50c6fa9d5420593a7df593fbfd4b0_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS05LTEtMS0w_c151a0e7-729b-475a-b68c-3452615fe6da">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50c50c6fa9d5420593a7df593fbfd4b0_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS0xMS0xLTEtMA_f08adfd6-a634-4475-b1e4-ceba95accea0">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c50c6fa9d5420593a7df593fbfd4b0_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS0xMy0xLTEtMA_1e83c0c3-9e4b-4022-a766-4d6471b8e4bd">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id699393e5c1e405cb9e349542a08565d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi0xLTEtMS0w_fbf8c502-9883-4a78-84e0-e9835560ab51">5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437864783a7b4db19f1011b84e670b30_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi0zLTEtMS0w_a586eaca-a1ea-4055-b2ff-37ce967f5102">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i437864783a7b4db19f1011b84e670b30_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi01LTEtMS0w_82761b13-7aa4-4f73-807e-ea3e38292863">100</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i437864783a7b4db19f1011b84e670b30_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi03LTEtMS0w_a5c40e3b-3e4f-45b2-8127-26e0b6605628">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d51148780249248ddb2e605bbe8abd_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi05LTEtMS0w_ebb962f5-1c46-4344-8bcb-261c54be9cc7">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75d51148780249248ddb2e605bbe8abd_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi0xMS0xLTEtMA_24b6c308-9efb-4b74-9b8e-72687e9a7a7d">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d51148780249248ddb2e605bbe8abd_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi0xMy0xLTEtMA_f6ee57f0-85cd-47e4-a697-dd0d805bb4b3">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i748efa01b96341229310868eca941647_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy0xLTEtMS0w_738f07ad-be0c-4b8b-ad3d-c80a22c9c59e">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb316df1367442cc90e4c2c5326acd80_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy0zLTEtMS0w_8c015134-4c05-4869-9a59-101a1e8fda9d">1,794</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb316df1367442cc90e4c2c5326acd80_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy01LTEtMS0w_15c7b5bf-46d5-4f04-87f2-40d4f2a2265d">878</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb316df1367442cc90e4c2c5326acd80_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy03LTEtMS0w_39539d38-fb9c-4114-9ce5-6d8381ce7a9c">916</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723c339a06ce4cf38176085ba130077e_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy05LTEtMS0w_c209086a-110d-4a7e-82db-b08daaeba292">1,731</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i723c339a06ce4cf38176085ba130077e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy0xMS0xLTEtMA_335c2ce8-dada-4d0f-aa86-b1212501fcea">800</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723c339a06ce4cf38176085ba130077e_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy0xMy0xLTEtMA_7fccef38-d07f-46ba-bce9-51366da0df0e">931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d6d052e08a40f3aeb61f740e03dac2_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTAtMy0xLTEtMA_622a5e7a-338d-429d-8fce-2b90e532f6cd">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d6d052e08a40f3aeb61f740e03dac2_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTAtNy0xLTEtMA_24b28335-5ec8-4152-8749-a9a31a52e81a">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i944e0f14985441db988806dbbf0e1725_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTAtOS0xLTEtMA_5f5484cd-5f06-46ed-9fcc-d97bd2000608">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i944e0f14985441db988806dbbf0e1725_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTAtMTMtMS0xLTA_0c5dc811-55c0-4f77-ae56-0061e03551d1">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa71f4cff13142c783bc54345c97e1b7_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTItMy0xLTEtMA_2b2da0c3-632b-49b2-a5ee-bbd53e71972e">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa71f4cff13142c783bc54345c97e1b7_I20210930" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTItNy0xLTEtMA_1a6edada-1247-42bb-9796-2cccc180d4c4">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386a526647e54047ad6392d22e224a8c_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTItOS0xLTEtMA_5a058238-f2f8-4b22-b2cb-e167fb56ca70">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386a526647e54047ad6392d22e224a8c_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTItMTMtMS0xLTA_96f59563-2beb-416c-bf7d-d2f92c812473">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtMy0xLTEtMA_029619e2-ec24-4a6c-9ad2-ac61419a47e8">2,030</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtNS0xLTEtMA_d1723379-9301-461e-84e1-7a206fea62a2">878</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtNy0xLTEtMA_e585a7ad-0310-4534-abd0-ab009d6798fd">1,152</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtOS0xLTEtMA_41712cdd-840f-4ff5-9205-4d9d730d5a6e">1,967</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtMTEtMS0xLTA_ebae6ec1-0d6f-4354-b3f7-ff2c08a79c48">800</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtMTMtMS0xLTA_0876a9d6-edff-4800-8670-e33c9b7424e2">1,167</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ia522c4b01de94e0997a6f20d025285f4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfMTIzNw_699e59b0-38a9-4f69-b5fe-411df180bf84" continuedAt="i652e192baf684fef9ef50d8fe4c11cea" escape="true">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2021 is as follows:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i652e192baf684fef9ef50d8fe4c11cea"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"></td><td style="width:72.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfMS0xLTEtMS0w_a63b90f8-bef6-4f4a-ae20-a7d55b6c69c7">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfMi0xLTEtMS0w_e4bd7d81-c444-44c4-8ebe-5298760c92b7">102</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfMy0xLTEtMS0w_9bb80ab8-6f5e-4a1d-bac4-6af0e6664f6d">100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfNC0xLTEtMS0w_5ca1e324-d45a-4fe4-9e7e-616bde5c6554">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfNS0xLTEtMS0w_729ac404-5919-4aca-aac0-51e229e0244a">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfNi0xLTEtMS0w_9699ac8f-2aea-4faa-af5f-440f9dfe9550">90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfNy0xLTEtMS0w_33a2e5b0-9f25-418b-bf7b-c5f73f720ed0">405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfOC0xLTEtMS0w_db360af6-5d55-47f2-b5c3-ba8752cfa343">916</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RleHRyZWdpb246NWUzYjM4NjY2NjU0NDUwMWE0MjlmY2E5ZDc4YWE1NmZfMzgzNQ_03a9908d-f5c5-4b51-aa55-d842e4fefa5c" continuedAt="i8facf174cbb54d08a4ffa2b311edf32b" escape="true">FINANCIAL INSTRUMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8facf174cbb54d08a4ffa2b311edf32b" continuedAt="i67a8ebf09c714da78c8a561101063fcb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RleHRyZWdpb246NWUzYjM4NjY2NjU0NDUwMWE0MjlmY2E5ZDc4YWE1NmZfMzgyMA_e99b5eb0-c02b-41ed-94b3-02ce8beedb2f" continuedAt="i5d2088db7486425ab0080621d922848b" escape="true">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5d2088db7486425ab0080621d922848b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RleHRyZWdpb246NWUzYjM4NjY2NjU0NDUwMWE0MjlmY2E5ZDc4YWE1NmZfMzgyOA_12e656de-22e6-4c4c-97fd-bbff5ef892ce" continuedAt="ib5fa88880134456ebc570559ed4a5227" escape="true">As of September&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i67a8ebf09c714da78c8a561101063fcb" continuedAt="i4757263b23a449d9a58a599c774af213"><ix:continuation id="ib5fa88880134456ebc570559ed4a5227"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7399b9274664c749e91f89957ec71bc_I20210930" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOmY4OGYxOWNkZjdjZTRkZmViMDU3M2U5OGQxYzFhYzNiL3RhYmxlcmFuZ2U6Zjg4ZjE5Y2RmN2NlNGRmZWIwNTczZTk4ZDFjMWFjM2JfMi01LTEtMS0w_e5df0bfd-f3eb-453b-8ebc-68fca1451645">41</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34cc7bf29a7c44409c7e67bcd16c4a18_I20201231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOmY4OGYxOWNkZjdjZTRkZmViMDU3M2U5OGQxYzFhYzNiL3RhYmxlcmFuZ2U6Zjg4ZjE5Y2RmN2NlNGRmZWIwNTczZTk4ZDFjMWFjM2JfMi05LTEtMS0w_1017951e-06a0-4c42-862b-eb3d950733a5">51</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both September&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RleHRyZWdpb246NWUzYjM4NjY2NjU0NDUwMWE0MjlmY2E5ZDc4YWE1NmZfMzgyNA_c2765516-f6a1-4c78-af76-8dabf5df3c9f" continuedAt="if4a74df149364f169f7021176f402d6f" escape="true">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and nine months ended September&#160;30, 2021 and 2020:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="if4a74df149364f169f7021176f402d6f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfMy0zLTEtMS0w_a4a41410-d761-4624-b2e5-738e9e3d1eb6">40</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfMy01LTEtMS0w_3e9c486a-b434-4919-92b7-fd25131bc2a1">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfMy03LTEtMS0w_164375a8-30c1-425e-bab3-fef0b62aeb50">366</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfMy05LTEtMS0w_ae973255-2f1a-4eff-bb3e-ee07e1240c52">74</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia59678286edb47a683efe4ca31c9d152_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNi0zLTEtMS0w_90d81b52-b67c-4305-9911-d53cbeb27281">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2cfcef6577746beaf2fc395bc84e9f4_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNi01LTEtMS0w_6220f490-c361-4817-ab58-a9bb7853cbb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i091b01bda5c84720a769c37a5b845045_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNi03LTEtMS0w_ed8e8916-ce23-4cd2-86c5-012f6444248c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec15589bf02e47779ded2be278cfe21a_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNi05LTEtMS0w_eda26ffa-9e38-4c6b-863e-c74107311c4b">68</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c9fb4948c0446498ff2b9b1edc0349b_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNy0zLTEtMS0w_d0f1244e-de2d-4df8-af11-9417294a9510">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93cec6591e0847ad8a42544b505883d4_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNy01LTEtMS0w_d0a46337-c858-4578-8d1a-3c477d57f553">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65a33d49c0b41508f0b15bc06443452_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNy03LTEtMS0w_b2e5f060-6795-4648-9e7c-a544ab120f0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib938d748462e4324a82c390775ef95f0_D20200101-20200930" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNy05LTEtMS0w_581c9ab5-827e-4c9b-890c-137accc42203">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i4757263b23a449d9a58a599c774af213" continuedAt="i5e7353a2072949d2b4fc72ec5dd4f182">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5e7353a2072949d2b4fc72ec5dd4f182">A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</ix:continuation>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNTE5OQ_f6b92f57-a138-4d32-9718-b7c6d85e0e87" continuedAt="i2df134fcfd4b426b8e48607a65180285" escape="true">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><ix:continuation id="i2df134fcfd4b426b8e48607a65180285" continuedAt="ic2c8aae88f9843988693abeb850a0f53"><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its <ix:nonFraction unitRef="number" contextRef="i246ee08978dd4f9281e49cde4052adb5_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTAxNg_d45f96b1-535d-4ddb-8dc8-bbff0c77336d">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the nine months ended September&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="id467bea9a9a042bd95d6970a12d3be15_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTIzMw_e3a61691-d672-4764-898d-f45b49ab4a0d">20</ix:nonFraction>&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income, net.  See Note 5 for further details. </span></div></ix:continuation><div style="text-indent:-36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ic2c8aae88f9843988693abeb850a0f53" continuedAt="i8ab1262d0b3e481b8176a80440b96db7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the first three quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="id96bc77fc8eb4e8e88dc16ca93868148_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTUzMg_1b92f9f2-a5a7-4b69-87b5-5db3fcf3021e"><ix:nonFraction unitRef="usdPerShare" contextRef="i55bf2898a19d4ec4ada12d71732989e7_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTUzMg_67e9c76b-4491-444a-8c14-13f6d383e7aa"><ix:nonFraction unitRef="usdPerShare" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTUzMg_9f18bf51-8097-411a-b047-756d94195ff4">0.62</ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7e7d971b76454263a15f1169e211c2a2_D20200101-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTY2NQ_21922d2e-9b0e-4580-8eaf-156bc08919ac"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ea29ec2e2ea47a79288bb5eb1c001b0_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTY2NQ_4140b7da-b6a2-4d0d-8e43-f6dbd70bbb7c"><ix:nonFraction unitRef="usdPerShare" contextRef="i5288d887a86f42969ff785028080679b_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTY2NQ_a279032a-2338-406a-837a-12f8077a0680"><ix:nonFraction unitRef="usdPerShare" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTY2NQ_f0efa2e1-4443-4d6a-a135-c632e08e45a2">0.56</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="i868f8637411d4f61887501630bc811b0_D20210201-20210228" decimals="INF" format="ixt:num-dot-decimal" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTg0Ng_1898fb96-7cc6-42b5-825e-cb2ed21395ae"><ix:nonFraction unitRef="usd" contextRef="i2d06b6e3f9dd4f56a49b29e3deefc334_D20210301-20210331" decimals="INF" format="ixt:num-dot-decimal" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTg0Ng_f2e108d4-996c-4ad1-8b8b-3b23a31b923a">1</ix:nonFraction></ix:nonFraction>&#160;billion. As of September&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTg2MA_d51c39d4-99bb-4241-9dc1-4cd0a635f0ca">1.3</ix:nonFraction> billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjA4OQ_9564f761-9cb4-4249-b631-210e022bb5ae">12.5</ix:nonFraction>&#160;million shares of its common stock for a value of $<ix:nonFraction unitRef="usd" contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjEyMw_7e284017-43c2-4bd4-8740-4ec92c7d1d85">1.6</ix:nonFraction>&#160;billion, including <ix:nonFraction unitRef="shares" contextRef="ibfda32ff821e42f7b4ed59c5648a0dd6_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTA5OTUxMTYzMzA0Mg_ec4b8408-f9b8-47af-868e-c53b0c460ee4">9.1</ix:nonFraction>&#160;million shares repurchased under ASRs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The repurchases under the ASRs were initiated in April 2021 with the Company's entry into ASRs with several financial institutions to repurchase $<ix:nonFraction unitRef="usd" contextRef="icfcf88539a60445eb9be5a8700c50fb6_I20210430" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjI3OQ_dd52c7ae-64f4-4484-9e85-8b95715628ca">1.5</ix:nonFraction>&#160;billion of the Company's common stock as part of the Company's share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract. For the nine months ended September&#160;30, 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="icfcf88539a60445eb9be5a8700c50fb6_I20210430" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjc4Nw_dd52c7ae-64f4-4484-9e85-8b95715628ca">1.5</ix:nonFraction>&#160;billion to the financial institutions and received <ix:nonFraction unitRef="shares" contextRef="ibfda32ff821e42f7b4ed59c5648a0dd6_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjgzMw_9e241a91-4aea-4919-a523-40925c2ea613">9.1</ix:nonFraction>&#160;million shares of its common stock, at an initial price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="INF" name="us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjg4Nw_ce95cd47-5579-4e64-bf6c-1cf66cbce185">132.27</ix:nonFraction> per share for a value of $<ix:nonFraction unitRef="usd" contextRef="i4f600b81db564760a3990025b8fe7516_D20210101-20210930" decimals="-8" format="ixt:num-dot-decimal" name="dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjkxNQ_5aaf907c-7e4e-47ec-811e-957983282493">1.2</ix:nonFraction>&#160;billion, which represents <ix:nonFraction unitRef="number" contextRef="i4f600b81db564760a3990025b8fe7516_D20210101-20210930" decimals="2" name="dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjkzNg_e400742a-35ed-426d-a557-d7ec5f003317">80</ix:nonFraction>% of the total value of shares to be repurchased under the ASRs. The ASR contracts will settle the remaining shares, based on the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, upon the completion of the ASRs during the fourth quarter of 2021. The Company recorded the transactions as an increase to treasury stock of $<ix:nonFraction unitRef="usd" contextRef="ibfda32ff821e42f7b4ed59c5648a0dd6_D20210101-20210930" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzMzMA_a3d8ea02-6291-4cd5-abbf-80eb285ebf02">1.2</ix:nonFraction>&#160;billion and it recorded the remaining $<ix:nonFraction unitRef="usd" contextRef="idf76d19dc0f440e89a7ca4bf2b2f2383_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzM2Mw_d6340d66-3679-4e67-acfb-1591bbb095de">300</ix:nonFraction>&#160;million as a decrease to additional paid-in capital in the Company&#8217;s consolidated balance sheet.  The $<ix:nonFraction unitRef="usd" contextRef="idf76d19dc0f440e89a7ca4bf2b2f2383_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="dgx:AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzQ2MA_8bf78fb1-b627-472d-8f26-0ff504afebc0">300</ix:nonFraction>&#160;million recorded in additional paid-in capital will be included in treasury stock upon completion of the ASRs.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzYyMA_782a0307-6f9a-4297-9a47-6bcd3b208d37">0.7</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzY1NA_a71ffc48-4aef-4aa6-803f-9fc1354a1fe3">75</ix:nonFraction> million.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the nine months ended September&#160;30, 2021 and 2020, the Company reissued <ix:nonFraction unitRef="shares" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNDE0NA_d52bd08f-ee08-4131-a8e8-12b119e38baa">1.7</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNDE1OA_b9b69e6a-2de4-4359-a8f9-7f3b3a70045b">2.1</ix:nonFraction> million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock Retirement &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended September 30, 2021, the Company retired <ix:nonFraction unitRef="shares" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesRetired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNDk0NzgwMjMzMDg2Mw_a44f06ee-6bbd-4f54-a946-6421a5115deb">55</ix:nonFraction>&#160;million shares of treasury stock. In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.</span></div></ix:continuation><div style="text-indent:-36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i8ab1262d0b3e481b8176a80440b96db7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i36fc1b4d87cc4ef59463dc14ae3e0809_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNDQ2Mw_9391b487-0529-46ce-9df6-fa5dfa907156">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of September&#160;30, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 6.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_58"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfMTMxMg_688965f7-39cc-47c4-91dc-0b2b54e1c52e" continuedAt="ife59e9d262524b28800129395214665e" escape="true">SUPPLEMENTAL CASH FLOW AND OTHER DATA</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ife59e9d262524b28800129395214665e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfMTMwOQ_3fe063ce-95a1-4c33-ade1-8a2fe709e66c" continuedAt="i6d37ed2485d3402cb2cdd8e9dbfd7a6c" escape="true">Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2021 and 2020 was as follows:</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6d37ed2485d3402cb2cdd8e9dbfd7a6c" continuedAt="ib7eb3017039141e48f61a2b5f41d8ca6"> </ix:continuation></span></div><div style="margin-top:5pt"><ix:continuation id="ib7eb3017039141e48f61a2b5f41d8ca6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:56.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMi0xLTEtMS0w_0612d3a3-aa44-4f7b-8055-a9af8fb8b0cb">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMi0zLTEtMS0w_7568419c-8276-4131-903a-3b61f8647dd6">62</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMi01LTEtMS0w_2885529d-02ed-49a1-b484-8bc05ee52ac1">225</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMi03LTEtMS0w_a8648d82-e8db-472a-b27c-9c2f01d25a9f">186</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMy0xLTEtMS0w_b0647898-4f1c-4161-a597-370ffced1845">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMy0zLTEtMS0w_64f51b29-a751-48c2-835f-99f89d2e2473">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMy01LTEtMS0w_40ed1f04-f0e3-4b0d-aaa3-df68fba7120e">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMy03LTEtMS0w_9b7d2de8-8f13-4e4d-b230-fca4bb164e82">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNC0xLTEtMS0w_3e1c85d9-59c9-40de-8885-b1a2b044caeb">101</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNC0zLTEtMS0w_535a2f11-a6e9-4a23-ab18-90abf5d0ee9a">89</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNC01LTEtMS0w_34cb24f3-e21a-43eb-9393-49793b626f2e">302</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNC03LTEtMS0w_d8af5a20-7131-4506-8fdc-e3517445d92c">263</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNi0xLTEtMS0w_98b55007-5705-492a-8dcd-d382492444cf">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNi0zLTEtMS0w_0f9930ef-82ad-4bbf-b518-ec7e1610254c">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNi01LTEtMS0w_fdc10582-44ac-4a3a-84dc-4561f1e5ba6d">114</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNi03LTEtMS0w_16692265-eb34-42c3-877f-56b5514bcdad">126</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNy0xLTEtMS0w_98447fb8-f92b-4092-8a88-623a726949fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNy0zLTEtMS0w_5da82493-719b-45d8-a361-fc9eec02974f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNy01LTEtMS0w_d23133e1-38d8-4082-b06c-de39efc89a3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNy03LTEtMS0w_96e80936-248d-4856-a51f-06867aa0090e">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfOC0xLTEtMS0w_1bf29d3e-6dda-4f80-9c3f-7ccc78a1916c">38</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfOC0zLTEtMS0w_d2e2fe32-5234-4d3d-bd71-da032a6e5f52">42</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfOC01LTEtMS0w_315c7699-7e66-4d6b-b434-f7a29dc23a19">114</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfOC03LTEtMS0w_b2d9c719-4f78-4faa-88b6-b847ac13823e">124</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="dgx:InterestPaid1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTAtMS0xLTEtMA_b0bed026-8c23-4cbd-8cac-6872d710c08a">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="dgx:InterestPaid1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTAtMy0xLTEtMA_4290a8e9-96ec-43e3-ac15-b6a8a62bc919">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="dgx:InterestPaid1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTAtNS0xLTEtMA_6aee1e4a-4c06-4186-8445-00f7e7f99ee8">111</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="dgx:InterestPaid1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTAtNy0xLTEtMA_4962f2a3-3f37-41a9-b21b-f2f518009559">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTEtMS0xLTEtMA_6a54f5f7-eaae-44e2-95d1-2c3634c40023">187</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTEtMy0xLTEtMA_53ce9d3a-0eb9-486e-bd40-a3263cbb335b">148</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTEtNS0xLTEtMA_31149436-27a1-4174-ba67-43f8c1665297">522</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTEtNy0xLTEtMA_bb9ac73f-3305-48de-b2c9-88566b97bfe1">168</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTMtMS0xLTEtMA_ffa20d6c-8245-4245-9227-96b0bb896253">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTMtMy0xLTEtMA_87bd9226-166a-412d-b53a-e449c2c3f936">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTMtNS0xLTEtMA_6c327ef4-f3b6-41b4-8353-4878acfc2a14">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTMtNy0xLTEtMA_8c71d7c4-18bd-4295-9818-54385232b4c9">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTUtMS0xLTEtMA_def9ce84-e0bc-47ed-b661-97313181cc4f">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f627c3af5db4299b234650d220eee56_I20200930" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTUtMy0xLTEtMA_430c30e9-c51d-4899-af40-aeea46731a6f">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTUtNS0xLTEtMA_7cbca707-dda3-4375-9064-2df717845c58">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f627c3af5db4299b234650d220eee56_I20200930" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTUtNy0xLTEtMA_6bffa763-f642-4171-848b-ec9578326b31">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTgtMS0xLTEtMA_4cc3fe6f-3f95-4085-aa02-ddd2af7b203a">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTgtMy0xLTEtMA_08019cc9-5dd6-41d5-9426-6dd85aaee184">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTgtNS0xLTEtMA_053b5288-7275-411f-8d57-9f1a56813066">254</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTgtNy0xLTEtMA_2d4ccedf-8e5f-4aea-828d-1a7a5cdec868">377</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTktMS0xLTEtMA_ad6cd8ba-ff69-48bd-9be4-9ee862ddb0bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTktMy0xLTEtMA_1d4ba44e-b72b-4013-8fdf-40ee32fea240">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTktNS0xLTEtMA_426cc77b-2983-4df3-9d4a-199e99bf6460">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTktNy0xLTEtMA_acd1c427-cbf3-4868-9d2e-857d40f21215">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjAtMS0xLTEtMA_fb457b0e-f3e3-40ad-9b71-e986f292e797">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjAtMy0xLTEtMA_9443ba01-e8ac-48ba-9d65-3b95cadbc5eb">117</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjAtNS0xLTEtMA_3fc4b763-9e93-4524-82f6-2c14c88bc6fd">251</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjAtNy0xLTEtMA_5464e5bf-1b52-4508-b403-01420ac958a6">348</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration receivable/payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjEtMS0xLTEtMA_98ce56f6-624b-4037-a15e-ec1daa49671b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjEtMy0xLTEtMA_4dfabb4b-96c1-4e58-9f91-4b6e43b00458">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjEtNS0xLTEtMA_2accdcdf-5d79-4b09-b4c5-91e320cee156">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjEtNy0xLTEtMA_f34306cf-e4ee-4404-9130-9c223c27fd67">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjItMS0xLTEtMA_1e0993ce-1eea-4445-87a4-0937429d1391">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjItMy0xLTEtMA_d1fd6c36-79b9-436b-8a3f-f108315b95e9">119</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjItNS0xLTEtMA_549c79a0-4038-49db-868a-a59ad22461bb">251</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjItNy0xLTEtMA_60da7fb5-a730-4495-aedc-25bf3fab1702">350</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjMtMS0xLTEtMA_64485ff9-9a64-4807-88d9-fe02cd67b478">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjMtMy0xLTEtMA_44a70a3a-c61c-4ed8-b643-5cc6c0bd0c36">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:fixed-zero" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjMtNS0xLTEtMA_80134ec4-e9d9-4109-a760-04b4e01e4d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjMtNy0xLTEtMA_deed9c19-8a11-4984-941d-7c0f17cfe563">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjQtMS0xLTEtMA_f1c063c1-fb58-4c43-856b-87a2251c0830">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjQtMy0xLTEtMA_793b749d-f786-4145-96ad-bb0bf1f01ea3">101</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjQtNS0xLTEtMA_0aa2fcb2-9c33-4e90-b47c-d81af2010a6f">251</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjQtNy0xLTEtMA_feed4f08-bc78-4809-bdd9-18ea0c3971b4">329</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMzEtMS0xLTEtMA_80205ff5-deaa-40bf-8d41-4fd7fa449462">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMzEtMy0xLTEtMA_23d71d21-c492-4236-9a35-de6b8133e0d0">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMzEtNS0xLTEtMA_86fc7f60-9961-4ef4-a020-07cee0bf57e6">115</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMzEtNy0xLTEtMA_190cce1a-63a8-4b4c-b9b3-ff5bd22653e6">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law.  In April 2020 and August 2020, the Company received approximately $<ix:nonFraction unitRef="usd" contextRef="ib80fc1942e984fd5a7949043c3093362_D20200401-20200430" decimals="-6" format="ixt:num-dot-decimal" name="dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfMzM5_3b27933c-2fa9-42f2-85d1-f4f2ebebd030">65</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i7542d9b6daf04822b7c7295e9573a8a3_D20200801-20200831" decimals="-6" format="ixt:num-dot-decimal" name="dgx:CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfNDk0NzgwMjMyNjM3OQ_b24f8683-b85d-421f-b6d2-4314e0c0df01">73</ix:nonFraction>&#160;million, respectively, of funds that were distributed to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic under the CARES Act.  The Company accounted for the receipt of the funds under a gain contingency model. Accordingly, the amounts were recognized when the funds were received and the Company determined that it satisfied the associated terms and conditions. During the three months ended June 30, 2020, based on the terms and conditions that were in effect at such time, the Company concluded that it had satisfied such terms and conditions for the $<ix:nonFraction unitRef="usd" contextRef="ie051564f2e734da28d818b7a4efcf77c_D20200401-20200630" decimals="-6" format="ixt:num-dot-decimal" name="dgx:CARESActProceedsRecognizedInTheStatementOfOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfOTMy_d4a9dea1-ffa9-4790-87bd-2bb498acdd2b">65</ix:nonFraction>&#160;million of funds that were received in April 2020 and, therefore, the Company recognized such amount in other operating expense (income), net during the second quarter of 2020.  During the three months ended September 30, 2020, the Company reversed the $<ix:nonFraction unitRef="usd" contextRef="id858b57b1f134c328d0f3870aff86791_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="dgx:ReversalOfRecognitionOfCARESActProceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfMTE3MA_66bc9e60-a424-4ef5-9260-37fe9aa39b3a">65</ix:nonFraction>&#160;million of funds that had previously been recognized and, during the three months ended December 31, 2020, the Company returned the entire $<ix:nonFraction unitRef="usd" contextRef="i5288d887a86f42969ff785028080679b_D20201001-20201231" decimals="-6" format="ixt:num-dot-decimal" name="dgx:ReturnOfCashCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfNDk0NzgwMjMyNjQzOQ_30fd2bec-1c60-4b6a-8a96-6616b374a2e5">138</ix:nonFraction>&#160;million of funds.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_61"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfODQ4NQ_a564c6ba-a03f-46dc-b3e1-f321760a7f32" continuedAt="ia983eb21063e46b7be5c3f146047321c" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia983eb21063e46b7be5c3f146047321c" continuedAt="i982c38a3f2da479ba9b4b85ff7773d07"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i01995b0930f44ae494baf9f00606c1be_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTEx_483c04ab-1438-4b6e-bbe3-67ee068c4ebe">100</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i71dae6d523044c6e86141e159ada5f54_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTI0_d4bb6860-b374-4cd6-9233-156774d5263d">600</ix:nonFraction>&#160;million secured receivables credit facility and $<ix:nonFraction unitRef="usd" contextRef="i23930df4ff5e47acbd2af40147c8310f_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTY3_e7e74e13-4019-4585-bf33-04e2217166bb">150</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i3fa4a1c7a8cf4bde9e060da17dd6138d_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTgw_fc7b58fd-82ec-4e9a-891a-5d9935ceee1c">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility.  See Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $<ix:nonFraction unitRef="usd" contextRef="i71dae6d523044c6e86141e159ada5f54_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMzgz_b67e614d-edf2-455c-b466-f9ecd26e1080">70</ix:nonFraction> million in letters of credit under the secured receivables credit facility were outstanding as of September&#160;30, 2021, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, <ix:nonFraction unitRef="claim" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTcyNw_df7992db-c9d6-467e-9258-08f23cc6d887">two</ix:nonFraction> putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="i27f9acec26b840b1a223ab39e755c0aa_I20201031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMjI3NQ_527a211f-f368-4d6e-9ec0-4b4b3d5f2322">two</ix:nonFraction> lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i982c38a3f2da479ba9b4b85ff7773d07" continuedAt="ibbd98a60c8554ab389d447b9be4237e5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of September&#160;30, 2021, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $<ix:nonFraction unitRef="usd" contextRef="i182a2b075333465998d6cc5c986d8320_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfNzE5MQ_7bd8f3d9-b7e9-4d4c-b11f-39e302be3177">6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i73ddab4100a944fea58ae374a6ff4845_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfNzE5OA_518febf3-e3e5-473c-b588-e06b883bff35">1</ix:nonFraction> million as of September&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibbd98a60c8554ab389d447b9be4237e5">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $<ix:nonFraction unitRef="usd" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfODMwNg_87839df2-cc7b-43d4-b8b0-dbfb09ea48ee">153</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfODMxMw_bcd95c9c-05a6-4dc9-8367-9361585ebae5">138</ix:nonFraction> million as of September&#160;30, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfMjQxNQ_8dcf857a-d1a9-4f4b-ad96-80973cb2c9b8" continuedAt="i46386e31ae5548a780d553f45e4f6098" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i46386e31ae5548a780d553f45e4f6098" continuedAt="i0bb2d26aaba54de18db8eb0e0476ba31"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i58a1a67d34d240d7b603eb953adc9835_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfODA2_1cc95e9d-5f33-4acf-928d-96ac86e2f772"><ix:nonFraction unitRef="number" contextRef="i1952efe7be544fe591e6315daee82f95_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfODA2_cfe883ed-a5fa-4078-b5db-8e80fc84b9e6">95</ix:nonFraction></ix:nonFraction>% of net revenues in 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2021, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfMjQwOQ_8843cda6-dbe1-4e89-afe1-a9ef56e87bea" continuedAt="id20d18d220e647eab3dd792e288aafab" escape="true">The following table is a summary of segment information for the three and nine months ended September&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i0bb2d26aaba54de18db8eb0e0476ba31"><div style="margin-top:5pt;text-align:center"><ix:continuation id="id20d18d220e647eab3dd792e288aafab"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida9a845517b14f2d85f82da38a53f275_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMy0xLTEtMS0w_03f7efdc-a7cc-4404-b35f-06f89f4d14ba">2,703</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia12055ea11a54f1890616da76bad2b80_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMy0zLTEtMS0w_f8b6436a-9994-42e4-a2e3-4ba5cca9d625">2,709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad4b891b3a584530a9cf508df0670b51_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMy01LTEtMS0w_698628c9-f6a2-4ca8-b1a6-36203465eb03">7,820</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88caa1b81b364b9fa199959abd7ed0d2_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMy03LTEtMS0w_29a37968-7f21-47d9-983d-b86648142a2f">6,217</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf2cd09b04849daae0be004f7617d14_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNC0xLTEtMS0w_48b7b4a6-d8a3-40df-9456-3b5d2aeed0ac">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537235110c194ee082108ce9a9ecc879_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNC0zLTEtMS0w_e583f179-6caa-40a6-b81b-18f14e1e349e">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9565fe343ad34611897d8c50225762c8_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNC01LTEtMS0w_4c28f349-b9e9-4dd2-858d-35aa6c3c5eed">224</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3be9f0b477af42a4a4c10b096f57639b_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNC03LTEtMS0w_40d97aaf-6ec2-4d87-8f76-f48896109209">218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNS0xLTEtMS0w_e2c220f0-8c9c-4bf6-85f8-501aec36bd7c">2,774</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNS0zLTEtMS0w_4003186c-574c-4da1-a9d8-536b371aa88c">2,786</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNS01LTEtMS0w_17bc90bf-115b-498d-a5ce-3de75e8e78ed">8,044</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNS03LTEtMS0w_0dd7c8b1-eb1a-43dd-a5ae-044e2659e58a">6,435</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida9a845517b14f2d85f82da38a53f275_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOC0xLTEtMS0w_429c0cda-e300-49e5-8e78-a00dbcf424bd">713</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia12055ea11a54f1890616da76bad2b80_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOC0zLTEtMS0w_400290fd-d4ce-4d30-ab1a-5fb7b7f8ffa6">840</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad4b891b3a584530a9cf508df0670b51_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOC01LTEtMS0w_aad42e3f-97e4-465d-97f5-3c25278bdf2d">2,026</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88caa1b81b364b9fa199959abd7ed0d2_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOC03LTEtMS0w_48aebbc0-9c63-43ba-b5a0-40066080c411">1,325</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf2cd09b04849daae0be004f7617d14_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOS0xLTEtMS0w_2e8bf432-60cf-4032-bd3d-38d4266c6765">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537235110c194ee082108ce9a9ecc879_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOS0zLTEtMS0w_93e9c33d-bd80-4710-a437-4a19cdadeb29">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9565fe343ad34611897d8c50225762c8_D20210101-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOS01LTEtMS0w_672c8619-d4de-4d38-91b4-e11ed9fdf0be">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3be9f0b477af42a4a4c10b096f57639b_D20200101-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOS03LTEtMS0w_28b6bf9d-0b2a-468c-9b95-a45c484d91fa">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i813b3cfd78584fa288cbfee1b07eba3a_D20210701-20210930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTAtMS0xLTEtMA_ae61645d-4f20-4ea0-868d-d0207c6510ff">69</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a59539f511c449187290980e118ba4d_D20200701-20200930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTAtMy0xLTEtMA_b7c11d6d-d0c4-41db-b0c5-eaf62df94246">138</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5acd767ddc8241cf9dfb969b29565a40_D20210101-20210930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTAtNS0xLTEtMA_7d40da68-0468-4dbf-b695-498bba7526b4">207</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a9fa386f73d4e2e82d8ed5c274ecabf_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTAtNy0xLTEtMA_a4d44098-5ef2-4142-8bed-7ecba7f305b0">178</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTEtMS0xLTEtMA_0ffa319d-6a17-4f00-b2fc-bcf620d67fe1">652</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTEtMy0xLTEtMA_552f91fb-b6a3-4661-967f-2e13fec67d98">718</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTEtNS0xLTEtMA_0d4bc2a3-f0bd-41ca-ad55-198f8893dbae">1,845</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTEtNy0xLTEtMA_4f02e8cd-8c80-4bd0-bbbc-4aeae5f171f4">1,176</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTItMS0xLTEtMA_0b4330d0-328d-4ed6-8df7-0d5fe5c5c019">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTItMy0xLTEtMA_44b7ce3f-13e5-40f5-8f34-1673879923aa">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTItNS0xLTEtMA_5a604094-5eff-4222-9d14-d4badc17e310">252</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTItNy0xLTEtMA_2c2be0a4-9cd0-4699-a69a-f7d04e212a1a">50</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTMtMS0xLTEtMA_61d538f1-4d8b-4e94-a27c-09bdc6e26bdd">654</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTMtMy0xLTEtMA_3f48ecd9-bb56-4c01-88f0-f1a3dbee98db">753</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTMtNS0xLTEtMA_6cd654b2-dbbe-4e2b-9c06-884591cca488">2,097</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTMtNy0xLTEtMA_fe8ea494-fbd4-458a-a4cc-8e3da19a6e51">1,126</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTQtMS0xLTEtMA_6a1ecee3-7bbf-4e31-81c2-4b694c2de61e">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTQtMy0xLTEtMA_7720c57a-1179-4bff-aa97-15df814d6367">177</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTQtNS0xLTEtMA_b31e6faa-26d7-4ec9-a623-04a2e13c2834">483</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTQtNy0xLTEtMA_d4f6832f-631d-4ca9-a631-e5a1e69ea675">269</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTUtMS0xLTEtMA_b4c8fd4a-c792-49d3-83e1-ed17cac15463">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTUtMy0xLTEtMA_7345adb9-3e31-4b7b-9213-c2ab6edb7e46">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTUtNS0xLTEtMA_07c66ae7-6954-451d-a306-210e81822f04">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTUtNy0xLTEtMA_96aee7be-7c7b-4f5c-b4a4-b3664143bd20">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTgtMS0xLTEtMA_9ce9442b-2cdf-4313-ac90-336178aea0cf">527</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTgtMy0xLTEtMA_52f6252d-c216-42d3-a9c3-4665155c5a0c">591</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTgtNS0xLTEtMA_2cc4cf4d-79b0-43ad-bedd-3f75c3242264">1,667</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTgtNy0xLTEtMA_86083ccd-022c-42b4-8d21-6afa95583b8e">890</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTktMS0xLTEtMA_bafb0a19-5bcd-4fbc-a47e-79fbb1fc64be">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTktMy0xLTEtMA_78df581f-3fcd-49e4-8814-1b2e29cb9ae3">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTktNS0xLTEtMA_796ead94-7b39-406b-9979-7c31214e4294">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTktNy0xLTEtMA_110eba59-8d09-48d7-bdd4-4c3c32eb2e99">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMjAtMS0xLTEtMA_796b8d7b-7529-4c6b-b870-76449e8d78a8">505</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMjAtMy0xLTEtMA_03e4f191-a790-480e-bb4a-0c3b2d48cacb">568</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMjAtNS0xLTEtMA_20365183-f8ad-4c01-898a-ac221495dde7">1,605</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMjAtNy0xLTEtMA_b4b0ac81-e8df-4d00-ad93-4dd2b67dec04">852</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfMjQyMA_dbabc2b8-17d5-491d-ba03-d288c24f334e" continuedAt="ieee6182c88014e35b20d0307a469c253" escape="true">Net revenues by major service were as follows:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><ix:continuation id="ieee6182c88014e35b20d0307a469c253"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.788%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8c3304c5b24c6698ca6cf99acb40f8_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfMy0xLTEtMS0w_d556b1cb-227c-4e6f-bab8-e1e7d6b97b60">1,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17915cdcfe1c4db0a3f41d20dcfb007b_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfMy0zLTEtMS0w_6884d84c-7ba3-430b-b741-28022f633a5d">1,055</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d583a2157a4461d84a68397c4aa9749_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfMy01LTEtMS0w_a63bf10a-a548-4004-8441-418a1bd7bfc9">3,392</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3b6e41b6d84008a6bbdb8a925027f4_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfMy03LTEtMS0w_061dc26f-a97c-48ff-90b1-46f631de0f57">2,812</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i534453e984bd4a6185b2140d89a55c40_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNC0xLTEtMS0w_14d2e2e0-2d80-442a-96c0-d4ade650bdf7">709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02fec1695bc94fb4b799f16df36a277a_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNC0zLTEtMS0w_78d8195d-28c1-426a-b285-6c2ee07db408">965</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e86467c36344bbf941f4c24f2436504_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNC01LTEtMS0w_cb9f060d-a688-430b-8b9e-067949ee9b02">2,048</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe9af73476c6465093764838622b5110_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNC03LTEtMS0w_dae31153-c694-406e-9cd4-1dc5ff771c1e">1,571</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2828a531f0ab4def88e14f6e27424f8c_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNS0xLTEtMS0w_4b878580-61cc-4211-afea-2ed337719c69">646</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2adc13627b04c52868f7d8eaae852b7_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNS0zLTEtMS0w_53370cae-ceba-4e86-b2a7-a8e9140dce47">556</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1864ddab8bfd440b964803911e9124ec_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNS01LTEtMS0w_3c13bc17-1b0e-4afd-956b-4b59a331f144">1,972</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd315ce487f94328842945669408cac6_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNS03LTEtMS0w_3826cdec-4f67-4254-8fe9-685040d35133">1,491</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5e43ad9212f4e578d1fb6094dc932e7_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNi0xLTEtMS0w_bc8bdf6f-76c7-44b4-babb-653ba0988167">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f86920b99e47a8acf4dd4cfafd0615_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNi0zLTEtMS0w_790cbaf9-5a0f-4969-936f-a44671ea8073">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id771c1175b884bbca27eafcc9a648410_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNi01LTEtMS0w_aa84b43f-d46d-4155-84eb-0334100ea95c">408</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af7c6063aec42389819aab63062e23e_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNi03LTEtMS0w_3df2b0a5-1461-4cd9-8e11-67532eb89211">343</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i048fe873cef04ee19ea2b9317513136c_D20210701-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNy0xLTEtMS0w_0ee5e938-4fc9-4f1d-8389-187610b7f222">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id44bc581e9ad4e67838ca4c123d65f5d_D20200701-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNy0zLTEtMS0w_bcd15b63-a5dc-4713-bdaf-c00965312b09">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b5cbcbc73384532a5dd309d11856852_D20210101-20210930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNy01LTEtMS0w_52b57de4-f492-40f1-8329-30c05963e13f">224</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a06c98f38fb4642a99ba9b0eeb69e85_D20200101-20200930" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNy03LTEtMS0w_22ca373b-b1ef-4c45-9062-d35f82c5d72b">218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfOC0xLTEtMS0w_60b8dff2-40e4-490b-a79c-12d02d2fc48c">2,774</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfOC0zLTEtMS0w_7b611b3a-5316-4320-b11b-5c8c65e046da">2,786</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfOC01LTEtMS0w_48180fa1-ac4c-4def-954a-22b871440fe9">8,044</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfOC03LTEtMS0w_9de88278-2f96-47af-8025-13bd71537078">6,435</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfMTU0OA_5af4f327-c5ef-489c-a585-9a9b6826a570" continuedAt="i7c2a6e21b266408a8ca1f0cabfc7fe18" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7c2a6e21b266408a8ca1f0cabfc7fe18" continuedAt="ib78616b9d334461c9a2ffaca4340c17d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over <ix:nonFraction unitRef="number" contextRef="i1952efe7be544fe591e6315daee82f95_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfOTk_20db9a67-be49-456b-ab59-d364e28840da"><ix:nonFraction unitRef="number" contextRef="ie5df9bb39dd94d1da9a87c3331dd1fc4_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfOTk_4ac88b5e-2b4b-471f-8ef2-6969bb19344a"><ix:nonFraction unitRef="number" contextRef="i21b8ec4029e44a988d269c3126940283_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfOTk_b3fcc3fb-536d-4b39-945d-8d6836cc9463"><ix:nonFraction unitRef="number" contextRef="i58a1a67d34d240d7b603eb953adc9835_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfOTk_c2ba5ea6-6802-46a1-bf05-00c534754c5a">95</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total net revenues for the three and nine months ended September&#160;30, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib78616b9d334461c9a2ffaca4340c17d" continuedAt="i9ef862ace3664a5c8dffacedf969a3ca"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfMTU0NQ_d897a2fe-c1d8-4267-8e42-044579d5d533" continuedAt="i42018f9d8ecc421aa9a00f2173d37040" escape="true">The approximate percentage of net revenue by type of customer was as follows:</ix:nonNumeric></span></div><ix:continuation id="i42018f9d8ecc421aa9a00f2173d37040"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie3acee20262b40d6b10903fb4afbe132_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMy0xLTEtMS0w_de71c18b-d632-42f7-be70-0a63bb030915">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia0e31adde43d46de97147148481af848_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMy0zLTEtMS0w_ea87d3cf-7e1e-435a-8b80-952301d6ff94">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia72c419b8ec64dba8571eec8d685eec3_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMy01LTEtMS0w_9d9b1d8d-d7ec-4abe-beb1-aba2ff5fe186">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a3d767b7d0c47bc9a4b5019b47e5bd9_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMy03LTEtMS0w_90ade04a-4f79-483b-9407-1af34a22d3f1">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d3091cfcdc640a6a96229526a63c9f3_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNC0xLTEtMS0w_93486b4f-e53b-478c-a23c-f46d959ef5f8">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iee01dc9e07e243b99354760cac0d4d32_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNC0zLTEtMS0w_4b67a934-4ba8-403e-b9cc-f0dea3e83a56">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3598a5751c24825831703722082a2cb_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNC01LTEtMS0w_229e1238-9238-4227-9a35-71f75d197e33">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i850f59cbde9f4344a88ebab6b1fc075b_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNC03LTEtMS0w_62cb17c4-2a74-4e1c-954f-c449539ba3c2">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87cba5d430f245a68bd0315c18e62086_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNS0xLTEtMS0w_01162123-d5b6-47f9-a142-def909335946">43</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic42802853a4a454699bda9d6dbae93ab_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNS0zLTEtMS0w_646213d0-a8ec-4304-9072-9a8ff0724140">35</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iddb27e7850474298b896873be1ac713d_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNS01LTEtMS0w_65bb33c6-a15e-47c3-8198-f63a63e7c11b">42</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98c4699f13a94272b16b1d74570e68fc_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNS03LTEtMS0w_3a9233b9-1f8e-485e-91de-2f9a350c37bb">36</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1213d16766764ac4b9e354347e502602_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNi0xLTEtMS0w_02da4fff-388d-4855-bca4-4add16a5fd3a">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90fe5caa0f59404680b57eb172b7feb0_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNi0zLTEtMS0w_ed4d6fcc-352a-41c4-b459-40b662bd55c7">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if617a3f687c7470babc0347a121c9e4d_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNi01LTEtMS0w_b817a9a3-f3ba-4451-ad2b-30fa1ede7186">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6c8d850bc0b470f9ed7d27f080d7d3e_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNi03LTEtMS0w_dbd0c2e1-2208-412d-9e92-cfbdbaea0f15">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5bda4a72cc2448eb1edd6aaf8e616da_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNy0xLTEtMS0w_309270a2-30c4-41b5-b0e4-f6f0eef892b2">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5aa4bbd4b0f842faa92582711d35880e_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNy0zLTEtMS0w_5303a538-fb99-4c4d-a6c6-03fc3f830601">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4f839de76b0f434eb190d581d2836010_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNy01LTEtMS0w_bc07ed6c-34d4-4ec6-a853-efa13dd3cdb9">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f651cc6ea1b471f8b7f8940efacc318_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNy03LTEtMS0w_31fd77b4-51a5-4c4a-a872-4e1925d9c392">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i78617df876924999b6673b596d4ec4bc_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOC0xLTEtMS0w_fb709873-452f-4095-a00e-cbbc094a4916">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7fa9139c7bb4f4499a1a4264ac05a1f_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOC0zLTEtMS0w_45cb033d-293b-456c-91d4-060e55d8c29a">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37b7a8a12d95433386c13963200412ff_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOC01LTEtMS0w_0e699b5e-282f-4ada-b726-d8a3e986861b">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b51a1e39a2f490fa85b27203276ef0c_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOC03LTEtMS0w_0a84ccd1-9467-4235-8b02-2716d4be158f">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida9a845517b14f2d85f82da38a53f275_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOS0xLTEtMS0w_d0a43838-05e4-4718-9760-98f2ed069866">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia12055ea11a54f1890616da76bad2b80_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOS0zLTEtMS0w_1687a60e-166b-4758-8451-bf26128951b0">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad4b891b3a584530a9cf508df0670b51_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOS01LTEtMS0w_7b86dbe6-91cd-4910-8bf9-8d712c538036">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88caa1b81b364b9fa199959abd7ed0d2_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOS03LTEtMS0w_93eda222-9cb7-4b3b-8179-317258c4a32f">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86a46fb310654cc4b552d2896fa0e4ce_D20210701-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTAtMS0xLTEtMA_10eacbf3-861a-49c7-ab18-90fdf801b42c">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia1e1c8f2d240445c9b8dcf6436139569_D20200701-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTAtMy0xLTEtMA_d35cccc0-a767-47ab-9389-3a86e60c7a7c">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40e0c746fc364568aca78621cf9fa220_D20210101-20210930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTAtNS0xLTEtMA_6d4c2d0c-a05d-485a-8a29-10613ebe9326">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea67ec5cbe4542ba8a94aa5c96aa362d_D20200101-20200930" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTAtNy0xLTEtMA_0d3163cc-3997-48be-974e-a1236fbf15cc">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTEtMS0xLTEtMA_8030ed3e-e54c-40ae-8a58-00f9fea71d45">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTEtMy0xLTEtMA_ebad5262-5630-4d6c-b573-5e336cf8d3fe">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTEtNS0xLTEtMA_2a15981c-635a-4ed9-825a-c58118a5d270">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTEtNy0xLTEtMA_74529a44-2f8d-4dd5-aa60-922ccc98fe9b">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="dgx:AccountsReceivableDisaggregationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfMTU1MQ_9ee5f490-0688-473f-b198-dd669b7b5338" continuedAt="ied56a23abce04b5d9683319bc313a821" escape="true">The approximate percentage of net accounts receivable by type of customer was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:5pt;text-align:center"><ix:continuation id="i9ef862ace3664a5c8dffacedf969a3ca"><ix:continuation id="ied56a23abce04b5d9683319bc313a821"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieea0bd6309b146afa41000f43a995747_I20210930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfMi0xLTEtMS0w_83c75467-6b38-4a37-9b24-79c70777ff37">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if642e1ad2c084744ab7670f7a6352dfa_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfMi0zLTEtMS0w_5d9a03d5-6825-456b-aade-706fce209551">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i104ac329ccf749b18a18c82c37f79955_I20210930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfMy0xLTEtMS0w_1ddd183f-f805-4926-adc5-6145b2e57a82">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b2258e70f904ecc8314266db2b2b0f9_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfMy0zLTEtMS0w_f4be3356-60f8-4e94-a211-8f1178bfb65e">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6bb57ee8aae4e0bb388398be620f121_I20210930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNC0xLTEtMS0w_e75713e9-99f6-4029-a382-806477ce00e8">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i22ec3dd09cf4437ea06fcdec19d1d6fd_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNC0zLTEtMS0w_d0636052-56b8-413d-ba1e-cdd13cefafa7">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iead44cad5e60407b9beab7d6f4ff0009_I20210930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNS0xLTEtMS0w_b54e9291-f34e-4af3-bd87-f3eeee2b323a">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68612d24937c4836b820313794721e70_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNS0zLTEtMS0w_b694ff06-43a4-49c9-874b-223ceda7f75d">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2caebe9557194cc5b637ac04007df5c4_I20210930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNi0xLTEtMS0w_7736d4d8-ac90-41fa-9045-90caa23fcd77">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i826e2caf620945adb4857cc3ca809c61_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNi0zLTEtMS0w_a291b0f2-d5af-4102-908c-ccd7a0658c26">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if655a31fafc740b5b2318f68e86b82a3_I20210930" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNy0xLTEtMS0w_57ab133a-c724-4039-982e-788b857479bf">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if312089fa21e46d6b6f06ec4ba94bd10_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNy0zLTEtMS0w_fb9263c9-d00e-4bdc-ab5c-6592e003a21f">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfOC0xLTEtMS0w_dbd46398-d12f-4efe-8685-076a239eaeb2">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfOC0zLTEtMS0w_2877494d-58bf-4741-ad53-8394441e5c60">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMTAxNg_86c26f25-b43f-4f42-bc24-fd48f8a9cd0a" continuedAt="if01755d1da674e73a327b515f908c72c" escape="true">TAXES ON INCOME</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if01755d1da674e73a327b515f908c72c" continuedAt="id398fd05e60f481cb22eaba049fc35bd">&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2021 and 2020, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTY_f2e41bce-f482-4f58-a36c-69161035ae7a">23.4</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMTAz_e74d3a85-dc7a-4124-af15-d425e1b50048">23.7</ix:nonFraction>%, respectively.  The effective income tax rate for the three months ended September&#160;30, 2021, benefited from a $<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTg4NA_cf3680cf-eeba-4e65-a412-3186aa4e952b">6</ix:nonFraction>&#160;million income tax benefit associated with changes in reserves for uncertain tax positions, and $<ix:nonFraction unitRef="usd" contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTM0NTg0ODgzODIxOQ_5b7be292-fcaa-409e-bd55-8b03b11f574a">6</ix:nonFraction> million of excess tax benefits associated with stock-based compensation.  The effective income tax rate for the three months ended September&#160;30, 2020, benefited from a lower effective income tax rate, <ix:nonFraction unitRef="number" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="3" name="dgx:EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTk1MA_f456fd9c-fc67-4b52-bf47-4e8cd9c08fcc">11.8</ix:nonFraction>%, associated with a $<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTM0NTg0ODgzNzc2MA_e7aa25fc-05de-424d-8782-5f2b216a86c2">70</ix:nonFraction>&#160;million gain recognized as a result of the remeasurement of the Company's previously held equity interest in Mid America Clinical Laboratories, LLC ("MACL") to fair value, and $<ix:nonFraction unitRef="usd" contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTM0NTg0ODgzNzY5Mg_c141cafb-97e3-46bf-9be2-76c5a36cb849">3</ix:nonFraction> million of excess tax benefits associated with stock-based compensation.</ix:continuation></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><ix:continuation id="id398fd05e60f481cb22eaba049fc35bd"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021 and 2020, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfNTkz_5940246b-4ec9-4004-9129-5161d575c481">23.1</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfNjAw_b0020e28-1c8d-4dbe-8d81-4e5225eddf27">23.9</ix:nonFraction>%, respectively.  For the nine months ended September&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, <ix:nonFraction unitRef="number" contextRef="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfNzI3_15bb1350-34ff-42b9-910f-dab38c736762">17.6</ix:nonFraction>%, on the gain on the sale of the Company's <ix:nonFraction unitRef="number" contextRef="i246ee08978dd4f9281e49cde4052adb5_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfNzcy_996e4619-c29b-427d-af3c-26c7dd292ba5">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions (see Note 5). For the nine months ended September&#160;30, 2020, the effective income tax rate benefited from a lower effective income tax rate, <ix:nonFraction unitRef="number" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="3" name="dgx:EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTk2Mw_c9761ae4-e7d4-49b4-b637-c8bd2c0ca04f">11.8</ix:nonFraction>%, associated with a $<ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTM0NTg0ODgzODUzNg_e7aa25fc-05de-424d-8782-5f2b216a86c2">70</ix:nonFraction>&#160;million gain recognized as a result of the remeasurement of the Company's previously held equity interest in MACL to fair value.  In addition, the effective income tax rate benefited from $<ix:nonFraction unitRef="usd" contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTk4OA_554827a1-5d18-4bbe-b5d9-e62c995faf7d"><ix:nonFraction unitRef="usd" contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930" decimals="-6" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTk4OA_a02ccdc3-8154-4289-94fb-79daf6e9fca3">15</ix:nonFraction></ix:nonFraction>&#160;million of excess tax benefits associated with stock-based compensation arrangements for both the nine months ended September&#160;30, 2021 and 2020.</span></ix:continuation></div><div id="idaf6b320c3f54d66937b4b767300a7e4_1110"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF8zODQ4MjkwNjk4ODQ5_4644299d-9fd3-4212-a5eb-786c3967607f" continuedAt="i0340c72b1a4142f4a24f0a753ab5aa26" escape="true">SUBSEQUENT EVENT</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0340c72b1a4142f4a24f0a753ab5aa26">&#160;&#160;&#160;&#160;During October 2021, the Company amended its $<ix:nonFraction unitRef="usd" contextRef="i9fb7b07b086a4309b9d46148ab2e12c2_I20211022" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NDAy_8879b6c4-4261-4e6f-94dc-d28be15637e0">600</ix:nonFraction>&#160;million secured receivables credit facility in order to extend the maturity dates for each underlying commitment by one year while maintaining the aggregate borrowing capacity under the secured receivables credit facility at $<ix:nonFraction unitRef="usd" contextRef="i9fb7b07b086a4309b9d46148ab2e12c2_I20211022" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NDM0_8879b6c4-4261-4e6f-94dc-d28be15637e0">600</ix:nonFraction>&#160;million.  Under the secured receivables credit facility, the Company can borrow against a $<ix:nonFraction unitRef="usd" contextRef="id6f992896609491290214875ab35a9d6_I20211022" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NDU0_75da8b42-54a5-408f-a9eb-bc53cf70a0e5">250</ix:nonFraction>&#160;million loan commitment maturing October 2022 and a $<ix:nonFraction unitRef="usd" contextRef="i47405452b21d4961b150a63aba4933d5_I20211022" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NTA4_7848acf0-c4d2-4385-8ec3-7eb8c445954c">250</ix:nonFraction>&#160;million loan commitment maturing October 2023.  Additionally, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="ic3263481a80b4afdbad8e84b720b498c_I20211022" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NTY2_0b1e984c-e867-42ed-8838-14f024c9844a">100</ix:nonFraction>&#160;million of letters of credit through October 2023.  Borrowings under the secured receivables credit facility are collateralized by certain domestic receivables.  Interest on borrowings under the secured receivables credit facility are based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of <ix:nonFraction unitRef="number" contextRef="ia8f19a89fa884900aca21d4657c555f7_D20211022-20211022" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NjM0_3f2599e4-416a-49c4-be6f-bc8b0ca1a63c">0.725</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i2f807339735446ff8d0868243f7b30d8_D20211022-20211022" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NjU5_8d18b936-2642-4cad-b140-841fb3100092">0.80</ix:nonFraction>%.</ix:continuation></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Information Services</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics empowers people to take action to improve health outcomes.  We use our extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  Our diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We provide services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  We offer the broadest access in the United States to diagnostic information services through our nationwide network of laboratories, patient service centers and phlebotomists in physician offices and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  We are the world's leading provider of diagnostic information services.  We provide interpretive consultation with one of the largest medical and scientific staffs in the industry.  Our DIS business makes up greater than 95% of our consolidated net revenues.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our revenue performance for the DIS business based upon, among other factors, volume (measured by test requisitions) and revenue per requisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each requisition accompanies patient specimens, indicating the test(s) to be performed and the party to be billed for the test(s).   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue per requisition is impacted by various factors, including, among other items, the impact of fee schedule changes (i.e., unit price), test mix, payer mix, and the number of tests per requisition. Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix.  Therefore, we believe that information related to changes in these metrics from period to period are useful information for investors as it allows them to assess the performance of the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Diagnostic Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Diagnostic Solutions ("DS") businesses, which represent the balance of our consolidated net revenues, we offer a variety of solutions for life insurers and healthcare organizations and clinicians.  We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third Quarter Highlights</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:60.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,774</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,786</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,703</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,709</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per requisition change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.4)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.3%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$71</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$77</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$505</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$568</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.02</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.14</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$561</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$862</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further discussion of the year-over-year changes for the three months ended September&#160;30, 2021 compared to the three months ended September&#160;30, 2020, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID - 19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a novel strain of coronavirus (COVID-19) continues to impact the economy of the United States and other countries around the world, we are committed to being a part of the coordinated public and private sector response to this unprecedented challenge. We have made substantial investments to expand the amount of COVID-19 testing available to the country. We have been effectively managing challenges in the global supply chain; and, at this point, we have sufficient supplies to conduct our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2020 and 2021, our testing volume and revenues were materially impacted by the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Beginning in March 2020, we experienced a material decline in base testing volume (which excludes COVID-19 testing) due to the COVID-19 pandemic.  The decrease in base testing volume was driven by federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19, a significant reduction in physician office visits, the cancellation of elective medical procedures, customers closing or severely curtailing their operations (voluntarily or in response to government orders), and the adoption of work-from-home policies, all of which have had, and may continue to have, an impact on our operating results, financial position and cash flows.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During May and June 2020, we began to experience a recovery in base testing volume, which continued in 2021.  The recovery trend stalled somewhat in August 2021, but resumed in September 2021.  The recovery has been driven by people returning to the healthcare system as well as contributions from new Professional Laboratory Services offerings.  For the first, second and third quarters of 2021, our base testing volume, excluding volume associated with recent acquisitions, was 2.8% below, 1.9% above and 3.8% above our historical first, second and third quarter of 2019 levels, respectively.  Recent agreements associated with our Professional Laboratory Services offerings contributed 5.2%, 5.8% and 5.2% volume growth compared to 2019 for the first, second and third quarters of 2021, respectively.  Unless there is a change in the severity of the COVID-19 pandemic, we believe that there will be a continued return to healthcare with, in some cases, patients pursuing care delayed during the COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Beginning in the second quarter of 2020, we experienced growing demand for COVID-19 testing services and we expanded our capacity throughout 2020 in order to satisfy the demand, which has had a significant impact on our testing volumes. During 2021, demand for our COVID-19 testing has generally fluctuated in line with changes in the prevalence of the virus and related variants.  We expect demand to trend down through the remainder of 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our revenue per requisition has been positively impacted by COVID-19 molecular testing. In April 2020 the Centers for Medicare and Medicaid Services ("CMS") announced that it would increase the reimbursement for certain COVID-19 molecular tests making use of high-throughput technologies developed by the private sector that allow for increased testing capacity, faster results, and more effective means of combating the spread of the virus to $100 per test, effective April 14, 2020. Beginning January 1, 2021, Medicare changed the base reimbursement rate for COVID-19 diagnostic tests run on high-throughput technologies to $75 per test with an additional payment of $25 per test if the laboratory (1) completes the test in two calendar days or less and (2) completes the majority of its COVID-19 tests that use high throughput technology in two calendar days or less for all of its patients in the previous month.  Certain healthcare insurers have now moved to a similar reimbursement model for COVID-19 molecular tests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the COVID-19 pandemic&#8217;s impact on our consolidated results of operations, financial position and cash flows will be primarily driven by: the severity and duration of the COVID-19 pandemic; healthcare insurer, government, and client payer reimbursement rates for COVID-19 molecular testing; the COVID-19 pandemic&#8217;s impact on the U.S. healthcare system and the U.S. economy; and the timing, scope and effectiveness of federal, state and local governmental responses to the COVID-19 pandemic, including the impact of vaccination efforts. We may also be impacted by changes in the severity of the COVID-19 pandemic at different times in the various cities and regions where we operate and offer services. Even as the COVID-19 pandemic moderates over time and the business and social distancing restrictions ease, we may continue to experience similar effects to our businesses, consolidated results of operations, financial position and cash flows.  In the longer term, given the many challenges that hospitals will face, we may have more opportunities to partner with hospitals to help achieve their laboratory strategies, and the COVID-19 pandemic may also be a further catalyst for consolidation in the laboratory testing industry.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of the Outreach Laboratory Services Business of Mercy Health</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 1, 2021, we completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225 million.  The acquired business is included in our DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Note 4 to the interim unaudited consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Ownership Interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Solutions") to IQVIA Holdings, Inc. ("IQVIA")</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, we sold our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, our clinical trials central laboratory services joint venture, to IQVIA, our joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, we accounted for our minority interest as an equity method investment.  As a result of the transaction, during the nine months ended September&#160;30, 2021, we recorded a $314&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the nine months ended September&#160;30, 2021, we also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, we will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Note 5 to the interim unaudited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accelerated Share Repurchase Agreements ("ASRs")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;In April 2021, we entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of our common stock as part of our share repurchase program.  Each of the ASRs was structured to permit us to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of our common stock during the repurchase period, less a fixed discount. During the nine months ended September&#160;30, 2021, we paid $1.5&#160;billion to the financial institutions and received 9.1&#160;million shares of our common stock, at an initial price of $132.27 per share for a value of $1.2&#160;billion, which represents 80% of the total value of shares to be repurchased under the ASRs.  The ASR contracts will be completed during the fourth quarter of 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details regarding the ASRs and our repurchases of our common stock, see Note 9 to the interim unaudited consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Sequestration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the suspension of Medicare sequestration, which has resulted in a small benefit to us in the form of higher reimbursement rates for diagnostic testing services performed on behalf of Medicare beneficiaries, was extended through the end of 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Invigorate Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are engaged in a multi-year program called Invigorate, which is designed to reduce our cost structure and improve our performance.  We currently aim annually to deliver savings of approximately 3% of our costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invigorate has consisted of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, we have identified key themes to change how we operate including reducing denials and patient price concessions; further digitizing our business; standardization and automation; and optimization initiatives in our lab network and patient service center network.  We believe that our efforts to standardize our information technology systems, equipment and data also foster our efforts to strengthen our foundation for growth and support the value creation initiatives of our clinical franchises by enhancing our operational flexibility, empowering and enhancing the customer experience, facilitating the delivery of actionable insights and bolstering our large data platform.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, we incurred $47&#160;million of pre-tax charges under our Invigorate program primarily consisting of systems conversion and integration costs, all of which result in cash expenditures. Additional restructuring charges may be incurred in future periods as we identify additional opportunities to achieve further cost savings.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There have been no significant changes to our critical accounting policies from those disclosed in our 2020 Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of new accounting standards, if any, is discussed in Note 2 to the interim unaudited consolidated financial statements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The impact of recent accounting pronouncements not yet effective on our consolidated financial statements, if any, is also discussed in Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables set forth certain results of operations data for the periods presented:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,603&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,199&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,259&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income (expense), net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(483)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share attributable to Quest Diagnostics' common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM - Not Meaningful</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table sets forth certain results of operations data as a percentage of net revenues for the periods presented:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:56.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended September&#160;30, 2021 were affected by certain items that on a net basis increased diluted earnings per share by $0.06 as follows:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $41&#160;million (a $42&#160;million gain recorded in other income, net and a $3 million gain recorded in equity in earnings of equity method investees, net of taxes, partially offset by $4 million of costs recorded in selling, general and administrative expenses), or $0.25 per diluted share, primarily due to gains associated with changes in the carrying value of our strategic investments, partially offset by costs associated with donations, contributions and other financial support through Quest for Health Equity, our initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $6 million, or $0.04 per diluted share, recorded in income tax expense; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $25 million, or $0.15 per diluted share; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $13 million ($7 million in cost of services and $6&#160;million in selling, general and administrative expenses), or $0.08 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the nine months ended September&#160;30, 2021 were affected by certain items that on a net basis increased diluted earnings per share by $1.50 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain recorded in other income, net of $314 million, or $2.00 per diluted share, on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $28&#160;million (a $42&#160;million gain recorded in other income, net, partially offset by $9 million of costs recorded in selling, general and administrative expenses, and $5 million of net charges recorded in equity in earnings of equity method investees), or $0.18 per diluted share, primarily due to gains associated with changes in the carrying value of our strategic investments, partially offset by costs associated with donations, contributions and other financial support through Quest for Health Equity, and a non-cash impairment charge to the carrying value of an equity method investment; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $15 million, or $0.11 per diluted share, recorded in income tax expense; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $79 million ($77 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes) or $0.46 per diluted share;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $51 million ($26 million in cost of services and $25 million in selling, general and administrative expenses), or $0.30 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $4 million in cost of services, or $0.03 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic including incremental costs incurred to protect the health and safety of our employees and customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For both the three and nine months ended September&#160;30, 2021, diluted earnings per share benefited from the impact of the ASRs on our weighted average shares outstanding as compared to the prior year periods.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended September 30, 2020 were affected by certain items that on a net basis reduced diluted earnings per share by $0.17 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net pre-tax charges of $69 million (charges of $65 million in other operating expense (income), net, $3&#160;million in cost of services and $1 million in equity in earnings of equity method investees, net of taxes), or $0.39 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic, including the reversal of $65&#160;million of income previously recognized during the second quarter of 2020 attributable to the receipt of funds from the government that were appropriated to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") and, to a lesser extent, incremental costs incurred primarily to protect the health and safety of our employees and customers;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $30 million ($27 million in amortization of intangible assets and $3 million in equity in earnings of equity method investees, net of taxes) or $0.16 per diluted share; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $18 million ($11 million in cost of services and $7&#160;million in selling, general and administrative expenses), or $0.10 per diluted share, representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain of $70 million, or $0.46 per diluted share, recognized in other income, net based on the difference between the fair value and the carrying value of an equity interest; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $3 million, or $0.02 per diluted share, recorded in income tax expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the nine months ended September 30, 2020 were affected by certain items that on a net basis reduced diluted earnings per share by $0.44 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $86 million ($77 million in amortization of intangible assets and $9 million in equity in earnings of equity method investees, net of taxes) or $0.47 per diluted share; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $52 million ($38&#160;million of charges in cost of services, $8&#160;million of charges in selling, general and administrative expenses and $8&#160;million of charges in other operating expense (income), net, partially offset by a $2&#160;million gain in equity in earnings of equity method investees, net of taxes), or $0.29 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with a one-time payment to eligible employees to help offset expenses they incurred as a result of COVID-19, certain asset impairment charges, and incremental costs incurred primarily to protect the health and safety of our employees and customers; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $43&#160;million ($21 million in cost of services and $22&#160;million in selling, general and administrative expenses), or $0.25 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain of $70 million, or $0.46 per diluted share, recognized in other income, net based on the difference between the fair value and the carrying value of an equity interest; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $15&#160;million, or $0.11 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the three months ended September&#160;30, 2021 decreased by 0.4% compared to the prior year period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the three months ended September&#160;30, 2021 decreased by 0.2% compared to the prior year period.  For the three months ended September&#160;30, 2021:</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acquisitions contributed approximately 1.5% to DIS revenue with organic revenue (revenue excluding the impact of recent acquisitions) down by 1.7% compared to the prior year period.  The decrease in organic revenue was driven by a decrease in COVID-19 molecular testing, partially offset by growth in the base business.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 14.3% compared to the prior year period, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in the third quarter of 2019, revenues in the base business, excluding revenue associated with recent acquisitions, increased by 1.7%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 2.3% revenue growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume increased by 5.3% with organic volume and acquisitions contributing approximately 3.2% and 2.1%, respectively.  Organic volume growth was driven by growth in the base business, partially offset by a decrease in volume associated with COVID-19 molecular testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) continued to recover and was up 13.6% compared to the prior year period, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in the third quarter of 2019, testing volume in the base business, excluding volume associated with recent acquisitions, increased 3.8%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 5.2% volume growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition decreased by 5.4% compared to the prior year period driven in large part by the decrease in COVID-19 molecular testing and growth in our Professional Laboratory Services engagements, which carry a lower revenue per requisition than the average for the remainder of the DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the nine months ended September&#160;30, 2021 increased by 25.0% compared to the prior year period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the nine months ended September&#160;30, 2021 increased by 25.8% compared to the prior year period.  For the nine months ended September&#160;30, 2021:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Organic revenue and acquisitions contributed approximately 23.6% and 2.2%, respectively, to DIS revenue growth compared to the prior year period.  Organic revenue growth was driven by growth in the base business and demand for COVID-19 molecular testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 24.2% compared to the prior year period, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in the first nine months of 2019, revenues in the base business, excluding revenue associated with recent acquisitions, increased by 0.1%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 2.3% revenue growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume increased by 22.9% with organic volume and acquisitions contributing approximately 19.2% and 3.7%, respectively.  Organic volume growth was driven by growth in the base business and, to a lesser extent, demand for COVID-19 molecular testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) continued to recover and was up 22.6% compared to the prior year period, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in the first nine months of 2019, testing volume in the base business, excluding volume associated with recent acquisitions, increased by 1.0%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 5.4% volume growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition increased by 2.2% compared to the prior year period driven, in large part, by COVID-19 molecular testing, partially offset by growth in our Professional Laboratory Services engagements, which carry a lower revenue per requisition than the average for the remainder of the DIS business.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services consists principally of costs for obtaining, transporting and testing specimens as well as facility costs used for the delivery of our services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2021, cost of services increased by $90 million compared to the prior year period.  The increase was primarily driven by higher compensation and benefit costs, higher variable expenses related to increased testing volumes, expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19, and additional operating costs associated with our acquisitions, partially offset by lower supplies expense as a result of test mix.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, cost of services increased by $790 million compared to the prior year period.  The increase was primarily driven by higher variable expenses related to increased testing volumes as well as test mix and a higher supply cost associated with COVID-19 testing, higher compensation and benefits costs, and, to a lesser extent, additional operating costs associated with our acquisitions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses ("SG&amp;A")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A consist principally of the costs associated with our sales and marketing efforts, billing operations, credit loss expense and general management and administrative support as well as administrative facility costs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $31 million for the three months ended September&#160;30, 2021, compared to the prior year period, primarily driven by higher variable expenses to support our increase in testing volumes, partially offset by lower performance-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $160 million for the nine months ended September&#160;30, 2021, compared to the prior year period, primarily driven by higher variable expenses to support our increase in testing volumes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Amortization Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2021, amortization expense decreased by $2 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, amortization expense was flat compared to the prior year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Operating Expense (Income), Net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense (income), net includes miscellaneous income and expense items and other charges related to operating activities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2020, other operating expense (income), net primarily represents the reversal of $65 million of income that was previously recognized during the three months ended June 30, 2020 relating to the receipt of funds that were appropriated to healthcare providers under the CARES Act.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, other operating expense (income), net primarily represents impairment charges due to the impact of the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest expense, net decreased for the three months ended September&#160;30, 2021 compared to the prior year period, primarily due to lower average outstanding indebtedness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest expense, net decreased for the nine months ended September&#160;30, 2021 compared to the prior year period, primarily due to lower average outstanding indebtedness and, to a lesser extent, lower interest rates due to recent refinancing transactions, including the termination of our interest rate swap agreements in April 2020, which resulted in a deferred gain that is being amortized as a reduction of interest expense, net over the remaining term of the associated debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Income, Net </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other income, net represents miscellaneous income and expense items related to non-operating activities, such as gains and losses associated with investments and other non-operating assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2021, other income, net includes $42&#160;million in gains associated with changes in the carrying value of our strategic investments.  For the three months ended September&#160;30, 2020, other income, net includes a $70&#160;million gain recognized as a result of the remeasurement of our previously held equity interest in Mid America Clinical Laboratories, LLC ("MACL") to fair value in conjunction with our acquisition of the remaining 56% interest in MACL from our joint venture partners.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, other income, net includes a $314&#160;million pre-tax gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, our clinical trials central laboratory services joint venture, to IQVIA, our joint venture partner and $42&#160;million in gains associated with changes in the carrying value of our strategic investments. For the nine months ended September&#160;30, 2020, other income, net includes a $70&#160;million gain recognized as a result of the remeasurement of our previously held equity interest in MACL.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Income Tax Expense </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the three months ended September&#160;30, 2021 and 2020 was $153 million and $177 million, respectively.  The decrease in income tax expense for the three months ended September&#160;30, 2021 compared to the prior year period was primarily driven by a decrease in income before income taxes and equity in earnings of equity method investees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2021 and 2020, the effective income tax rate was 23.4% and 23.7%, respectively.  The effective income tax rate for the three months ended September&#160;30, 2021, benefited from a $6 million income tax benefit associated with changes in reserves for uncertain tax positions, and $6 million of excess tax benefits associated with stock-based compensation.  The effective income tax rate for the three months ended September&#160;30, 2020, benefited from a lower effective income tax rate, 11.8%, associated with a $70&#160;million gain recognized as a result of the remeasurement of our previously held equity interest in MACL to fair value, and $3 million of excess tax benefits associated with stock-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the nine months ended September&#160;30, 2021 and 2020 was $483 million and $269 million, respectively.  The increase in income tax expense for the nine months ended September&#160;30, 2021 compared to the prior year period was primarily driven by an increase in income before income taxes and equity in earnings of equity method investees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021 and 2020, the effective income tax rate was 23.1% and 23.9%, respectively.  For the nine months ended September&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions. For the nine months ended September&#160;30, 2020, the effective income tax rate benefited from a lower effective income tax rate, 11.8%, associated with a $70&#160;million gain recognized as a result of the remeasurement of our previously held equity interest in MACL to fair value.  In addition, the effective income tax rate benefited from $15 million of excess tax benefits associated with stock-based compensation arrangements for both the nine months ended September&#160;30, 2021 and 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Equity Method Investees, Net of Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes increased for the three months ended September&#160;30, 2021 by $11 million compared to the prior year period primarily due to recovery in the base business (which excludes COVID-19 testing) of the investees, which was negatively impacted in 2020 as a result of the COVID-19 pandemic, and demand for COVID-19 testing services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes increased for the nine months ended September&#160;30, 2021 by $20 million compared to the prior year period primarily due to the demand for COVID-19 testing services and recovery in the base business of the investees, partially offset by lower equity earnings as a result of the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We address our exposure to market risks, principally the risk of changes in interest rates, through a controlled program of risk management that includes the use of derivative financial instruments.  We do not hold or issue derivative financial instruments for speculative purposes.  We seek to mitigate the variability in cash outflows that result from changes in interest rates by maintaining a balanced mix of fixed-rate and variable-rate debt obligations.  In order to achieve this objective, we have historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements are recognized as an adjustment to interest expense, net.  We believe that our exposures to foreign exchange impacts and changes in commodity prices are not material to our consolidated results of operations, financial position or cash flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2021 and December&#160;31, 2020, the fair value of our debt was estimated at approximately $4.5&#160;billion and $4.6&#160;billion, respectively, principally using quoted prices in active markets and yields for the same or similar types of borrowings, taking into account the underlying terms of the debt instruments.  As of September&#160;30, 2021 and December&#160;31, 2020, the estimated fair value exceeded the carrying value of the debt by $461&#160;million and $597&#160;million, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively.  A hypothetical 10% increase in interest rates (representing 21 basis points as of September&#160;30, 2021 and 17 basis points as of December&#160;31, 2020) would potentially reduce the estimated fair value of our debt by approximately $86&#160;million and $82&#160;million as of September&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our secured receivables credit facility and our senior unsecured revolving credit facility are subject to variable interest rates.  Interest on our secured receivables credit facility is based on either commercial paper rates for highly rated issuers, or LIBOR, plus a spread.  As of September&#160;30, 2021, interest on our senior unsecured revolving credit facility is based on certain published rates plus an applicable margin based on changes in our public debt ratings and our leverage ratio. As such, our borrowing cost under this credit arrangement is subject to fluctuations in interest rates, our leverage ratio and changes in our public debt ratings.  As of September&#160;30, 2021, the borrowing rates under these debt instruments were: for our secured receivables credit facility, commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.825% to 0.950%; and for our senior unsecured revolving credit facility, LIBOR plus 1.125%.  During October 2021, we amended the secured receivables credit facility and the borrowing rates are based on commercial paper rates for highly rated issuers, or, LIBOR, plus a spread, following the amendment, of 0.725% to 0.80%.  As of September&#160;30, 2021, there were no borrowings outstanding under either our $600&#160;million secured receivables credit facility or our $750&#160;million senior unsecured revolving credit facility. The amendment to the secured receivables credit facility did not change the total borrowing capacity under the facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A hypothetical 10% change to the variable rate component of our variable rate indebtedness would not materially change our annual interest expense. &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our outstanding debt, see Note 13 to the audited consolidated financial statements included in our 2020 Annual Report on Form 10-K.  For details regarding our financial instruments and hedging activities, see Note 8 to the interim unaudited consolidated financial statements and Note 15 to the audited consolidated financial statements included in our 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Associated with Investment Portfolio</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in our consolidated balance sheet.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  During the three months ended September 30, 2021, certain of our equity investments became publicly-traded and, based on the readily determinable fair values of such investments, we recognized gains of $42&#160;million in other income, net in our consolidated statement of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We regularly evaluate equity investments that do not have readily determinable fair values to determine if there are any indicators that the investments are impaired.  The carrying value of our equity investments that do not have readily determinable fair values was $6&#160;million as of September&#160;30, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not hedge our equity price risk.  As of September 30, 2021, a 10% change in the fair values of our equity investments with readily determinable fair values would have impacted our consolidated statement of operations by $5&#160;million.  The impact of an adverse movement in equity prices on our holdings in privately held companies cannot be easily quantified, as our ability to realize returns on investments depends on, among other things, the enterprises&#8217; ability to raise additional capital or derive cash inflows from continuing operations or through liquidity events such as initial public offerings, mergers or private sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our September&#160;30, 2021 financial statements, we considered whether the carrying values of our investments were impaired and concluded that no such impairment existed. </span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,171)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,724)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(584)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents consist of cash and highly-liquid short-term investments.  Cash and cash equivalents as of September&#160;30, 2021 totaled $987 million, compared to $1,158 million as of December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2021, approximately 5% of our $987 million of consolidated cash and cash equivalents were held outside of the United States.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by operating activities for the nine months ended September&#160;30, 2021 and 2020 was $1,752 million and $1,464 million, respectively.  The $288 million increase in net cash provided by operating activities for the nine months ended September&#160;30, 2021, compared to the prior year period was primarily a result of:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher operating income in 2021 as compared to 2020; and, to a lesser extent,</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of movements in our working capital accounts; partially offset by </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $354 million increase in income tax payments due to higher operating income in 2021 as compared to 2020; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher performance-based compensation payments in 2021 compared to 2020; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$138 million in proceeds in the 2020 period that we received from funds that were appropriated to healthcare providers under the CARES Act, which funds were returned during the fourth quarter of 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Days sales outstanding ("DSO"), a measure of billing and collection efficiency, was 47 days as of September&#160;30, 2021, 46 days as of December&#160;31, 2020 and 47 days as of September&#160;30, 2020.  Recent changes in our DSO are partially due to fluctuations in our monthly revenue due to the impact of the COVID-19 pandemic.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by (used in) investing activities for the nine months ended September&#160;30, 2021 and 2020 was $248 million and $(604) million, respectively.  This $852 million change in cash provided by (used in) investing activities for the nine months ended September&#160;30, 2021, compared to the prior year period was primarily a result of $755 million of net cash proceeds received from the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, and, to a lesser extent, a $78 million decrease in business acquisitions, net of cash acquired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in financing activities for the nine months ended September&#160;30, 2021 and 2020 was $2,171 million and $447 million, respectively.  This $1,724 million increase in cash used in financing activities for the nine months ended September&#160;30, 2021, compared to the prior year period was primarily a result of: </span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $1,835 million increase in repurchases of our common stock (see "Share Repurchase Program" for further details); and, to a lesser extent,</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $41 million increase in distributions to noncontrolling interest partners; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $36 million decrease in proceeds from the exercise of stock options, which was a result of a decrease in the volume of stock options exercised compared to the prior year; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$253 million of net debt repayments (repayments of debt less proceeds from borrowings) in 2020 compared to $2 million of net debt repayments in 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the nine months ended September&#160;30, 2021, there were no borrowings or repayments under our secured receivables credit facility or senior unsecured revolving credit facility.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the nine months ended September&#160;30, 2020, we completed the issuance of our 2.80% senior notes due June 2031. Additionally, during the nine months ended September&#160;30, 2020, we redeemed in full the outstanding indebtedness under our senior notes due January 2020 and senior notes due March 2020 using net proceeds from the issuance, in December 2019, of our 2.95% senior notes due June 2030, along with cash on hand.  During the nine months ended September&#160;30, 2020, we borrowed $100&#160;million under our secured receivables credit facility and $100&#160;million under our senior unsecured revolving credit facility, which were repaid prior to September&#160;30, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the first three quarters of 2021, our Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, our Board of Directors declared a quarterly cash dividend of $0.56 per common share. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February and March 2021, our Board of Directors increased the size of our share repurchase program by $1&#160;billion.  As of September&#160;30, 2021, $1.3 billion remained available under our share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, we repurchased 12.5 million shares of our common stock for a value of $1.6 billion, including 9.1&#160;million shares repurchased under ASRs.  See "Third Quarter Highlights" above for further details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2020, we repurchased 0.7 million shares of our common stock for $75 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investees</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our equity method investees primarily consist of a diagnostic information services joint venture and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  Such investees are accounted for under the equity method of accounting.  Our investment in equity method investees is less than 5% of our consolidated total assets.  Our proportionate share of income before income taxes associated with our equity method investees is less than 5% of our consolidated income before income taxes and equity in earnings of equity method investees.  We have no material unconditional obligations or guarantees to, or in support of, our equity method investees and their operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our September&#160;30, 2021 financial statements, we considered whether the carrying values of our equity method investments were impaired and, during the nine months ended September&#160;30, 2021, we recorded an $8&#160;million impairment charge for one of the investments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding related party transactions with our equity method investees, see Note 20 to the audited consolidated financial statements in our 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements and Capital Resources </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We estimate that we will invest approximately $400&#160;million during 2021 for capital expenditures, to support and grow our existing operations, principally related to investments in information technology, laboratory equipment and facilities, including COVID-19 testing equipment and completion of our new multi-year laboratory construction in New Jersey, and investments in our advanced diagnostics and consumer growth strategies.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Together with the Quest Diagnostics Foundation, during 2020 we launched a multi-year initiative to reduce health disparities in underserved communities, including those impacted by the COVID-19 pandemic.  As part of this initiative, we plan to offer testing services and fund a range of initiatives estimated to total more than $100&#160;million aimed at improving access to testing and awareness of the value of diagnostic insights in managing overall health.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2021, we had $1.3 billion of borrowing capacity available under our existing credit facilities, including $530&#160;million available under our secured receivables credit facility and $750 million available under our senior unsecured revolving credit facility.  There were no borrowings under these credit facilities as of September&#160;30, 2021.   In support of our risk management program, $70&#160;million in letters of credit under the secured receivables credit facility were outstanding as of September&#160;30, 2021.  The secured receivables credit facility includes a $250 million loan commitment which matures in October 2022, and a $250 million loan commitment and a $100 million letter of credit facility which matures in October 2023.  The senior unsecured revolving credit facility matures in March 2023. For further details regarding our credit facilities, see Note 13 to the audited consolidated financial statements in our 2020 Annual Report on Form 10-K and Note 15 to the interim unaudited consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our secured receivables credit facility is subject to customary affirmative and negative covenants, and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility. Our senior unsecured revolving credit facility is also subject to certain financial covenants and limitations on indebtedness.  As of September&#160;30, 2021, we were in compliance with all such applicable financial covenants.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our cash and cash equivalents and cash from operations, together with our borrowing capacity under our credit facilities, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares, share repurchases and additional growth opportunities for the foreseeable future.  However, should it become necessary, we believe that our credit profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_85"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some statements and disclosures in this document are forward-looking statements.  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan&#8221; or &#8220;continue.&#8221;  These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking statements.  Risks and uncertainties that may affect our future results include, but are not limited to, impacts of the COVID-19 pandemic and measures taken in response, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in our most recently filed Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; &#8220;Cautionary Factors that May Affect Future Results&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of those reports.</span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).  Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the third quarter of 2021, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_94"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART II - OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="idaf6b320c3f54d66937b4b767300a7e4_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 11 to the interim unaudited consolidated financial statements for information regarding the status of legal proceedings involving the Company.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_1123"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The IT systems that we rely on may be subject to unauthorized tampering, cyberattack or other security breach</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our IT systems have been and are subject to potential cyberattacks, tampering or other security breaches. These attacks, if successful, could result in shutdowns or significant disruptions of our IT systems and/or in unauthorized persons exfiltrating and misappropriating intellectual property and other confidential information, including patient and employee data that we collect, transmit and store on and through our IT systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;External actors may develop and deploy viruses, other malicious software programs, ransomware attacks, distributed denial of service attacks or other attempts to harm or obtain unauthorized access to our systems.  External actors may also deploy programs targeting our employees which are designed to attack our IT systems or otherwise exploit security vulnerabilities through programs such as electronic spamming, phishing, smishing, spear phishing or similar tactics. As a result of the difficulty in detecting many of these attacks, intrusions and breaches, failures or losses may be repeated or compounded before they are discovered or rectified, which could further increase these costs and consequences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although the Company has robust security measures implemented, which are monitored and routinely tested both by internal resources and external parties, cyber threats against us continue to evolve and may not be recognized until after an incident.  In August 2021, ReproSource, our subsidiary, experienced a data security incident in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients (in connection with the incident, ReproSource discovered and contained ransomware). The Company&#8217;s other systems were not impacted or compromised by this incident.  The attacks we have experienced have not materially disrupted, interrupted, damaged or shutdown the Company's IT systems, or materially disrupted the Company's performance of its business, but the mitigation or remediation efforts that we undertake may require expenditures of significant resources and divert the attention of management.  There can be no assurance that the Company can anticipate all evolving future attacks, viruses or intrusions, implement adequate preventative measures, or remediate any security vulnerabilities. If our IT systems are successfully attacked, it could result in major disruption of our business, compromise confidential information, and result in litigation and potential liability for the Company, government investigation, significant damage to our reputation or otherwise adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, third parties to whom we outsource certain of our services or functions, or with whom we interface, store or process confidential patient and employee data or other confidential information, as well as those third parties&#8217; providers, are also subject to the risks outlined above. For example, in June 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;), informed the Company about a data security incident involving AMCA. AMCA, which provided debt collection services for a company that provides revenue management services to the Company, informed the Company in May 2019 that AMCA had learned that an unauthorized user had access to AMCA&#8217;s system during 2018 and 2019. AMCA&#8217;s affected system included financial, medical and other personal information. The Company&#8217;s systems or databases were not involved in this incident.  A breach or attack affecting third parties with whom we engage could also harm our business, results of operations and reputation and subject us to liability.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have taken, and continue to take, precautionary measures to reduce the risk of, and detect and respond to, future cyber threats, and prevent or minimize vulnerabilities in our IT systems, including the loss or theft of intellectual property, patient and employee data or other confidential information that we obtain and store on our systems. We also have taken, and will continue to take, measures to assess the cybersecurity protections used by third parties to whom we outsource certain of our services or functions, or with whom we interface, store or process confidential patient and employee data or other confidential information. In addition, we collaborate with government agencies regarding potential cyber threats and have worked with firms that have cyber security expertise to evaluate our systems and the attacks we experience and strengthen our systems. There can be no assurances that our precautionary measures or measures used by our third party providers will prevent, contain or successfully defend against cyber or information security threats that could have a significant impact on our business, results of operations and reputation and subject us to liability.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_100"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the third quarter of 2021.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.435%"><tr><td style="width:1.0%"></td><td style="width:43.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.170%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yet Be Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Under the Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">or Programs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2021 &#8211; July 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2021 &#8211; August 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2021 &#8211; September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Since the share repurchase program&#8217;s inception in May 2003, our Board of Directors has authorized $11 billion of share repurchases of our common stock through September&#160;30, 2021.  The share repurchase authorization has no set expiration or termination date.  In each of February and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1 billion.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Includes: (1) shares delivered or attested to in satisfaction of the exercise price and/or tax withholding obligations by holders of stock options (granted under the Company&#8217;s Amended and Restated Employee Long-Term Incentive Plan) who exercised options; and (2) shares withheld (under the terms of grants under the Amended and Restated Employee Long-Term Incentive Plan) to offset tax withholding obligations that occur upon the delivery of outstanding common shares underlying restricted stock units and performance share units.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(C)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Does not include $300&#160;million of the $1.5 billion second quarter 2021 payment associated with the April 2021 accelerated share repurchase agreements ("ASRs"), which represents 20% percent of the total initial value of shares expected to be repurchased under the ASRs during the fourth quarter of 2021. See Note 9 to the interim unaudited consolidated financial statements for further information regarding the ASRs.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="-sec-extract:summary;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Exhibits </span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibits:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302021ex101.htm">The Quest Diagnostics Profit Sharing Plan (Amendment and Restatement, effective as of August 15, 2021) </a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302021ex102.htm">Quest Diagnostics Supplemental Deferred Compensation Plan (Post - 2004) Amended and Restated December 1, 2020</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302021ex22.htm">Subsidiary Guarantors</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302021ex311.htm">Rule 13a-14(a) Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302021ex312.htm">Rule 13a-14(a) Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302021ex321.htm">Section 1350 Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx09302021ex322.htm">Section 1350 Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">mendment</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm"> N</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">o</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">. 5 T</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">o</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm"> S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">ixth</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm"> A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">mended</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm"> A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">nd</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm"> R</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">estated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm"> C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dgx09302021ex991.htm">redit and Security Agreement</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document  - dgx-20210930.xsd</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20210930_cal.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20210930_def.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20210930_lab.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20210930_pre.xml</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="idaf6b320c3f54d66937b4b767300a7e4_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idaf6b320c3f54d66937b4b767300a7e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;22, 2021 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.087%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and President</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark J. Guinan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div id="idaf6b320c3f54d66937b4b767300a7e4_109"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>dgx09302021ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4885bbf2d36f4ff7b3d651be4df4c476_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%">THE QUEST DIAGNOSTICS PROFIT SHARING PLAN </font></div><div style="margin-bottom:36pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">(Amendment and Restatement,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Effective as of August 15, 2021)</font></div><div style="margin-bottom:84pt;text-align:center"><font><br></font></div><div style="margin-bottom:42pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_4"></div><hr style="page-break-after:always"><div style="min-height:108.03pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.302%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE I DEFINITIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">3</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE II ELIGIBILITY AND PARTICIPATION</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Eligibility</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Beneficiary Designation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE III CONTRIBUTIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">21</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee Pre-Tax Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">21</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employer Matching Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">25</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employer Discretionary Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">26</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Rollover Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">27</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Maximum Deductible Contribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">28</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Actual Deferral Percentage Test Safe Harbor</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">28</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.7.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Payment of Employer Contributions to Trustee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">29</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.8.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Employee After-Tax or Roth Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">29</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.9.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Average Contribution Percentage Test Safe Harbor</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">29</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.10.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">USERRA</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">30</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.11.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Corrective Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">31</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE IV ALLOCATIONS TO ACCOUNTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">33</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Accounts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">33</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Valuation of Accounts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">33</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notification of Account Balance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">33</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Allocation of Employee Pre-Tax Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">34</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Allocation of Employer Matching Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">34</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Allocation of Employer Discretionary Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">34</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.7.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Maximum Additions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">34</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.8.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Aggregation and Disaggregation under Code Section 415</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">38</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE V VESTING AND DISTRIBUTIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Normal Retirement</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">40</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">i</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:108.03pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents (continued)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Death Before Severance from Employment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Death After Severance from Employment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Severance from Employment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">41</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Method of Payment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">44</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.7.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cash-Outs&#59; Consent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">45</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.8.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Payment of Benefits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">46</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.9.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Direct Rollovers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">51</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.10.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Payment to Alternate Payee under QDRO</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">53</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.11.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Voluntary Direct Transfers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">54</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.12.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Restrictions on Certain Distributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5</a>4</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE VI LOANS AND WITHDRAWALS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">56</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Loans to Participants</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">56</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Hardship Withdrawals</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">59</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Non-Hardship Withdrawals</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">61</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Withdrawal of Dividends on Quest Common Stock</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">62</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vesting of Certain Dividends on Quest Common Stock</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Qualified Reservist Distribution</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE VII TRUST FUND</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6</a>5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Contributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.62pt;padding-right:3.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6</a>5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Trustee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.62pt;padding-right:3.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6</a>5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investment Options</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6</a>5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Investment Direction by Participants</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6</a>6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Transactional and other Fees and Expenses of Plan and Trust</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6</a>7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE VIII PLAN ADMINISTRATION</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">General</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Sponsor and Plan Administrator</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Named Fiduciaries</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">69</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Organization and Operation of the Appeals Committee, the Benefits Administration Committee and the Investment Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">72</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employers&#58; Indemnification and Information</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">73</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Claims for Benefits &#8212; Initial Review</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">73</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.7.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Denial of Benefits &#8212; Appeal Procedure</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">7</a>5</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ii</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:108.03pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents (continued)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.8.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Other Provisions relating to Claims for Benefits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">76</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.9.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhaustion of Administrative Remedies&#59; Limitations Period&#59; Venue</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">76</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.10.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Records</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">7</a>6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE IX AMENDMENT AND TERMINATION OF THE PLAN&#59; MERGERS AND TRANSFERS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">78</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Amendment of the Plan</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">78</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Termination of the Plan</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">79</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Merged Plans&#59; Transferred Funds</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">79</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE X PROVISIONS RELATIVE TO EMPLOYERS INCLUDED IN PLAN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">82</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participation in the Plan by an Affiliate</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">82</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participation in the Plan by other Organizations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">84</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Service and Termination of Service</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8</a>4</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE XI TOP HEAVY PROVISIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i4885bbf2d36f4ff7b3d651be4df4c476_7" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8</a>5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Determination of Top Heavy Status</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">85</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Minimum Allocations</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">85</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Impact on Minimum Benefits where Employer Maintains Both Defined Benefit and Defined Contribution Plans</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">86</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Impact on Vesting</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">86</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Requirements Not Applicable</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">87</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Top-Heavy Definitions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">87</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE XII MISCELLANEOUS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">89</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Governing Law</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">89</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Construction</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">89</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participant&#8217;s Rights&#59; Acquittance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">89</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Spendthrift Clause</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">90</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mistake of Fact</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">90</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Recovery of Overpayment</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">90</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.7.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Plan Corrections</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">91</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.8.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Consent to Plan Terms</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">91</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.9.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Facility of Payment&#59; Uncashed Checks&#59; Recipients Who Cannot Be Located</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">91</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.10.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Income Tax Withholding</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">92</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iii</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:108.03pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Table of Contents (continued)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.11.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Writings and Electronic Communications</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">92</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ARTICLE XIII ADOPTION OF THE PLAN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:4.5pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">93</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:72pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">APPENDIX A &#160;&#160;&#160;&#160;PARTICIPATING EMPLOYERS&#160;&#160;&#160;&#160;A-1</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:72pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">APPENDIX B&#160;&#160;&#160;&#160;PRE-2016 PLAN AND MERGED PLANS&#58;  SPECIAL RULES AND PROTECTED BENEFITS&#160;&#160;&#160;&#160;B-1</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:72pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">APPENDIX C &#160;&#160;&#160;&#160;PRE-2009 AMP PLAN, AMP PLAN AND AMP MERGED PLANS&#58;  SPECIAL RULES AND PROTECTED BENEFITS&#160;&#160;&#160;&#160;C-1</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:72pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">APPENDIX D&#160;&#160;&#160;&#160;SUB-ACCOUNTS FROM PRE-2016 PLAN AND MERGED PLANS, AND SUB-ACCOUNTS TRANSFERRED FROM THE AMP PLAN&#160;&#160;&#160;&#160;D-1</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:72pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">APPENDIX E &#160;&#160;&#160;&#160;CELERA PLAN AND SOLSTAS PLAN ROTH CONTRIBUTION SUBACCOUNTS&#160;&#160;&#160;&#160;E-1</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:72pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">APPENDIX F &#160;&#160;&#160;&#160;SURVIVOR ANNUITY DISTRIBUTION PROVISIONS&#160;&#160;&#160;&#160;F-1</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:72pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">APPENDIX G&#160;&#160;&#160;&#160;POST-2015 MERGED PLANS&#58;<br>SPECIAL RULES AND PROTECTED BENEFITS&#160;&#160;&#160;&#160;G-1</font></div><div style="margin-bottom:6pt;padding-left:90pt;padding-right:72pt;text-indent:-90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">APPENDIX H&#160;&#160;&#160;&#160;PARTICIPANT TRANSFERRED FROM HACKENSACK MERIDIAN HEALTH SYSTEM&#160;&#160;&#160;&#160;H-1</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iv</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">INTRODUCTION</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Effective October 1, 1973, MetPath Inc. established the Profit Sharing Plan of MetPath Inc. for the benefit of its eligible employees.  That plan was subsequently amended and restated, renamed and underwent mergers with a number of other plans.  Effective December 31, 1996, that plan was again amended and restated in its entirety to reflect the spinoff of Quest Diagnostics Incorporated (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Quest Diagnostics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) from Corning Incorporated and the adoption of an employee stock ownership plan, and was renamed The Profit Sharing Plan of Quest Diagnostics Incorporated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;).  In 2010, the entire value of the accounts of certain participants who were bona fide residents of Puerto Rico was transferred, as permitted by Internal Revenue Service (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">IRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) Revenue Ruling 2008-40, to the Quest Diagnostics Puerto Rico Defined Contribution Plan.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Effective as of January 1, 2016, the Plan was amended and restated to incorporate&#58;  (i) Plan amendments through the close of business on December 31, 2015 and (ii) mergers with different plans through that date including, but not limited to, the merger of The 401(k) Savings Plan of Quest Diagnostics Incorporated into the Plan effective as of the close of business on December 31, 2015.  Effective as of January 1, 2021 the Plan was amended and restated to incorporate amendments 1 - 8 to the prior restatement.  Effective as of August 15, 2021, this amended and restated Plan document incorporates changes as to&#58; (i) Quest Diagnostics Clinical Laboratories, Inc. becoming the sponsor of the Plan&#59;  (ii) Quest Diagnostics Profit Sharing Plan becoming the name of the Plan&#59; and (iii) the allocation of governance related responsibilities and authority pursuant to the Plan.  The above Plan restatements, except as otherwise specified or as required by law, also included certain technical or clarifying amendments deemed necessary or appropriate to facilitate and be consistent with the administration, management or interpretation of the Plan.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">It is intended that the Plan continue to be tax-qualified under Internal Revenue Code (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) Sections 401(a) and 401(k) as a profit sharing plan under Code Section 401(a)(27) that includes an employee stock ownership plan under ERISA Section 407(d)(6) and Code Sections 409 and 4975(e)(7), which shall include the share distribution requirements of Code Section 409(h) and the participant pass-through voting rights required under Code Section 409(e), and a cash or deferred arrangement under Code Section 401(k).  It also is intended that the Plan be an eligible individual account plan under ERISA Section 407(d)(3), and that it meet the requirements of ERISA Section </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 1 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">404(c) and be construed, maintained and administered as an &#8220;ERISA Section 404(c) plan&#8221; within the meaning of Department of Labor Regulation &#167;2550.404c&#8211;1(b)(1).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Except as expressly provided herein, the benefits and rights of a participant who severs (or severed) from employment (or his beneficiary) will be determined in accordance with the terms of the Plan, or the then-applicable Merged Plan, as in effect as of the date of such severance from employment.  Any provision that restricted or limited withdrawals, loans or other distributions, or otherwise required separate accounting with respect to any portion of a participant&#8217;s account and the elimination of which would adversely affect the qualification of the Plan under Code Sections 401(a) and 401(k), shall continue in effect with respect to such portion of the participant&#8217;s account, and no provision of this Plan shall be construed to eliminate or reduce any early retirement benefit or subsidy that continues after retirement or optional form of benefit applicable to a participant&#8217;s account except to the extent permitted under Regulations &#167;&#167;1.401(a)-4, 1.411(d)-3 and 1.411(d)-4.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 2 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9.7pt"><br><br>DEFINITIONS</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">As used herein, unless otherwise required by the context, the following words and phrases shall have the meanings indicated&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The aggregate, as applicable, of&#58;  (1) a Participant&#8217;s Employee Regular Pre-Tax Sub-Account, Employee Pre-Tax Catch-Up Sub-Account, Employer Matching Sub-Account and Rollover Sub-Account&#59; (2) such other recordkeeping sub-accounts as the Participant may have pursuant to an Appendix attached hereto&#59; and (3) such other recordkeeping sub-accounts as may be authorized by the Department.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; A corporation or unincorporated trade or business while it is&#58;  (1) a member of a controlled group of corporations (as defined in Code Section 414(b)) of which an Employer is a member&#59; (2) a trade or business under common control (as defined in Code Section 414(c)) of an Employer &#59; (3) a member of an affiliated service group (as defined in Code Section 414(m)) which includes an Employer&#59; or (4) required to be aggregated with an Employer pursuant to Code Section 414(o)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that no such corporation or unincorporated trade or business shall be considered an Affiliate at any time prior or subsequent to the time during which it meets the above definition and, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> further, that the status of being employed by an Affiliate shall pertain to an individual only during the time when his employer is an Affiliate and not to any time prior or subsequent to its Affiliate status.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Allocable Income&#47;Loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The income or loss allocable for the Plan Year to contributions that must be returned to a Participant or forfeited under any of the limitations of Articles III or IV.  Income or loss may be determined by any reasonable method for computing income or loss if the method is used consistently for all Participants and all corrective distributions under the Plan for the Plan Year, and is the same method used by the Plan for allocating income or loss to Participants&#8217; Accounts.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Appeals Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The Appeals Committee, as provided for in Section 8.3(d).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Appropriate Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; A request by a Participant in the form and manner provided by the Department or by the Plan&#8217;s recordkeeper that is appropriate for the intended purpose.  If the Department and the Plan&#8217;s recordkeeper so agree, an Appropriate Request may be executed over the telephone or Internet.  To constitute an Appropriate Request, such request must be completed correctly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 3 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">and, if required to be in writing, duly executed and delivered to the Department or the Plan&#8217;s recordkeeper, as the case may be.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Any person designated by a Participant under Section 2.3 to receive such benefits as may become payable hereunder after the death of such Participant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Benefits Administration Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> - The Benefits Administration Committee as appointed by the Board with the authority to act as specified in the Plan, including as plan administrator specified in Section 8.2(a),  and to delegate such of its responsibilities as it may determine.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Benefits Design Committee </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">- The Benefits Design Committee as appointed by the Board with the authority to act as specified by the Board and in the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The Board of Directors of the Company, or a committee of such board, authorized by, and acting on behalf of, such board.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Catch-Up Pre-Tax Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Contributions made to the Plan by Employers under Section 3.1(b) pursuant to salary reduction agreements made by Eligible Employees.  Catch-Up Pre-Tax Contributions also refer to pre-tax contributions under Code Section 414(v) made by a Participant who was a participant in a Merged Plan containing a qualified cash or deferred arrangement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The Internal Revenue Code of 1986, as amended from time to time.  Reference to a specific provision of the Code shall include such provision, any valid Regulation promulgated thereunder and any comparable provision of future law that amends, supplements or supersedes such provision.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">- Quest Diagnostics Clinical Laboratories, Inc., a Delaware corporation, or any successor thereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Deferral Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; An Employee&#8217;s wages as defined in Code Section 3401(a) and all other payments of compensation to an Employee by an Employer (in the course of the Employer&#8217;s trade or business) for which the Employer is required to furnish the Employee a written statement under Code Sections 6041(d), 6051(a)(3) and 6052, excluding reimbursements or other expense allowances, service awards, RecognitionQuest awards, cash and non-cash fringe benefits </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 4 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e.g., employee discounts), moving expenses, deferred compensation, and welfare benefits, but including Employee Pre-Tax Contributions to this Plan, pre-tax employee contributions to a Code Section 125 plan and pre-tax employee contributions to purchase qualified transportation fringe benefits pursuant to Code Section 132(f)(4).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For these purposes&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Amounts under Code Section 125 include any amounts not available to an Employee in cash in lieu of group health coverage because the Employee is unable to certify that he has other health coverage.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">An amount will be treated as an amount under Code Section 125 only if the Employer does not request or collect information regarding the Employee&#8217;s other health coverage as part of the enrollment process for the health plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding the preceding paragraphs, (1) Deferral Compensation shall include amounts (e.g., bonuses, commissions or unused vacation) paid by the Employer following the Employee&#8217;s severance from employment with the Employer, but only if such amounts are paid no later than 30 days after the Employee&#8217;s severance from employment&#59; (2) except as specifically provided in (1) above, Deferral Compensation shall not include severance pay or other form of post-termination compensation&#59; and (3) Deferral Compensation shall not include compensation generated from any of the following&#58;  the disqualifying disposition of a statutory stock option&#59; the disposition of shares of stock under an employee stock purchase plan if the option price was below the fair market value of the stock at the time the option was granted&#59; the value of a nonstatutory stock option at the time of grant or exercise&#59; the vesting of restricted stock&#59; the payment of dividends or dividend equivalents on restricted stock&#59; or similar elements of equity-based compensation.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Deferral Compensation in excess of $265,000 (or such other amount as may be applicable under Code Section 401(a)(17)(B)) for any Plan Year shall not be taken into account, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that the dollar increase, if any, in effect on January 1 of any calendar year is effective for Plan Years beginning in such calendar year.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Department</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> - The human resources department of Quest Diagnostics under the supervision of the Chief Human Resources Officer of Quest Diagnostics.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 5 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Eligibility Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">As of any date, the aggregate of an Employee&#8217;s periods of eligibility service (as defined in the next sentence), including any eligibility service credited under subsection (b).  For this purpose, a period of eligibility service is a period of time required to be recognized under this Plan commencing on the Employee&#8217;s Employment Commencement Date, or a subsequent Reemployment Commencement Date, and ending on a Severance from Service Date.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Eligibility service also shall include the following&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Periods of employment with an Affiliate (while such organization is an Affiliate) which would have constituted eligibility service under the Plan had the Employee been employed by an Employer&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Periods of employment with an Employer other than as an Employee, including employment as a leased employee within the meaning of Code Section 414(n), which would have constituted eligibility service under the Plan had the individual been employed as an Employee&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that employment as a leased employee within the meaning of Code Section 414(n) shall not be taken into account if more than five (5) calendar days elapses between the last day of employment as a leased employee and the individual&#8217;s Employment Commencement Date&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">With respect to a corporate transaction, (i) those periods of employment with the prior employer which constituted eligibility service under the terms of the plan sponsored by the prior employer or (ii) those periods of employment specified pursuant to the corporate transaction, in each case as applied in a uniform and nondiscriminatory manner and  consistent with applicable law&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">With respect to any Employee of an Employer that is a joint venture, periods of contiguous employment with the joint venture partner of such Employer (or an Affiliate that is not an Employer) prior to the establishment of the joint venture which constituted eligibility service under the plan of the joint venture partner, as applied in a uniform and nondiscriminatory manner and  consistent with applicable law&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt"> With respect to an Employee who directly transferred employment to an Employer from a joint venture that is not an Employer&#58; (i) periods of contiguous employment with the joint venture which constituted eligibility service under the Plan had the joint venture been an Employer, and (ii) periods of contiguous employment with the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 6 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">joint venture partner prior to the establishment of the joint venture which constituted eligibility service under the terms of the plan sponsored by the joint venture partner,  as applied in a uniform and nondiscriminatory manner and consistent with  applicable law&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Periods of Qualified Military Service required under Code Section 414(u)&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Periods of employment with an entity that adopts this Plan and that is not an Affiliate, but solely with respect to periods after the date of such adoption and only while the Plan is maintained by such entity.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">In no event shall Eligibility Service be credited under more than one paragraph of subsection (b).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; An Employee of an Employer eligible for participation under Section 2.1.  Notwithstanding the preceding, the following Employees shall not be considered Eligible Employees for purposes of this Plan&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">an Employee who is covered by a collective bargaining agreement where such agreement provides for a different retirement plan, or where no provision is made for any retirement plan, after good faith bargaining between the Employer and Employee representatives&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">an Employee who is excluded from participation hereunder by the terms of his Employer&#8217;s adoption of this Plan&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">an Employee who is a nonresident alien and who receives no earned income (within the meaning of Code Section 911(d)(2)) from the Employer which constitutes income from sources within the United States (within the meaning of Code Section 861(a)(3))&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">an Employee performing services only in Puerto Rico.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; An individual who is carried on the payroll of an Employer or an Affiliate as a common-law employee.  Notwithstanding the preceding, the following individuals shall not be considered Employees for purposes of this Plan&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">an individual who is classified as an &#8220;independent contractor&#8221; or &#8220;consultant&#8221; by his Employer, regardless of such individual&#8217;s reclassification for any reason by the Internal Revenue Service, other governmental agency or any other entity&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 7 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">an individual who is classified as a leased employee of an Employer within the meaning of Code Section 414(n) (other than a leased employee of a joint venture Employer who is leased from another Employer), regardless of such individual&#8217;s reclassification for any reason by the Internal Revenue Service, other governmental agency or any other entity.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For these purposes, a &#8220;leased employee&#8221; or an &#8220;independent contractor&#8221; or &#8220;consultant&#8221; includes any individual treated by an Employer as a leased employee (without regard to the individual&#8217;s length of service or hours of service for purposes of determining such status under Code Section 414(n)) or as an independent contractor or consultant, even if the individual&#8217;s status is retroactively or prospectively changed or if the individual is deemed to be a common law employee for any other purpose.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employee Pre-Tax Catch-Up Sub-Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The portion of a Participant&#8217;s Account attributable to Catch-Up Pre-Tax Contributions allocated to such Participant under Section 4.4.  The Employee Pre-Tax Catch-Up Sub-Account of a Participant who was a participant in a Merged Plan containing a qualified cash or deferred arrangement also shall hold any amount transferred to this Plan from such Merged Plan representing the balance of such Participant&#8217;s pre-tax catch-up account under such Merged Plan if such account had the same properties as the Employee Pre-Tax Catch-Up Sub-Account under the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employee Pre-Tax Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Regular Pre-Tax Contributions and Catch-Up Pre-Tax Contributions made to the Plan by the Employers under Section 3.1 pursuant to salary reduction agreements entered into between an Employer and a Participant, and including Regular Pre-Tax Contributions and Catch-Up Pre-Tax Contributions transferred to this Plan from a Merged Plan that contained a qualified cash or deferred arrangement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employee Regular Pre-Tax Sub-Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The portion of a Participant&#8217;s Account attributable to Regular Pre-Tax Contributions allocated to such Participant under Section 4.4.  The Employee Regular Pre-Tax Sub-Account of a Participant who was a participant in a Merged Plan that contained a qualified cash or deferred arrangement also shall hold any amount transferred to this Plan from such Merged Plan representing the balance of such Participant&#8217;s regular pre-tax contributions account under such Merged Plan if such account had the same properties as the Employee Regular Pre-Tax Sub-Account under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 8 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Collectively or individually as the context may indicate, the Company and any other entity (or successor thereto) that has adopted the Plan and has not terminated its participation in the Plan.  The Employers are listed in Appendix A, as updated from time to time.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employer Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Payments as provided herein by the Employers to the Trustee for the purpose of providing the benefits under this Plan.  Employer Contributions include Employee Pre-Tax Contributions, Employer Discretionary Contributions, Employer Matching Contributions and similar contributions (including Roth contributions) under a Merged Plan.  However, rollover contributions and after-tax (but not Roth) contributions made by Participants are not considered Employer Contributions.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employer Discretionary Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Contributions made to the Plan by the Employers under Section 3.3.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employer Matching Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Contributions made to the Plan by the Employers under Section 3.2.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employer Matching Sub-Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The portion of a Participant&#8217;s Account attributable to Employer Matching Contributions made and allocated to such Participant under Section 4.5.  The Employer Matching Sub-Account of a Participant who was a participant in a Merged Plan containing a qualified cash or deferred arrangement also shall hold any amount transferred to this Plan from such Merged Plan representing the balance of such Participant&#8217;s employer matching contribution account under such Merged Plan if such account had the same properties as the Employer Matching Sub-Account under the Plan.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Employment Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The earlier of&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">the later of&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the date when an Employee first performs an Hour of Service for an Employer&#59; or</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the date when the Employer of the Employee became an Affiliate&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;an adjusted date in the case of an Employee being credited with prior service.  For a corporate transaction resulting in a Merged Plan, unless the Department determines that the transaction directs otherwise, credit for prior service shall be given to all employees of the controlled group which included the sponsor of that plan who become employees of the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 9 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:0.36pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">or an Affiliate in connection with that transaction.  For a corporate transaction not resulting in a Merged Plan or in connection with a joint venture, credit for prior service shall be given to those individuals who in connection with the transaction become employees of the Company or an Affiliate, as directed by the Department consistent with the transaction terms.  In both cases, the Department will notify the Plan&#8217;s recordkeeper of the names of the individuals who will receive credit for prior service and what their adjusted Employment Commencement Dates will be.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">However, in the case of a reemployed Employee (and subject to Section 2.2), his Employment Commencement Date shall be his Reemployment Commencement Date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The Employee Retirement Income Security Act of 1974, as amended from time to time.  Reference to a specific provision of ERISA shall include such provision, any valid Regulation promulgated thereunder and any comparable provision of future law that amends, supplements or supersedes such provision.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Highly Compensated Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; For any Plan Year, any active or former Employee who is a &#8220;highly compensated active Employee&#8221; or a &#8220;highly compensated former Employee&#8221; as determined below&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">A &#8220;highly compensated active Employee&#8221; is an Employee who&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">was a 5% owner (within the meaning of Code Section 416(i)) of an Employer or an Affiliate at any time during the preceding or current Plan Year&#59; or</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">received Section 415 Compensation from an Employer or an Affiliate in excess of $120,000 (as adjusted at the same time and in the same manner as under Code Section 415(d), except that the base period is the calendar quarter ending September 30, 1996) for the preceding Plan Year and was a member of the top-paid 20% of Employees ranked on the basis of Section 415 Compensation for the preceding Plan Year.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A &#8220;highly compensated former Employee&#8221; is an Employee who separated from service (or was deemed to have separated from service) prior to the current Plan Year, performs no service for an Employer or an Affiliate during the current Plan Year and was a &#8220;highly compensated active Employee&#8221; for either the separation year or for any Plan Year ending on or after his 55th birthday.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Hour of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; An hour for which an Employee is paid or entitled to payment for the performance of duties for an Employer or for an Affiliate.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 10 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Investment Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The Investment Committee, as provided for in Section 8.3(e).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Investment Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; An investment alternative under Section 7.3 available to be selected by the Participant, in accordance with Section 7.4, for investment of his Account.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Merged Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; A plan that merged into this Plan or, if the context so requires, a plan that merged into another Merged Plan, as described in an Appendix hereto as it may be amended or supplemented from time to time. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Normal Retirement Age</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Age 65, except as provided in an Appendix hereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; An Eligible Employee who has commenced, but not terminated, participation in the Plan pursuant to the provisions of Article II, or a former Eligible Employee who has a nonzero Account balance under the Plan.  Pursuant to Section 5.10, an alternate payee under a QDRO for whom an Account has been established is considered a Participant for purposes of specifying Investment Options for his Account, making an election under Section 6.4, designating a Beneficiary for his Account and charging expenses to his Account.  Similarly, a Beneficiary of a deceased Participant for whom an Account has been established, or an Eligible Employee who has not otherwise commenced participation in the Plan but has made a rollover contribution, is considered a Participant for purposes of specifying Investment Options for his Account, making an election under Section 6.4, designating a Beneficiary for his Account and charging expenses to his Account.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Period of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The period of time commencing on an Employee&#8217;s Severance from Service Date and ending on his Reemployment Commencement Date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The Quest Diagnostics Profit Sharing Plan, contained herein or as hereafter amended.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Plan Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; January 1 &#8211; December 31.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">QDRO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; A judgment, decree or order that&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">relates to the provision of child support, alimony or marital property rights to a spouse, former spouse, child or other dependent of a Participant (an &#8220;alternate payee&#8221;)&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">creates or recognizes the existence of an alternate payee&#8217;s right to, or assigns to an alternate payee the right to, receive all or a portion of the Participant&#8217;s benefits&#59;</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 11 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">is made pursuant to a state domestic relations law (including community property law)&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">otherwise meets the requirements of Code Section 414(p).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">QJSA Portion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; That portion of a Participant&#8217;s Account, as described in Appendix F, that is subject to mandatory joint and survivor annuity distributions and related requirements of applicable law.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Qualified Military Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Qualified military service as defined in Code Section 414(u)(5) and Chapter 43 of Title 38 of the United States Code.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Quest Diagnostics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Quest Diagnostics Incorporated, a Delaware corporation, or any successor thereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Quest Diagnostics Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Any class of Quest Diagnostics&#8217; common stock or any class of Quest Diagnostics&#8217; noncallable preferred stock that is convertible into common stock, that is readily tradable on an established securities market (such terms as defined under Code Section 409(l)), that meet the requirements of ERISA Section 407(d)(5) and held under the Quest Diagnostics Incorporated Stock Fund, including securities that met these requirements when first held under the Quest Diagnostics Incorporated Stock Fund.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Quest Diagnostics Incorporated Stock Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The Investment Option described in Section 7.3(b).  The Plan is an eligible individual account plan under ERISA Section 407(d)(3), and the portion of a Participant&#8217;s Account under the Plan that is invested in the Quest Diagnostics Incorporated Stock Fund is intended to qualify as a stock bonus plan under Code Section 401(a) and an employee stock ownership plan under ERISA Section 407(d)(6) and Code Sections 409 and 4975(e)(7) including the share distribution requirements of Code Section 409(h) and the participant pass-through voting requirements of Code Section 409(e).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Reemployment Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The first date when an Employee again performs an Hour of Service for an Employer following a Period of Severance.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Regular Pre-Tax Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Contributions made to the Plan by Employers under Section 3.1(a) pursuant to salary reduction agreements made by Eligible Employees.  Regular Pre-Tax Contributions also refer to pre-tax contributions under Code Section 401(k), but not Code </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 12 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Section 414(v), made by a Participant who was a participant in a Merged Plan containing a qualified cash or deferred arrangement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Any regulation, ruling or other interpretation, validly promulgated by the U.S. Department of Treasury, U.S. Department of Labor, or other federal agency as the case may be, and in effect at the time in question.  Reference to a Regulation or section thereof includes that Regulation or section and any comparable Regulation or section that amends, supplements or supersedes that Regulation or section.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Rollover Sub-Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The portion of a Participant&#8217;s Account attributable to his rollover contributions made under Section 3.4.  The Rollover Sub-Account of a Participant who was a participant in a Merged Plan permitting rollover contributions thereto also shall hold any amount transferred to this Plan from such Merged Plan representing the balance of such Participant&#8217;s rollover contribution account under such Merged Plan if such account had the same properties as the Rollover Sub-Account under the Plan.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Section 415 Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Compensation within the meaning of Code Section 415(c)(3), including &#8220;post-severance compensation.&#8221;  &#8220;Post-severance compensation&#8221; means the following amount(s) that would have been Section 415 Compensation if the amount(s) were paid prior to the Employee&#8217;s severance from employment (as defined in Regulation &#167;1.415(a)-1(f)(5)) with the Employer, and that are paid to him by the later of 2&#189; months after his severance from employment with the Employer or the end of the Limitation Year that includes his Severance from Service Date with the Employer, if the amount is&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">regular compensation for services during his regular working hours or compensation for services outside his regular working hours (e.g., overtime or shift differential), commissions, bonuses or other similar payments and the payment would have been made to him prior to a severance from employment if he had continued in employment with the Employer&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">for unused accrued bona fide sick, vacation or other leave, but only if he would have been able to use the leave if his employment had continued&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">received by him pursuant to a nonqualified unfunded deferred compensation plan, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> the payment would have been made to him at the same time if he had continued in employment with the Employer and only to the extent that the payment is includible in his gross income&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 13 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">made by the Employer to a former Employee who does not currently perform services for the Employer by reason of Qualified Military Service to the extent those payments do not exceed the amounts he would have received if he had continued to perform services for the Employer rather than entering Qualified Military Service.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Severance from Service Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Except as provided in subsection (b), the earlier of (1) or (2)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The date on which the Employee quits, retires, is discharged or dies, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that he does not earn an Hour of Service for an Employer or an Affiliate within 12 months after such date&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The first anniversary of the first date of a period in which an Employee remains absent from service (with or without pay) with an Employer or an Affiliate for any reason (such as vacation, holiday, sickness, disability or leave of absence) other than quit, retirement, discharge or death&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that if he is absent from service by reason of (A) a leave of absence granted by his Employer or an Affiliate (including, but not limited to, leave pursuant to the Family and Medical Leave Act of 1993 or certain circumstances related to the Qualified Military Service of a family member) and he returns to active employment with the Employer or an Affiliate at the end of such leave of absence, or (B) Qualified Military Service and he returns to active service within the period that his re-employment rights are protected by federal law, then he shall not be deemed to have had a Severance from Service Date by reason of such absence.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">(1)&#160;&#160;&#160;&#160;With respect to an Employee who is absent from work beyond the first anniversary of the first day of absence by reason of a &#8220;parenthood purpose&#8221; described in paragraph (2), his Severance from Service Date shall be the second anniversary of the first day of such absence.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The following are deemed &#8220;parenthood purposes&#8221;&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">the pregnancy of the Employee&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">the birth of a child of the Employee&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">the placement of a child with the Employee in connection with the Employee&#8217;s adoption of such child&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">caring for such child for a period beginning immediately following such birth or placement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 14 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The period between the first and second anniversaries of the first day of absence from work by reason of a &#8220;parenthood purpose&#8221; is neither a period credited as a Year of Vesting Service nor a Period of Severance.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Benefits Administration Committee may request that the Employee furnish information to establish that the absence is for a &#8220;parenthood purpose&#8221; and the number of days for which there was such an absence.  If the Employee does not submit such information in a timely manner, this subsection (b) shall not apply to him.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Total and Permanent Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; A Participant shall be considered totally and permanently disabled when he has incurred a physical or mental condition which prevents him from performing his duties for an Employer or an Affiliate and which is expected to result in death or to be of long and continued duration and for which he is entitled to receive disability benefits payments under the federal Social Security Act or his Employer&#8217;s long-term disability plan (if any).  The determination under the federal Social Security Act or his Employer&#8217;s long-term disability plan (if any) is conclusive for purposes of this Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Trust Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The agreement with  the Trustee pursuant to  Article VII.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Trust Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; All funds received by the Trustee together with all income, profits and increments thereon, and less any expenses or payments made therefrom.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Such individuals or financial institutions, or a combination of them as designated in the applicable Trust Agreement, to hold in trust any assets of the Plan for the purpose of providing benefits under the Plan, and including any successor trustee to the Trustee initially designated thereunder.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Valuation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Each business day.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Vested Quest Diagnostics Common Stock Dividend Sub-Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Under Section 6.5(a), the portion of a Participant&#8217;s Account comprised of cash dividends received under the Quest Diagnostics Incorporated Stock Fund associated with the portion of the Participant&#8217;s Account, other than the Money Purchase Pension Plan Sub-Account or other part of the QJSA Portion, that is not fully vested.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 15 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Years of Vesting Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The aggregate of an Employee&#8217;s periods of vesting service (as defined in the next sentence), including any vesting service credited under subsection (b) and excluding any vesting service disregarded under subsection (c).  For purposes of this subsection (a), a period of vesting service is each period of time required to be recognized under this Plan commencing on the Employee&#8217;s Employment Commencement Date, or any subsequent Reemployment Commencement Date, and ending on a Severance from Service Date.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Vesting service also shall include the following&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Periods of service with an Affiliate (while such organization is an Affiliate) which would have constituted vesting service under the Plan had the Participant been employed by an Employer&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Periods of service with an Employer as a leased employee within the meaning of Code Section 414(n) (but without regard to the requirements of Section 414(n)(2)(B)) which would have constituted vesting service under the Plan had the Participant been employed as an Employee&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that such service shall not be taken into account if more than five (5) calendar days elapses between the individual&#8217;s last day of service as such a leased employee and his Employment Commencement Date&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">With respect to a corporate transaction, (i) those periods of employment with the prior employer which constituted vesting service under the terms of the plan sponsored by the prior employer, or (ii) those periods of employment specified pursuant to the corporate transaction, in each case as applied in a uniform and nondiscriminatory manner and consistent with applicable law&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">With respect to any Employee of an Employer that is a joint venture, periods of contiguous employment with the joint venture partner of such Employer (or an Affiliate that is not an Employer) prior to the establishment of the joint venture which constituted vesting service under the plan of the joint venture partner, as applied in a uniform and nondiscriminatory manner and consistent with applicable law&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">With respect to an Employee who directly transferred employment to an Employer from a joint venture that is not an Employer&#58;  (i) periods of contiguous employment with the joint venture which constituted vesting service under the Plan had the joint venture been an Employer, and (ii) periods of contiguous employment with the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 16 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">joint venture partner prior to the establishment of the joint venture which constituted vesting service under the terms of the plan sponsored by the joint venture partner, as applied in a uniform and nondiscriminatory manner and consistent with applicable law&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Periods of Qualified Military Service required under Code Section 414(u)&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Periods of employment with an entity that adopts this Plan and that is not an Affiliate, but solely with respect to periods after the date of such adoption and only while the Plan is maintained by such entity.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">In no event shall Years of Vesting Service be credited under more than one paragraph of subsection (b).</font></div><div style="margin-bottom:6pt;padding-left:31.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 17 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:5.04pt"><br><br>ELIGIBILITY AND PARTICIPATION</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Eligibility</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">An Eligible Employee may make Employee Pre-Tax Contributions as soon as administratively feasible after he becomes an Eligible Employee.  An Eligible Employee shall become eligible to receive&#58;  (a) Employer Matching Contributions as soon as administratively feasible after he completes 12 months of Eligibility Service&#59; and (b) Employer Discretionary Contributions (if any) as soon as administratively feasible after he completes 12 months of Eligibility Service or, if earlier, after he meets the eligibility requirements specified pursuant to Section 3.3(b).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Participation</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Each Eligible Employee who has met the requirements of Section 2.1 may, by making an Appropriate Request, enter into a salary reduction agreement in accordance with Section 3.1(a) and, if applicable Section 3.1(b).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">An Eligible Employee who becomes a Participant shall remain a Participant so long as he remains an Employee or is a former Employee who maintains an amount credited to his Account.  However, if he remains an Employee but not an Eligible Employee, he shall not be eligible to make Employee Pre-Tax Contributions or to receive Employer Matching Contributions and Employer Discretionary Contributions (if any).  If he severs from employment with no amount credited to his Account, he shall cease being a Participant as of his Severance from Service Date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If an Employee who was a Participant severs from employment and is reemployed as an Eligible Employee, he shall be eligible to make Employee Pre-Tax Contributions as soon as administratively feasible following his Reemployment Commencement Date.  He also will be credited, for purposes of his eligibility to receive Employer Matching Contributions and Employer Discretionary Contributions (if any), with his Eligibility Service earned prior to his Severance from Service Date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If an Employee who was not a Participant severs from employment and is reemployed as an Eligible Employee, he shall become a Participant as soon as administratively feasible after his Reemployment Commencement Date.  He then shall be eligible to make </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 18 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Employee Pre-Tax Contributions as soon as administratively feasible after the date he becomes a Participant and shall be eligible to receive Employer Matching Contributions and Employer Discretionary Contributions (if any) as soon as administratively feasible after the date he completes 12 months of Eligibility Service, considering Eligibility Service both before and after his Reemployment Commencement Date.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Beneficiary Designation</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Upon commencing participation, each Participant shall designate a Beneficiary in such manner as the Department may determine from time to time.  In the absence of a Participant&#8217;s valid designation of Beneficiary, he is deemed to have designated his spouse as his Beneficiary but if he is unmarried upon his death or if all persons he designated as a Beneficiary do not survive him, he is deemed to have designated the following as his Beneficiary&#58;  (1) the beneficiary designated under the group-term life insurance plan sponsored by a member of the Quest Diagnostics controlled group in which he then participates&#59; (2) the beneficiary designated under the group-term life insurance plan sponsored by his Employer, who is not a member of the Quest Diagnostics controlled group, in which he then participates&#59; or (3) his estate, if no beneficiary has effectively been designated under an employer group-term life insurance plan described in (1) or (2) above.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Beneficiary of a married Participant shall be his spouse unless&#58;  (1) he obtains spousal consent (as described below) to his designation of another person as his primary Beneficiary&#59; or (2) he establishes to the satisfaction of the Department that spousal consent cannot be obtained because there is no spouse, the spouse cannot be located or such other circumstances exist as prescribed in applicable Regulations.  Spousal consent shall&#58;  (i) be made on a form approved by the Department, (ii) be irrevocable by the spouse, (iii)&#160;acknowledge the designation and the effect of such designation and (iv) be witnessed by a representative of the Department or a notary public.  As an alternative to clause (iii) above, the spouse may execute an irrevocable general consent that does not identify the designated Beneficiary and that allows the Participant to make future changes in his Beneficiary designation without further spousal consent.  Any such general consent shall satisfy Regulation &#167;1.401(a)-20, Q&#38;A-31(c).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If a Participant who was unmarried when he filed (or was deemed to have filed) a Beneficiary designation later marries, or if a Participant who was married when he filed (or was</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 19 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">deemed to have filed) a Beneficiary designation later becomes married to a different spouse, his prior designation (or deemed designation) of a Beneficiary other than the spouse to whom he is married on the date of his death shall be null and void unless consented to by such spouse in the manner provided in subsection (b).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">After the death of a Participant and before distribution of his Account balance has been completed, his Beneficiary for whom an Account has been established is considered a Participant for purposes of specifying Investment Options for his Account, making an election under Section 6.4, designating a Beneficiary for his Account and charging expenses to his Account.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The right of any spouse or Beneficiary hereunder is subject to the provisions of any QDRO issued with respect to the Participant&#8217;s Account under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 20 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:0.38pt"><br><br>CONTRIBUTIONS</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Employee Pre-Tax Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Regular Pre-Tax Contributions</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">An Eligible Employee may enter into a salary reduction agreement with his Employer in which it is agreed that the Employer will reduce the Eligible Employee&#8217;s Deferral Compensation during each pay period by a designated percentage and contribute the amount so determined to the Plan on behalf of the Eligible Employee.  Such contributions are referred to as &#8220;Regular Pre-Tax Contributions.&#8221;  The Department may disregard or modify an Eligible Employee&#8217;s salary reduction agreement with respect to Regular Pre-Tax Contributions to the extent necessary to ensure that (A) the excess deferral rules of subsection (c) are met&#59; (B) the limitations set forth in Sections 3.5 and 4.7 are not exceeded&#59; and (C) all contributions are deductible under Code Section 404.  Regular Pre-Tax Contributions may be any whole percentage between 1% and 35% of the Deferral Compensation otherwise payable to the Eligible Employee during the applicable payroll period.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The salary reduction agreement of an Eligible Employee who becomes eligible to make Regular Pre-Tax Contributions is effective as soon as administratively feasible following the date on which his Appropriate Request is made.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant&#8217;s Regular Pre-Tax Contributions shall be invested among the various Investment Options in accordance with his Investment Option election as in effect under Section 7.4.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant who has in effect a salary reduction agreement with respect to Regular Pre-Tax Contributions may elect to change such agreement, including prospectively suspending such agreement, by making an Appropriate Request.  Such new election shall become effective as soon as administratively feasible following the date on which his Appropriate Request is made.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant&#8217;s Regular Pre-Tax Contributions shall be credited to his Employee Regular Pre-Tax Sub-Account under Section 4.4.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 21 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Catch-Up Pre-Tax Contributions</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">An Eligible Employee who will have attained age 50 by the end of the Plan Year may enter into a salary reduction agreement with his Employer in which it is agreed that the Employer will reduce his Deferral Compensation during each pay period by a designated percentage (beyond the designated percentage by which his Deferral Compensation is reduced with respect to Regular Pre-Tax Contributions) and contribute the amount so determined to the Plan on behalf of the Eligible Employee.  Such additional contributions are referred to as &#8220;Catch-Up Pre-Tax Contributions.&#8221;  Catch-Up Pre-Tax Contributions may be any whole percentage between 1% and, when added to Regular Pre-Tax Contributions, 70% of the Deferral Compensation otherwise payable to the Eligible Employee during the applicable payroll period.  Catch-Up Pre-Tax Contributions shall be made in accordance with, and subject to the limitations of, Code Section 414(v).  Catch-Up Pre-Tax Contributions shall not be taken into account for purposes of the Code Section 402(g) limitation set forth in Section 3.1(c)(1) (except as modified by Code Sections 414(v)) or the Code Section 415 limitation set forth in Section 4.7.  The Plan shall not be treated as failing to satisfy the provisions of the Plan implementing the requirements of Code Sections 401(k)(3), 401(k)(12), 410(b) or 416, as applicable, by reason of the making of Catch-Up Pre-Tax Contributions.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The salary reduction agreement of a Participant who becomes eligible to make Catch-Up Pre-Tax Contributions is effective as soon as administratively feasible following the date on which his Appropriate Request is made.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant&#8217;s Catch-Up Pre-Tax Contributions shall be invested in accordance with the Investment Option election applicable to the investment of his Regular Pre-Tax Contributions.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant who has in effect a salary reduction agreement with respect to Catch-Up Pre-Tax Contributions may elect to change such agreement, including prospectively suspending such agreement, by making an Appropriate Request.  Such new election shall become effective as soon as administratively feasible following the date on which his Appropriate Request is made.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant&#8217;s Catch-Up Pre-Tax Contributions shall be credited to his Employee Pre-Tax Catch-Up Sub-Account under Section 4.4.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 22 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If, by the end of the Plan Year, the amount of a Participant&#8217;s Employee Pre-Tax Contributions originally designated as Regular Pre-Tax Contributions does not exceed either (A) the Code Section 402(g) limitation for such Plan Year, (B) the 35% of Deferral Compensation limitation set forth in Section 3.1(a)(1) or (C) the maximum Code Section 415(c) limitation for such Plan Year, then any Employee Pre-Tax Contributions made by him and originally designated as Catch-Up Pre-Tax Contributions shall be recharacterized as Regular Pre-Tax Contributions to the extent the sum of his Employee Pre-Tax Contributions originally designated as Regular Pre-Tax Contributions and Employee Pre-Tax Contributions previously recharacterized as Regular Pre-Tax Contributions does not exceed such limitations.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">In order to make a Catch-Up Pre-Tax Contribution, a Participant must make a Regular Pre-Tax Contribution of at least 5% of Deferral Compensation throughout the portion of the Plan Year during which he is an Eligible Employee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Excess deferrals</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">No Participant may have Regular Pre-Tax Contributions made on his behalf under this Plan in any calendar year which in the aggregate exceed the dollar limitation contained in Code Section 402(g) in effect for such calendar year.  For purposes of the preceding sentence, Regular Pre-Tax Contributions are deemed made as of the pay date for which the salary is deferred, regardless of when the contributions are actually transmitted to the Trust Fund.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">(A)&#160;&#160;&#160;&#160;If in any calendar year the aggregate of the Regular Pre-Tax Contributions made on a Participant&#8217;s behalf under this Plan, plus his other elective deferrals under any other qualified cash or deferred arrangement (as defined in Code Section 401(k)) maintained by any sponsor, under any simplified employee pension (as defined in Code Section 408(k)), or used to have an annuity contract purchased on his behalf under Code Section 403(b), exceed the limitation of paragraph (1), then no later than the March 1st following such calendar year he may notify the Department&#58;  (i) that he has exceeded the limitation and (ii)&#160;of the amount of (A) his Regular Pre-Tax Contributions under this Plan which he wants distributed to him (as adjusted for Allocable Income&#47;Loss) or (B) his Regular Pre-Tax Contributions under this Plan which (if he is so eligible) he wants recharacterized as Catch-Up Pre-Tax Contributions (as adjusted for Allocable</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 23 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> Income&#47;Loss), notwithstanding his salary reduction agreement, so that he will not exceed the limitation.  The Department may require him to provide reasonable proof that he has exceeded the limitation of paragraph (1).</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">If in any calendar year the aggregate of the Regular Pre-Tax Contributions made on a Participant&#8217;s behalf under the Plan, plus his other elective deferrals under any other qualified cash or deferred arrangement (as defined in Code Section 401(k)) maintained by the Employer or an Affiliate, under a simplified employee pension (as defined in Code Section 408(k)) sponsored by the Employer or an Affiliate, or used to have the Employer or an Affiliate purchase an annuity contract on his behalf under Code Section 403(b), exceed the limitation of paragraph (1), then he is deemed to have notified the Department that notwithstanding his salary reduction agreement&#58;  (i) he has exceeded the limitation and (ii) he wants distributed to him or (if he is so eligible) recharacterized as Catch-Up Pre-Tax Contributions (to the extent permitted under Code Section 414(v)) the amount of such excess deferrals (as adjusted for Allocable Income&#47;Loss) so that he will not exceed the limitation.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">No later than the next April 15, the Department may (but shall not be obligated to) make the distribution requested, or deemed to have been requested, by him under this subparagraph (A).  Such distribution may be made notwithstanding any other provision of law or this Plan.  Except as otherwise provided by applicable Regulations, such distribution shall not reduce the amount of Regular Pre-Tax Contributions considered as Annual Additions under Section 4.7.  Any amounts not distributed under this subparagraph (A) shall continue to be held in accordance with the terms of the Plan.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">After a distribution of excess Regular Pre-Tax Contributions (if any) under subparagraph (A), Employer Matching Contributions (if any) made with respect to such distributed Regular Pre-Tax Contributions shall be withdrawn (with Allocable Income&#47;Loss thereon) from such Participant&#8217;s Employer Matching Sub-Account and applied to reduce future Employer Matching Contributions under Section 3.2.  After a recharacterization of excess Regular Pre-Tax Contributions (if any) under subparagraph (A), Employer Matching Contributions (if any) made with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 24 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">respect to such recharacterized Regular Pre-Tax Contributions shall, to the extent such Employer Matching Contributions would not have been made had such amount originally been considered Catch-Up Matching Contributions, be withdrawn (with Allocable Income&#47;Loss thereon) from such Participant&#8217;s Employer Matching Sub-Account and applied to reduce future Employer Matching Contributions under Section 3.2.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Catch-Up Pre-Tax Contributions exceeding the limitations of Code Section 414(v) shall be returned to the Participant under rules similar to those described in subparagraphs (1) and (2) above.  Employer Matching Contributions made with respect to excess Catch-Up Pre-Tax Contributions shall be treated as provided in subparagraph (2)(B) above.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Employer Matching Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Employer shall make Employer Matching Contributions to the Trust Fund equal to 100% of the Employee Pre-Tax Contributions made by each Eligible Employee with respect to each payroll period, but taking into account only those Employee Pre-Tax Contributions made by him with respect to such payroll period which are made at a rate that does not exceed 5% of his Deferral Compensation (but only up to the Code Section 401(a)(17)(B) limit).  Employer Matching Contributions may be made, at the discretion of  the Benefits Design Committee, solely in cash, solely in Quest Diagnostics Common Stock or in a combination of cash and Quest Diagnostics Common Stock.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Employer Matching Contributions made on behalf of a Participant shall be invested in accordance with the Investment Option election applicable to his Regular Pre-Tax Contributions.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If the Code Section 402(g) limit is less than 5% of the Code Section 401(a)(17) limit when a Non-highly Compensated Employee makes Regular Pre-tax Contributions equal to the Code Section 402(g) limit and also makes Catch-up Pre-tax Contributions, then the Non-highly Compensated Employee will receive Employer Matching Contributions on his Catch-up Pre-tax Contributions.  Notwithstanding, the Non-highly Compensated Employee will only receive Employer Matching Contributions on his Catch-up Pre-tax Contributions to the extent necessary to meet the matching contributions formula of this Section 3.2.  Otherwise, the Employer shall not</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 25 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">make Employer Matching Contributions with respect to Catch-Up Pre-Tax Contributions, except as applicable to Catch-Up Pre-Tax Contributions that have been recharacterized as Regular Pre-Tax Contributions pursuant to Section 3.1(b)(6).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Employer Matching Contributions shall be remitted to the Trustee in accordance with Regulation &#167;1.401(k)-3(c)(5)(ii), except that any Employer Matching Contributions with respect to recharacterized Regular Pre-Tax Contributions under Section 3.1(b)(6) shall be made as soon as administratively feasible following the end of the Plan Year for which the Regular Pre-Tax Contributions were originally designated as Catch-Up Pre-Tax Contributions.  Employer Matching Contributions made on behalf of a Participant shall be credited to his Employer Matching Sub-Account under Section 4.5.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Employer Discretionary Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">An Employer may elect for any Plan Year to make an Employer Discretionary Contribution in an amount expressed as a percentage of Deferral Compensation and which shall be allocated in accordance with Section 4.6.  Employer Discretionary Contributions may be made, at the discretion of Benefits Design Committee solely in cash, solely in Quest Diagnostics Common Stock or in a combination of cash and Quest Diagnostics Common Stock.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">With the written approval of the Benefits Design Committee, the Employer may elect to make an Employer Discretionary Contribution consisting of a single payment or payments over a specified time period, in cash, subject to compliance with the Code. The requirements, if any, applicable to such an Employer Discretionary Contribution shall be specified in the written approval by the Benefits Design Committee  and may include provisions related to&#58; (1) eligibility&#59; (2) allocation&#59; (3) vesting&#59; and (4) treatment of forfeitures. If not otherwise specified in the Benefits Design Committee approval, Employer Discretionary Contributions authorized pursuant to this Section 3.3(b) shall have the same requirements as to vesting, allocation and forfeiture as apply to Employer Discretionary Contributions authorized pursuant to Section 3.3(a).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">In cash Employer Discretionary Contributions shall be invested in the same manner as Regular Pre-Tax Contributions.  If Employer Discretionary Contributions are made, they shall be credited to such a sub-account as determined by the Department.</font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 26 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Rollover Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">An Eligible Employee (regardless of whether he has satisfied the initial eligibility requirements of Section 2.1) may, by making an Appropriate Request, request to make a rollover contribution to the Plan from the type of plans described in subsection (b) below.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">(1)&#160;&#160;&#160;&#160;The Plan will accept a direct rollover of an eligible rollover distribution, as defined in Code Section 402(f)(2)(A), from&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">a qualified plan described in Code Sections 401(a) or 403(a), excluding after-tax employee or Roth contributions&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">an annuity contract described in Code Section 403(b), excluding after-tax employee or Roth contributions&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">an eligible plan under Code Section 457(b) which is maintained by a state, political subdivision of a state, or any agency or instrumentality of a state or political subdivision of a state, but excluding after-tax employee or Roth contributions.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Plan will accept an Eligible Employee&#8217;s contribution of an eligible rollover distribution, as defined in Code Section 402(f)(2)(A), from&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">a qualified plan described in Code Sections 401(a) or 403(a), excluding after-tax employee contributions&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">an annuity contract described in Code Section 403(b), excluding after-tax employee contributions&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">an eligible plan under Code Section 457(b) which is maintained by a state, political subdivision of a state, or any agency or instrumentality of a state or political subdivision of a state, but excluding after-tax employee contributions.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Plan will accept an Eligible Employee&#8217;s rollover contribution of a portion of a distribution from an individual retirement account or annuity described in Code Sections 408(a) or 408(b), but not from a Roth individual retirement account or annuity described in Code Section 408A, an inherited IRA or a SIMPLE IRA maintained for less than two (2) years. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Department may require the Eligible Employee requesting to make a rollover contribution to provide whatever documentation and&#47;or certifications the Department deems </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 27 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">necessary to reasonably conclude that the rollover contribution satisfies the conditions set forth in subsection (b) above.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Rollover contributions generally must be in cash&#59; in-kind rollover contributions (but excluding stock of a prior employer) are permitted only in connection with a corporate transaction (as determined by the Department) involving an Employer and then only if the Department and the Trustee determine that management of such contribution is administratively feasible.  A rollover contribution shall be credited to the Participant&#8217;s Rollover Sub-Account and shall be 100% vested at all times.  If an Eligible Employee who has not otherwise commenced participation in the Plan makes a rollover contribution, he shall be considered a Participant with respect to his Rollover Sub-Account, which shall be invested in the applicable qualified default Investment Option specified by the Investment Committee unless and until he makes a different Investment Option election pursuant to Section 7.4.  A rollover contribution of a Participant shall be invested in accordance with his outstanding Investment Option election as in effect under Section 7.4.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If the Department, after reasonably concluding that a rollover contribution made by an Eligible Employee met the conditions set forth in subsection (b) above, later determines that the contribution did not meet those conditions, it shall direct the Trustee to distribute to him the amount of such rollover contribution, as adjusted by the investment experience, expenses (if any), distributions (if any) and withdrawals (if any) attributable to such amount, within a reasonable time after such determination.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Maximum Deductible Contribution</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">In no event shall the Employer be obligated to make an Employer Contribution for a Plan Year in excess of the maximum amount deductible by it under Code Section 404.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Actual Deferral Percentage Test Safe Harbor</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Plan is intended to satisfy Code Section 401(k)(3)(A)(ii) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">ADP Test</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) since&#58;  (1)(A)&#160;the rate of Employer Matching Contributions does not increase as a Participant&#8217;s rate of Employee Pre-Tax Contributions increases, (B) the aggregate amount of Employer Matching Contributions at each rate of Employee Pre-Tax Contributions is at least equal to the aggregate amount of Employer Matching Contributions that would be made if Employer Matching Contributions were made on the basis of the percentages described in Code Section</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 28 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">401(k)(12)(B)(i), and (C) the rate of Employer Matching Contributions with respect to any Employee Pre-Tax Contributions of a Highly Compensated Employee at any rate of Employee Pre-Tax Contributions is not greater than that with respect to an Eligible Employee who is not a Highly Compensated Employee&#59; and (2) the Department provides each Eligible Employee, within a reasonable period before the Plan Year begins (or, if applicable, a reasonable period before becoming an Eligible Employee), written notice of his rights and obligations under the Plan sufficiently accurate and comprehensive to appraise him of such rights and obligations and written in a manner calculated to be understood by the average Eligible Employee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding that the Plan is intended to be a &#8220;safe harbor&#8221; 401(k) plan with respect to Employee Pre-Tax Contributions, the provisions of the following sentence shall be applicable to Eligible Employees during such period as they are able to make Employee Pre-Tax Contributions but are not eligible to receive Employer Matching Contributions.  The Plan shall satisfy the ADP Test with respect to such Participants, using the current year testing method.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Payment of Employer Contributions to Trustee</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Unless an earlier time for contribution is specified in Sections 3.1 or 3.2, the Employer shall pay to the Trustee its Employer Contributions for each Plan Year within the time prescribed by law, including extensions of time for the filing of its federal income tax return for its taxable year during which such Plan Year ended.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">No Employee After-Tax or Roth Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Participants are not permitted to make after-tax, including Roth, contributions to the Plan.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Average Contribution Percentage Test Safe Harbor</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Plan is intended to satisfy Code Section 401(m)(2) (the &#8220;ACP Test&#8221;) since&#58;  (1)(A) the rate of Employer Matching Contributions does not increase as a Participant&#8217;s rate of Employee Pre-Tax Contributions increases, (B) the aggregate amount of Employer Matching Contributions at each rate of Employee Pre-Tax Contributions is at least equal to the aggregate amount of Employer Matching Contributions which would be made if Employer Matching Contributions were made on the basis of the percentages described in Code Section 401(k)(12)(B)(i), and (C) the rate of Employer Matching Contributions with respect to any Employee Pre-Tax Contributions of a Highly Compensated Employee at any rate of Employee Pre-Tax Contributions is not greater than that with respect to an Employee who is not a Highly Compensated Employee&#59; (2) the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 29 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Department provides each Eligible Employee, within a reasonable period before the Plan Year begins (or, if applicable, a reasonable period before becoming eligible for Employer Matching Contributions), written notice of his rights and obligations under the Plan sufficiently accurate and comprehensive to appraise him of such rights and obligations and written in a manner calculated to be understood by the average Eligible Employee&#59; and (3) Employer Matching Contributions on behalf of a Participant are not made with respect to his Employee Pre-Tax Contributions in excess of 6% of his Deferral Compensation.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">USERRA</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding any provision of this Plan to the contrary, contributions, benefits and service credit with respect to Qualified Military Service will be provided in accordance with the provisions of USERRA and Code Section 414(u).  An Eligible Employee who is absent from employment solely by reason of Qualified Military Service shall be subject to the following special rules and have the privileges described below&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Solely for the purposes of determining all limitations applicable under the Plan and the Code, all &#8220;make-up contributions&#8221; by the Participant or the Employer pursuant to this Section is deemed to be made in the Plan Year in which originally missed.  For the purposes of applying these limitations, the Participant will be imputed with Compensation in an amount equal to the amount he would have earned during his period of Qualified Military Service in the Plan Year (or the fraction thereof) had he been employed through the entirety of such period as an Eligible Employee at his regular rate of wages or salary in effect (including any contractual holiday, vacation or sick pay, contractual bonuses and other contractual direct remuneration) immediately prior to the commencement of such Qualified Military Service.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant who resumes employment with an Employer or an Affiliate following Qualified Military Service within the time during which his reemployment rights are protected by the provisions of USERRA shall be entitled to make up missed Employee Pre-Tax Contributions which he could have made but for such Qualified Military Service at any time during the period commencing with his resumption of employment with the Employer or Affiliate (whether or not then an Eligible Employee) and ending on the earliest to occur of&#58;  (1)&#160;the date that occurs five (5) years from the date on which such Qualified Military Service absence commenced&#59; (2) the date on which his employment terminates after having been resumed following Qualified Military Service&#59; or (3) the date that occurs after a passage of time commencing on his resumption of employment</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 30 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">following Qualified Military Service which is equal to three (3) times the duration of such absence for Qualified Military Service.  Any such &#8220;make-up&#8221; Employee Pre-Tax Contributions shall be made by payroll withholding unless otherwise permitted by applicable Regulations.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">To the extent that the Employer is required to make contributions to the Plan for a Participant in order to comply with the provisions of USERRA and Code Section 414(u), such contributions shall be made when he presents himself to resume services as an Employee of an Employer or an Affiliate within the time his reemployment rights are protected by federal law.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">To the extent a Participant makes &#8220;make-up&#8221; Employee Pre-Tax Contributions described in paragraph (c) above, the Employer shall contribute for allocation to his Employer Matching Contributions Account an amount equal to the Employer Matching Contributions that would have been made for his benefit if his make-up Elective Deferral Contributions had been made at the time his imputed Compensation would have been earned (without adjustment to reflect investment gains or losses or income or expenses that would have been attributable thereto).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If a Participant dies while in Qualified Military Service, his Beneficiary shall be entitled to any additional benefits (other than benefit accruals relating to the period of Qualified Military Service) provided under the Plan had the Participant resumed employment and then on the following day severed from employment on account of death.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt">If a Participant in Qualified Military Service elects to receive a distribution from the Plan on account of his severance from employment pursuant to Section 5.5(a), he shall not be permitted to make Employee Pre-Tax Contributions during, or to &#8220;make-up&#8221; Employee Pre-Tax Contributions with respect to, the six-month period beginning on the date of the distribution.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant in Qualified Military Service receiving a differential wage payment (as defined in Code Section 3401(h)(2)) shall be treated as an Eligible Employee of the Employer making the payment if he would be so considered had he not entered Qualified Military Service, and the differential wage payment shall be treated as Section 415 Compensation and as Deferral Compensation.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Corrective Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If it becomes necessary to correct a failure to follow the provisions of the Plan, to correct mistakes made in amounts distributed from or credited to Accounts, to restore the portion       </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 31 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">of an Account that was forfeited pursuant to any provision of the Plan or if an Employee should have been included as a Participant but is mistakenly excluded for any reason, correction or restoration shall first be made out of Employer Contributions and forfeitures and then out of Trust Fund earnings for the Plan Year in question, but only to the extent that such amounts have not already been allocated under the provisions of the Plan.  Any additional amounts needed may be provided by a special contribution to the Plan which the Employer, in its sole discretion (but considering the rules on deductibility under Code Section 162 and, if applicable, subject to  limitations on deductible contributions and maximum Annual Additions (as defined in Section 4.7(a)(1))), may elect to make.  Any such correction of mistake or special contribution shall be corrected, allocated or credited in the manner specified by the Department.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The provisions of this subsection (b) shall apply only to an Employee or former Employee who becomes entitled to back pay by an award or agreement of an Employer without regard to mitigation of damages.  If a person to whom this subsection applies was an Eligible Employee or would have become an Eligible Employee, after such back pay award or agreement has been effected, and if he had not previously elected to make Employee Pre-Tax Contributions pursuant to Section 3.1 but within 30 days of the date he receives notice of the provisions of this Section he makes an election to make Employee Pre-Tax Contributions in accordance with Section 3.1 (retroactive to any date as of which he was or has become eligible to do so), then he may elect that any Employee Pre-Tax Contributions not previously made on his behalf but which, after application of the foregoing provisions of this subsection, would have been made under the provisions of Article III shall be made out of the proceeds of such back pay award or agreement.  In addition, if any such Employee or former Employee would have been eligible to participate in the allocation of Employer Matching or Discretionary Contributions under the provisions of Articles III or XI for any prior Plan Year, after such back pay award or agreement has been effected his Employer shall make Employer Matching and Discretionary Contributions equal to the amount of the Employer Matching and Discretionary Contributions (respectively) which would have been allocated to him under the provisions of Articles III or XI as in effect during each such Plan Year after giving effect to any Employee Pre-Tax Contributions made previously or made pursuant to the preceding sentence.  The amounts of such additional contributions shall be credited to his Account.  Any additional contributions made pursuant to this subsection shall be made in accordance with, and subject to the limitations of, the applicable provisions of the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 32 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:1.04pt"><br><br>ALLOCATIONS TO ACCOUNTS</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Accounts</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Department shall establish and maintain a recordkeeping Account in the name of each Participant, including the following recordkeeping sub-accounts to which are credited all amounts allocated to each such Participant under this Article IV as well as earnings or losses thereon and shall debit expenses (if any), distributions (if any) and withdrawals (if any) attributable to such sub-account&#58;  an Employee Regular Pre-Tax Sub-Account, an Employee Pre-Tax Catch-Up Sub-Account and an Employer Matching Sub-Account.  The Department also shall maintain such other recordkeeping sub-accounts as the Participant may have pursuant to an Appendix hereto, and such other recordkeeping sub-accounts, e.g., a Rollover Sub-Account, as may be authorized by the Plan or the Department as well as earnings or losses thereon and shall debit expenses (if any), distributions (if any) and withdrawals (if any) attributable to each such sub-account.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The maintenance of separate Accounts or sub-accounts shall not require a segregation of the Trust assets and no Participant shall acquire any right to or interest in any specific asset of the Trust as a result of the allocations provided for in the Plan or by reason of the maintenance of Accounts or sub-accounts.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Valuation of Accounts</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A Participant&#8217;s Account (or applicable sub-account thereof) shall be valued at fair market value as of  each business day of the Plan Year (a &#8220;Valuation Date&#8221;).  As of each such Valuation Date, the earnings or losses of the Trust Fund shall be allocated to each affected Participant&#8217;s Account (or applicable sub-account thereof) pursuant to a consistent non-discriminatory method.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Notification of Account Balance</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">As of the last day of each calendar quarter, and at such other times as the Department may direct, the Plan&#8217;s recordkeeper shall make available to each Participant information regarding the amount of contributions credited to his Account and applicable sub-accounts for the period just completed and the balance of his Account and applicable sub-accounts, including any distributions, loans and withdrawals or expenses charged to his Account and applicable sub-accounts since the effective date of the last such statement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 33 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Allocation of Employee Pre-Tax Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">An Eligible Employee&#8217;s Regular Pre-Tax Contributions under Section 3.1(a) shall be allocated to his Employee Regular Pre-Tax Sub-Account and invested among the Investment Options then available in accordance with Section 7.4.  An Eligible Employee&#8217;s Catch-Up Pre-Tax Contributions under Section 3.1(b) shall be allocated to his Employee Pre-Tax Catch-Up Sub-Account and invested in the same manner as his Regular Pre-Tax Contributions.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Allocation of Employer Matching Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Employer Matching Contributions made on behalf of an Eligible Employee under Section 3.2 shall be allocated to his Employer Matching Sub-Account and shall be invested in the same manner as his Regular Pre-Tax Contributions.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Allocation of Employer Discretionary Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Any Employer Discretionary Contributions under Section 3.3(a), or forfeitures subject to allocation under Section 5.5(e), shall be allocated among those Participants who are active Eligible Employees as of the last day of such Plan Year and who have met the eligibility requirements of Section 2.1 to receive such Employer Discretionary Contributions.  Such allocation shall be in proportion to their respective Deferral Compensation (as limited by Code Section 401(a)(17)(B)) for the Plan Year.  Employer Discretionary Contributions required under Section 11.2, and any Employer contributions needed under Section 3.11, shall be allocated as provided in those sections and invested in the same manner as Regular Pre-Tax Contributions, and may be made, at the discretion of Benefits Design Committee solely in cash, solely in Quest Diagnostics Common Stock or in a combination of cash and Quest Diagnostics Common Stock.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Maximum Additions</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">For purposes of this Section, the following terms have the following meanings&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Annual Additions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221; means for any Limitation Year (as defined below)&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">The sum of the following amounts credited to a Participant&#8217;s account in all qualified defined contribution plans (including an annuity contract described in Code Section 403(b)) maintained by the Employer or an Affiliate (or a predecessor employer as defined in Regulation &#167;1.415(f)-1(c))&#58;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.69pt">Employer contributions, even if such Employer contributions are excess contributions (as described in Code                          </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 34 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Section 401(k)(8)(B)) or excess aggregate contributions (as described in Code Section 401(m)(6)(B)), or such excess contributions or excess aggregate contributions are corrected through distribution&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:21.36pt">Employee contributions, including mandatory contributions (as defined in Code Section 411(c)(2)(C) and Regulations thereunder) and voluntary employee contributions&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.03pt">Forfeitures&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.69pt">Contributions allocated to any individual medical account, as defined in Code Section 415(1)(2), that is part of a pension or annuity plan established under Code Section 401(h) and maintained by the Employer or an Affiliate&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Amounts attributable to post-retirement medical benefits allocated to a separate account for any Employee who, at any time during the Plan Year or any preceding Plan Year, is or was a key employee pursuant to Code Section 419A(d)), maintained by the Employer or an Affiliate&#59; and</font></div><div style="margin-bottom:3pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.69pt">The difference between the value of any assets transferred to the Plan and the consideration, where an Employee or the Employer transfers assets to the Plan in exchange for consideration that is less than the fair market value of the assets transferred to the Plan.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">Notwithstanding the foregoing, a Participant&#8217;s Annual Additions do not include the following&#58;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.69pt">The restoration of his accrued benefit by an Employer in accordance with Code Sections 411(a)(3)(D) or (7)(C) or resulting from the repayment of cashouts (as described in Code Section 415(k)(3)) under a governmental plan (as defined in Code Section 414(d)) for the Limitation Year in which the restoration occurs, regardless of whether the Plan                   </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 35 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">restricts the timing of repayments to the maximum extent allowed by Code Section 411(a)&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:21.36pt">Catch-Up Pre-Tax Contributions made in accordance with Code Section 414(v) and Regulation &#167;1.414(v)-1&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.03pt">A payment made to restore some or all of the Plan&#8217;s losses resulting from an action (or a failure to act) by a fiduciary for which there is reasonable risk of liability for breach of a fiduciary duty (other than a breach of fiduciary duty arising from failure to remit contributions to the Plan) under ERISA or under other applicable federal or state law, where Participants who are similarly situated are treated similarly with respect to the payments.  This includes payments to the Plan made pursuant to a Department of Labor order, the Department of Labor&#8217;s Voluntary Fiduciary Correction Program, or a court-approved settlement, to restore losses to a qualified defined contribution plan&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.69pt">Excess elective deferrals distributed in accordance with Regulation &#167;&#167;1.402(g)-1(e)(2) or (3)&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Rollover Contributions (as described in Code Sections 401(a)(31), 402(c)(1), 403(a)(4), 403(b)(8), 408(d)(3) and 457(e)(16))&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.69pt">Repayments of loans made to the Participant from the Plan&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:15.36pt">Repayments of prior Plan distributions described in Code Section 411(a)(7)(B) (in accordance with Code Section 411(a)(7)(C)) and Code Section 411(a)(3)(D) or repayment of contributions to a governmental plan (as defined in Code Section 414(d)) as described in Code Section 415(k)(3)&#59;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:12.03pt">The direct transfer of a benefit or employee contributions from a qualified plan to a defined contribution plan&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 36 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ix)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.69pt">The reinvestment of dividends on employer securities under an employee stock ownership plan pursuant to Code Section 404(k)(2)(A)(iii)(II)&#59; and</font></div><div style="margin-bottom:3pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Employee contributions to a qualified cost of living arrangement as defined in Code Section 415(k)(2)(B).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Limitation Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221; means the Plan Year unless changed by a Plan amendment.  Notwithstanding the preceding, if the Plan is terminated effective as of a date other than the last day of the Limitation Year, the Plan shall be treated as if amended to change its Limitation Year.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Code Section 415 Limit</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding anything herein to the contrary, in no event may the Annual Additions (except for Catch-Up Pre-Tax Contributions under Code Section 414(v)) made with respect to a Participant for a Limitation Year under the Plan and any other defined contribution plan, within the meaning of Code Section 415(c), maintained by an Employer or an Affiliate exceed the lesser of $53,000 (as adjusted pursuant to Code Section 415(d)) or 100% of his annual Section 415 Compensation from the Employer or an Affiliate for the Limitation Year.  The compensation limitation referred to in the preceding sentence shall not apply to any contribution for medical benefits (within the meaning of Code Sections 401(h) or 419A(f)(2)) which is otherwise treated as an Annual Addition under Code Sections 415(a)(2) or 415(l)(1).  In the event a short Limitation Year is created because of an amendment changing the Limitation Year to a different 12-consecutive month period, the maximum amount indicated above shall be reduced pro rata in accordance with the number of months in the short Limitation Year.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If due to a reasonable error in calculating a Participant&#8217;s Section 415 Compensation for a Plan Year, due to the allocation of forfeitures or such other facts and circumstances as may justify the availability of this special rule, as determined by the IRS, the Annual Additions to the Participant&#8217;s Account under this Plan and any other defined contribution plan of the Employer exceeds the limitations of paragraph (1) for a Limitation Year, then the excess amounts may be corrected only in accordance with the IRS Employee Plans Compliance Resolution System (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">EPCRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) as set forth in Revenue Procedure 2019-19 or any superseding guidance.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 37 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The provisions of Code Section 415 and Regulations thereunder are hereby incorporated by reference to the extent not provided above.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Plan Aggregation and Disaggregation under Code Section 415</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">For purposes of applying the limitations of Section 4.7, all defined contribution plans (without regard to whether a plan has been terminated) ever maintained by the &#8220;employer&#8221; (or a &#8220;predecessor employer&#8221;) under which the Participant receives Annual Additions (as defined in Section 4.7(a)(1)) are treated as one plan.  The &#8220;employer&#8221; means an Employer that adopts this Plan and its Affiliates, except that for purposes of Section 4.7 and this Section, the determination will be made by applying Code Section 415(h) and will take into account tax-exempt organizations under Regulation &#167;1.414(c)-5, as modified by Regulation &#167;1.415(a)-1(f)(1).  For purposes of this subsection (a)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A former employer is a &#8220;predecessor employer&#8221; with respect to a participant in a plan maintained by an employer if the employer maintains a plan under which the participant had accrued a benefit while performing services for the former employer, but only if that benefit is provided under the plan maintained by the employer.  For this purpose, the formerly affiliated plan rules in Regulation &#167;1.415(f)-1(b)(2) apply as if the employer and the predecessor employer constituted a single employer under the rules described in Regulation &#167;&#167;1.415(a)-1(f)(1) and (2) immediately prior to the cessation of affiliation (and as if they constituted unrelated employers under the rules described in Regulation &#167;&#167;1.415(a)-1(f)(1) and (2) immediately after the cessation of affiliation), and cessation of affiliation was the event that gives rise to the predecessor employer relationship, such as a transfer of benefits or of plan sponsorship.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">With respect to an employer of a Participant, a former entity that antedates the employer is a &#8220;predecessor employer&#8221; with respect to the Participant if, under the facts and circumstances, the employer is a continuation of all or a portion of the trade or business of the former entity for which the Participant performed services.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">For purposes of aggregating plans under Code Section 415, a &#8220;formerly affiliated plan&#8221; of an employer is taken into account for purposes of applying the Code Section 415 limitations to the employer, but the formerly affiliated plan is treated as if it had terminated immediately prior to the &#8220;cessation of affiliation.&#8221;  For purposes of this paragraph, a &#8220;formerly affiliated plan&#8221; of an employer is a plan that, immediately prior to the cessation of affiliation, was                                                </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 38 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">actually maintained by one or more of the entities that constitute the employer (as determined under the employer affiliation rules described in Regulation &#167;&#167;1.415(a)-1(f)(1) and (2)), and immediately after the cessation of affiliation, is not actually maintained by any of the entities that constitute the employer (as determined under the employer affiliation rules described in Regulation &#167;&#167;1.415(a)-1(f)(1) and (2)).  For purposes of this paragraph, a &#8220;cessation of affiliation&#8221; means the event that causes an entity to no longer be aggregated with one or more other entities as a single employer under the employer affiliation rules described in Regulation &#167;&#167;1.415(a)-1(f)(1) and (2) (such as the sale of a subsidiary outside a controlled group), or that causes a plan to not actually be maintained by any of the entities that constitute the employer under the employer affiliation rules of Regulation &#167;&#167;1.415(a)-1(f)(1) and (2) (such as a transfer of plan sponsorship outside of a controlled group).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Two or more defined contribution plans that are not required to be aggregated pursuant to Code Section 415(f) and regulations thereunder as of the first day of a Limitation Year (as defined in Section 4.7(a)(2)) do not fail to satisfy the requirements of Code Section 415 with respect to a Participant for the Limitation Year merely because they are aggregated later in that Limitation Year, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that no Annual Additions are credited to the Participant&#8217;s account after the date on which the plans are required to be aggregated.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 39 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:5.7pt"><br><br>VESTING AND DISTRIBUTIONS</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Normal Retirement</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Upon the severance from employment of a Participant on or after attaining his Normal Retirement Age, the value (as determined under Section 4.2) of his entire Account shall become 100% vested and shall become payable as soon as administratively feasible following his retirement.  Subject to Section 5.7(a), the Department thereupon shall direct the Trustee to make available to the retiring Participant such vested amount in accordance with Sections 5.6 and 5.7.  Failure of the Participant to elect a distribution is deemed a current election to defer distribution to his &#8220;required beginning date&#8221; under Section 5.8(g)(5). </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Disability</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Upon the Total and Permanent Disability of a Participant before his Severance from Service Date, the value (as determined under Section 4.2) of his entire Account shall become 100% vested.  As soon as administratively feasible following a Participant&#8217;s Total and Permanent Disability, the Department, subject to Section 5.7(a), shall direct the Trustee to make available to the Participant such amount in accordance with Sections 5.6 and 5.7.  Failure of the Participant to elect a distribution is deemed a current election to defer distribution to his &#8220;required beginning date&#8221; under Section 5.8(g)(5).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Death Before Severance from Employment</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">If a Participant dies before his Severance from Service Date, the value (as determined under Section 4.2) of his entire Account automatically shall become 100% vested and shall become payable to his Beneficiary in accordance with Section 5.6 as soon as administratively feasible unless the Beneficiary defers distribution, subject to Section 5.8(c).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Death After Severance from Employment</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">If a Participant dies after his Severance from Service Date but before he has begun receiving his benefit pursuant to the Plan, the value (as determined under Section 4.2) of the vested portion of his Account (as determined under Section 5.5(b)) shall become payable under Section 5.6 as soon as administratively feasible after the Department is notified of the death unless, subject to Section 5.8(c), the Beneficiary defers distribution.  However, if such Participant began benefit &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 40 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">payments under the Plan before his death, the provisions of such form of distribution shall control payments after his death.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Severance from Employment</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">As soon as administratively feasible following a Participant&#8217;s severance from employment for any reason other than retirement under Section 5.1&#59; disability under Section 5.2&#59; death under Section 5.3&#59; reduction-in-force under subsection (b)(1) below&#59; or a termination, partial termination or deemed partial termination of the Plan under Section 9.2, the Department shall direct the Trustee to distribute to such Participant the value (as determined under Section 4.2) of the vested portion of his Account (as determined under subsection (b)).  Notwithstanding the preceding sentence, pursuant to Section 5.7(b), consent of the Participant may be required before distribution can be made.  A Participant in Qualified Military Service for a period of more than 30 days is deemed to have incurred a severance from employment under Code Section 401(k)(2)(B)(i)(I) and may elect to receive a distribution from his Employee Pre-Tax Contributions sub-accounts on account of such severance from employment&#59; pursuant to Section 3.10(g), his right to make Employee Pre-Tax Contributions shall be suspended for six (6) months following such distribution.  If a Participant who severed his employment with an Employer is reemployed by an Employer or an Affiliate prior to receiving a distribution of his Account, he shall not be entitled to a distribution as provided in this Section 5.5 due to such severance, but shall be entitled to a distribution as determined herein upon a subsequent severance from employment for any reason.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">(1)&#160;&#160;&#160;&#160;A Participant always has a 100% vested percentage in his Employee Pre-Tax Contribution, Employer Matching, Rollover Contribution, Vested Quest Diagnostics Common Stock Dividend and Vested Money Purchase Pension Plan Dividend Sub-Accounts, as applicable, as well as in his Employer Discretionary Contributions (if any) made before 2016 under the Plan.  Also, if a Participant is employed by an Employer or an Affiliate on the date he attains his Normal Retirement Age, or if he severs from employment with his Employer or an Affiliate due to a reduction-in-force, he shall be 100% vested in his entire Account.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Except as provided in paragraph (1) above or pursuant to Section 3.3(b), a Participant shall have a vested percentage in the balance of Employer Discretionary</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 41 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> Contributions, and any earnings or losses thereon, made after 2015 under the Plan determined in accordance with the following schedule&#58;</font></div><div style="margin-bottom:6pt;padding-left:144pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:56.969%"><tr><td style="width:1.0%"></td><td style="width:49.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Years of Vesting Service</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Vested Interest</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 2 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2 but less than 3 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">20%</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 but less than 4 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">40%</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4 but less than 5 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">60%</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 but less than 6 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">80%</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">6 or more years</font></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Any portion of a Participant&#8217;s Account in which he is not vested upon his Severance from Service Date for any reason will be forfeited as of the earlier of&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the last day of the Plan Year in which the Participant incurs five (5) consecutive One-Year Periods of Severance&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the distribution of the balance of the Participant&#8217;s entire vested Account.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of paragraph (2) above, a terminated Participant who has no vested benefit in his Account (other than a Rollover Contributions Sub-Account) is deemed to have received a distribution of the balance of his entire vested Account as of his Severance from Service Date.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">Withdrawal of Vested Portion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8212; If a withdrawal is made at a time when a Participant has a vested right to less than 100% of the value of his entire Account and the non-vested portion of his Account has not yet been forfeited pursuant to subsection (c) above&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">separate sub-accounts shall be established for the Participant&#8217;s interest in his non-vested sub-accounts as of the time of distribution&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">at any relevant time the Participant&#8217;s vested portion of the separate sub-accounts shall be an amount (&#8220;X&#8221;) determined by the formula&#58;</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">X&#61;P(AB+ (RxD))-(RxD).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of the above formula&#58;  P is the vested percentage at the relevant time&#59; AB is the particular sub-account balance at the relevant time&#59; D is the amount of the distribution&#59; and R is the ratio of such sub-account balance at the relevant time to such sub-account balance after distribution.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt;text-decoration:underline">Application of Forfeitures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8212; Forfeitures occurring during the Plan Year first shall be used to reinstate previously forfeited sub-accounts of reemployed Participants, if any, and any remaining forfeitures then will be used either to reduce or supplement Employer Matching or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 42 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Discretionary Contributions to the Plan, to make corrective allocations to the Plan (and earnings on such corrective allocations) pursuant to Section 3.11 or to pay Plan expenses.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt;text-decoration:underline">Restoration of Forfeitures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8212;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding anything herein to the contrary, if a Participant forfeits any portion of his Account pursuant to this Plan but returns to the employ of an Employer or an Affiliate, the amount forfeited will be recredited to his Account if he repays to the Plan the full amount of the prior distribution from his Account, without interest, prior to the earlier of&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">five (5) consecutive One-Year Periods of Severance&#59; or</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">the 5th anniversary of his Reemployment Commencement Date.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">In the case of a Participant whose Severance from Service Date occurred prior to his earning a vested interest in his Account (other than a Rollover Contributions Sub-Account) and who was deemed to have received a distribution of such vested interest under subsection (c) above, the amount forfeited will be recredited to his Account if he is reemployed by an Employer or an Affiliate prior to incurring five (5) consecutive One-Year Periods of Severance.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant&#8217;s vested percentage in the amount recredited under this subsection (f) will thereafter be determined under the terms of the Plan as if no forfeiture had previously occurred.  The monies required to effect the restoration of a Participant&#8217;s Accounts shall come from other Participant&#8217;s Accounts forfeited in accordance with this Section or, if necessary, additional Employer contributions.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">One-Year Period of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; For purposes of this Section, a One-Year Period of Severance means a 12-consecutive month Period of Severance.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If the Plan&#8217;s vesting schedule is amended, or the Plan is amended in any way that directly or indirectly affects the computation of a Participant&#8217;s vested percentage, each Participant who has completed three (3) or more Years of Vesting Service, may elect, within the period described below, to have his vested percentage determined without regard to such amendment or change.  The election period referred to in the preceding sentence will begin on the date the amendment of the vesting schedule is adopted and will end 60 days thereafter or, if later, 60 days after the later of&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 43 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the date on which such amendment becomes effective&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the date on which the Participant is issued written notice of such amendment by the Department.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of this subsection (h), a Participant will be considered to have completed three (3) Years of Service if he has completed three (3) Years of Service, whether or not consecutive, without regard to the exceptions contained in Code Section 411(a)(4) prior to the expiration of the election period described above.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Method of Payment</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Normal Form</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The normal form of distribution under the Plan is a lump sum.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">At the election of the Participant, payments from investments held in the Quest Diagnostics Incorporated Stock Fund will be distributed in Quest Diagnostics Common Stock (whole shares only) but, in the absence of such an election, will be distributed in cash.  Payments from other investments will be made only in cash except that, in the case of a distribution made in connection with a corporate transaction, in the discretion of the Trustee in-kind payments may be made if such in-kind payments will be accepted as rollover contributions by the trustee of the subsequent employer&#8217;s plan.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">During the 180-day period ending on the day his distribution commences, a Participant may elect to have his Plan benefit paid in one of the options under subsection (b).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant who desires to have his benefit paid in an option under subsection (b) shall make such an election through an Appropriate Request.  His election to receive his benefit in an option provided in subsection (b) may be revoked by him at any time and any number of times during the 180-day period ending on the day benefit payments commence.  After benefit payments have commenced, no elections or revocations of an optional method will be permitted under any circumstances.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Participants who have a portion of their vested Account attributable to the QJSA Portion will be subject to the rules of Appendix F in respect to the distribution of such portion.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 44 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">Available Options</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">In lieu of a lump sum, a Participant may elect monthly, quarterly or annual installments from the Trust Fund over a period not to exceed the lesser of&#58;  (A) 10 years&#59; or (B) the life expectancy of the Participant or the joint life expectancies of him and his Beneficiary.  Life expectancies are determined when payments commence and are not later recalculated.  Installment payments shall be made pro-rata from the various sub-accounts within his Account.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Cash-Outs&#59; Consent</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If a Participant retires under Section 5.1, becomes disabled under Section 5.2 or severs from employment under Section 5.5 and the value (as determined under Section 4.2) of the vested portion of his Account does not exceed $1,000 as of the first Valuation Date (and its confirmation date) thereafter upon which such Account is valued for purposes of determining if it exceeds $1,000, the Department shall direct the Trustee to distribute to him such amount in accordance with Section 5.6(a) as soon as administratively feasible following such Valuation Date (and its confirmation date).  If the value of the vested portion of his Account exceeds $1,000 upon such Valuation Date (or its confirmation date), but is $1,000 or less as of any subsequent Valuation Date upon which such Account is valued for purposes of determining if it exceeds $1,000, the Department shall direct the Trustee to distribute to him such amount in accordance with Section 5.6(a) as soon as administratively feasible following such Valuation Date.  For purposes of this Section 5.7(a), the value of a Participant&#8217;s Account shall be determined by including that portion of the account that is attributable to rollover contributions (and earnings or losses attributable thereto) within the meaning of Code Sections 402(c), 403(a)(4), 403(b)(8), 408(d)(3)(A)(ii) and 457(e)(16).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If a Participant retires under Section 5.1, becomes disabled under Section 5.2 or severs from employment under Section 5.5 and the value (as determined under Section 4.2) of the vested portion of his Account exceeds $1,000 (and such value exceeds $1,000 as of each subsequent Valuation Date (or its confirmation date) upon which such Account is valued for purposes of determining if it exceeds $1,000), then no distribution shall be made prior to his &#8220;required beginning date&#8221; under Section 5.8(g)(5) unless he consents to the making of such distribution through an Appropriate Request.  Distribution shall commence no later than 180 days from the date his written consent is obtained.  He shall be given a notice of the right to defer any distribution to his &#8220;required beginning date&#8221; under Section 5.8(g)(5).  Such notification shall be&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 45 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">given no less than 30 days and no more than 180 days prior to the date distribution commences.  Notwithstanding the preceding sentence, distribution may commence less than 30 days after the notification was given, as long as the notification informs him that he has a right to a period of at least 30 days after receiving the notice to decide whether to elect a distribution.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Payment of Benefits</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Except as provided in subsection (b), in the event a Participant&#8217;s Account shall be due and payable under this Article V and he has not elected (or been deemed to have elected) otherwise in accordance with the Plan, the payment of his Account shall begin not later than 60 days after the close of the Plan Year in which occurs the latest of&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the date on which he attains age 65&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the 10th anniversary of the date on which he commenced participation in the Plan&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">his severance from employment with the Employer.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The requirements of subsections (c) &#8211; (f) of this Section will apply for purposes of determining required minimum distributions and will take precedence over any inconsistent provisions of the Plan.  All distributions required under subsections (c)&#160;&#8211;&#160;(f) will be determined and made in accordance with the Regulations under Code Section 401(a)(9) and the minimum distribution incidental benefit requirements of Code Section 401(a)(9)(G).</font></div><div style="padding-left:28.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:29.9pt">(1)&#160;&#160;&#160;&#160;The Participant&#8217;s entire interest will be, or will begin to be, distributed to him no later than his required beginning date.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">As of the first distribution calendar year, distributions, if not made in a single-sum, may be made only over one of the following periods (or a combination thereof)&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">his life&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">the lives of him and his designated beneficiary&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">a period certain not extending beyond his life expectancy&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">a period certain not extending beyond the joint and last survivor expectancy of him and his designated beneficiary.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If he dies before distributions begin, his entire interest will be, or will begin to be, distributed no later than as follows&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 46 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">If his surviving spouse is his sole designated beneficiary, then except as provided in (D) below, distributions to the surviving spouse will begin by December 31 of the calendar year immediately following the calendar year in which he died, or by December 31 of the calendar year in which he would have attained age 70&#189;, if later.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">If his surviving spouse is not his sole designated beneficiary, distributions to the designated beneficiary will begin by December 31 of the calendar year immediately following the calendar year in which he died.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">If there is no designated beneficiary as of the date of his death who remains a beneficiary as of September 30 of the year following the year of his death, his entire interest will be distributed by December 31 of the calendar year containing the fifth anniversary of his death.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">If his surviving spouse is his sole designated beneficiary and the surviving spouse dies after him but before distributions to the surviving spouse begin, this paragraph (3), other than subparagraph (A), will apply as if the surviving spouse were the Participant.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of this subsection (c)(3) and subsection (e), unless subparagraph (D) above applies, distributions are considered to begin on his required beginning date.  If distributions under an annuity purchased from any insurance company irrevocably commence to him before his required beginning date (or to his surviving spouse before the date distributions are required to begin under subparagraph (A)), the date distributions are considered to begin is the date distributions actually commence.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Unless his interest is distributed in the form of an annuity purchased from an insurance company or in a single sum on or before the required beginning date, as of the first distribution calendar year distributions will be made in accordance with subsections (d) and (e) of this Section 5.8.  If his interest is distributed in the form of an annuity purchased from an insurance company, distributions thereunder will be made in accordance with the requirements of Code Section 401(a)(9) and Regulations thereunder.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">(1)&#160;&#160;&#160;&#160;During the Participant&#8217;s lifetime, the minimum amount that will be distributed for each distribution calendar year is the lesser of&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 47 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">the quotient obtained by dividing his account balance by the distribution period in the Uniform Lifetime Table in Regulation &#167;1.401(a)(9)-9, using his age as of his birthday in the distribution calendar year&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">if his sole designated beneficiary for the distribution calendar year is his spouse, the quotient obtained by dividing his account balance by the number in the Joint and Last Survivor Table in Regulation &#167;1.401(a)(9)-9, using their attained ages as of their birthdays in the distribution calendar year.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Required minimum distributions will be determined under this subsection&#160;(d) beginning with the first distribution calendar year and up to and including the distribution calendar year that includes the date of his death.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">(1)&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;If the Participant dies on or after the date required distributions begin and there is a designated beneficiary, the minimum amount that will be distributed for each distribution calendar year after the year of his death is the quotient obtained by dividing his account balance by the longer of his remaining life expectancy or the remaining life expectancy of his designated beneficiary, determined as follows&#58;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.69pt">His remaining life expectancy is calculated using his age in the year of death, reduced by one for each subsequent year.</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:21.36pt">If his surviving spouse is his sole designated beneficiary, the remaining life expectancy of the surviving spouse is calculated for each distribution calendar year after the year of his death using the surviving spouse&#8217;s age as of the spouse&#8217;s birthday in that year.  For distribution calendar years after the year of the surviving spouse&#8217;s death, the remaining life expectancy of the surviving spouse is calculated using the age of the surviving spouse as of the spouse&#8217;s birthday in the calendar year of the spouse&#8217;s death, reduced by one for each subsequent calendar year.</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.03pt">If his surviving spouse is not his sole designated beneficiary, the designated beneficiary&#8217;s remaining life expectancy is calculated using the age of the beneficiary in the year</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 48 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">following the year of his death, reduced by one for each subsequent year.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">If the Participant dies on or after the date required distributions begin and there is no designated beneficiary as of his death who remains a beneficiary as of September 30 of the year after the year of his death, the minimum amount that will be distributed for each distribution calendar year after the year of his death is the quotient obtained by dividing his account balance by his remaining life expectancy calculated using his age in the year of death, reduced by one for each subsequent year.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">(A)&#160;&#160;&#160;&#160;Except as provided in subsection (c)(4), if the Participant dies before the date required distributions begin and there is a designated beneficiary, the minimum amount that will be distributed for each distribution calendar year after the year of his death is the quotient obtained by dividing his account balance by the remaining life expectancy of his designated beneficiary, as determined under subsection (e)(1).</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">If he dies before the date required distributions begin and there is no designated beneficiary as of his death who remains a beneficiary as of September 30 of the year following the year of his death, distribution of his entire interest will be completed by December 31 of the calendar year containing the fifth anniversary of his death.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">If he dies before the date required distributions begin, his surviving spouse is his sole designated beneficiary, and the surviving spouse dies before distributions are required to begin to the surviving spouse under subsection (c)(2)(A), this subsection (e)(2) will apply as if the surviving spouse were the Participant.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt">For purposes of this Section 5.8, the following words and phrases shall have the meanings indicated&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">Designated beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The individual who is designated as the Beneficiary under Section 2.3 of the Plan and who is a designated beneficiary under Code Section 401(a)(9) and Regulation &#167;1.401(a)(9)-1, Q&#38;A 4.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 49 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">Distribution calendar year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; A calendar year for which a minimum distribution is required.  For distributions beginning before the Participant&#8217;s death, the first distribution calendar year is the calendar year immediately preceding the calendar year that contains his required beginning date.  For distributions beginning after his death, the first distribution calendar year is the calendar year in which distributions are required to begin pursuant to subsection (c)(3).  The required minimum distribution for his first distribution calendar year will be made on or before his required beginning date.  The required minimum distribution for other distribution calendar years, including the required minimum distribution for the distribution calendar year in which his required beginning date occurs, will be made on or before December 31 of that distribution calendar year.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">Life expectancy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Life expectancy as computed by use of one of the following tables, as appropriate&#58;  (i) Single Life Table, (ii) Uniform Life Table, or (iii) Joint and Last Survivor Table, found in Regulation &#167;1.401(a)(9)-9.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">Account balance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The account balance as of the last Valuation Date in the calendar year immediately preceding the distribution calendar year (valuation calendar year) increased by the amount of any contributions made and allocated or forfeitures allocated to the account balance as of dates in the valuation calendar year after the Valuation Date and decreased by distributions made in the valuation calendar year after the Valuation Date.  The account balance for the valuation calendar year includes any amounts rolled over or transferred to the Plan either in the valuation calendar year or in the distribution calendar year if distributed or transferred in the valuation calendar year.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">Required beginning date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; April 1 of the calendar year following the later of the calendar year in which the Participant attains age 70&#189; or retires, except in the case of a Participant who is a 5% owner in which case it is April 1 of the calendar year following the calendar year in which he attains age 70&#189;.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">5% owner</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; A Participant is treated as a 5% owner for purposes of this Section if he is a 5% owner as defined in Code Section 416 at any time during the Plan Year ending with or within the calendar year in which he attains age 70&#189;.  Once required distributions have begun to a 5% owner under this Section, they must continue to be distributed, even if he ceases to be a 5% owner in a subsequent year.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 50 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Direct Rollovers</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Notwithstanding any provision of the Plan to the contrary that would otherwise limit a distributee&#8217;s election under this Section, a distributee may elect, at the time and in the manner prescribed by the Department, to have any portion of an eligible rollover distribution paid in a direct rollover directly to an eligible retirement plan specified by the distributee.  For purposes of this Section, the following terms have the meanings below&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">(1)&#160;&#160;&#160;&#160;An &#8220;eligible rollover distribution&#8221; is any distribution of all or any portion of the balance to the credit of the distributee, except that an eligible rollover distribution does not include&#58;  (i) any distribution that is one of a series of substantially equal periodic payments (not less frequently than annually) made for the life (or life expectancy) of the distributee or the joint lives (or joint life expectancies) of the distributee and the distributee&#8217;s designated beneficiary, or for a specified period of ten years or more&#59; (ii)&#160;any distribution to the extent such distribution is required under Code Section 401(a)(9)&#59; (iii) a hardship distribution&#59; (iv) a corrective distribution pursuant to Sections 3.1(c), 3.4(e), 3.6, 4.7(b)(2) or 5.12(c), or similar correction&#59; (v) a deemed distribution resulting from a defaulted loan under Section 6.1 that is not also an offset distribution&#59; (vi) any distribution that is reasonably expected to total less than $200 during a calendar year&#59; (vii) the portion of any distribution that is not includible in gross income (determined without regard to the exclusion for net unrealized appreciation with respect to employer securities)&#59; (viii)&#160;dividends on Quest Diagnostics Common Stock paid directly to a Participant pursuant to an election under Section 6.4&#59; and (ix) any other distribution described in Regulation &#167;1.402(c)-2.  For purposes of clause (vi) above, a distribution from a designated Roth account and a distribution from other accounts under the Plan may be treated as made under separate plans.  Any distribution of Roth contributions is deemed to be an eligible rollover distribution only to the extent that such Roth contributions are rolled over to a Roth individual retirement account or annuity described in Code Section 408A or to a qualified trust that accepts, and agrees to separately account for, Roth Contributions.  A portion of a distribution shall not fail to be an eligible rollover distribution merely because the portion consists of after-tax employee contributions which are not includible in gross income.  However, such portion may be transferred only to a traditional individual retirement account or annuity described in Code Sections 408(a) or 408(b), a Roth </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 51 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:31.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">individual retirement account or annuity described in Code Section 408A, or to a defined contribution plan described in Code Sections 401(a) or 403(b) that agrees to account separately for amounts so transferred, including accounting separately for the portion of such distribution which is includible in gross income and the portion of such distribution which is not so includible.  An &#8220;eligible rollover distribution&#8221; also includes a distribution to a non-spouse Beneficiary designated by a Participant in accordance with Section 2.3, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> the distribution otherwise qualifies as an eligible rollover distribution hereunder and the distribution is made to an eligible retirement plan.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">An &#8220;eligible retirement plan&#8221; is a traditional individual retirement account or annuity described in Code Sections 408(a) or 408(b), a Roth individual retirement account or annuity described in Code Section 408A, an annuity plan described in Code Section 403(a), an annuity contract described in Code Section 403(b), a qualified plan described in Code Section 401(a) or an eligible plan under Code Section 457(b) maintained by a state, political subdivision of a state, or any agency or instrumentality of a state or political subdivision of a state and which agrees to account separately for amounts transferred into such plan from this Plan.  If any portion of an eligible rollover distribution is attributable to payments or distributions from a designated Roth sub-account, an eligible retirement plan with respect to such portion is only either a designated Roth account under another employer&#8217;s plan of the individual from whose sub-account the payments or distributions was made or a Roth individual retirement account or annuity of such individual.  The definition of eligible retirement plan also applies to a distribution to a surviving spouse, or to a spouse or former spouse who is the alternate payee under a QDRO.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A &#8220;distributee&#8221; generally means an Employee or former Employee.  In addition, the Employee&#8217;s or former Employee&#8217;s surviving spouse and the Employee&#8217;s or former Employee&#8217;s spouse or former spouse who is the alternate payee under a QDRO are distributees with regard to the interest of the spouse or former spouse.  The definition of eligible retirement plan in (2) above applies to distributees described herein.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A &#8220;distributee&#8221; also includes an individual who is a designated beneficiary (as defined by Code Section 401(a)(9)(E)) of the Employee or former Employee and who is not the surviving spouse (or former spouse pursuant to a QDRO) of the Employee or former Employee.  An &#8220;eligible retirement plan&#8221; for such a distributee who is a non-spouse  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 52 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">designated beneficiary is a traditional individual retirement account or annuity described in Code Sections 408(a) or 408(b) that will be treated as an inherited IRA pursuant to Code Section 402(c)(11), or a Roth individual retirement account or annuity described in Code Section 408A but the non-spouse designated beneficiary cannot elect to treat the Roth individual retirement account or annuity as the beneficiary&#8217;s own.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">For these purposes, to the extent provided in Regulations, a trust maintained for the benefit of one or more designated beneficiaries will be treated in the same manner as a designated beneficiary.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A &#8220;direct rollover&#8221; is a payment by the Plan to the eligible retirement plan specified by the distributee.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Department will adopt procedures for elections made pursuant to this Section.  Within a reasonable period of time before payment of an eligible rollover distribution, the Department will provide a notice to the distributee describing his rights under this Section and such other information as may be required under Code Section 402(f).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">This Section is intended to comply with Code Section 401(a)(31) and will be interpreted in accordance with such Code Section and Regulations thereunder.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Payment to Alternate Payee under QDRO</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Notwithstanding any other provision of this Plan, if the Department determines that a domestic relations order is a QDRO, unless the QDRO specifically provides otherwise, the alternate payee specified in the QDRO shall receive a distribution of the amount assigned to him in the QDRO in a lump sum.  The Department shall direct the Trustee to distribute to the alternate payee such amount as soon as administratively feasible following receipt of an Appropriate Request by the alternate payee.  The Department&#8217;s decision whether a domestic relations order is a QDRO is final and conclusive.  An alternate payee for whom an Account is established under the Plan shall be considered a Participant for purposes of specifying Investment Options for his Account, making an election under Section 6.4, designating a Beneficiary for his Account and charging expenses to his Account, but shall not be eligible to have contributions made on his behalf except as may become necessary under Section 3.11.  A former spouse may be treated as a spouse or surviving spouse of an Employee to the extent required under the terms of a QDRO.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 53 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding any other provision of the Plan, upon receipt of an executed QDRO, upon receipt of a joinder that references the Plan, or upon direction provided to the Plan&#8217;s recordkeeper by the Department, the Plan&#8217;s recordkeeper shall place a disbursement restriction upon the Participant&#8217;s Account.  The scope and duration of such disbursement restriction shall be determined by procedures adopted by the Department and applied in a uniform and nondiscriminatory manner.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">An administrative charge, in an amount determined by the Department, may be imposed on the Account of a Participant who is subject to a domestic relations order and on the separate Account, if any, established on behalf of the alternate payee specified in the order.  Such charges shall be imposed pursuant to procedures adopted by the Department and applied in a uniform and nondiscriminatory manner.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Voluntary Direct Transfers</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A Participant whose employment status has changed, e.g., through transfer to an Affiliate that is not an Employer, so that he no longer is an Eligible Employee and who is not expected to regain such eligibility in the foreseeable future, is deemed to have requested a distribution of his Account prior to his Severance from Service Date unless he affirmatively elects to the contrary.  Such Account may be distributed only through transfer to another cash or deferred arrangement under Code Section 401(k) maintained by the Employer or an Affiliate under which the Participant currently is, or soon will be, eligible to participate.  The provisions of Section 5.5(h) shall apply to the vesting schedule of such transferee plan as if an amendment to the vesting schedule of this Plan.  Payments made pursuant to this Section shall operate as a complete discharge of the Appeals Committee, the Benefits Administration Committee, the Benefits Design Committee, the Investment Committee, the Department and its Employer in respect to this Plan.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Restrictions on Certain Distributions</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Amounts credited to a Participant&#8217;s Account attributable to Regular or Catch-up Pre-Tax Contributions or Employer Matching Contributions are not distributable prior to the earliest of the following events or other events permitted by the Code or applicable Regulations&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">his &#8220;severance from employment,&#8221; as such term is defined under Code Section 401(k)(2)(B)(i)(I) (regardless of when the severance from employment occurred), Total and Permanent Disability or death&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 54 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">his attainment of age 59&#189;&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">his proven financial hardship under Section 6.2&#59; or</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the termination of the Plan without the establishment or maintenance by the Employer or an Affiliate of an alternative defined contribution plan as defined in Regulation &#167;1.401(k)-1(d)((4)(i).  A distribution that is made under this subparagraph (4) must be made in a lump-sum.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding any provision of this Plan to the contrary, to the extent that any optional form of benefit under this Plan permits a distribution prior to the Participant&#8217;s attaining age 62, retirement, death, Total and Permanent Disability or Severance from Service Date and prior to Plan termination, the optional form of benefit is not available with respect to benefits attributable to assets (including the post-transfer earnings thereon) and liabilities that are transferred, within the meaning of Code Section 414(l), to this Plan from a money purchase pension plan or a defined benefit plan qualified under Code Section 401(a) (other than the portion of those transferred assets and liabilities attributable to after-tax voluntary Employee contributions or to a direct or indirect rollover contribution, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that portion was not subject to such distribution restrictions under the transferor plan or such distribution restrictions have been waived under this Plan).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Nothing in this Section shall preclude the Benefits Administration Committee from making a distribution to a Participant to the extent such distribution is determined by the Benefits Administration Committee to be necessary to correct a qualification defect in accordance with the corrective procedures permissible under the EPCRS or any other voluntary compliance program.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 55 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE VI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:1.04pt"><br><br>LOANS AND WITHDRAWALS</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Loans to Participants</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A Participant who is a &#8220;party in interest&#8221; as defined in ERISA Section 3(14) may, by making an Appropriate Request, request a loan from the Trust Fund.  The following additional rules shall apply&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Loans shall be made available to all eligible Participants on a reasonably equivalent basis&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that the Department shall retain the power to approve or decline a loan and may make reasonable distinctions based upon creditworthiness, other obligations of the Participant, state laws affecting payroll deductions and any other factors that may adversely affect the Employer&#8217;s ability to deduct loan repayments from a Participant&#8217;s pay.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Except with respect to pre-existing loans transferred to or merged into this Plan under subsection (k), or as set forth in the last sentence of this subsection (b), a Participant may have only one (1) loan outstanding at any time. For purposes of this subsection (b), a loan that is in default under subsection (e) is treated as outstanding. There must be a minimum of fourteen (14) days (or such other period determined by the Department) between the payoff of one Plan loan and the issuance of a new loan, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that the minimum-day restriction may be waived under procedures established by the Department.  Notwithstanding the foregoing, during the period from March 27, 2020, through January 31, 2021, a Participant may receive a loan even if the Participant already has a loan outstanding, and the maximum number of loans shall be increased to two (2) for so long as both such loans are outstanding.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The minimum new loan amount shall be $1,000.  If a Participant&#8217;s vested Account balance is insufficient to support the minimum loan amount loan because of the restrictions below, no loan shall be made.  The maximum amount of any loan, when added to the outstanding balance of any existing loan from this Plan, shall be the lesser of (1) or (2)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">$50,000, reduced by the excess of the highest outstanding balance of loans from the Plan during the one-year period ending on the day before the date the loan is made over the outstanding balance of loans from the Plan on the date the loan is made&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">One-half (&#189;) of the value (as determined under Section 4.2) of the vested portion of the Participant&#8217;s Account on the date the loan is made.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 56 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of this limit, all plans of the Employer and its Affiliates shall be considered one plan.  For purposes of this subsection (c), a loan that is in default under this Plan or another plan is treated as an outstanding loan, and interest accrued on such loan since it was deemed in default is considered part of the outstanding balance of such loan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Participant must agree in writing to pledge one-half (&#189;) of the value (or, if lesser, the borrowed amount) of the vested portion of his Account in the Plan as security for the loan.  All loans shall be repayable in substantially level payments of principal and interest, not less frequently than quarterly, over a period of not more than five (5) years, except that a loan used by the Participant to acquire or construct any dwelling unit which within a reasonable time is to be used (determined at the time the loan is made) as a principal residence of the Participant shall be repayable over a period of not more than ten (10) years. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Any loan shall be made pursuant to a written Participant loan program contained in a separate written document, which is hereby incorporated by reference and made a part of the Plan.  Such Participant loan program may be modified or amended in writing from time to time by the Benefits Administration Committee without the necessity of amending this Section.  Such loan program will include, but need not be limited to, the following&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the identity of the person or positions authorized to administer the Participant loan program&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the procedure for applying for loans&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the basis on which loans will be approved or denied&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">limitations, if any, on the types and amounts of loans offered&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the procedure for determining a reasonable rate of interest&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the procedure for repayment of the loan, e.g., under what circumstances repayment by payroll deduction is not required and whether prepayment (full or partial) is permitted&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the treatment of loans during leaves of absence and upon termination of employment&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the events constituting default and the steps that will be taken to preserve Plan assets.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 57 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt">The amount of the loan shall be withdrawn from the investments in his Account in accordance with such procedures as the Department shall determine.  Payments of principal and interest against a loan shall be credited to the investments in his Account in accordance with such procedures as the Department shall determine.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding anything in this Plan to the contrary, if a Participant defaults on a loan made pursuant to this Section, the loan default will be a distributable event to the extent permitted by the Code and Regulations.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Department shall apply the provisions of this Section in a uniform and nondiscriminatory manner that is not inconsistent with Regulations &#167;2550.408b-1.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.69pt">A married Participant with a part of his vested Account attributable to the QJSA Portion may not make a loan under this Section 6.1 from such part unless, during the 180-day period ending on the date on which the loan is secured, his spouse has filed a written consent to such loan with the Department, which consent shall be notarized or witnessed by a representative of the Department, and shall acknowledge the effect of the loan.  In the absence of spousal consent, such part of his vested Account shall be disregarded for purposes of subsection (c)(2).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:28.99pt">Notwithstanding anything in this Section to the contrary, loans made prior to January 1, 2016 shall be subject to the terms of the Plan (or a Merged Plan, as applicable) and the loan program in effect at the time such loan was made.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:26.32pt">Notwithstanding any other provision of the Plan,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">for Participants on a leave of absence for Qualified Military Service, loan repayments will be suspended under the Plan as permitted under Code Section 414(u)(4) and the loan interest will be adjusted as may be required under applicable law&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">loan repayments for Participants on another type of approved leave of absence may be suspended for the period of leave (up to a twelve-month grace period), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that the entire amount of any loan must be repaid within the original repayment period applicable to the loan as extended, but not beyond the maximum period permitted under the Plan, by the period of suspension.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.69pt">In the event of a corporate transaction in connection with which there is a facilitated mass rollover of the accounts of participants in the plan of the former employer into this Plan, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 58 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">participant loans from the predecessor plan that meet the administrative requirements of the Trustee can be included in such rollover.  Pre-existing loans rolled over to or merged into this Plan shall remain subject to their terms at the time of such rollover or merger except to the extent reamortization occurs, as determined by the Department, due to a suspension in repayments during the pendency of the rollover or merger, a change in payroll frequency or similar circumstance.  Any such rolled-over or merged loans will not be subject to any limitations on loans imposed by this Plan but not required by law, but will be considered in determining whether the Participant can take a subsequent loan from this Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:18.69pt">Notwithstanding the preceding provisions of this Section, loans may not be made to the extent a disbursement restriction is in effect under Section 5.10(b).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Hardship Withdrawals</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Upon making an Appropriate Request, and with the approval of the Department or recordkeeper, a Participant shall be allowed to withdraw all or part of the value of his Account while still employed by the Employer.  Withdrawn amounts may not be repaid to the Trust Fund.  Withdrawals shall be charged against the available sub-accounts within the Account in such order as the Department may determine.  Within each sub-account, withdrawals shall be charged against the separate Investment Options under such procedures as the Department may determine.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant may make a withdrawal under this Section 6.2 only if the withdrawal is made on account of his immediate and heavy financial need, as determined under subsection (c)(1), and is necessary to satisfy such need, as determined under subsection (c)(2).  The determination of the existence of financial hardship and the amount necessary to be withdrawn to satisfy the immediate financial need created by the hardship shall be made by the Department in a uniform and nondiscriminatory manner, in accordance with the standards and restrictions set forth in subsection (c).  A Participant requesting a withdrawal hereunder may be required to submit whatever documentation the Department deems necessary to establish the existence of a financial hardship and the amount necessary to be withdrawn to satisfy the need created by the hardship.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">(1)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Immediate and heavy financial need</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.  A withdrawal will be considered to be made on account of an immediate and heavy financial need of the Participant for purposes of subsection (b) only if it is for&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 59 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">Expenses of him, his spouse, children or dependents (as defined in Code Section 152 without regard to Code Sections 152(b)(1), (b)(2) and (d)1)(B)) for (or necessary to obtain) medical care that would be deductible under Code Section 213(d) (determined without regard to whether the expenses exceed 7.5% of adjusted gross income)&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">Costs directly related to the purchase or construction of his principal residence (excluding mortgage payments)&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">Payment of tuition, related educational fees and room and board expenses for up to the next twelve (12) months of post-secondary education for him, his spouse, children, or dependents (as defined in Code Section 152 without regard to Code Sections 152(b)(1), (b)(2) and (d)1)(B))&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">Payments necessary to prevent his eviction from his principal residence or foreclosure on the mortgage of his principal residence&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.69pt">Payments for burial or funeral expenses for his deceased parent, spouse, children, or dependents (as defined in Code Section 152 without regard to Code Section 152(d)(1)(B))&#59; </font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:21.35pt">Expenses for the repair of damage to his principal residence that would qualify for the casualty deduction under Code Section 165 (determined without regard to Code Section 165(h)(5) and whether the loss exceeds 10% of his adjusted gross income)&#59; or</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">Expenses and losses (including loss of income) incurred by him on account of a disaster declared by the Federal Emergency Management Agency (FEMA) under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, Pub. L. 100-707, provided that his principal residence or principal place of employment at the time of the disaster was located in an area designated by FEMA for individual assistance with respect to the disaster.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">Expenses under subsections (A), (C) and (E) above as it relates to his &#8220;primary Beneficiary&#8221; in the same manner as expenses for a spouse or other dependent if such expenses satisfy all the requirements of this Section.  For this purpose, a &#8220;primary Beneficiary&#8221; is an individual named as a Beneficiary who has an unconditional right to all or a portion of the Participant&#8217;s Account upon his death.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 60 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt;text-decoration:underline">Amount necessary to satisfy the need</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.  A withdrawal will be considered to be in an amount necessary to satisfy a Participant&#8217;s need under paragraph (1) for purposes of subsection (b) only if&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">It does not exceed the amount of the need under paragraph (1)&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">He has obtained all non-hardship distributions he is eligible for under any plan the Employer or an Affiliate may sponsor (including this Plan)&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">He has provided to the Department a representation in writing (including by using an electronic medium as defined in Regulation &#167;&#160;1.401(a)-21(e)(3) or in other such form as may be prescribed by the Commissioner of Internal Revenue that he has insufficient cash or other liquid assets reasonably available to satisfy the need and the Department does not have actual knowledge to the contrary&#59; and </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:19.36pt">Notwithstanding subparagraphs (A) &#8211; (C), his withdrawal may be considered to be in an amount necessary to satisfy a need under paragraph (1) if it satisfies a method prescribed under Regulation &#167;1.401(k)-1(d)(2)(iv)(C).  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">In addition to the amount necessary to meet the immediate financial need created by the hardship, the Participant also may withdraw an amount necessary to pay any federal, state or local income taxes or penalties reasonably anticipated to result from the distribution.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">A Participant who has requested a hardship withdrawal and who has any portion of his Account invested in the Quest Diagnostics Incorporated Stock Fund shall be subject to restrictions on his election under Section 6.4 to the extent so provided in Section 6.4(a).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt">Notwithstanding the preceding provisions of this Section, a hardship withdrawal may not be made from the QJSA Portion or safe harbor matching contributions, nor to the extent a disbursement restriction is in effect under Section 5.10(b).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Non-Hardship Withdrawals</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">A Participant who is employed by an Employer or an Affiliate after attaining age 62 may elect to receive distribution of all or any part of his vested Account in the form provided under Article V (or Appendix F, if applicable) at any time following attainment of such age.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 61 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant who is employed by an Employer or an Affiliate and who has attained age 59&#189; may elect to make a cash withdrawal from his vested Account, other than from his QJSA Portion.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">In addition to the withdrawals available under Section 6.2, but no more than once in any 12-month period, a Participant shall be allowed to withdraw all or part of the value of his Employee After-Tax Sub-Account (if any) for any reason.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Any withdrawal elected pursuant to this Section 6.3 shall be made through an Appropriate Request, and shall be paid as soon as administratively feasible following receipt of the Appropriate Request.  Withdrawn amounts may not be repaid to the Trust Fund.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Withdrawals shall be charged against the available sub-accounts within the Account in such order as the Department shall determine.  Within each sub-account, withdrawals shall be charged against the separate Investment Options under such procedures as the Department may determine.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt">Certain Merged Plans are subject to additional rules contained in an Appendix to the Plan.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding the preceding, non-hardship withdrawals may not be made to the extent a disbursement restriction is in effect under Section 5.10(b).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Withdrawal of Dividends on Quest Common Stock</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Under procedures established by the Department, a Participant may elect&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">to receive a direct payment of any cash dividends on Quest Diagnostics Common Stock otherwise allocable to his Account&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">to have such cash dividends reinvested and allocated to his Account.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A Participant who does not have in effect an election under subsection (a)(1) will be deemed to have elected reinvestment under subsection (a)(2).  A Participant who does not have in effect an election under subsection (a)(1) and who has made an election under Article V&#58;  (i) to receive a lump sum distribution of his Account which is made after the &#8220;ex-dividend&#8221; date (e.g., three (3) business days prior to the record date)&#59; or (ii) to commence receiving distribution of his Account which is pending during the ten (10) business day period (or such other period as the Department may determine) prior to the dividend payment date, will be deemed to have elected</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 62 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">reinvestment under subsection (a)(2) with respect to&#58;  (i) his dividend rights as of the record date or (ii) the portion of his Account which has not been distributed prior to the dividend payment date, respectively.  If a Participant has made a request for a hardship withdrawal pursuant to Section 6.2 which is pending during the ten (10) business day period (or such other period as the Department may determine) prior to the dividend payment date or has a hardship withdrawal approved during such period (or such other period as the Department may determine), he will be deemed to have elected a direct cash payment under subsection (a)(1) for that quarterly dividend payment.  Such cash payment will be considered in determining the amount of any hardship distribution, and such Participant&#8217;s election with respect to future cash dividend payments will revert to his prior election unless changed in accordance with this Section 6.4.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">In no event shall any distribution of cash dividends on Quest Diagnostics Common Stock paid into the Trust Fund be made pursuant to this Section 6.4 later than 90 days following the end of the Plan Year in which such dividends were paid into the Trust Fund.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Stock dividends on Quest Diagnostics Common Stock shall be reinvested in the Quest Diagnostics Incorporated Stock Fund.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">An election to receive direct payment of dividends under Section 6.4(a)(1) made not later than ten (10) business days (or such other period as the Department may determine) prior to a dividend payment date will be effective as of that dividend payment date&#59; otherwise the election will be effective only as to subsequent dividend payment dates.  Except as provided in subsection (e) below, the dividends with respect to which he may elect a direct payment under Section 6.4(a)(1) are 100% of the cash dividends on shares of Quest Diagnostics Common Stock in the Quest Diagnostics Incorporated Stock Fund and allocated to his Account as of the record date for the dividend (which, for Plan purposes, shall be determined on the &#8220;ex-dividend date&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that the total cash dividend that would be payable if he elected a direct payment of 100% of dividends subject to his election must equal or exceed a de minimis amount.  The initial de minimis amount is $10 and may be increased in the discretion of the Department.  For purposes of this Section 6.4, &#8220;business days&#8221; do not include holidays or weekend days.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Any election under this Section 6.4 shall continue in effect until revoked prospectively by the Participant.  Any such election or revocation shall be made at such time and in such manner as the Department shall specify.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 63 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding subsections (b) and (c), under subsection (a) a Participant&#8217;s election may be revoked in connection with his request for a hardship distribution under Section 6.2, and a Participant&#8217;s election also may be revoked if necessary under the Plan&#8217;s domestic relations order procedures as described in Section 5.10(b).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If, with respect to cash dividends declared on shares of Quest Diagnostics Common Stock, the direct payment under Section 6.4(a)(1) of less than 100% of such dividends is authorized, a Participant may elect, in accordance with procedures established by the Department, a direct payment under this Section 6.4 of such percentage.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt">Any dividend payment check that is not promptly cashed shall be treated in accordance with Section 12.9.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">This Section 6.4 is intended to comply with the requirements of Code Section 404(k) and shall be administered and interpreted accordingly.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Vesting of Certain Dividends on Quest Common Stock</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Cash dividends on Quest Diagnostics Common Stock that are received on the part of a Participant&#8217;s Account other than the QJSA Portion that is not fully vested, and that is allocated to the Quest Diagnostics Incorporated Stock Fund, shall be directed to the Vested Quest Diagnostics Common Stock Dividend Sub-Account when received by the Trust Fund and shall be 100% vested upon receipt.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Cash dividends on Quest Diagnostics Common Stock that are received on the part of a Participant&#8217;s QJSA Portion that is not fully vested, and that is allocated to the Quest Diagnostics Incorporated Stock Fund, shall be directed to the Vested Money Purchase Pension Plan Dividend Sub-Account when received by the Trust Fund and shall be 100% vested upon receipt.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Qualified Reservist Distribution</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Upon making an Appropriate Request, a Participant who is a member of a reserve component or is ordered or called to active duty for a period in excess of 179 days or an indefinite period may withdraw all or part of the value of his Employee Pre-Tax Contributions sub-accounts.  A distribution under this Section must be made during the period beginning on the date of such order or call and ending no later than the close of the period of active duty.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 64 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>ARTICLE VII</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br>TRUST FUND</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Contributions by the Employers and Participants as provided for in Article III shall be paid to the Trustee.  All Employer Contributions shall be irrevocable, except as provided in Section 12.5 of this Plan, and may be used only for the exclusive benefit of Participants and their Beneficiaries or for the payment of reasonable expenses of administering the Plan.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Trustee</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Benefits Administration Committee has the authority to appoint the Trustee and to  maintain the  Trust Agreement with the Trustee, including any successor appointed in accordance with the Trust Agreement, establishing the Trust Fund under the Plan.  The Trustee is subject to directions made in accordance with the terms of the Trust Agreement, the Plan and ERISA.  No Plan fiduciary, other than the Trustee itself, shall be liable for any act or omission of any Trustee with respect to any duties allocated or delegated to such Trustee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Except to the extent provided in the Trust Agreement, the Trustee shall have no authority to manage the Trust Fund.  Participants shall be able to direct the investment of amounts credited to their Accounts and future contributions to their Accounts among the Investment Options then available in accordance with Section 7.4.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Investment Options</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Except as provided in Sections 7.3(b)(1) and 8.3(e)(3), the Investment Committee has been delegated the authority to select, monitor and replace, as it determines, the Investment Options available for Participant direction under Section 7.4, which Investment Options shall constitute&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">an interest or interests in registered regulated investment companies (&#8220;mutual funds&#8221;) that are independent of, or proprietary to, the Trustee or its affiliates&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">an interest or interests in a group, common or collective trust maintained for the collective investment of employee benefit plans qualified under Code Section 401(a) that is independent of, or proprietary to, the Trustee or its affiliates.  If a group, common or collective investment fund or trust maintained by the Trustee (or other person) that may be invested in by a plan and trust qualified under Code Sections 401(a) and 501(a) is so &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 65 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">used, the governing provisions of such fund or trust shall be incorporated by reference to the extent required by applicable law&#59; or</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">such other investment vehicles as the Investment Committee may from time to time determine.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">(1)&#160;&#160;&#160;&#160;To the extent consistent with ERISA and applicable law, one of the Investment Options will be the Quest Diagnostics Incorporated Stock Fund, which will be invested (except as may be required for liquidity) in Quest Diagnostics Common Stock.  In accordance with Section 8.3(e), the Investment Committee is responsible for monitoring that continuing to provide this Investment Option pursuant to this Section 7.3(b), without change or adjustment, is consistent with the requirements of ERISA and applicable law. </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;The Quest Diagnostics Incorporated Stock Fund will be administered on a unit accounting basis.  In the event of any cash or stock dividend, stock split or recapitalization with respect to Quest Diagnostics Common Stock, such dividend, split or recapitalization shall be allocated to Accounts based on the number of shares of Quest Diagnostics Common Stock credited to the units held by each Account as of the record date of such dividend, split or recapitalization.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Investment Direction by Participants</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Participants shall be able to direct the investment, subject to Section 7.4(d), of all amounts credited to their Accounts among the Investment Options then available in accordance with such administrative rules and procedures as the Department or the recordkeeper may establish from time to time.  It is intended that the Plan meet the requirements of ERISA Section 404(c) and be construed, maintained and administered as an &#8220;ERISA Section 404(c) plan&#8221; within the meaning of Regulation &#167;2550.404c&#8211;1(b)(1).  Subject to subsection (d) below, a Participant&#8217;s investment directions shall remain in effect until changed by him.  Transfers between Investment Options shall be subject to any restrictions imposed under Section 7.4(d), the terms of such Investment Options and, with respect to the Quest Diagnostics Incorporated Stock Fund, Quest Diagnostics&#8217; securities law compliance policy.  No portion of a Participant&#8217;s Account is required to be maintained in the Quest Diagnostics Incorporated Stock Fund.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">In the absence of a valid Investment Option election, a Participant&#8217;s Account automatically shall be invested in the applicable default Investment Option specified by the &#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 66 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Investment Committee.  It is intended that such default Investment Option be a &#8220;qualified default investment alternative&#8221; in compliance with ERISA Section 404(c)(5).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">A loan under Section 6.1 is considered a self-directed investment by the borrower of the portion of his Account that is invested in the note reflecting such loan that he executed in accordance with the provisions of Section 6.1.  Notwithstanding any other provision of the Plan to the contrary, no Account other than the borrower&#8217;s Account shall share in the interest paid on the loan or bear any expense or loss incurred because of the loan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant may not elect to have more than twenty-five percent (25%) of contributions on his behalf for any  pay period allocated to the Quest Diagnostics Incorporated Stock Fund.  In addition,  a Participant cannot direct the transfer of assets in his Account to the Quest Diagnostics Incorporated Stock Fund  if twenty-five percent (25%) or more of the value of the Participant&#8217;s Account is invested in the Quest Diagnostics Incorporated Stock Fund or if the transfer would result in twenty-five percent (25%) or more of his Account being invested in  the Quest Diagnostics Incorporated Stock Fund.  Notwithstanding the preceding sentences of this subsection (d), if any Employer Matching or Employer Discretionary Contributions are made in Quest Diagnostics Common Stock, that portion shall be invested in the Quest Diagnostics Incorporated Stock Fund without regard to the 25% limitation.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Transactional and other Fees and Expenses of Plan and Trust</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Participant-specific expenses.  The Benefits Administration Committee may provide that any investment-related transactional fees (e.g., charges for the acquisition, sale or exchange of assets, brokerage commissions and service charges) imposed or incurred with respect to an Investment Option as a result of Participant directions shall be charged to the respective Accounts of the Participants directing such investments.  Fees for transactions directed by Participants including, but not limited to, fees associated with a loan under Section 6.1 and fees associated with a QDRO determination, also may be charged to the directing Participant&#8217;s Account.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">General Plan expenses.  All other expenses of administering the Plan and the Trust Fund, including recordkeeping expenses, administrative expenses and expenses of the Appeals Committee, the Benefits Administration Committee or the Investment Committee, shall be paid from the Trust Fund, including such charges to some or all Participant Accounts as authorized by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 67 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">the Benefits Administration Committee, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that such expenses of administration (or a portion thereof) may, in the discretion of the Benefits Administration Committee, instead be paid by the Employers.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 68 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27.72pt"><br><br>PLAN ADMINISTRATION</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">General</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A person may serve in more than one fiduciary capacity with respect to the Plan and may employ one or more persons to render advice with regard to his fiduciary responsibilities.  If a person is serving as a fiduciary without compensation, all proper expenses incurred by such person in such service shall be reimbursed from the assets of the Trust Fund unless paid by the Employers.  A Plan fiduciary shall have only those specific powers, duties, responsibilities and obligations explicitly allocated to such person under the Plan and the Trust Agreement.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Plan Sponsor and Plan Administrator</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Company is the &#8220;plan sponsor&#8221; (as such term is defined in ERISA Section 3(16)(B) and maintains the Plan for the benefit of the Eligible Employees of the Employers.  The Benefits Administration Committee is the &#8220;plan administrator&#8221; and the &#8220;administrator&#8221; of the Plan (as such term is defined respectively in ERISA Section 3(16)(A) and Code Section 414(g)).  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Responsibility for the day-to-day ministerial administration of the Plan lies with the Department.  The Benefits Administration Committee may delegate all or any portion of such ministerial duties to a recordkeeper or other service provider to the Plan it selects.  References in the Plan to forms, notices or applications submitted to, and procedures established by, the Department or Plan recordkeeper or service provider, are deemed to include submissions to, and procedures established by, the Department or Plan recordkeeper or other person or service provider with whom such instruments may be filed.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Plan Named Fiduciaries </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Benefits Administration Committee  shall be the &#8220;named fiduciary&#8221; of the Plan, as that term is defined in ERISA Section 402(a)(2), with respect to all discretionary decisions relating to the operation and administration of the Plan, including the authority to interpret the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Board shall have the authority to designate another person or committee as such named fiduciary for discretionary administrative matters.  Any person acting in such a named fiduciary function with respect to administrative matters shall be paid no compensation from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 69 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">the Trust Fund for such services.  Except as may be required by law, no bond or other security will be required of any person acting in such a named fiduciary capacity. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Benefits Administration Committee has discretionary authority to construe and interpret the Plan, and to determine, consistent with the terms of the Plan and except as provided in subsection (d) with respect to a claim or appeal under Sections 8.6 or 8.7, all questions that may arise thereunder relating to&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the eligibility of individuals to participate in the Plan&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the amount of benefits to which any Participant or Beneficiary may become entitled hereunder&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">discretionary decisions regarding the administration of the Plan not specifically covered by the provisions of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">When the Benefits Administration Committee is required in the performance of its duties hereunder to administer, construe or reach a determination under any provision of the Plan, it shall do so on a uniform, equitable and nondiscriminatory basis.  A determination of the Benefits Administration Committee (or its delegate) shall be final and binding on all interested parties. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Board shall appoint the members of the Appeals Committee, whose members need not be members of another Plan committee, or acting in any other fiduciary capacity with respect to the Plan, and to whom has been delegated the discretionary responsibility and authority as the named fiduciary&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">to review appeals under Section 8.7 from initial claim denials&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">upon such an appeal, to determine the eligibility of any Participant or Beneficiary for benefits under the Plan&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">to resolve upon such an appeal any situation not specifically covered by the provisions of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A determination by the Appeals Committee (or its delegate) shall be final and binding on all interested parties.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">(1)&#160;&#160;&#160;&#160;The Board shall appoint the members of the Investment Committee, whose members need not be members of another Plan committee, or acting in any other fiduciary capacity with respect to the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 70 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Subject to the limitations in  Section 8.3(e)(3) with respect to the Quest Diagnostics Incorporated Stock Fund, the Investment Committee has the discretionary responsibility and authority as the named fiduciary (as defined in ERISA) with respect to the selection and monitoring of the Investment Options provided for Participant-directed investment pursuant to the Plan.  The Investment Committee also has the responsibility to select and monitor, in accordance with the terms of the Plan, the default Investment Option(s), to determine the amount of liquidity to be maintained within the Quest Diagnostics Incorporated Stock Fund and the investment of such liquid assets, to retain and discharge investment managers and to make other investment-related discretionary decisions, including without limitation by specification, an investment consultant providing advice pursuant to Section 3(21) of ERISA and   an investment manager pursuant to Section 3(38) of ERISA.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">With respect to the Quest Diagnostics Incorporated Stock Fund, the Investment Committee has the responsibility of monitoring that continuing to maintain this Investment Option is consistent with the requirements of ERISA and applicable law.  The Investment Committee shall advise the Board  if its monitoring indicates that a change to the then-existing Quest Diagnostics Incorporated Stock Fund structure may be appropriate in light of these requirements, as well as any recommendations by the Investment Committee as to possible action to be taken.  The Board  then shall determine, as the named fiduciary with respect to the Quest Diagnostics Incorporated Stock Fund, what action, if any, should be taken with respect to the continued maintenance of this fund as  an Investment Options for Participant-directed investment pursuant to the Plan.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Investment Committee also shall establish, or cause to be established, an investment policy statement consistent with the objectives of the Plan and the requirements of ERISA.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt">Disbursements from the Trust Fund by the Trustee shall be made upon, and in accordance with, the written directions of the Department (or its delegate).  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Investment Committee also shall be the fiduciary identified under the Plan to the extent so required by the Regulations under ERISA Section 404(c).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 71 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Organization and Operation of the Appeals Committee, the Benefits Administration Committee and the Investment Committee </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The  Appeals Committee, the Benefits Administration Committee and the Investment Committee, respectively, may choose from among its members a chairman and will appoint a secretary, who need not be a member.  Actions of each committee shall be determined by the vote of a majority of its members.  Either the chairman or the secretary of the respective committees, as applicable, may execute any certificate or other written direction on behalf of the committee.  Each such committee may adopt and enforce such rules of procedure as may be appropriate with respect to its functioning.  Each committee may establish a charter setting forth principles under which the Committee shall conduct its business.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Each of the Appeals Committee, the Benefits Administration Committee and the Investment Committee, respectively,  shall hold meetings upon such notice, at such place or places and at such time or times as each such  committee may from time to time determine.  Meetings may be called by the chairman (if any), the secretary or by any two members.  A majority of the members of the respective committees at the time in office shall constitute a quorum for the transaction of business.  Each committee also may act by unanimous written consent in lieu of a meeting.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">A member may resign from the Appeals Committee,  the Benefits Administration Committee and the Investment Committee, respectively, at any time by giving written notice of his resignation to the Board.  The Board shall appoint replacement committee members.  An individual employed by an Employer or an Affiliate when appointed as a member of the Appeals Committee, the Benefits Administration Committee and the Investment Committee, respectively, is deemed to have resigned committee membership effective as of the date he ceases to be so employed, unless the Board affirmatively acts to retain him on the applicable committee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Nothing herein shall prevent a member of the  Appeals Committee, the Benefits Administration Committee and the Investment Committee, respectively, from being a Participant, or from acting on Plan matters which affect himself by virtue of affecting all Participants generally.  However, a committee member shall not act on any matter which affects himself specially.  If application of the preceding sentence results in there not being a quorum to act on any matter, the Board shall appoint the necessary number of temporary members for the committee to take action.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 72 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The  Benefits Administration Committee may retain such accountants, attorneys, advisors, record-keeper and other persons as it deems necessary or desirable to the administration of the Plan, and is entitled to rely upon all records furnished by the Employers and upon tables, valuations, certificates and reports furnished by the Trustee or by the accountants, attorneys, advisors, record-keeper and other persons it has appointed and upon all opinions given by any counsel selected or approved by the Benefits Administration Committee .</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.03pt">The provisions of this Section, other than subsection (e), also shall apply to such other committee or subcommittee as may be established by the Board or the Benefits Administration Committee. </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Employers&#58; Indemnification and Information</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Company and the other Employers, jointly and severally, shall indemnify each member of the Board, the Appeals Committee, the Benefits Administration Committee, the Benefits Design Committee, the Investment Committee and any other employee of an Employer or an Affiliate to whom any fiduciary or other responsibility with respect to the Plan is allocated or delegated, from and against any and all liabilities, costs and expenses incurred by such individuals as a result of any act or omission to act in connection with the performance of their duties, responsibilities and obligations under the Plan and under ERISA, except for liabilities and claims arising from such individual&#8217;s willful misconduct or gross negligence.  For such purpose, the Company and other Employers may obtain, pay for and keep current a policy or policies of insurance.  No Plan assets may be used for any indemnification.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The Employers shall supply such full and timely information for all matters relating to the Plan as the Appeals Committee, the Benefits Administration Committee, the Benefits Design Committee, the Investment Committee, the Department, the Trustee or other service providers engaged on behalf of the Plan may require for the effective discharge of their respective duties.  The recipient of this information shall be entitled to rely upon all records furnished by the Employers.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Claims for Benefits &#8212; Initial Review</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">All claims under the Plan must be submitted within one (1) year after the date on which a communication from the Plan or from a Plan fiduciary (or one of their delegates or agents) contains the information contested or challenged by the claim.  All claims for benefits under the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 73 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Plan shall be submitted to the Department pursuant to Section    8.2(b) which shall have the initial responsibility for determining the eligibility of any Participant or Beneficiary for benefits.  All claims for benefits shall be made in writing and shall set forth the facts which such Participant or Beneficiary believes to be sufficient to entitle him to the benefit claimed.  The Department may adopt forms for the submission of claims for benefits, in which case all claims for benefits shall be filed on such forms.  Upon request, the Department shall provide Participants and Beneficiaries with all such forms.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Upon receipt by the Department of a claim for benefits, it shall determine all facts which are necessary to establish the right of an applicant to benefits under the provisions of the Plan and the amount thereof as herein provided.  The claimant shall be notified in writing by the Department of its decision with respect to such claim within 90 days after the receipt of a written request for benefits.  If the decision is not furnished within the time specified above, the claim shall be deemed denied.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If any claim for benefits is denied, the notice shall be written in a manner calculated to be understood by the claimant and shall include&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The specific reason or reasons for the denial&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Specific references to the pertinent Plan provision(s) on which the denial is based&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A description of any additional material or information necessary for the applicant to perfect the claim and an explanation why such material or information is necessary&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">An explanation of the Plan&#8217;s claim review procedures&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A statement of the claimant&#8217;s right to bring a civil action under ERISA Section 502(a) following denial of his appeal on review.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If special circumstances require an extension of time for processing the initial claim, a written notice of the extension and the reason therefor shall be furnished to the claimant by the Department before the end of the initial 90-day period.  In no event shall such extension exceed 180 days after the receipt of the initial claim for benefits.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 74 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Denial of Benefits &#8212; Appeal Procedure</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If a claim for benefits is denied by the Department, the claimant or his duly authorized representative, at the claimant&#8217;s sole expense, may appeal the denial by filing a written request for review with the Appeals Committee within 60 days of the receipt of written notice of denial or 60 days from the date such claim is deemed to be denied.  In pursuing such appeal, the claimant or his duly authorized representative may review pertinent Plan documents, and may submit issues and comments in writing.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The decision on review shall be made by the Appeals Committee within 60 days of receipt of the request for review, unless special circumstances require an extension of time for processing, in which case a decision shall be rendered as soon as possible, but not later than 120 days after receipt of a request for review.  If such an extension of time is required, written notice of the extension shall be furnished to the claimant before the end of the original 60-day period, and such extension notice shall indicate the special circumstance requiring an extension of the time and the date by which the Appeals Committee expects to render a decision.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The decision on review will consider all information submitted, regardless whether such information was submitted or considered in the original decision.  The decision on review shall be in writing, written in a manner calculated to be understood by the claimant, and shall include&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The specific reason or reasons for the denial&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Specific references to the pertinent Plan provision(s) on which the denial is based&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A statement that the claimant is entitled to receive, upon request and free of charge, reasonable access to and copies of all documents, records or other information relevant to the claimant&#8217;s claim&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A statement of the claimant&#8217;s right to bring a civil action under ERISA Section 502(a) following denial of his appeal on review.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If the decision on review is not furnished within the time specified above, the claim shall be deemed denied on review.  The decision of the Appeals Committee upon review will be final and binding on all parties.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 75 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Other Provisions relating to Claims for Benefits</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of Sections 8.6 and 8.7, a document, record or other information shall be considered &#8220;relevant&#8221; to a claim if such document, record or other information&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">was relied upon in making the benefit determination&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">was submitted, considered or generated in the course of making the benefit determination, without regard to whether such document, record or other information was relied upon in making the benefit determination&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">demonstrates compliance with the administrative processes and safeguards required in making the benefit determination.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Exhaustion of Administrative Remedies&#59; Limitations Period&#59; Venue</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">No claimant shall institute any action or proceeding in any state or federal court of law or equity, or before any administrative tribunal or arbitrator, for a claim for benefits under the Plan unless and until he has exhausted the claim appeal procedures described in the preceding Sections above.  All such claims and appeals must be brought within the timeframes set forth in the Plan document or summary plan description.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If the claimant has complied with and exhausted the appropriate claims and appeals procedures under the Plan and intends to exercise his right to bring civil action under ERISA Section 502(a), he must bring such action within one (1) year following the date of the denial of his last required appeal.  If the claimant does not bring such action within such one year period, he shall be barred from bringing an action under ERISA related to his claim.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">All action(s) or litigation arising out of or relating to this Plan shall be commenced and prosecuted in the federal district court whose jurisdiction includes Hudson County, New Jersey.  Each Participant, claimant or other person consents and submits to the personal jurisdiction over him of the federal district court whose jurisdiction includes Hudson County, New Jersey in respect of any such action(s) or litigation.  Each Participant, claimant or other person consents to service of process upon him with respect to any such action(s) or litigation by registered mail, return receipt requested, and by any other means permitted by rule or law.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Records</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">All acts and determinations of the Appeals Committee, the Benefits Administration Committee and the  Investment Committee shall be duly recorded by the secretary thereof and all &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 76 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">such records, together with such other documents as may be necessary in exercising its duties under the Plan, shall be preserved in the custody of such secretary.  The records and documents of any such committee shall at all times be open for inspection and for the purpose of making copies by any person designated by that committee.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 77 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:1.04pt"><br><br>AMENDMENT AND TERMINATION OF THE PLAN&#59; MERGERS AND TRANSFERS</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Amendment of the Plan</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Board and the Benefits Design Committee each shall have the right at any time to amend the Plan in whole or in part, including retroactively to the extent considered necessary.  Notwithstanding the preceding sentence, any officer of the Company may execute&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">any technical or clarifying amendment deemed necessary or appropriate to facilitate the administration, management or interpretation of the Plan or to conform the Plan thereto or to qualify and maintain the Plan as a plan meeting the requirements of the Code or other applicable law&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">any amendment adding or modifying an operational provision resulting from a corporate transaction or joint venture arrangement by an Employer (e.g., credit for prior service)&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">in connection with a corporate transaction or as otherwise deemed appropriate, an amendment effecting the merger of another tax-qualified defined contribution plan into this Plan&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">any amendment that does not, in the consideration of the relevant officer, increase the benefits under the Plan or otherwise increase the Employers&#8217; costs with respect to the Plan&#59; or</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">an amendment as to the participation in the Plan as an Employer by any entity.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">The amount of benefits which, at the later of the adoption or effective date of such amendment, shall have accrued for any Participant or Beneficiary shall not be adversely affected thereby.  No such amendment shall have the effect of revesting in the Employers any part of the principal or income of the Trust Fund.  No amendment may eliminate or reduce any early retirement benefit or subsidy that continues after retirement or optional form of benefit protected under Code Section 411(d)(6).  Unless expressly provided for in such amendment, an amendment shall not affect the rights and obligations of any Participant who severed from employment prior to the effective date of the amendment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 78 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Termination of the Plan</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Company expects to continue the Plan indefinitely, but continuance is not assumed as a contractual obligation and the Board  may terminate the Plan at any time in whole or in part.  Further, each Employer reserves the right at any time to terminate the Plan as applicable to itself.  If an Employer terminates or partially terminates  Plan participation or permanently discontinues its contributions at any time, or if a partial termination of the Plan occurs, each Participant affected thereby shall be fully vested in his Account to the extent then funded or credited except as otherwise required or permitted by applicable Regulations.  Also, the Benefits Design Committee may fully vest the Accounts of a group of Participants because they are affected by a business divestiture, layoff, reduction-in-force or other similar transaction, in which case the rules relating to partial termination referred to above shall apply, even if a true partial termination under Code Section 411(d)(3) has not occurred.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">In the event of termination of the Plan by an Employer, the Benefits Administration Committee shall value the Trust Fund as of the date of termination.  That portion of the Trust Fund applicable to any Employer for which the Plan has not been terminated shall be unaffected.  The Accounts of Participants and Beneficiaries affected by the termination shall, at the direction of the terminating Employer, continue to be administered as part of the Trust Fund, distributed to such Participants or Beneficiaries pursuant to Section 5.6 or transferred to a qualified plan maintained by such Employer.  Distributions upon Plan termination of amounts attributable to Employee Pre-Tax Contributions and amounts credited to sub-accounts subject to similar distribution restrictions shall be made only to the extent permitted by Code Section 401(k)(10).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Merged Plans&#59; Transferred Funds</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">Upon direction pursuant to authorization under Section 9.1, the Trustee may effect merger agreements or direct transfer of asset agreements with the trustees of other retirement plans described in Code Section 401(a), including any elective transfer, and to accept the direct transfer of plan assets, or to directly transfer plan assets, as a party to any such agreement, or otherwise take such steps as are appropriate to effect the merger of another tax-qualified defined contribution plan into this Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">In the event another defined contribution plan is or has been merged into and made a part of the Plan (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Merged Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;), each participant in the Merged Plan immediately prior to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 79 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">merger shall become a Participant in this Plan on the date of the merger, but shall be an active Participant only if he is then an Eligible Employee and has satisfied the eligibility requirements of Section 2.1.  In no event shall a Participant&#8217;s vested interest in his Account attributable to amounts transferred (which may be maintained for recordkeeping purposes in one or more &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Merged Plan Sub-Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) to the Plan from the Merged Plan upon and immediately after the merger be less (except as a result of applicable investment losses, fees, withdrawals or distributions) than his vested interest in such amounts under the Merged Plan immediately prior to the merger, and such transfer, merger or consolidation (to the extent required by law) may not otherwise result in the elimination or reduction of any Section 411(d)(6) protected benefits of such Participant except to the extent permitted under Regulations &#167;&#167;1.401(a)-4 and 1.411(d)-4, or violation of any of the distribution restrictions of Section 5.12 or other restrictions applicable to them under such other plan.  Notwithstanding any other provision of the Plan to the contrary, a Participant&#8217;s service, if any, credited for eligibility and vesting purposes under the Merged Plan as of the merger shall be included as Eligibility Service and Years of Vesting Service under the Plan.  Special provisions, if any, applicable to a Participant&#8217;s Merged Plan Sub-Account(s) shall be specifically reflected in an Appendix hereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The provisions of Section 9.3(b) also apply to a plan that merged into the Plan before January 1, 2016. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding any provision in this Plan to the contrary, no contribution by or on behalf of any Participant shall be made under this Plan with respect to any period for which any contribution is made by or on behalf of him under a Merged Plan.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">(1)&#160;&#160;&#160;&#160;With the consent of the  Benefits Administration Committee , amounts may be transferred (within the meaning of Code Section 414(l)) to this Plan from other tax-qualified plans under Code Section 401(a), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that&#58;  (A) the plan from which such funds are transferred permits the transfer to be made and (B) the transfer will not jeopardize the tax-exempt status of the Plan or Trust or create adverse tax consequences for the Employers.  As directed by the Department, the amounts so transferred shall be established as a separate sub-account.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Notwithstanding anything herein to the contrary, a transfer directly to this Plan from another qualified plan (or a transaction having the effect of such a transfer) shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 80 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">be permitted only if it will not result in the elimination or reduction of any Section 411(d)(6) protected benefit, as described in Section 9.3(b), under the transferor plan except to the extent permitted under Regulations &#167;&#167;1.401(a)-4 and 1.411(d)-4.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 81 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:5.7pt"><br><br>PROVISIONS RELATIVE TO EMPLOYERS INCLUDED IN PLAN</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Participation in the Plan by an Affiliate </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">With the consent of the Benefits Design Committee  any Affiliate may adopt the Plan for the benefit of its Employees.  An Affiliate  that has adopted the Plan may, at any time,  terminate its participation in the Plan.   An Affiliate which has not terminated its participation in the Plan, shall be listed in Appendix A.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">By becoming an Employer, such an Affiliate agrees that&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the provisions of this Plan including, but not limited to, this Article X and any amendments hereto shall control with respect to the duties, rights and benefits under the Plan of the Employer&#8217;s Employees and their Beneficiaries&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the Board, the Appeals Committee, the Benefits Administration Committee, the Benefits Design Committee, the Investment Committee, the Department and any other Plan representative are its agents to exercise on its behalf all the powers and authority conferred, respectively, upon the Appeals Committee, the Benefits Administration Committee, the Benefits Design Committee, the Investment Committee and the Department  under the Plan.  This delegation of authority to act as such agents shall continue until the Plan is terminated as to such Employer&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the Trustee shall commingle, hold and invest as one Trust Fund all contributions made by the Employers, as well as all increments thereof&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">any expenses of the Plan which are to be paid by the Employers shall be paid by each Employer in the same ratio that the total amount standing to the credit of all Participants employed by such Employer bears to the total amount standing to the credit of all Participants, or in such other manner as may be determined by the Benefits Administration Committee&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">it will be bound by all interpretations, determinations and actions taken by the Appeals Committee, the Benefits Administration Committee, the Benefits Design Committee, the Department and the Investment Committee respectively and all actions taken by the Board, directly or through the Benefits Design Committee, as settlor of the Plan&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 82 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">it will perform such other acts including, but not limited to, payment of such amounts into the Plan to be allocated to Employees of the Employer as the Department deems necessary in order to maintain the Plan&#8217;s compliance with applicable law&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">it will, as provided in Section 8.5, jointly and severally indemnify and hold harmless each member of the Board, the Appeals Committee, the Benefits Administration Committee, the Benefits Design Committee, the Investment Committee and any other employees of an Employer or an Affiliate to whom any fiduciary or other responsibility with respect to the Plan is allocated (delegated or assumed)&#59; and Participants and Beneficiaries of the Plan, as well as their respective successors and assigns, against any cause of action, loss, liability, damage, cost, or expense of any nature whatsoever (including, but not limited to, attorney&#8217;s fees and costs, whether or not suit is brought, as well as IRS plan disqualifications, other sanctions or compliance fees or Department of Labor fiduciary breach sanctions and penalties) arising out of or relating to the Employer&#8217;s noncompliance with any of the Plan&#8217;s terms or requirements&#59; any intentional or negligent act or omission the Employer commits with regard to the Plan&#59; and any omission or provision of incorrect information by the Employer with regard to the Plan which causes the Plan to fail to satisfy the requirements of a tax-qualified plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If an Employee is transferred between Employers, accumulated vesting and eligibility service shall be carried with the Employee involved.  No such transfer shall effect a severance from employment hereunder, and the Employer to which the Employee is transferred shall thereupon become obligated hereunder with respect to such Employee in the same manner as was the Employer from which the Employee was transferred.  An Employee&#8217;s transfer of employment from an Employer to an Affiliate that is not an Employer also shall not effect a severance from employment hereunder.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">Contributions made by any Employer generally shall be treated as Employer Contributions made by the Company or the Employer for purposes of interpretation of the Plan.  Forfeitures arising from those Employer Contributions shall be used for the benefit of all Participants.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 83 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Participation in the Plan by other Organizations</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">An organization that is not an Affiliate may, with the consent of the Benefits Design Committee, adopt the Plan.  Any unaffiliated organization that becomes an Employer under the Plan shall promptly deliver to the Benefits Administration Committee a copy of the resolutions or other documents evidencing its adoption of the Plan, which resolutions shall include the same undertakings as required of an Affiliate under Section 10.1.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If any Employer is not an Affiliate, then the Plan shall be considered a multiple employer plan as described in Code Section 413(c).  Nothing in this Article X shall be treated as modifying the definition of &#8220;Employer&#8221; stated in Article I.  For example, a controlled group of corporations that is unrelated to any Affiliate may adopt the Plan, but that group shall be treated as one Employer to the extent required by the Plan and applicable Regulations.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Service and Termination of Service</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">An Employee&#8217;s service under the Plan includes all service with any and all Employers during the period such entities were Employers.  An Employee who terminates employment with one Employer and immediately commences employment with another Employer has not terminated employment, had a severance from employment, incurred a Severance from Service Date or had a separation from service.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 84 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:1.04pt"><br><br>TOP HEAVY PROVISIONS</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Determination of Top Heavy Status</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">The Plan will be considered a &#8220;Top Heavy Plan&#8221; for any Plan Year if as of the Determination Date&#58;  (1) the value of the Accounts of Participants who are Key Employees as of such Determination Date exceeds 60% of the value of the Accounts (but excluding catch-up contributions under Code Section 414(v) and earnings thereon) of all Participants as of such Determination Date, excluding former Key Employees (the &#8220;60% Test&#8221;)&#59; or (2) the Plan is part of a Required Aggregation Group which is Top Heavy.  Notwithstanding the results of the 60% Test, the Plan shall not be considered a Top Heavy Plan for any Plan Year in which the Plan is a part of a Required or Permissive Aggregation Group that is not Top Heavy.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">For purposes of the 60% Test&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">all distributions made from Accounts within the one-year period ending on the Determination Date (or, in the case of a distribution made for a reason other than severance from employment, death or disability, within the five-year period ending on the Determination Date) shall be taken into account&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">if a Participant is a non-Key Employee with respect to the Plan for the Plan Year in question, but he was a Key Employee with respect to the Plan for any prior Plan Year, his Account shall not be considered&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">if a Participant has not performed any service for an Employer at any time during the one-year period ending on the Determination Date, his Account shall not be considered.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Minimum Allocations</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding Sections 4.5 and 4.6, for any Plan Year during which the Plan is a Top Heavy Plan, the rate of Employer Matching Contributions and Discretionary Contributions (collectively) for such Plan Year allocated to the Accounts of Participants who are non-Key Employees and who remain employed by the Employer (or any Affiliate) at the end of the Plan Year (regardless of any such Participant&#8217;s hours of service or level of compensation during the Plan Year) shall not be less than the lesser of&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 85 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">three percent (3%) of such non-Key Employee&#8217;s Section 415 Compensation, as limited under Code Section 401(a)(17) as adjusted&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">the highest aggregate percentage of Section 415 Compensation, as limited under Code Section 401(a)(17) as adjusted, at which Employer Matching Contributions, Discretionary Contributions and Employee Pre-Tax Contributions are made (or required to be made) and allocated under Article IV for any Key Employee for the Plan Year.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">If a Participant is covered by more than one defined contribution plan on account of his employment with the Employer or any Affiliate, the minimum allocation required by this Section shall be determined by aggregating the allocations under all such plans.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Impact on Minimum Benefits where Employer Maintains Both Defined Benefit and Defined Contribution Plans</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">If the Employer (or any Affiliate) maintains a defined benefit plan in addition to this defined contribution plan, both of which are Top-Heavy, then&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">in the case of eligible non-Key Employees covered only by the defined benefit plan, the minimum benefit under the defined benefit plan shall be provided&#59; and</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">in the case of an eligible non-Key Employee not covered by the defined benefit plan but covered under a defined contribution plan, or covered by both plans, a minimum allocation of five percent (5%) of such non-Key Employee&#8217;s Section 415 Compensation shall be provided.  If a Participant is covered by more than one defined contribution plan on account of his employment with the Employer and&#47;or any Affiliate, the minimum allocation required by this Section shall be determined by aggregating the allocations under all such defined contribution plans.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Impact on Vesting</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If the Plan is top-heavy in any Plan Year, then notwithstanding anything contained in the Plan to the contrary, each Participant with an Hour of Service after the Plan becomes top-heavy shall be vested in the portion of his Account attributable to Employer contributions (to the extent such portion is not then fully vested and nonforfeitable) as determined under the following table&#58;</font></div><div style="margin-bottom:6pt;padding-left:41.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.818%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Years of Vesting Service</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Vested Percentage</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Less than 3</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3 or more</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">0%</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">100%</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 86 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">A Participant&#8217;s vested percentage in his Account shall not be less than that determined as of the last day of the most recent top-heavy Plan Year.  Further, if the Plan at any time has been top heavy and then ceases being top-heavy, the vested percentage in the Account of a Participant who has at least three (3) Years of Vesting Service (determined as of the last day of the most recent top-heavy year) shall not be less than what it would be if the Plan had not ceased being top-heavy.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Requirements Not Applicable</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The requirements of this Article shall not apply with respect to any Plan Year in which the Plan consists solely of a cash or deferred arrangement which meets the requirements of Code Sections 401(k)(12) or 401(k)(13), and matching contributions with respect to which the requirements of Code Sections 401(m)(11) or 401(m)(12) are met.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Top-Heavy Definitions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Determination Date &#8211; With respect to any Plan Year, the last day of the preceding Plan Year.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Key Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; An Employee or former Employee who at any time during the Plan Year containing the Determination Date is or was&#58;  (1) an officer of the Employer having annual Section 415 Compensation for such Plan Year which is in excess of $170,000 (as adjusted pursuant to Code Section 416(i)(1)(A)), but in no event shall the number of officers taken into account as Key Employees exceed the lesser of&#58;  (A) 50 or (B) the greater of 3 or 10% of all employees&#59; (2) a 5% owner of the Employer&#59; or (3) a 1% owner of the Employer who has annual Section 415 Compensation of more than $150,000.  For purposes of determining 5% and 1% owners, neither the aggregation rules nor the rules of Code Sections 414(b), (c) and (m) apply.  Beneficiaries of a Key Employee are considered Key Employees, and inherited benefits will retain the character of the benefits of the Employee who performed services for the Employer.  The identification of Key Employees will be made in accordance with Code Section 416(i)(1).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Non-Key Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Any Employee who is not a Key Employee, or who is a former Key Employee.  A Beneficiary of a Non-Key Employee is treated as a Non-Key Employee, but only if the Beneficiary is neither a Key Employee nor a Beneficiary of a Key Employee.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Permissive Aggregation Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Each employee pension benefit plan maintained by the Employer (or an Affiliate) which is considered part of the Required Aggregation Group, plus </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 87 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">or more other employee pension benefit plans maintained by the Employer (or an Affiliate) that are not part of the Required Aggregation Group but that satisfy the requirements of Code Sections 401(a)(4) and 410 when considered together with the Required Aggregation Group.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Required Aggregation Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Each employee pension benefit plan maintained by the Employer (or any Affiliate), whether or not terminated, in which a Key Employee participates in the Plan Year containing the Determination Date, and each other employee pension benefit plan maintained by the Employer (or any Affiliate), whether or not terminated, in which no Key Employee participates but which during that period enables an employee pension benefit plan in which a Key Employee participates to meet the requirements of Code Sections 401(a)(4) or 410.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 88 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:32.38pt"><br><br>MISCELLANEOUS</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Governing Law</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Except as preempted by federal law, the Plan shall be construed, regulated and administered according to the laws of the state of New Jersey (without regard to its conflict of laws provisions).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Construction</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The headings and subheadings in the Plan (other than in Article I) have been inserted for convenience of reference only and shall not affect the construction of the provisions hereof.  In any necessary construction, the masculine shall include the feminine or neuter and the singular the plural, and vice versa.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Participant&#8217;s Rights&#59; Acquittance</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Neither the establishment of the Plan and the Trust Fund nor any modification thereof, nor the creation of any fund or account nor the payment of any benefits, will give, or be construed as giving, to any Participant, Beneficiary or other person any legal or equitable right against an Employer or Affiliate, or any director, officer or employee thereof, or, except as provided herein, the Trustee, other than to the extent provided under ERISA and other applicable law.  An Employer or Affiliate expressly reserves its right to discipline, discharge, layoff or terminate the association of any Employee with the Employer or Affiliate at any time to the same extent as if the Plan had never gone into effect irrespective of the effect of such action upon his rights hereunder, and such action will not create any claim against the Employer or an Affiliate or against the Trust Fund for any payment except to the extent specifically provided herein.  The Employer shall not be liable for the payment of any benefit provided for herein, and all benefits hereunder shall be payable only from the Fund.  No Participant, Beneficiary or other person will have any right whatever to inspect for any purpose any book or record of the Employer or Affiliate other than any document as to which ERISA grants inspection rights, and the furnishing to such Participant, Beneficiary or other person by the Benefits Administration Committee of any information or statement with respect to matters appearing in, or which may be based upon, any such book or record will be final, binding and conclusive upon such Participant, Beneficiary or other person.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 89 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Spendthrift Clause</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Except as provided by a QDRO and except pursuant to certain judgments and settlements under ERISA Section 206(d)(4) or as may be required pursuant to the Code or the Mandatory Victims Restitution Act of 1996, none of the benefits, payments, proceeds or distributions under this Plan shall be subject to the claim of any creditor of a Participant or a Beneficiary hereunder or to any legal process by any creditor of a Participant or Beneficiary.  Neither a Participant nor a Beneficiary shall have any right to alienate, commute, anticipate or assign any of the benefits, payments, proceeds or distributions under this Plan.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Mistake of Fact</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding anything herein to the contrary, upon the Employer&#8217;s request, an Employer Contribution which was made by a mistake of fact, or conditioned upon the deductibility of the Employer Contribution under Code Section 404, may be returned to the Employer by the Trustee within one (1) year after the payment of the Employer Contribution or the disallowance of the deduction (to the extent disallowed), whichever is later.  For purposes of the preceding sentence, all Employer Contributions shall be conditioned on their deductibility under Code Section 404.  Except as this Plan may otherwise provide, any Employer Contribution so returned shall be adjusted to reflect its proportionate share of any Trust Fund gain or loss if, and to the extent, allowable under applicable Regulations.  Notwithstanding any provision of this Plan to the contrary, the right or claim of any Participant or Beneficiary to any asset of the Trust Fund or to any benefit under the Plan shall be subject to, and limited by, the provisions of this Section.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Recovery of Overpayment</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">If the Plan makes an overpayment, the Plan has the right, as elected by the Benefits Administration Committee, at any time to&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">recover that overpayment from the person to whom it was made&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">offset the amount of that overpayment from any subsequent payment(s)&#59; or</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">a combination of both.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Plan shall be considered to have established an equitable lien by agreement with the person to whom such overpayment was made.  Such payee shall, upon request, execute and deliver such instruments and papers as may be required, and shall do whatever else is necessary, to secure such rights of recovery to the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 90 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Plan Corrections</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">In addition to the actions contemplated under Sections 3.11 and 5.12(c), the Benefits Administration Committee or the Department, in conjunction with the Employers, may undertake such correction of Plan errors as it deems necessary including, but not limited to, correction to preserve tax qualification of the Plan under Code Section 401(a) or to correct a possible fiduciary breach under ERISA.  Without limiting its authority under the prior sentence, the Benefits Administration Committee may undertake correction of Plan document, operational, demographic and Employer eligibility failures under a method described in the Plan or permissible under the EPCRS or any successor thereto.  The Benefits Administration Committee or the Department also may undertake or assist the appropriate Plan fiduciary or Plan official in undertaking correction of a possible fiduciary breach including, but not limited to, correction under the U.S. Department of Labor Voluntary Fiduciary Correction Program or any successor thereto.  To correct an operational error, the Trustee may be required to distribute from the Plan (or deduct from Accounts) Pre-Tax Contributions or vested Employer Matching Contributions, including earnings or losses thereon, where such amounts result from an operational error other than a failure of Code Sections 402(g) or 415, or a failure of the ADP or ACP Tests.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Consent to Plan Terms</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">An Eligible Employee, upon becoming a Participant, and any other person, upon becoming a Beneficiary or an alternate payee, is deemed conclusively for all purposes hereof to have consented to the terms and conditions of the Plan and to be bound thereby.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12pt;text-decoration:underline">Facility of Payment&#59; Uncashed Checks&#59; Recipients Who Cannot Be Located</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If the Department finds that any Participant or Beneficiary to whom a benefit is payable is unable to care for his affairs because of physical, mental or legal incompetence, the Department, in its sole discretion, may cause any payment due to such individual to be paid to the person deemed by the Department to be maintaining or responsible for the maintenance of such individual.  Any such payment will be deemed a payment for the account of such individual and will constitute a complete discharge of the Plan and the Trust Fund of any liability for such payment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 91 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If an individual dies before receiving all the payments to be made or before cashing any or all of the checks representing such payment or payments, such payment(s) will be made to his Beneficiary or, if there is no Beneficiary, as provided in Section 2.3(a).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.7pt">If the Trustee is unable to make payment to a Participant or other person to whom a payment is due under the Plan because it cannot ascertain his identity or whereabouts after reasonable efforts have been made to identify or locate him (including a notice of the payment so due mailed to his last known address as shown on the records of the Employer) or because a check issued to him has remained uncashed for at least 90 days, the amount so distributable (or distributed) shall be treated in accordance with the Plan&#8217;s then-current &#8220;outstanding check reduction automated process&#8221; regarding &#8220;stale-dated&#8221; checks (in the former situation, acting as if a check had in fact been issued).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6pt;text-decoration:underline">Income Tax Withholding</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Amounts shall be withheld from any payment due under this Plan as required to conform with applicable income tax laws.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6pt;text-decoration:underline">Writings and Electronic Communications</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">All notices and other communications with respect to the Plan, including signatures relating to such documents, may be executed and stored on paper, electronically or in another medium.  Any documentation executed or stored electronically shall comply with the Electronic Signatures Act.  To the extent permitted under applicable Regulations, the Department and the Plan&#8217;s recordkeeper may use telephonic or electronic media to satisfy any notice requirements of this Plan.  In addition, to the extent permitted under applicable Regulations, a Participant&#8217;s consent to immediate distribution may be provided through telephonic or electronic means.  To the extent permitted under applicable Regulations, the Department and the Plan&#8217;s recordkeeper also may use telephonic or electronic media to conduct Plan transactions such as enrolling Participants, making or changing salary reduction elections, electing or changing investment allocations, applying for Plan loans and other transactions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 92 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ARTICLE XIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27.72pt"><br><br>ADOPTION OF THE PLAN</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Anything herein to the contrary notwithstanding, this amended and restated Plan is adopted and maintained under the conditions that it is deemed qualified by the Internal Revenue Service under Code Sections 401(a) and 401(k), and that the Trust hereunder is exempt under Code Section 501(a).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">As evidence of its adoption of the Plan, the Company has caused this instrument to be signed by its authorized officer this __August 26, 2021_ , effective as of August 15, 2021 except as otherwise provided herein or as required by law.</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS CLINICAL LABORATORIES, INC.</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47;Cecilia K. McKenney</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;SVP &#38; CHRO</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">- 93 -</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:114%">APPENDIX A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PARTICIPATING EMPLOYERS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The names (and jurisdictions of organization) of Employers participating in the Plan  as of January&#160;1, 2021, in the Plan are&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MEMBERS OF THE QUEST CONTROLLED GROUP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>American Medical Laboratories, Incorporated (DE)<br>Athena Diagnostics, Inc. (DE)<br>Blueprint Genetics Inc. (DE)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:line-through"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic Reference Services, Inc. (MD)<br>ExamOne LLC (DE)<br>ExamOne World Wide, Inc. (PA)<br>ExamOne World Wide of NJ, Inc. (NJ)<br>LabOne, LLC (MO)<br>LabOne of Ohio, Inc. (DE)<br>Mid America Clinical Laboratories, LLC (IN)*</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest HealthConnect, LLC (CA)<br>Nomad Massachusetts, Inc. (MA)<br>Pathology Building Partnership (MD)<br>PhenoPath Laboratories, PLLC (WA)<br>Quest Diagnostics Clinical Laboratories, Inc. (DE)<br>Quest Diagnostics Domestic Holder LLC (DE)<br>Quest Diagnostics Holdings Incorporated (DE)<br>Quest Diagnostics Incorporated (DE)<br>Quest Diagnostics Incorporated (MD)<br>Quest Diagnostics Incorporated (NV)<br>Quest Diagnostics Infectious Disease, Inc. (DE)<br>Quest Diagnostics International LLC (DE)<br>Quest Diagnostics Investments LLC (DE)<br>Quest Diagnostics LLC (CT)<br>Quest Diagnostics LLC (IL)<br>Quest Diagnostics LLC (MA)<br>Quest Diagnostics Massachusetts LLC (MA)<br>Quest Diagnostics Nichols Institute (CA)<br>Quest Diagnostics Nichols Institute, Inc. (VA)<br>Quest Diagnostics of Pennsylvania Inc. (DE)<br>Quest Diagnostics Receivables Inc. (DE)<br>Quest Diagnostics TB, LLC (DE)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Terracotta LLC (DE)<br>Quest Diagnostics Ventures, LLC (DE)<br>Reprosource Fertility Diagnostics, Inc. (MA)<br>Specialty Laboratories, Inc. (CA)<br>Quest Diagnostics Health &#38; Wellness, LLC (DE)<br>Unilab Corporation (DE)<br>AmeriPath Cincinnati, Inc. (OH)<br>AmeriPath Cleveland, Inc. (OH)<br>AmeriPath Consolidated Labs, Inc. (FL)<br>AmeriPath Florida, LLC (DE)<br>AmeriPath Hospital Services Florida, LLC (DE)<br>AmeriPath, Inc. (DE)<br>AmeriPath Indianapolis, P.C. (IN)<br>AmeriPath Kentucky, Inc. (KY)<br>AmeriPath Lubbock 5.01(a) Corporation (TX)<br>AmeriPath New York, LLC (DE)<br>AmeriPath Texas Inc. (TX)<br>AmeriPath Tucson, Inc. (AZ)<br>Clearpoint Diagnostic Laboratories, LLC (TX)<br>Cleveland Heartlab, Inc. (DE)<br>Colorado Pathology Consultants, P.C. (CO)<br>Consolidated DermPath, Inc. (DE)<br>Dermatopathology of Wisconsin, S.C. (WI)<br>DFW 5.01(a) Corporation (TX)<br>Diagnostic Pathology Services, Inc. (OK)<br>Institute for Dermatopathology, P.C. (PA)<br>Kailash B. Sharma, M.D., Inc. (GA)<br>Kilpatrick Pathology, P.A. (NC)<br>Med Fusion, LLC (TX)<br>Nuclear Medicine and Pathology Associates (GA)<br>Ocmulgee Medical Pathology Association, Inc. (GA)</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EMPLOYERS THAT ARE NOT MEMBERS OF THE QUEST CONTROLLED GROUP<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Desert Pathology Medical Group, Inc. (CA)<br>Associated Pathologists, Chartered (NV)<br>Diagnostic Laboratory of Oklahoma LLC (OK)<br>DGXWMT JV, LLC (DE)<br>Quest Diagnostics Venture LLC (PA)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*  &#160;&#160;&#160;&#160;The vesting service as of January 1, 2021, of a Participant who was a participant in the Mid America Clinical Laboratories Retirement Savings Plan on January 1, 2021, shall be equal to the total period of time commencing on such Participant&#8217;s Benefit Service Date, as communicated to the Company by Mid America Clinical Laboratories, LLC, which </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">amount shall be final and conclusive as to the number of years of vesting service to which such Participant was entitled as of January 1, 2021.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_13"></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX B<br><br>PRE-2016 PLAN AND MERGED PLANS&#58;<br>SPECIAL RULES AND PROTECTED BENEFITS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of Appendices B, C and D,  the following definitions apply&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Merged Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">. &#8211; The Advance Medical Plan, the AML-East Plan, the AML-West Plan, the AMP Plan, the CBCLS Plan, the Celera Plan, the CDS Plan, the Converge Plan, the CPF Pension Plan, the CPF Savings Plan, the Damon Plan, the DeYor Plan, the Focus Plan, the HemoCue Plan, the LabOne (k) Plan, the LabOne Pension Plan, the LabPortal Plan, the Maryland Medical Laboratory Plan, the MedPlus Plan, the MetWest Plan, the Nichols Institute Plan, the Quest Employee Stock Ownership Plan, the Podiatric Pathology Laboratories Plan, the Solstas Plan, the Statlab Plan, the Summit Plan and the Unilab Plan, either individually or collectively as the case may be.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Merger Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The date as of which a Merged Plan was merged into this Plan.  The Merger Date for each Merged Plan is set forth in a table at the end of this Appendix.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The following provisions supplement the corresponding Sections of Articles V and VI.  Corresponding provisions relating to the AMP Plan are contained in Appendix C. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death Before Severance from Employment</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">If a Participant whose Account includes a QJSA Portion dies with his surviving spouse as Beneficiary, the QJSA Portion shall be paid by purchase of an annuity contract providing for annuity payments for the spouse&#8217;s lifetime, unless the spouse elects to receive the QJSA Portion in a lump sum or in installments under Section 5.6.  Subject to Section 5.8(c), payments shall commence at a time designated by the spouse, but in no event earlier than a date that falls as soon as administratively feasible following the Participant&#8217;s date of death.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance from Employment</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;(1)     A Participant shall at all times be 100% vested in each portion of his Account attributable to the Plan as in effect prior to 2016 or a Merged Plan other than his Prior ESOP Employer Stock Sub-Account, his Prior ESOP Employer Contributions Sub-Account, his AML-East or AML-West Prior Employer Match Sub-Account, his prior Focus Plan Match Sub-Account, his Prior Unilab Employer </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Contribution Sub-Account, his Prior LabOne Money Purchase Sub-Account, his Prior LabOne Employer Match Sub-Account, his prior Employer Five-Year Sub-Account, his Prior Employer Six-Year Money Purchase Sub-Account, his Prior Employer Six-Year Sub-Account, his Celera Plan Match Sub-Account, his Converge Plan employer nonelective contributions sub-account, his Converge Plan employer matching contributions sub-account (unless he was a participant in the Converge Plan hired before January 1, 2011), his Solstas Plan employer nonelective and pre-2011 and post-2012 matching contributions sub-accounts, his Carilion Plan Transfer Nonelective Account sub-account, his Medex Transfer Matching Account sub-account, his Medex Transfer Nonelective Account sub-account and his Summit Plan employer matching and nonelective contributions sub-account. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;A Participant has a vested interest in the following percentage of his Prior ESOP Employer Stock Sub-Account (if any), taking into account only Years of Vesting Service credited for periods of employment on or after December 31, 1996&#58;</font></div><div style="padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding the preceding, (i) a Participant who was an active Employee or who was on an authorized leave of absence as of August 16, 1999 automatically shall be 100% vested in his Prior ESOP Employer Stock Sub-Account&#59; and (ii) a Participant who terminated employment prior to August 16, 1999 with fewer than two Years of Vesting Service (taking into account only Years of Vesting Service credited for periods of employment on or after December 31, 1996), and who subsequently returns as an Employee after August 16, 1999 prior to incurring five (5) consecutive One-Year Periods of Severance beginning immediately after the date his employment terminated, automatically shall become 100% vested in his Prior ESOP Employer Stock Sub-Account as of the date of his reemployment.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)&#160;&#160;&#160;&#160;A Participant has a vested interest in the following percentage of his Prior ESOP Employer Contributions Sub-Account (if any), taking into account all Years of Vesting Service&#58;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:149.4pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)&#160;&#160;&#160;&#160;An AML-East Plan Participant or an AML-West Plan Participant has a vested interest in the following percentage of his Prior Employer Match Sub-Account (if any)&#58;</font></div><div style="padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">25%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">50%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)&#160;&#160;&#160;&#160;A Unilab Plan Participant has a vested interest in the following percentage of his Prior Unilab Employer Contribution Sub-Account (if any)&#58;</font></div><div style="padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">10%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">20%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">50%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)&#160;&#160;&#160;&#160;A LabOne (k) Plan Participant has a vested interest in the following percentage of his Prior LabOne Employer Match Sub Account (if any)&#58;</font></div><div style="padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(7)&#160;&#160;&#160;&#160;A LabOne Pension Plan Participant has a vested interest in the following percentage of his Prior LabOne Money Purchase Plan Sub-Account&#58;</font></div><div style="padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 5</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(8)&#160;&#160;&#160;&#160;A Participant has a vested interest in the following percentage of his Prior Focus Plan Match Sub-Account (if any)&#58;</font></div><div style="padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">20%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">40%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">60%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">80%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(9)&#160;&#160;&#160;&#160;A Participant has a vested interest in the following percentage of his Prior Employer Five-Year Sub-Account (if any)&#58;</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">20%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">40%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">60%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">80%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(10)&#160;&#160;&#160;&#160;A Participant has a vested interest in the following percentage of his Prior Employer Six-Year Money Purchase and Prior Employer Six-Year Sub-Accounts (if any)&#58;</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0-1</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">20%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">40%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">60%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">80%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">6 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(11)&#160;&#160;&#160;&#160;A Participant has a vested interest in the following percentage of his Celera Plan matching contributions (if any)&#58;</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.392%"><tr><td style="width:1.0%"></td><td style="width:57.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">25%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">50%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">75%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A Participant whose Celera BHL Plan matching contributions (if any) were transferred to the Celera Plan as of January 1, 2009 has a 100% vested interest in those matching contributions.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding the preceding, a Participant shall be 100% vested in his Celera Plan matching contributions (if any) upon termination of employment after (A) his attainment of age 59&#189; (which was the Normal Retirement Age under the Celera Plan)&#59; (B) his attainment of age 55 and completion of at least 5 Years of Service (which was the Early Retirement Age under the Celera Plan)&#59; or (C) he has become Totally and Permanently Disabled (which for this purpose includes being&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-4</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">so determined by a physician approved by his Employer in lieu of being so determined under the federal Social Security Act or his Employer&#8217;s long-term disability plan (if any)).</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(12)&#160;&#160;&#160;&#160;Notwithstanding the preceding, a Participant shall be 100% vested in his Celera Plan sub-accounts upon his attainment of age 59&#189;.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(13)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:16.02pt">A Participant in the Converge Plan has a vested interest in the following percentage of his Converge Plan employer nonelective contributions (if any)&#59; this schedule also applies to Converge Plan employer matching contributions (if any) of Participants hired on or after January 1, 2011&#58;</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.244%"><tr><td style="width:1.0%"></td><td style="width:56.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">33%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">66%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A Participant in the Converge Plan hired before January 1, 2011 is fully (100%) vested in his Converge Plan employer matching contributions (if any).</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(14)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:16.02pt">A Participant in the Solstas Plan has a vested interest in the following percentage of his Solstas Plan post-2012 employer matching contributions (if any)&#58;</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.244%"><tr><td style="width:1.0%"></td><td style="width:56.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(15)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:16.02pt">A Participant in the Solstas Plan has a vested interest in the following percentage of his Solstas Plan employer nonelective and pre-2011 matching contributions (if any)&#58;</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.244%"><tr><td style="width:1.0%"></td><td style="width:56.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">25%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">50%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">75%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(16)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:16.02pt">A Participant in the Solstas Plan has a vested interest in certain sub-accounts arising from plans that merged into the Solstas Plan as follows&#58;</font></div><div style="padding-left:126pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)&#160;&#160;&#160;&#160;The following vesting schedule applies to the&#58;  (1) Carilion Plan Transfer Nonelective Account&#59; (2) Medex Transfer Matching Account&#59; </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-5</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:126pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">and (3) Medex Transfer Nonelective Account if such former Medex Employee has an Hour of Service after January 1, 2007.</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.244%"><tr><td style="width:1.0%"></td><td style="width:56.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:126pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)&#160;&#160;&#160;&#160;The following vesting schedule applies to the Medex Transfer Nonelective Account of a former Medex Employee who does not have an Hour of Service after January 1, 2007.</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.244%"><tr><td style="width:1.0%"></td><td style="width:56.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 5</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:126pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(iii)&#160;&#160;&#160;&#160; To the extent applicable, a Participant shall be fully (100%) vested in his&#58;  (1) Medex Highlands Transfer Account&#59; (2)&#160;DLI Plan Account&#59; (3) Carilion Plan Transfer Matching Account&#59; (4)&#160;Oracle Diagnostic Laboratories, Inc. Transfer Account&#59; (5) Hayes Clinical Laboratory Transfer Account&#59; and (6) prior money purchase pension plan contributions under the Solstas Plan.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(17)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:16.02pt">A Participant in the Summit Plan has a vested interest in the following percentage of his Summit Plan employer matching and nonelective contributions (if any)&#58;</font></div><div style="margin-bottom:6pt;padding-left:149.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.244%"><tr><td style="width:1.0%"></td><td style="width:56.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">YEARS OF VESTING SERVICE</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">VESTED INTEREST</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 3</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 or more</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(18)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:16.02pt">Vesting provisions applicable to the AMP Plan are contained in Appendix C.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(h)&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;If a Participant&#8217;s employment terminates for any reason other than retirement under Section 5.1, disability under Section 5.2, death under Section 5.3 or reduction in-force under Section 5.5(a) at a time when he has no vested interest in his Prior ESOP Employer Stock Sub-Account and&#47;or his Prior ESOP Employer Contributions Sub-Account, the Benefits Administration Committee nonetheless shall treat him as if he had received a distribution of his Prior ESOP Employer Stock Sub-Account and&#47;or his Prior ESOP Employer Contributions Sub-Account on the date his employment terminated and shall forfeit his entire Prior ESOP </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-6</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Employer Stock Sub-Account and&#47;or his entire Prior ESOP Employer Contributions Sub-Account as soon as administratively feasible after the date his employment terminated.  If the former Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance beginning immediately after the date his employment terminated, his Prior ESOP Employer Stock Sub-Account and&#47;or his Prior ESOP Employer Contributions Sub-Account, determined as of the date of forfeiture, shall be fully restored to him as soon as administratively feasible after his reemployment.  In such case, these Sub-Accounts shall be restored first out of forfeitures for such Plan Year and, if such forfeitures are insufficient to restore such Sub-Accounts, the Employer shall make a special contribution to the extent necessary so that his Sub-Accounts are fully restored.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;If the employment of an AML-East Plan Participant or an AML-West Plan Participant terminates for any reason other than retirement under Section 5.1, disability under Section 5.2, death under Section 5.3 or reduction-in-force under Section 5.5(b)(1) at a time when he is not fully vested in his Prior Employer Match Sub-Account, then the Benefits Administration Committee shall follow the procedure set forth in clause (i) or that set forth in clause (ii) below, as appropriate&#58;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;If the Participant had no vested interest in his Prior Employer Match Sub-Account at the time of his termination of employment, the Benefits Administration Committee nonetheless shall treat him as if he had received a distribution on the date his employment terminated and shall forfeit his entire Prior Employer Match Sub Account as soon as administratively feasible after the date his employment terminated.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance, his Prior Employer Match Sub-Account, determined as of the date of his deemed distribution, shall be fully restored to him as soon as administratively feasible after his reemployment.</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)&#160;&#160;&#160;&#160;If the Participant had a 25% or 50% vested interest in his Prior Employer Match Sub-Account at the time of his termination of employment and if he receives a distribution of such vested </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-7</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of his Prior Employer Match Sub-Account shall be forfeited as soon as administratively feasible after the date of distribution.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance and if he repays the full amount of the distribution paid to him by reason of his termination of employment no later than the fifth anniversary of the date of his reemployment, then his Prior Employer Match Sub-Account, determined as of the date of the distribution of his vested interest, shall be fully restored to him as soon as administratively feasible after such repayment is made.</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)&#160;&#160;&#160;&#160;A Participant&#8217;s Prior Employer Match Sub Account shall be restored first out of forfeitures for such Plan Year and, if such forfeitures are insufficient to restore such Prior Employer Match Sub-Account, the Employer shall make a special contribution to the extent necessary so that the Participant&#8217;s Prior Employer Match Sub-Account is fully restored.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)&#160;&#160;&#160;&#160;If the Participant had a 25% or 50% vested interest in his Prior Employer Match Sub-Account at the time of his termination of employment and if he does not receive a distribution of such vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of his Prior Employer Match Sub-Account shall be forfeited as soon as administratively feasible after five (5) consecutive One-Year Periods of Severance have been incurred.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)&#160;&#160;&#160;&#160;If the employment of a Unilab Plan Participant terminates for any reason other than retirement under Section 5.1, disability under Section 5.2, death under Section 5.3 or reduction-in-force under Section 5.5(b)(1) at a time when he is not fully vested in his Prior Unilab Employer Contribution Sub-Account, then the Benefits Administration Committee shall follow the procedure set forth below in clause (i) or clause (ii), as appropriate&#58;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-8</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;If the Participant had no vested interest in his Prior Unilab Employer Contribution Sub-Account at the time of his termination of employment, the Benefits Administration Committee nonetheless shall treat him as if he had received a distribution on the date his employment terminated and shall forfeit his entire Prior Unilab Employer Contribution Sub-Account as soon as administratively feasible after the date his employment terminated.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance, his Prior Unilab Employer Contribution Sub-Account, determined as of the date of his deemed distribution, shall be fully restored to him as soon as administratively feasible after his reemployment.</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)&#160;&#160;&#160;&#160;If the Participant is partially vested in his Prior Unilab Employer Contribution Sub-Account at the time of his termination of employment and if he receives a distribution of his vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of his Prior Unilab Employer Contribution Sub-Account shall be forfeited as soon as administratively feasible after the date of distribution.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance and if he repays the full amount of the distribution paid to him by reason of his termination of employment no later than the fifth anniversary of the date of his reemployment, then his Prior Unilab Employer Contribution Sub Account, determined as of the date of the distribution of his vested interest, shall be fully restored to him as soon as administratively feasible after such repayment is made.</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)&#160;&#160;&#160;&#160;A Participant&#8217;s Prior Unilab Employer Contribution Sub Account shall be restored first out of forfeitures for such Plan Year and, if such forfeitures are insufficient to restore such Prior Unilab Employer Contribution Sub-Account, the Employer shall make a</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-9</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">special contribution to the extent necessary so that the Participant&#8217;s Prior Unilab Employer Contribution Sub-Account is fully restored.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)&#160;&#160;&#160;&#160;If the Participant is partially vested in his Prior Unilab Employer Contribution Sub-Account at the time of his termination of employment and if he does not receive a distribution of such vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of his Prior Unilab Employer Contribution Sub-Account shall be forfeited as soon as administratively feasible after five (5) consecutive One-Year Periods of Severance have been incurred.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(4)&#160;&#160;&#160;&#160;If the employment of a Participant terminates for any reason other than retirement under Section 5.1, disability under Section 5.2, death under Section 5.3 or reduction-in-force under Section 5.5(a) at a time when he is not fully vested in his Prior Focus Plan Match Sub-Account (if any), then the Benefits Administration Committee shall follow the procedure set forth below in clause (i) or clause (ii), as appropriate&#58;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)&#160;&#160;&#160;&#160;If the Participant had no vested interest in his Prior Focus Plan Match Sub-Account at the time of his termination of employment, the Benefits Administration Committee nonetheless shall treat him as if he had received a distribution on the date his employment terminated and shall forfeit his entire Prior Focus Plan Match Sub-Account as soon as administratively feasible after the date his employment terminated.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance, his Prior Focus Plan Match Sub-Account, determined as of the date of his deemed distribution, shall be fully restored to him as soon as administratively feasible after his reemployment.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;If the Participant is partially vested in his Prior Focus Plan Match Sub-Account at the time of his termination of employment and if he receives a distribution of his vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-10</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">remaining portion of his Prior Focus Plan Match Sub-Account shall be forfeited as soon as administratively feasible after the date of distribution.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance and if he repays the full amount of the distribution paid to him by reason of his termination of employment no later than the fifth anniversary of the date of his reemployment, then his Prior Focus Plan Match Sub-Account, determined as of the date of the distribution of his vested interest, shall be fully restored to him as soon as administratively feasible after such repayment is made.</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)&#160;&#160;&#160;&#160;A Participant&#8217;s Prior Focus Plan Match Sub-Account shall be restored first out of forfeitures for such Plan Year and, if such forfeitures are insufficient to restore such Prior Focus Plan Match Sub-Account, the Employer shall make a special contribution to the extent necessary so that the Participant&#8217;s Prior Focus Plan Match Sub-Account is fully restored.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(iii)&#160;&#160;&#160;&#160;If the Participant is partially vested in his Prior Focus Plan Match Sub-Account at the time of his termination of employment and if he does not receive a distribution of such vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of his Prior Focus Plan Match Sub-Account shall be forfeited as soon as administratively feasible after five (5) consecutive One-Year Periods of Severance have been incurred.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(5)&#160;&#160;&#160;&#160;If the employment of a Converge Plan Participant terminates for any reason other than retirement under Section 5.1, disability under Section 5.2, death under Section 5.3 or reduction-in-force under Section 5.5(b)(1) at a time when he is not fully vested in his Converge Plan employer nonelective contributions or employer matching contributions (for post-2010 hires) Sub-Accounts, then the Benefits Administration Committee shall follow the procedure set forth in clause (i) or that set forth in clause (ii) below, as appropriate&#58;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-11</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;If the Participant had no vested interest in such Converge Plan Sub-Accounts at the time of his termination of employment, the Benefits Administration Committee nonetheless shall treat him as if he had received a distribution on the date his employment terminated and shall forfeit his entire interest in such Converge Plan Sub-Accounts as soon as administratively feasible after the date his employment terminated.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance, such Converge Plan Sub-Accounts, determined as of the date of his deemed distribution, shall be fully restored to him as soon as administratively feasible after his reemployment.</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)&#160;&#160;&#160;&#160;If the Participant had a 33% or 66% vested interest in such Converge Plan Sub-Accounts at the time of his termination of employment and if he receives a distribution of such vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of such Converge Plan Sub-Accounts shall be forfeited as soon as administratively feasible after the date of distribution.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance and if he repays the full amount of the distribution paid to him by reason of his termination of employment no later than the fifth anniversary of the date of his reemployment, then such Converge Plan Sub-Accounts, determined as of the date of the distribution of his vested interest, shall be fully restored to him as soon as administratively feasible after such repayment is made.</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)&#160;&#160;&#160;&#160;The Converge Plan Sub-Accounts of such a Participant shall be restored first out of forfeitures for such Plan Year and, if such forfeitures are insufficient to restore such Converge Plan Sub-Accounts, the Employer shall make a special contribution to the extent necessary so that the Converge Plan Sub-Accounts of such Participant are fully restored.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-12</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)&#160;&#160;&#160;&#160;If the Participant had a 33% or 66% vested interest in such Converge Plan Sub-Accounts at the time of his termination of employment and if he does not receive a distribution of such vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of such Converge Plan Sub-Accounts shall be forfeited as soon as administratively feasible after five (5) consecutive One-Year Periods of Severance have been incurred.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(6)&#160;&#160;&#160;&#160;If a Participant&#8217;s employment terminates for any reason other than retirement under Section 5.1, disability under Section 5.2, death under Section 5.3 or reduction in-force under Section 5.5(a) at a time when he has no vested interest in his Carilion Plan Transfer Nonelective, Medex Transfer Matching, Medex Transfer Nonelective, Summit Plan employer matching contributions or Summit Plan nonelective contributions Sub-Accounts (as the case may be), the Benefits Administration Committee nonetheless shall treat him as if he had received a distribution of the relevant Sub-Accounts on the date his employment terminated and shall forfeit his entire interest in such Sub-Accounts as soon as administratively feasible after the date his employment terminated.  If the former Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance beginning immediately after the date his employment terminated, his interest in such Sub-Accounts, determined as of the date of forfeiture, shall be fully restored to him as soon as administratively feasible after his reemployment.  In such case, the Sub-Accounts shall be restored first out of forfeitures for such Plan Year and, if such forfeitures are insufficient to restore such Sub-Accounts, the Employer shall make a special contribution to the extent necessary so that his Sub-Accounts are fully restored.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:22.02pt">If the employment of a Solstas Plan Participant terminates for any reason other than retirement under Section 5.1, disability under Section 5.2, death under Section 5.3 or reduction-in-force under Section 5.5(b)(1) at a time when he is not fully vested in his Solstas Plan employer nonelective and pre-2011 or post-2012 matching contributions Sub-Accounts, then the Benefits Administration </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-13</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Committee shall follow the procedure set forth in clause (i) or that set forth in clause (ii) below, as appropriate&#58;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:24.69pt">(A)&#160;&#160;&#160;&#160;If the Participant had no vested interest in his Solstas Plan employer nonelective and pre-2011 or post-2012 matching contributions Sub-Account at the time of his termination of employment, the Benefits Administration Committee nonetheless shall treat him as if he had received a distribution on the date his employment terminated and shall forfeit his entire Solstas Plan employer nonelective and pre-2011 or post-2012 matching contributions Sub-Accounts as soon as administratively feasible after the date his employment terminated.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance, his Solstas Plan employer nonelective and pre-2011 or post-2012 matching contributions Sub-Accounts, determined as of the date of his deemed distribution, shall be fully restored to him as soon as administratively feasible after his reemployment.</font></div><div style="padding-left:144pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;padding-left:20.02pt">If the Participant is partially vested in his Solstas Plan employer nonelective and pre-2011 matching contributions Sub-Account at the time of his termination of employment and if he receives a distribution of his vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of his Solstas Plan employer nonelective and pre-2011 matching contributions Sub-Account shall be forfeited as soon as administratively feasible after the date of distribution.  If such a Participant returns as an Employee prior to incurring five (5) consecutive One-Year Periods of Severance and if he repays the full amount of the distribution paid to him by reason of his termination of employment no later than the fifth anniversary of the date of his reemployment, then his Solstas Plan employer nonelective and pre-2011 matching contributions Sub Account, determined as of the date </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-14</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">of the distribution of his vested interest, shall be fully restored to him as soon as administratively feasible after such repayment is made.</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)&#160;&#160;&#160;&#160;A Participant&#8217;s Solstas Plan employer nonelective and pre-2011 or post-2012 matching contributions Sub-Accounts shall be restored first out of forfeitures for such Plan Year and, if such forfeitures are insufficient to restore such Solstas Plan employer nonelective and pre-2011 or post-2012 matching contributions Sub-Accounts, the Employer shall make a special contribution to the extent necessary so that the Participant&#8217;s Solstas Plan employer nonelective and pre-2011 or post-2012 matching contributions Sub-Accounts are fully restored.</font></div><div style="margin-bottom:6pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)&#160;&#160;&#160;&#160;If the Participant is partially vested in his Solstas Plan employer nonelective and pre-2011 matching contributions Sub-Account at the time of his termination of employment and if he does not receive a distribution of such vested interest before he incurs five (5) consecutive One-Year Periods of Severance, the remaining portion of his Solstas Plan employer nonelective and pre-2011 matching contributions Sub-Account shall be forfeited as soon as administratively feasible after five (5) consecutive One-Year Periods of Severance have been incurred.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Hardship Withdrawals</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)&#160;&#160;&#160;&#160;An AML-East Plan Participant shall be allowed to make up to two withdrawals from his Employee After-Tax Sub-Account in any 12-month period.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;In addition to the withdrawals available under Section 6.2, a MedPlus Plan Participant, a LabPortal Plan Participant, an AML-East Plan Participant, an AML-West Plan Participant, a Unilab Plan Participant or a LabOne 401(k) Plan Participant shall be allowed to withdraw all or part of the value of his Prior Plan Rollover Sub-Account for any reason.  Similarly, a Converge Plan Participant or a Summit Plan Participant shall be allowed to withdraw all or part of the value of his Converge Plan or Summit Plan, respectively, Rollover Sub-Account for any reason.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-15</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)&#160;&#160;&#160;&#160;Notwithstanding any other provision of Section 6.3, in no event may&#58;  (1)&#160;a CPF Pension Plan Participant be allowed to make a withdrawal from his Money Purchase Pension Plan Sub-Account, (2) a LabOne Pension Plan Participant be allowed to make a withdrawal from his Prior LabOne Money Purchase Plan Sub-Account or (3) a Solstas Plan Participant be allowed to make a withdrawal from his Money Purchase Pension Plan Sub-Account prior to attaining age 62 or incurring a Severance from Service Date.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)&#160;&#160;&#160;&#160;A Participant may make an in-service withdrawal from his Celera Plan or Hayes Clinical Laboratories sub-accounts if he is determined to be Totally and Permanently Disabled.</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">MERGER DATES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Merger Date for each Merged Plan is set forth below&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.708%"><tr><td style="width:1.0%"></td><td style="width:79.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">NAME OF MERGED PLAN</font></td><td colspan="3" style="background-color:#bfbfbf;border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">MERGER DATE</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Advance Medical &#38; Research Center, Inc. Retirement Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">May 1, 1990</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Continental Bio Clinical Laboratory Service, Inc. Profit Sharing and Retirement Savings Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1992</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Statlab, Inc. Retirement Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">March 1, 1993</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">CPF&#47;MetPath Savings and Retirement Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">July 1, 1993</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Clinical Pathology Facility, Inc. Pension Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">July 1, 1993</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">DeYor Laboratories 401(k) Profit Sharing Plan and Trust</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The Profit Sharing Plan and Trust Agreement for Employees of MetWest Inc.</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">April 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Damon Corporation Pension Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 1994 to June&#160;1,&#160;1994</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</font></div></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Maryland Medical Laboratory, Inc. 401(k) Profit Sharing Plan and Trust</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1995</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Nichols Institute 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1995</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Podiatric Pathology Laboratories, Inc. Profit Sharing Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1995</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">MedPlus, Inc. 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 2, 2002</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">LabPortal, Inc. 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">July 1, 2002</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Quest Diagnostics Incorporated Employee Stock Ownership Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">October 1, 2002</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">AML-East 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 3, 2003</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">APL Healthcare Group Inc. Profit Sharing and 401(k) Plan &#123;a&#47;k&#47;a AML-West Plan&#125;</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 3, 2003</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Clinical Diagnostics Services 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">June 2, 2003</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Unilab 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 2, 2004</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">LabOne, Inc. Profit Sharing 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">March 1, 2007</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">LabOne, Inc. Money Purchase Pension Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">March 1, 2007</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Focus Diagnostics, Inc. Profit Sharing and 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">March 13, 2008</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">HemoCue, Inc. 401(k) Profit Sharing Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">July 14, 2009</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Celera 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">May 31, 2012</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Solstas Lab Partners Group, LLC 401(k) Savings Plan</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">February 17, 2015</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-16</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.708%"><tr><td style="width:1.0%"></td><td style="width:79.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Converge Diagnostic Services 401(k) Profit Sharing Plan Trust</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">February 27, 2015</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Summit Health, Inc. 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">November 30, 2015</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The 401(k) Savings Plan of Quest Diagnostics Incorporated &#123;a&#47;k&#47;a AMP Plan&#125;</font></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">December 31, 2015</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are several different Merger Dates for Participants who were former participants in the Damon Corporation Pension Plan, depending on the Damon Corporation entity with which such former participant was employed before transferring to an Employer&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.708%"><tr><td style="width:1.0%"></td><td style="width:79.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">NAME OF DAMON CORPORATION ENTITY</font></td><td colspan="3" style="background-color:#bfbfbf;border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">MERGER DATE</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">American Health Resources, Inc.</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Damon Clinical Laboratories, Inc. (FL)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Damon Clinical Laboratories, Inc. (MA) &#8211; Connecticut locations</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Damon Clinical Laboratories, Inc. (PA)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Damon Clinical Laboratories, Inc. (TX) &#8211; Kansas and Missouri locations</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Damon Corporation</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Health Care Laboratories, Inc.</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Damon Clinical Laboratories, an Illinois general partnership</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">March 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damon Clinical Laboratories, Inc. (AZ)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">April 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damon Clinical Laboratories, Inc. (TX) &#8211; All locations other than Kansas and Missouri</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">April 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damon Clinical Laboratories &#8211; Houston, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">April 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">New York Damon Clinical Laboratories, Inc.</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">April 1, 1994</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Damon Clinical Laboratories, Inc. (MA) &#8211; All locations other than Connecticut</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">**</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">May 1, 1994</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Damon Clinical Laboratories &#8211; Pittsburgh, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:0.25pt solid #000000;border-right:1.5pt double #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">June 1, 1994</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;As of January 1, 1994, individuals who had been employed with these entities became employees of MetWest Inc., but continued to participate in the Damon Plan through March&#160;31, 1994.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;As of January 1, 1994, individuals who had been employed with this entity became employees of MetPath New England Inc., but continued to participate in the Damon Plan through April 30, 1994.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E.&#160;&#160;&#160;&#160;PRE-2014 SERVICE UNDER CONVERGE PLAN</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.&#160;&#160;&#160;&#160;The following definitions applied to the Converge Plan and may need to be referenced in the current administration of the Plan.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Hour of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> &#8211; Prior to January 1, 2014&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)&#160;&#160;&#160;&#160;each hour for which an Employee is directly or indirectly compensated or entitled to compensation by the Employer for the performance of duties (these hours to be credited to the Employee for the computation period in which the duties are performed)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;each hour for which an Employee is directly or indirectly compensated or entitled to compensation by the Employer (irrespective of whether the employment relationship has terminated) for reasons other than performance of duties (such as vacation, holidays, sickness, jury </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-17</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">duty, disability, lay-off, military duty or leave of absence) during the applicable computation period (these hours will be calculated and credited pursuant to Regulation &#167;2530.200b-2, incorporated herein by reference)&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)&#160;&#160;&#160;&#160;each hour for which back pay is awarded or agreed to by the Employer without regard to mitigation of damages (these hours to be credited to the Employee for the computation period(s) to which the award or agreement pertains rather than the computation period in which the award, agreement or payment is made).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The same Hours of Service shall not be credited both under (1) or (2), as the case may be, and under (3).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding the above&#58;  (a) no more than 501 Hours of Service were required to be credited to an Employee on account of any single continuous period during which the Employee performs no duties (whether or not such period occurs in a single computation period)&#59; (b) an hour for which an Employee was directly or indirectly paid, or entitled to payment, on account of a period during which no duties were performed is not required to be credited to the Employee if such payment was made or due under a plan maintained solely for the purpose of complying with applicable worker&#8217;s compensation, or unemployment compensation or disability insurance laws&#59; and (c) Hours of Service are not required to be credited for a payment which solely reimburses an Employee for medical or medically-related expenses incurred by the Employee.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of this definition, a payment is deemed to be made by or due from the Employer regardless of whether such payment is made by or due from the Employer directly or indirectly through, among others, a trust fund or insurer to which the Employer contributes or pays premiums, and regardless of whether contributions made or due to the trust fund, insurer or other entity are for the benefit of particular Employees or are on behalf of a group of Employees in the aggregate.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A period of Qualified Military Service shall be included with Hours of Service to the extent it has not already been credited.  For purposes of crediting Hours of Service during a period of Qualified Military Service, an Hour of Service shall be credited for each hour such Employee would normally have been scheduled to work for the Employer or an Affiliate during such period.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding the preceding provisions of this definition, if an Employer does not maintain records that accurately reflect actual Hours of Service creditable to an Employee </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-18</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">hereunder, such Employee will be credited with 45 Hours of Service for each week he performs at least one Hour of Service.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of this definition, Hours of Service will be credited for employment with nonparticipating Affiliates for eligibility and vesting purposes.  The provisions of Regulation &#167;&#167;2530.200b-2(b) and (c) are incorporated herein by reference.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">One-Year Break in Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> &#8211; Prior to January 1, 2014&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)&#160;&#160;&#160;&#160;A 12-consecutive month computation period (as defined under the definition of a Year of Vesting Service) in which the Employee does not complete at least 501 Hours of Service.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;Any period of unpaid leave pursuant to the Family and Medical Leave Act of 1993 or certain circumstances related to the Qualified Military Service of a family member shall not be treated or counted toward a One-Year Break in Service.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)&#160;&#160;&#160;&#160;Solely for determining whether a One-Year Break in Service has occurred in a computation period for participation and vesting purposes, an individual who is absent from work for maternity or paternity reasons or for Qualified Military Service will receive credit for the Hours of Service which would otherwise have been credited to such individual.  In the event these hours cannot be determined, eight (8) Hours of Service per day will be used.  For purposes of this paragraph, an absence from work for maternity or paternity reasons means an absence&#58;  (a) by reason of the pregnancy of the individual&#59; (b)&#160;by reason of the birth of a child of the individual&#59; (c) by reason of the placement of a child with the individual in connection with the adoption of the child by such individual&#59; or (d) for purposes of caring for the child for a period beginning immediately following such birth or placement.  However, in no event will the hours treated as Hours of Service under this paragraph by reason of any absence from work for maternity or paternity reasons exceed 501 hours.  The Hours of Service credited under this paragraph will be credited&#58;  (i) in the computation period in which the absence begins if the crediting is necessary to prevent a One-Year Break in Service in that period&#59; or (ii) in all other cases, in the following computation period.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Conversion of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.&#160;&#160;&#160;&#160;The following rules apply to the conversion from an hours of service method to an elapsed time method that became effective on January 1, 2014, and may need to be referenced in the current administration of the Plan&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)&#160;&#160;&#160;&#160;The Converge Plan determined Vesting Service under an Hours of Service counting methodology.  If a Participant was participating in the Converge Plan during the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-19</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Plan Year beginning January 1, 2013, had at least 1,000 Hours of Service for vesting purposes during the Plan Year beginning January 1, 2013 and also had a Year of Vesting Service (under the elapsed time method) with respect to the year beginning on the anniversary of his Employment Commencement Date occurring in 2014, such Participant shall be credited with two Years of Vesting Service for the period from January 1, 2013 through the anniversary of his Employment Commencement Date occurring in 2014.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;The Converge Plan determined Eligibility Service under an Hours of Service counting methodology.  If an Employee under the Converge Plan had at least 1,000 Hours of Service for eligibility purposes during the Plan Year beginning January 1, 2013 and also had 12 months Service (under the elapsed time method) with respect to the year beginning on the anniversary of his Employment Commencement Date occurring in 2014, such Participant shall be credited with 24 months of Eligibility Service for the period from January 1, 2013 through the anniversary of his Employment Commencement Date occurring in 2014.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B-20</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX C<br><br>PRE-2009 AMP PLAN, AMP PLAN AND AMP MERGED PLANS&#58;<br>SPECIAL RULES AND PROTECTED BENEFITS</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;PRE-2009 AMP PLAN</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)&#160;&#160;&#160;&#160;Rules regarding the crediting of service under The 401(k) Savings Plan of Quest Diagnostics Incorporated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">AMP Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) as in effect through December 31, 2008, and the conversion which occurred as of January 1, 2009 from an hour-of-service-based service crediting method under the AMP Plan as in effect through December 31, 2008 to an elapsed-time-based service crediting method under the AMP Plan, can be found in subsection C below.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;A Participant in the AMP Plan as in effect through December 31, 2008 has a vested percentage in the balance of Matching Contributions (and earnings or losses thereon) made to his Account under the AMP Plan with respect to Plan Years before 2009 determined in accordance with the following schedule&#58;</font></div><div style="margin-bottom:6pt;padding-left:95.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.256%"><tr><td style="width:1.0%"></td><td style="width:49.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Years of Vesting Service</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Vested Interest</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 1 year</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1 but less than 2 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">20%</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2 but less than 3 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">40%</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 but less than 4 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">60%</font></td></tr><tr><td colspan="3" style="border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4 but less than 5 years</font></td><td colspan="3" style="border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">80%</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 or more years</font></td><td colspan="3" style="border-bottom:1.5pt double #000000;border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)&#160;&#160;&#160;&#160;Participants in the AMP Plan as in effect through December 31, 2008 will become 100% vested in their pre-2009 AMP Plan Account if they are employed by Quest Diagnostics or an Affiliate when they attain age 59&#189;.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)&#160;&#160;&#160;&#160;Participants in the AMP Plan as in effect through December 31, 2008 may elect at any time to withdraw all or part of the portion of their rollover contributions sub-account that was established prior to 2009 under the AMP Plan.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;AMP MERGED PLANS AND MERGER DATES</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For purposes of this Appendix C, the following definitions apply&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">AMP Merged Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">. &#8211; The Anatomic Pathology Associates Plan, the Chappell-Joyce Plan, the Jill A. Cohen, M.D., P.C. Plan, the Pathology Affiliated Services Plan, the Pathology </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C-1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Associates, P.C. Plan, the Pathology Associates, P.S.C. Plan, and the Specialty Laboratories Plan, either individually or collectively as the case may be.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Merger Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The date as of which an AMP Merged Plan was merged into the AMP Plan.  The Merger Date for each AMP Merged Plan is set forth in the table below.</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:77.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#a6a6a6;border-left:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">NAME OF AMP MERGED PLAN</font></td><td colspan="3" style="background-color:#a6a6a6;border-left:1.5pt double #000000;border-right:1.5pt double #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">MERGER DATE</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1.5pt double #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Chappell-Joyce Pathology Association, P.A. Profit Sharing Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:1.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 2001</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Pathology Associates, P.S.C. Retirement Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 2002</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Reference Pathology Services Profit Sharing 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 2003</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Anatomic Pathology Associates Retirement Savings Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 2005</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Pathology Associates, P.C. Incentive Savings Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">May 1, 2005</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Specialty Laboratories, Inc. 401(k) Profit Sharing Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">January 1, 2007</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Jill A. Cohen, M.D., P.C. 401(k) Profit Sharing Plan and Trust</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">March 1, 2007</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Pathology Affiliated Services, Inc. Employees&#8217; 401(k) Profit Sharing Plan and Trust</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">February 22, 2010</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;GRANDFATHERED PROVISIONS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The following provisions supplement the corresponding Sections of Articles V and VI&#58;  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Each Eligible Employee who was eligible to participate in an AMP Merged Plan (as listed above) immediately prior to the respective effective date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Merger Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) (as listed above) of the merger of such AMP Merged Plan into the AMP Plan was eligible to participate in the AMP Plan on and after that Merger Date.  A Participant&#8217;s vested interest in his Account attributable to amounts transferred into the AMP Plan from an AMP Merged Plan on and after the respective Merger Date will not be less, as a result of such merger, than his vested interest in his account under the AMP Merged Plan immediately prior to the respective Merger Date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">If an AMP Merged Plan determined Eligibility Service or Vesting Service, respectively, under an hours counting methodology, then Eligibility Service or Vesting Service, respectively, shall be determined under rules promulgated by the Benefits Administration Committee applied in a uniform and nondiscriminatory manner, and to the extent permitted by applicable law, but not less than that determined under the methodology, hours counting or elapsed time, whichever results in the greater Eligibility Service or Vesting Service, respectively.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The Employee Pre-Tax Contributions Account of a Participant who was a participant in an AMP Merged Plan that contained a qualified cash or deferred arrangement also shall hold any amount transferred to the AMP Plan from such AMP Merged Plan representing the balance of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C-2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">such Participant&#8217;s pre-tax contribution account under such AMP Merged Plan and the investment experience, expenses, distributions and withdrawals attributable to such account.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Notwithstanding any other provision of the Plan to the contrary, the following shall apply with respect to benefits accrued by Participants who were participants in the AMP Merged Plans listed below&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1)&#160;&#160;&#160;&#160;Definitions for Purposes of Appendix C</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)&#160;&#160;&#160;&#160;&#8220;Early Retirement Date&#8221; means, with respect to a former participant in the Jill A. Cohen, M.D., P.C. Plan, the later of age 55 or the date he completes ten (10) years of service.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;&#8220;Prior Company Contributions&#8221; means the prior company contributions attributable to assets transferred to the AMP Plan from the Anatomic Pathology Associates Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)&#160;&#160;&#160;&#160;&#8220;Prior Employer Discretionary Contributions&#8221; means the prior Employer Discretionary Contributions attributable to assets transferred to the AMP Plan from the Pathology Associates, P.C. Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)&#160;&#160;&#160;&#160;&#8220;Prior Employer Matching Contributions&#8221; means the prior Employer Matching Contributions attributable to assets transferred to the AMP Plan from the Pathology Affiliated Services Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)&#160;&#160;&#160;&#160;&#8220;Prior Safe Harbor Nonelective Contribution&#8221; means any safe harbor nonelective employer contribution which was made under the Jill A. Cohen, M.D., P.C. Plan and transferred to the AMP Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)&#160;&#160;&#160;&#160;&#8220;Prior Specialty Laboratories Contribution&#8221; means any matching or employer nonelective contribution which was made under the terms of the Specialty Laboratories Plan and transferred to the AMP Plan.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2)&#160;&#160;&#160;&#160;Vesting in Employer Contributions</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)&#160;&#160;&#160;&#160;A former participant in the Jill A. Cohen, M.D., P.C. Plan at all times shall have a 100% vested percentage in his Prior Employer Safe Harbor Nonelective Contributions.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;A former participant in the Anatomic Pathology Associates Plan at all times shall have a 100% vested interest in his Prior Company Contributions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C-3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)&#160;&#160;&#160;&#160;A former participant in the Pathology Affiliated Services Plan or the Pathology Associates, P.C. Plan shall have his vested interest in his Prior Employer Discretionary Contributions or his Prior Employer Matching Contributions, respectively, determined in accordance with the following schedule&#58;</font></div><div style="padding-left:113.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.974%"><tr><td style="width:1.0%"></td><td style="width:55.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Years of Vesting Service</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Vested Percentage</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 2 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2 but less than 3 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">20%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 but less than 4 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">40%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4 but less than 5 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">60%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 but less than 6 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">80%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">6 or more years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)&#160;&#160;&#160;&#160;A former participant in the Specialty Laboratories Plan who had completed three (3) or more years of vesting service under such plan as of December&#160;31, 2006 and who enrolled in the AMP Plan on or after January 1, 2007, at all times shall have a 100% vested interest in his Prior Specialty Laboratories Contributions.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)&#160;&#160;&#160;&#160;Subject to the foregoing paragraph (d), a former participant in the Specialty Laboratories, Inc. 401(k) Profit Sharing Plan, who had not completed three (3) or more years of vesting service under such plan as of December 31, 2006 or who had completed three (3) or more years of vesting service under such plan as of December 31, 2006, but does not enroll in the AMP Plan or this Plan on or after January 1, 2007, shall have his vested interest in his Prior Specialty Laboratories Contributions determined in accordance with the following schedule&#58;</font></div><div style="padding-left:113.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.974%"><tr><td style="width:1.0%"></td><td style="width:55.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Years of Vesting Service</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%;text-decoration:underline">Vested Percentage</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 1 year</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1 but less than 2 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">20%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">2 but less than 3 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">40%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">3 but less than 4 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">60%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">4 but less than 5 years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">80%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">5 or more years</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The provisions of Section 5.5 in the main text apply to Employer Discretionary Contributions (if any) made after 2008 under the AMP Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(g)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, if a Participant is employed by an Employer or an Affiliate on his Normal Retirement Date, his Early Retirement Date (applicable only to former </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C-4</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">participants in the Jill A. Cohen, M.D., P.C. Plan), the date of determination of his Total and Permanent Disability or the date he dies, he shall be 100% vested in his Prior Employer Discretionary Contributions and his Prior Employer Matching Contributions respectively.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(h)&#160;&#160;&#160;&#160;Notwithstanding the preceding, a Participant shall be 100% vested in his entire AMP Plan Account after his attainment of age 65.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;OTHER SUB-ACCOUNTS</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">A Participant in this Plan also may have additional sub-accounts including, but not limited to, the preceding and those listed in Appendix D.  All benefits, rights and features that are required to be preserved with respect to such sub-accounts under Code Section 411(d)(6) shall be preserved including, but not limited to, rights to in-service withdrawals, rights to annuity or other optional forms of distribution and the requirement, where applicable, of spousal consent to distributions, loans or in-service withdrawals.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C-5</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_19"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX D<br><br>SUB-ACCOUNTS FROM PRE-2016 PLAN AND MERGED PLANS,<br>AND SUB-ACCOUNTS TRANSFERRED FROM THE AMP PLAN</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;The Sub-Accounts maintained with respect to Participants who participated in a Merged Plan (other than the AMP Plan, addressed in B. below) or in the Plan as in effect before 2016 (unless aggregated with another Sub-Account having the same characteristics and privileges) include, but are not limited to, the following&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)&#160;&#160;&#160;&#160;Advance Medical Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;AML-East Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)&#160;&#160;&#160;&#160;AML-West Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)&#160;&#160;&#160;&#160;CBCLS Employer Contribution Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)&#160;&#160;&#160;&#160;CDS Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)&#160;&#160;&#160;&#160;Celera Plan BHL Match Sub-Account</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(g)&#160;&#160;&#160;&#160;Celera Plan Match Sub-Account</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(h)&#160;&#160;&#160;&#160;Prior Plan Roth Sub-Account</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(i)&#160;&#160;&#160;&#160;Corning Stock Fund Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(j)&#160;&#160;&#160;&#160;Covance Stock Fund Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(k)&#160;&#160;&#160;&#160;CPF Money Purchase Pension Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(l)&#160;&#160;&#160;&#160;CPF Pension Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(m)&#160;&#160;&#160;&#160;CPF Savings Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(n)&#160;&#160;&#160;&#160;Damon Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(o)&#160;&#160;&#160;&#160;DeYor Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(p)&#160;&#160;&#160;&#160;Employee After-Tax Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(q)&#160;&#160;&#160;&#160;Employee Pre-Tax Catch-Up Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(r)&#160;&#160;&#160;&#160;Employee Regular Pre-Tax Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(s)&#160;&#160;&#160;&#160;Employer Matching Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(t)&#160;&#160;&#160;&#160;Quest Stock Matching Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(u)&#160;&#160;&#160;&#160;ESOP Diversification Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(v)&#160;&#160;&#160;&#160;LabOne (k) Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(w)&#160;&#160;&#160;&#160;LabOne Pension Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(x)&#160;&#160;&#160;&#160;LabPortal Plan Sub-Account&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D-1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(y)&#160;&#160;&#160;&#160;Maryland Medical Laboratory Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(z)&#160;&#160;&#160;&#160;MedPlus Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(aa)&#160;&#160;&#160;&#160;MetWest Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(bb)&#160;&#160;&#160;&#160;Money Purchase Pension Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(cc)&#160;&#160;&#160;&#160;Nichols Institute Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(dd)&#160;&#160;&#160;&#160;Partnership Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ee)&#160;&#160;&#160;&#160;Podiatric Pathology Laboratories Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ff)&#160;&#160;&#160;&#160;Post-1999 Cash Match Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(gg)&#160;&#160;&#160;&#160;Post-1999 Stock Match Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(hh)&#160;&#160;&#160;&#160;Pre-1999 Cash Match Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ii)&#160;&#160;&#160;&#160;Pre-1999 Stock Match Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(jj)&#160;&#160;&#160;&#160;Prior Employer Match Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(kk)&#160;&#160;&#160;&#160;Prior ESOP Employer Contributions Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ll)&#160;&#160;&#160;&#160;Prior ESOP Quest Stock Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(mm)&#160;&#160;&#160;&#160;Prior Focus Plan Match Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(nn)&#160;&#160;&#160;&#160;Prior LabOne Money Purchase Pension Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(oo)&#160;&#160;&#160;&#160;Prior LabOne Employer Match Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(pp)&#160;&#160;&#160;&#160;Prior Plan Employer Contribution Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(qq)&#160;&#160;&#160;&#160;Prior Plan Employer Qualified Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(rr)&#160;&#160;&#160;&#160;Prior Plan Rollover Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ss)&#160;&#160;&#160;&#160;Prior Profit Sharing Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(tt)&#160;&#160;&#160;&#160;Prior Unilab Employer Contribution Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(uu)&#160;&#160;&#160;&#160;Qualified Nonelective Contribution Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(vv)&#160;&#160;&#160;&#160;Rollover Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ww)&#160;&#160;&#160;&#160;Statlab Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(xx)&#160;&#160;&#160;&#160;Unilab Plan Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(yy)&#160;&#160;&#160;&#160;Vested Employer Stock Dividend Sub-Account&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(zz)&#160;&#160;&#160;&#160;Vested Money Purchase Pension Plan Dividend Sub-Account&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(aaa)&#160;&#160;&#160;&#160;Converge Plan employer nonelective and employer matching (post-2010 hires) Sub-Account&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(bbb)&#160;&#160;&#160;&#160;Solstas Plan employer nonelective and pre-2011 matching contributions Sub-Account&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D-2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ccc)&#160;&#160;&#160;&#160;Solstas Plan 2011 and 2012 employer matching contributions Sub-Account&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ddd)&#160;&#160;&#160;&#160;Solstas Plan post-2012 employer matching contributions Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(eee)&#160;&#160;&#160;&#160;Carilion Plan Transfer Nonelective Sub-Account&#59; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(fff)&#160;&#160;&#160;&#160;Medex Transfer Matching Sub-Account&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ggg)&#160;&#160;&#160;&#160;Medex Transfer Nonelective Sub-Account if such former Medex Employee has an Hour of Service after January 1, 2007&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(hhh)&#160;&#160;&#160;&#160;Medex Transfer Nonelective Sub-Account if such former Medex Employee does not have an Hour of Service after January 1, 2007&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Medex Highlands Transfer Sub-Account&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(jjj)&#160;&#160;&#160;&#160;DLI Plan Sub-Account&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(kkk)&#160;&#160;&#160;&#160;Carilion Plan Transfer Matching Sub-Account&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(lll)&#160;&#160;&#160;&#160;Oracle Diagnostic Laboratories, Inc. Transfer Sub-Account&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(mmm)&#160;&#160;&#160;&#160;Hayes Clinical Laboratory Transfer Sub-Account&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(nnn)&#160;&#160;&#160;&#160;Prior money purchase pension plan contributions under the Solstas Plan Sub-Account&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(ooo)&#160;&#160;&#160;&#160;Summit Plan employer matching and nonelective contributions Sub-Account. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;In the case of a pre-2016 participant in the AMP Plan, all applicable sub-accounts of such individual under the AMP Plan, including those arising from an AMP Merged Plan or the AMP Plan as in effect through December 31, 2008, generally will continue to be maintained under this Plan unless aggregated with another sub-account having the same characteristics and privileges.  In addition to the Sub-Accounts listed above, such sub-accounts may include, but are not limited to, the following&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(aaaa)&#160;&#160;&#160;&#160;Prior Company Contributions Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(bbbb)&#160;&#160;&#160;&#160;Prior Employer Discretionary Contributions Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(cccc)&#160;&#160;&#160;&#160;Prior Employer Matching Contributions Sub-Account&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(dddd)&#160;&#160;&#160;&#160;Prior Safe Harbor Nonelective Contributions Sub-Account&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(eeee)&#160;&#160;&#160;&#160;Prior Specialty Laboratories Contribution Sub-Account.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;All benefits, rights and features that are required to be preserved with respect to such sub-accounts under Code Section 411(d)(6) shall be preserved following such transfer including, but not limited to, rights to in-service withdrawals, rights to annuity or other optional forms of distribution and the requirement, where applicable, of spousal consent to distributions, loans or in-service withdrawals.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D-3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_22"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX E<br><br>CELERA PLAN AND SOLSTAS PLAN ROTH CONTRIBUTION SUB-ACCOUNTS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The following provisions apply to Roth contribution sub-accounts under a plan that merged into the Celera 401(k) Plan, which merged into the Plan as of May 31, 2012 and under the Solstas Plan, which merged into the Plan as of February 17, 2015.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;The following definitions apply for purposes of this Appendix E&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Designated Roth Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221; means contributions made for the account of a participant in the Celera Plan or the Solstas Plan that were irrevocably designated by the participant as Roth contributions subject to Code Section 402A.  A portion of a Celera Plan participant&#8217;s or a Solstas Plan participant&#8217;s Designated Roth Contributions may consist of Roth catch-up contributions under Code Section 414(v).</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Roth Rollover Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221; means a direct rollover from a Roth elective deferral account under an applicable retirement plan described in Code Section 402A(e)(1) or, in the case of a contribution by a participant in the Celera Plan or the Solstas Plan and solely if made in accordance with procedures established by the Celera plan or by the Solstas Plan, as applicable, from a Roth IRA described in Code Section 408A but only to the extent the distribution from such Roth IRA was eligible for rollover to a qualified plan.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;Subsection (a) of Section 4.1 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) is modified as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Separate sub-accounts shall be maintained for each Celera Plan or Solstas Plan participant to which shall be recorded pertinent data relating to the amount of contributions made on his behalf under the plan that merged into the Celera Plan or made on his behalf under the Solstas Plan which were Designated Roth Contributions and the amount of his rollover contributions which were Roth Rollover Contributions.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;No &#8220;Roth conversions&#8221; were permitted under the Celera Plan or the Solstas Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">E-1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_25"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX F<br><br>SURVIVOR ANNUITY DISTRIBUTION PROVISIONS</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">The provisions of this Appendix F apply to only a Participant who has a portion of his Account attributable to the Money Purchase Pension Plan Sub-Account, the Vested Money Purchase Pension Plan Dividend Sub-Account or any other sub-account attributable to a money purchase pension plan as indicated in Appendix B, Appendix C or Appendix D (or his Account includes assets transferred directly, or merged, from a plan subject to Code Section 417).  The annuity provisions of this Appendix F applies only to such portion of his Account (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">QJSA Portion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8221;) and may be waived through a &#8220;Qualified Election&#8221; described in paragraph (c) below.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">For these purposes, the following definitions apply&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Money Purchase Pension Plan Sub-Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; The portion of the Account of a Participant who was a participant in a money purchase pension plan that was a predecessor to or merged into the Plan or the AMP Plan, or that merges into this Plan.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Vested Money Purchase Pension Plan Dividend Sub-Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> &#8211; Under Section 6.5(b), the portion of a Participant&#8217;s Account comprised of cash dividends received under the Quest Diagnostics Incorporated Stock Fund associated with a portion of the Participant&#8217;s Money Purchase Pension Plan Sub-Account (or any other sub-account attributable to a money purchase pension plan as indicated in Appendix B, Appendix C or Appendix D or to assets transferred directly, or merged, from a plan subject to Code Section 417) that is not fully vested.  A Participant always has a 100% vested percentage in his Vested Money Purchase Pension Plan Dividend Sub-Account.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Automatic and Optional Annuity Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.  If a Participant has a QJSA Portion, distribution of his QJSA Portion shall be made through the purchase of an annuity contract that provides for payment in one of the following annuity forms unless he elects a different form of payment available under Section 5.6&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)&#160;&#160;&#160;&#160;The &#8220;automatic annuity form&#8221; for a Participant who is married on his Benefit Payment Date is a 50% Qualified Joint and Survivor Annuity.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;The &#8220;optional annuity form&#8221; for a Participant who is married on his Benefit Payment Date is a 75% Qualified Joint and Survivor Annuity.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">F-1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)&#160;&#160;&#160;&#160;The &#8220;automatic annuity form&#8221; for a Participant who is not married on his Benefit Payment Date is a Single Life Annuity.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">His election of any form of payment other than the &#8220;automatic annuity form&#8221; shall not be effective unless it is a &#8220;qualified election&#59;&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> that consent of his spouse shall not be required if he elects the &#8220;optional annuity form&#8221; of (2) above.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Qualified Preretirement Survivor Annuity Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.  If a married Participant with a QJSA Portion dies before his Benefit Payment Date, his spouse shall receive distribution of his vested interest in the QJSA Portion through the purchase of an annuity contract that provides for payment over the life of the spouse unless his spouse elects to receive distribution under another form of payment available under Section 5.6.  Such Participant may designate a non-spouse Beneficiary to receive distribution of his QJSA Portion only pursuant to a &#8220;qualified election&#8221; unless his spouse has previously consented to the naming of such non-spouse Beneficiary as the sole Beneficiary of his QJSA Portion.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Qualified Election Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)&#160;&#160;&#160;&#160;No less than seven (7) and no more than 180 days before distribution of such a Participant&#8217;s benefit commences, he and his spouse (if any) shall be given a written notice to the effect that if he is married on the date of commencement of payments, benefits will be payable in form of a 50% (or 75%) Qualified Joint and Survivor Annuity under this Appendix unless he, with the consent of his spouse, elects to the contrary prior to the commencement of payments.  Spousal consent is not required for an election if the Beneficiary is not the spouse.  The notice shall describe, in a manner intended to be understood by him and his spouse, the terms and conditions of the Qualified Joint and Survivor Annuity, the financial effect of the election of an optional form or to revoke such an election, and the rights of the spouse to consent to an election of an optional form.  In addition, the notice shall inform him that he has 30 days to elect whether to have benefits paid in an optional form described in Section 5.6 in lieu of the automatic form provided for in paragraph (b) above.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;A Participant may elect, through an Appropriate Request, to have his QJSA Portion paid in a lump sum under Section 5.6 or in one of the options under subsection (d) below.  His election to receive his benefit in a lump sum under Section 5.6 or in an option provided under subsection (d) may be revoked by him at any time, and any number of times, during the 180-day period ending on the day his benefit payments </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">F-2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">commence.  After benefit payments have commenced, no elections or revocations of an optional method of distribution will be permitted under any circumstances.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)&#160;&#160;&#160;&#160;The date payment of his benefit is to commence for a distribution in a form other than the 50% (or 75%) Qualified Joint and Survivor Annuity under this Appendix may be less than 30 days after receipt of the written notice described above if&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)&#160;&#160;&#160;&#160;he has been provided with information that clearly indicates that he has at least 30 days to consider whether to waive the 50% (or 75%) Qualified Joint and Survivor Annuity, and elects (with written consent of his spouse, if necessary) another form of distribution&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)&#160;&#160;&#160;&#160;he is permitted to revoke any affirmative distribution election at least until the Benefit Payment Date or, if later, at any time prior to the expiration of the seven (7) day period that begins the day after he is provided the explanation of the 50% (or 75%) Qualified Joint and Survivor Annuity&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)&#160;&#160;&#160;&#160;the date payment of his benefit is to commence is a date after the date that the written notice was provided to him.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Optional Forms</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)&#160;&#160;&#160;&#160;An annuity contract, purchased from an insurance company (or similar source) by the Investment Committee, utilizing the value of the vested portion of the Participant&#8217;s QJSA Portion, which provides for equal monthly payments over his lifetime and which contains such other terms and provisions required under applicable Regulations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;An annuity contract, purchased from an insurance company (or similar source) by the Investment Committee, utilizing the value of the vested portion of the Participant&#8217;s QJSA Portion, which provides for equal monthly payments over his lifetime and for such monthly payments (or one-half (&#189;) or three-quarters (&#190;) thereof) to be continued after his death to his Beneficiary over the lifetime of the Beneficiary.  If his Beneficiary is not living at the time of his death, no additional benefit shall be payable hereunder.  Such annuity contract shall contain such other terms and provisions required under applicable Regulations.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)&#160;&#160;&#160;&#160;An annuity contract, purchased from an insurance company (or similar source) by the Investment Committee, utilizing the value of the vested portion of the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">F-3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Participant&#8217;s QJSA Portion, which provides for equal monthly payments over his lifetime and in the event of his death before 120 monthly payments have been made, such payments shall be continued to his Beneficiary until the remainder of the 120 monthly payments have been made.  Such annuity contract shall contain such other terms and provisions required under applicable Regulations.  (This option is not available to a Beneficiary.)</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)&#160;&#160;&#160;&#160;Notwithstanding any provision of this Plan to the contrary, to the extent that any optional form of benefit under this Plan permits a distribution prior to the Participant&#8217;s retirement, death, Total and Permanent Disability or Severance from Service Date, and prior to Plan termination, the optional form of benefit is not available with respect to his QJSA Portion, other than any portion of those assets and liabilities attributable to after-tax voluntary Employee contributions or to a direct or indirect rollover contribution.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)&#160;&#160;&#160;&#160;For purposes of this Appendix, the following terms have the following meanings&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(1)&#160;&#160;&#160;&#160;&#8220;Qualified Joint and Survivor Annuity&#8221; means an immediate annuity payable at earliest retirement age under the Plan, as defined in Regulations under Code Section 401(a)(11), that is payable for the life of a Participant with a survivor annuity payable for the life of his spouse that is equal to at least 50% but no more than 100% of the amount of the annuity payable during the joint lives of him and his spouse.  No survivor annuity shall be payable to his spouse under a Qualified Joint and Survivor Annuity if such spouse is not the same spouse to whom he was married on his Benefit Payment Date.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(2)&#160;&#160;&#160;&#160;&#8220;Qualified Pre-Retirement Survivor Annuity&#8221; means an annuity payable for the life of a Participant&#8217;s surviving spouse upon his death prior to his Benefit Payment Date.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(3)&#160;&#160;&#160;&#160;&#8220;Benefit Payment Date&#8221; means&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(A)&#160;&#160;&#160;&#160;the first day of the first period for which an amount is payable as an annuity, as described in Code Section 417(f)(2)(A)(i)&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(B)&#160;&#160;&#160;&#160;in the case of a benefit not payable in the form of an annuity, the starting date for the Qualified Joint and Survivor Annuity that is payable under the Plan at the same time and form as the benefit that is not payable as an annuity&#59;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">F-4</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(C)&#160;&#160;&#160;&#160;in the case of an amount payable under a retroactive annuity starting date, the retroactive annuity starting date&#59; or</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(D)&#160;&#160;&#160;&#160;the date of the purchase of an irrevocable commitment from an insurer to pay the benefits due under the Plan.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">F-5</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_28"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX G<br><br>POST-2015 MERGED PLANS&#58;<br>SPECIAL RULES AND PROTECTED BENEFITS</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.&#160;&#160;&#160;&#160;For purposes of this Appendix G, the following definitions apply&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Merged Plan&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  means a plan which has been merged into this Plan on or after January 1, 2016.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Merger Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  means the date as of which a Merged Plan merged into this Plan.  The Merger Date for each Merged Plan which merged into this Plan on or after January 1, 2016 is set forth in the table below&#58;</font></div><div style="padding-left:62.75pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.961%"><tr><td style="width:1.0%"></td><td style="width:47.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ddd9c4;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%;text-decoration:underline">Name of Merged Plan</font></td><td colspan="3" style="background-color:#ddd9c4;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%;text-decoration:underline">Merger Date</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">med fusion 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">January 18, 2018</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">MedXM 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">March 1, 2019</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Cleveland Heartlab 401(k) Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">May 2, 2019</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ReproSource, Inc. 401(k) Retirement Plan</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">July 25, 2019</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">PhenoPath Laboratories 401(k) Plan</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">August 1, 2019</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">          ADD&#58; Mid America Clinical Laboratories 401(k) Plan</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;The subaccounts maintained with respect to Participants who participated in a Merged Plan (unless aggregated with another sub-account having the same characteristics and privileges) include, but are not limited to, the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Prior Plan Roth Sub-Account consisting of contributions made on behalf of a Participant to a Merged Plan indicated below that the Participant irrevocably designated as Roth contributions subject to Code Section 402A, including any Roth catch-up contributions under Code Section 414(v), and any Roth rollover contributions, to the&#58;</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;med fusion 401(k) Plan.</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;MedXM 401(k) Plan.</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Cleveland Heartlab 401(k) Plan.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;ReproSource, Inc. 401(k) Retirement Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">G-1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;PhenoPath Laboratories 401(k) Plan.</font></div><div style="margin-bottom:12pt;padding-left:31.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C.&#160;&#160;&#160;&#160;Special Provisions and Protected Benefits</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(a)&#160;&#160;&#160;&#160;med fusion 401(k) Plan</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;A Participant who was a med fusion 401(k) Plan participant shall be 100% vested in the sub-accounts that were transferred to this Plan upon the merger of the med fusion 401(k) Plan into this Plan.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;A Participant who was a med fusion 401(k) Plan participant may make an in-service withdrawal from his med fusion 401(k) Plan sub-accounts that were transferred to this Plan upon the merger of the med fusion 401(k) Plan into this Plan if he is determined to be Totally and Permanently Disabled.&#8221;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(b)&#160;&#160;&#160;&#160;MedXM 401(k) Plan</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;None </font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(c)&#160;&#160;&#160;&#160;Cleveland Heartlab 401(k) Plan</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;A Participant who was a Cleveland Heartlab 401(k) Plan participant shall be subject to a 2-year cliff vesting schedule, on an elapsed time basis, with respect to his QACA match sub-account that was transferred to this Plan upon the merger of the Cleveland Heartlab 401(k) Plan into this Plan.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(d)&#160;&#160;&#160;&#160;ReproSource, Inc. 401(k) Retirement Plan</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;A Participant who was a ReproSource, Inc. 401(k) Retirement Plan participant shall be 100% vested in the sub-accounts that were transferred to this Plan upon the merger of the ReproSource, Inc. 401(k) Retirement Plan into this Plan.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(e)&#160;&#160;&#160;&#160;PhenoPath Laboratories 401(k) Plan</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;A Participant who was a PhenoPath Laboratories 401(k) Plan participant, who has attained age 55 and who has completed at least five (5) years of service may make a withdrawal from his employer contribution sub-account that was transferred to this Plan upon the merger of the PhenoPath Laboratories 401(k) Plan into this Plan.  Withdrawn amounts may not be repaid to the Trust Fund.  Within such sub-account, withdrawals shall be charged against the separate Investment Options under such procedures as the Benefits Administration Committee may determine.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;A Participant who was a PhenoPath Laboratories 401(k) Plan participant and who has retired or otherwise terminated employment may make a partial withdrawal of all or any portion of his PhenoPath Laboratories </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">G-2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">401(k) Plan sub-accounts that were transferred to this Plan upon the merger of the PhenoPath Laboratories 401(k) Plan into this Plan.  Withdrawn amounts may not be repaid to the Trust Fund.  Withdrawals shall be charged against the available sub-accounts within the Account in such order as the Benefits Administration Committee may determine.  Within each sub-account, withdrawals shall be charged against the separate Investment Options under such procedures as the Benefits Administration Committee may determine.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">(f)&#160;&#160;&#160;&#160;ADD&#58; Mid America Clinical Laboratories 401(k) Plan </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">G-3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><div id="i4885bbf2d36f4ff7b3d651be4df4c476_31"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX H</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PARTICIPANTS TRANSFERRED FROM <br>HACKENSACK MERIDIAN HEALTH SYSTEM</font></div><div style="margin-bottom:12pt;margin-top:24pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The provisions of this Appendix H shall apply to certain Participants who were formerly employees of Hackensack Meridian Health, Inc., a New Jersey not-for-profit corporation (&#8220;HMH&#8221;). Pursuant to the terms of the Laboratory Management Agreement, dated as of July 2, 2020, and as amended from time to time (the &#8220;LMA&#8221;), between Quest Diagnostic Incorporated (&#8220;QDI&#8221;) and HMH, QDI has agreed to offer to employ each person employed by HMH at one of the Laboratories listed in Exhibit A to the LMA who (i) is not subject to an active performance improvement plan, not on a final written warning , and not subject to disciplinary action for a Level 2 Gross Infraction (as defined in HMH&#8217;s policies) which had been initiated within 12 months prior to January 1, 2021, (ii) satisfies all applicable federal and state laws and regulations, including but not limited to requirements of the Clinical Laboratory Improvement Amendments of 1988, as amended, and related regulations, regarding his or her job duties, (iii) is ready, willing and able to perform the essential functions of his&#47;her job with or without reasonable accommodation as specified in Exhibit I to the LMA&#59; and (iv) satisfactorily completes QDI&#8217;s pre-employment screens and requirements applicable to all QDI employees in the relevant function or having similar job responsibilities. Any such person who accepts an Employer&#8217;s offer of employment, reports for duty, and begins active employment with an Employer either on January 1, 2021, or such later date as may be specified in the LMA, is herein referred to as a &#8220;Transferred Employee.&#8221;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Each Transferred Employee shall be immediately eligible to participate in the Plan upon his or her date of hire by an Employer (the &#8220;Commencement Date&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">The vesting service of each Transferred Employee shall equal the number of years of vesting service to which he or she is entitled under the terms of the retirement plan sponsored by HMH in which he or she is participating immediately prior to the Commencement Date (collectively the &#8220;HMH Plans&#8221;) as of the Commencement Date, plus the period of vesting service to which he or she is entitled pursuant to the terms of the Plan commencing on the Commencement Date. For purposes of the immediately preceding sentence, the number of years of vesting service communicated to QDI by HMH pursuant to Exhibit O to the LMA shall be final and conclusive as to the number of years of vesting service to which the Transferred Employee is entitled under the HMH Plans.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Each Transferred Employee shall be entitled to transfer to the Plan all or any portion of his or her account in the HMH Plan if and only if the amount transferred satisfies the requirements of the Plan for a Rollover Contribution.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">QDI shall make (or cause the applicable Employer to make) additional Employer Contributions (&#8220;Transition Credits&#8221;) to the Accounts of certain Transferred Employees, in amounts equal to the percentage of each such Transferred Employee&#8217;s Deferral Compensation specified in the following table, for the periods described in paragraph (a) below&#58;</font></div><div style="height:59.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">H-1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:38.65pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:71.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.348%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 100.55pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">Transferred Employees</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">Percentage of Deferral <br>Compensation</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.8pt;padding-left:5.4pt;padding-right:16.2pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:126%">Active participants continuing to accrue a benefit under the PMC Active Pension Plan (including union participants) or the HUMC Active Pension Plan as of December 31, 2020</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">2%</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12.3pt;padding-left:5.4pt;padding-right:18pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:125%">Participants in the Carrier Defined Contribution Plan who had an accrued benefit for 2020</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">2%</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:13.5pt;padding-left:5.4pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:126%">Former Meridian Cash Balance Plan participants eligible to receive transition credits under the HMH 401(k) Plan as of December 31, 2020</font></div></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">3%</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%">Such Transition Credits shall be subject to the following provisions&#58;</font></div><div style="margin-bottom:12pt;margin-top:12.35pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(a)&#160;&#160;&#160;&#160;Transition Credits shall be contributed</font></div><div style="margin-top:11.85pt;padding-left:144pt;padding-right:3.6pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:24.69pt">as soon as practical following December 31, 2021, to all Transferred Employees who are employed on December 31, 2021, based on each such Transferred Employee&#8217;s Deferral Compensation paid by an Employer during the period commencing on the Transferred Employee&#8217;s Commencement Date and ending on December 31, 2021&#59; and</font></div><div style="margin-top:12.15pt;padding-left:144pt;padding-right:3.6pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21.36pt">as soon as practical following June 30, 2022, to all eligible Transferred Employees who are employed on June 30, 2022, based on each such Transferred Employee&#8217;s Deferral Compensation paid by an Employer during the period commencing on January 1, 2022 and ending on June 30, 2022.</font></div><div style="margin-bottom:12pt;margin-top:11.85pt;padding-left:108pt;padding-right:3.6pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;A Transferred Employee who is on approved leave of absence in accordance with QDI policy on December 31, 2021, or June 30, 2022, shall be entitled to the Transition Credit payable as of such date, but for avoidance of doubt, a Transferred Employee who has incurred a termination of employment for any reason, including without limitation death, disability, or voluntary or involuntary termination, prior to either of such dates shall not be entitled to any portion of the Transition Credit payable as of such date.</font></div><div style="margin-bottom:12pt;margin-top:12.35pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(c)&#160;&#160;&#160;&#160;Transition Credits shall be fully vested.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Any person who is hired by an Employer and who does not qualify as a Transferred Employee shall be treated as a newly hired employee, and his or her prior service with HMH shall not be taken into account for any purpose.</font></div><div style="margin-bottom:12pt;margin-top:11.85pt;padding-left:90pt;padding-right:18pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="height:59.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">H-2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">141815.2</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>dgx09302021ex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0b51af854ed142808210bca4eb598dbb_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL DEFERRED COMPENSATION PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(POST &#8211; 2004)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED DECEMBER 1, 2020</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="i0b51af854ed142808210bca4eb598dbb_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PREAMBLE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Effective as of January&#160;1, 1999, Quest Diagnostics adopted the Quest Diagnostics Supplemental Deferred Compensation Plan for the benefit of certain of its Employees.  As a result of the enactment in 2004 of Section 409A of the Internal Revenue Code of 1986, as amended, Quest Diagnostics has adopted this document, the Quest Diagnostics Supplemental Deferred Compensation Plan (Post &#8211; 2004), to reflect the terms that will govern amounts that are deferred (within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) under the Plan in taxable years beginning on and after January 1, 2005.  The terms of the Plan as in effect on October 3, 2004 will continue to govern amounts under the Plan that were deferred (within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) during taxable years beginning prior to January 1, 2005.  For these purposes, an amount is considered deferred before January 1, 2005, if before such date, the Participant had a legally binding right to be paid the amount (within the meaning of Treas. Reg. &#167;1.409A-1(b)(1)), and the right to the amount was earned and vested (within the meaning of Treas. Reg. &#167;1.409A-6(a)).  The purpose of the Plan is to provide supplemental retirement income and to permit eligible Employees the option to defer receipt of Compensation, pursuant to the terms of the Plan.  The Plan is intended to be an unfunded deferred compensation plan maintained for the benefit of a select group of management or highly compensated employees under Sections&#160;201(2), 301(a)(3) and 401(a)(1) of ERISA and therefore to be exempt from Parts 2, 3 and 4 of Subtitle B of Title I of ERISA to the maximum extent permissible under the provisions thereof.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Effective December 1, 2020, the sponsor of the Plan is Quest Diagnostics Clinical Laboratories, Inc.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="i0b51af854ed142808210bca4eb598dbb_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 1.&#160;&#160;&#160;&#160;Definitions.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;Definitions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 2.&#160;&#160;&#160;&#160;Participation.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1&#160;&#160;&#160;&#160;Commencement of Participation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;Resumption of Participation Following Reemployment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.3&#160;&#160;&#160;&#160;Change in Employment Status</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">4</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 3.&#160;&#160;&#160;&#160;Contributions.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1&#160;&#160;&#160;&#160;Deferral Contributions.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">5</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2&#160;&#160;&#160;&#160;Participating Employer Contributions.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.3&#160;&#160;&#160;&#160;Transfer of Funds</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">7</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 4.&#160;&#160;&#160;&#160;Participants&#8217; Accounts.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;Individual Accounts</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2&#160;&#160;&#160;&#160;Accounting for Payments</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">8</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 5.&#160;&#160;&#160;&#160;Investment of Contributions.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1&#160;&#160;&#160;&#160;Manner of Investment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.2&#160;&#160;&#160;&#160;Investment Decisions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">9</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 6.&#160;&#160;&#160;&#160;Payment of Account.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1&#160;&#160;&#160;&#160;Payment on Specified Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2&#160;&#160;&#160;&#160;Distribution of Vested Account upon Termination of Employment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3&#160;&#160;&#160;&#160;Distribution upon Death&#59; Beneficiaries</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">10</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.4&#160;&#160;&#160;&#160;Payment Due to an Unforeseen Emergency</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.5&#160;&#160;&#160;&#160;Adjustment for Investment Experience During Installment Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.6&#160;&#160;&#160;&#160;Section 409A and Payment Dates</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.7&#160;&#160;&#160;&#160;Payment in the Event of Taxation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">11</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.8&#160;&#160;&#160;&#160;Valuations</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.9&#160;&#160;&#160;&#160;Spendthrift Provision</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.10&#160;&#160;&#160;&#160;Facility of Payment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.11&#160;&#160;&#160;&#160;Discharge of Obligations</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.12&#160;&#160;&#160;&#160;Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">12</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 7.&#160;&#160;&#160;&#160;Amendment and Termination.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.1&#160;&#160;&#160;&#160;Amendment by Quest Diagnostics</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.2&#160;&#160;&#160;&#160;Retroactive Amendments</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.3&#160;&#160;&#160;&#160;Plan Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">14</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-i-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.4&#160;&#160;&#160;&#160;Payment upon Termination of the Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 8.&#160;&#160;&#160;&#160;The Trust</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.1&#160;&#160;&#160;&#160;Establishment of Trust</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">15</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 9.&#160;&#160;&#160;&#160;Miscellaneous.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1&#160;&#160;&#160;&#160;Limitation of Rights</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.2&#160;&#160;&#160;&#160;Furnishing Information</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.3&#160;&#160;&#160;&#160;Information between the Administrator and Trustee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.4&#160;&#160;&#160;&#160;Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.5&#160;&#160;&#160;&#160;Writings and Electronic Communications</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.6&#160;&#160;&#160;&#160;Governing Law</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.7&#160;&#160;&#160;&#160;Construction</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.8&#160;&#160;&#160;&#160;Section 409A Compliance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">17</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 10.&#160;&#160;&#160;&#160;Plan Administration.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.1&#160;&#160;&#160;&#160;Powers and Responsibilities of the Administrator</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.2&#160;&#160;&#160;&#160;Claims and Review Procedures.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.3&#160;&#160;&#160;&#160;Plan&#8217;s Administrative Costs.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i0b51af854ed142808210bca4eb598dbb_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">20</a></font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-ii-</font></div><div><font><br></font></div></div></div><div id="i0b51af854ed142808210bca4eb598dbb_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Pronouns used in the Plan are in the masculine gender but include the feminine gender unless the context clearly indicates otherwise.  Wherever used herein, the following terms have the meanings set forth below, unless a different meaning is clearly required by the context&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">&#8220;Account&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an account established on the books of a Participant&#8217;s Employer for the purpose of recording Deferral Contributions, Employer Contributions and Supplemental Contributions credited on behalf of a Participant in respect of compensation for services to such Employer and any notional income, expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 10.3), gains or losses related thereto.  For purposes of this Plan document, &#8220;Account&#8221; shall include only amounts that are deferred within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) during taxable years beginning on and after January 1, 2005.  The Administrator may establish such subaccounts as it deems appropriate for the administration of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Administrator&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Benefits Administration Committee and any person or service provider to whom the Benefits Administration Committee has delegated authority.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">&#8220;Appeals Committee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Appeals Committee. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Beneficiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the person or persons entitled under Section&#160;6.3 to receive benefits under the Plan upon the death of a Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">&#8220;Bonus&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the cash bonus that is payable each March (if not deferred pursuant to Section&#160;3.1) under the Senior Management Incentive Plan or the Quest Diagnostics Incorporated Annual Incentive Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">&#8220;Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Internal Revenue Code of 1986, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Compensation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall have the meaning ascribed to the term &#8220;Deferral Compensation&#8221; by the Profit Sharing Plan&#59; provided that any exclusion attributable to (i) deferred compensation deferred pursuant to this Plan or (ii) limits imposed by Code Section 401(a)(17) shall not apply. </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the preceding, with respect to an Eligible Employee whose primary place of employment is outside the United States, Compensation shall exclude such items as housing allowances, educational expenses, trips back and forth to the United States, tax gross-ups and such other similar items of remuneration as may be determined by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Deferral Contributions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means those amounts credited to a Participant&#8217;s Account pursuant to Section&#160;3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.69pt">&#8220;Eligible Employee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an Employee of an Employer who is determined by the Administrator to be among a select group of management or highly compensated Employees and who is designated by the Administrator as an Eligible Employee for purposes of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.69pt">&#8220;Employee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employee of an Employer.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Employer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Quest Diagnostics and any successors and assigns unless otherwise provided herein, and shall include any Related Employer or other affiliated employer adopting this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.69pt">&#8220;Employer Contributions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means amounts credited to a Participant&#8217;s Account pursuant to Section&#160;3.2.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:18.69pt">&#8220;Employer Stock&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any class of common stock of Quest Diagnostics Incorporated or the preferred stock of Quest Diagnostics Incorporated that is convertible into common stock.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;ERISA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Employee Retirement Income Security Act of 1974, as from time to time amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt"> &#8220;Investment Committee&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Quest Diagnostics Investment Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Participant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any Eligible Employee who has filed in accordance with Article&#160;2 an election to defer Compensation pursuant to Section&#160;3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Supplemental Deferred Compensation Plan as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">&#8220;Plan Year&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the calendar year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:23.36pt">&#8220;Profit Sharing Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Profit Sharing Plan of Quest Diagnostics, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.69pt">&#8220;Quest Diagnostics&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Quest Diagnostics Clinical Laboratories, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Quest Diagnostics Incorporated Annual Incentive Plan&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Quest Diagnostics Incorporated Annual Incentive Plan, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Related Employer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employer other than Quest Diagnostics, if Quest Diagnostics and such other employer are members of a controlled group of corporations (as defined in Section&#160;414(b) of the Code) or an affiliated service group (as defined in Code Section&#160;414(m)), or are trades or businesses (whether or not incorporated) which are under common control (as defined in Code Section&#160;414(c)), or such other employer is required to be aggregated with Quest Diagnostics pursuant to regulations issued under Code Section&#160;414(o).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:19.36pt">&#8220;Section&#160;401(a)(17) Limit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the maximum amount of annual compensation that can be taken into account by the Profit Sharing Plan pursuant to Code Section&#160;401(a)(17).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">&#8220;Section 409A Regulations&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the regulations and other administrative guidance issued under Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Senior Management Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Incorporated Senior Management Incentive Plan, as in effect from time to time.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-2-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">&#8220;Signing Bonus&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a bonus that is negotiated with an Employee prior to the commencement of his employment and that is designated a &#8220;signing bonus&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.38pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SMIP Bonus Subaccount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the portion of a Participant&#8217;s Account that may be established and maintained by the Administrator on behalf of each Participant who elects to defer a portion of his Bonus payable under the Senior Management Incentive Plan and any other plan intended to pay performance-based compensation within the meaning of Code Section 162(m)(4)(c).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Supplemental Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an additional discretionary Employer Contribution credited to a Participant&#8217;s Account pursuant to Section&#160;3.2.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(cc)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#8220;Trust&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the trust fund established pursuant to the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Trust Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the agreement establishing the Trust.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ee)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#8220;Trustee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the corporation or individuals named in the Trust Agreement and such successor and&#47;or additional trustees as may be named in accordance with the Trust Agreement.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-3-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">Participation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Commencement of Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Eligible Employee who has an election in effect to defer Compensation in accordance with Section&#160;3.1 or has an Account is a Participant in this Plan.  Each other Eligible Employee shall become a Participant in this Plan after he has timely filed an election to defer Compensation pursuant to Section&#160;3.1 that has become irrevocable or has a Supplemental Contribution credited to his Account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Resumption of Participation Following Reemployment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be an Employee and thereafter returns to the employ of an Employer, he may again become a Participant following his reemployment, provided he is an Eligible Employee and has timely filed an election to defer Compensation pursuant to Section&#160;3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Change in Employment Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any Participant continues in the employ of an Employer but ceases to be an Eligible Employee, he shall continue to be a Participant until the entire amount of the value of his Account is paid&#59; provided, however, he shall not be entitled to make Deferral Contributions or receive an allocation of Employer Contributions or Supplemental Contributions after the end of the Plan Year in which he ceases to be an Eligible Employee and during the remainder of the period that he is not an Eligible Employee.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-4-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">Contributions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Deferral Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Participant deferral elections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Participant may elect to defer (1) up to fifty (50) percent (in whole percentages) of his regular salary to the extent his Compensation that is taken into account under the Profit Sharing Plan for the Plan Year in which his regular salary is earned exceeds the Section&#160;401(a)(17) Limit (no portion of any bonus payment, including the Bonus, shall be eligible for deferral under this provision), (2) up to ninety-five (95) percent (in whole percentages) of his Bonus to the extent his Compensation that is taken into account under the Profit Sharing Plan for the Plan Year in which the Bonus is paid exceeds the Section 401(a)(17) Limit and (3)  up to one hundred (100) percent (in whole percentages) of his Signing Bonus, regardless of whether his Compensation is in excess of the Section 401(a)(17) Limit.              </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Timing of deferral elections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.     </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In general</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An election to defer Compensation will be timely if it is filed in accordance with procedures established by the Administrator which shall require elections to be filed no later than December 31 of the Plan Year prior to the Plan Year to which the deferral election applies. </font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">First year of eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If an individual is designated by the Administrator as an Eligible Employee during the Plan Year, such Employee may file an election to defer Compensation within 30&#160;days following the date of such designation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such Employee is not already participating in another elective nonqualified deferred compensation plan that would be aggregated with this Plan under the Section 409A Regulations, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such election shall apply only to Compensation earned for periods after the election is made in accordance with the Section 409A Regulations.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Effectiveness of deferral election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An election made in accordance with Section 3.1(b)(1), shall become effective on the first day of the Plan Year following the Plan Year in which the deferral election is made. It will apply only to Compensation earned and payable with respect to services rendered after such date.  Thus, for example, an election that becomes irrevocable on December 31, 2009 will apply to defer any salary to be earned in 2010 or a Bonus that will be earned in 2010 and paid in early 2011. An election made in accordance with Section 3.1(b)(2) will apply on the first day of the first payroll period that follows receipt by the Administrator of such election and shall apply to defer Compensation relating to all services performed from the date that it becomes effective through the balance of the Plan Year (unless such election expressly extends beyond such time).  Once an election becomes irrevocable, it will apply to all covered Compensation for services performed through the end of the Plan Year (except as provided in Section 3.1(f)).       </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Commencement of deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:42pt;text-align:justify;text-indent:-42pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Deferrals made pursuant to Sections 3.1(a)(1) and 3.1(a)(2).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  For a Participant who has a deferral election solely under 3.1(a)(1), deferrals shall commence as of the payroll </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-5-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:42pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">period next following the payroll period in which the Participant&#8217;s Compensation exceeds the Section&#160;401(a)(17) Limit.  If a Participant&#8217;s Compensation for a Plan Year exceeds the Section&#160;401(a)(17) Limit on account of payment of Bonus and the Participant has made a deferral election pursuant to Section 3.1(a)(2), then deferrals shall commence as of the payroll period coincident with the payroll period in which the Bonus is paid.    </font></div><div style="margin-bottom:12pt;padding-left:42pt;text-align:justify;text-indent:-42pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Deferrals made pursuant to Sections 3.1(a)(3).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Deferrals of Signing Bonus pursuant to Sections 3.1(a)(3) shall be made in the payroll period in which the Signing Bonus otherwise would have been paid.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Crediting to Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Employer shall credit to the Account maintained on behalf of a Participant the amount of Compensation deferred pursuant to such Participant&#8217;s election under Section 3.1(a).  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">&#91;Intentionally omitted&#93; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Election forms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All Participant elections pursuant to this Section 3.1 shall be on forms prescribed by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Vesting of Deferral Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant shall be fully vested in the Deferral Contributions credited to his Account.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Participating Employer Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Employer Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Employer shall credit an Employer Contribution to the Account maintained on behalf of each Participant who had Deferral Contributions credited to his Account for a payroll period&#59; provided, that such Employer Contributions shall only be credited on Compensation that is in excess of the Section 401(a)(17) Limit.  Notwithstanding the preceding sentence, no Employer Contribution shall be credited to the Account of a Participant who is also a participant in the Quest Diagnostics Transferee Pension Plan for former Corning Incorporated employees.  The amount of the Employer Contribution to be credited on behalf of a Participant shall be equal to the applicable percentage that is specified from time to time in Section&#160;3.2 of the Profit Sharing Plan of the Deferral Contributions made on behalf of the Participant.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Supplemental Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant&#8217;s Employer may, from time to time in its sole discretion, credit a Supplemental Contribution to a Participant&#8217;s Account in an amount determined by such Employer in its sole discretion and without regard to any Deferral Contribution elected by such Participant.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Vesting of Employer Contributions and Supplemental Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall be fully vested in the Employer Contributions credited to his Account.  Unless otherwise specified by the Employer at the time the Supplemental Contribution is made, a Participant shall be fully vested in the Supplemental Contributions credited to his Account.  Any portion of the value of a Participant&#8217;s Account attributable to a Supplemental Contribution that is not fully vested at the time he terminates employment shall be forfeited.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-6-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Transfer of Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator shall provide the Trustee with information on the amount to be credited to each Participant&#8217;s Account.  Each Employer may, as soon as administratively practicable after each payroll period, make a transfer of assets to the Trustee.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-7-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">Participants&#8217; Accounts.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Individual Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator will establish and maintain an Account for each Participant which will reflect Deferral Contributions, Employer Contributions and Supplemental Contributions credited to the Account and any notional earnings, expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 10.3), gains and losses credited thereto attributable to the investments in which the Participant&#8217;s Account is treated as invested. The Administrator will establish and maintain such other accounts and records as it decides in its discretion to be reasonably required or appropriate.  Participants will be furnished statements of their Account value at least once each Plan Year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Accounting for Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A payment to the Participant or to the Participant&#8217;s Beneficiary(ies) shall be charged to the Participant&#8217;s Account as of the date of such payment.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-8-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">Investment of Contributions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Manner of Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All amounts credited to the Accounts of Participants shall be treated as though invested in eligible investments offered by the Investment Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Investment Decisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Investments in which the Accounts of Participants shall be treated as invested shall be directed by the Employer, each Participant, or both, as specified pursuant to procedures established by the Administrator from time to time.  No portion of the Employer Contributions or Deferrals Contributions credited to a Participant&#8217;s Account may be treated as though invested in Employer Stock.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-9-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">Payment of Account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Payment on Specified Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Concurrently with a Participant&#8217;s election to defer Compensation pursuant to Section&#160;3.1 for any Plan Year, the Administrator shall permit a Participant to designate a specific date on which 100% of the value of his Account attributable to such election  shall be paid in a lump sum&#59; provided that in the event of such Participant&#8217;s termination of employment or death before the specified date, his Account shall be paid in accordance with Section&#160;6.2 or 6.3, as the case may be, and his election under this Section 6.1 shall no longer be effective.  Once an election is made pursuant to this Section 6.1, it shall be irrevocable. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Distribution of Vested Account upon Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. (a)   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In general</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Upon a Participant&#8217;s termination of employment other than by reason of death, the vested portion of the Participant&#8217;s Account shall be paid in a lump sum or, if permitted by the Administrator and specified in the Participant&#8217;s election to defer Compensation under Section 3.1, under an installment plan not exceeding 10&#160;years.  Unless otherwise required pursuant to Section 6.6, payments shall be made or begin within ninety (90) days of the Participant&#8217;s employment termination. The unvested portion, if any, of the Participant&#8217;s Account shall be immediately forfeited.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Installments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Distributions under an installment plan must be made in substantially equal annual installments, over a period certain which does not exceed 10&#160;years.  Each installment shall be based on the value of the Participant&#8217;s Account, as determined prior to the payment of the relevant installment, divided by the remaining number of installments.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Distribution upon Death&#59; Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Distributions upon death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon a Participant&#8217;s death prior to the commencement of benefit payments pursuant to Section 6.2, the vested portion of the Participant&#8217;s Account shall be paid in a lump sum to the Participant&#8217;s Beneficiary or Beneficiaries.  Payment shall be made as soon as practicable during the remainder of the calendar year in which the Participant died. The unvested portion, if any, of the Participant&#8217;s Account shall be immediately forfeited. Upon a Participant&#8217;s death after distributions have begun under an installment plan, no further installments shall be paid and, instead, payment shall be made of the balance of the Participant&#8217;s Account as soon as practicable during the remainder of the calendar year in which the Participant died.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.02pt">Beneficiary designations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant may designate a Beneficiary or Beneficiaries, or change any prior designation of Beneficiary or Beneficiaries, by giving notice to the Administrator on a form designated by the Administrator.  A Participant&#8217;s spouse must consent to his designation of a Beneficiary other than his spouse.  If more than one person is designated as the Beneficiary, their respective interests shall be indicated on the designation form.  Prior to distribution pursuant to Section 6.3, a copy of the death notice or other sufficient documentation must be filed with and approved by the Administrator.  If upon the death of the Participant there is, in the opinion of the Administrator, no designated Beneficiary for part or all of the value of the Participant&#8217;s Account, such amount will be paid to his surviving spouse or, if none, to his estate (such spouse or estate shall be deemed to be the Beneficiary for purposes of the Plan).  If a Beneficiary dies after payment to such Beneficiary has commenced, but before the full value of the Participant&#8217;s Account has been paid, and, in the opinion of the Administrator, no person has </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-10-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">been designated to receive such remaining balance, then such balance shall be paid to the deceased Beneficiary&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Payment Due to an Unforeseen Emergency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;margin-top:6.15pt;padding-left:52.35pt;padding-right:5.75pt;text-align:justify;text-indent:0.6pt"><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:117%">   </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:117%">A </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">Participant shall not be permitted to withdraw any portion of the value of his Account prior to termination of employment or any date specified pursuant to Section 6.1 (whichever occurs first), except that a Participant may apply to the Administrator, in accordance with procedures specified by the Administrator, to withdraw some or all of the value of his Account if such withdrawal is required on account of a financial hardship resulting from an unforeseen emergency. The Administrator shall establish criteria to determine what constitutes financial hardship that are consistent with the Section 409A Regulations. Withdrawals made on account of financial hardship shall be made in a lump sum, and may include such additional amount as necessary to pay any federal, state, local or foreign income taxes reasonably anticipated to result from the distribution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Adjustment for Investment Experience During Installment Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the total value of a Participant&#8217;s Account is not paid in a single sum, the amount remaining in the Account after the first payment will continue to be treated as invested in accordance with Article 5 and will be subject to adjustment until paid to reflect the income, gains and losses on such deemed investment, as well as any expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 10.3).  Unless otherwise permitted by the Administrator, each installment payment shall reduce each investment of the Participant&#8217;s Account on a pro-rata basis.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Section 409A and Payment Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise permitted under the Section 409A Regulations, all payments shall be made or commence no later than the end of the calendar year in which the applicable payment date occurs or, if later, by the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of the third calendar month following the applicable payment date.   If a Participant is determined to be a &#8220;Specified Employee&#8221; within the meaning of Code Section 409A(a)(2)(B)(i) (pursuant to procedures developed by the Administrator consistent with the Section 409A Regulations), then to the extent required in order to comply with Code Section 409A and the Section 409A Regulations, payments under the Plan to such Participant pursuant to Section 6.2 shall be made or commence after the day following the six month anniversary of the Participant&#8217;s termination of employment, subject to earlier payment upon the Participant&#8217;s death.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Payment in the Event of Taxation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If, for any reason, all or any portion of the value of a Participant&#8217;s Account under this Plan becomes taxable to the Participant prior to receipt, a Participant may petition the Administrator for a payment of that portion of the value of his Account that has become taxable.  Upon the grant of such a petition, a payment shall immediately be made to a Participant in an amount equal to the taxable portion of the value of his Account (which amount shall not exceed the remaining balance of a Participant&#8217;s Account).  If the petition is granted, the tax liability payment shall be made as soon as practicable after the Participant&#8217;s petition is granted in accordance with Treasury Regulation Sections 1.409A-3(j)(4)(vii) and 1.49A-3(j)(4)(xi).</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-11-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Valuations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Article 6, the valuation of a Participant&#8217;s Account shall be determined as of such valuation dates preceding the payment date as may be determined from time to time by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Spendthrift Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant&#8217;s or Beneficiary&#8217;s right to payment under the Plan is not subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, judgment, seizure, alimony or separate maintenance owed by Participant or his Beneficiary or garnishment by creditors of the Participant or his Beneficiary, either voluntarily, involuntarily by operation of law or as a result of property settlement, and any attempt to cause such right to payment to be so subjected will not be recognized, except to such extent as shall be required by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Facility of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event the Administrator determines, on the basis of medical reports or other evidence satisfactory to the Administrator, that the recipient of any benefit payments under the Plan is incapable of handling his affairs by reason of minority, illness, infirmity or other incapacity, the Administrator may make such payments to a person or institution designated by a court which has jurisdiction over such recipient or a person or institution otherwise having the legal authority under State law for the care and control of such recipient.  The receipt by such person or institution of any such payments therefore, and any such payment to the extent thereof, shall discharge the liability of the Employers and the Trust for the payment of benefits hereunder to such recipient.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Discharge of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Payment of the value of an Account under the Plan to a person believed in good faith by the Administrator to be a valid Beneficiary shall fully and completely discharge the Employers from all further obligations under this Plan with respect to the Participant.  Neither the Administrator nor Quest Diagnostics shall be obliged to search for any Participant or Beneficiary beyond the sending of a registered letter to the Participant&#8217;s or Beneficiary&#8217;s last known address.  If the Administrator notifies any Participant or Beneficiary that he is entitled to an amount under the Plan and the Participant or Beneficiary fails to claim such amount or make his location known to the Administrator within one year thereafter, then, except as otherwise required by law, if the location of one or more of the next of kin of the Participant is known to the Administrator, the Administrator may direct payment of such amount to any one or more or all of such next of kin, and in such proportions as the Administrator determines.  If the location of none of the foregoing persons can be determined, the Administrator shall have the right to direct that the amount payable shall be deemed to be forfeited and retained by the Employers, except that the dollar amount of the forfeiture, unadjusted for deemed earnings, gains or losses in the interim, may be paid in full satisfaction of the Employers&#8217; obligations under this Plan in the sole discretion of the Administrator if a claim for payment subsequently is made by the Participant or the Beneficiary to whom it was payable.  If any benefit payable to a Participant or Beneficiary who has not been located is subject to escheat pursuant to applicable state law, neither the Administrator nor Quest Diagnostics shall be liable to any person for any payment made in accordance with such law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.    There shall be deducted from each payment made under the Plan to the Participant (or Beneficiary) all taxes that the Administrator determines are required to be withheld or deducted by the Employer in respect to such payment or the Plan.  The </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-12-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Administrator shall have the right to reduce any payment by the amount of cash sufficient to provide the amount of such taxes.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-13-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">Amendment and Termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Plan Amendment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Board of Directors of Quest Diagnostics shall have the authority to approve amendments to the Plan at any time and from time to time.  Such amendments may amend the Plan in whole or in part.    Notwithstanding the foregoing, no amendment of the Plan may reduce the value of any Participant&#8217;s Account determined as though the Participant terminated his employment as of the date of such amendment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Retroactive Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An amendment made in accordance with Section&#160;7.1 may be made effective on a date prior to the first day of the Plan Year in which it is adopted.  Any retroactive amendment shall be subject to the provisions of Section&#160;7.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Plan Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither Quest Diagnostics nor any other Employer has any obligation or liability whatsoever to maintain the Plan for any length of time and may discontinue deferrals under the Plan or terminate the Plan at any time without any liability hereunder for any such discontinuance or termination.</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Any termination of the Plan shall be accomplished in accordance with Section 409A of the Code and the Section 409A Regulations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Payment upon Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon termination of the Plan, no further Deferral Contributions, Employer Contributions or Supplemental Contributions shall be made under the Plan, but Accounts of Participants maintained under the Plan at the time of termination shall continue to be governed by the terms of the Plan until paid out in accordance with the terms of the Plan.  In its discretion, and notwithstanding any prior election made by the Participant, the Administrator may, upon Plan termination or at any time thereafter, cause each Participant to be paid in a single lump sum the value of the Participant&#8217;s Account in full satisfaction of all obligations to the Participant under the Plan if such payment would be consistent with the requirements of Code Section 409A.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-14-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">The Trust</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Establishment of Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Trust has been established  in accordance with the terms and conditions as set forth in a separate agreement, under which assets are held, administered and managed, subject to the claims of creditors in the event of insolvency, until paid to Participants and their Beneficiaries as specified in the Plan.  The Trust is intended to be treated as a grantor trust under the Code, and the establishment of the Trust is not intended to cause Participants to realize current income on amounts contributed thereto or earnings on the Trust&#8217;s assets.  Notwithstanding the establishment of the Trust, a Participant&#8217;s rights under the Plan shall be solely those of a general unsecured creditor of Quest Diagnostics and the Employers.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-15-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.73pt">Miscellaneous.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Limitation of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  None of the establishment of the Plan or the Trust, or any amendment thereof, or the creation of any fund or Account, or the payment of any benefits, will be construed as giving to any Participant or other person any legal or equitable right against an Employer, the Administrator or the Trustee, except as provided herein, and in no event will the terms of employment or service of any Participant be modified or in any way affected hereby.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Furnishing Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant or his Beneficiary will cooperate with the Administrator by furnishing any and all information requested by the Administrator and take such other actions as may be requested in order to facilitate the administration of the Plan and the payments of amounts hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Information between the Administrator and Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator agrees to furnish the Trustee, and the Trustee agrees to furnish the Administrator, with such information relating to the Plan and Trust as may be required by the other in order to carry out their respective duties hereunder, including without limitation information required under the Code or ERISA and any regulations issued or forms adopted thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any notice or other communication in connection with this Plan shall be deemed delivered in writing if addressed as provided below and if either actually delivered at said address or, in the case of a letter, three business&#160;days shall have elapsed after the same shall have been deposited in the United States mails, first-class postage prepaid and registered or certified&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">If it is sent to Quest Diagnostics, an Employer or the Administrator, it will be at the address specified by Quest Diagnostics, such Employer or the Administrator, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">If it is sent to the Trustee, it will be sent to the address set forth in the Trust Agreement, or, in each case, at such other address as the addressee shall have specified by written notice delivered in accordance with the foregoing to the addressee&#8217;s then-effective notice address.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Writings and Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All elections, notices and other communication with respect to the Plan, including signatures relating to such documentation, may be executed and stored on paper, electronically or in another medium.  Any documentation executed or stored electronically shall comply with the Electronic Signatures Act. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Plan will be construed, administered and enforced according to ERISA, and to the extent not preempted thereby, the laws of the State of New Jersey.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that it is determined that a Participant or group of Participants does not qualify as a select group of management or highly compensated employees as determined in accordance with Sections&#160;201(2), 301(a)(3) and 401(a)(1) of ERISA, the Administrator shall have the right, in its sole discretion, to prevent the Participant from making future elections to defer Compensation.  Following such determination the Plan shall constitute two plans, one covering such non-qualifying Participants and one covering the remaining Participants up to the maximum number of participants permissible for an unfunded deferred </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-16-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">compensation plan maintained for the benefit of a select group of management or highly compensated employees under such sections of ERISA. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  It is the intent of the Employers that this Plan be considered and interpreted in all respects as a nonqualified deferred compensation plan satisfying the requirements of Code Section 409A and deferring the recognition of income by Participants in respect of Deferrals until amounts are actually paid to them pursuant to Article 6.   For purposes of this Plan, a &#8220;termination of employment&#8221; shall be deemed to have occurred when the Participant has a &#8220;separation from service&#8221; from all Employers as defined in section 1.409A-1(h) of the Section 409A Regulations.  Prior to January 1, 2009, the Company operated the Plan in good faith compliance with Section 409A and certain Internal Revenue Service transitional rules then in effect.  Written deferral and distribution elections made during, or with respect to, Plan Years 2005-2008 shall remain in effect hereunder, even to the extent that the specific election choices offered for such years may not be available under the terms of this Plan document and&#47;or specific election choices available under this Plan document may not have been offered, provided that subsequent actions with respect to such elections (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, changes thereto, forms of distribution) shall be governed by the terms of this Plan document.  The distribution provisions in Article 6 of this Plan document shall apply to the distribution of amounts deferred (within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) on and after January 1, 2005 that commence on or after January 1, 2009.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt"> </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Recovery of Overpayment.</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If there is an overpayment under the Plan, Quest Diagnostics has the right at any time, as elected by Quest Diagnostics, to&#58;</font></div><div style="margin-top:6.25pt;padding-left:161.5pt;padding-right:6.85pt;text-indent:-36.5pt"><font style="color:#070707;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.85pt">recover that overpayment from the person to whom it was made&#59;</font></div><div style="margin-top:6.3pt;padding-left:161.25pt;padding-right:6.8pt;text-indent:-36.5pt"><font style="color:#070707;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.85pt">offset   the   amount   of that overpayment from a future payment&#59; or</font></div><div style="margin-top:6.05pt;padding-left:161.35pt;text-indent:-36.6pt"><font style="color:#070707;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.62pt">a combination of both.</font></div><div style="margin-top:6.05pt;padding-left:161.35pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Quest Diagnostics shall be considered to have established an equitable lien by agreement with the person to whom such overpayment was made. Such payee shall, upon request, execute and deliver such instruments and papers as may be required, and shall do whatever else is necessary, to secure such rights of recovery to Quest Diagnostics. Quest Diagnostics also may determine to compromise its right to a full recovery in order to facilitate a partial recovery that, in its sole discretion, it deems acceptable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Right of Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Payments to  be  made  under  the  terms  of the Plan may be used to reimburse the Employer, in accordance with procedures established by the Administrator, any amount the Participant owes an Employer at the time payment under the Plan is required to be made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  that  no such reimbursement  will be made to the extent that in the reasonable  judgment of the Administrator it would cause the Participant to recognize income for United States federal income tax purposes before the payment is made or to incur additional tax or interest pursuant to Code Section 409A or the Section 409A Regulations.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-17-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">9.11 Clawback.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All amounts credited to a Participant's Account under the Plan shall be subject to cancellation and recoupment by Quest Diagnostics, and shall be repaid by the Participant to Quest Diagnostics, to the extent required by law, regulation, listing requirement or as determined in accordance with any Quest Diagnostics policy, in each case, as in effect from time to time&#59; </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such cancellation or recoupment will be made to the extent that in the reasonable judgment of the Administrator it would cause the Participant to recognize income for United States federal income tax purposes before the payment is made or to incur additional tax or interest pursuant to Code Section 409A or the Section 409A Regulations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-18-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:18.73pt">Plan Administration.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Powers and Responsibilities of the Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator has the full power and the full responsibility to administer the Plan in all of its details, subject, however, to the applicable requirements of ERISA.  The Administrator&#8217;s powers and responsibilities include, but are not limited to, the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">To make and enforce such rules and regulations as it deems necessary or proper for the efficient administration of the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">To interpret the Plan, its interpretation thereof in good faith to be final, conclusive and binding on all persons claiming payment under the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">To decide all questions concerning the Plan and the eligibility of any person to participate in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">To compute the amount of benefits which will be payable to any Participant, former Participant or Beneficiary in accordance with the provisions of the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">To determine the person or persons to whom such benefits will be paid&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">To authorize the payment of benefits&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">To comply with applicable requirements of Part&#160;1 of Subtitle&#160;B of Title&#160;I of ERISA&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">To appoint such agents, counsel, accountants, and consultants as may be required to assist in administering the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Claims and Review Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Claims Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any person believes he is being denied any rights or benefits under the Plan, such person may file a claim in writing with the Administrator.  </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All claims under the Plan must be submitted within one (1) year after the date on which a communication from the Plan, the Employer or the Administrator (or one of their delegates or agents) contains the information contested or challenged by the claim.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any such claim is wholly or partially denied, the Administrator will notify such person of its decision in writing.  Such notification will contain (i)&#160;specific reasons for the denial, (ii)&#160;specific reference to pertinent Plan provisions, (iii)&#160;a description of any additional material or information necessary for such person to perfect such claim and an explanation of why such material or information is necessary, and (iv)&#160;information as to the steps to be taken if the person wishes to submit a request for review.  Such notification will be given within 90&#160;days after the claim is received by the Administrator (or within 180&#160;days, if special circumstances require an extension of time for processing the claim, and if written notice of such extension and circumstances is given to such person within the initial 90-day period).  If such notification is not given within such period, the claim will be considered denied as of the last day of such period and such person may request a review of his claim.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-19-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Review Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Within 60&#160;days after the date on which a person receives written notice of a denied claim (or, if applicable, within 60&#160;days after the date on which such denial is considered to have occurred), such person (or his duly authorized representative) may (i)&#160;file a written request with the Appeals Committee for a review of his denied claim and of pertinent documents and (ii)&#160;submit issues and comments to the Appeals Committee.  The Appeals Committee will notify such person of its decision in writing.  Such notification will be written in a manner calculated to be understood by such person and will contain specific reasons for the decision as well as specific references to pertinent Plan provisions.  The decision on review will be made within 60&#160;days after the request for review is received by the Appeals Committee (or within 120&#160;days, if special circumstances require an extension of time for processing the request, such as an election by the Appeals Committee to hold a hearing, and if written notice of such extension and circumstances is given to such person within the initial 60-day period).  If the decision on review is not made within such period, the claim will be considered denied.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">LIMITATIONS ON ACTIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  NO ACTION (WHETHER AT LAW, IN EQUITY OR OTHERWISE) SHALL BE BROUGHT BY OR ON BEHALF OF ANY PARTICIPANT OR BENEFICIARY FOR OR WITH RESPECT TO PAYMENT DUE UNDER THIS PLAN UNLESS THE PERSON BRINGING SUCH ACTION HAS TIMELY EXHAUSTED THE PLAN&#8217;S CLAIM REVIEW PROCEDURE.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ANY ACTION (WHETHER AT LAW, IN EQUITY OR OTHERWISE) MUST BE COMMENCED WITHIN ONE YEAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  THIS ONE-YEAR PERIOD SHALL BE COMPUTED FROM THE EARLIER OF (I)&#160;THE DATE A FINAL DETERMINATION DENYING SUCH BENEFIT, IN WHOLE OR IN PART, IS ISSUED UNDER THE PLAN&#8217;S CLAIM REVIEW PROCEDURE AND (II)&#160;THE DATE SUCH INDIVIDUAL&#8217;S CAUSE OF ACTION FIRST ACCRUED (AS DETERMINED UNDER THE LAWS OF THE STATE OF NEW JERSEY WITHOUT REGARD TO PRINCIPLES OF CHOICE OF LAWS).</font></div><div style="margin-bottom:12pt;margin-top:6.15pt;padding-left:4.5pt;padding-right:5.05pt;text-align:justify;text-indent:-4.5pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(d) All action(s) or litigation arising out of or relating to this Plan shall be commenced and prosecuted in the federal district court whose jurisdiction includes Morris County, New Jersey. Each Employee, claimant or other person consents and submits, as a condition to continued participation in the Plan, to the personal jurisdiction over him of the federal district court whose jurisdiction includes Morris County, New Jersey in respect of any such action(s) or litigation. Each Employee, claimant or other person also consents to service of process upon him with respect to any such action(s) or litigation by registered mail, return receipt requested, and by any other means permitted by rule or law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:15pt;text-decoration:underline">Plan&#8217;s Administrative Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">The Employers may pay the reasonable costs and expenses (including legal, accounting, and employee communication fees) incurred by the Administrator and the Trustee in administering the Plan and Trust.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Notwithstanding anything in Section 10.3(a) to the contrary, the Administrator may determine that each Participant in one or more classes of Participants (as designated by the Administrator) shall be responsible for an amount equal to the reasonable costs and expenses </font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-20-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">incurred by the Administrator and the Trustee in administering the Plan and the Trust divided by the total number of Participants in (x) the Plan to the extent the costs and expenses apply to all Participants in the Plan or (y) the class or classes designated by the Administrator pursuant to this Section 10.3(b) to the extent the costs and expenses apply solely to the Participants in such class or classes. </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-21-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Quest Diagnostics has caused this Plan document to be executed by its duly authorized officer.   </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.089%"><tr><td style="width:1.0%"></td><td style="width:6.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS CLINICAL LABORATORIES, INC.</font></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47;Cecilia K. McKenney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:-2.65pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:-2.65pt"><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cecilia K. McKenney</font></div><div style="padding-left:2.75pt;padding-right:-119.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Senior Vice President, Chief Human Resources Officer</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.551%"><tr><td style="width:1.0%"></td><td style="width:7.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.404%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-top:3.2pt;padding-left:209.15pt"><font><br></font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-22-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:209.15pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX A</font></div><div style="margin-bottom:12pt;margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:16.55pt;padding-right:6.95pt;text-align:justify"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">This Appendix A describes special provisions applicable to accounts under the Celera Corporation Non-Qualified Savings and Deferral Plan (the &#34;Celera Plan&#34;) which was established effective as of July 1, 2008 and which was merged into this Plan effective as of June 25, 2012. Contributions under the Celera Plan ceased, and no new participants were admitted, effective as of December 31, 2011.</font></div><div style="padding-left:16.4pt;padding-right:6.55pt;text-align:justify;text-indent:0.35pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">1.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:10.25pt;text-decoration:underline">Annual Deferral Amounts.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%"> The Celera Plan provided for an &#34;Annual Deferral Amount&#34; to record a participant's deferred salary and bonus for the calendar year in question and any employer contributions with respect to that year, as well as earnings or losses thereon. The Plan will continue to maintain such Annual Deferral Amounts for recordkeeping purposes.</font></div><div style="margin-bottom:12pt;margin-top:0.5pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-left:16.25pt;padding-right:6.3pt;text-align:justify;text-indent:0.25pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">2.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:10.5pt;text-decoration:underline">Vesting.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%"> A Celera Plan participant's deferred salary and bonus were 100% vested. The Celera Plan applied (and the Plan will continue to apply) a 4-year graded vesting schedule to employer contributions, provided that a participant will become 100% vested if he or she dies or becomes disabled while employed by Celera and its affiliates. For these purposes&#58;</font></div><div style="margin-top:5.75pt;padding-left:16.3pt;padding-right:6.65pt;text-align:justify;text-indent:36.1pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:5.62pt">years of service are measured using the &#34;elapsed time&#34; method and include service with Applera Corporation and Berkeley HeartLab, Inc.&#59;</font></div><div style="margin-top:6.05pt;padding-left:16.6pt;padding-right:6.2pt;text-align:justify;text-indent:35.8pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(2)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:5.62pt">service with Quest Diagnostics and its affiliates on or after May 17, 2011 is considered service with Celera and its affiliates&#59;</font></div><div style="margin-top:6.05pt;padding-left:88.15pt;text-indent:-35.75pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.77pt">&#34;Retirement Age&#34; means the later of age 65 or five years of service&#59; and</font></div><div style="margin-top:6.15pt;padding-left:16.3pt;padding-right:6.05pt;text-align:justify;text-indent:36.1pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(4)</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:5.62pt">a participant shall be considered &#34;disabled&#34; once he or she is, by reason of any medically determinable physical or mental impairment that can be expected to  result in death or to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of Celera or its affiliates.</font></div><div style="margin-bottom:12pt;margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="padding-left:16.05pt;padding-right:5.85pt;text-align:justify;text-indent:0.55pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">3.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:10.4pt;text-decoration:underline">Time of Distribution.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%"> The time of distribution of Annual Deferral Amounts shall be the same as under the Celera Plan. Under the Celera Plan,  with  respect  to each Annual Deferral Amount, a participant was permitted to elect either a &#34;specified date payout&#34; or a payout upon separation from service&#59; the specified  payout  date had to be at least one year after the close of the year to which the specification applied, e.g., the earliest permitted specified payout date with respect to the Annual Deferral Amount for 2010 was January 1, 2012. Those elections were (and continue to be) irrevocable unless changed in accordance with paragraph 5 below. However, if a participant dies, his or her vested Annual Payment Amounts will be distributed in a lump sum notwithstanding any election he or she may have made. Payments of Annual Payment Amounts will commence (or will be made) on the 15th day of the month following the month in which the triggering event occurs.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-23-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:11.1pt;padding-left:16.15pt;padding-right:6.55pt;text-align:justify;text-indent:0.05pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">4.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:10.8pt;text-decoration:underline">Method of Distribution.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%"> The method of distribution of Annual Deferral Amounts and distribution elections shall be the same as under the Celera Plan. Further, </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">installments are not considered a series of separate payments for purposes of Section 409A. Those distributions elections will remain in effect unless changed in accordance with paragraph 5 below.</font></div><div style="margin-bottom:12pt;margin-top:0.55pt;text-align:justify"><font><br></font></div><div style="padding-left:17.35pt;padding-right:5.6pt;text-align:justify;text-indent:0.2pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.45pt;text-decoration:underline">Change in Method of Distribution.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> A participant in the Celera Plan may elect to change the method of payment of, but not the time of payment of, an Annual Deferral Amount&#59; provided, however, that&#58;</font></div><div style="margin-top:6.2pt;padding-left:52.9pt;padding-right:5.95pt;text-align:justify;text-indent:36.3pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.82pt">any such change must be made at least 12 months before the first day of the calendar year in which the specified payout date would have occurred (but for the requirements of (2) below applicable to a change of election)&#59;</font></div><div style="margin-top:6.2pt;padding-left:53pt;padding-right:5.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(2)</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:5.07pt">the payment with respect to such changed election must be deferred for a period of not less than 5 years from the date such payment would otherwise originally have been made (or commenced to be made)&#59;</font></div><div style="margin-top:6pt;padding-left:52.95pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:5.07pt">the change will not become effective for at least 12 months after the election&#59; and</font></div><div style="margin-top:6.05pt;padding-left:125.6pt;text-indent:-36.65pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.67pt">only one such change is permitted.</font></div><div style="margin-top:6.4pt;padding-left:16.8pt;padding-right:5.35pt;text-align:justify;text-indent:0.05pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">6.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:10.15pt;text-decoration:underline">Lump Sum Distribution of Small Benefit Payments.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%"> Notwithstanding anything contained herein to the contrary, if the Administrator determines that a participant's vested balance under the Celera Plan, taking into account all plans that would be aggregated with the Celera Plan under Section 409A of the Code, is $17,000 (as adjusted under Section 402(g)(1)(8) of the Code) or less, the Administrator may pay such vested balance in a lump sum on the 15th day of the month following the month in which the Administrator makes a written decision to make such payment.</font></div><div style="margin-bottom:12pt;margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="padding-left:16.4pt;padding-right:5.7pt;text-align:justify;text-indent:0.35pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.25pt;text-decoration:underline">Designations of Beneficiaries</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Beneficiary designations made under the Celera Plan shall not continue to apply to amounts arising under the Celera Plan. Instead, participants in the Celera Plan must file new beneficiary designations in accordance with the procedures established under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:0.25pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-left:16.65pt;padding-right:5.8pt;text-align:justify;text-indent:0.2pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">8.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:10.15pt;text-decoration:underline">Trust.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%"> Effective June 25, 2012, the grantor trust established under the Celera Plan shall be considered as merged into, and superseded by, the grantor trust established under the Plan.</font></div><div style="margin-top:6pt;padding-right:5.2pt;text-indent:18.4pt"><font><br></font></div><div style="padding-left:16.4pt;padding-right:5.2pt;text-indent:0.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.04pt;text-decoration:underline">Applera Provisions.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The following provisions relate to amounts under the Celera Plan attributable to the Applera Corporation Supplemental Executive Retirement Plan&#58; the election (made not later than December 31, 2008) by Kathy Ordonez with respect to her benefits under the Applera Corporation Supplemental Executive Retirement Plan shall be applied as if such benefits were a single Annual Deferral Amount under the Celera Plan.</font></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-24-</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>4
<FILENAME>dgx09302021ex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iadc43d05b6c748509ef93c9420ee76b6_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit 22</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Subsidiary Guarantors of Securities</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of October&#160;22, 2021, the following subsidiaries of Quest Diagnostics Incorporated provided, subject to the terms of such senior notes, unconditional and irrevocable guarantees to the senior notes listed below that were issued by Quest Diagnostics Incorporated pursuant to an offering registered under the Securities Act of 1933, as amended&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:27.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Securities</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Issuer</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsidiary Guarantor</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">State of Organization</font></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.95% Senior Notes due 2037</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.75% Senior Notes due 2040</font></div></td><td colspan="3" rowspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">American Medical Laboratories, Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Consolidated Labs, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Hospital Services Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Kentucky, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kentucky</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath New York, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Texas, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Athena Diagnostics, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Pathology Services, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Oklahoma</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pennsylvania</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide of NJ, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New Jersey</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kailash B. Sharma, M.D., Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Missouri</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne of Ohio, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ocmulgee Medical Pathology Association, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Clinical Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Holdings Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Maryland</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nevada</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Infectious Disease, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Investments LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Connecticut</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Illinois</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Massachusetts</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Virginia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics of Pennsylvania Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Specialty Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unilab Corporation</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>dgx09302021ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iaa4cf87d7c2c4fcf97bbb7cfa072b4cc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen H. Rusckowski, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;22, 2021 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.134%"><tr><td style="width:1.0%"></td><td style="width:11.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>dgx09302021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ief7fe4a70f9043078305f4adaa35a4b8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark J. Guinan, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October&#160;22, 2021 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.140%"><tr><td style="width:1.0%"></td><td style="width:14.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>dgx09302021ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8637ef01e58b4559813f8be8bb09a4fb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended September&#160;30, 2021 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 22, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>dgx09302021ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i369cf570bec24e129069fea2f1a7958e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended September&#160;30, 2021 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 22, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>9
<FILENAME>dgx09302021ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9c79e4d2edfd44788a1f9c6b7007fab9_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.1</font><font style="color:#00b050;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AMENDMENT NO. 5 TO SIXTH AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Amendment No. 5 to Sixth Amended and Restated Credit and Security Agreement (this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Amendment&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) is entered into as of August 13, 2021 (the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), by and among&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(1) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">QUEST DIAGNOSTICS RECEIVABLES INC., a Delaware corporation (together with its successors and permitted assigns, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(2) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">QUEST DIAGNOSTICS INCORPORATED, a Delaware corporation, as initial servicer (in such capacity, together with any successor servicer or sub-servicer, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Servicer&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(3) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PNC BANK, NATIONAL ASSOCIATION, in its individual capacity as a Lender (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PNC&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PNC Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and as issuer of the Letters of Credit,</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(4) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">GOTHAM FUNDING CORPORATION, a Delaware corporation (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Gotham&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), in its capacity as a Liquidity Bank to Gotham (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;MUFG&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, together with Gotham, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Gotham Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(5)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> ATLANTIC ASSET SECURITIZATION LLC, a Delaware limited liability company (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Atlantic&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and CR&#201;DIT AGRICOLE CORPORATE AND INVESTMENT BANK, in its capacity as a Liquidity Bank to Atlantic (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;CACIB&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, together with Atlantic, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Atlantic Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(6) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PNC BANK, NATIONAL ASSOCIATION, in its capacity as agent for the PNC Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), CR&#201;DIT AGRICOLE CORPORATE AND INVESTMENT BANK, in its capacity as agent for the Atlantic Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), in its capacity as agent for the Gotham Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(7) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PNC BANK, NATIONAL ASSOCIATION, in its capacity as Letter of Credit issuer (together with its successors in such capacity, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;LC Issuer&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(8) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), as administrative agent for the Atlantic Group, the PNC Group, the Gotham Group and the Co-Agents (in such capacity, together with any successors thereto in such capacity, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Agent&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and together with each of the Co-Agents, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agents&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">RECITALS&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.87pt">The Borrower, the Servicer, the PNC Group, the Gotham Group, the Atlantic Group and the Agents are parties to that certain Sixth Amended and Restated Credit and Security Agreement, dated as of October 27, 2017 (as amended, restated or otherwise modified from time to time, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit and Security Agreement&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; capitalized terms used and not otherwise defined herein are used with the meanings attributed thereto in the Credit and Security Agreement).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;Each of the parties hereto desires to amend the Credit and Security Agreement as hereinafter set forth.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">NOW, THEREFORE,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in consideration of the premises, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Amendments to the Credit and Security Agreement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Effective as of the Effective Date&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Credit and Security Agreement is hereby amended and restated in its entirety to read as follows&#58; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Benchmark Transition Event</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benchmark Replacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein or in any other Transaction Document, if a Benchmark Transition Event or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Transaction Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein or in any other Transaction Document, if a Term SOFR Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then the applicable Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder or under any Transaction Document in respect of such Benchmark setting and subsequent Benchmark settings, without any amendment to, or further action or consent of any other party to, this Agreement or any other Transaction Document&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that this clause (ii) shall not be effective unless the Administrative Agent has delivered to the Borrower a Term SOFR Notice.  For the avoidance of doubt, the Administrative Agent shall not be required to deliver a Term SOFR Notice after a Term SOFR Transition Event and may do so in its sole discretion.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In connection with the implementation of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Transaction Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Notices&#59; Standards for Decisions and Determinations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent will promptly notify the Borrower of (i) any occurrence of a Benchmark Transition Event, a Term SOFR Transition Event or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date, (ii) the implementation of any Benchmark </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Replacement and any Benchmark Replacement Adjustment, (iii) the effectiveness of any Benchmark Replacement Conforming Changes and (iv) the removal or reinstatement of any tenor of a Benchmark pursuant to clause (d) below. Any determination, decision or election that may be made by the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section 4.5 or any related definition, with the consent of or in agreement with the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Unavailability of Tenor of Benchmark</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary herein or in any other Transaction Document, at any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a term rate (including Term SOFR or USD LIBOR) and either (A) any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (B) the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is or will be no longer representative, then the Administrative Agent may modify the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor and (ii) if a tenor that was removed pursuant to clause (i) above either (A) is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (B) is not, or is no longer, subject to an announcement that it is or will no longer be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent (in consultation with the Borrower) may modify the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for all Benchmark settings at or after such time to reinstate such previously removed tenor.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Benchmark Rates</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Administrative Agent does not warrant or accept responsibility for, and shall not have any liability with respect to (i) the administration of, submission of or any other matter related to the Benchmark, any component definition thereof or rates referred to in the definition thereof or any alternative, comparable or successor rate thereto (including any then-current Benchmark or any Benchmark Replacement), including whether the composition or characteristics of any such alternative, comparable or successor rate (including any Benchmark Replacement) will be similar to, or produce the same value or economic equivalence of, or have the same volume or liquidity as, the then-current Benchmark or (ii) the effect, implementation or composition of any Benchmark Replacement Conforming Changes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">London Interbank Offered Rate Benchmark Transition Event</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  On March 5, 2021, the ICE Benchmark Administration (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">IBA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;), the administrator of the London interbank offered rate, and the Financial Conduct Authority (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">FCA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;), the regulatory supervisor of the IBA, announced in public statements (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Announcements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;) that the final publication or representativeness date for (i) 1-week and 2-month London interbank offered rate tenor settings will be December 31, 2021 and (ii) overnight, 1-month, 3-month, 6-month and 12-month London interbank offered rate tenor settings </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">will be June 30, 2023.  No successor administrator for the IBA was identified in such Announcements.  The parties hereto agree and acknowledge that the Announcements resulted in the occurrence of a Benchmark Transition Event with respect to the London interbank offered rate pursuant to the terms of this Agreement and that any obligation of the Administrative Agent to notify any parties of such Benchmark Transition Event pursuant to clause (c) of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed satisfied.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Certain Defined Terms</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  As used in this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Available Tenor&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if the then-current Benchmark is a term rate, any tenor for such Benchmark or (y) otherwise, any payment period for interest calculated with reference to such Benchmark, as applicable, that is or may be used for determining the length of an Interest Period pursuant to this Agreement as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> pursuant to clause (d) of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, initially, USD LIBOR&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if a Benchmark Transition Event, a Term SOFR Transition Event or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date have occurred with respect to USD LIBOR or the then-current Benchmark, then </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to clause (a) of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, for any Available Tenor, </font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) with respect to any Benchmark Transition Event or Early Opt-in Election, the first alternative set forth in the order below that can be determined by the Administrative Agent (in consultation with the Borrower) for the applicable Benchmark Replacement Date&#58;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">the sum of&#58; (A) Term SOFR and (B) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">the sum of&#58; (A) Daily Simple SOFR and (B) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">the sum of&#58; (A) the alternate benchmark rate that has been selected by the Administrative Agent in consultation with the Borrower as the replacement for the then-current Benchmark for the applicable Corresponding Tenor and (B) the related Benchmark Replacement Adjustment&#59; or</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) with respect to any Term SOFR Transition Event, the sum of (i) Term SOFR and (ii) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, in the case of clause (a)(1) or clause (b), such Unadjusted Benchmark Replacement is displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion. If the Benchmark Replacement as determined pursuant to clause (a)(1), (a)(2) or (a)(3) or clause (b) above would be less than the Floor, the Benchmark Replacement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>4</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">will be deemed to be the Floor for the purposes of this Agreement and the other Transaction Documents.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement Adjustment&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement for any applicable Interest Period and Available Tenor for any setting of such Unadjusted Benchmark Replacement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">for purposes of clauses (a)(1) and (a)(2) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the first alternative set forth in the order below that can be determined by the Administrative Agent (in consultation with the Borrower)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:24.08pt">the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that has been selected or recommended by the Relevant Governmental Body for the replacement of such Available Tenor of such Benchmark with the applicable Unadjusted Benchmark Replacement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.57pt">the spread adjustment (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that would apply to the fallback rate for a derivative transaction referencing the ISDA Definitions to be effective upon an index cessation event with respect to such Available Tenor of such Benchmark&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">for purposes of clause (a)(3) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent in consultation with the Borrower&#59; and</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">for purposes of clause (b) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that has been selected or recommended by the Relevant Governmental Body for the replacement of such Available Tenor of USD LIBOR with a SOFR-based rate&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (x) in the case of clause (1) above, such adjustment is displayed on a screen or other information service that publishes such Benchmark Replacement Adjustment from time to time as selected by the Administrative Agent in its reasonable discretion and (y) if the then-current Benchmark is a term rate, more than one tenor of such Benchmark is available as of the applicable Benchmark Replacement Date and the applicable Unadjusted Benchmark Replacement that will replace such Benchmark in accordance with this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> will not be a term rate, the Available Tenor of such Benchmark for purposes of this definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement Adjustment&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to be, with respect to each Unadjusted Benchmark Replacement having a payment period for interest calculated with reference thereto, the Available Tenor that has approximately the same length (disregarding business day adjustments) as such payment period.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>5</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement Conforming Changes&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Business Day,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Period,&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage provisions and other technical, administrative or operational matters) that the Administrative Agent and the Borrower reasonably determine is reasonably necessary or appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent and the Borrower decide that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent and the Borrower reasonably determine that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Administrative Agent and the Borrower reasonably determine is reasonably necessary in connection with the administration of this Agreement and the other Transaction Documents).</font></div><div style="margin-bottom:5pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement Date&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means the earliest to occur of the following events with respect to the then-current Benchmark&#58;</font></div><div style="margin-bottom:5pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">in the case of clause (1) or (2) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Transition Event,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:5pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">in the case of clause (3) of the definition of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Transition Event,&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the date of the public statement or publication of information referenced therein&#59;</font></div><div style="margin-bottom:5pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">in the case of a Term SOFR Transition Event, the date that is thirty (30) days after the Administrative Agent has provided a Term SOFR Notice to the Borrower pursuant to clause (a)(ii) of this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; or</font></div><div style="margin-bottom:5pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">in the case of an Early Opt-in Election, the first (1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) Business Day after the date notice of such Early Opt-in Election is provided to the Borrower.</font></div><div style="margin-bottom:5pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the avoidance of doubt, (i) if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination and (ii) the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Replacement Date&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> will be deemed to have occurred in the case of clause (1) or (2) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:5pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Transition Event&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means the occurrence of one or more of the following events with respect to the then-current Benchmark&#58;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased to provide all Available Tenors </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of such Benchmark (or such component thereof), permanently or indefinitely, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">provided </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Board of Governors of the Federal Reserve System, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), which states that the administrator of such Benchmark (or such component) has ceased to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are no longer representative.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the avoidance of doubt, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benchmark Transition Event&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Corresponding Tenor&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Daily Simple SOFR&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means, for any day, SOFR, with the conventions for this rate (which will include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate selected or recommended by the Relevant Governmental Body for determining </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Daily Simple SOFR&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for bilateral business loans&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Early Opt-in Election&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, if the then-current Benchmark is USD LIBOR, the occurrence of&#58;</font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">a notification by the Administrative Agent (or a request by the Borrower to the Administrative Agent to notify) each of the other parties hereto that at least ten (10 ) currently outstanding U.S. dollar-denominated syndicated or bilateral credit facilities at such time contain (as a result of amendment or as originally executed) a SOFR-based rate (including SOFR, a term SOFR or any other rate based upon SOFR) as a benchmark rate, and</font></div><div style="padding-left:72pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>7</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.77pt">the joint election by the Administrative Agent and the Borrower to trigger a fallback from USD LIBOR and the provision by the Administrative Agent of written notice of such election to the Lenders.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Floor&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means zero percent (0%) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">per annum</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ISDA Definitions&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means the 2006 ISDA Definitions published by the International Swaps and Derivatives Association, Inc. or any successor thereto, as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time to time by the International Swaps and Derivatives Association, Inc. or such successor thereto.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reference Time&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with respect to any setting of the then-current Benchmark means (1) if such Benchmark is USD LIBOR, 11&#58;00 a.m. (London time) on the day that is two London banking days preceding the date of such setting, and (2) if such Benchmark is not USD LIBOR, the time determined by the Administrative Agent in its reasonable discretion in consultation with the Borrower.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Relevant Governmental Body&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;SOFR&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, with respect to any Business Day, a rate per annum equal to the secured overnight financing rate for such Business Day published by the SOFR Administrator on the SOFR Administrator&#8217;s Website on the immediately succeeding Business Day. </font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;SOFR Administrator&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;SOFR Administrator&#8217;s Website&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means the website of the Federal Reserve Bank of New York, currently at http&#58;&#47;&#47;www.newyorkfed.org, or any successor source for the secured overnight financing rate identified as such by the SOFR Administrator from time to time.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means, for the applicable Corresponding Tenor as of the applicable Reference Time, the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant Governmental Body.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Notice&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means a written notification by the Administrative Agent to the Borrower of the occurrence of a Term SOFR Transition Event.</font></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Term SOFR Transition Event&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means the determination by the Administrative Agent and the Borrower that (a) Term SOFR has been recommended for use by the Relevant Governmental Body, (b) the administration of Term SOFR is administratively feasible for the Administrative Agent and (c) a Benchmark Transition Event or an Early Opt-in Election, as applicable, has previously occurred resulting in the replacement of the then-current Benchmark for all purposes hereunder and under any Transaction Document in accordance with this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with a Benchmark Replacement the Unadjusted Benchmark Replacement component of which is not Term SOFR.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Unadjusted Benchmark Replacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Benchmark Replacement excluding the Benchmark Replacement Adjustment.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.2.&#160;&#160;&#160;&#160;Section 14.2 of the Credit and Security Agreement is hereby amended to delete all references to giving notices by facsimile and the effective date of such notices.  To the extent any notice is given by electronic mail to the Administrative Agent or to MUFG individually, it shall be sent with a copy to securitization_reporting&#64;us.mufg.jp</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall become effective as of the Effective Date provided that each of the following conditions precedent is satisfied&#58;  (a) The Administrative Agent shall have received counterparts of this Amendment (whether by facsimile, electronic mail or otherwise) duly executed by each of the parties hereto&#59; (b)  the Group Joinder Agreement, dated as of the date hereof, by and among Reprosource Fertility Diagnostics, Inc., a Massachusetts corporation, Blueprint Genetics, Inc., a Delaware corporation, and Mid America Clinical Laboratories, LLC, an Indiana limited liability company (collectively, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;New Sellers&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), the Borrower and the Administrative Agent (the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Group Joinder Agreement&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall have been executed by all parties thereto, and all conditions precedent to its effectiveness shall have been satisfied in accordance with the Sale Agreement&#59; (c) each of the Co-Agents shall have completed any necessary &#8220;know your customer&#8221; or similar diligence with respect to the New Sellers&#59; and (d) each of the representations and warranties set forth in Section 3 of this Amendment is true and correct as of the Effective Date. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Borrower hereby represents and warrants to the Agents and the Lenders as of the Effective Date as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.08pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The representations and warranties contained in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Article VI</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Credit and Security Agreement are true and correct as of the date hereof (unless stated to relate solely to an earlier date, in which case such representations or warranties were true and correct as of such earlier date).</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.57pt;text-decoration:underline">Enforceability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The execution and delivery by each of the Borrower and the Servicer of this Amendment, and the performance of each of its obligations under this Amendment and the Credit and Security Agreement, as amended hereby, are within each of its organizational powers and have been duly authorized by all necessary action on each of its parts.  This Amendment and the Credit and Security Agreement, as amended hereby, are each of the Borrower&#8217;s and the Servicer&#8217;s valid and legally binding obligations, enforceable in accordance with its terms.</font></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.69pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Immediately after giving effect to this Amendment and the transactions contemplated hereby, no Event of Default or Unmatured Default exists or shall exist.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 4. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Legal Fees and Disbursements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Borrower hereby acknowledges and agrees that this Amendment constitutes a Transaction Document and that the provisions of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 14.5(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Credit and Security Agreement apply hereto.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to any otherwise applicable conflicts of law principles (other than Sections 5-1401 and 5-1402 of the New York General Obligations Law which shall apply hereto).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Effect of Amendment&#59; Ratification</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Except as specifically amended hereby, the Credit and Security Agreement is hereby ratified and confirmed in all respects, and all of its provisions shall remain in full force and effect.  After this Amendment becomes effective, all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>9</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">references in the Credit and Security Agreement (or in any other Transaction Document) to &#8220;the Credit and Security Agreement&#8221;, &#8220;this Agreement&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221;, or words of similar effect, in each case referring to the Credit and Security Agreement, shall be deemed to be references to the Credit and Security Agreement as amended hereby.  This Amendment shall not be deemed to expressly or impliedly waive, amend, or supplement any provision of the Credit and Security Agreement other than as specifically set forth herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 7. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.  To the fullest extent permitted by applicable law, delivery of an executed counterpart of a signature page of this Amendment by telefacsimile or electronic image scan transmission (such as a &#8220;pdf&#8221; file) will be effective to the same extent as delivery of a manually executed original counterpart of this Amendment.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The various headings of this Amendment are inserted for convenience only and shall not affect the meaning or interpretation of this Amendment or the Credit and Security Agreement or any provision hereof or thereof.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 10. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If any one or more of the provisions or terms of this Amendment shall for any reason whatsoever be held invalid or unenforceable, then such agreements, provisions or terms shall be deemed severable from the remaining agreements, provisions and terms of this Amendment and shall in no way affect the validity or enforceability of the provisions of this Amendment or the Credit and Security Agreement.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 11. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt;text-decoration:underline">Consent to the Group Joinder Agreement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Each of the Agents hereby consents to the Group Joinder Agreement and authorizes the Administrative Agent to enter into such agreement.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#60;Balance of page intentionally left blank&#62;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>10</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div id="i9c79e4d2edfd44788a1f9c6b7007fab9_4"></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">IN WITNESS WHEREOF,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the parties have executed this Amendment as of the date first written above.</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">QUEST DIAGNOSTICS RECEIVABLES INC.<br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; &#160;&#160;&#160;&#160;&#47;s&#47; Sandip R. Patel<br>Name&#58;   Sandip R. Patel<br>Title&#58;     Vice President and Treasurer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">QUEST DIAGNOSTICS INCORPORATED, as Servicer<br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; &#160;&#160;&#160;&#160;&#47;s&#47; Sandip R. Patel</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Sandip R. Patel<br>Title&#58;     Vice President and Treasurer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>11</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Agents' and Lender's Signatures follow&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:203.05pt;text-indent:-1.45pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ATLANTIC ASSET SECURITIZATION LLC, as a Conduit</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47;Konstantina Kourmpetis</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Konstantina Kourmpetis</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;   Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">___&#47;s&#47;Roger Klepper_____________________</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Name&#58;  Roger Klepper<br>Title&#58;    Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CR&#201;DIT AGRICOLE CORPORATE AND INVESTMENT BANK, individually as a Liquidity Bank for Atlantic and as Atlantic Group Agent</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47;Konstantina Kourmpetis</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Konstantina Kourmpetis</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;   Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">___&#47;s&#47;Roger Klepper_____________________</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Name&#58;  Roger Klepper<br>Title&#58;    Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PNC BANK, NATIONAL ASSOCIATION,</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">individually as a Lender, as PNC Group Agent and as LC Issuer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Henry Chan&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Name&#58;   Henry Chan<br>Title&#58;    Senior VIce President</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">GOTHAM FUNDING CORPORATION, as a Conduit</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;Kevin J. Corrigan</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<br>Name&#58;  Kevin J. Corrigan<br>Title&#58;    Vice President</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), INDIVIDUALLY AS A LIQUIDITY BANK FOR GOTHAM</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;  ____</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;Eric Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">___________________________                                   </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; &#160;&#160;&#160;&#160;       Eric Williams</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;             Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), AS GOTHAM AGENT</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;  ____</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;Eric Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">___________________________                                   </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;&#160;&#160;&#160;&#160;       Eric Williams</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;             Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), AS ADMINISTRATIVE AGENT</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;   ____</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;Eric Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">___________________________                                   </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;          Eric Williams</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;             Managing Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 5 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>dgx-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3dfc3e15-f0aa-46bd-8aee-40e417fed44b,g:988a0070-0eae-4f69-89e4-5f07a4cdd401-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dgx="http://questdiagnostics.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://questdiagnostics.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://questdiagnostics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE">
        <link:definition>2104103 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables">
        <link:definition>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails">
        <link:definition>2406401 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS">
        <link:definition>2107104 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISPOSITION" roleURI="http://questdiagnostics.com/role/DISPOSITION">
        <link:definition>2109105 - Disclosure - DISPOSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISPOSITIONDetails" roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails">
        <link:definition>2410403 - Disclosure - DISPOSITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2111106 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2115107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSGoodwillDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails">
        <link:definition>2417406 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSSchedulesDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
        <link:definition>2418407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2119108 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSBalanceSheetsDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails">
        <link:definition>2421408 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSIncomeStatementDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails">
        <link:definition>2422409 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>2123109 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
        <link:definition>2424410 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATA" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA">
        <link:definition>2125110 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATATables" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables">
        <link:definition>2326305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails">
        <link:definition>2427411 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails">
        <link:definition>2428412 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2129111 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2430413 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>2131112 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>2332306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>2433414 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION">
        <link:definition>2134113 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables">
        <link:definition>2335307 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails">
        <link:definition>2436415 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOME" roleURI="http://questdiagnostics.com/role/TAXESONINCOME">
        <link:definition>2137114 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMEDetails" roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails">
        <link:definition>2438416 - Disclosure - TAXES ON INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENT" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENT">
        <link:definition>2139115 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTDetails" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails">
        <link:definition>2440417 - Disclosure - SUBSEQUENT EVENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dgx_ClientPayersMember" abstract="true" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_GainLossOnDispositionOfJointVenture" abstract="false" name="GainLossOnDispositionOfJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_MercyHealthMember" abstract="true" name="MercyHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataLineItems" abstract="true" name="SupplementalCashFlowAndOtherDataLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_RoutineclinicaltestingservicesMember" abstract="true" name="RoutineclinicaltestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" abstract="false" name="PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_AnatomicpathologytestingservicesMember" abstract="true" name="AnatomicpathologytestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_Mergerconsiderationpaidpayablenet" abstract="false" name="Mergerconsiderationpaidpayablenet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DescriptionOfBusinessAbstract" abstract="true" name="DescriptionOfBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_LoanCommitmentMaturingOctober2022Member" abstract="true" name="LoanCommitmentMaturingOctober2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_HealthcareInsurersMember" abstract="true" name="HealthcareInsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" abstract="false" name="EquityMethodInvestmentOwnershipPercentDisposedOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" abstract="false" name="ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_CARESActProceedsRecognizedInTheStatementOfOperations" abstract="false" name="CARESActProceedsRecognizedInTheStatementOfOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" abstract="false" name="ProceedsFromSaleOfEquityMethodInvestmentsGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_CapitatedMember" abstract="true" name="CapitatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TerminationOfInterestRateSwapAgreements" abstract="false" name="TerminationOfInterestRateSwapAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_CommercialPaperOrLIBORMember" abstract="true" name="CommercialPaperOrLIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" abstract="false" name="ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_GenebasedandesoterictestingservicesMember" abstract="true" name="GenebasedandesoterictestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" abstract="false" name="CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ForeignCurrencyTranslationMember" abstract="true" name="ForeignCurrencyTranslationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" abstract="false" name="EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_LoanCommitmentMaturingOctober2023Member" abstract="true" name="LoanCommitmentMaturingOctober2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AccountsReceivableDisaggregationTableTextBlock" abstract="false" name="AccountsReceivableDisaggregationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_PercentageofNetRevenues" abstract="false" name="PercentageofNetRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_FairValueOfNetAssetsAcquired" abstract="false" name="FairValueOfNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_StockRepurchaseProgramAdditionalAmountAuthorized" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_COVID19TestingServicesMember" abstract="true" name="COVID19TestingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_Q2SolutionsMember" abstract="true" name="Q2SolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PercentageofNetAccountsReceivable" abstract="false" name="PercentageofNetAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_AcceleratedShareRepurchasesInitialPricePaid" abstract="false" name="AcceleratedShareRepurchasesInitialPricePaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AcceleratedShareRepurchaseAgreementsMember" abstract="true" name="AcceleratedShareRepurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" abstract="false" name="AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_GovernmentPayersMember" abstract="true" name="GovernmentPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" abstract="true" name="ExcludesgeneralandprofessionalliabilityclaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DSBusinessesMember" abstract="true" name="DSBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_TotalAmortizingIntangibleAssetsMember" abstract="true" name="TotalAmortizingIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ReturnOfCashCARESAct" abstract="false" name="ReturnOfCashCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" abstract="false" name="EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_UMassJointVentureMember" abstract="true" name="UMassJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataTable" abstract="true" name="SupplementalCashFlowAndOtherDataTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_InterestPaid1" abstract="false" name="InterestPaid1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FeeforserviceMember" abstract="true" name="FeeforserviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_AllotherservicesMember" abstract="true" name="AllotherservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" abstract="false" name="ScheduleOfRevenuesByMajorServiceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_DiagnosticInformationServicesBusinessMember" abstract="true" name="DiagnosticInformationServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" abstract="false" name="CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_SeniorunsecuredrevolvingcreditfacilityMember" abstract="true" name="SeniorunsecuredrevolvingcreditfacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ReversalOfRecognitionOfCARESActProceeds" abstract="false" name="ReversalOfRecognitionOfCARESActProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" abstract="true" name="MidAmericaClinicalLaboratoriesLLCMACLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PatientsMember" abstract="true" name="PatientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>dgx-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3dfc3e15-f0aa-46bd-8aee-40e417fed44b,g:988a0070-0eae-4f69-89e4-5f07a4cdd401-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c59e735-62ce-4220-92a8-04ff302cf1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ef27c05b-58d6-4b98-b7b5-0f6cd3d241c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c59e735-62ce-4220-92a8-04ff302cf1be" xlink:to="loc_us-gaap_CostsAndExpenses_ef27c05b-58d6-4b98-b7b5-0f6cd3d241c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_51967f93-f3e1-4f38-b94d-885b2e2f13bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c59e735-62ce-4220-92a8-04ff302cf1be" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_51967f93-f3e1-4f38-b94d-885b2e2f13bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9fcbcfb2-67a7-48c3-adb9-283c91a0e3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_15a07e56-5532-43ac-925b-a8f31e311fda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9fcbcfb2-67a7-48c3-adb9-283c91a0e3e6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_15a07e56-5532-43ac-925b-a8f31e311fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_90587ad7-82e2-46b6-8390-be4370ce4df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9fcbcfb2-67a7-48c3-adb9-283c91a0e3e6" xlink:to="loc_us-gaap_CostOfRevenue_90587ad7-82e2-46b6-8390-be4370ce4df0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_5bf2d1f6-9439-462b-a507-17d7ad2320b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9fcbcfb2-67a7-48c3-adb9-283c91a0e3e6" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_5bf2d1f6-9439-462b-a507-17d7ad2320b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6f1dade6-0536-443c-bc60-23debea8aa18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9fcbcfb2-67a7-48c3-adb9-283c91a0e3e6" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6f1dade6-0536-443c-bc60-23debea8aa18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb863d5-401d-4bbd-ae6a-38c30b47a68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_23e374de-942b-4476-a22f-b2ee0ec8df78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb863d5-401d-4bbd-ae6a-38c30b47a68c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_23e374de-942b-4476-a22f-b2ee0ec8df78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_24ddfdae-cd92-481e-b857-c790f0efc49e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb863d5-401d-4bbd-ae6a-38c30b47a68c" xlink:to="loc_us-gaap_OperatingIncomeLoss_24ddfdae-cd92-481e-b857-c790f0efc49e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dd12f72a-7c15-43ab-90bc-112089bf3a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e0b39109-c40c-4eb1-8bd9-0ec577627b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_dd12f72a-7c15-43ab-90bc-112089bf3a5e" xlink:to="loc_us-gaap_ProfitLoss_e0b39109-c40c-4eb1-8bd9-0ec577627b3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e59bcf9d-0d9a-463c-8a7f-be207a730598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_dd12f72a-7c15-43ab-90bc-112089bf3a5e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e59bcf9d-0d9a-463c-8a7f-be207a730598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f0a55ea0-f49b-475e-a9f6-bc4b2227e598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6a347918-15a6-4d89-a47c-47b1ff96b1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f0a55ea0-f49b-475e-a9f6-bc4b2227e598" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6a347918-15a6-4d89-a47c-47b1ff96b1d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0e6aa8e2-b122-476f-88ba-2a883583d0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_f0a55ea0-f49b-475e-a9f6-bc4b2227e598" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0e6aa8e2-b122-476f-88ba-2a883583d0fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_88dbd828-618e-4099-86ec-0f41028867b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_17fc47e5-7e84-407d-bf89-c76ef407431a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_88dbd828-618e-4099-86ec-0f41028867b7" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_17fc47e5-7e84-407d-bf89-c76ef407431a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0cd80988-9255-408f-a6b0-00cb56cbada6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_88dbd828-618e-4099-86ec-0f41028867b7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0cd80988-9255-408f-a6b0-00cb56cbada6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d79731b8-f808-45e9-9297-598ba18a4fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_88dbd828-618e-4099-86ec-0f41028867b7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d79731b8-f808-45e9-9297-598ba18a4fc2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eb3ed0f3-1e87-48fb-bf79-a2fcce253915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_73c3dce5-4435-436f-94b2-3961b6b60d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eb3ed0f3-1e87-48fb-bf79-a2fcce253915" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_73c3dce5-4435-436f-94b2-3961b6b60d58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_84348bc0-ef28-40c3-9165-5c68133500a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eb3ed0f3-1e87-48fb-bf79-a2fcce253915" xlink:to="loc_us-gaap_ProfitLoss_84348bc0-ef28-40c3-9165-5c68133500a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b0bc482-0618-4d30-8804-dfd0cc15be46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_07348908-40ec-4413-9b36-2376df6c64b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b0bc482-0618-4d30-8804-dfd0cc15be46" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_07348908-40ec-4413-9b36-2376df6c64b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1b311e67-d907-41da-b019-98e62a983873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b0bc482-0618-4d30-8804-dfd0cc15be46" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1b311e67-d907-41da-b019-98e62a983873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5eda68b3-aed9-40f9-8ff1-88ac43f13732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4bdfb63f-906a-4ef7-8329-1758a27812d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5eda68b3-aed9-40f9-8ff1-88ac43f13732" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4bdfb63f-906a-4ef7-8329-1758a27812d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c912e628-9607-48af-8679-66b545205595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5eda68b3-aed9-40f9-8ff1-88ac43f13732" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c912e628-9607-48af-8679-66b545205595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5d0a68d9-da6b-4023-8517-39da9cfd7b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5eda68b3-aed9-40f9-8ff1-88ac43f13732" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5d0a68d9-da6b-4023-8517-39da9cfd7b05" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c2e4cbd8-e58c-4504-9f6f-55b716b8f23e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a5ca5a5-3cfe-4aca-90ea-76d8e4e44451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2e4cbd8-e58c-4504-9f6f-55b716b8f23e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a5ca5a5-3cfe-4aca-90ea-76d8e4e44451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d805e80c-b576-45bb-b306-dc9207d7052b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2e4cbd8-e58c-4504-9f6f-55b716b8f23e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d805e80c-b576-45bb-b306-dc9207d7052b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4a99fd42-3b74-4237-839f-7e6b2c0376d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2e4cbd8-e58c-4504-9f6f-55b716b8f23e" xlink:to="loc_us-gaap_InventoryNet_4a99fd42-3b74-4237-839f-7e6b2c0376d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_19a451ca-0eef-4675-bf5d-cf23c39dc774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2e4cbd8-e58c-4504-9f6f-55b716b8f23e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_19a451ca-0eef-4675-bf5d-cf23c39dc774" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_74c52d94-9d0e-4e2b-971c-5896753a9605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f9bcefa7-0a81-4abb-b95a-e0b4a8e974d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c52d94-9d0e-4e2b-971c-5896753a9605" xlink:to="loc_us-gaap_AssetsCurrent_f9bcefa7-0a81-4abb-b95a-e0b4a8e974d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_94801acb-f9d1-44cc-9ed9-d99b488aeac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c52d94-9d0e-4e2b-971c-5896753a9605" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_94801acb-f9d1-44cc-9ed9-d99b488aeac2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d0bab699-9874-4d66-b494-7e8fd63d3e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c52d94-9d0e-4e2b-971c-5896753a9605" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d0bab699-9874-4d66-b494-7e8fd63d3e6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_774be435-22bb-4115-90f3-76065ebea3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c52d94-9d0e-4e2b-971c-5896753a9605" xlink:to="loc_us-gaap_Goodwill_774be435-22bb-4115-90f3-76065ebea3a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2ba457c0-412f-4744-ba94-738cd281c050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c52d94-9d0e-4e2b-971c-5896753a9605" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2ba457c0-412f-4744-ba94-738cd281c050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_dacfc541-19ba-460b-8d26-5a9809dd31a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c52d94-9d0e-4e2b-971c-5896753a9605" xlink:to="loc_us-gaap_EquityMethodInvestments_dacfc541-19ba-460b-8d26-5a9809dd31a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f6a2a24-965f-4cdc-9ac8-59aaa51e361b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c52d94-9d0e-4e2b-971c-5896753a9605" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f6a2a24-965f-4cdc-9ac8-59aaa51e361b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7a8db3d4-8336-4ffc-8fc0-5bb3f2cfa2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_865e0a98-9f29-4bd8-8a8d-976ee1ca07e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7a8db3d4-8336-4ffc-8fc0-5bb3f2cfa2fd" xlink:to="loc_us-gaap_CommonStockValue_865e0a98-9f29-4bd8-8a8d-976ee1ca07e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ee1ff09a-a3be-43f8-b788-4582f4fea346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7a8db3d4-8336-4ffc-8fc0-5bb3f2cfa2fd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ee1ff09a-a3be-43f8-b788-4582f4fea346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c880c61-68f3-4938-a1f1-6d2925ae6422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7a8db3d4-8336-4ffc-8fc0-5bb3f2cfa2fd" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c880c61-68f3-4938-a1f1-6d2925ae6422" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5772907a-bbe7-4936-9b8f-813236b7148e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7a8db3d4-8336-4ffc-8fc0-5bb3f2cfa2fd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5772907a-bbe7-4936-9b8f-813236b7148e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e579564f-a844-42e1-8488-058db50a8ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7a8db3d4-8336-4ffc-8fc0-5bb3f2cfa2fd" xlink:to="loc_us-gaap_TreasuryStockValue_e579564f-a844-42e1-8488-058db50a8ec1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ec652668-898e-43a3-98e1-77e82fdc0588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e0616c8a-c12d-4d42-bbea-1c92b12c22f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ec652668-898e-43a3-98e1-77e82fdc0588" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e0616c8a-c12d-4d42-bbea-1c92b12c22f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_615a4219-fff2-4263-a020-b25739488963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ec652668-898e-43a3-98e1-77e82fdc0588" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_615a4219-fff2-4263-a020-b25739488963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e8ee10e9-9bd1-4a2e-886f-5dba3880b26f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ec652668-898e-43a3-98e1-77e82fdc0588" xlink:to="loc_us-gaap_LongTermDebtCurrent_e8ee10e9-9bd1-4a2e-886f-5dba3880b26f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ac32c49-eb23-4005-b44c-4277933a26ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2f01c737-38d0-406e-bb1d-aa7ab2c35857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ac32c49-eb23-4005-b44c-4277933a26ca" xlink:to="loc_us-gaap_StockholdersEquity_2f01c737-38d0-406e-bb1d-aa7ab2c35857" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c090757c-3939-462c-9e3f-de143d51325e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5ac32c49-eb23-4005-b44c-4277933a26ca" xlink:to="loc_us-gaap_MinorityInterest_c090757c-3939-462c-9e3f-de143d51325e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fb628806-2b89-48c8-94cc-07d9fd1966be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_aa3831fb-fba5-4022-bdc3-9c170ca7346a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fb628806-2b89-48c8-94cc-07d9fd1966be" xlink:to="loc_us-gaap_LiabilitiesCurrent_aa3831fb-fba5-4022-bdc3-9c170ca7346a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9fc9921b-3c40-4083-b43a-61796b5f1eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fb628806-2b89-48c8-94cc-07d9fd1966be" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9fc9921b-3c40-4083-b43a-61796b5f1eda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e61da251-c3ee-4ba6-b6b7-0cb2cc465b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fb628806-2b89-48c8-94cc-07d9fd1966be" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e61da251-c3ee-4ba6-b6b7-0cb2cc465b6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1670009d-32fb-4531-8e97-ada3dcf9b9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fb628806-2b89-48c8-94cc-07d9fd1966be" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1670009d-32fb-4531-8e97-ada3dcf9b9a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_5c583332-b212-4fbb-bca4-b000cc9f9ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fb628806-2b89-48c8-94cc-07d9fd1966be" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_5c583332-b212-4fbb-bca4-b000cc9f9ac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9d898973-14b4-4ddc-99f9-e4f08bb80e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fb628806-2b89-48c8-94cc-07d9fd1966be" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9d898973-14b4-4ddc-99f9-e4f08bb80e52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_63ef524e-a146-48d5-9293-2dfbbe21b4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fb628806-2b89-48c8-94cc-07d9fd1966be" xlink:to="loc_us-gaap_CommitmentsAndContingencies_63ef524e-a146-48d5-9293-2dfbbe21b4ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_30838ee4-9a43-4238-b14f-bcf98ee4a8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_30838ee4-9a43-4238-b14f-bcf98ee4a8c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4d46679a-5447-4987-9b74-7d977fd0d73b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:to="loc_us-gaap_RepaymentsOfDebt_4d46679a-5447-4987-9b74-7d977fd0d73b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_90c5a373-b47a-4cad-81cf-50de90bab410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_90c5a373-b47a-4cad-81cf-50de90bab410" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c9b956ed-5c0f-4ccc-8f02-09434eee8f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c9b956ed-5c0f-4ccc-8f02-09434eee8f3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8064b904-cec2-4b86-aff8-7ef11784c805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8064b904-cec2-4b86-aff8-7ef11784c805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_13321f3d-f057-409f-a7a2-4852d329beec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_13321f3d-f057-409f-a7a2-4852d329beec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_baecbd5b-0cab-4f49-9343-037367a73eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_baecbd5b-0cab-4f49-9343-037367a73eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_25e9996e-53b6-4573-90aa-ceaa87b14fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baa84aaa-1f31-49e1-8815-9205071fde9d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_25e9996e-53b6-4573-90aa-ceaa87b14fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_739e800b-c70c-4a8e-8d5f-c9f4dfa01e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7329dbd4-f0c0-4606-b311-50d68c96cee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_739e800b-c70c-4a8e-8d5f-c9f4dfa01e68" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7329dbd4-f0c0-4606-b311-50d68c96cee7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8f9b58a2-b827-45b9-aad7-78d20acaeb53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_739e800b-c70c-4a8e-8d5f-c9f4dfa01e68" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8f9b58a2-b827-45b9-aad7-78d20acaeb53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_11d72530-be2e-4500-8c3a-e3d5c93dfa61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_739e800b-c70c-4a8e-8d5f-c9f4dfa01e68" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_11d72530-be2e-4500-8c3a-e3d5c93dfa61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d407706b-cfcc-402b-a68e-c81878d47cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_739e800b-c70c-4a8e-8d5f-c9f4dfa01e68" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d407706b-cfcc-402b-a68e-c81878d47cc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eac80821-737a-4660-9806-c9ff9f4276c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_ProfitLoss_eac80821-737a-4660-9806-c9ff9f4276c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture_462b5ba4-0064-4108-858e-f087e659a471" xlink:href="dgx-20210930.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_dgx_GainLossOnDispositionOfJointVenture_462b5ba4-0064-4108-858e-f087e659a471" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_06d41221-f448-4279-a7ab-68bb7f1e44aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_06d41221-f448-4279-a7ab-68bb7f1e44aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_f96d895a-00c2-48c7-8954-e67bc9feca2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_f96d895a-00c2-48c7-8954-e67bc9feca2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c5d92882-791c-4eb2-818b-935147e48500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c5d92882-791c-4eb2-818b-935147e48500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9268b4f5-8689-45de-82e9-7d7f49f8950b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_ShareBasedCompensation_9268b4f5-8689-45de-82e9-7d7f49f8950b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9f67ed7c-7b09-4a84-bc87-31010237005b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9f67ed7c-7b09-4a84-bc87-31010237005b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8f5a50a3-bad0-47a3-8cf3-fc24842e2c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8f5a50a3-bad0-47a3-8cf3-fc24842e2c21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements_ae8f5a40-01be-4ddc-9869-8d45dac19031" xlink:href="dgx-20210930.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_dgx_TerminationOfInterestRateSwapAgreements_ae8f5a40-01be-4ddc-9869-8d45dac19031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_366cb326-552f-4312-bbe9-3ccb2c400927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_366cb326-552f-4312-bbe9-3ccb2c400927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d9167480-057f-4b58-a04b-1147940595d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d9167480-057f-4b58-a04b-1147940595d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d477eb7c-7780-417a-84d5-ca1eb6e7d521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d92b8ce3-7312-4e51-9831-4743a48fff35" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d477eb7c-7780-417a-84d5-ca1eb6e7d521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4aa84076-bc1b-4d42-b2cc-2e34e5bea584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2d106887-a9ee-4b28-9986-390feaba1678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4aa84076-bc1b-4d42-b2cc-2e34e5bea584" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2d106887-a9ee-4b28-9986-390feaba1678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_736d0c15-f521-42af-8dcb-7a6d3f20e77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4aa84076-bc1b-4d42-b2cc-2e34e5bea584" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_736d0c15-f521-42af-8dcb-7a6d3f20e77b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cc060238-cea3-46b2-99a4-70d21012c693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4aa84076-bc1b-4d42-b2cc-2e34e5bea584" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cc060238-cea3-46b2-99a4-70d21012c693" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_b277417c-941e-4525-a548-760d3740d8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e571df58-948e-4798-bed3-486e5f0a68bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_b277417c-941e-4525-a548-760d3740d8d8" xlink:to="loc_us-gaap_NetIncomeLoss_e571df58-948e-4798-bed3-486e5f0a68bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_b39220fe-c260-4fb8-acf6-d821766ffd08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_b277417c-941e-4525-a548-760d3740d8d8" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_b39220fe-c260-4fb8-acf6-d821766ffd08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ab44a25-b71e-49ac-973d-a759929d3534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e8a2967-9b09-4aba-96e3-d1e20ad7bd43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ab44a25-b71e-49ac-973d-a759929d3534" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7e8a2967-9b09-4aba-96e3-d1e20ad7bd43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_775ee722-85fe-4665-a2e6-0274108aaf91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ab44a25-b71e-49ac-973d-a759929d3534" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_775ee722-85fe-4665-a2e6-0274108aaf91" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_353b4e7b-0d52-4404-bca6-2f7de83a42cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_5c450057-e5e9-47de-92c4-f8383b47e86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_353b4e7b-0d52-4404-bca6-2f7de83a42cb" xlink:to="loc_us-gaap_TradingSecurities_5c450057-e5e9-47de-92c4-f8383b47e86b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_bc601cf2-31df-4d8d-ac8e-9ce1c22f0302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_353b4e7b-0d52-4404-bca6-2f7de83a42cb" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_bc601cf2-31df-4d8d-ac8e-9ce1c22f0302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_5be82a07-fc18-4a92-b8b3-aa2e5f8af7f1" xlink:href="dgx-20210930.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_353b4e7b-0d52-4404-bca6-2f7de83a42cb" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_5be82a07-fc18-4a92-b8b3-aa2e5f8af7f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9a261ac3-65b8-4509-8e51-8572f48d628d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_353b4e7b-0d52-4404-bca6-2f7de83a42cb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9a261ac3-65b8-4509-8e51-8572f48d628d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_32ceb704-e2ad-4101-9830-5e77f51a0347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_65fe2cf2-5a57-4c98-9bdd-08b19d12dc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_32ceb704-e2ad-4101-9830-5e77f51a0347" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_65fe2cf2-5a57-4c98-9bdd-08b19d12dc6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecdcbab0-9b74-47f2-a3fc-742aa96bb826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_32ceb704-e2ad-4101-9830-5e77f51a0347" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ecdcbab0-9b74-47f2-a3fc-742aa96bb826" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b9d4225c-a8e2-46ae-b591-ad8bc48fac90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b576d10f-83fd-4fca-86b1-d3cec57e99cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b9d4225c-a8e2-46ae-b591-ad8bc48fac90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b576d10f-83fd-4fca-86b1-d3cec57e99cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_75d234b1-b733-4695-a5f7-7c30b2ea6b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b9d4225c-a8e2-46ae-b591-ad8bc48fac90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_75d234b1-b733-4695-a5f7-7c30b2ea6b4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c280c84c-ba22-4441-b23b-12d8eda7ea29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b9d4225c-a8e2-46ae-b591-ad8bc48fac90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c280c84c-ba22-4441-b23b-12d8eda7ea29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_655ed69b-5593-43be-a92b-208ef051b385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b9d4225c-a8e2-46ae-b591-ad8bc48fac90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_655ed69b-5593-43be-a92b-208ef051b385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_962d2ad6-8820-49f2-941a-c768601ecf18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b9d4225c-a8e2-46ae-b591-ad8bc48fac90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_962d2ad6-8820-49f2-941a-c768601ecf18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8ab5d676-92cf-459c-815b-6fb19167a255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b9d4225c-a8e2-46ae-b591-ad8bc48fac90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8ab5d676-92cf-459c-815b-6fb19167a255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_718baf9b-2bfb-4bba-960a-d1338797088e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b9d4225c-a8e2-46ae-b591-ad8bc48fac90" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_718baf9b-2bfb-4bba-960a-d1338797088e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_96a74a9d-0940-4b61-a2f7-5b85d5d37219" xlink:href="dgx-20210930.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_c48027d9-2f4f-4aa0-bd1b-aaca96b2794a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_96a74a9d-0940-4b61-a2f7-5b85d5d37219" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_c48027d9-2f4f-4aa0-bd1b-aaca96b2794a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_c259bb67-a828-458e-87ca-8110fe181b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_96a74a9d-0940-4b61-a2f7-5b85d5d37219" xlink:to="loc_us-gaap_LiabilitiesAssumed1_c259bb67-a828-458e-87ca-8110fe181b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0586d9fd-88cd-4863-bab7-abcd7bdf09ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_02e6f206-c277-46e3-9176-7304626145d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_0586d9fd-88cd-4863-bab7-abcd7bdf09ec" xlink:to="loc_us-gaap_Depreciation_02e6f206-c277-46e3-9176-7304626145d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3d3fed75-2f66-4d08-b3af-1743132c408a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_0586d9fd-88cd-4863-bab7-abcd7bdf09ec" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3d3fed75-2f66-4d08-b3af-1743132c408a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_eee4f266-26f2-41b3-806a-f38bb132b817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7b0b35a5-bd81-4f4a-9e65-1bf0fd7f964e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_eee4f266-26f2-41b3-806a-f38bb132b817" xlink:to="loc_us-gaap_InterestExpense_7b0b35a5-bd81-4f4a-9e65-1bf0fd7f964e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_afef0b2a-7da9-457f-98f0-092465e3316f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_eee4f266-26f2-41b3-806a-f38bb132b817" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_afef0b2a-7da9-457f-98f0-092465e3316f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>dgx-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3dfc3e15-f0aa-46bd-8aee-40e417fed44b,g:988a0070-0eae-4f69-89e4-5f07a4cdd401-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i9a1bb22ed1bb4ece901b0b20b0df42bb_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_34ee1355-b2d2-4f43-acec-a4f86e96bbec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34ee1355-b2d2-4f43-acec-a4f86e96bbec" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4faec15a-7681-4828-9388-780c97e242fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4faec15a-7681-4828-9388-780c97e242fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6133ce98-7c17-454e-904c-eb7c398c0884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6133ce98-7c17-454e-904c-eb7c398c0884" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_93174e34-b2e5-49bb-bccf-768982327d4d" xlink:href="dgx-20210930.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_93174e34-b2e5-49bb-bccf-768982327d4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee5fc627-8aae-4d34-a7dd-6e037524a9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee5fc627-8aae-4d34-a7dd-6e037524a9af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_ad6f17d7-095e-4dab-8794-6728e97a4986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_DividendsCommonStockCash_ad6f17d7-095e-4dab-8794-6728e97a4986" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_ce4add59-41b2-4df2-8fdc-8957ee729b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_ce4add59-41b2-4df2-8fdc-8957ee729b30" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d4d0ecbe-f084-4090-bcae-e884a0d59a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d4d0ecbe-f084-4090-bcae-e884a0d59a15" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_04bf12b1-0b9d-4128-af2e-25b62e0aefef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_04bf12b1-0b9d-4128-af2e-25b62e0aefef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_239e5c15-081e-48f3-af18-c3ca729322ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_239e5c15-081e-48f3-af18-c3ca729322ca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_755f3fd5-7968-4620-8435-189a9adcb94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_755f3fd5-7968-4620-8435-189a9adcb94e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c3f0413e-464a-4343-8ed1-de6ca0ac783b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c3f0413e-464a-4343-8ed1-de6ca0ac783b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1f1976ae-8771-49f6-8723-027bc1d2aba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1f1976ae-8771-49f6-8723-027bc1d2aba4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_bda01ac7-89fd-4c3e-b508-358bb53eba90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_bda01ac7-89fd-4c3e-b508-358bb53eba90" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_daac374c-c763-453e-b61a-bda0775d5e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_daac374c-c763-453e-b61a-bda0775d5e67" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_389f8916-168d-4cca-ac4d-85e6ba2a0903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_389f8916-168d-4cca-ac4d-85e6ba2a0903" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b3daf8f2-44b5-4d2f-be98-bfe5d68752d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8f89ea6-c7ca-49c3-ab9d-34d6d2d286f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34ee1355-b2d2-4f43-acec-a4f86e96bbec" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d7836d51-b2a0-45cc-8df1-51305647ce50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d7836d51-b2a0-45cc-8df1-51305647ce50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_cb466e8b-2b23-41ea-9c72-88d0c5250a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_cb466e8b-2b23-41ea-9c72-88d0c5250a01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_607458d1-9268-4218-88f4-85eb0d2f4908" xlink:href="dgx-20210930.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_607458d1-9268-4218-88f4-85eb0d2f4908" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1e4be99c-153a-4fce-be11-bf7a14b19af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1cfed139-77ab-4558-901b-e4ac206efce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_34ee1355-b2d2-4f43-acec-a4f86e96bbec" xlink:to="loc_us-gaap_StatementTable_1cfed139-77ab-4558-901b-e4ac206efce1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ee822fd1-83cf-437b-8ede-e56b0e4a55f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1cfed139-77ab-4558-901b-e4ac206efce1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ee822fd1-83cf-437b-8ede-e56b0e4a55f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee822fd1-83cf-437b-8ede-e56b0e4a55f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee822fd1-83cf-437b-8ede-e56b0e4a55f9" xlink:to="loc_us-gaap_EquityComponentDomain_ee822fd1-83cf-437b-8ede-e56b0e4a55f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee822fd1-83cf-437b-8ede-e56b0e4a55f9" xlink:to="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bbd26574-3f9c-47f1-8571-738cce2eb624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_CommonStockMember_bbd26574-3f9c-47f1-8571-738cce2eb624" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f8d5bcdd-a349-4bb6-b206-b3791244e320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f8d5bcdd-a349-4bb6-b206-b3791244e320" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_68e8fe95-1fd7-49e9-a5bd-697436c386c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_RetainedEarningsMember_68e8fe95-1fd7-49e9-a5bd-697436c386c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fe55b620-a02e-48aa-827d-3ae795f89566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fe55b620-a02e-48aa-827d-3ae795f89566" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c2540c14-388c-4256-b841-2d07b1ed030d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_TreasuryStockMember_c2540c14-388c-4256-b841-2d07b1ed030d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f417352c-659c-4520-8fa3-62aead7f037b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f417352c-659c-4520-8fa3-62aead7f037b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#EARNINGSPERSHAREDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended" id="i61750a8a61584c2aa5ca43a9d4c2ab83_EARNINGSPERSHAREDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_3d1ccb35-a00e-433d-8a73-10efbb9b1caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid_602b1e72-56ed-4760-90dc-ede8c385de03" xlink:href="dgx-20210930.xsd#dgx_AcceleratedShareRepurchasesInitialPricePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_3d1ccb35-a00e-433d-8a73-10efbb9b1caa" xlink:to="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid_602b1e72-56ed-4760-90dc-ede8c385de03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_9ff63213-f356-4578-a7c7-500604aa1a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_3d1ccb35-a00e-433d-8a73-10efbb9b1caa" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_9ff63213-f356-4578-a7c7-500604aa1a36" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e9df3436-411e-4c56-8bb1-052c2a827909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_9ff63213-f356-4578-a7c7-500604aa1a36" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e9df3436-411e-4c56-8bb1-052c2a827909" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e9df3436-411e-4c56-8bb1-052c2a827909_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e9df3436-411e-4c56-8bb1-052c2a827909" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e9df3436-411e-4c56-8bb1-052c2a827909_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_b74450bb-65f9-4ef4-8531-4fd4cbb466b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e9df3436-411e-4c56-8bb1-052c2a827909" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_b74450bb-65f9-4ef4-8531-4fd4cbb466b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b83385ba-ab62-4d92-a637-faeae8347fec" xlink:href="dgx-20210930.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_b74450bb-65f9-4ef4-8531-4fd4cbb466b5" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b83385ba-ab62-4d92-a637-faeae8347fec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="ia2180e1cd9db4d64b3f1c6bff6987568_BUSINESSACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1603e169-c464-4188-b592-8e5f7107bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1603e169-c464-4188-b592-8e5f7107bd1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7f1d2e40-cc82-4886-a57d-6ad0f3102fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7f1d2e40-cc82-4886-a57d-6ad0f3102fdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9ed0470a-19a5-42f7-b901-02697ddf9785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_Goodwill_9ed0470a-19a5-42f7-b901-02697ddf9785" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_c38ec5d9-115b-4421-98b7-234c2ec37855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_c38ec5d9-115b-4421-98b7-234c2ec37855" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4c110e3c-d01f-460c-80d2-9fa7a984b715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4c110e3c-d01f-460c-80d2-9fa7a984b715" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f272d220-0119-43a9-b3cf-90fedc784b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f272d220-0119-43a9-b3cf-90fedc784b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f272d220-0119-43a9-b3cf-90fedc784b09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f272d220-0119-43a9-b3cf-90fedc784b09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f272d220-0119-43a9-b3cf-90fedc784b09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0075d031-2887-45ab-9794-e733d259223b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f272d220-0119-43a9-b3cf-90fedc784b09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0075d031-2887-45ab-9794-e733d259223b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember_c232b443-bba4-459d-a5bd-dc018aef632d" xlink:href="dgx-20210930.xsd#dgx_MercyHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0075d031-2887-45ab-9794-e733d259223b" xlink:to="loc_dgx_MercyHealthMember_c232b443-bba4-459d-a5bd-dc018aef632d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d0851de-61a9-4ade-a6d3-99997ba0a8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d0851de-61a9-4ade-a6d3-99997ba0a8eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4d0851de-61a9-4ade-a6d3-99997ba0a8eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d0851de-61a9-4ade-a6d3-99997ba0a8eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4d0851de-61a9-4ade-a6d3-99997ba0a8eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_680177f4-46d6-42bc-bbe9-f5b97f659458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d0851de-61a9-4ade-a6d3-99997ba0a8eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_680177f4-46d6-42bc-bbe9-f5b97f659458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1244aaa0-0bc3-402d-b717-c48ea5d128ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_680177f4-46d6-42bc-bbe9-f5b97f659458" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1244aaa0-0bc3-402d-b717-c48ea5d128ad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#DISPOSITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="extended" id="i06666b100abc4506b8dddcb6dbea33b6_DISPOSITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_7beeea0d-852f-4f62-b74a-55b3f4670083" xlink:href="dgx-20210930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_7beeea0d-852f-4f62-b74a-55b3f4670083" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_01e7f221-cccd-45ca-be50-f21747e505bf" xlink:href="dgx-20210930.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_01e7f221-cccd-45ca-be50-f21747e505bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_1a0354c4-c0b7-422e-a835-e8d9f0c4b787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_1a0354c4-c0b7-422e-a835-e8d9f0c4b787" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0ef0937e-ad4f-4f87-8527-917e265bc587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0ef0937e-ad4f-4f87-8527-917e265bc587" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_976b58ca-c2f8-4b72-af98-2c86e205e8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_976b58ca-c2f8-4b72-af98-2c86e205e8fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3f6addb2-9d69-4c8b-80d2-5a1b339b0570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3f6addb2-9d69-4c8b-80d2-5a1b339b0570" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_05ff84e6-e202-41be-8909-96140bbab161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_05ff84e6-e202-41be-8909-96140bbab161" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5b78db07-448f-455d-839c-8b24022f8e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5b78db07-448f-455d-839c-8b24022f8e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b78db07-448f-455d-839c-8b24022f8e5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5b78db07-448f-455d-839c-8b24022f8e5d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b78db07-448f-455d-839c-8b24022f8e5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f7192b84-ec34-4c9d-80c4-23fba6fbdcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5b78db07-448f-455d-839c-8b24022f8e5d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f7192b84-ec34-4c9d-80c4-23fba6fbdcc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_4f7397eb-2b14-42a4-9312-de1919f6ab83" xlink:href="dgx-20210930.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f7192b84-ec34-4c9d-80c4-23fba6fbdcc5" xlink:to="loc_dgx_Q2SolutionsMember_4f7397eb-2b14-42a4-9312-de1919f6ab83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e9f6de55-fc03-4b32-91e7-1b9388630aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e9f6de55-fc03-4b32-91e7-1b9388630aa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_b87941f3-bf37-4f25-8ff6-5427ae52f7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e9f6de55-fc03-4b32-91e7-1b9388630aa3" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_b87941f3-bf37-4f25-8ff6-5427ae52f7b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e55042db-9aa4-4382-8364-bb2475688b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e55042db-9aa4-4382-8364-bb2475688b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_e06541a2-766c-4f84-a1f6-109ea199a6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e55042db-9aa4-4382-8364-bb2475688b5d" xlink:to="loc_us-gaap_OtherIncomeMember_e06541a2-766c-4f84-a1f6-109ea199a6fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f" xlink:to="loc_us-gaap_EquityComponentDomain_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8eaaaf62-111c-40d8-be6f-6c4484ecb923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f" xlink:to="loc_us-gaap_EquityComponentDomain_8eaaaf62-111c-40d8-be6f-6c4484ecb923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_6befcd4e-ba82-4d04-aa1d-2536719e36ab" xlink:href="dgx-20210930.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8eaaaf62-111c-40d8-be6f-6c4484ecb923" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_6befcd4e-ba82-4d04-aa1d-2536719e36ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i131713293b3341759aa42285d4d6a770_FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e1b3087d-ae6c-4a23-bc35-caa7665e3e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_TradingSecurities_e1b3087d-ae6c-4a23-bc35-caa7665e3e6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_61b88399-ffc5-4ca1-8e02-e05ce360ab24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_61b88399-ffc5-4ca1-8e02-e05ce360ab24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_f6c51393-dd25-4a29-b7cc-b386ee53fa6a" xlink:href="dgx-20210930.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_f6c51393-dd25-4a29-b7cc-b386ee53fa6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_993df16e-e9fe-4646-b64d-344652a69e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_993df16e-e9fe-4646-b64d-344652a69e34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_da6d2d4b-c6a8-43e3-bdb6-ec16912bec71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_da6d2d4b-c6a8-43e3-bdb6-ec16912bec71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_10a01523-5340-4a35-8c3c-814a568290e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_10a01523-5340-4a35-8c3c-814a568290e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_25729937-3cd1-4a0b-aa2f-b9fba54c781e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_25729937-3cd1-4a0b-aa2f-b9fba54c781e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7c39ac9a-4261-4438-861c-2196a73fcd22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7c39ac9a-4261-4438-861c-2196a73fcd22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_39df8c6f-4e06-4d81-9025-72ea5500f7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7c39ac9a-4261-4438-861c-2196a73fcd22" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_39df8c6f-4e06-4d81-9025-72ea5500f7cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67fb55ab-c58d-4711-9b39-14573db934f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67fb55ab-c58d-4711-9b39-14573db934f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67fb55ab-c58d-4711-9b39-14573db934f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67fb55ab-c58d-4711-9b39-14573db934f2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_67fb55ab-c58d-4711-9b39-14573db934f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67fb55ab-c58d-4711-9b39-14573db934f2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ccc8dcef-7698-4975-aabd-84642c98ae45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ccc8dcef-7698-4975-aabd-84642c98ae45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9dfe604f-7e32-453d-b2c3-fb7fad332fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9dfe604f-7e32-453d-b2c3-fb7fad332fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7106ab83-d355-4851-8771-537f9dd25ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7106ab83-d355-4851-8771-537f9dd25ac9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i2bc221cdf61e408d9a9987e3cba293ca_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03ea0a34-1a5a-44dd-ab2d-688a3471ea6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_7a85be73-63cb-49df-b952-2e8d7ca03ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03ea0a34-1a5a-44dd-ab2d-688a3471ea6e" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_7a85be73-63cb-49df-b952-2e8d7ca03ce6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_609bf5d1-99f8-41b8-b1f4-b9efeadbafbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03ea0a34-1a5a-44dd-ab2d-688a3471ea6e" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_609bf5d1-99f8-41b8-b1f4-b9efeadbafbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03ea0a34-1a5a-44dd-ab2d-688a3471ea6e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_448559ae-1d62-4718-bdd0-6a9168853066" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:to="loc_srt_OwnershipAxis_448559ae-1d62-4718-bdd0-6a9168853066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_448559ae-1d62-4718-bdd0-6a9168853066_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_448559ae-1d62-4718-bdd0-6a9168853066" xlink:to="loc_srt_OwnershipDomain_448559ae-1d62-4718-bdd0-6a9168853066_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_87132731-3c8e-481a-aeb8-83b3c298a41e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_448559ae-1d62-4718-bdd0-6a9168853066" xlink:to="loc_srt_OwnershipDomain_87132731-3c8e-481a-aeb8-83b3c298a41e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_772382d7-7cb0-405d-9855-aa647d8ffafa" xlink:href="dgx-20210930.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_87132731-3c8e-481a-aeb8-83b3c298a41e" xlink:to="loc_dgx_UMassJointVentureMember_772382d7-7cb0-405d-9855-aa647d8ffafa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_457e480c-5881-47d6-acbf-7a7777a938fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_457e480c-5881-47d6-acbf-7a7777a938fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_457e480c-5881-47d6-acbf-7a7777a938fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_457e480c-5881-47d6-acbf-7a7777a938fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_457e480c-5881-47d6-acbf-7a7777a938fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d96263ba-3116-41eb-91a3-28cbe7cdc285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_457e480c-5881-47d6-acbf-7a7777a938fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d96263ba-3116-41eb-91a3-28cbe7cdc285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b55d6b2e-563a-46dc-bb79-ed1cc62b9316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d96263ba-3116-41eb-91a3-28cbe7cdc285" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b55d6b2e-563a-46dc-bb79-ed1cc62b9316" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended" id="i91743b353fba438c95d36cfc7ab1f209_GOODWILLANDINTANGIBLEASSETSGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6580131e-ef17-41a7-9677-28c7bb31f948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_7780007b-9053-4d98-85b9-f4587112838c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6580131e-ef17-41a7-9677-28c7bb31f948" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_7780007b-9053-4d98-85b9-f4587112838c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d527dbb-3cc1-47d1-afdb-41722843de22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6580131e-ef17-41a7-9677-28c7bb31f948" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d527dbb-3cc1-47d1-afdb-41722843de22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cd614c09-d6b0-49fc-ab96-08a396c00039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d527dbb-3cc1-47d1-afdb-41722843de22" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cd614c09-d6b0-49fc-ab96-08a396c00039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cd614c09-d6b0-49fc-ab96-08a396c00039_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd614c09-d6b0-49fc-ab96-08a396c00039" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cd614c09-d6b0-49fc-ab96-08a396c00039_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e41c7cc8-5645-4d41-bd13-64ad2ac437f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd614c09-d6b0-49fc-ab96-08a396c00039" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e41c7cc8-5645-4d41-bd13-64ad2ac437f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_7504bc8d-c810-4627-9b9a-659c19a1b457" xlink:href="dgx-20210930.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e41c7cc8-5645-4d41-bd13-64ad2ac437f2" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_7504bc8d-c810-4627-9b9a-659c19a1b457" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended" id="ica0d14a825054366b847b6ee818bc518_GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:href="dgx-20210930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2bb905b4-37f2-4243-8736-005de986e7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2bb905b4-37f2-4243-8736-005de986e7dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4acb5032-185a-46ef-bdb8-2e2678c9e9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4acb5032-185a-46ef-bdb8-2e2678c9e9e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9dae3272-52e4-47f1-92e3-c7f2136bf7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9dae3272-52e4-47f1-92e3-c7f2136bf7cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7ffb7630-a352-475a-99eb-4f473a6833c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7ffb7630-a352-475a-99eb-4f473a6833c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d771ce8f-f500-40a1-adaa-0c69d76570ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d771ce8f-f500-40a1-adaa-0c69d76570ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d6bce12f-4a81-4fa9-9406-9fd2240b193d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d6bce12f-4a81-4fa9-9406-9fd2240b193d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_44987bd6-5e1c-40d5-8c19-c4b215e126e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_44987bd6-5e1c-40d5-8c19-c4b215e126e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_27f69576-2b38-400a-b66a-d789bcc90810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_27f69576-2b38-400a-b66a-d789bcc90810" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3c222c7a-5c96-4348-8546-03a9214a4d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3c222c7a-5c96-4348-8546-03a9214a4d75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_eb0af2e0-0137-45ba-a029-d65b215fd70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_eb0af2e0-0137-45ba-a029-d65b215fd70f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5f0e472a-a9d5-4fdf-bee2-c48df6c7cb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5f0e472a-a9d5-4fdf-bee2-c48df6c7cb01" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e1c64771-e324-4955-9dae-7421e70ed687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e1c64771-e324-4955-9dae-7421e70ed687" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8a8ea952-ba02-4f09-b69a-c9700631d140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8a8ea952-ba02-4f09-b69a-c9700631d140" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:href="dgx-20210930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ea439b9-ba83-4100-9671-9828ec66bbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ea439b9-ba83-4100-9671-9828ec66bbcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ea439b9-ba83-4100-9671-9828ec66bbcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ea439b9-ba83-4100-9671-9828ec66bbcb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ea439b9-ba83-4100-9671-9828ec66bbcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ea439b9-ba83-4100-9671-9828ec66bbcb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9b946adf-4704-4d2d-bc61-de5ccfcb9cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9b946adf-4704-4d2d-bc61-de5ccfcb9cc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_8cac2a77-8f5a-419d-b963-02135e8e2a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_8cac2a77-8f5a-419d-b963-02135e8e2a22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_4d5ddef7-7295-489f-a13b-97e0bbd6a56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_4d5ddef7-7295-489f-a13b-97e0bbd6a56b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_056890b5-086b-4935-97d2-cb365b7a15dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_056890b5-086b-4935-97d2-cb365b7a15dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_864506f1-410f-4b61-9ca3-acac9dd28878" xlink:href="dgx-20210930.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_864506f1-410f-4b61-9ca3-acac9dd28878" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8595b8e2-974b-4946-bb9e-b90d5b189538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8595b8e2-974b-4946-bb9e-b90d5b189538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8595b8e2-974b-4946-bb9e-b90d5b189538_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8595b8e2-974b-4946-bb9e-b90d5b189538" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8595b8e2-974b-4946-bb9e-b90d5b189538_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3ac3f29-df29-4beb-96f8-dbeb845e266d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8595b8e2-974b-4946-bb9e-b90d5b189538" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3ac3f29-df29-4beb-96f8-dbeb845e266d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_74e27c05-ff31-4ee3-a1e5-74957afcc2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3ac3f29-df29-4beb-96f8-dbeb845e266d" xlink:to="loc_us-gaap_TradeNamesMember_74e27c05-ff31-4ee3-a1e5-74957afcc2f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_082d3a46-3046-4835-89f4-069b63b14d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3ac3f29-df29-4beb-96f8-dbeb845e266d" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_082d3a46-3046-4835-89f4-069b63b14d54" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended" id="ibb1acf2c534243418a2dcdc49bd4d242_FINANCIALINSTRUMENTSBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_36054ab5-17d1-4a13-b778-ca5f4b980b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_7bcafba4-c770-4cc2-9165-5c01d67d4510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_36054ab5-17d1-4a13-b778-ca5f4b980b97" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_7bcafba4-c770-4cc2-9165-5c01d67d4510" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_36054ab5-17d1-4a13-b778-ca5f4b980b97" xlink:to="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8f08a9f9-fedc-48bb-b28b-91d806ebcc64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8f08a9f9-fedc-48bb-b28b-91d806ebcc64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_0f5bb55c-3b78-4539-a7e0-3c67731e8359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f08a9f9-fedc-48bb-b28b-91d806ebcc64" xlink:to="loc_us-gaap_LongTermDebtMember_0f5bb55c-3b78-4539-a7e0-3c67731e8359" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c309511d-5a79-4278-ba22-2936659cacb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c309511d-5a79-4278-ba22-2936659cacb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_62b457fc-dfe5-4dd9-97c8-06648bb9b677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c309511d-5a79-4278-ba22-2936659cacb4" xlink:to="loc_us-gaap_FairValueHedgingMember_62b457fc-dfe5-4dd9-97c8-06648bb9b677" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended" id="i6c4c75acdbd54d149c5043bc7f0d506b_FINANCIALINSTRUMENTSIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_731eeafc-415e-4802-9884-1c6dfa9dea78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_731eeafc-415e-4802-9884-1c6dfa9dea78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_0d4becae-8eaf-4394-96e3-fa1c85a63fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_0d4becae-8eaf-4394-96e3-fa1c85a63fbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6d176144-db3e-4172-b1cf-32e851bdd3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6d176144-db3e-4172-b1cf-32e851bdd3d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:to="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_864d014f-e802-44b5-8943-51b7ce741b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_864d014f-e802-44b5-8943-51b7ce741b58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_447a4727-9d25-44cd-b9d6-c07d583b26da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_864d014f-e802-44b5-8943-51b7ce741b58" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_447a4727-9d25-44cd-b9d6-c07d583b26da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cffed391-5b5e-49eb-ba5d-40b8d247f7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cffed391-5b5e-49eb-ba5d-40b8d247f7c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_d37258d6-4c98-427b-8aa1-f3eeb42956fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_cffed391-5b5e-49eb-ba5d-40b8d247f7c6" xlink:to="loc_us-gaap_FairValueHedgingMember_d37258d6-4c98-427b-8aa1-f3eeb42956fc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended" id="ib43ccb5f129e4d2a9e491086fd8cce91_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:href="dgx-20210930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_6e7f6ac1-1337-4eda-9586-ca99fbfeaca2" xlink:href="dgx-20210930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_6e7f6ac1-1337-4eda-9586-ca99fbfeaca2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3f355b48-8192-482c-b351-8404e4647c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3f355b48-8192-482c-b351-8404e4647c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e507794a-6907-4aae-984d-bb5647803240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e507794a-6907-4aae-984d-bb5647803240" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e69c044b-1d66-41f8-aefc-4f038520e8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e69c044b-1d66-41f8-aefc-4f038520e8f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_e231d0fb-9289-4612-af45-5573b2650d7c" xlink:href="dgx-20210930.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_e231d0fb-9289-4612-af45-5573b2650d7c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f5653f7d-d8a3-41cd-8329-44b67a79293c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f5653f7d-d8a3-41cd-8329-44b67a79293c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_88eb1458-79b1-4afd-8e2c-b65dc32e3642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_88eb1458-79b1-4afd-8e2c-b65dc32e3642" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b660047a-46bf-4d98-ba8b-53e9b740a5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b660047a-46bf-4d98-ba8b-53e9b740a5f2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_0f4edba5-3aad-46b2-ae15-aeabefffff8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_0f4edba5-3aad-46b2-ae15-aeabefffff8e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_a341a060-0585-4ceb-ae1b-9d9e67dfe844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_a341a060-0585-4ceb-ae1b-9d9e67dfe844" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_29a135d1-ebfb-40b9-9b0c-24cfc63193a7" xlink:href="dgx-20210930.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_29a135d1-ebfb-40b9-9b0c-24cfc63193a7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_499a533c-d8db-466a-8fb1-c597b437468b" xlink:href="dgx-20210930.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_499a533c-d8db-466a-8fb1-c597b437468b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_ca7d156d-baa5-461b-9239-988a8cc96575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_ca7d156d-baa5-461b-9239-988a8cc96575" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_61536e52-9f78-4de7-b0dc-cd83a43b2a69" xlink:href="dgx-20210930.xsd#dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_61536e52-9f78-4de7-b0dc-cd83a43b2a69" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_805a94db-88c9-4cf9-8337-fcf508a061c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_805a94db-88c9-4cf9-8337-fcf508a061c3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_5f937428-6e04-4f54-99a6-3b85d39cc607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_5f937428-6e04-4f54-99a6-3b85d39cc607" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_af072d36-8880-4334-8eaa-804b279ca948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_af072d36-8880-4334-8eaa-804b279ca948" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:href="dgx-20210930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_566c2852-952f-4e4f-8572-c2d517111fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_566c2852-952f-4e4f-8572-c2d517111fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_566c2852-952f-4e4f-8572-c2d517111fa3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_566c2852-952f-4e4f-8572-c2d517111fa3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_566c2852-952f-4e4f-8572-c2d517111fa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b633fc9d-2704-4418-a078-ba29b038f32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_566c2852-952f-4e4f-8572-c2d517111fa3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b633fc9d-2704-4418-a078-ba29b038f32c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_fb9d133f-9db7-4751-a48d-1c4b02672ded" xlink:href="dgx-20210930.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b633fc9d-2704-4418-a078-ba29b038f32c" xlink:to="loc_dgx_Q2SolutionsMember_fb9d133f-9db7-4751-a48d-1c4b02672ded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_751f4848-8a95-459a-bca4-f1d504848d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_751f4848-8a95-459a-bca4-f1d504848d20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_751f4848-8a95-459a-bca4-f1d504848d20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_751f4848-8a95-459a-bca4-f1d504848d20" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_751f4848-8a95-459a-bca4-f1d504848d20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f7fc302b-dd27-46cc-a458-64e157f46a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_751f4848-8a95-459a-bca4-f1d504848d20" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f7fc302b-dd27-46cc-a458-64e157f46a8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_fb17a57a-4184-437d-93b1-8ac9af46e250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f7fc302b-dd27-46cc-a458-64e157f46a8c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_fb17a57a-4184-437d-93b1-8ac9af46e250" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7eea04b9-425a-42b5-967a-6b7efc39e7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7eea04b9-425a-42b5-967a-6b7efc39e7aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7eea04b9-425a-42b5-967a-6b7efc39e7aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7eea04b9-425a-42b5-967a-6b7efc39e7aa" xlink:to="loc_us-gaap_EquityComponentDomain_7eea04b9-425a-42b5-967a-6b7efc39e7aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7eea04b9-425a-42b5-967a-6b7efc39e7aa" xlink:to="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_1fec7df9-f949-445c-ac96-0aac9db61102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:to="loc_us-gaap_TreasuryStockMember_1fec7df9-f949-445c-ac96-0aac9db61102" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5b231ae7-6015-43bf-a5cb-a8dfdd173065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5b231ae7-6015-43bf-a5cb-a8dfdd173065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_d7203c58-c2fa-43f5-ad53-d9664a2f26a8" xlink:href="dgx-20210930.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_d7203c58-c2fa-43f5-ad53-d9664a2f26a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16b0157d-d54b-4c30-96f0-79cfcaddc26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16b0157d-d54b-4c30-96f0-79cfcaddc26b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_16b0157d-d54b-4c30-96f0-79cfcaddc26b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16b0157d-d54b-4c30-96f0-79cfcaddc26b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_16b0157d-d54b-4c30-96f0-79cfcaddc26b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_205ec0d3-9571-4e6e-bf49-459958c69e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16b0157d-d54b-4c30-96f0-79cfcaddc26b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_205ec0d3-9571-4e6e-bf49-459958c69e66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b04bd66b-ebe0-4d3f-b219-20ae83638a14" xlink:href="dgx-20210930.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_205ec0d3-9571-4e6e-bf49-459958c69e66" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b04bd66b-ebe0-4d3f-b219-20ae83638a14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_c6675351-e7ff-4b0e-95af-61e9a4abc623" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_srt_OwnershipAxis_c6675351-e7ff-4b0e-95af-61e9a4abc623" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_c6675351-e7ff-4b0e-95af-61e9a4abc623_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_c6675351-e7ff-4b0e-95af-61e9a4abc623" xlink:to="loc_srt_OwnershipDomain_c6675351-e7ff-4b0e-95af-61e9a4abc623_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_478d71d5-201f-462c-b43d-d8a06b3e7bcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_c6675351-e7ff-4b0e-95af-61e9a4abc623" xlink:to="loc_srt_OwnershipDomain_478d71d5-201f-462c-b43d-d8a06b3e7bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_a4a75946-4802-4b19-a7b9-ea20ba1e8292" xlink:href="dgx-20210930.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_478d71d5-201f-462c-b43d-d8a06b3e7bcc" xlink:to="loc_dgx_UMassJointVentureMember_a4a75946-4802-4b19-a7b9-ea20ba1e8292" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="extended" id="i58d27cb55e4c4dc0aab32e71d04266ae_SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:href="dgx-20210930.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_2992a879-b19b-4187-8f28-7c58b10dd6ba" xlink:href="dgx-20210930.xsd#dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_2992a879-b19b-4187-8f28-7c58b10dd6ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche_8db02ea8-a63f-4413-91c1-b24868e84000" xlink:href="dgx-20210930.xsd#dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche_8db02ea8-a63f-4413-91c1-b24868e84000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_ad75361f-5e0c-47bd-8eaa-c38080d99ebf" xlink:href="dgx-20210930.xsd#dgx_CARESActProceedsRecognizedInTheStatementOfOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_ad75361f-5e0c-47bd-8eaa-c38080d99ebf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfRecognitionOfCARESActProceeds_6321f8af-815c-4111-96bb-1c53c9ddb1fa" xlink:href="dgx-20210930.xsd#dgx_ReversalOfRecognitionOfCARESActProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_ReversalOfRecognitionOfCARESActProceeds_6321f8af-815c-4111-96bb-1c53c9ddb1fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReturnOfCashCARESAct_6f228359-a980-41b6-a72f-bae4e0c8d1f9" xlink:href="dgx-20210930.xsd#dgx_ReturnOfCashCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_ReturnOfCashCARESAct_6f228359-a980-41b6-a72f-bae4e0c8d1f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_7fbb9b23-e331-44b7-b320-94e1e9befc84" xlink:href="dgx-20210930.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_7fbb9b23-e331-44b7-b320-94e1e9befc84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4fb57fca-fb42-49d0-8986-99abf74b7a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_7fbb9b23-e331-44b7-b320-94e1e9befc84" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4fb57fca-fb42-49d0-8986-99abf74b7a3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4fb57fca-fb42-49d0-8986-99abf74b7a3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4fb57fca-fb42-49d0-8986-99abf74b7a3b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4fb57fca-fb42-49d0-8986-99abf74b7a3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_563cc2a2-e7f7-4e66-84e3-4cf83a344d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4fb57fca-fb42-49d0-8986-99abf74b7a3b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_563cc2a2-e7f7-4e66-84e3-4cf83a344d60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_0b479b4f-db4f-40df-9a74-df21f8763fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_563cc2a2-e7f7-4e66-84e3-4cf83a344d60" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_0b479b4f-db4f-40df-9a74-df21f8763fc1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="i1b1adcbc47f14cecaaeb82b1e3771510_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b5accc7c-3a48-4782-af0d-6a03d3564086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_bbeca181-310b-48e0-821f-02126e126a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b5accc7c-3a48-4782-af0d-6a03d3564086" xlink:to="loc_us-gaap_LitigationReserve_bbeca181-310b-48e0-821f-02126e126a8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_70d73086-5c74-48ff-96c7-a2492ff5dd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b5accc7c-3a48-4782-af0d-6a03d3564086" xlink:to="loc_us-gaap_LossContingenciesTable_70d73086-5c74-48ff-96c7-a2492ff5dd4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_6be7b9c2-9416-4986-aef6-080c346fcc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_70d73086-5c74-48ff-96c7-a2492ff5dd4c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_6be7b9c2-9416-4986-aef6-080c346fcc7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6be7b9c2-9416-4986-aef6-080c346fcc7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_6be7b9c2-9416-4986-aef6-080c346fcc7a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6be7b9c2-9416-4986-aef6-080c346fcc7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_64d5ff55-9240-45f6-a0c2-286782310dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_6be7b9c2-9416-4986-aef6-080c346fcc7a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_64d5ff55-9240-45f6-a0c2-286782310dd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_966f4134-ceef-470e-b988-24f4b8eaeddf" xlink:href="dgx-20210930.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_64d5ff55-9240-45f6-a0c2-286782310dd7" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_966f4134-ceef-470e-b988-24f4b8eaeddf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3ea7e7fb-68af-448d-8b1c-9a244bbf640c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_76f94902-eb05-498d-af50-e64ad1ea2603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ea7e7fb-68af-448d-8b1c-9a244bbf640c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_76f94902-eb05-498d-af50-e64ad1ea2603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c1fe18b2-62a6-40b8-aaad-2c7059fbbd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ea7e7fb-68af-448d-8b1c-9a244bbf640c" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c1fe18b2-62a6-40b8-aaad-2c7059fbbd68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ea7e7fb-68af-448d-8b1c-9a244bbf640c" xlink:to="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2e73773e-06a9-4195-a463-0dbd87a458fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2e73773e-06a9-4195-a463-0dbd87a458fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2e73773e-06a9-4195-a463-0dbd87a458fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2e73773e-06a9-4195-a463-0dbd87a458fe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2e73773e-06a9-4195-a463-0dbd87a458fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_600d5e9d-5863-465e-8107-bba32ad36723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2e73773e-06a9-4195-a463-0dbd87a458fe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_600d5e9d-5863-465e-8107-bba32ad36723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_597f4624-20eb-4421-9e0f-01bf689fbcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_600d5e9d-5863-465e-8107-bba32ad36723" xlink:to="loc_us-gaap_SecuredDebtMember_597f4624-20eb-4421-9e0f-01bf689fbcd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_f7748543-052c-4926-a197-89261660c8ac" xlink:href="dgx-20210930.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_600d5e9d-5863-465e-8107-bba32ad36723" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_f7748543-052c-4926-a197-89261660c8ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1c0ba848-1580-4840-b901-73a323dfc87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:to="loc_us-gaap_CreditFacilityAxis_1c0ba848-1580-4840-b901-73a323dfc87e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1c0ba848-1580-4840-b901-73a323dfc87e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1c0ba848-1580-4840-b901-73a323dfc87e" xlink:to="loc_us-gaap_CreditFacilityDomain_1c0ba848-1580-4840-b901-73a323dfc87e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6374feb-47ef-4687-a756-3520cdc8d34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1c0ba848-1580-4840-b901-73a323dfc87e" xlink:to="loc_us-gaap_CreditFacilityDomain_d6374feb-47ef-4687-a756-3520cdc8d34f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b6d3c89e-b9b2-4d7c-b970-9f2c7c369084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d6374feb-47ef-4687-a756-3520cdc8d34f" xlink:to="loc_us-gaap_LetterOfCreditMember_b6d3c89e-b9b2-4d7c-b970-9f2c7c369084" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="ide0ab7116b1c4db0ac39f07216aee6ba_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_dff168b6-754e-43df-a30d-b15fb2126f40" xlink:href="dgx-20210930.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_dgx_PercentageofNetRevenues_dff168b6-754e-43df-a30d-b15fb2126f40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_835e0934-2068-4d2b-a683-01458d0c9abc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_835e0934-2068-4d2b-a683-01458d0c9abc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_97a60555-d563-4d22-8715-c0c427ebf6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_OperatingIncomeLoss_97a60555-d563-4d22-8715-c0c427ebf6e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2e73b2a9-a4d2-4430-a50e-359169b2c1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2e73b2a9-a4d2-4430-a50e-359169b2c1a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0545bb8e-08ef-4fc4-bad7-20d398570721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0545bb8e-08ef-4fc4-bad7-20d398570721" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_32acad11-414d-483d-8d64-d4c6e738ee36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_32acad11-414d-483d-8d64-d4c6e738ee36" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b886356b-460c-442b-a0c7-e739c85fff91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b886356b-460c-442b-a0c7-e739c85fff91" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0912d2ba-346e-4d60-889c-49ea870ad564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_ProfitLoss_0912d2ba-346e-4d60-889c-49ea870ad564" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f8def7d1-6ae3-46de-92d3-aa9c2db99467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f8def7d1-6ae3-46de-92d3-aa9c2db99467" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ff5cc4eb-d78a-4c14-b5b6-d4a345c82494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_NetIncomeLoss_ff5cc4eb-d78a-4c14-b5b6-d4a345c82494" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_651812df-0767-4ad5-b274-83ac7b322ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_651812df-0767-4ad5-b274-83ac7b322ea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_651812df-0767-4ad5-b274-83ac7b322ea4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_651812df-0767-4ad5-b274-83ac7b322ea4" xlink:to="loc_us-gaap_SegmentDomain_651812df-0767-4ad5-b274-83ac7b322ea4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_651812df-0767-4ad5-b274-83ac7b322ea4" xlink:to="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_271c0399-3cdf-40eb-a248-a50ffe348c48" xlink:href="dgx-20210930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_271c0399-3cdf-40eb-a248-a50ffe348c48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_23e69553-5e65-4462-8b33-c19996c8a722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:to="loc_us-gaap_AllOtherSegmentsMember_23e69553-5e65-4462-8b33-c19996c8a722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_b794498e-d77c-46f4-ae0e-031fdc7f1e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:to="loc_us-gaap_CorporateMember_b794498e-d77c-46f4-ae0e-031fdc7f1e88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:to="loc_srt_RangeAxis_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6" xlink:to="loc_srt_RangeMember_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7d2ee807-cc82-44bc-b026-06a65327af42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6" xlink:to="loc_srt_RangeMember_7d2ee807-cc82-44bc-b026-06a65327af42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8f85c6f9-5f03-43f2-aac9-6a4b92d4fc1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7d2ee807-cc82-44bc-b026-06a65327af42" xlink:to="loc_srt_MinimumMember_8f85c6f9-5f03-43f2-aac9-6a4b92d4fc1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a2469819-8370-4971-b1ed-cebd72593d7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:to="loc_srt_ProductOrServiceAxis_a2469819-8370-4971-b1ed-cebd72593d7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a2469819-8370-4971-b1ed-cebd72593d7c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a2469819-8370-4971-b1ed-cebd72593d7c" xlink:to="loc_srt_ProductsAndServicesDomain_a2469819-8370-4971-b1ed-cebd72593d7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a2469819-8370-4971-b1ed-cebd72593d7c" xlink:to="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_c2ad5922-e435-4997-8f7d-593f661c9baf" xlink:href="dgx-20210930.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_c2ad5922-e435-4997-8f7d-593f661c9baf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_ebb44e3c-9229-4a93-a296-2281576eabb1" xlink:href="dgx-20210930.xsd#dgx_COVID19TestingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_COVID19TestingServicesMember_ebb44e3c-9229-4a93-a296-2281576eabb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_55b615f8-6053-44cf-8950-98465ff3c196" xlink:href="dgx-20210930.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_55b615f8-6053-44cf-8950-98465ff3c196" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_5c9ba478-8192-4298-b29d-a420550b0406" xlink:href="dgx-20210930.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_5c9ba478-8192-4298-b29d-a420550b0406" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_644074e3-fc81-4449-ae9b-a2d7681821ed" xlink:href="dgx-20210930.xsd#dgx_AllotherservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_AllotherservicesMember_644074e3-fc81-4449-ae9b-a2d7681821ed" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="ic5768ba536b1459bbc81a3a9f0818d7a_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c99a11d2-5120-4e3e-902e-9a6be6e36d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_b031bbe1-6ef5-4894-92e0-3a8d68b6ce1a" xlink:href="dgx-20210930.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c99a11d2-5120-4e3e-902e-9a6be6e36d38" xlink:to="loc_dgx_PercentageofNetRevenues_b031bbe1-6ef5-4894-92e0-3a8d68b6ce1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_4b6aafd3-75aa-4467-a237-4d9980f95cf8" xlink:href="dgx-20210930.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c99a11d2-5120-4e3e-902e-9a6be6e36d38" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_4b6aafd3-75aa-4467-a237-4d9980f95cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c99a11d2-5120-4e3e-902e-9a6be6e36d38" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_db156f78-206f-4960-92ec-49ee916b1fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_db156f78-206f-4960-92ec-49ee916b1fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_db156f78-206f-4960-92ec-49ee916b1fac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_db156f78-206f-4960-92ec-49ee916b1fac" xlink:to="loc_us-gaap_SegmentDomain_db156f78-206f-4960-92ec-49ee916b1fac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_25405377-d25c-488b-9b1b-db42fcac728a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_db156f78-206f-4960-92ec-49ee916b1fac" xlink:to="loc_us-gaap_SegmentDomain_25405377-d25c-488b-9b1b-db42fcac728a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_c66a14fb-4bd2-4521-8c01-ee0727398fb8" xlink:href="dgx-20210930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_25405377-d25c-488b-9b1b-db42fcac728a" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_c66a14fb-4bd2-4521-8c01-ee0727398fb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_669794ab-fe36-4a6d-ada9-e930639656a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_25405377-d25c-488b-9b1b-db42fcac728a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_669794ab-fe36-4a6d-ada9-e930639656a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_27f78581-b0be-4de9-a60d-be68099a80f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_srt_RangeAxis_27f78581-b0be-4de9-a60d-be68099a80f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_27f78581-b0be-4de9-a60d-be68099a80f5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_27f78581-b0be-4de9-a60d-be68099a80f5" xlink:to="loc_srt_RangeMember_27f78581-b0be-4de9-a60d-be68099a80f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd9ec6c0-4b16-4c78-8053-4056345bc20d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_27f78581-b0be-4de9-a60d-be68099a80f5" xlink:to="loc_srt_RangeMember_cd9ec6c0-4b16-4c78-8053-4056345bc20d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_884d67b4-729e-4867-83df-3b0ddb297d7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cd9ec6c0-4b16-4c78-8053-4056345bc20d" xlink:to="loc_srt_MinimumMember_884d67b4-729e-4867-83df-3b0ddb297d7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_7aae88d5-87ec-42ac-a603-db876d359e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_us-gaap_SubsegmentsAxis_7aae88d5-87ec-42ac-a603-db876d359e89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_7aae88d5-87ec-42ac-a603-db876d359e89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_7aae88d5-87ec-42ac-a603-db876d359e89" xlink:to="loc_us-gaap_SubsegmentsDomain_7aae88d5-87ec-42ac-a603-db876d359e89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_7aae88d5-87ec-42ac-a603-db876d359e89" xlink:to="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_3bcd524d-63c5-45e6-8c6a-efaa44d020ed" xlink:href="dgx-20210930.xsd#dgx_HealthcareInsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_HealthcareInsurersMember_3bcd524d-63c5-45e6-8c6a-efaa44d020ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_902943a3-5e49-48da-8774-d500dabc0961" xlink:href="dgx-20210930.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_GovernmentPayersMember_902943a3-5e49-48da-8774-d500dabc0961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_e1e52395-d768-4db1-82bf-fe4a06ee83b7" xlink:href="dgx-20210930.xsd#dgx_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_ClientPayersMember_e1e52395-d768-4db1-82bf-fe4a06ee83b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_e6e4e88a-0ef9-48c0-95ef-595b41709271" xlink:href="dgx-20210930.xsd#dgx_PatientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_PatientsMember_e6e4e88a-0ef9-48c0-95ef-595b41709271" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_07b6b833-4f7e-4145-bef9-66967a4d019d" xlink:href="dgx-20210930.xsd#dgx_DSBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_DSBusinessesMember_07b6b833-4f7e-4145-bef9-66967a4d019d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_36d0ef28-670e-4f3e-8978-8425d260e96a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_srt_ProductOrServiceAxis_36d0ef28-670e-4f3e-8978-8425d260e96a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_36d0ef28-670e-4f3e-8978-8425d260e96a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_36d0ef28-670e-4f3e-8978-8425d260e96a" xlink:to="loc_srt_ProductsAndServicesDomain_36d0ef28-670e-4f3e-8978-8425d260e96a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_096f1579-1f03-4315-b215-05cab33fc7d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_36d0ef28-670e-4f3e-8978-8425d260e96a" xlink:to="loc_srt_ProductsAndServicesDomain_096f1579-1f03-4315-b215-05cab33fc7d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_34159dd5-2877-45b4-9d08-6c4f6633a6f7" xlink:href="dgx-20210930.xsd#dgx_FeeforserviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_096f1579-1f03-4315-b215-05cab33fc7d9" xlink:to="loc_dgx_FeeforserviceMember_34159dd5-2877-45b4-9d08-6c4f6633a6f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_9c43eec1-6adb-4218-8af2-032513cdd974" xlink:href="dgx-20210930.xsd#dgx_CapitatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_096f1579-1f03-4315-b215-05cab33fc7d9" xlink:to="loc_dgx_CapitatedMember_9c43eec1-6adb-4218-8af2-032513cdd974" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#TAXESONINCOMEDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended" id="i067cccc71b3c48879ee8d9956a2eab98_TAXESONINCOMEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e3c81e-72b2-4301-8511-8323ea39f1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e3c81e-72b2-4301-8511-8323ea39f1fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_11281851-5f76-470f-8bec-6a3a30da0a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_11281851-5f76-470f-8bec-6a3a30da0a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_68e4fe66-c451-4bf8-8afe-ae63a129adc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_68e4fe66-c451-4bf8-8afe-ae63a129adc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest_d7fad2d9-96f2-4518-9f7e-6c71ea012cfb" xlink:href="dgx-20210930.xsd#dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest_d7fad2d9-96f2-4518-9f7e-6c71ea012cfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_fcc77938-638c-4e47-a2d1-f7e151565e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_fcc77938-638c-4e47-a2d1-f7e151565e0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_e467ca5e-a36b-4802-b2ca-a8fec26ed9c5" xlink:href="dgx-20210930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_e467ca5e-a36b-4802-b2ca-a8fec26ed9c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_01f4ba6e-720a-4bf7-b254-3c725062cf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_01f4ba6e-720a-4bf7-b254-3c725062cf3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_01f4ba6e-720a-4bf7-b254-3c725062cf3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_01f4ba6e-720a-4bf7-b254-3c725062cf3b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_01f4ba6e-720a-4bf7-b254-3c725062cf3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_475c29fa-0b7d-4f74-8a07-ec1e28e3369b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_01f4ba6e-720a-4bf7-b254-3c725062cf3b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_475c29fa-0b7d-4f74-8a07-ec1e28e3369b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_301a2f5e-9405-4f37-b83c-1969cda09f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_475c29fa-0b7d-4f74-8a07-ec1e28e3369b" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_301a2f5e-9405-4f37-b83c-1969cda09f25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_735b0bab-4084-45f0-83fd-3f69a16766ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_735b0bab-4084-45f0-83fd-3f69a16766ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_735b0bab-4084-45f0-83fd-3f69a16766ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_735b0bab-4084-45f0-83fd-3f69a16766ef" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_735b0bab-4084-45f0-83fd-3f69a16766ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f93de4ac-7da7-46ad-bf1f-85bdfdc92d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_735b0bab-4084-45f0-83fd-3f69a16766ef" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f93de4ac-7da7-46ad-bf1f-85bdfdc92d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_46d7b4eb-6751-414b-8c6d-540665e88bf0" xlink:href="dgx-20210930.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f93de4ac-7da7-46ad-bf1f-85bdfdc92d7e" xlink:to="loc_dgx_Q2SolutionsMember_46d7b4eb-6751-414b-8c6d-540665e88bf0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUBSEQUENTEVENTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended" id="i245839e3bb174a43adfb00d7e05c9afb_SUBSEQUENTEVENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_fbf15d75-4b10-4574-9762-6ff3f903dd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c5a3f969-2953-4fee-aa07-58307443bb21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_fbf15d75-4b10-4574-9762-6ff3f903dd3a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c5a3f969-2953-4fee-aa07-58307443bb21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_41455c96-147b-459c-9011-247b195054c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_fbf15d75-4b10-4574-9762-6ff3f903dd3a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_41455c96-147b-459c-9011-247b195054c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_fbf15d75-4b10-4574-9762-6ff3f903dd3a" xlink:to="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a8ea5943-a0a5-4258-af1b-cb79b80952fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a8ea5943-a0a5-4258-af1b-cb79b80952fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a8ea5943-a0a5-4258-af1b-cb79b80952fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a8ea5943-a0a5-4258-af1b-cb79b80952fd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a8ea5943-a0a5-4258-af1b-cb79b80952fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_10d02577-b93d-4f9d-aad8-74923fbe756e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a8ea5943-a0a5-4258-af1b-cb79b80952fd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_10d02577-b93d-4f9d-aad8-74923fbe756e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6c02ed30-c362-4d90-8c73-104642847185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_10d02577-b93d-4f9d-aad8-74923fbe756e" xlink:to="loc_us-gaap_SubsequentEventMember_6c02ed30-c362-4d90-8c73-104642847185" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_71ceb5b2-ebc3-42fd-bf03-57e42c325a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_71ceb5b2-ebc3-42fd-bf03-57e42c325a81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_71ceb5b2-ebc3-42fd-bf03-57e42c325a81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71ceb5b2-ebc3-42fd-bf03-57e42c325a81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_71ceb5b2-ebc3-42fd-bf03-57e42c325a81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6999ad99-c7ff-4d6e-8e1c-6334ffa50cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71ceb5b2-ebc3-42fd-bf03-57e42c325a81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6999ad99-c7ff-4d6e-8e1c-6334ffa50cdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_0fa8b6b2-e4ae-4a3d-8ba5-d770f0d43b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6999ad99-c7ff-4d6e-8e1c-6334ffa50cdc" xlink:to="loc_us-gaap_SecuredDebtMember_0fa8b6b2-e4ae-4a3d-8ba5-d770f0d43b11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c0d7d353-1474-4b20-85c0-bf3cca3535c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_DebtInstrumentAxis_c0d7d353-1474-4b20-85c0-bf3cca3535c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c0d7d353-1474-4b20-85c0-bf3cca3535c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0d7d353-1474-4b20-85c0-bf3cca3535c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c0d7d353-1474-4b20-85c0-bf3cca3535c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4c99a662-cebe-4975-bf4b-7e5805ce6b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0d7d353-1474-4b20-85c0-bf3cca3535c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4c99a662-cebe-4975-bf4b-7e5805ce6b27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member_fe512209-8dc9-4554-868b-303a4b834cd6" xlink:href="dgx-20210930.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c99a662-cebe-4975-bf4b-7e5805ce6b27" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2022Member_fe512209-8dc9-4554-868b-303a4b834cd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2023Member_ef8c0b52-71ea-438b-9c62-559cb0adc1ab" xlink:href="dgx-20210930.xsd#dgx_LoanCommitmentMaturingOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c99a662-cebe-4975-bf4b-7e5805ce6b27" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2023Member_ef8c0b52-71ea-438b-9c62-559cb0adc1ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_093c5c0d-597d-4190-b843-402eaa9df2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_CreditFacilityAxis_093c5c0d-597d-4190-b843-402eaa9df2b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_093c5c0d-597d-4190-b843-402eaa9df2b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_093c5c0d-597d-4190-b843-402eaa9df2b2" xlink:to="loc_us-gaap_CreditFacilityDomain_093c5c0d-597d-4190-b843-402eaa9df2b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b5b64862-3514-4097-87c9-63b323a9e93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_093c5c0d-597d-4190-b843-402eaa9df2b2" xlink:to="loc_us-gaap_CreditFacilityDomain_b5b64862-3514-4097-87c9-63b323a9e93d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_87f45acb-bb59-4b4b-8fef-8c910cd200cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b5b64862-3514-4097-87c9-63b323a9e93d" xlink:to="loc_us-gaap_LetterOfCreditMember_87f45acb-bb59-4b4b-8fef-8c910cd200cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7e8beccb-e2a1-4a73-a204-d8d1709c84d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_VariableRateAxis_7e8beccb-e2a1-4a73-a204-d8d1709c84d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7e8beccb-e2a1-4a73-a204-d8d1709c84d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_7e8beccb-e2a1-4a73-a204-d8d1709c84d1" xlink:to="loc_us-gaap_VariableRateDomain_7e8beccb-e2a1-4a73-a204-d8d1709c84d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3a5b3ed3-e5ce-4d57-8ddd-abd23602ecf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_7e8beccb-e2a1-4a73-a204-d8d1709c84d1" xlink:to="loc_us-gaap_VariableRateDomain_3a5b3ed3-e5ce-4d57-8ddd-abd23602ecf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialPaperOrLIBORMember_e62d3ce5-cecc-4ef1-993b-30e31d2d51d6" xlink:href="dgx-20210930.xsd#dgx_CommercialPaperOrLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3a5b3ed3-e5ce-4d57-8ddd-abd23602ecf5" xlink:to="loc_dgx_CommercialPaperOrLIBORMember_e62d3ce5-cecc-4ef1-993b-30e31d2d51d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_34896fad-e03c-4b32-95cc-26a1c29f5072" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_srt_RangeAxis_34896fad-e03c-4b32-95cc-26a1c29f5072" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_34896fad-e03c-4b32-95cc-26a1c29f5072_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_34896fad-e03c-4b32-95cc-26a1c29f5072" xlink:to="loc_srt_RangeMember_34896fad-e03c-4b32-95cc-26a1c29f5072_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dde6c1e8-773e-4a76-a92a-ab39f5d20747" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_34896fad-e03c-4b32-95cc-26a1c29f5072" xlink:to="loc_srt_RangeMember_dde6c1e8-773e-4a76-a92a-ab39f5d20747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d231276f-4a1a-4fea-a713-8a14e203a485" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dde6c1e8-773e-4a76-a92a-ab39f5d20747" xlink:to="loc_srt_MinimumMember_d231276f-4a1a-4fea-a713-8a14e203a485" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_738ba11b-9f48-4321-a367-fc7feca3ca77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dde6c1e8-773e-4a76-a92a-ab39f5d20747" xlink:to="loc_srt_MaximumMember_738ba11b-9f48-4321-a367-fc7feca3ca77" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>dgx-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3dfc3e15-f0aa-46bd-8aee-40e417fed44b,g:988a0070-0eae-4f69-89e4-5f07a4cdd401-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_LetterOfCreditMember_b5140415-3962-48e4-b08f-f8afa2a97eb7_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_11863f67-c049-4b15-aa4c-57e2e076d48b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c5211501-95ed-47b2-ac16-f973021b07f3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_fca21e9d-e55c-4e6e-913d-3ad5e6d52b4b_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3c9d0fa0-7c2b-4add-8ca0-61b276fd379a_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b3df5bff-8d17-45a5-b34f-82c226706437_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CommercialPaperOrLIBORMember_0d078740-6405-4731-9ea4-7c23420ddcbb_terseLabel_en-US" xlink:label="lab_dgx_CommercialPaperOrLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper or LIBOR</link:label>
    <link:label id="lab_dgx_CommercialPaperOrLIBORMember_label_en-US" xlink:label="lab_dgx_CommercialPaperOrLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper or LIBOR [Member]</link:label>
    <link:label id="lab_dgx_CommercialPaperOrLIBORMember_documentation_en-US" xlink:label="lab_dgx_CommercialPaperOrLIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper or LIBOR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialPaperOrLIBORMember" xlink:href="dgx-20210930.xsd#dgx_CommercialPaperOrLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CommercialPaperOrLIBORMember" xlink:to="lab_dgx_CommercialPaperOrLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e8211918-4636-4db2-9ed6-51ad466959aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_a499102e-8969-4bf5-8b1c-3d94a857b4de_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of investment, before tax</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2b46fc83-39e9-4e08-a22e-da8e39423847_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of investment, before tax</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_9a300f6d-31d3-4a3a-9e2d-f3c0ca2a3bfe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_35621d12-b103-4b34-9e80-a7bc10ba2fc0_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0d46782d-d2ef-4baf-bc25-7834cd7cac9d_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_768a2e72-5ea8-4a23-8c8d-41dec93beb39_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_9789c07c-333c-42dd-bbda-97ef5d1842c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche_8060a517-4427-478a-ac52-13942f9120cf_terseLabel_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, amount received from secondary tranche</link:label>
    <link:label id="lab_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche_label_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Related Expenses or Lost Revenues, Amount Received from Secondary Tranche</link:label>
    <link:label id="lab_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche_documentation_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Related Expenses or Lost Revenues, Amount Received from Secondary Tranche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" xlink:href="dgx-20210930.xsd#dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" xlink:to="lab_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_b6e1f7d2-e40f-49f5-8906-20d2f75239f3_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_246185a9-3bc4-4fe7-a009-7d9c4ef68b08_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_05144981-c266-43e9-8111-6fdaa6422540_terseLabel_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_label_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_documentation_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:href="dgx-20210930.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:to="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_570f529e-2d03-4c74-b210-f83e7bdddaaa_terseLabel_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_label_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_documentation_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:href="dgx-20210930.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:to="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_ba41ee9f-69f7-42b1-aec8-779987cf0f03_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_25938e6c-ee48-4bc3-9929-bb1d81bc527b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e9372df8-eba0-47c3-b419-f19965c4dd86_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_831114cc-a61b-4b12-bbb2-7ad67a136a6e_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_cf7e6517-47ae-4c18-899a-77febd2797ee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_1d45545b-2c37-4b87-9766-881fe047a7e2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_63ee62b8-4477-426d-928e-60933593c5cf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7919970-6b95-42f3-ad75-f95744d86db3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_6d4422c0-5626-4dc1-b224-02380b84f5ee_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposition of joint venture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_6d4340c2-e856-4278-a49f-9341a4964572_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f9f6f84f-2b38-4157-be91-0d761122c0bd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_02967d84-a7dc-4773-9349-3467dc92bfa7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3ab5069c-b29c-46d9-a7fa-3978d015d537_netLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISPOSITION</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_2a2043fe-bf15-4f7e-a2a3-fa2d809e32c3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a63cb9e9-ae37-4c17-a915-42d8c65d16b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedge Accounting on the Statement of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4d2d8e4f-b069-4df0-8f06-d603501c9375_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UMassJointVentureMember_0f6271fd-7282-4795-a480-c1c64538f721_terseLabel_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_label_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_documentation_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember" xlink:href="dgx-20210930.xsd#dgx_UMassJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UMassJointVentureMember" xlink:to="lab_dgx_UMassJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_857a495c-f9f5-449b-803e-4f6e5bce99fd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_5fb6d509-8d98-4a99-af1d-a509d3364512_terseLabel_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:href="dgx-20210930.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:to="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c4b80e87-7829-4efb-a96e-27bfdf3c38fe_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_fed3ba43-6405-4403-bab3-1d925d8dfd3b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_43167379-34e2-45a0-8b93-dec873110ef3_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization remaining available</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_2dd50aa6-61b8-4c5d-8768-1952fa66d61e_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Other</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_71569c80-ee1b-4f23-af99-44e54f8c8929_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9cb646dc-b69b-4af9-a0d0-c7ec600706f3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_ddf663e5-6018-48ee-9b6f-ef02ce97ba56_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Accounting Basis Adjustment</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_635be1d1-3db4-420f-8eb5-5aa57949bad3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_2b680061-85df-4366-879f-00b86c5a5af2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_165fed83-4b7b-4dc4-94dd-9202782502d9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_474488d8-bcf8-410f-888a-78a0ae243506_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_fe19ef97-939b-4c10-bc1d-453f8243c738_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_InterestPaid1_ae67e414-fb37-4995-b5fb-b3fd868d3fa5_terseLabel_en-US" xlink:label="lab_dgx_InterestPaid1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_dgx_InterestPaid1_label_en-US" xlink:label="lab_dgx_InterestPaid1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid1</link:label>
    <link:label id="lab_dgx_InterestPaid1_documentation_en-US" xlink:label="lab_dgx_InterestPaid1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InterestPaid1" xlink:href="dgx-20210930.xsd#dgx_InterestPaid1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_InterestPaid1" xlink:to="lab_dgx_InterestPaid1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6b7ca375-08d7-4c41-ac03-8756fa23ac94_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f1e0f5c6-3a1a-4e63-9d3a-e6070d458f71_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetRevenues_4162052d-1763-47d9-bc0e-eb4a8a22c4a0_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_label_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_documentation_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues" xlink:href="dgx-20210930.xsd#dgx_PercentageofNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetRevenues" xlink:to="lab_dgx_PercentageofNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_2699b46a-daa2-418b-bc68-38080443f83a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_0d7650b1-188b-4291-ad91-7349ea1c1130_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_65d25d80-b43e-4691-ac25-747e579d6990_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_ea1fc120-999d-4c80-8b2c-b3d912b20dfa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ReversalOfRecognitionOfCARESActProceeds_2733a1db-1e00-4f4f-b5ec-8eead26c0e07_terseLabel_en-US" xlink:label="lab_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of recognition of CARES Act proceeds</link:label>
    <link:label id="lab_dgx_ReversalOfRecognitionOfCARESActProceeds_label_en-US" xlink:label="lab_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of recognition of CARES Act proceeds</link:label>
    <link:label id="lab_dgx_ReversalOfRecognitionOfCARESActProceeds_documentation_en-US" xlink:label="lab_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of recognition of CARES Act proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:href="dgx-20210930.xsd#dgx_ReversalOfRecognitionOfCARESActProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:to="lab_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1eebd64d-4679-4e73-85b7-94de8aa9ad4a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f6a25d3c-2151-4fd3-8e3e-f425e0c0a29e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b205ec65-4013-4d08-a353-e5eb5bd73342_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5ea69e43-8c48-4d56-ae8b-96a2de3dca57_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapitatedMember_51ee4bea-66df-4bd3-8094-c7bdddc5f0f7_terseLabel_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated</link:label>
    <link:label id="lab_dgx_CapitatedMember_label_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:label id="lab_dgx_CapitatedMember_documentation_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember" xlink:href="dgx-20210930.xsd#dgx_CapitatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapitatedMember" xlink:to="lab_dgx_CapitatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_a1f4ad3d-afd7-4efb-b9ee-100ccae2cf0c_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5fd7bc3c-1d75-4984-97d7-2d6434f64d5f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_02e00e16-1a6a-4f67-91b9-3bc04d505d0e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_bb163fda-da55-408e-8f41-c669d5437df9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_edb1f0f7-e050-4edf-abec-cbde5153e24d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_126da222-ea05-4772-bb13-2aba6965c8d1_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Receivables Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_85765603-2141-4f9d-8b27-0bee75cda2dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7baf8588-35f5-43c3-b291-a6d6923f4b29_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_bf411b9a-ae47-45ba-9fdb-60fb1102df09_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_38df5cb7-14dd-40f3-a1fa-335396c89221_terseLabel_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_label_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_documentation_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:href="dgx-20210930.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:to="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_95985e7c-1a22-4b9d-8563-659ca0a3a02d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7a5dfcd8-02ff-46e8-b035-e60f2325257f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_864185c7-8e78-4db6-bf74-06c038d13cb9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9998fcc5-5468-4b93-ab59-6ef77b7d9c94_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8c991e74-3ecb-46d8-965a-f5d96433dfdc_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_952d90b1-1248-4f8c-8eab-048c9219e990_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5e639c73-7f54-4583-b682-41e39f3d3470_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic(in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_859bdf85-481a-4945-b5c8-75e44fd87299_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action lawsuits</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8a385820-e2bf-4f2d-96ae-718ed7c77eb3_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_78c10f91-3df0-4ac9-9abf-48f38ccae71f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_96877a11-ea0c-4cb2-8bc5-ce10b9907966_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fc1db014-1b28-4818-b49a-aa8e5101a6a6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b0ffe2d0-43aa-48da-83c9-6096c82232a7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_95496934-2102-4da1-9c1d-d30a4621d305_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_2410d34a-c595-48d2-bb46-ae0e7293f31c_terseLabel_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of ownership interest sold</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_label_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_documentation_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:href="dgx-20210930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:to="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_43b5d199-9aaa-47a8-9a26-8e311886e6e7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a950af3b-48b3-4b3a-9659-2618f722882c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_0260b94d-45b1-47df-a308-9e62b885daf5_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_c02197e0-c4fd-4749-9d7d-bf22effd5508_terseLabel_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration receivable/payable</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_label_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_documentation_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:href="dgx-20210930.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:to="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_622b874a-754a-4e11-aefb-3209ae6cc014_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_fc36f3ba-64c8-470f-82a7-13a611a7ac01_netLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_44e61468-cbb5-48e8-813d-4391614cb00e_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:href="dgx-20210930.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:to="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_91549f5f-23f0-4443-ae83-73408b0e9289_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_48d2c702-006d-4def-866c-a54ae2582954_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_594d7c41-d788-4f7a-99f5-9b58a8a87769_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Q2SolutionsMember_e0d76708-8de9-46d1-b21f-8f2855d66d2d_terseLabel_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_label_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions [Member]</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_documentation_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember" xlink:href="dgx-20210930.xsd#dgx_Q2SolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Q2SolutionsMember" xlink:to="lab_dgx_Q2SolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_305d051b-eec4-4803-8a49-efdc506b6ec9_terseLabel_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_label_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</link:label>
    <link:label id="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_documentation_en-US" xlink:label="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:href="dgx-20210930.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:to="lab_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_b21791d9-41dc-48c2-a063-608c53b9c906_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_03cc6857-8ea3-45a3-a3ac-f812b056e6c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d483b57-8cfc-49d4-992d-60839f482127_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_107feb0e-8f7c-4bd5-9727-b93a5efbf3a0_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accounts receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_label_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_documentation_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable" xlink:href="dgx-20210930.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetAccountsReceivable" xlink:to="lab_dgx_PercentageofNetAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b1823c90-22c1-4031-9bb7-aeb63cfc369d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_60d1ceb6-5418-4348-ac20-92593846cd2d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_bcca346e-449d-40e5-afa7-a618f68874f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_a81550eb-8419-447b-be9c-f0d6d3027793_terseLabel_en-US" xlink:label="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act proceeds recognized in the statement of operations</link:label>
    <link:label id="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_label_en-US" xlink:label="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act proceeds recognized in the statement of operations</link:label>
    <link:label id="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_documentation_en-US" xlink:label="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act proceeds recognized in the statement of operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:href="dgx-20210930.xsd#dgx_CARESActProceedsRecognizedInTheStatementOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:to="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AllotherservicesMember_83574035-6f11-42bd-961d-74a51d96a434_terseLabel_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_label_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_documentation_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember" xlink:href="dgx-20210930.xsd#dgx_AllotherservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AllotherservicesMember" xlink:to="lab_dgx_AllotherservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_bd186f9f-2ee2-44d6-9869-c25dbbad6ba9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_f90845e0-d57a-4b5a-b258-485f9e14432e_terseLabel_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase, percent of total value to be repurchased</link:label>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_label_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</link:label>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_documentation_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:href="dgx-20210930.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:to="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_e22aeffa-f825-4e38-a4c4-c1b52d7eaee2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_389936c8-d0dd-4f80-b0bc-cefe90af6ab9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred gain on cash flow hedges, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PatientsMember_6e40a824-e690-4da1-aa72-2a3a9b8cd729_terseLabel_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients</link:label>
    <link:label id="lab_dgx_PatientsMember_label_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:label id="lab_dgx_PatientsMember_documentation_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember" xlink:href="dgx-20210930.xsd#dgx_PatientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PatientsMember" xlink:to="lab_dgx_PatientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_9e5facfc-dce2-41c2-9550-bb71084e85e0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, period Increase (decrease)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_66bd3b53-71c7-44ee-8eb3-6f672d6e332e_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_1f05a55a-a5a1-4479-b43a-3791f5f8db69_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_8c7ee495-eda5-4c3d-916e-0c8d4a415765_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_843b3c96-7c9b-4f90-8616-194e00add8e5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_b75293de-9688-4b0f-97a3-87ba4acc7c44_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_0040aa75-d3d9-4898-a490-e579c36bedeb_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_773628d4-2269-4845-93ec-3381b3f21bef_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_a62ee27f-9a60-4a68-bd47-35123d7e8bf0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_11710e43-228c-400d-aca6-5d7901a35dff_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_35eefdfd-7c9b-433d-bf90-0a901b143d72_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_3c13817d-484b-4a88-a8c1-ebb052ffad64_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, gains</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b222c36e-baab-4503-8a4d-7725fff723aa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e45fa616-4344-4cda-90fa-0a0ca1028dd6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a1c43ccc-2a90-4c1c-b28c-54f4c2772afe_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_343e3d97-1eab-42bf-b3c6-f23c59ecaab3_terseLabel_en-US" xlink:label="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</link:label>
    <link:label id="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_label_en-US" xlink:label="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</link:label>
    <link:label id="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_documentation_en-US" xlink:label="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:href="dgx-20210930.xsd#dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:to="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1821d40e-d373-4c79-a88b-a6736b9d4a1b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_c733c473-fcea-4401-ab06-143f6376f63f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_702bbb70-3fc9-4b7f-afcd-96a5aabe48bb_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DSBusinessesMember_a306a8ac-8640-4a16-9b40-fda0061a4a2d_terseLabel_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_label_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_documentation_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember" xlink:href="dgx-20210930.xsd#dgx_DSBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DSBusinessesMember" xlink:to="lab_dgx_DSBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_d90bd042-2204-4c47-87d5-0a41e5118725_terseLabel_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_label_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_documentation_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract" xlink:href="dgx-20210930.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DescriptionOfBusinessAbstract" xlink:to="lab_dgx_DescriptionOfBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_334ef589-502b-4891-a012-4b64fa6830c9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in earnings of equity method investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_fd09d435-ddbc-40df-b590-f9a74ce1643d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e6e051c1-bfbf-487a-9322-c5bad191653f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_8d9c8c3f-7f2c-4dc9-9ab4-354f8de08486_terseLabel_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIS business</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_label_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_documentation_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:href="dgx-20210930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:to="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_ff2b2789-969d-410b-b72d-ee2f91dfb7b6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_904fd482-4c72-4d66-9d6d-3a66fa3a98eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_ff7a67d2-9358-468e-9674-4e536190050d_terseLabel_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_label_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022 [Member]</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_documentation_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member" xlink:href="dgx-20210930.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LoanCommitmentMaturingOctober2022Member" xlink:to="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_c7616216-cfce-4dfd-8211-bc01362adfb0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_2767ce5c-a78c-4c75-81a3-8de1fc2ada0a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a1c0afe4-2cb7-4f9a-ac5e-c63fd847fe51_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d655ec45-1b8a-47b6-879a-f821342d4c57_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_92b700c2-6f57-464b-8b93-940eac54a4b7_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="dgx-20210930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_50a1a199-c55a-4335-b146-688a9078268d_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_287e5b9e-41eb-4a56-b9a9-4c646635369c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_d20f792d-2bfb-4b69-89af-5c1a1fd3f666_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_515c0220-9670-4dab-8c4d-c83fa05c6f48_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_ea17197b-9bb5-413c-a414-2e994afb2135_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:href="dgx-20210930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_50a3d84a-8269-48d3-89c1-41c77dcdf4a6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses and other operating income:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_5aea10be-b7f6-42a8-9686-2271d2c8a972_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_5cade4b6-42fb-456a-b90a-057e95871b38_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f4979c2d-33a5-40db-932c-9130a235a87a_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_da4663ca-4399-40f4-a466-f44c87abf320_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2021 and December 31, 2020; 162 and 217 shares issued as of September 30, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_a49885cd-cdfc-4123-8f0e-ae014975df3e_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-operating income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_ca042b49-d530-45c0-a1ba-6302a4002ce0_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_bc80bb15-4822-40c3-b466-903e6f3108eb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during the period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_117f87d7-3ef2-4505-9c1d-d0b9d7a8bea2_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_066f92ad-4ed3-4b5d-b15e-d3275250844d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ClientPayersMember_5e3b5851-563e-46ee-901c-8481ef75efbf_terseLabel_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers</link:label>
    <link:label id="lab_dgx_ClientPayersMember_label_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_dgx_ClientPayersMember_documentation_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember" xlink:href="dgx-20210930.xsd#dgx_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ClientPayersMember" xlink:to="lab_dgx_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_023835c2-83ec-4897-b0b1-e6a0cada3769_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7d65daca-203c-4b04-a41c-b5f0464de1a6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1cb6d523-21d1-4699-b937-116667dbaf18_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_5019c7f3-b99d-4dbb-91b2-19d84a9321b3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_9c566325-6702-45ec-920b-f94ef916f714_terseLabel_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, amount received from initial tranche</link:label>
    <link:label id="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_label_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche</link:label>
    <link:label id="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_documentation_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:href="dgx-20210930.xsd#dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:to="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_184b75b5-741c-4f07-9138-8149f8fee32e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_8d2cfb9a-2386-4024-a4ef-846433d3cb38_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_b1857f74-a613-4bb9-a53c-ed37032aeffa_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e0fefe4e-ad8e-4c55-b541-266b6d1069e2_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d06807ae-5d5c-4e92-bcc9-57ee03ea89d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_4440b39b-1d6a-4ae0-8d0f-d6b32a3d04a9_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses, net</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_25e27e7c-1570-4f0f-87b6-32ab76083270_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_0ce5465e-eb1f-4e46-a2b5-321c35f700c9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_7b0444fa-7e0a-4e5b-ad6a-3cf25ea3172b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_835a8e50-63bb-4a0f-84ce-3d32a42b777a_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_ec180192-7d71-4571-b971-9205c0914484_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0a7a868a-cb95-437a-a497-9bf91cf49663_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_7c2e0a93-9ca8-4cfc-889b-cb4ad053666e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bcc872cf-b5d6-4d92-b146-227c7b31acff_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a4dbc261-fa74-4129-8ab1-57fb178d2fbc_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5668bb0c-1338-4413-8de7-17d6a40fae71_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_26c57a5a-7748-4263-8059-336aec28ed34_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_153bcde1-a823-4fc7-8fa7-0e0e495e7a53_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_5b8a9b77-cc9f-4c3e-932a-cb922a7609ef_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2f49348e-62a1-40e1-beb0-b884ffe6e86e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_26770858-9538-4dd6-b161-631047b7fdec_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_cfb840e8-ab18-4c0b-9add-058c46917028_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_76482a64-dcbc-4691-8327-ed2d52adbf10_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_42559e13-1ace-4133-9481-eb90af51dd94_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f1a0b772-b1b9-4fb0-b31c-f6406a6b22d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_afff316b-745c-4d5a-8cfa-315ed91e052a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_15dd48f1-c539-4c46-bbcf-4e66750801f0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_64da6880-c4ca-478c-b8af-37c5a97a2875_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_903f9e13-5dec-4e78-8a7e-69b827c1da29_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_b8b08f60-6b85-4b9a-a7e3-49db499efba1_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_aa90efb3-ef0c-4949-b062-66669960aa94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f2d83ad4-9bb2-4196-9251-b0910edffa23_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_26e79ca4-6d68-42e7-ab69-db5146db93ca_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_066cce10-e491-4a46-9180-9cbd0ffc1617_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_f193538a-a4b8-4716-8bd4-892ca31f02c1_totalLabel_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_label_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_documentation_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired" xlink:href="dgx-20210930.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired" xlink:to="lab_dgx_FairValueOfNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_9ba31275-dbf7-47b6-86cb-bb8504e18250_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d6f46753-0bc1-448f-9ea1-57e4db0d1d81_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_841bd07e-fab6-44f3-81f7-e353f438f8b5_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:href="dgx-20210930.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest_93251f47-f3f6-4566-9e6d-eb42a971ddb6_terseLabel_en-US" xlink:label="lab_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate on remeasurement in previously held interest</link:label>
    <link:label id="lab_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest_label_en-US" xlink:label="lab_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate on Remeasurement of Previously Held Equity Interest</link:label>
    <link:label id="lab_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest_documentation_en-US" xlink:label="lab_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate on Remeasurement of Previously Held Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" xlink:href="dgx-20210930.xsd#dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" xlink:to="lab_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_acbaa822-9ee5-46d2-bb67-1758b00748d6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in investments and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f3fffcd9-68eb-4722-b3a1-39c0d8f1e899_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_a35dbb12-944e-41c3-a419-43a5c63bc9c7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_bb8b4b6c-feb7-41ca-926f-1a4d8d942045_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_c19bb2d0-03fc-49a6-8409-1f4dc22a86bb_terseLabel_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of interest rate swap agreements</link:label>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_label_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of interest rate swap agreements</link:label>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_documentation_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of interest rate swap agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements" xlink:href="dgx-20210930.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TerminationOfInterestRateSwapAgreements" xlink:to="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_bc989040-1725-482c-ae03-940b8e56a0d5_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_COVID19TestingServicesMember_2dca621e-ac11-454b-8d74-1102541b66f3_terseLabel_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_label_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services [Member]</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_documentation_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember" xlink:href="dgx-20210930.xsd#dgx_COVID19TestingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_COVID19TestingServicesMember" xlink:to="lab_dgx_COVID19TestingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f5c6244b-64b9-4969-8e88-045c51aeba63_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edd8775d-8a38-4258-9e2e-6ca269f564ab_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d9fdfe0b-e4ee-4167-ac5c-e92b6fff64ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_f335b206-5170-4552-87d0-ebc4985f9379_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f041f6b5-3c6e-4f71-b9f7-c0aae8a6c58d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Quest Diagnostics stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_69c8baed-4a0f-44da-8f4a-56f87f496448_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_7c03ca53-fb0e-402a-a6d4-836adcfb1361_terseLabel_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MACL</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_label_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL) [Member]</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_documentation_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:href="dgx-20210930.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:to="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_acd20be8-9fe2-4f02-8a78-1b07d72bd7fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_91178e78-681b-4394-ad81-07de6ca29311_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_664e79d5-ce92-4b00-b099-39faebf853ec_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:href="dgx-20210930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_746895eb-dc65-4e81-b625-33e978923041_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_2e1f74d7-4c30-473e-ae4d-eda755e876a5_terseLabel_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_label_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_documentation_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember" xlink:href="dgx-20210930.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AnatomicpathologytestingservicesMember" xlink:to="lab_dgx_AnatomicpathologytestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_2bf72433-1c69-44d4-b991-ec630ef4dd72_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Excluding Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_57fb1074-99d9-4955-b5fd-64eff15dbbd8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_abdf64c3-908c-49c4-90a0-4e22539c0da3_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quest Diagnostics stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b5103404-778f-4ee7-9893-d2f77a7dab89_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_f30cd4ed-77c9-4b7a-8415-1bc3e661e7b6_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_8ac90036-cfeb-4ef5-894c-5db6a0e9becf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_e6184316-c28a-4f73-9bd0-5b8700d69d2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_41326fbf-1a3a-4185-a238-80441cfd046f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_fe4c0994-117b-4af0-a5a8-465e965835f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_f49dc907-307c-4a67-9071-9643e7e67694_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_49e6d817-47ce-4f80-9c2b-197921f7d5ac_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_b5cd9e37-8325-421d-a079-f565a7e37ff5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c10127c9-6780-4d51-80ed-aa7e2b0ab0d5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_38ed789d-caf9-41cd-a6a5-b85882d2106c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_5df75025-b6d0-4913-82bf-b5595cabb593_terseLabel_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_label_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services [Member]</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_documentation_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember" xlink:href="dgx-20210930.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RoutineclinicaltestingservicesMember" xlink:to="lab_dgx_RoutineclinicaltestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7fe945ae-62ed-451e-b2a9-a95c52a72d37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_68742a8a-45f8-4017-a8c6-414dac9d3197_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_b055aea1-41cd-4c1a-a185-e77fd137d85d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_9c38b867-778c-4246-9bba-0f8fbf5e9478_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_00a75b87-ab80-4456-849a-645b92711c16_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_a8339f4c-a30a-4204-83ad-5b46fcaaae77_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_5f78969e-fb05-4a27-8448-3ddcc30e0303_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_0a66e4ce-30c3-4b5a-b9b6-0cc116299cfe_terseLabel_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_label_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_documentation_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:href="dgx-20210930.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:to="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_325b8d2b-78d5-450b-b298-5568ec96ec0d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_37da8c86-a5e0-4222-8623-8f6b7f89d152_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f30a118-1394-4045-bff6-bfd357c5ebbe_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b09bf134-68d9-4af7-a35e-3882fc60d2bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_88d2703a-97f9-4466-8881-6e91607dd8b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1eb7f3e0-6517-436e-a90d-f994552feb6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_c5f819e0-f38f-4630-8380-2e478bf9e2b5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $29 and $28 as of September&#160;30, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e8a2a0ef-54d1-4d1e-8a1f-60e299b09f89_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_9e8760a5-ddd4-469f-80b6-f31a63afcf42_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5d671954-8d75-47e2-bdc0-dbeca60807ad_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_c9781c4f-889f-498e-bc91-fe837f26fd73_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_d33cbe3f-79d5-4124-8e02-178c946f7a30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Reporting Information by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3868d8c4-9419-4d77-93bc-684351dcc4f5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_abd067ab-bdef-41d9-9184-53945891f902_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_e6254a37-409d-4faf-93a3-1f4c2aa9b118_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_645b8380-4ce5-48c2-9611-a1ff8b700d69_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_edbace7a-f03f-48fc-8c02-81c4bc6e0ccd_terseLabel_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpatentedTechnologyMember" xlink:to="lab_us-gaap_UnpatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_64ddb06c-3ef9-4268-9c36-b4611c73a32d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d2ee7c13-e62c-4f1c-98c0-dc694f4a8849_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_555b3493-0449-48bf-96be-11a997220415_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_32215f24-e3ea-4089-a305-292a8a0adc81_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_56823be4-75ce-40d2-a2b7-7ad48ea976e2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c4a2cd4f-a395-47b2-a08a-3578827eb751_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3f82f5b0-0676-48e1-a75c-bd62ab24373e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MercyHealthMember_b849d1eb-4375-45db-b040-8212ce7884ab_terseLabel_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health</link:label>
    <link:label id="lab_dgx_MercyHealthMember_label_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health [Member]</link:label>
    <link:label id="lab_dgx_MercyHealthMember_documentation_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember" xlink:href="dgx-20210930.xsd#dgx_MercyHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MercyHealthMember" xlink:to="lab_dgx_MercyHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_e74fc539-c785-42f2-94cc-bc89af34e81b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_01254b26-822c-48e2-bbfd-890cf24680b4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_77c6e583-93b0-4cf1-a7e8-d37cb6d3a4e5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4b552f88-6038-4c26-96a2-5a76c5af9943_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_f6635f88-dde4-45e1-be79-a812890e556b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d70c176b-0dcd-4c04-b824-74b2332a7a3d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_7590e75f-c30b-466d-8d91-418f1b8af2f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a28630bf-1eb2-4774-968d-6f000679b0ad_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_462ef2a5-2f8d-4dfb-8e12-38d92f445889_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_31d52942-b5b0-4586-b1e0-38bb8e3b7df4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c195497f-c87d-4d8e-9898-e50cfbf571e3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_6a6e6fdc-6325-4688-a875-772c3a30f38b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f649ae2f-a581-4146-a35f-686a52bec74e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GovernmentPayersMember_bf8205ba-7fee-4303-9bf8-caa2a66f8f05_terseLabel_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_label_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_documentation_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember" xlink:href="dgx-20210930.xsd#dgx_GovernmentPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GovernmentPayersMember" xlink:to="lab_dgx_GovernmentPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_e2eba62f-9920-46ce-b75a-3596952f16e0_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_014de078-8049-4c64-a000-660cc377c01a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d6e83f56-34c6-42a1-83f7-fc5c54ef8950_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c0ed9e0a-ab89-4335-876b-94006d38967b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f57627a9-5569-48dd-8688-e2b4bd26953b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d16e2b6f-236c-4a82-9153-905190643b22_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5856432c-16b8-4ea8-8ad5-1b58e9db96fa_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_907c6190-94a8-490a-98a1-baef5898f964_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_869d58ab-3574-4dbf-bd6f-3368d223c2cc_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_9654ff13-1cc1-42fc-b6a6-da88a6290ac0_terseLabel_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from disposition of joint venture</link:label>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_label_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments, Gross</link:label>
    <link:label id="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_documentation_en-US" xlink:label="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:href="dgx-20210930.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:to="lab_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_2472c87c-f802-405d-9cee-2ee697d3a44c_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_ff851201-4c48-49e1-9ce2-0fe40343d228_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_1c0af5a5-ec53-472f-85ab-7ad602900903_terseLabel_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_label_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_documentation_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:href="dgx-20210930.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:to="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_9e42a2b5-7ab7-4a6f-a607-582c9efff786_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:href="dgx-20210930.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:to="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_68214844-471b-4a5a-bcbc-832ab339e9e6_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_bcf35880-bdd4-4877-8ffb-a3d5908623c6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in reserves for uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_becbe0d4-4ab8-4720-801b-f41fbabadc3b_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_4795f9e8-1188-4551-8124-d800aac8ecec_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4c195f6a-0591-48bc-b544-26a42cf9d7a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cfb502e6-52c2-411f-bd58-fc2c4dbe97dd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_f3371e56-9c79-4be4-841b-1e2c72c06b4d_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other operating segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_b6daa422-6c9d-4045-818e-f194a3fd9447_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_54bd458e-c01b-47ae-8790-fa984a6a46d9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_d75d3f9e-6d3d-47f6-b586-eab14588756a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3105c5be-4969-4bed-bc9e-0f383422116d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e9cd90b-50d8-44e4-8dbe-9428731cfa93_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_42d902f7-270e-4f4a-b9af-19a088f8392c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_cc67c73c-3b52-415a-a330-abad1e82666a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HealthcareInsurersMember_f5c7da57-0298-4b03-95ba-a0972fcaf2a1_terseLabel_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_label_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_documentation_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember" xlink:href="dgx-20210930.xsd#dgx_HealthcareInsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HealthcareInsurersMember" xlink:to="lab_dgx_HealthcareInsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a77d75d0-dc0e-4759-bf91-1d199977930f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_2acf9846-9a7d-443a-a629-f8c61c14d4be_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reissuance of shares for employee benefit plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_4ee8b89a-cef6-4326-89a6-bccc28e73cf9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2023Member_a2191d45-d247-4b33-80dd-6fdc18c7a675_terseLabel_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2023</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2023Member_label_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2023 [Member]</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2023Member_documentation_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2023Member" xlink:href="dgx-20210930.xsd#dgx_LoanCommitmentMaturingOctober2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LoanCommitmentMaturingOctober2023Member" xlink:to="lab_dgx_LoanCommitmentMaturingOctober2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_e2be979d-facc-403f-aaa5-75b570706f46_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_dbebaef4-c2e8-4d8a-82ec-7ebd3ccfc200_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a3710278-1955-4097-84d9-a8ef4148c651_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_54d956cb-6deb-4361-a35e-dafe9f0105aa_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2eead630-c820-4ec6-8071-98f252055f20_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_63b006cd-7a3e-46ae-a579-324097ec2834_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_99a6dd21-a95f-47ac-8a01-591b2d08ef56_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate activities</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_b11bcbf2-9da6-4a7b-bb5c-c864a7c9c78a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_a0dcc02d-01e7-4a1d-b406-877b88466467_terseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Earnings allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_571a4065-8334-4160-ae07-0f7d4595e8d0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_71de785e-858f-4684-8f18-bf8df2da52d7_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 39 and 84 shares as of September&#160;30, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d2e96fbb-22a2-48bd-bbb7-e00ccd3f71a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_b387ad4f-4894-49bc-a2ad-d743188bc636_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance reserves</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_8a5c31b1-29a6-40ab-86a3-3ded0a89fcae_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of equity method investees, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_bed2e328-3047-4644-841f-84b0667b1820_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d6936ea1-1688-47b6-91a9-ad308b49cb6c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_cfde4f08-8ada-4ced-bb8f-773f657c5ba0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_22c42a23-f240-47d1-9f05-e2e52483cca1_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_71d00870-0b5c-4133-8d13-f01d8f522920_totalLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_01b42a33-1fec-4923-8d0a-a12cbbb853ff_verboseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase, initial purchase price, per share</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Initial Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_5097930e-9e82-4f51-b317-ba57a7936bc9_negatedTerseLabel_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dgx-20210930.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e529611d-7a2d-4b19-9ce5-a0412675716f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_116bae8f-d4e0-40b5-b617-eb49594e20e5_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:href="dgx-20210930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6b26ea7f-37c7-437f-94bf-a55321783d13_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5853430e-92fe-4d47-acf6-8d9a33d4d2ab_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_ac3697c4-261d-4986-84f3-d67784f73192_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_57484a27-1cd5-4401-9fdb-291e41fc0b3a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ef109e64-1cdf-46b2-b6a2-b6724950cb43_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_d37a1c54-905e-4156-a841-dcd63af9d55d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_dc2cb493-087f-48b4-b7b3-80121ddcb5ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_28362fe2-2936-41c6-a7cc-bbd986d25e84_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_65b16762-fc4d-4ea9-a7a5-f6e7c24c9d98_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_fe62317c-7941-4a1c-b103-70ba5db09fb8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c6ccff5e-eab4-4003-940c-15b75bb9e245_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in available-for-sale debt securities, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3e351bcc-7ded-4dbd-a20e-7caa12464379_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_b2d0bba5-1af4-4c61-9922-90638fb678ab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e6fd46c0-539d-4b0b-9229-3593f56ffeb3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1b94e6d3-1459-4f2d-978a-b9f879a4d6ae_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_6dc6e9e8-49ed-4c5f-8751-926a6557e51a_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-related intangibles</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_7f8f3336-f03b-4a74-929a-417cb6dd3406_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b53c409c-01e5-4338-87aa-5f0447c3befb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_29baeab4-0a2c-4e86-89ce-741f5f9c073d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_1dc1c1bf-f86c-4505-87f5-7ce0491f26dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_ebce1a00-367c-4b18-9ab3-d099f732d09e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_5429d230-f353-440d-879f-1c4b930f18ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b482977c-c50d-4f2e-9b3a-29792db378a2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock- shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_e7de3a27-3e31-4e8d-a93c-68e897935bc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_1fe9f73e-7d92-4f3c-abe2-fca32063e34d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_3ed77736-0744-48e6-9d7f-eb268c4cc555_terseLabel_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares to be received under accelerated share repurchase agreements at execution</link:label>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_label_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</link:label>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_documentation_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:href="dgx-20210930.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:to="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_118ce80f-d504-4e69-8846-3325fad468ae_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_970396c7-432e-417e-be11-c495198866c5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FeeforserviceMember_a9792d69-d5ae-42df-8357-8ac7b75a544a_terseLabel_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_label_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_documentation_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember" xlink:href="dgx-20210930.xsd#dgx_FeeforserviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FeeforserviceMember" xlink:to="lab_dgx_FeeforserviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f8a51c34-c57c-403e-975b-646c19301391_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b3d3a336-47ca-40d8-8c0e-13ee313b33ef_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c8781c94-78a6-4772-9ea7-12ddab632aa5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_cbb8e156-cb2b-4bbf-ae7f-038f415c3855_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0758ef5b-ee83-4ca0-b64f-f50eea0dcb7e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_44459eca-a7eb-4f5c-b8a1-9474cda1755f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5a4c68a3-0c3f-4482-a18b-7d87a910aed7_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_4e1c4383-6d26-4044-bc39-f68c1ec0848f_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8ecb6a89-60b8-4e9d-8e40-997b515a0911_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17233f97-171d-41ac-920a-73abfd1055c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_1cf6a2d2-03b7-423b-9662-bb7fec9cb47e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_1707fdaa-25be-4493-b736-7d87fb48f682_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:href="dgx-20210930.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:to="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e93e2005-cd7a-419d-bf7e-0fb2dffc1c02_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_62d8f602-4dc7-4d9d-a04b-8010107eb7eb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6b63e718-750c-4585-8f37-52d71f106f90_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9da65997-af6c-4673-93a6-6dd4491aecac_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_cb37d443-c830-41e1-addb-74f145ef178a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4e884137-db50-447f-86de-f253abe6db5a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_33658aa6-4001-440b-9605-6444a1bfd9b5_terseLabel_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_label_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation [Member]</link:label>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_documentation_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember" xlink:href="dgx-20210930.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ForeignCurrencyTranslationMember" xlink:to="lab_dgx_ForeignCurrencyTranslationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b9a78c31-507b-456e-a4b3-d6a53abb1cd4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_aea530fb-440c-423d-808c-072a2432ed36_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5ad3f1c3-1a8e-4b68-8b50-1e7810eb4a60_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_59a45ca8-7870-4d13-94f1-a83fb009d1d7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_61cfbcf3-d9c1-40d0-8995-f1ad27bf3b21_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_b7e45b6f-8294-40ad-8480-6153238dc0e8_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_57de9172-f91e-4f8f-8e0b-afaeae2f0a5e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAXES ON INCOME</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_47c45611-05cb-4f07-9d5e-a9eb0066de2a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9ad53bb3-0124-4978-a2bc-2c59f3b09b2b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7e6b3022-5e3e-4a50-94b3-b89180ea95c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d2c5342e-1624-4424-b1fa-607227c30c32_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b9685aa2-ea46-49e8-8a5a-a65c5d997e1e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a4a7ca5e-23ee-4390-bead-8aaf0474c8e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a3d0851d-96c5-4db9-b4de-a9fdcacd30ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_ea72ce8c-7c5d-4952-afeb-c49fb8eccef2_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_f35ef4a9-ac5d-4ace-8699-998484228ee6_terseLabel_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASRs</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_label_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements [Member]</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_documentation_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:href="dgx-20210930.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:to="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_0f2654af-ce79-45a3-a02d-65ec0f76c80c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_584ec241-aac4-4a19-a80c-51d2be5db230_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6b81988-42e7-4c45-9ebe-b246ef3bb1b9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20540bb-695b-4036-ac3a-51fe08868e09_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5ba1fd63-c3e4-4b7e-bc21-b6c4640507cc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_73eef50c-b67f-4617-a342-284a5eb39242_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ReturnOfCashCARESAct_bb360537-8304-45c0-b48e-c791040ad4cd_terseLabel_en-US" xlink:label="lab_dgx_ReturnOfCashCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of cash, CARES Act</link:label>
    <link:label id="lab_dgx_ReturnOfCashCARESAct_label_en-US" xlink:label="lab_dgx_ReturnOfCashCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of Cash, CARES Act</link:label>
    <link:label id="lab_dgx_ReturnOfCashCARESAct_documentation_en-US" xlink:label="lab_dgx_ReturnOfCashCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return of Cash, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReturnOfCashCARESAct" xlink:href="dgx-20210930.xsd#dgx_ReturnOfCashCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ReturnOfCashCARESAct" xlink:to="lab_dgx_ReturnOfCashCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_bd0f26e2-ae96-4b5a-84c1-9e614d07bcb5_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items (Long-term debt)</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid_4da6b611-2020-420e-93a0-e457196fbe07_terseLabel_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases price paid</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid_label_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Initial Price Paid</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid_documentation_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Initial Price Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:href="dgx-20210930.xsd#dgx_AcceleratedShareRepurchasesInitialPricePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:to="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a227d4c5-8fe6-4bc3-a7b2-7daa9491b767_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_cfbdbad2-f706-40c4-b58b-a322ca395682_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7cba718f-ad1d-4803-aa4c-bc80b5f545cc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_25e44f96-8ac9-475d-8bc9-d8584efcece4_negatedTerseLabel_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposition of joint venture</link:label>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_label_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Joint Venture</link:label>
    <link:label id="lab_dgx_GainLossOnDispositionOfJointVenture_documentation_en-US" xlink:label="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture" xlink:href="dgx-20210930.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GainLossOnDispositionOfJointVenture" xlink:to="lab_dgx_GainLossOnDispositionOfJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_1e7ba7f9-0922-48c6-b554-c93b09047a13_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_84ac9b12-6bcc-418d-9fe9-25b08353c7e7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_6c46d9a8-859d-4e8f-9a91-47a649130359_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ce91a98a-1982-4a34-ba32-c870f3b1cb31_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6f322a57-0a39-45e2-9320-9c32ebaf9369_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_93a0ddd9-67b5-4a45-a668-f3d0e797ff82_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5081869b-3b19-4e2b-a989-da933f86c9b2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c79ba732-4b41-4c7e-a641-5fe99a406f7d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards to be Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b3c4dda1-d410-46b1-a700-ab55e679cdcb_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_32f6dfcb-4a1e-4f2a-84a6-2cd1cb832066_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_053603df-221f-4bcb-987b-44e678ac5654_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_41300022-3ea0-4e6c-9a55-b78c9461c8c2_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:href="dgx-20210930.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_62f3c013-f73b-4d3b-94d0-578d54328550_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_bc167f35-9193-468a-9d33-508761305600_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_025e9bba-fa6c-4e85-a64a-ff6bd5ec4305_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_1997822d-ac78-4299-beba-38b643b0796d_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_ae8a2be6-7e3e-4e54-be23-f8c0090efb2a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_32a42608-2cee-4729-ad0c-1e2cae47c1a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_3a5d9288-2a1c-4845-9c71-f2227e05cc86_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_9af8f33c-13cf-471a-9774-81ab1e7629b4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f0486e20-77ba-4992-94f6-0ddc310c69aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02d1eaa8-7602-469c-bd86-50127096954c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>dgx-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:3dfc3e15-f0aa-46bd-8aee-40e417fed44b,g:988a0070-0eae-4f69-89e4-5f07a4cdd401-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_05d61fc5-eaa8-4614-81f7-7c89b9b4a536" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_DocumentType_05d61fc5-eaa8-4614-81f7-7c89b9b4a536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_2e4d0e18-0a5f-4009-af71-a83eebc1bb28" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_DocumentQuarterlyReport_2e4d0e18-0a5f-4009-af71-a83eebc1bb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a9bf0cab-5916-4f2d-a820-1ecad2534d16" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_DocumentPeriodEndDate_a9bf0cab-5916-4f2d-a820-1ecad2534d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_39d22ec9-443e-4147-9805-89cc23d69adf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_DocumentTransitionReport_39d22ec9-443e-4147-9805-89cc23d69adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0ca752fd-a1bb-4c72-aca7-23e81d925b84" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityFileNumber_0ca752fd-a1bb-4c72-aca7-23e81d925b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_eda57d81-a4fc-4b75-8cbe-d297a4d03705" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityRegistrantName_eda57d81-a4fc-4b75-8cbe-d297a4d03705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6eb3b48f-1e68-4c5c-8084-abfbd0493722" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityCentralIndexKey_6eb3b48f-1e68-4c5c-8084-abfbd0493722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d74699f3-a324-4860-969b-18c018fab41c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_CurrentFiscalYearEndDate_d74699f3-a324-4860-969b-18c018fab41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_cb7c4a11-3a04-4012-ac73-8732844ded91" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_DocumentFiscalYearFocus_cb7c4a11-3a04-4012-ac73-8732844ded91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9c043d7b-151f-4aeb-9843-d9d6e55244ae" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9c043d7b-151f-4aeb-9843-d9d6e55244ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4fe1dd92-f90a-4f4a-b0f6-3292b6af7eed" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_AmendmentFlag_4fe1dd92-f90a-4f4a-b0f6-3292b6af7eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6a71c46a-df4c-4be2-b270-b4fdc24a659c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6a71c46a-df4c-4be2-b270-b4fdc24a659c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ace3d102-0d95-478a-ac9a-d0f5f950f8de" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityTaxIdentificationNumber_ace3d102-0d95-478a-ac9a-d0f5f950f8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_26e0b80e-4881-4386-84f4-790e5bfde134" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityAddressAddressLine1_26e0b80e-4881-4386-84f4-790e5bfde134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6cc7bec6-1dba-4d82-b8d1-7e532ab58200" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityAddressCityOrTown_6cc7bec6-1dba-4d82-b8d1-7e532ab58200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5f155412-a739-4b68-8348-80fc6951ea03" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityAddressStateOrProvince_5f155412-a739-4b68-8348-80fc6951ea03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e1ebfeb3-e952-4e8c-9512-93094496f0f1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityAddressPostalZipCode_e1ebfeb3-e952-4e8c-9512-93094496f0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e03b668a-7ea7-4adb-9c14-3d4496c232de" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_CityAreaCode_e03b668a-7ea7-4adb-9c14-3d4496c232de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3c98418c-6030-440a-99f0-10402f8a93ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_LocalPhoneNumber_3c98418c-6030-440a-99f0-10402f8a93ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_274be099-8576-4f09-a26c-ff20ae3562c5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_Security12bTitle_274be099-8576-4f09-a26c-ff20ae3562c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3216b20d-5e7a-4390-974d-380a9b5d208f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_TradingSymbol_3216b20d-5e7a-4390-974d-380a9b5d208f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_bee546c5-ec90-4354-b46e-2671174aa7b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_SecurityExchangeName_bee546c5-ec90-4354-b46e-2671174aa7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c88f4ca8-dfe2-4c02-b811-e3b0e60e1d1f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityCurrentReportingStatus_c88f4ca8-dfe2-4c02-b811-e3b0e60e1d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_cc0e271b-da7c-4715-8140-27c70d056e8d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityInteractiveDataCurrent_cc0e271b-da7c-4715-8140-27c70d056e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_cab65217-078b-4d7b-93f7-b9c4db151f80" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityFilerCategory_cab65217-078b-4d7b-93f7-b9c4db151f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b433241f-349a-452f-97a0-248b64e39aef" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntitySmallBusiness_b433241f-349a-452f-97a0-248b64e39aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d9ca07f4-96cc-46ec-a724-beb42b73574f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityEmergingGrowthCompany_d9ca07f4-96cc-46ec-a724-beb42b73574f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_52d603e6-5b42-4586-b40c-2fb53855923d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityShellCompany_52d603e6-5b42-4586-b40c-2fb53855923d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a9fc9518-d646-4332-ad8b-c60cf1d939d8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64746c29-7806-4172-a90e-eaa32b3f2118" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a9fc9518-d646-4332-ad8b-c60cf1d939d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b00416bb-fa87-4941-b288-a8b6819c27c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b00416bb-fa87-4941-b288-a8b6819c27c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_190c981c-a95a-461f-85b5-f1c3d3a61149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_CostOfRevenueAbstract_190c981c-a95a-461f-85b5-f1c3d3a61149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_5171915b-67af-48d8-82b3-6b6c753c24a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_190c981c-a95a-461f-85b5-f1c3d3a61149" xlink:to="loc_us-gaap_CostOfRevenue_5171915b-67af-48d8-82b3-6b6c753c24a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_66cd2ad8-6593-4fa2-89b1-9009b62d401f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_190c981c-a95a-461f-85b5-f1c3d3a61149" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_66cd2ad8-6593-4fa2-89b1-9009b62d401f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dc5c6fdd-5a53-4fdc-b34a-7941fdb79e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_190c981c-a95a-461f-85b5-f1c3d3a61149" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dc5c6fdd-5a53-4fdc-b34a-7941fdb79e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_b46babbf-a6d7-49e6-b60e-12af88b232c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_190c981c-a95a-461f-85b5-f1c3d3a61149" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_b46babbf-a6d7-49e6-b60e-12af88b232c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_de6d839e-1205-44ad-a231-26a59e29c548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_CostsAndExpenses_de6d839e-1205-44ad-a231-26a59e29c548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cebcb8d3-91aa-4f57-9fe7-b784b967080f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_OperatingIncomeLoss_cebcb8d3-91aa-4f57-9fe7-b784b967080f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5db9a1c5-f8ec-4fa9-88b5-7933e57e6841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5db9a1c5-f8ec-4fa9-88b5-7933e57e6841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_494c7213-5de6-42c7-93c2-938ca3e6c2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5db9a1c5-f8ec-4fa9-88b5-7933e57e6841" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_494c7213-5de6-42c7-93c2-938ca3e6c2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_99228963-d3de-4663-a59d-e386af0e2346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5db9a1c5-f8ec-4fa9-88b5-7933e57e6841" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_99228963-d3de-4663-a59d-e386af0e2346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c8b0a8d1-b3b3-4cab-a971-191756b0c9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_5db9a1c5-f8ec-4fa9-88b5-7933e57e6841" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c8b0a8d1-b3b3-4cab-a971-191756b0c9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c4317d88-7951-4ceb-b0aa-5d7517081851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c4317d88-7951-4ceb-b0aa-5d7517081851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a3e21b98-a13c-4c8c-816a-cc55d14b1885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a3e21b98-a13c-4c8c-816a-cc55d14b1885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dd995f9a-c0a8-4bdb-b20d-d2c1b6fa15a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dd995f9a-c0a8-4bdb-b20d-d2c1b6fa15a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9a0e9aea-d669-4b61-bba7-c11d3e3a5add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_ProfitLoss_9a0e9aea-d669-4b61-bba7-c11d3e3a5add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec63016b-c8e6-4244-80f5-c6e5f523b0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec63016b-c8e6-4244-80f5-c6e5f523b0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d1372cf5-d6e5-45f6-9518-d2e95c2fd26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_NetIncomeLoss_d1372cf5-d6e5-45f6-9518-d2e95c2fd26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_28c40a6e-a8e5-4a79-bde0-5d674c1c6ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_28c40a6e-a8e5-4a79-bde0-5d674c1c6ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1451ff92-7dba-4aa6-af1e-a9b67b481bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_28c40a6e-a8e5-4a79-bde0-5d674c1c6ed5" xlink:to="loc_us-gaap_EarningsPerShareBasic_1451ff92-7dba-4aa6-af1e-a9b67b481bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ac8fa93e-7da5-4b12-92dd-e87b75c1be66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_28c40a6e-a8e5-4a79-bde0-5d674c1c6ed5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ac8fa93e-7da5-4b12-92dd-e87b75c1be66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_443be5f9-e100-400f-bd97-775f36a8353e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_584c635e-4eac-4c88-a9fe-19798dcc4d7f" xlink:to="loc_us-gaap_EarningsPerShareAbstract_443be5f9-e100-400f-bd97-775f36a8353e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a54f573e-482e-4b5c-96ea-31c35ee1ed9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_443be5f9-e100-400f-bd97-775f36a8353e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a54f573e-482e-4b5c-96ea-31c35ee1ed9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7ada78a8-9820-4ea1-b953-6f1e7a558328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_443be5f9-e100-400f-bd97-775f36a8353e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7ada78a8-9820-4ea1-b953-6f1e7a558328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_90c2ab57-b49d-44a7-ac3f-e5a598ee956f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_76af9728-2ea5-414c-920b-271867a116fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_90c2ab57-b49d-44a7-ac3f-e5a598ee956f" xlink:to="loc_us-gaap_ProfitLoss_76af9728-2ea5-414c-920b-271867a116fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9ac6c310-7a18-4e90-bc58-e89583a5d1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_90c2ab57-b49d-44a7-ac3f-e5a598ee956f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9ac6c310-7a18-4e90-bc58-e89583a5d1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6983819a-ab46-4dd1-8fba-c19d87a78006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9ac6c310-7a18-4e90-bc58-e89583a5d1a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6983819a-ab46-4dd1-8fba-c19d87a78006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_10944cdf-20ae-4ffd-bf0b-67f417c7a7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9ac6c310-7a18-4e90-bc58-e89583a5d1a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_10944cdf-20ae-4ffd-bf0b-67f417c7a7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a90c4fc7-ce6a-40b2-803d-054244e994b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9ac6c310-7a18-4e90-bc58-e89583a5d1a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a90c4fc7-ce6a-40b2-803d-054244e994b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5b549900-8e3d-43fb-aa8a-6adc0d5c3e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9ac6c310-7a18-4e90-bc58-e89583a5d1a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5b549900-8e3d-43fb-aa8a-6adc0d5c3e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2725aa5c-d271-44fc-beab-198d8721c312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_90c2ab57-b49d-44a7-ac3f-e5a598ee956f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2725aa5c-d271-44fc-beab-198d8721c312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_98e785b6-4dbc-47f2-a057-8463b873eb75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_90c2ab57-b49d-44a7-ac3f-e5a598ee956f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_98e785b6-4dbc-47f2-a057-8463b873eb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c462a5b5-85ce-463a-9375-9282d59ca563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_90c2ab57-b49d-44a7-ac3f-e5a598ee956f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_c462a5b5-85ce-463a-9375-9282d59ca563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1ae8ef78-8509-465b-b906-cc48a66741b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ae8ef78-8509-465b-b906-cc48a66741b9" xlink:to="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_77576cd4-557d-4a89-90df-85e0b047cfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_77576cd4-557d-4a89-90df-85e0b047cfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_45e9edc4-2a6f-4389-a6fd-591d5534947f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_45e9edc4-2a6f-4389-a6fd-591d5534947f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bccc483c-f181-4095-b391-c049302ff56d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_InventoryNet_bccc483c-f181-4095-b391-c049302ff56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1347d811-9428-4116-a0a9-b1125c6900d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1347d811-9428-4116-a0a9-b1125c6900d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f67c6444-188b-4256-ba8b-b5974ef1803a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_AssetsCurrent_f67c6444-188b-4256-ba8b-b5974ef1803a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d194a53f-fbb2-4229-bd60-27196fd988ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d194a53f-fbb2-4229-bd60-27196fd988ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b682c7b6-2337-411e-88ae-705b24a1d917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b682c7b6-2337-411e-88ae-705b24a1d917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d58510d1-857e-4a0a-9e61-20533bbafcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_Goodwill_d58510d1-857e-4a0a-9e61-20533bbafcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d5beb533-d159-43a7-ad9b-c09205cbfdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d5beb533-d159-43a7-ad9b-c09205cbfdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_541f92cf-02d5-4d91-b1b6-7111e0bd8853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_EquityMethodInvestments_541f92cf-02d5-4d91-b1b6-7111e0bd8853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ca64b045-ca40-40dd-875e-b9b382335062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ca64b045-ca40-40dd-875e-b9b382335062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_54f1280a-8e73-47d3-a2ee-dd4997156279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8b82d30-da98-46fb-9e40-8aa39f158c4f" xlink:to="loc_us-gaap_Assets_54f1280a-8e73-47d3-a2ee-dd4997156279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ae8ef78-8509-465b-b906-cc48a66741b9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9c8153ee-3660-462f-bd20-3704a2582b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9c8153ee-3660-462f-bd20-3704a2582b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5ee3bc36-8397-4209-bfbb-a5eeb31b8929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_LongTermDebtCurrent_5ee3bc36-8397-4209-bfbb-a5eeb31b8929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_78438542-fe99-4032-b30d-381d4b0e8ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_78438542-fe99-4032-b30d-381d4b0e8ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_42481c86-51b3-454c-91cb-cf5f2de449e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_LiabilitiesCurrent_42481c86-51b3-454c-91cb-cf5f2de449e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6dd1ef90-346c-4876-a128-4d23313b5eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6dd1ef90-346c-4876-a128-4d23313b5eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f2ccbdf-e1c0-4696-b6ef-a69d5e8796b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f2ccbdf-e1c0-4696-b6ef-a69d5e8796b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5c188414-91ae-4283-9d40-0d0a181a1a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5c188414-91ae-4283-9d40-0d0a181a1a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_52e2600d-63b3-4c52-80f3-53a7f59fcb32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_52e2600d-63b3-4c52-80f3-53a7f59fcb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b3639e8f-ed58-4388-88b9-f12c0db2e0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b3639e8f-ed58-4388-88b9-f12c0db2e0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f69aa087-51ad-436f-ae7e-002dc74a9a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f69aa087-51ad-436f-ae7e-002dc74a9a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c07474f2-c991-403f-a807-00abbefe7156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f69aa087-51ad-436f-ae7e-002dc74a9a05" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c07474f2-c991-403f-a807-00abbefe7156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_57ecf045-5edf-4749-844e-d8acf6e7859d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c07474f2-c991-403f-a807-00abbefe7156" xlink:to="loc_us-gaap_CommonStockValue_57ecf045-5edf-4749-844e-d8acf6e7859d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d55ff1d2-1fed-4ddc-aa68-c2de7cdaac2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c07474f2-c991-403f-a807-00abbefe7156" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d55ff1d2-1fed-4ddc-aa68-c2de7cdaac2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_64e014e9-cdaf-423e-b35e-7b87c64279d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c07474f2-c991-403f-a807-00abbefe7156" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_64e014e9-cdaf-423e-b35e-7b87c64279d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_292584ce-3033-44c7-8012-5425ffbd84f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c07474f2-c991-403f-a807-00abbefe7156" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_292584ce-3033-44c7-8012-5425ffbd84f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d542c91a-9e29-474b-b5c0-4bc1ba9388f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c07474f2-c991-403f-a807-00abbefe7156" xlink:to="loc_us-gaap_TreasuryStockValue_d542c91a-9e29-474b-b5c0-4bc1ba9388f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ffb082cf-48fc-435d-bf72-4c1f7dc02d16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c07474f2-c991-403f-a807-00abbefe7156" xlink:to="loc_us-gaap_StockholdersEquity_ffb082cf-48fc-435d-bf72-4c1f7dc02d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_482b7e21-89f4-41b5-8e4f-f401bb0b7cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f69aa087-51ad-436f-ae7e-002dc74a9a05" xlink:to="loc_us-gaap_MinorityInterest_482b7e21-89f4-41b5-8e4f-f401bb0b7cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b15beb4e-a30b-47f8-8d69-4f9efc4df2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f69aa087-51ad-436f-ae7e-002dc74a9a05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b15beb4e-a30b-47f8-8d69-4f9efc4df2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4b9e142b-b329-4c50-bb0f-63b4873c659b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a4d0b17b-f9c4-46dd-8005-00663dea7ab8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4b9e142b-b329-4c50-bb0f-63b4873c659b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6037f502-18cd-4ce4-a14a-bf3131dc0f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1ae8ef78-8509-465b-b906-cc48a66741b9" xlink:to="loc_us-gaap_CommonStockSharesIssued_6037f502-18cd-4ce4-a14a-bf3131dc0f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c5fe64b1-866a-4dc2-9b39-69b32b07e007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e9284816-7609-4f2b-b254-4da7a91cf6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c5fe64b1-866a-4dc2-9b39-69b32b07e007" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e9284816-7609-4f2b-b254-4da7a91cf6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_57fba029-95de-4492-b7d7-66e053562cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c5fe64b1-866a-4dc2-9b39-69b32b07e007" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_57fba029-95de-4492-b7d7-66e053562cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_16a637d7-6ea3-474b-84a8-d526de63fec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c5fe64b1-866a-4dc2-9b39-69b32b07e007" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_16a637d7-6ea3-474b-84a8-d526de63fec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e3561c2e-e537-4a5d-a3e8-1b51b4b72e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c5fe64b1-866a-4dc2-9b39-69b32b07e007" xlink:to="loc_us-gaap_CommonStockSharesIssued_e3561c2e-e537-4a5d-a3e8-1b51b4b72e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_3085c627-cf2c-44a6-b0c7-0ece3c3e02f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c5fe64b1-866a-4dc2-9b39-69b32b07e007" xlink:to="loc_us-gaap_TreasuryStockShares_3085c627-cf2c-44a6-b0c7-0ece3c3e02f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a48d0807-465b-4794-92b1-67c5c7dea204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_ee2f8096-cce3-4813-a6a9-9b03d7e91421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a48d0807-465b-4794-92b1-67c5c7dea204" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_ee2f8096-cce3-4813-a6a9-9b03d7e91421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2639aa5a-90b8-4712-ae6e-5def21ac006e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_ee2f8096-cce3-4813-a6a9-9b03d7e91421" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2639aa5a-90b8-4712-ae6e-5def21ac006e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6c6f00ab-7f15-4655-8ccf-1cce2014e987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2639aa5a-90b8-4712-ae6e-5def21ac006e" xlink:to="loc_us-gaap_ProfitLoss_6c6f00ab-7f15-4655-8ccf-1cce2014e987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b26fe822-4a38-4d81-80bd-2811340afb87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2639aa5a-90b8-4712-ae6e-5def21ac006e" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b26fe822-4a38-4d81-80bd-2811340afb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_44be4860-ef17-40f9-931c-5399562559aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b26fe822-4a38-4d81-80bd-2811340afb87" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_44be4860-ef17-40f9-931c-5399562559aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_4a306303-0e7e-4783-9db9-359c4e96599f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b26fe822-4a38-4d81-80bd-2811340afb87" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_4a306303-0e7e-4783-9db9-359c4e96599f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4526a683-7c41-46b7-b5af-038674e06609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b26fe822-4a38-4d81-80bd-2811340afb87" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4526a683-7c41-46b7-b5af-038674e06609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_457bb8d0-6505-4fd5-a394-30488b6d6a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b26fe822-4a38-4d81-80bd-2811340afb87" xlink:to="loc_us-gaap_ShareBasedCompensation_457bb8d0-6505-4fd5-a394-30488b6d6a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossOnDispositionOfJointVenture_6396623a-1b9c-41c8-9132-f330312ffc74" xlink:href="dgx-20210930.xsd#dgx_GainLossOnDispositionOfJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b26fe822-4a38-4d81-80bd-2811340afb87" xlink:to="loc_dgx_GainLossOnDispositionOfJointVenture_6396623a-1b9c-41c8-9132-f330312ffc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_2ad39be3-c810-4842-879f-ca90b52aab39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b26fe822-4a38-4d81-80bd-2811340afb87" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_2ad39be3-c810-4842-879f-ca90b52aab39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba57044f-c9a7-4c2e-b393-7298a0657a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2639aa5a-90b8-4712-ae6e-5def21ac006e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba57044f-c9a7-4c2e-b393-7298a0657a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d31dd96b-cc7a-4b75-add6-46830ab0e9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba57044f-c9a7-4c2e-b393-7298a0657a96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d31dd96b-cc7a-4b75-add6-46830ab0e9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1db8e363-639a-4ccb-853a-8c5a43fd6a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba57044f-c9a7-4c2e-b393-7298a0657a96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1db8e363-639a-4ccb-853a-8c5a43fd6a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_25b19884-1ad0-42e1-9260-b7e8157dd2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba57044f-c9a7-4c2e-b393-7298a0657a96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_25b19884-1ad0-42e1-9260-b7e8157dd2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements_61999603-17e5-4df2-9f61-b78f2878aa0c" xlink:href="dgx-20210930.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba57044f-c9a7-4c2e-b393-7298a0657a96" xlink:to="loc_dgx_TerminationOfInterestRateSwapAgreements_61999603-17e5-4df2-9f61-b78f2878aa0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4e1da8de-cda6-4a5c-b28b-b0677c0b7167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba57044f-c9a7-4c2e-b393-7298a0657a96" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4e1da8de-cda6-4a5c-b28b-b0677c0b7167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ed31964d-7105-4f8f-8119-c5bc91c6ee54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2639aa5a-90b8-4712-ae6e-5def21ac006e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ed31964d-7105-4f8f-8119-c5bc91c6ee54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d0f6871f-1d68-484a-8d60-d0a12ee62478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_ee2f8096-cce3-4813-a6a9-9b03d7e91421" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d0f6871f-1d68-484a-8d60-d0a12ee62478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fb46c003-5277-430a-8ff3-42c4f0b4b64e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d0f6871f-1d68-484a-8d60-d0a12ee62478" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_fb46c003-5277-430a-8ff3-42c4f0b4b64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f2004905-6078-4463-a9a0-e6f4adb3628c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d0f6871f-1d68-484a-8d60-d0a12ee62478" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f2004905-6078-4463-a9a0-e6f4adb3628c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_4130758a-1b2e-48df-9977-56c5b8c4f35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d0f6871f-1d68-484a-8d60-d0a12ee62478" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_4130758a-1b2e-48df-9977-56c5b8c4f35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_36f58ef2-9b86-477d-b111-09d247d0cd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d0f6871f-1d68-484a-8d60-d0a12ee62478" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_36f58ef2-9b86-477d-b111-09d247d0cd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_407b73f5-4815-41d7-9710-48cfdc6534e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d0f6871f-1d68-484a-8d60-d0a12ee62478" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_407b73f5-4815-41d7-9710-48cfdc6534e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_ee2f8096-cce3-4813-a6a9-9b03d7e91421" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_ca7cd101-f368-45a8-ab81-68d98270b9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_ca7cd101-f368-45a8-ab81-68d98270b9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_ba5c804c-0fe1-47d7-9ab5-0a4a1605bf5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_RepaymentsOfDebt_ba5c804c-0fe1-47d7-9ab5-0a4a1605bf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_27818fc3-cca9-4522-9eda-e800acfd5136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_27818fc3-cca9-4522-9eda-e800acfd5136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_177b664c-edc4-4be0-9ef7-e0265a684a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_177b664c-edc4-4be0-9ef7-e0265a684a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4c44723f-967e-45e8-bbee-8d3440c4443a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4c44723f-967e-45e8-bbee-8d3440c4443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_e394bcfe-996e-40dd-b49d-95c0e6e72a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_e394bcfe-996e-40dd-b49d-95c0e6e72a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_9ce205d4-a3e0-4249-b617-fecc47b0e9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_9ce205d4-a3e0-4249-b617-fecc47b0e9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_64107dfd-2521-425a-bc2c-05c03bf64699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_64107dfd-2521-425a-bc2c-05c03bf64699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ff02a7ea-5e05-4c2e-98de-245ff1557898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fa23d23-b65d-40a0-8aee-d1b033256a3b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ff02a7ea-5e05-4c2e-98de-245ff1557898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2322744-1293-4d92-9505-f6a3077271a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_ee2f8096-cce3-4813-a6a9-9b03d7e91421" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d2322744-1293-4d92-9505-f6a3077271a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_54e1cd41-77c1-4895-afb9-6a474f5b5f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_ee2f8096-cce3-4813-a6a9-9b03d7e91421" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_54e1cd41-77c1-4895-afb9-6a474f5b5f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7231b6ac-fc2b-48eb-9398-e9645546344a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_ee2f8096-cce3-4813-a6a9-9b03d7e91421" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7231b6ac-fc2b-48eb-9398-e9645546344a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20210930.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2fadd9e3-8cd8-4423-8958-0ccea85d5b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1cfed139-77ab-4558-901b-e4ac206efce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2fadd9e3-8cd8-4423-8958-0ccea85d5b96" xlink:to="loc_us-gaap_StatementTable_1cfed139-77ab-4558-901b-e4ac206efce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ee822fd1-83cf-437b-8ede-e56b0e4a55f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1cfed139-77ab-4558-901b-e4ac206efce1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ee822fd1-83cf-437b-8ede-e56b0e4a55f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee822fd1-83cf-437b-8ede-e56b0e4a55f9" xlink:to="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bbd26574-3f9c-47f1-8571-738cce2eb624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_CommonStockMember_bbd26574-3f9c-47f1-8571-738cce2eb624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f8d5bcdd-a349-4bb6-b206-b3791244e320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f8d5bcdd-a349-4bb6-b206-b3791244e320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_68e8fe95-1fd7-49e9-a5bd-697436c386c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_RetainedEarningsMember_68e8fe95-1fd7-49e9-a5bd-697436c386c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fe55b620-a02e-48aa-827d-3ae795f89566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fe55b620-a02e-48aa-827d-3ae795f89566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c2540c14-388c-4256-b841-2d07b1ed030d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_TreasuryStockMember_c2540c14-388c-4256-b841-2d07b1ed030d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f417352c-659c-4520-8fa3-62aead7f037b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b306f15-63a8-4731-980f-f8a21d73bd54" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f417352c-659c-4520-8fa3-62aead7f037b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_34ee1355-b2d2-4f43-acec-a4f86e96bbec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1cfed139-77ab-4558-901b-e4ac206efce1" xlink:to="loc_us-gaap_StatementLineItems_34ee1355-b2d2-4f43-acec-a4f86e96bbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34ee1355-b2d2-4f43-acec-a4f86e96bbec" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4faec15a-7681-4828-9388-780c97e242fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4faec15a-7681-4828-9388-780c97e242fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6133ce98-7c17-454e-904c-eb7c398c0884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6133ce98-7c17-454e-904c-eb7c398c0884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_93174e34-b2e5-49bb-bccf-768982327d4d" xlink:href="dgx-20210930.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_93174e34-b2e5-49bb-bccf-768982327d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee5fc627-8aae-4d34-a7dd-6e037524a9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee5fc627-8aae-4d34-a7dd-6e037524a9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_ad6f17d7-095e-4dab-8794-6728e97a4986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_DividendsCommonStockCash_ad6f17d7-095e-4dab-8794-6728e97a4986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_ce4add59-41b2-4df2-8fdc-8957ee729b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_ce4add59-41b2-4df2-8fdc-8957ee729b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d4d0ecbe-f084-4090-bcae-e884a0d59a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d4d0ecbe-f084-4090-bcae-e884a0d59a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_04bf12b1-0b9d-4128-af2e-25b62e0aefef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_04bf12b1-0b9d-4128-af2e-25b62e0aefef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_239e5c15-081e-48f3-af18-c3ca729322ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_239e5c15-081e-48f3-af18-c3ca729322ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_755f3fd5-7968-4620-8435-189a9adcb94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_755f3fd5-7968-4620-8435-189a9adcb94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c3f0413e-464a-4343-8ed1-de6ca0ac783b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c3f0413e-464a-4343-8ed1-de6ca0ac783b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1f1976ae-8771-49f6-8723-027bc1d2aba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1f1976ae-8771-49f6-8723-027bc1d2aba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_bda01ac7-89fd-4c3e-b508-358bb53eba90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_bda01ac7-89fd-4c3e-b508-358bb53eba90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_daac374c-c763-453e-b61a-bda0775d5e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_daac374c-c763-453e-b61a-bda0775d5e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_389f8916-168d-4cca-ac4d-85e6ba2a0903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_389f8916-168d-4cca-ac4d-85e6ba2a0903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b3daf8f2-44b5-4d2f-be98-bfe5d68752d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b3daf8f2-44b5-4d2f-be98-bfe5d68752d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8f89ea6-c7ca-49c3-ab9d-34d6d2d286f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5b22ad71-8313-41ad-85bb-c0f735417216" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8f89ea6-c7ca-49c3-ab9d-34d6d2d286f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34ee1355-b2d2-4f43-acec-a4f86e96bbec" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d7836d51-b2a0-45cc-8df1-51305647ce50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d7836d51-b2a0-45cc-8df1-51305647ce50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_cb466e8b-2b23-41ea-9c72-88d0c5250a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_cb466e8b-2b23-41ea-9c72-88d0c5250a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_607458d1-9268-4218-88f4-85eb0d2f4908" xlink:href="dgx-20210930.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_607458d1-9268-4218-88f4-85eb0d2f4908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1e4be99c-153a-4fce-be11-bf7a14b19af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e20e9e08-8938-4d3a-8b13-a40736ce3b8b" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1e4be99c-153a-4fce-be11-bf7a14b19af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20210930.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract_6e857ba5-2139-48c9-9ebf-74188a621ccc" xlink:href="dgx-20210930.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_d672e5d5-1e16-4d42-9e2d-2166e1741495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_DescriptionOfBusinessAbstract_6e857ba5-2139-48c9-9ebf-74188a621ccc" xlink:to="loc_us-gaap_NatureOfOperations_d672e5d5-1e16-4d42-9e2d-2166e1741495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_68d4f7a3-6b95-46c9-a83a-78fcd792f876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_2a1f1119-5776-4696-8aa9-f5f0a75505e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_68d4f7a3-6b95-46c9-a83a-78fcd792f876" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_2a1f1119-5776-4696-8aa9-f5f0a75505e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1c078636-b94e-4067-85de-fb143ec119dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_40c0060a-ede0-4a14-bd4b-ce5544f9d3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c078636-b94e-4067-85de-fb143ec119dc" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_40c0060a-ede0-4a14-bd4b-ce5544f9d3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_9d2f0246-73d3-442e-9312-3737809248cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c078636-b94e-4067-85de-fb143ec119dc" xlink:to="loc_us-gaap_UseOfEstimates_9d2f0246-73d3-442e-9312-3737809248cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_1e4a5de5-2df7-476a-8ed6-7d7424ec935a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c078636-b94e-4067-85de-fb143ec119dc" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_1e4a5de5-2df7-476a-8ed6-7d7424ec935a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_aa3645e9-fe3f-46c5-a749-f14c082168f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c078636-b94e-4067-85de-fb143ec119dc" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_aa3645e9-fe3f-46c5-a749-f14c082168f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_c0faeaf4-5d9d-4200-9ff9-dc6c805be9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c078636-b94e-4067-85de-fb143ec119dc" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_c0faeaf4-5d9d-4200-9ff9-dc6c805be9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20210930.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0c8a548e-d1f1-4daf-834d-68d56e73548e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_da4f4f1e-b88c-4c3b-8cab-52c1e5275aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0c8a548e-d1f1-4daf-834d-68d56e73548e" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_da4f4f1e-b88c-4c3b-8cab-52c1e5275aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="dgx-20210930.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d3f2f944-6bc6-44f4-88cf-ab8da8b6b91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9928a764-6d92-434f-b150-0138fb7956c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d3f2f944-6bc6-44f4-88cf-ab8da8b6b91c" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9928a764-6d92-434f-b150-0138fb7956c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4ac8a1e5-b4f1-43ce-a15b-ce9e626b8ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d3f2f944-6bc6-44f4-88cf-ab8da8b6b91c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_4ac8a1e5-b4f1-43ce-a15b-ce9e626b8ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_8fdc3512-fd75-4b76-935b-86bcd1d8d1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_8fdc3512-fd75-4b76-935b-86bcd1d8d1d0" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a41e7af2-1f26-49e0-ae8e-5aa57bc69588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:to="loc_us-gaap_NetIncomeLoss_a41e7af2-1f26-49e0-ae8e-5aa57bc69588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_da340b86-8959-4e4a-92ec-f583f24a8293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_da340b86-8959-4e4a-92ec-f583f24a8293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_383705d4-1f6b-4ef4-99d1-fa2dadb97f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_383705d4-1f6b-4ef4-99d1-fa2dadb97f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4797cb12-3ceb-4756-bdfa-04b7409eefdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4797cb12-3ceb-4756-bdfa-04b7409eefdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3868ae1c-1ff3-41e9-9136-5aebabab75a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3868ae1c-1ff3-41e9-9136-5aebabab75a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_aac8d5d4-2653-4f1c-b8a2-4a32ebc282e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_aac8d5d4-2653-4f1c-b8a2-4a32ebc282e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_78ffeaaa-79e1-457f-9ba8-183b84aeef4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:to="loc_us-gaap_EarningsPerShareBasic_78ffeaaa-79e1-457f-9ba8-183b84aeef4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5dfead11-1d51-4a41-92db-93f6ba3982a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_757275d7-923d-4d43-a423-ed08f18e3fae" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5dfead11-1d51-4a41-92db-93f6ba3982a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_af1ec31b-6f19-4f87-a4c2-e2fd9e9fdec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_8fdc3512-fd75-4b76-935b-86bcd1d8d1d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_af1ec31b-6f19-4f87-a4c2-e2fd9e9fdec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_9ff63213-f356-4578-a7c7-500604aa1a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_8fdc3512-fd75-4b76-935b-86bcd1d8d1d0" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_9ff63213-f356-4578-a7c7-500604aa1a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e9df3436-411e-4c56-8bb1-052c2a827909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_9ff63213-f356-4578-a7c7-500604aa1a36" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e9df3436-411e-4c56-8bb1-052c2a827909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_b74450bb-65f9-4ef4-8531-4fd4cbb466b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e9df3436-411e-4c56-8bb1-052c2a827909" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_b74450bb-65f9-4ef4-8531-4fd4cbb466b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b83385ba-ab62-4d92-a637-faeae8347fec" xlink:href="dgx-20210930.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_b74450bb-65f9-4ef4-8531-4fd4cbb466b5" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b83385ba-ab62-4d92-a637-faeae8347fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_3d1ccb35-a00e-433d-8a73-10efbb9b1caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_9ff63213-f356-4578-a7c7-500604aa1a36" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_3d1ccb35-a00e-433d-8a73-10efbb9b1caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid_602b1e72-56ed-4760-90dc-ede8c385de03" xlink:href="dgx-20210930.xsd#dgx_AcceleratedShareRepurchasesInitialPricePaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_3d1ccb35-a00e-433d-8a73-10efbb9b1caa" xlink:to="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid_602b1e72-56ed-4760-90dc-ede8c385de03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20210930.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c6706f24-a305-4853-a52d-eed48788c825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_707eae29-19da-4aa7-aeee-911d2248e1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c6706f24-a305-4853-a52d-eed48788c825" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_707eae29-19da-4aa7-aeee-911d2248e1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6180c3b9-99f9-4729-9c9e-5303b7e0ea76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6180c3b9-99f9-4729-9c9e-5303b7e0ea76" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f272d220-0119-43a9-b3cf-90fedc784b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f272d220-0119-43a9-b3cf-90fedc784b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0075d031-2887-45ab-9794-e733d259223b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f272d220-0119-43a9-b3cf-90fedc784b09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0075d031-2887-45ab-9794-e733d259223b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember_c232b443-bba4-459d-a5bd-dc018aef632d" xlink:href="dgx-20210930.xsd#dgx_MercyHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0075d031-2887-45ab-9794-e733d259223b" xlink:to="loc_dgx_MercyHealthMember_c232b443-bba4-459d-a5bd-dc018aef632d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d0851de-61a9-4ade-a6d3-99997ba0a8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d0851de-61a9-4ade-a6d3-99997ba0a8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_680177f4-46d6-42bc-bbe9-f5b97f659458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d0851de-61a9-4ade-a6d3-99997ba0a8eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_680177f4-46d6-42bc-bbe9-f5b97f659458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1244aaa0-0bc3-402d-b717-c48ea5d128ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_680177f4-46d6-42bc-bbe9-f5b97f659458" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1244aaa0-0bc3-402d-b717-c48ea5d128ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_491a2723-fb98-4220-bf1e-34f720a03fca" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1603e169-c464-4188-b592-8e5f7107bd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1603e169-c464-4188-b592-8e5f7107bd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7f1d2e40-cc82-4886-a57d-6ad0f3102fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7f1d2e40-cc82-4886-a57d-6ad0f3102fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9ed0470a-19a5-42f7-b901-02697ddf9785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_Goodwill_9ed0470a-19a5-42f7-b901-02697ddf9785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_c38ec5d9-115b-4421-98b7-234c2ec37855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_c38ec5d9-115b-4421-98b7-234c2ec37855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4c110e3c-d01f-460c-80d2-9fa7a984b715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ccc9f07f-9fe1-4350-8e41-f5559b464d10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4c110e3c-d01f-460c-80d2-9fa7a984b715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITION" xlink:type="simple" xlink:href="dgx-20210930.xsd#DISPOSITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISPOSITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_614f5a2e-fea8-4832-aef8-dcbf27b50563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_cd17f7da-97e6-43ba-951e-5503e4f83eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_614f5a2e-fea8-4832-aef8-dcbf27b50563" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_cd17f7da-97e6-43ba-951e-5503e4f83eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#DISPOSITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0e40fb0d-11fa-46dc-9b3a-6e4ac237c6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0e40fb0d-11fa-46dc-9b3a-6e4ac237c6e7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5b78db07-448f-455d-839c-8b24022f8e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5b78db07-448f-455d-839c-8b24022f8e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f7192b84-ec34-4c9d-80c4-23fba6fbdcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5b78db07-448f-455d-839c-8b24022f8e5d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f7192b84-ec34-4c9d-80c4-23fba6fbdcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_4f7397eb-2b14-42a4-9312-de1919f6ab83" xlink:href="dgx-20210930.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f7192b84-ec34-4c9d-80c4-23fba6fbdcc5" xlink:to="loc_dgx_Q2SolutionsMember_4f7397eb-2b14-42a4-9312-de1919f6ab83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e9f6de55-fc03-4b32-91e7-1b9388630aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c0e3adf9-9ce0-4793-9aaa-17bbc6d9ae4c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e9f6de55-fc03-4b32-91e7-1b9388630aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_b87941f3-bf37-4f25-8ff6-5427ae52f7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e9f6de55-fc03-4b32-91e7-1b9388630aa3" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_b87941f3-bf37-4f25-8ff6-5427ae52f7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e55042db-9aa4-4382-8364-bb2475688b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5dac3b3-22bd-4550-aa8c-0a6b4d4f9332" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e55042db-9aa4-4382-8364-bb2475688b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_e06541a2-766c-4f84-a1f6-109ea199a6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e55042db-9aa4-4382-8364-bb2475688b5d" xlink:to="loc_us-gaap_OtherIncomeMember_e06541a2-766c-4f84-a1f6-109ea199a6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8eaaaf62-111c-40d8-be6f-6c4484ecb923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b17c4ae9-e6c6-4e43-8f4f-c0061e2ad56f" xlink:to="loc_us-gaap_EquityComponentDomain_8eaaaf62-111c-40d8-be6f-6c4484ecb923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_6befcd4e-ba82-4d04-aa1d-2536719e36ab" xlink:href="dgx-20210930.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8eaaaf62-111c-40d8-be6f-6c4484ecb923" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_6befcd4e-ba82-4d04-aa1d-2536719e36ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_67f5f823-3cab-45c1-9bfc-5a3155c43a91" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_7beeea0d-852f-4f62-b74a-55b3f4670083" xlink:href="dgx-20210930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_7beeea0d-852f-4f62-b74a-55b3f4670083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_01e7f221-cccd-45ca-be50-f21747e505bf" xlink:href="dgx-20210930.xsd#dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross_01e7f221-cccd-45ca-be50-f21747e505bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_1a0354c4-c0b7-422e-a835-e8d9f0c4b787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_1a0354c4-c0b7-422e-a835-e8d9f0c4b787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0ef0937e-ad4f-4f87-8527-917e265bc587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0ef0937e-ad4f-4f87-8527-917e265bc587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_976b58ca-c2f8-4b72-af98-2c86e205e8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_976b58ca-c2f8-4b72-af98-2c86e205e8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3f6addb2-9d69-4c8b-80d2-5a1b339b0570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3f6addb2-9d69-4c8b-80d2-5a1b339b0570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_05ff84e6-e202-41be-8909-96140bbab161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0c052acf-dd3f-45d5-9a87-1327065e4481" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_05ff84e6-e202-41be-8909-96140bbab161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20210930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a8ccc37d-3f82-4d9f-a846-582c6db79d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_1d0f67a5-fa34-43c0-8513-946dadfb1674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a8ccc37d-3f82-4d9f-a846-582c6db79d09" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_1d0f67a5-fa34-43c0-8513-946dadfb1674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20210930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e7e2c63f-281e-45d0-bfaf-346aa7e0e275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_a0356dbc-907c-45af-9212-7363bbadfb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e7e2c63f-281e-45d0-bfaf-346aa7e0e275" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_a0356dbc-907c-45af-9212-7363bbadfb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6368db8e-1757-42fb-80a6-52bbf7dce75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6368db8e-1757-42fb-80a6-52bbf7dce75c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7c39ac9a-4261-4438-861c-2196a73fcd22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1da938da-8e7f-4533-bc44-ddd1a4ce3e4e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7c39ac9a-4261-4438-861c-2196a73fcd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_39df8c6f-4e06-4d81-9025-72ea5500f7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_7c39ac9a-4261-4438-861c-2196a73fcd22" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_39df8c6f-4e06-4d81-9025-72ea5500f7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67fb55ab-c58d-4711-9b39-14573db934f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67fb55ab-c58d-4711-9b39-14573db934f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_67fb55ab-c58d-4711-9b39-14573db934f2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ccc8dcef-7698-4975-aabd-84642c98ae45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ccc8dcef-7698-4975-aabd-84642c98ae45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9dfe604f-7e32-453d-b2c3-fb7fad332fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9dfe604f-7e32-453d-b2c3-fb7fad332fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7106ab83-d355-4851-8771-537f9dd25ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_20803f79-3430-46a8-8719-d0dd2b3f98f6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7106ab83-d355-4851-8771-537f9dd25ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_746a2ebd-f608-4a35-a712-9ad52f877a9c" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e1b3087d-ae6c-4a23-bc35-caa7665e3e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_TradingSecurities_e1b3087d-ae6c-4a23-bc35-caa7665e3e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_61b88399-ffc5-4ca1-8e02-e05ce360ab24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_61b88399-ffc5-4ca1-8e02-e05ce360ab24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_f6c51393-dd25-4a29-b7cc-b386ee53fa6a" xlink:href="dgx-20210930.xsd#dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities_f6c51393-dd25-4a29-b7cc-b386ee53fa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_993df16e-e9fe-4646-b64d-344652a69e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_993df16e-e9fe-4646-b64d-344652a69e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_da6d2d4b-c6a8-43e3-bdb6-ec16912bec71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_da6d2d4b-c6a8-43e3-bdb6-ec16912bec71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_10a01523-5340-4a35-8c3c-814a568290e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_10a01523-5340-4a35-8c3c-814a568290e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_25729937-3cd1-4a0b-aa2f-b9fba54c781e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f39dd9cf-a431-4f0b-b919-6f067f674017" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_25729937-3cd1-4a0b-aa2f-b9fba54c781e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d4b52efb-154d-4997-95da-397ddd7a0c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_59ea2c24-02f3-44e6-975c-bb7a3cd4f6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d4b52efb-154d-4997-95da-397ddd7a0c0d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_59ea2c24-02f3-44e6-975c-bb7a3cd4f6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d4b52efb-154d-4997-95da-397ddd7a0c0d" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_448559ae-1d62-4718-bdd0-6a9168853066" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:to="loc_srt_OwnershipAxis_448559ae-1d62-4718-bdd0-6a9168853066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_87132731-3c8e-481a-aeb8-83b3c298a41e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_448559ae-1d62-4718-bdd0-6a9168853066" xlink:to="loc_srt_OwnershipDomain_87132731-3c8e-481a-aeb8-83b3c298a41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_772382d7-7cb0-405d-9855-aa647d8ffafa" xlink:href="dgx-20210930.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_87132731-3c8e-481a-aeb8-83b3c298a41e" xlink:to="loc_dgx_UMassJointVentureMember_772382d7-7cb0-405d-9855-aa647d8ffafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_457e480c-5881-47d6-acbf-7a7777a938fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_457e480c-5881-47d6-acbf-7a7777a938fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d96263ba-3116-41eb-91a3-28cbe7cdc285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_457e480c-5881-47d6-acbf-7a7777a938fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d96263ba-3116-41eb-91a3-28cbe7cdc285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b55d6b2e-563a-46dc-bb79-ed1cc62b9316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d96263ba-3116-41eb-91a3-28cbe7cdc285" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b55d6b2e-563a-46dc-bb79-ed1cc62b9316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03ea0a34-1a5a-44dd-ab2d-688a3471ea6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_5f49add0-b385-4b4a-aba6-bc049e8e850b" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03ea0a34-1a5a-44dd-ab2d-688a3471ea6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_7a85be73-63cb-49df-b952-2e8d7ca03ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03ea0a34-1a5a-44dd-ab2d-688a3471ea6e" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_7a85be73-63cb-49df-b952-2e8d7ca03ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_609bf5d1-99f8-41b8-b1f4-b9efeadbafbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03ea0a34-1a5a-44dd-ab2d-688a3471ea6e" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_609bf5d1-99f8-41b8-b1f4-b9efeadbafbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_74a43466-d383-4b09-9cc4-0be471b96832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d4b52efb-154d-4997-95da-397ddd7a0c0d" xlink:to="loc_us-gaap_DebtInstrumentFairValue_74a43466-d383-4b09-9cc4-0be471b96832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20210930.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6ec1a7a-85ff-459a-a463-fad88315c65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_544fc95e-2d0e-4d2b-bc30-a3fe78865479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6ec1a7a-85ff-459a-a463-fad88315c65d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_544fc95e-2d0e-4d2b-bc30-a3fe78865479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fa74d3-ac32-4a12-8a6b-63267059a6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_444efcc1-17f4-4e8a-a3b2-239ae22612b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fa74d3-ac32-4a12-8a6b-63267059a6d7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_444efcc1-17f4-4e8a-a3b2-239ae22612b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_ef13ab13-0f42-4641-ad71-922485d63539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fa74d3-ac32-4a12-8a6b-63267059a6d7" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_ef13ab13-0f42-4641-ad71-922485d63539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2b95b1e1-cd59-48a1-9f8c-4059330d194f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fa74d3-ac32-4a12-8a6b-63267059a6d7" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2b95b1e1-cd59-48a1-9f8c-4059330d194f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4d42d0a-314a-497d-af77-f2b989b846e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0c2084fd-ce02-41fe-bae7-27cf10f24804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4d42d0a-314a-497d-af77-f2b989b846e8" xlink:to="loc_us-gaap_GoodwillRollForward_0c2084fd-ce02-41fe-bae7-27cf10f24804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1ff83157-b84b-4db1-a6e0-d23c672251ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0c2084fd-ce02-41fe-bae7-27cf10f24804" xlink:to="loc_us-gaap_Goodwill_1ff83157-b84b-4db1-a6e0-d23c672251ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5f091e5e-be9c-4548-af8a-f013b84ed034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0c2084fd-ce02-41fe-bae7-27cf10f24804" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5f091e5e-be9c-4548-af8a-f013b84ed034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_a4380d17-7d0c-4182-84d0-3be7def10f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0c2084fd-ce02-41fe-bae7-27cf10f24804" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_a4380d17-7d0c-4182-84d0-3be7def10f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf10b4a7-df76-4d96-8ca2-fe66c99c155f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0c2084fd-ce02-41fe-bae7-27cf10f24804" xlink:to="loc_us-gaap_Goodwill_cf10b4a7-df76-4d96-8ca2-fe66c99c155f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d527dbb-3cc1-47d1-afdb-41722843de22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4d42d0a-314a-497d-af77-f2b989b846e8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d527dbb-3cc1-47d1-afdb-41722843de22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cd614c09-d6b0-49fc-ab96-08a396c00039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d527dbb-3cc1-47d1-afdb-41722843de22" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cd614c09-d6b0-49fc-ab96-08a396c00039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e41c7cc8-5645-4d41-bd13-64ad2ac437f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cd614c09-d6b0-49fc-ab96-08a396c00039" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e41c7cc8-5645-4d41-bd13-64ad2ac437f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_7504bc8d-c810-4627-9b9a-659c19a1b457" xlink:href="dgx-20210930.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e41c7cc8-5645-4d41-bd13-64ad2ac437f2" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_7504bc8d-c810-4627-9b9a-659c19a1b457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6580131e-ef17-41a7-9677-28c7bb31f948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4d527dbb-3cc1-47d1-afdb-41722843de22" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6580131e-ef17-41a7-9677-28c7bb31f948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_7780007b-9053-4d98-85b9-f4587112838c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6580131e-ef17-41a7-9677-28c7bb31f948" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_7780007b-9053-4d98-85b9-f4587112838c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b2c6b15-def7-4f90-a243-6c0c3d92f2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:href="dgx-20210930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5b2c6b15-def7-4f90-a243-6c0c3d92f2c7" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ea439b9-ba83-4100-9671-9828ec66bbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ea439b9-ba83-4100-9671-9828ec66bbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1ea439b9-ba83-4100-9671-9828ec66bbcb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9b946adf-4704-4d2d-bc61-de5ccfcb9cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9b946adf-4704-4d2d-bc61-de5ccfcb9cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_8cac2a77-8f5a-419d-b963-02135e8e2a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_8cac2a77-8f5a-419d-b963-02135e8e2a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_4d5ddef7-7295-489f-a13b-97e0bbd6a56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_4d5ddef7-7295-489f-a13b-97e0bbd6a56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_056890b5-086b-4935-97d2-cb365b7a15dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_056890b5-086b-4935-97d2-cb365b7a15dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_864506f1-410f-4b61-9ca3-acac9dd28878" xlink:href="dgx-20210930.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_75f4ccbb-7399-4e45-a538-87e14d4b2d27" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_864506f1-410f-4b61-9ca3-acac9dd28878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8595b8e2-974b-4946-bb9e-b90d5b189538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8595b8e2-974b-4946-bb9e-b90d5b189538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3ac3f29-df29-4beb-96f8-dbeb845e266d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8595b8e2-974b-4946-bb9e-b90d5b189538" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3ac3f29-df29-4beb-96f8-dbeb845e266d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_74e27c05-ff31-4ee3-a1e5-74957afcc2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3ac3f29-df29-4beb-96f8-dbeb845e266d" xlink:to="loc_us-gaap_TradeNamesMember_74e27c05-ff31-4ee3-a1e5-74957afcc2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_082d3a46-3046-4835-89f4-069b63b14d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d3ac3f29-df29-4beb-96f8-dbeb845e266d" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_082d3a46-3046-4835-89f4-069b63b14d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:href="dgx-20210930.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_fbaf2d34-1d28-4e43-8676-2db9539f35d8" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2bb905b4-37f2-4243-8736-005de986e7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2bb905b4-37f2-4243-8736-005de986e7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4acb5032-185a-46ef-bdb8-2e2678c9e9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4acb5032-185a-46ef-bdb8-2e2678c9e9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9dae3272-52e4-47f1-92e3-c7f2136bf7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9dae3272-52e4-47f1-92e3-c7f2136bf7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7ffb7630-a352-475a-99eb-4f473a6833c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7ffb7630-a352-475a-99eb-4f473a6833c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d771ce8f-f500-40a1-adaa-0c69d76570ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d771ce8f-f500-40a1-adaa-0c69d76570ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_97e85ca1-f746-44e4-bbc6-989eea9666fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d6bce12f-4a81-4fa9-9406-9fd2240b193d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d6bce12f-4a81-4fa9-9406-9fd2240b193d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_44987bd6-5e1c-40d5-8c19-c4b215e126e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_44987bd6-5e1c-40d5-8c19-c4b215e126e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_27f69576-2b38-400a-b66a-d789bcc90810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_27f69576-2b38-400a-b66a-d789bcc90810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3c222c7a-5c96-4348-8546-03a9214a4d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3c222c7a-5c96-4348-8546-03a9214a4d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_eb0af2e0-0137-45ba-a029-d65b215fd70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_eb0af2e0-0137-45ba-a029-d65b215fd70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5f0e472a-a9d5-4fdf-bee2-c48df6c7cb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5f0e472a-a9d5-4fdf-bee2-c48df6c7cb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e1c64771-e324-4955-9dae-7421e70ed687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e1c64771-e324-4955-9dae-7421e70ed687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8a8ea952-ba02-4f09-b69a-c9700631d140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_d0aca8cf-5b3c-40ac-81e4-d708a35b6641" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8a8ea952-ba02-4f09-b69a-c9700631d140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20210930.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_08a3d52b-ef2d-4d14-9af4-d1824856b8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_20e47648-1160-4e58-b98c-4686b2e09dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_08a3d52b-ef2d-4d14-9af4-d1824856b8e6" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_20e47648-1160-4e58-b98c-4686b2e09dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20210930.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a9d92ffe-b971-4ec5-b544-7ca7ef0c902e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_2a622f9d-e337-4bda-905f-b3d4d19b199c" xlink:href="dgx-20210930.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a9d92ffe-b971-4ec5-b544-7ca7ef0c902e" xlink:to="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_2a622f9d-e337-4bda-905f-b3d4d19b199c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ef8b3994-81f8-4b6b-8851-7bc0518b418f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a9d92ffe-b971-4ec5-b544-7ca7ef0c902e" xlink:to="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_ef8b3994-81f8-4b6b-8851-7bc0518b418f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1874a17e-ac70-4dbd-8e95-6a6503b343af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1874a17e-ac70-4dbd-8e95-6a6503b343af" xlink:to="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8f08a9f9-fedc-48bb-b28b-91d806ebcc64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c7fbdbf6-e5aa-4f0e-8692-2a0b6759a055" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8f08a9f9-fedc-48bb-b28b-91d806ebcc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_0f5bb55c-3b78-4539-a7e0-3c67731e8359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8f08a9f9-fedc-48bb-b28b-91d806ebcc64" xlink:to="loc_us-gaap_LongTermDebtMember_0f5bb55c-3b78-4539-a7e0-3c67731e8359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c309511d-5a79-4278-ba22-2936659cacb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e6f6a426-cc7a-443a-a34f-5f4a5a7f201f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c309511d-5a79-4278-ba22-2936659cacb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_62b457fc-dfe5-4dd9-97c8-06648bb9b677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c309511d-5a79-4278-ba22-2936659cacb4" xlink:to="loc_us-gaap_FairValueHedgingMember_62b457fc-dfe5-4dd9-97c8-06648bb9b677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_36054ab5-17d1-4a13-b778-ca5f4b980b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fd0a22c6-e04b-467b-8b4e-b4ce705d8290" xlink:to="loc_us-gaap_DerivativeLineItems_36054ab5-17d1-4a13-b778-ca5f4b980b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_7bcafba4-c770-4cc2-9165-5c01d67d4510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_36054ab5-17d1-4a13-b778-ca5f4b980b97" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_7bcafba4-c770-4cc2-9165-5c01d67d4510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0a5d6e7b-a0f9-4d3c-9703-202c38f86674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0a5d6e7b-a0f9-4d3c-9703-202c38f86674" xlink:to="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_864d014f-e802-44b5-8943-51b7ce741b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c5c8bcb3-5ef8-4799-96c1-157cf1acb7e6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_864d014f-e802-44b5-8943-51b7ce741b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_447a4727-9d25-44cd-b9d6-c07d583b26da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_864d014f-e802-44b5-8943-51b7ce741b58" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_447a4727-9d25-44cd-b9d6-c07d583b26da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cffed391-5b5e-49eb-ba5d-40b8d247f7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697fe9b9-9bcf-4b9f-90c8-a8b81cbdef8b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cffed391-5b5e-49eb-ba5d-40b8d247f7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_d37258d6-4c98-427b-8aa1-f3eeb42956fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_cffed391-5b5e-49eb-ba5d-40b8d247f7c6" xlink:to="loc_us-gaap_FairValueHedgingMember_d37258d6-4c98-427b-8aa1-f3eeb42956fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0c8b6f13-b69a-43d7-9f21-24c87350de8f" xlink:to="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_731eeafc-415e-4802-9884-1c6dfa9dea78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_731eeafc-415e-4802-9884-1c6dfa9dea78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_0d4becae-8eaf-4394-96e3-fa1c85a63fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_0d4becae-8eaf-4394-96e3-fa1c85a63fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6d176144-db3e-4172-b1cf-32e851bdd3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ddec0906-ac9d-4bcb-a5f3-1b6fa366c597" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6d176144-db3e-4172-b1cf-32e851bdd3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20210930.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f25d74d6-985c-47ef-acb7-be9654d3eeea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cb7b418f-4802-4aac-82cf-fdb83cb74df5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f25d74d6-985c-47ef-acb7-be9654d3eeea" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cb7b418f-4802-4aac-82cf-fdb83cb74df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_847ef028-b007-43e5-bee3-82bb863c1f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:href="dgx-20210930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_847ef028-b007-43e5-bee3-82bb863c1f3e" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_566c2852-952f-4e4f-8572-c2d517111fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_566c2852-952f-4e4f-8572-c2d517111fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b633fc9d-2704-4418-a078-ba29b038f32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_566c2852-952f-4e4f-8572-c2d517111fa3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b633fc9d-2704-4418-a078-ba29b038f32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_fb9d133f-9db7-4751-a48d-1c4b02672ded" xlink:href="dgx-20210930.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b633fc9d-2704-4418-a078-ba29b038f32c" xlink:to="loc_dgx_Q2SolutionsMember_fb9d133f-9db7-4751-a48d-1c4b02672ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_751f4848-8a95-459a-bca4-f1d504848d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_751f4848-8a95-459a-bca4-f1d504848d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f7fc302b-dd27-46cc-a458-64e157f46a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_751f4848-8a95-459a-bca4-f1d504848d20" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f7fc302b-dd27-46cc-a458-64e157f46a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_fb17a57a-4184-437d-93b1-8ac9af46e250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f7fc302b-dd27-46cc-a458-64e157f46a8c" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_fb17a57a-4184-437d-93b1-8ac9af46e250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7eea04b9-425a-42b5-967a-6b7efc39e7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7eea04b9-425a-42b5-967a-6b7efc39e7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7eea04b9-425a-42b5-967a-6b7efc39e7aa" xlink:to="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_1fec7df9-f949-445c-ac96-0aac9db61102" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:to="loc_us-gaap_TreasuryStockMember_1fec7df9-f949-445c-ac96-0aac9db61102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_5b231ae7-6015-43bf-a5cb-a8dfdd173065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_5b231ae7-6015-43bf-a5cb-a8dfdd173065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_d7203c58-c2fa-43f5-ad53-d9664a2f26a8" xlink:href="dgx-20210930.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fd54c3d-58a5-4750-b396-ad46ae08bb73" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_d7203c58-c2fa-43f5-ad53-d9664a2f26a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16b0157d-d54b-4c30-96f0-79cfcaddc26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16b0157d-d54b-4c30-96f0-79cfcaddc26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_205ec0d3-9571-4e6e-bf49-459958c69e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_16b0157d-d54b-4c30-96f0-79cfcaddc26b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_205ec0d3-9571-4e6e-bf49-459958c69e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b04bd66b-ebe0-4d3f-b219-20ae83638a14" xlink:href="dgx-20210930.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_205ec0d3-9571-4e6e-bf49-459958c69e66" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_b04bd66b-ebe0-4d3f-b219-20ae83638a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_c6675351-e7ff-4b0e-95af-61e9a4abc623" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_srt_OwnershipAxis_c6675351-e7ff-4b0e-95af-61e9a4abc623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_478d71d5-201f-462c-b43d-d8a06b3e7bcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_c6675351-e7ff-4b0e-95af-61e9a4abc623" xlink:to="loc_srt_OwnershipDomain_478d71d5-201f-462c-b43d-d8a06b3e7bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_a4a75946-4802-4b19-a7b9-ea20ba1e8292" xlink:href="dgx-20210930.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_478d71d5-201f-462c-b43d-d8a06b3e7bcc" xlink:to="loc_dgx_UMassJointVentureMember_a4a75946-4802-4b19-a7b9-ea20ba1e8292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:href="dgx-20210930.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_deebc2f8-60fb-4ecb-8f8b-ba5711c996cc" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_6e7f6ac1-1337-4eda-9586-ca99fbfeaca2" xlink:href="dgx-20210930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_6e7f6ac1-1337-4eda-9586-ca99fbfeaca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3f355b48-8192-482c-b351-8404e4647c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3f355b48-8192-482c-b351-8404e4647c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e507794a-6907-4aae-984d-bb5647803240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e507794a-6907-4aae-984d-bb5647803240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e69c044b-1d66-41f8-aefc-4f038520e8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e69c044b-1d66-41f8-aefc-4f038520e8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_e231d0fb-9289-4612-af45-5573b2650d7c" xlink:href="dgx-20210930.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_e231d0fb-9289-4612-af45-5573b2650d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f5653f7d-d8a3-41cd-8329-44b67a79293c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f5653f7d-d8a3-41cd-8329-44b67a79293c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_88eb1458-79b1-4afd-8e2c-b65dc32e3642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_88eb1458-79b1-4afd-8e2c-b65dc32e3642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b660047a-46bf-4d98-ba8b-53e9b740a5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_b660047a-46bf-4d98-ba8b-53e9b740a5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_0f4edba5-3aad-46b2-ae15-aeabefffff8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_0f4edba5-3aad-46b2-ae15-aeabefffff8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_a341a060-0585-4ceb-ae1b-9d9e67dfe844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_a341a060-0585-4ceb-ae1b-9d9e67dfe844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_29a135d1-ebfb-40b9-9b0c-24cfc63193a7" xlink:href="dgx-20210930.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_29a135d1-ebfb-40b9-9b0c-24cfc63193a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_499a533c-d8db-466a-8fb1-c597b437468b" xlink:href="dgx-20210930.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_499a533c-d8db-466a-8fb1-c597b437468b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_ca7d156d-baa5-461b-9239-988a8cc96575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_ca7d156d-baa5-461b-9239-988a8cc96575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_61536e52-9f78-4de7-b0dc-cd83a43b2a69" xlink:href="dgx-20210930.xsd#dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_61536e52-9f78-4de7-b0dc-cd83a43b2a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_805a94db-88c9-4cf9-8337-fcf508a061c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_805a94db-88c9-4cf9-8337-fcf508a061c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_5f937428-6e04-4f54-99a6-3b85d39cc607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_5f937428-6e04-4f54-99a6-3b85d39cc607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_af072d36-8880-4334-8eaa-804b279ca948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_81217417-bf7c-4b77-b8c8-0974bd81fd1d" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_af072d36-8880-4334-8eaa-804b279ca948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_99f779f6-79ca-4d90-a0e6-0953ae8d9bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_ebce15d2-9a09-43ac-a063-2fe703242a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_99f779f6-79ca-4d90-a0e6-0953ae8d9bca" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_ebce15d2-9a09-43ac-a063-2fe703242a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_1b9d7ee5-9ce0-4d24-b7e8-6ff81dad4e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_47fc1b15-3e74-4330-93a7-9114bc143447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_1b9d7ee5-9ce0-4d24-b7e8-6ff81dad4e94" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_47fc1b15-3e74-4330-93a7-9114bc143447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c8535eb5-613c-401d-8bf9-52e939767ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_Depreciation_c8535eb5-613c-401d-8bf9-52e939767ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b9f9a14e-25cd-4759-825c-efd14a310c69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b9f9a14e-25cd-4759-825c-efd14a310c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_93c4f852-90be-4fe8-ae7d-8e8c21ab34fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_93c4f852-90be-4fe8-ae7d-8e8c21ab34fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_53165b30-d9e0-4abf-b1c3-81292fd1a4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_InterestExpense_53165b30-d9e0-4abf-b1c3-81292fd1a4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_8a497820-e62b-45bc-9797-27cedcb59275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_8a497820-e62b-45bc-9797-27cedcb59275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_1e13569f-b3ff-4094-971e-932448ed8cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_1e13569f-b3ff-4094-971e-932448ed8cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InterestPaid1_fccfb1de-7aa8-49b5-ba06-40df24fc4446" xlink:href="dgx-20210930.xsd#dgx_InterestPaid1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_dgx_InterestPaid1_fccfb1de-7aa8-49b5-ba06-40df24fc4446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_68a69054-997b-4506-94b3-2b3626aa32ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_IncomeTaxesPaid_68a69054-997b-4506-94b3-2b3626aa32ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_45614dbb-2ffe-4c48-9a94-21ab2a8b8389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_45614dbb-2ffe-4c48-9a94-21ab2a8b8389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_08854bda-7f6d-4063-9bf5-dd367461e4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_08854bda-7f6d-4063-9bf5-dd367461e4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_dbcd10e9-f1f5-4470-bf7f-f618d330489c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_dbcd10e9-f1f5-4470-bf7f-f618d330489c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_ed59d4a9-c733-480d-974a-5008dc668c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_LiabilitiesAssumed1_ed59d4a9-c733-480d-974a-5008dc668c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_a94b71ed-174d-43b6-ab11-c0ed45d66e53" xlink:href="dgx-20210930.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_dgx_FairValueOfNetAssetsAcquired_a94b71ed-174d-43b6-ab11-c0ed45d66e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet_e54a23a7-7b8a-4ea7-9b98-fe75d4fbe02d" xlink:href="dgx-20210930.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_dgx_Mergerconsiderationpaidpayablenet_e54a23a7-7b8a-4ea7-9b98-fe75d4fbe02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_2298c0e8-245e-4acd-8f38-7a66605567a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_2298c0e8-245e-4acd-8f38-7a66605567a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_1fc8a265-c2b3-493e-868b-be8894914cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_1fc8a265-c2b3-493e-868b-be8894914cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e0c6120f-b106-4f0f-844c-5694b93c3978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e0c6120f-b106-4f0f-844c-5694b93c3978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_7a977a6f-8d36-4094-abb5-7cca94461770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4b21d4c8-769f-49e1-9762-b968d9f36e9f" xlink:to="loc_us-gaap_LeaseCostAbstract_7a977a6f-8d36-4094-abb5-7cca94461770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a070f70d-29b3-43f1-8cec-73e1ab8c4a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_7a977a6f-8d36-4094-abb5-7cca94461770" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a070f70d-29b3-43f1-8cec-73e1ab8c4a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_7cb760e8-896f-44ef-a5c7-d0f002e420bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_7fbb9b23-e331-44b7-b320-94e1e9befc84" xlink:href="dgx-20210930.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_7cb760e8-896f-44ef-a5c7-d0f002e420bd" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_7fbb9b23-e331-44b7-b320-94e1e9befc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4fb57fca-fb42-49d0-8986-99abf74b7a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_7fbb9b23-e331-44b7-b320-94e1e9befc84" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4fb57fca-fb42-49d0-8986-99abf74b7a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_563cc2a2-e7f7-4e66-84e3-4cf83a344d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4fb57fca-fb42-49d0-8986-99abf74b7a3b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_563cc2a2-e7f7-4e66-84e3-4cf83a344d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_0b479b4f-db4f-40df-9a74-df21f8763fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_563cc2a2-e7f7-4e66-84e3-4cf83a344d60" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_0b479b4f-db4f-40df-9a74-df21f8763fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:href="dgx-20210930.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_7fbb9b23-e331-44b7-b320-94e1e9befc84" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_2992a879-b19b-4187-8f28-7c58b10dd6ba" xlink:href="dgx-20210930.xsd#dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_2992a879-b19b-4187-8f28-7c58b10dd6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche_8db02ea8-a63f-4413-91c1-b24868e84000" xlink:href="dgx-20210930.xsd#dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche_8db02ea8-a63f-4413-91c1-b24868e84000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_ad75361f-5e0c-47bd-8eaa-c38080d99ebf" xlink:href="dgx-20210930.xsd#dgx_CARESActProceedsRecognizedInTheStatementOfOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_ad75361f-5e0c-47bd-8eaa-c38080d99ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfRecognitionOfCARESActProceeds_6321f8af-815c-4111-96bb-1c53c9ddb1fa" xlink:href="dgx-20210930.xsd#dgx_ReversalOfRecognitionOfCARESActProceeds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_ReversalOfRecognitionOfCARESActProceeds_6321f8af-815c-4111-96bb-1c53c9ddb1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReturnOfCashCARESAct_6f228359-a980-41b6-a72f-bae4e0c8d1f9" xlink:href="dgx-20210930.xsd#dgx_ReturnOfCashCARESAct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_a326dfc5-27b2-4541-96ca-4757cf5a574b" xlink:to="loc_dgx_ReturnOfCashCARESAct_6f228359-a980-41b6-a72f-bae4e0c8d1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20210930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8937dc20-7bd6-4ca9-a8c9-33e0a0d3cfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c7666633-36a6-4589-a2c2-00a962643b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8937dc20-7bd6-4ca9-a8c9-33e0a0d3cfa4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c7666633-36a6-4589-a2c2-00a962643b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9684c97a-b46b-415c-a05c-15ba9559d9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_70d73086-5c74-48ff-96c7-a2492ff5dd4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9684c97a-b46b-415c-a05c-15ba9559d9bd" xlink:to="loc_us-gaap_LossContingenciesTable_70d73086-5c74-48ff-96c7-a2492ff5dd4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_6be7b9c2-9416-4986-aef6-080c346fcc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_70d73086-5c74-48ff-96c7-a2492ff5dd4c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_6be7b9c2-9416-4986-aef6-080c346fcc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_64d5ff55-9240-45f6-a0c2-286782310dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_6be7b9c2-9416-4986-aef6-080c346fcc7a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_64d5ff55-9240-45f6-a0c2-286782310dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_966f4134-ceef-470e-b988-24f4b8eaeddf" xlink:href="dgx-20210930.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_64d5ff55-9240-45f6-a0c2-286782310dd7" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_966f4134-ceef-470e-b988-24f4b8eaeddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b5accc7c-3a48-4782-af0d-6a03d3564086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_70d73086-5c74-48ff-96c7-a2492ff5dd4c" xlink:to="loc_us-gaap_LossContingenciesLineItems_b5accc7c-3a48-4782-af0d-6a03d3564086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_bbeca181-310b-48e0-821f-02126e126a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b5accc7c-3a48-4782-af0d-6a03d3564086" xlink:to="loc_us-gaap_LitigationReserve_bbeca181-310b-48e0-821f-02126e126a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9684c97a-b46b-415c-a05c-15ba9559d9bd" xlink:to="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2e73773e-06a9-4195-a463-0dbd87a458fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2e73773e-06a9-4195-a463-0dbd87a458fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_600d5e9d-5863-465e-8107-bba32ad36723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2e73773e-06a9-4195-a463-0dbd87a458fe" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_600d5e9d-5863-465e-8107-bba32ad36723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_597f4624-20eb-4421-9e0f-01bf689fbcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_600d5e9d-5863-465e-8107-bba32ad36723" xlink:to="loc_us-gaap_SecuredDebtMember_597f4624-20eb-4421-9e0f-01bf689fbcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_f7748543-052c-4926-a197-89261660c8ac" xlink:href="dgx-20210930.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_600d5e9d-5863-465e-8107-bba32ad36723" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_f7748543-052c-4926-a197-89261660c8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1c0ba848-1580-4840-b901-73a323dfc87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:to="loc_us-gaap_CreditFacilityAxis_1c0ba848-1580-4840-b901-73a323dfc87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d6374feb-47ef-4687-a756-3520cdc8d34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1c0ba848-1580-4840-b901-73a323dfc87e" xlink:to="loc_us-gaap_CreditFacilityDomain_d6374feb-47ef-4687-a756-3520cdc8d34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b6d3c89e-b9b2-4d7c-b970-9f2c7c369084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d6374feb-47ef-4687-a756-3520cdc8d34f" xlink:to="loc_us-gaap_LetterOfCreditMember_b6d3c89e-b9b2-4d7c-b970-9f2c7c369084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3ea7e7fb-68af-448d-8b1c-9a244bbf640c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0ecae98a-f59b-4174-ac9a-a0ca517da92b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3ea7e7fb-68af-448d-8b1c-9a244bbf640c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_76f94902-eb05-498d-af50-e64ad1ea2603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ea7e7fb-68af-448d-8b1c-9a244bbf640c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_76f94902-eb05-498d-af50-e64ad1ea2603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_c1fe18b2-62a6-40b8-aaad-2c7059fbbd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3ea7e7fb-68af-448d-8b1c-9a244bbf640c" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_c1fe18b2-62a6-40b8-aaad-2c7059fbbd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_41d301e8-75f7-4481-93a4-2d263d8b9df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9684c97a-b46b-415c-a05c-15ba9559d9bd" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_41d301e8-75f7-4481-93a4-2d263d8b9df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_bf8cc4e7-71cf-4b28-a25b-85827fd58052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9684c97a-b46b-415c-a05c-15ba9559d9bd" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_bf8cc4e7-71cf-4b28-a25b-85827fd58052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20210930.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e924daf0-0c20-429f-be5d-87a28f02c596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_43d032df-05bd-4530-b950-df1969ca25e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e924daf0-0c20-429f-be5d-87a28f02c596" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_43d032df-05bd-4530-b950-df1969ca25e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20210930.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_953b17b0-d5c7-4135-9c45-5c1a9bfb80e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b0f53a94-874f-49bc-87d6-e663a9e7eecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_953b17b0-d5c7-4135-9c45-5c1a9bfb80e0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b0f53a94-874f-49bc-87d6-e663a9e7eecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_62c9555a-6cf0-4177-84f1-b314af66538a" xlink:href="dgx-20210930.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_953b17b0-d5c7-4135-9c45-5c1a9bfb80e0" xlink:to="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_62c9555a-6cf0-4177-84f1-b314af66538a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0c49f3e0-0264-48b2-9ed7-aaac6f601bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0c49f3e0-0264-48b2-9ed7-aaac6f601bd6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_651812df-0767-4ad5-b274-83ac7b322ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_651812df-0767-4ad5-b274-83ac7b322ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_651812df-0767-4ad5-b274-83ac7b322ea4" xlink:to="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_271c0399-3cdf-40eb-a248-a50ffe348c48" xlink:href="dgx-20210930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_271c0399-3cdf-40eb-a248-a50ffe348c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_23e69553-5e65-4462-8b33-c19996c8a722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:to="loc_us-gaap_AllOtherSegmentsMember_23e69553-5e65-4462-8b33-c19996c8a722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_b794498e-d77c-46f4-ae0e-031fdc7f1e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c45e558c-5e42-4cb5-a34c-c6fe855663af" xlink:to="loc_us-gaap_CorporateMember_b794498e-d77c-46f4-ae0e-031fdc7f1e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:to="loc_srt_RangeAxis_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7d2ee807-cc82-44bc-b026-06a65327af42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4e4b8fc4-a4e4-4afe-9b9c-be0ab9aa20d6" xlink:to="loc_srt_RangeMember_7d2ee807-cc82-44bc-b026-06a65327af42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8f85c6f9-5f03-43f2-aac9-6a4b92d4fc1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7d2ee807-cc82-44bc-b026-06a65327af42" xlink:to="loc_srt_MinimumMember_8f85c6f9-5f03-43f2-aac9-6a4b92d4fc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a2469819-8370-4971-b1ed-cebd72593d7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:to="loc_srt_ProductOrServiceAxis_a2469819-8370-4971-b1ed-cebd72593d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a2469819-8370-4971-b1ed-cebd72593d7c" xlink:to="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_c2ad5922-e435-4997-8f7d-593f661c9baf" xlink:href="dgx-20210930.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_c2ad5922-e435-4997-8f7d-593f661c9baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_ebb44e3c-9229-4a93-a296-2281576eabb1" xlink:href="dgx-20210930.xsd#dgx_COVID19TestingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_COVID19TestingServicesMember_ebb44e3c-9229-4a93-a296-2281576eabb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_55b615f8-6053-44cf-8950-98465ff3c196" xlink:href="dgx-20210930.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_55b615f8-6053-44cf-8950-98465ff3c196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_5c9ba478-8192-4298-b29d-a420550b0406" xlink:href="dgx-20210930.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_5c9ba478-8192-4298-b29d-a420550b0406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_644074e3-fc81-4449-ae9b-a2d7681821ed" xlink:href="dgx-20210930.xsd#dgx_AllotherservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ac141056-15b9-47c5-8318-d8e167c31e86" xlink:to="loc_dgx_AllotherservicesMember_644074e3-fc81-4449-ae9b-a2d7681821ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b04a2585-cb39-4675-b011-b442899a133e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_dff168b6-754e-43df-a30d-b15fb2126f40" xlink:href="dgx-20210930.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_dgx_PercentageofNetRevenues_dff168b6-754e-43df-a30d-b15fb2126f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_835e0934-2068-4d2b-a683-01458d0c9abc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_835e0934-2068-4d2b-a683-01458d0c9abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_97a60555-d563-4d22-8715-c0c427ebf6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_OperatingIncomeLoss_97a60555-d563-4d22-8715-c0c427ebf6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2e73b2a9-a4d2-4430-a50e-359169b2c1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2e73b2a9-a4d2-4430-a50e-359169b2c1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0545bb8e-08ef-4fc4-bad7-20d398570721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0545bb8e-08ef-4fc4-bad7-20d398570721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_32acad11-414d-483d-8d64-d4c6e738ee36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_32acad11-414d-483d-8d64-d4c6e738ee36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b886356b-460c-442b-a0c7-e739c85fff91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b886356b-460c-442b-a0c7-e739c85fff91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0912d2ba-346e-4d60-889c-49ea870ad564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_ProfitLoss_0912d2ba-346e-4d60-889c-49ea870ad564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f8def7d1-6ae3-46de-92d3-aa9c2db99467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f8def7d1-6ae3-46de-92d3-aa9c2db99467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ff5cc4eb-d78a-4c14-b5b6-d4a345c82494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_814740ee-525c-4550-b81c-0ab5dc60e398" xlink:to="loc_us-gaap_NetIncomeLoss_ff5cc4eb-d78a-4c14-b5b6-d4a345c82494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20210930.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9b9932c4-df16-47f5-8b71-09e9d84b81ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_28a09a46-eba9-4d5e-9f5b-2406be5b745c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9b9932c4-df16-47f5-8b71-09e9d84b81ee" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_28a09a46-eba9-4d5e-9f5b-2406be5b745c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20210930.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4f98bc74-7aca-4b8d-a572-74af342511b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_5fb6e292-55b1-410e-9016-a56d01b9b94b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4f98bc74-7aca-4b8d-a572-74af342511b0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_5fb6e292-55b1-410e-9016-a56d01b9b94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_a8d854f6-3ff8-4899-9a18-98a124295616" xlink:href="dgx-20210930.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4f98bc74-7aca-4b8d-a572-74af342511b0" xlink:to="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_a8d854f6-3ff8-4899-9a18-98a124295616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_14b09a91-2a2c-4abe-b5d1-0c6905b63679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_14b09a91-2a2c-4abe-b5d1-0c6905b63679" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_db156f78-206f-4960-92ec-49ee916b1fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_db156f78-206f-4960-92ec-49ee916b1fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_25405377-d25c-488b-9b1b-db42fcac728a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_db156f78-206f-4960-92ec-49ee916b1fac" xlink:to="loc_us-gaap_SegmentDomain_25405377-d25c-488b-9b1b-db42fcac728a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_c66a14fb-4bd2-4521-8c01-ee0727398fb8" xlink:href="dgx-20210930.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_25405377-d25c-488b-9b1b-db42fcac728a" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_c66a14fb-4bd2-4521-8c01-ee0727398fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_669794ab-fe36-4a6d-ada9-e930639656a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_25405377-d25c-488b-9b1b-db42fcac728a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_669794ab-fe36-4a6d-ada9-e930639656a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_27f78581-b0be-4de9-a60d-be68099a80f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_srt_RangeAxis_27f78581-b0be-4de9-a60d-be68099a80f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd9ec6c0-4b16-4c78-8053-4056345bc20d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_27f78581-b0be-4de9-a60d-be68099a80f5" xlink:to="loc_srt_RangeMember_cd9ec6c0-4b16-4c78-8053-4056345bc20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_884d67b4-729e-4867-83df-3b0ddb297d7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cd9ec6c0-4b16-4c78-8053-4056345bc20d" xlink:to="loc_srt_MinimumMember_884d67b4-729e-4867-83df-3b0ddb297d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_7aae88d5-87ec-42ac-a603-db876d359e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_us-gaap_SubsegmentsAxis_7aae88d5-87ec-42ac-a603-db876d359e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_7aae88d5-87ec-42ac-a603-db876d359e89" xlink:to="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_3bcd524d-63c5-45e6-8c6a-efaa44d020ed" xlink:href="dgx-20210930.xsd#dgx_HealthcareInsurersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_HealthcareInsurersMember_3bcd524d-63c5-45e6-8c6a-efaa44d020ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_902943a3-5e49-48da-8774-d500dabc0961" xlink:href="dgx-20210930.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_GovernmentPayersMember_902943a3-5e49-48da-8774-d500dabc0961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_e1e52395-d768-4db1-82bf-fe4a06ee83b7" xlink:href="dgx-20210930.xsd#dgx_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_ClientPayersMember_e1e52395-d768-4db1-82bf-fe4a06ee83b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_e6e4e88a-0ef9-48c0-95ef-595b41709271" xlink:href="dgx-20210930.xsd#dgx_PatientsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_PatientsMember_e6e4e88a-0ef9-48c0-95ef-595b41709271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_07b6b833-4f7e-4145-bef9-66967a4d019d" xlink:href="dgx-20210930.xsd#dgx_DSBusinessesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_e79af674-04ad-4b59-b76d-ce7f7bac10bc" xlink:to="loc_dgx_DSBusinessesMember_07b6b833-4f7e-4145-bef9-66967a4d019d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_36d0ef28-670e-4f3e-8978-8425d260e96a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_srt_ProductOrServiceAxis_36d0ef28-670e-4f3e-8978-8425d260e96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_096f1579-1f03-4315-b215-05cab33fc7d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_36d0ef28-670e-4f3e-8978-8425d260e96a" xlink:to="loc_srt_ProductsAndServicesDomain_096f1579-1f03-4315-b215-05cab33fc7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_34159dd5-2877-45b4-9d08-6c4f6633a6f7" xlink:href="dgx-20210930.xsd#dgx_FeeforserviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_096f1579-1f03-4315-b215-05cab33fc7d9" xlink:to="loc_dgx_FeeforserviceMember_34159dd5-2877-45b4-9d08-6c4f6633a6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_9c43eec1-6adb-4218-8af2-032513cdd974" xlink:href="dgx-20210930.xsd#dgx_CapitatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_096f1579-1f03-4315-b215-05cab33fc7d9" xlink:to="loc_dgx_CapitatedMember_9c43eec1-6adb-4218-8af2-032513cdd974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c99a11d2-5120-4e3e-902e-9a6be6e36d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b3a1a5c7-5fb6-4b4a-8b13-76451c729c00" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c99a11d2-5120-4e3e-902e-9a6be6e36d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_b031bbe1-6ef5-4894-92e0-3a8d68b6ce1a" xlink:href="dgx-20210930.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c99a11d2-5120-4e3e-902e-9a6be6e36d38" xlink:to="loc_dgx_PercentageofNetRevenues_b031bbe1-6ef5-4894-92e0-3a8d68b6ce1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_4b6aafd3-75aa-4467-a237-4d9980f95cf8" xlink:href="dgx-20210930.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c99a11d2-5120-4e3e-902e-9a6be6e36d38" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_4b6aafd3-75aa-4467-a237-4d9980f95cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="dgx-20210930.xsd#TAXESONINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e342fa22-dca0-4f3c-9c7d-29954b1bb2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_40c60cc3-8121-4b0b-a4db-f36c68c340b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e342fa22-dca0-4f3c-9c7d-29954b1bb2c6" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_40c60cc3-8121-4b0b-a4db-f36c68c340b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#TAXESONINCOMEDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9633362f-b108-4667-90e8-84ba8dc93acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9633362f-b108-4667-90e8-84ba8dc93acc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_01f4ba6e-720a-4bf7-b254-3c725062cf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_01f4ba6e-720a-4bf7-b254-3c725062cf3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_475c29fa-0b7d-4f74-8a07-ec1e28e3369b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_01f4ba6e-720a-4bf7-b254-3c725062cf3b" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_475c29fa-0b7d-4f74-8a07-ec1e28e3369b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_301a2f5e-9405-4f37-b83c-1969cda09f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_475c29fa-0b7d-4f74-8a07-ec1e28e3369b" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_301a2f5e-9405-4f37-b83c-1969cda09f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_735b0bab-4084-45f0-83fd-3f69a16766ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_735b0bab-4084-45f0-83fd-3f69a16766ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f93de4ac-7da7-46ad-bf1f-85bdfdc92d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_735b0bab-4084-45f0-83fd-3f69a16766ef" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f93de4ac-7da7-46ad-bf1f-85bdfdc92d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_46d7b4eb-6751-414b-8c6d-540665e88bf0" xlink:href="dgx-20210930.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f93de4ac-7da7-46ad-bf1f-85bdfdc92d7e" xlink:to="loc_dgx_Q2SolutionsMember_46d7b4eb-6751-414b-8c6d-540665e88bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2b42331b-89b7-4003-bdd6-6dc220c2339b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e3c81e-72b2-4301-8511-8323ea39f1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_12e3c81e-72b2-4301-8511-8323ea39f1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_11281851-5f76-470f-8bec-6a3a30da0a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_11281851-5f76-470f-8bec-6a3a30da0a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_68e4fe66-c451-4bf8-8afe-ae63a129adc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_68e4fe66-c451-4bf8-8afe-ae63a129adc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest_d7fad2d9-96f2-4518-9f7e-6c71ea012cfb" xlink:href="dgx-20210930.xsd#dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest_d7fad2d9-96f2-4518-9f7e-6c71ea012cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_fcc77938-638c-4e47-a2d1-f7e151565e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_fcc77938-638c-4e47-a2d1-f7e151565e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_e467ca5e-a36b-4802-b2ca-a8fec26ed9c5" xlink:href="dgx-20210930.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1110ca48-8b31-4514-8626-4cdf24052705" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_e467ca5e-a36b-4802-b2ca-a8fec26ed9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENT" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUBSEQUENTEVENT"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_eae37cfc-ecb0-4d7c-8eb1-ab701e1cd432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_94b352ad-5fd1-4548-9ec6-36e172117baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_eae37cfc-ecb0-4d7c-8eb1-ab701e1cd432" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_94b352ad-5fd1-4548-9ec6-36e172117baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="dgx-20210930.xsd#SUBSEQUENTEVENTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_3488a528-a4e3-49e4-a81b-2aed0806335c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_3488a528-a4e3-49e4-a81b-2aed0806335c" xlink:to="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a8ea5943-a0a5-4258-af1b-cb79b80952fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a8ea5943-a0a5-4258-af1b-cb79b80952fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_10d02577-b93d-4f9d-aad8-74923fbe756e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a8ea5943-a0a5-4258-af1b-cb79b80952fd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_10d02577-b93d-4f9d-aad8-74923fbe756e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6c02ed30-c362-4d90-8c73-104642847185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_10d02577-b93d-4f9d-aad8-74923fbe756e" xlink:to="loc_us-gaap_SubsequentEventMember_6c02ed30-c362-4d90-8c73-104642847185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_71ceb5b2-ebc3-42fd-bf03-57e42c325a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_71ceb5b2-ebc3-42fd-bf03-57e42c325a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6999ad99-c7ff-4d6e-8e1c-6334ffa50cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_71ceb5b2-ebc3-42fd-bf03-57e42c325a81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6999ad99-c7ff-4d6e-8e1c-6334ffa50cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_0fa8b6b2-e4ae-4a3d-8ba5-d770f0d43b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6999ad99-c7ff-4d6e-8e1c-6334ffa50cdc" xlink:to="loc_us-gaap_SecuredDebtMember_0fa8b6b2-e4ae-4a3d-8ba5-d770f0d43b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c0d7d353-1474-4b20-85c0-bf3cca3535c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_DebtInstrumentAxis_c0d7d353-1474-4b20-85c0-bf3cca3535c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4c99a662-cebe-4975-bf4b-7e5805ce6b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c0d7d353-1474-4b20-85c0-bf3cca3535c2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4c99a662-cebe-4975-bf4b-7e5805ce6b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member_fe512209-8dc9-4554-868b-303a4b834cd6" xlink:href="dgx-20210930.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c99a662-cebe-4975-bf4b-7e5805ce6b27" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2022Member_fe512209-8dc9-4554-868b-303a4b834cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2023Member_ef8c0b52-71ea-438b-9c62-559cb0adc1ab" xlink:href="dgx-20210930.xsd#dgx_LoanCommitmentMaturingOctober2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4c99a662-cebe-4975-bf4b-7e5805ce6b27" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2023Member_ef8c0b52-71ea-438b-9c62-559cb0adc1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_093c5c0d-597d-4190-b843-402eaa9df2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_CreditFacilityAxis_093c5c0d-597d-4190-b843-402eaa9df2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b5b64862-3514-4097-87c9-63b323a9e93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_093c5c0d-597d-4190-b843-402eaa9df2b2" xlink:to="loc_us-gaap_CreditFacilityDomain_b5b64862-3514-4097-87c9-63b323a9e93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_87f45acb-bb59-4b4b-8fef-8c910cd200cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b5b64862-3514-4097-87c9-63b323a9e93d" xlink:to="loc_us-gaap_LetterOfCreditMember_87f45acb-bb59-4b4b-8fef-8c910cd200cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7e8beccb-e2a1-4a73-a204-d8d1709c84d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_VariableRateAxis_7e8beccb-e2a1-4a73-a204-d8d1709c84d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3a5b3ed3-e5ce-4d57-8ddd-abd23602ecf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_7e8beccb-e2a1-4a73-a204-d8d1709c84d1" xlink:to="loc_us-gaap_VariableRateDomain_3a5b3ed3-e5ce-4d57-8ddd-abd23602ecf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialPaperOrLIBORMember_e62d3ce5-cecc-4ef1-993b-30e31d2d51d6" xlink:href="dgx-20210930.xsd#dgx_CommercialPaperOrLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3a5b3ed3-e5ce-4d57-8ddd-abd23602ecf5" xlink:to="loc_dgx_CommercialPaperOrLIBORMember_e62d3ce5-cecc-4ef1-993b-30e31d2d51d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_34896fad-e03c-4b32-95cc-26a1c29f5072" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_srt_RangeAxis_34896fad-e03c-4b32-95cc-26a1c29f5072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dde6c1e8-773e-4a76-a92a-ab39f5d20747" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_34896fad-e03c-4b32-95cc-26a1c29f5072" xlink:to="loc_srt_RangeMember_dde6c1e8-773e-4a76-a92a-ab39f5d20747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d231276f-4a1a-4fea-a713-8a14e203a485" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dde6c1e8-773e-4a76-a92a-ab39f5d20747" xlink:to="loc_srt_MinimumMember_d231276f-4a1a-4fea-a713-8a14e203a485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_738ba11b-9f48-4321-a367-fc7feca3ca77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dde6c1e8-773e-4a76-a92a-ab39f5d20747" xlink:to="loc_srt_MaximumMember_738ba11b-9f48-4321-a367-fc7feca3ca77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_fbf15d75-4b10-4574-9762-6ff3f903dd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_02e18a98-084b-4eb1-91a2-d41bb2912186" xlink:to="loc_us-gaap_SubsequentEventLineItems_fbf15d75-4b10-4574-9762-6ff3f903dd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c5a3f969-2953-4fee-aa07-58307443bb21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_fbf15d75-4b10-4574-9762-6ff3f903dd3a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c5a3f969-2953-4fee-aa07-58307443bb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_41455c96-147b-459c-9011-247b195054c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_fbf15d75-4b10-4574-9762-6ff3f903dd3a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_41455c96-147b-459c-9011-247b195054c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>dgx-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:dgx="http://questdiagnostics.com/20210930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dgx-20210930.xsd" xlink:type="simple"/>
    <context id="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idb6102b3487f457aa5e512c514af4c6c_I20211015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-10-15</instant>
        </period>
    </context>
    <context id="i799f05ff39a24712b253c3e931752e30_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i240ccb0d73a24cda883d17698d2669f7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6bc28e1736a04d9e9f222c1998dbf195_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44797d3e9c614839926a9c2f3bb5be17_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1f627c3af5db4299b234650d220eee56_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia2e684a75e28400dbbfc768d86f47ec7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia69f34e8c6f742d4a439c6a90e6dbb84_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i60818a25d0774d728fc8875bec533fcb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i30536b78fd3e41639c5a631d6df42e38_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5c26a3bcfeb74909a10ba5fbcc6ec947_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibf447d1f13b744eca3e676fb375b1f08_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5c9436c528694ee1ac54e6f8ce941854_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6bcf39ba3ca3490ba9b723f846d97a93_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8d322c01404548d7bc8bcc50e7fc7e90_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id6b3aa2d9a704d3890aa1d3b20c761cd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i61a8b1a97ea54a2cb0efda370034cf33_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2c9526dd81d14acbb165fbdb21bc7d5b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia5469e4b199e4f6bba9dd760df124408_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia1082d06815c4d1cbcdd4183ef7a7054_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i90a31327e6d4444faef566d46a5e0076_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6b159649f77f410ebe5d069195864be4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i39fbe907b9a04ba88fd377e9c3ee0c5b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2de9bd88816b4b76a24f2e5e45391d53_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id7a7da46099a44378da1a233e2933299_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0bc8004207f6457d8e91cab661dc9d7d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i530936cdd95443c38a6ee1dac2f95b5d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd797ff06d5347448e67d12d0a112a21_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28ba8ee8faa74b07aa6d9f1fe6d24c42_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6efac86a7154479b5393be974cf5b8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1ebeea55bd143e7a34428dfb1cb8d7b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i462380c5fb3941a2be00f2507dfe4337_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9be3cd77042747cfacd90361f64c7ca8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idf43e9ec0f474249909c8e64ca28aa9e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1e728b108435425ca56aae502185c623_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i44095c144c7847d1864cff543b26d594_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibb2c2ba8e2984a5ebf8b1e80612267d0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2877089917b44598af747bd1c932cea2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iaec86bf908d1470cb320f0f36f8501f6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie5469af2e4e646ff9485e5ea6fe72b27_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4291d6d468a544eda0577ac487a2c725_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6a95a06eb0f94af39dece3892ff96d29_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib2db14ecc4974269854d7acb2c998846_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3eb4acc4683141d68c6b2262176ea057_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i496e5c6bce0145338271871a4b19a534_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7c7076b530f6444a947bc2cada186634_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8c4d3b899b3a4c27920b9a7a1c4341f5_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i854a56aad60640659955246cba8db3d1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0ead955e97d24ea98107e5fdafbb5933_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i26471b06607740b18133552b7813a289_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i81dfabce71384a93b5d745045e2c2b24_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1284835d8c794866b627a0391c20a3d7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie2e7ae5dc9104f20a5ce0b4a9350ec65_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ied656b411f5c494fa95a8a47cdf2ea4b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id87c9e74f17947c78a11adfcb138af02_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib217db8b923647049bb39b949b84c79e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if16bcecb1e6d4dd9afec8d10d7899999_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i16a5de19f2d549a9a4351e241b197e97_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8cb4bcbff08f44cdbccc42febe3b29cb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9b4c9dc3e1504cc5ad275c05e942afdc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib05a9b6900b545f2b5c4580d8153e641_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib54bc123a8304d1b95560ab37cf81299_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7a3f89fd967647879e6f70cc4eced07a_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i5cc6b1efe84f4f65907f66036143af31_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="i666d9c35a6194943a43fbcf1f9c9b1df_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="i53b9c62c8412401893a2366a618ab917_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="iafd5f573146f490584b2d02d1a275200_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="i246ee08978dd4f9281e49cde4052adb5_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i1f8b2bbcf7b442d5b60c4726c660f0b2_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i62dc4fadac874b26b838080327833f3a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id467bea9a9a042bd95d6970a12d3be15_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i86982bd9508a4400a05b7e7954cd17e4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i19c606c4a927487086b61b79e8c8374b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6717324b738441d5b2882980e7f96534_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36fc1b4d87cc4ef59463dc14ae3e0809_I20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="i259a5f13f5bc45e7813aca65d4056271_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i285e961758554fd5ac030b44fe9867ff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id248109e93494be5ab0649ef082cb608_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibba5357fd8bf4d2f8cb494c4ee189328_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if8117f4bb2f54d20ae84cf958f833fc9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3a5dcd0ab13e41d480cf6fd05837a2dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c1dfb7b00dd40caa23f7b20aa962872_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b6c581188914f048902746e4d6c62a5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i53fde28f195345cdaa042f2d8f3d61df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8125b809d77340e4a919837e287c04be_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1aafd4a99f5b40e9855fa6aef485af35_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i50c50c6fa9d5420593a7df593fbfd4b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id699393e5c1e405cb9e349542a08565d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i437864783a7b4db19f1011b84e670b30_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75d51148780249248ddb2e605bbe8abd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i748efa01b96341229310868eca941647_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibb316df1367442cc90e4c2c5326acd80_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i723c339a06ce4cf38176085ba130077e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3d6d052e08a40f3aeb61f740e03dac2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i944e0f14985441db988806dbbf0e1725_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa71f4cff13142c783bc54345c97e1b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i386a526647e54047ad6392d22e224a8c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7399b9274664c749e91f89957ec71bc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i34cc7bf29a7c44409c7e67bcd16c4a18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia59678286edb47a683efe4ca31c9d152_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib2cfcef6577746beaf2fc395bc84e9f4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i091b01bda5c84720a769c37a5b845045_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iec15589bf02e47779ded2be278cfe21a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6c9fb4948c0446498ff2b9b1edc0349b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i93cec6591e0847ad8a42544b505883d4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia65a33d49c0b41508f0b15bc06443452_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib938d748462e4324a82c390775ef95f0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id96bc77fc8eb4e8e88dc16ca93868148_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i55bf2898a19d4ec4ada12d71732989e7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7e7d971b76454263a15f1169e211c2a2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1ea29ec2e2ea47a79288bb5eb1c001b0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5288d887a86f42969ff785028080679b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i868f8637411d4f61887501630bc811b0_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i2d06b6e3f9dd4f56a49b29e3deefc334_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibfda32ff821e42f7b4ed59c5648a0dd6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icfcf88539a60445eb9be5a8700c50fb6_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i4f600b81db564760a3990025b8fe7516_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idf76d19dc0f440e89a7ca4bf2b2f2383_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib80fc1942e984fd5a7949043c3093362_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i7542d9b6daf04822b7c7295e9573a8a3_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ie051564f2e734da28d818b7a4efcf77c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id858b57b1f134c328d0f3870aff86791_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i01995b0930f44ae494baf9f00606c1be_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i71dae6d523044c6e86141e159ada5f54_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i23930df4ff5e47acbd2af40147c8310f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3fa4a1c7a8cf4bde9e060da17dd6138d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i27f9acec26b840b1a223ab39e755c0aa_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i182a2b075333465998d6cc5c986d8320_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i73ddab4100a944fea58ae374a6ff4845_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58a1a67d34d240d7b603eb953adc9835_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1952efe7be544fe591e6315daee82f95_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ida9a845517b14f2d85f82da38a53f275_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia12055ea11a54f1890616da76bad2b80_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iad4b891b3a584530a9cf508df0670b51_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i88caa1b81b364b9fa199959abd7ed0d2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iecf2cd09b04849daae0be004f7617d14_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i537235110c194ee082108ce9a9ecc879_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9565fe343ad34611897d8c50225762c8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3be9f0b477af42a4a4c10b096f57639b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i813b3cfd78584fa288cbfee1b07eba3a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1a59539f511c449187290980e118ba4d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5acd767ddc8241cf9dfb969b29565a40_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a9fa386f73d4e2e82d8ed5c274ecabf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2d8c3304c5b24c6698ca6cf99acb40f8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i17915cdcfe1c4db0a3f41d20dcfb007b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8d583a2157a4461d84a68397c4aa9749_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ida3b6e41b6d84008a6bbdb8a925027f4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i534453e984bd4a6185b2140d89a55c40_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i02fec1695bc94fb4b799f16df36a277a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7e86467c36344bbf941f4c24f2436504_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibe9af73476c6465093764838622b5110_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2828a531f0ab4def88e14f6e27424f8c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie2adc13627b04c52868f7d8eaae852b7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1864ddab8bfd440b964803911e9124ec_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd315ce487f94328842945669408cac6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if5e43ad9212f4e578d1fb6094dc932e7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15f86920b99e47a8acf4dd4cfafd0615_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id771c1175b884bbca27eafcc9a648410_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6af7c6063aec42389819aab63062e23e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i048fe873cef04ee19ea2b9317513136c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id44bc581e9ad4e67838ca4c123d65f5d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2b5cbcbc73384532a5dd309d11856852_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7a06c98f38fb4642a99ba9b0eeb69e85_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie5df9bb39dd94d1da9a87c3331dd1fc4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i21b8ec4029e44a988d269c3126940283_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie3acee20262b40d6b10903fb4afbe132_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0e31adde43d46de97147148481af848_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia72c419b8ec64dba8571eec8d685eec3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0a3d767b7d0c47bc9a4b5019b47e5bd9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4d3091cfcdc640a6a96229526a63c9f3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iee01dc9e07e243b99354760cac0d4d32_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3598a5751c24825831703722082a2cb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i850f59cbde9f4344a88ebab6b1fc075b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i87cba5d430f245a68bd0315c18e62086_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic42802853a4a454699bda9d6dbae93ab_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iddb27e7850474298b896873be1ac713d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i98c4699f13a94272b16b1d74570e68fc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1213d16766764ac4b9e354347e502602_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i90fe5caa0f59404680b57eb172b7feb0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if617a3f687c7470babc0347a121c9e4d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic6c8d850bc0b470f9ed7d27f080d7d3e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia5bda4a72cc2448eb1edd6aaf8e616da_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5aa4bbd4b0f842faa92582711d35880e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4f839de76b0f434eb190d581d2836010_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3f651cc6ea1b471f8b7f8940efacc318_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i78617df876924999b6673b596d4ec4bc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic7fa9139c7bb4f4499a1a4264ac05a1f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i37b7a8a12d95433386c13963200412ff_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7b51a1e39a2f490fa85b27203276ef0c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i86a46fb310654cc4b552d2896fa0e4ce_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia1e1c8f2d240445c9b8dcf6436139569_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i40e0c746fc364568aca78621cf9fa220_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iea67ec5cbe4542ba8a94aa5c96aa362d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieea0bd6309b146afa41000f43a995747_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if642e1ad2c084744ab7670f7a6352dfa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i104ac329ccf749b18a18c82c37f79955_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7b2258e70f904ecc8314266db2b2b0f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6bb57ee8aae4e0bb388398be620f121_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i22ec3dd09cf4437ea06fcdec19d1d6fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iead44cad5e60407b9beab7d6f4ff0009_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i68612d24937c4836b820313794721e70_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2caebe9557194cc5b637ac04007df5c4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i826e2caf620945adb4857cc3ca809c61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if655a31fafc740b5b2318f68e86b82a3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if312089fa21e46d6b6f06ec4ba94bd10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9fb7b07b086a4309b9d46148ab2e12c2_I20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-22</instant>
        </period>
    </context>
    <context id="id6f992896609491290214875ab35a9d6_I20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-22</instant>
        </period>
    </context>
    <context id="i47405452b21d4961b150a63aba4933d5_I20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-22</instant>
        </period>
    </context>
    <context id="ic3263481a80b4afdbad8e84b720b498c_I20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-22</instant>
        </period>
    </context>
    <context id="ia8f19a89fa884900aca21d4657c555f7_D20211022-20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialPaperOrLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-22</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <context id="i2f807339735446ff8d0868243f7b30d8_D20211022-20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialPaperOrLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-22</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>dgx:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV8xLTEtMS0xLTA_7d9929f1-247e-491f-8acf-e6aa139b43ed">0001022079</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV8yLTEtMS0xLTA_a901812e-d7d7-4f6b-815d-a975c82e8786">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV8zLTEtMS0xLTA_4f54c29c-9e16-4c4e-b77a-898633c4c973">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV80LTEtMS0xLTA_b015879c-2502-4679-ab2f-8b3ee56e1a23">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80L2ZyYWc6MWU5NTJlYWFjYWM4NGU2ODk4N2MwZjM5YWE1NDIwMjIvdGFibGU6M2I2MGFhYmQ5YTNlNGUxYzg5MmE2ODM4MzdjZjk4YjEvdGFibGVyYW5nZTozYjYwYWFiZDlhM2U0ZTFjODkyYTY4MzgzN2NmOThiMV81LTEtMS0xLTA_6da6c1e6-0200-4929-badc-34544961aa1d">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI4_44dfe980-5f06-4a3b-b1a1-6189b5456352">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI5_3325cb90-aba8-4d8e-b6e2-8bb5b92dd543">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8zODQ4MjkwNjk5MTcx_57e6f6f6-0457-4682-b78f-cace2bba435f">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTIy_c1e61d99-ef19-4726-9f62-2934ea87f22f">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTIz_4f18ef91-2a77-4603-9de1-c133afae2c2b">001-12215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI0_d031ec93-914b-4dca-83ba-833be84fb49d">Quest Diagnostics Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8wLTAtMS0xLTA_e04409ea-efea-4ad1-9104-31cf18b9fe37">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8wLTUtMS0xLTA_1d145290-2848-4132-993e-411f1cf6985a">16-1387862</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8yLTAtMS0xLTA_96d6c888-a562-4111-bc79-e2da43d6febc">500 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8zLTAtMS0xLTA_de9c930f-b0a3-46b4-882e-edeed9eea63c">Secaucus,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8zLTEtMS0xLTA_e51569d9-be28-4546-bd0b-4cc888254341">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV8zLTItMS0xLTA_ef5c4f58-0ee4-4f03-9957-cd94aed8dae1">07094</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV80LTAtMS0xLTA_b8c2f583-3a24-47e1-8821-7f3219b0fbb7">(973)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6OGE3NmYyZmRkM2Q1NGRmMTliNmUzZGQ4YTM2NDQ1MTkvdGFibGVyYW5nZTo4YTc2ZjJmZGQzZDU0ZGYxOWI2ZTNkZDhhMzY0NDUxOV80LTEtMS0xLTA_c11276ea-94ec-4a58-82a6-81560000765a">520-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6YWE2YTEwNWYzNzA5NDExY2FkNTNhZmU4NDRlZTgyNTUvdGFibGVyYW5nZTphYTZhMTA1ZjM3MDk0MTFjYWQ1M2FmZTg0NGVlODI1NV8xLTAtMS0xLTA_b6785615-75ec-4cc0-b625-b8a45a94c069">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6YWE2YTEwNWYzNzA5NDExY2FkNTNhZmU4NDRlZTgyNTUvdGFibGVyYW5nZTphYTZhMTA1ZjM3MDk0MTFjYWQ1M2FmZTg0NGVlODI1NV8xLTEtMS0xLTA_a0a045b3-5215-4fe2-9912-afccc347491e">DGX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6YWE2YTEwNWYzNzA5NDExY2FkNTNhZmU4NDRlZTgyNTUvdGFibGVyYW5nZTphYTZhMTA1ZjM3MDk0MTFjYWQ1M2FmZTg0NGVlODI1NV8xLTItMS0xLTA_e733a5c5-36bd-43d0-b6d7-0b47553aa64e">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI1_81adb1ce-485d-4331-82bc-b4bbeb62c04a">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI2_3e92f0fb-1096-4bad-8582-0540ed06fb6a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6NmQxZWMwNjEyMzlkNGJkYThkZDhiYzJlNGJmZDllNmQvdGFibGVyYW5nZTo2ZDFlYzA2MTIzOWQ0YmRhOGRkOGJjMmU0YmZkOWU2ZF8wLTAtMS0xLTA_44504869-e816-41b1-ac90-030f20324c9e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6NmQxZWMwNjEyMzlkNGJkYThkZDhiYzJlNGJmZDllNmQvdGFibGVyYW5nZTo2ZDFlYzA2MTIzOWQ0YmRhOGRkOGJjMmU0YmZkOWU2ZF8xLTMtMS0xLTA_50f8ea9c-6c83-4baa-b13e-89e2a8c370cc">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGFibGU6NmQxZWMwNjEyMzlkNGJkYThkZDhiYzJlNGJmZDllNmQvdGFibGVyYW5nZTo2ZDFlYzA2MTIzOWQ0YmRhOGRkOGJjMmU0YmZkOWU2ZF8yLTMtMS0xLTA_141d91d6-ff45-49de-a540-51f526a95a43">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xOTI3_01cdec58-9f93-4d3e-8b99-1d70af6dc536">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="idb6102b3487f457aa5e512c514af4c6c_I20211015"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xL2ZyYWc6OTU2MTYyYWNmOTIyNDVkMmE0ZTRjNWUxYTRiNWEyZDIvdGV4dHJlZ2lvbjo5NTYxNjJhY2Y5MjI0NWQyYTRlNGM1ZTFhNGI1YTJkMl8xODYz_2790642f-42e4-4ac3-86f8-e39056c32da0"
      unitRef="shares">122674771</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMi0xLTEtMS0w_2c24fee6-36e6-4aa4-9c2c-13e30f25bfe2"
      unitRef="usd">2774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMi0zLTEtMS0w_d94ca49b-7efd-4d2c-9948-f04aee135448"
      unitRef="usd">2786000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMi01LTEtMS0w_59412367-7f32-4c22-b10f-6bd566db20f8"
      unitRef="usd">8044000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMi03LTEtMS0w_a4c1b6f1-10d1-4a62-8143-3ef195c2dc55"
      unitRef="usd">6435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNS0xLTEtMS0w_c507e104-b459-4a42-9b73-70df727a702b"
      unitRef="usd">1670000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNS0zLTEtMS0w_06e44c05-325f-4a72-b444-0551bcf4ace8"
      unitRef="usd">1580000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNS01LTEtMS0w_a4052aa0-0877-4b85-81e5-2048a47ea75c"
      unitRef="usd">4861000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNS03LTEtMS0w_7338ff8f-c844-4322-b674-18c51fab2d75"
      unitRef="usd">4071000000</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNi0xLTEtMS0w_6344d714-bb9e-4e78-b624-5a9b8945ab9f"
      unitRef="usd">427000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNi0zLTEtMS0w_d396f0ac-deb9-4cd9-877f-1a53d0f6e30c"
      unitRef="usd">396000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNi01LTEtMS0w_2b070055-8810-4301-bb15-b8936894f28f"
      unitRef="usd">1263000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNi03LTEtMS0w_cf460c37-ef7e-4850-b267-3b8fd6297a0c"
      unitRef="usd">1103000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNy0xLTEtMS0w_b0647898-4f1c-4161-a597-370ffced1845"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNy0zLTEtMS0w_7334b98f-d913-4f79-92ef-5b2467875ff3"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNy01LTEtMS0w_40ed1f04-f0e3-4b0d-aaa3-df68fba7120e"
      unitRef="usd">77000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNy03LTEtMS0w_43729272-f16f-4624-b617-0da5e4c65a6b"
      unitRef="usd">77000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfOS0xLTEtMS0w_7df482e6-fd7d-4e4b-a4ce-6aa63f6d06f7"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfOS0zLTEtMS0w_b245c082-0c40-4bcc-939b-a8b95df241df"
      unitRef="usd">-65000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfOS01LTEtMS0w_d5c6c799-2e99-45c4-86c8-5bc9cd9ef197"
      unitRef="usd">2000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfOS03LTEtMS0w_b004a498-d5b4-48a3-8115-cdc8f8bd4e17"
      unitRef="usd">-8000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTAtMS0xLTEtMA_e6934736-ff71-44f0-a794-0b36b2dcec49"
      unitRef="usd">2122000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTAtMy0xLTEtMA_05806e05-3ba6-4e87-8ec4-f0e2887c6d5b"
      unitRef="usd">2068000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTAtNS0xLTEtMA_db9faa50-f9e0-42da-b415-26790307e9fd"
      unitRef="usd">6199000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTAtNy0xLTEtMA_e374a0c4-bec5-45a3-9f25-f79556eff645"
      unitRef="usd">5259000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTItMS0xLTEtMA_1068cab5-4ebb-4468-a031-992f021bbd2e"
      unitRef="usd">652000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTItMy0xLTEtMA_384c4402-1f4d-441f-9719-d9baf9b4ef7a"
      unitRef="usd">718000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTItNS0xLTEtMA_9d1ae501-aaad-439a-8ada-23c45b51bc46"
      unitRef="usd">1845000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTItNy0xLTEtMA_2bf9f21d-4053-4789-9642-ae2d0ab2af81"
      unitRef="usd">1176000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTUtMS0xLTEtMA_6a97e41a-d16f-46d1-8a1f-40c5053b7d94"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTUtMy0xLTEtMA_59e03dee-8d01-45d2-8bbe-c180edeafd1a"
      unitRef="usd">-42000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTUtNS0xLTEtMA_5c101fd1-8ff8-45b7-bed6-f9274951df1a"
      unitRef="usd">-114000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTUtNy0xLTEtMA_8287f2b1-bf33-417d-8ece-185478db01cc"
      unitRef="usd">-124000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTYtMS0xLTEtMA_a4a41410-d761-4624-b2e5-738e9e3d1eb6"
      unitRef="usd">40000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTYtMy0xLTEtMA_3e9c486a-b434-4919-92b7-fd25131bc2a1"
      unitRef="usd">77000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTYtNS0xLTEtMA_164375a8-30c1-425e-bab3-fef0b62aeb50"
      unitRef="usd">366000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTYtNy0xLTEtMA_ae973255-2f1a-4eff-bb3e-ee07e1240c52"
      unitRef="usd">74000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTctMS0xLTEtMA_0b4330d0-328d-4ed6-8df7-0d5fe5c5c019"
      unitRef="usd">2000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTctMy0xLTEtMA_44b7ce3f-13e5-40f5-8f34-1673879923aa"
      unitRef="usd">35000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTctNS0xLTEtMA_5a604094-5eff-4222-9d14-d4badc17e310"
      unitRef="usd">252000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTctNy0xLTEtMA_2c2be0a4-9cd0-4699-a69a-f7d04e212a1a"
      unitRef="usd">-50000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTktMS0xLTEtMA_61d538f1-4d8b-4e94-a27c-09bdc6e26bdd"
      unitRef="usd">654000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTktMy0xLTEtMA_3f48ecd9-bb56-4c01-88f0-f1a3dbee98db"
      unitRef="usd">753000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTktNS0xLTEtMA_6cd654b2-dbbe-4e2b-9c06-884591cca488"
      unitRef="usd">2097000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMTktNy0xLTEtMA_fe8ea494-fbd4-458a-a4cc-8e3da19a6e51"
      unitRef="usd">1126000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjAtMS0xLTEtMA_6a1ecee3-7bbf-4e31-81c2-4b694c2de61e"
      unitRef="usd">153000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjAtMy0xLTEtMA_7720c57a-1179-4bff-aa97-15df814d6367"
      unitRef="usd">177000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjAtNS0xLTEtMA_b31e6faa-26d7-4ec9-a623-04a2e13c2834"
      unitRef="usd">483000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjAtNy0xLTEtMA_d4f6832f-631d-4ca9-a631-e5a1e69ea675"
      unitRef="usd">269000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjEtMS0xLTEtMA_b4c8fd4a-c792-49d3-83e1-ed17cac15463"
      unitRef="usd">26000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjEtMy0xLTEtMA_7345adb9-3e31-4b7b-9213-c2ab6edb7e46"
      unitRef="usd">15000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjEtNS0xLTEtMA_07c66ae7-6954-451d-a306-210e81822f04"
      unitRef="usd">53000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjEtNy0xLTEtMA_96aee7be-7c7b-4f5c-b4a4-b3664143bd20"
      unitRef="usd">33000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjQtMS0xLTEtMA_9ce9442b-2cdf-4313-ac90-336178aea0cf"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjQtMy0xLTEtMA_52f6252d-c216-42d3-a9c3-4665155c5a0c"
      unitRef="usd">591000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjQtNS0xLTEtMA_2cc4cf4d-79b0-43ad-bedd-3f75c3242264"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjQtNy0xLTEtMA_86083ccd-022c-42b4-8d21-6afa95583b8e"
      unitRef="usd">890000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjUtMS0xLTEtMA_bafb0a19-5bcd-4fbc-a47e-79fbb1fc64be"
      unitRef="usd">22000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjUtMy0xLTEtMA_78df581f-3fcd-49e4-8814-1b2e29cb9ae3"
      unitRef="usd">23000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjUtNS0xLTEtMA_796ead94-7b39-406b-9979-7c31214e4294"
      unitRef="usd">62000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjUtNy0xLTEtMA_110eba59-8d09-48d7-bdd4-4c3c32eb2e99"
      unitRef="usd">38000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjYtMS0xLTEtMA_796b8d7b-7529-4c6b-b870-76449e8d78a8"
      unitRef="usd">505000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjYtMy0xLTEtMA_03e4f191-a790-480e-bb4a-0c3b2d48cacb"
      unitRef="usd">568000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjYtNS0xLTEtMA_20365183-f8ad-4c01-898a-ac221495dde7"
      unitRef="usd">1605000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMjYtNy0xLTEtMA_b4b0ac81-e8df-4d00-ad93-4dd2b67dec04"
      unitRef="usd">852000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMzYtMS0xLTEtMA_7e005735-f261-4374-9993-caad80b0d8fa"
      unitRef="usdPerShare">4.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMzYtMy0xLTEtMA_e7ef52ac-3cf6-414b-9e6c-d61ec8ffc529"
      unitRef="usdPerShare">4.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMzYtNS0xLTEtMA_aaadb5de-b42d-4799-a728-c4c19683268d"
      unitRef="usdPerShare">12.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfMzYtNy0xLTEtMA_d86e0dca-a7ab-4c30-9567-61052f05470d"
      unitRef="usdPerShare">6.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDEtMS0xLTEtMA_1ec819eb-01fa-486e-82fb-41c76b1546d5"
      unitRef="usdPerShare">4.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDEtMy0xLTEtMA_0ead1d89-d362-4c24-9a50-030b9af3311a"
      unitRef="usdPerShare">4.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDEtNS0xLTEtMA_6dea6946-1663-40ac-9819-0c2feac69f89"
      unitRef="usdPerShare">12.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDEtNy0xLTEtMA_0cb64d9b-d511-47a9-8715-fd3478550ff5"
      unitRef="usdPerShare">6.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDQtMS0xLTEtMA_b2f3161d-9f21-41c8-8dd3-0abf0eb00ab9"
      unitRef="shares">123000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDQtMy0xLTEtMA_fd15d5ad-d272-46bc-ab9a-aaf5578fee1e"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDQtNS0xLTEtMA_5d08dc81-58c6-45dc-9772-7cdbdfef14d0"
      unitRef="shares">127000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDQtNy0xLTEtMA_c697f6a5-e0dd-45a1-872b-b3d62bd74c69"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDYtMS0xLTEtMA_6db951db-f7d0-477d-ac49-0d12bd87d4b1"
      unitRef="shares">125000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDYtMy0xLTEtMA_931f7e2e-9deb-4741-86cd-3d3d6c8f5ad5"
      unitRef="shares">137000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDYtNS0xLTEtMA_5505b0f7-fb2a-4a9e-89df-121e14865a65"
      unitRef="shares">129000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMy9mcmFnOmQzOTk2YzYzN2RiMDRhMzdhY2IyYzU1YzBmOWY2YjcxL3RhYmxlOjUzMzEwNDM5NTZlYTRmNjc5MzY4YzAxNDhlODM0MWUxL3RhYmxlcmFuZ2U6NTMzMTA0Mzk1NmVhNGY2NzkzNjhjMDE0OGU4MzQxZTFfNDYtNy0xLTEtMA_c3d97b24-605f-41fa-aaa9-e74527e58e90"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMi0xLTEtMS0w_9ce9442b-2cdf-4313-ac90-336178aea0cf"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMi0zLTEtMS0w_52f6252d-c216-42d3-a9c3-4665155c5a0c"
      unitRef="usd">591000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMi01LTEtMS0w_2cc4cf4d-79b0-43ad-bedd-3f75c3242264"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMi03LTEtMS0w_86083ccd-022c-42b4-8d21-6afa95583b8e"
      unitRef="usd">890000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNS0xLTEtMS0w_9850eafe-d324-41fb-acd5-ac03326ec738"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNS0zLTEtMS0w_51884c60-3633-4b72-855c-d15fc6c3f7a7"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNS01LTEtMS0w_266dd706-7951-4fc1-b8e2-cc7613fe10e5"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNS03LTEtMS0w_8ca1d5a5-d667-49c4-8543-10debc613430"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNi0xLTEtMS0w_96a38151-7d26-42d2-90a2-583056f3d34f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNi0zLTEtMS0w_2f4e2216-6901-4ad5-ba21-b00ab867a6ca"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNi01LTEtMS0w_cd509de7-c608-4543-b32f-e9d4f745f322"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNi03LTEtMS0w_fbf30a90-b1c8-4571-817f-96cb176c35ac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNy0xLTEtMS0w_c64ad11b-d043-407e-81ae-e08515ea4132"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNy0zLTEtMS0w_3feca964-4dd9-4b3d-914d-17383a152031"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNy01LTEtMS0w_191ba2c0-d0a7-4082-9f9e-554c10d36a5d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfNy03LTEtMS0w_f8c1b4e8-d67c-4ab1-933f-fd00e576fd2b"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfOS0xLTEtMS0w_cd3ae2d9-06ca-44f8-9082-bbf8d393933e"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfOS0zLTEtMS0w_fee3b2cd-4efc-4a4d-a364-e01b5af8954c"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfOS01LTEtMS0w_93599d6f-f09a-406c-bca5-7fe6bc1266b4"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfOS03LTEtMS0w_fe6c20a6-a679-4039-9f8e-e29c72387b65"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTEtMS0xLTEtMA_83bd1294-206d-4260-92f5-898c77ab9253"
      unitRef="usd">524000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTEtMy0xLTEtMA_3e37a10b-9d37-4db0-9541-fc2e195ac667"
      unitRef="usd">604000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTEtNS0xLTEtMA_962072e2-f358-489d-b53d-e245553d3f1f"
      unitRef="usd">1675000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTEtNy0xLTEtMA_105c6743-6e4e-4a82-af8c-f94d04440bfa"
      unitRef="usd">887000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTItMS0xLTEtMA_1e1b5a42-4df8-4b6d-ae31-3b5ae7f7ce8b"
      unitRef="usd">22000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTItMy0xLTEtMA_4f3136c4-84ba-4699-abbf-611015dc4e15"
      unitRef="usd">23000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTItNS0xLTEtMA_a0d42623-de2e-4350-9ea8-413d2f8736f5"
      unitRef="usd">62000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTItNy0xLTEtMA_5148985b-0880-4fb1-b2bf-3f86169e21cb"
      unitRef="usd">38000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTMtMS0xLTEtMA_6abc4792-3d8b-455e-aec4-698bc2cdd2b2"
      unitRef="usd">502000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTMtMy0xLTEtMA_852702d3-e6ad-4bc1-ba0d-fd798cade5a6"
      unitRef="usd">581000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTMtNS0xLTEtMA_28d78c5d-6c4a-410d-a828-2f0d27f99135"
      unitRef="usd">1613000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xNi9mcmFnOmEzY2M0ZWFjNDlkNDQ3NzRiYjJlZTNmMzZhYmJiMzRkL3RhYmxlOmVlMWZiMGM5ZTUzZDRlYTU4MzMyZDA3OGY2YmI4OWRhL3RhYmxlcmFuZ2U6ZWUxZmIwYzllNTNkNGVhNTgzMzJkMDc4ZjZiYjg5ZGFfMTMtNy0xLTEtMA_96ddac5e-44c1-4f26-9250-4256a494ca5a"
      unitRef="usd">849000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMy0xLTEtMS0w_5b0b4267-2575-47c9-9f01-5ff786d58678"
      unitRef="usd">987000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMy0zLTEtMS0w_3535c4da-1c48-412e-b9e9-da23a24c3297"
      unitRef="usd">1158000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNC0wLTEtMS0wL3RleHRyZWdpb246NDMxMjE0Zjc1YTRjNDNkMmJjZWRmODI4N2RjYmQ3ZjFfNjM_8ee24f22-d2ce-4573-bc5c-3b8907deec04"
      unitRef="usd">29000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNC0wLTEtMS0wL3RleHRyZWdpb246NDMxMjE0Zjc1YTRjNDNkMmJjZWRmODI4N2RjYmQ3ZjFfNzA_274ba934-ddd0-43f6-a3a3-dcc0eff89da0"
      unitRef="usd">28000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNC0xLTEtMS0w_096dc231-bb55-49b0-a009-834d30340207"
      unitRef="usd">1473000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNC0zLTEtMS0w_f6230797-8d90-4cba-b039-7b4d12f62902"
      unitRef="usd">1520000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNS0xLTEtMS0w_516bd3f6-ad64-481e-8374-a171ab1af047"
      unitRef="usd">205000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNS0zLTEtMS0w_4b1bae83-c8a4-4ed0-8e2c-57e51af048c1"
      unitRef="usd">223000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNi0xLTEtMS0w_c2ccf9c6-6163-4758-aca3-8bcd6001a310"
      unitRef="usd">189000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNi0zLTEtMS0w_ed4463f8-459f-4e35-a47a-628084c51c3b"
      unitRef="usd">157000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfOC0xLTEtMS0w_49bd26aa-f776-40ff-9622-de907de103ed"
      unitRef="usd">2854000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfOC0zLTEtMS0w_c7ac50a8-72ec-48ef-bd6f-505e0c7fe1a3"
      unitRef="usd">3058000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfOS0xLTEtMS0w_d29589a1-f79c-44b3-b9cd-30a2a9a38695"
      unitRef="usd">1634000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfOS0zLTEtMS0w_9799c803-133d-4e47-b2f9-c932dddc02b6"
      unitRef="usd">1627000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTAtMS0xLTEtMA_301dbebf-38f9-4fc1-baad-83e603ad718b"
      unitRef="usd">596000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTAtMy0xLTEtMA_742440ab-1769-49c2-ac1b-77c2ad3de9e0"
      unitRef="usd">604000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTEtMS0xLTEtMA_9873946d-55ce-4d47-8e34-4c7bf1dfa255"
      unitRef="usd">7057000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTEtMy0xLTEtMA_a6422eaa-109d-4598-9cb9-fdbc49784f82"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTItMS0xLTEtMA_4eba30f6-bdc8-4408-8d30-f504c6c35acc"
      unitRef="usd">1152000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTItMy0xLTEtMA_d39411c7-7c85-4c37-8e90-e14a76595329"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTMtMS0xLTEtMA_68e3b12a-86c3-43de-aa84-5ca074635509"
      unitRef="usd">124000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTMtMy0xLTEtMA_c4f2325a-b0e1-47bb-aed2-d8962fbc105e"
      unitRef="usd">521000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTQtMS0xLTEtMA_c49df8df-585d-4e10-9cc0-31363886f71b"
      unitRef="usd">155000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTQtMy0xLTEtMA_73f794f6-1d19-43d9-99bd-25a0cd78902a"
      unitRef="usd">176000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTYtMS0xLTEtMA_276cb83c-cb8a-40c7-a887-7afbb50ab1ea"
      unitRef="usd">13572000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMTYtMy0xLTEtMA_fe1c133d-7a0c-48b7-8627-1b10a8274335"
      unitRef="usd">14026000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjAtMS0xLTEtMA_a95f55cd-d868-429b-9dc5-af5fecdbc554"
      unitRef="usd">1610000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjAtMy0xLTEtMA_fd53ab66-105e-44ba-a9c3-d816394999fc"
      unitRef="usd">1633000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjEtMS0xLTEtMA_cc658200-4cbf-4e49-a687-ff9c8eb0d1a0"
      unitRef="usd">1000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjEtMy0xLTEtMA_d6b504ef-b613-4ac2-8aba-f4762c8d3f3f"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjItMS0xLTEtMA_442fb733-3291-44bd-a27a-a90c27b6acbd"
      unitRef="usd">148000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjItMy0xLTEtMA_ef9e4911-b7f5-438a-b9ab-37ba47f76b26"
      unitRef="usd">141000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjQtMS0xLTEtMA_13ccc3fc-58e8-44ee-b532-8b25cdf47707"
      unitRef="usd">1759000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjQtMy0xLTEtMA_869a33b4-50cf-4567-a16d-64f0f6d13a1a"
      unitRef="usd">1776000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjUtMS0xLTEtMA_d806fe30-ab2b-4194-97b7-05a8bc1b8568"
      unitRef="usd">4006000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjUtMy0xLTEtMA_a510edd8-f1a8-431c-ade1-5158074785ac"
      unitRef="usd">4013000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjYtMS0xLTEtMA_73e0c837-662f-44d6-9841-fecc19573e63"
      unitRef="usd">495000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjYtMy0xLTEtMA_2b9b6576-9524-4d14-b10e-9d5a1466658d"
      unitRef="usd">499000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjctMS0xLTEtMA_26e17297-96c0-440b-ad35-043d35008289"
      unitRef="usd">801000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjctMy0xLTEtMA_1c353ed1-d46c-42c3-8691-5bb550a4dcab"
      unitRef="usd">847000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjktMS0xLTEtMA_baf0e933-ae5b-4f2b-8121-445be347cc17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMjktMy0xLTEtMA_688baa9a-63b1-4228-b375-0ed107c6d4fb"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzAtMS0xLTEtMA_627ff0c5-4e9b-46c0-b608-901b92c547df"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzAtMy0xLTEtMA_9522bef0-920f-4838-8f70-4ff4dfb751d1"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0Mjc_56baa32a-4bfe-4b65-a446-8137767ea44d"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0Mjc_5d0b21ae-8751-4488-b078-192c0a4ecd30"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0MzM_1a4321f0-e8ce-422b-890f-9729931494ee"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0MzM_e3ce4843-8d9f-4d19-9d4a-62f2be6af859"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0NDU_e4492107-b5d8-47df-8e9c-22c7669d88e6"
      unitRef="shares">162000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmQ4NTlhMzA1MTFlNDQ1OWQ5NDE0NDlhYzFjMzM4Y2U2XzM4NDgyOTA2OTc0Mzk_5112bbc5-4583-4b6d-95f0-328f55165a84"
      unitRef="shares">217000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMS0xLTEtMA_9d442212-4565-4f58-8e26-1953537a6eb0"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzMtMy0xLTEtMA_8e46f839-8e7d-41ac-82cd-ef06b11bdc16"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzQtMS0xLTEtMA_2fc4ef99-d1a9-420c-b2c3-fa7afe709e3d"
      unitRef="usd">1936000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzQtMy0xLTEtMA_364e546b-0e7a-42e9-ab8a-be8dafdc5f28"
      unitRef="usd">2841000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzUtMS0xLTEtMA_62d71a63-3362-4a3e-8f2e-c3513e2adbae"
      unitRef="usd">7333000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzUtMy0xLTEtMA_10fd6a17-88cc-4943-9bae-6825b768face"
      unitRef="usd">9303000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzYtMS0xLTEtMA_8d6b5c09-6ad0-4243-a885-4dee20a61b58"
      unitRef="usd">-13000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzYtMy0xLTEtMA_b43a3067-afe6-4ccb-9d55-b1ab99fd7254"
      unitRef="usd">-21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmE0MmZmY2E5OTFhYjQzZmRhN2RjZDhhODJmZWJmZDI2XzI5_2a1cb216-bc3f-49ba-b484-5c5dd3fea5d5"
      unitRef="shares">39000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmE0MmZmY2E5OTFhYjQzZmRhN2RjZDhhODJmZWJmZDI2XzM2_c47c143c-8482-405e-91b1-00a6ec52d626"
      unitRef="shares">84000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzctMS0xLTEtMA_af8acaa1-5b26-4988-b49f-bb2704e08853"
      unitRef="usd">2866000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzctMy0xLTEtMA_7d39487c-d178-46e8-9cbb-14f708bf87dc"
      unitRef="usd">5366000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzgtMS0xLTEtMA_c61da7a1-55d8-40ae-8ea7-5cacc3475581"
      unitRef="usd">6392000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzgtMy0xLTEtMA_47a6d582-0a2d-4265-bc44-24f744c87644"
      unitRef="usd">6759000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzktMS0xLTEtMA_844fea1a-6dbd-48ef-81ba-7685506fdfab"
      unitRef="usd">40000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfMzktMy0xLTEtMA_d7d2433f-c34b-494c-8736-c6b67aad8ee2"
      unitRef="usd">50000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNDAtMS0xLTEtMA_bb13e832-6e94-4b88-9698-65fd3e20343f"
      unitRef="usd">6432000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNDAtMy0xLTEtMA_5668008b-f26b-4888-83c6-6d49c32f005a"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNDEtMS0xLTEtMA_d0136345-8ba0-4a82-ab52-739719ba962c"
      unitRef="usd">13572000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xOS9mcmFnOjUzNTRlZjk0ODU3ZjQyZjNhYTk2Mjg0OTQ1MTQ2YzMyL3RhYmxlOjg3MzE4NjA4ZjE1YzRiMmZiN2JmZDJhMWRkNmM3MWZmL3RhYmxlcmFuZ2U6ODczMTg2MDhmMTVjNGIyZmI3YmZkMmExZGQ2YzcxZmZfNDEtMy0xLTEtMA_a5289411-be5e-4546-86d0-5f09123b239a"
      unitRef="usd">14026000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMy0xLTEtMS0w_2cc4cf4d-79b0-43ad-bedd-3f75c3242264"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMy0zLTEtMS0w_86083ccd-022c-42b4-8d21-6afa95583b8e"
      unitRef="usd">890000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNS0xLTEtMS0w_cfa364c6-f749-4dfb-b99c-fc879bc7cde3"
      unitRef="usd">302000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNS0zLTEtMS0w_5821094e-a0b7-4768-96f5-8b6f6a37b29c"
      unitRef="usd">263000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNi0xLTEtMS0w_5ef8f964-60f4-43c1-bfb3-fcaada062701"
      unitRef="usd">3000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNi0zLTEtMS0w_e648b290-4b05-4433-bb08-c57bf3d8bcb6"
      unitRef="usd">18000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNy0xLTEtMS0w_7ff374be-7c80-4505-986e-6116d8a681a9"
      unitRef="usd">-87000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNy0zLTEtMS0w_4d274e00-05a3-49d2-8eb6-4126297a231c"
      unitRef="usd">12000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfOC0xLTEtMS0w_243ebcbe-82ef-436a-a028-47d5674bb732"
      unitRef="usd">60000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfOC0zLTEtMS0w_cf3a4314-5fea-469f-8905-241f8111e3fc"
      unitRef="usd">63000000</us-gaap:ShareBasedCompensation>
    <dgx:GainLossOnDispositionOfJointVenture
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTAtMS0xLTEtMA_2736c910-9f0e-4cb2-8044-d6108738d63f"
      unitRef="usd">314000000</dgx:GainLossOnDispositionOfJointVenture>
    <dgx:GainLossOnDispositionOfJointVenture
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTAtMy0xLTEtMA_5bf9cbb5-10d2-40a5-87a9-1c22b63df89b"
      unitRef="usd">0</dgx:GainLossOnDispositionOfJointVenture>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTEtMS0xLTEtMA_a0d1376f-c06d-496e-a5f3-6633086a89ee"
      unitRef="usd">48000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTEtMy0xLTEtMA_07d31dc9-1f1e-4e99-a9b7-8927ba74232a"
      unitRef="usd">60000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTMtMS0xLTEtMA_a8308d2b-85d1-4d67-b58d-91c73f8dd979"
      unitRef="usd">-45000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTMtMy0xLTEtMA_d45ffb61-fa90-4241-909e-238ca337f517"
      unitRef="usd">355000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTQtMS0xLTEtMA_61b8fd3c-ad43-4d3b-a9a4-718012abd331"
      unitRef="usd">36000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTQtMy0xLTEtMA_f5eed82c-3acc-41cd-90a4-bf485318bd72"
      unitRef="usd">514000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTUtMS0xLTEtMA_ad829ce1-f3aa-4ab3-8549-c40265fafb33"
      unitRef="usd">49000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTUtMy0xLTEtMA_2a9ac30f-022e-40a9-b1ca-779c09637c89"
      unitRef="usd">95000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTYtMS0xLTEtMA_742c2a7f-c140-44b8-a7f8-26a0a6e034a1"
      unitRef="usd">0</dgx:TerminationOfInterestRateSwapAgreements>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTYtMy0xLTEtMA_185c1a4f-7638-414f-a372-c1fce7093cd2"
      unitRef="usd">40000000</dgx:TerminationOfInterestRateSwapAgreements>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTctMS0xLTEtMA_abebe853-bc13-4071-ae3e-b5d8a277a674"
      unitRef="usd">-39000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTctMy0xLTEtMA_bd3d0142-422e-45cf-83a6-c55911060928"
      unitRef="usd">16000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTgtMS0xLTEtMA_f9c8a371-4502-464d-8e72-84834139a5ee"
      unitRef="usd">1752000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMTgtMy0xLTEtMA_115cd2d3-958f-4506-b8fe-b9e7b6cafde2"
      unitRef="usd">1464000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjEtMS0xLTEtMA_77a62b9d-7ff8-4177-a13c-876d70f1ab81"
      unitRef="usd">251000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjEtMy0xLTEtMA_962f0425-4caa-4a20-b318-eb9ef208c349"
      unitRef="usd">329000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjQtMS0xLTEtMA_61844536-aece-4442-bbd1-09d8c84061b0"
      unitRef="usd">259000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjQtMy0xLTEtMA_d2ee482b-a73d-4138-8c56-85db5fed5c79"
      unitRef="usd">256000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjYtMS0xLTEtMA_10e69b57-4e99-4562-ac80-eb680bb7b41c"
      unitRef="usd">755000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjYtMy0xLTEtMA_35bfb8b5-30f5-487c-9480-0c3fd6bf12d0"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjctMS0xLTEtMA_eed4d28d-8024-4f81-a0c8-bf37b094a42c"
      unitRef="usd">-3000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjctMy0xLTEtMA_92ce98a6-6c74-490e-8605-27b404f0cc87"
      unitRef="usd">19000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjgtMS0xLTEtMA_e1104aca-a6a2-4b6a-8b17-4e63d3d8ea4a"
      unitRef="usd">248000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMjgtMy0xLTEtMA_56637a5b-0345-41cc-bae0-beca06b1d15f"
      unitRef="usd">-604000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzEtMS0xLTEtMA_5c9766c8-8881-4c8e-9693-e1e126b2375b"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzEtMy0xLTEtMA_0b2e5022-d0e9-4993-b350-551fc57153f3"
      unitRef="usd">749000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzItMS0xLTEtMA_f4ca9201-48b1-420c-b09e-b598233c7526"
      unitRef="usd">2000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzItMy0xLTEtMA_497d2d0c-5c6a-4d37-b366-a0c32a52962f"
      unitRef="usd">1002000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzMtMS0xLTEtMA_318f0e19-bb65-4bfa-a1c0-65b938a798f1"
      unitRef="usd">1910000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzMtMy0xLTEtMA_38682c16-ecdc-4e8b-afea-6a4c06c33606"
      unitRef="usd">75000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzQtMS0xLTEtMA_04ddf071-d61c-44e9-96ce-1a18a17176f5"
      unitRef="usd">108000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzQtMy0xLTEtMA_80157ed7-8c6a-4804-8075-693b69348cb7"
      unitRef="usd">144000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzUtMS0xLTEtMA_f0a63ccb-f180-4b14-90d2-733d2304b8c3"
      unitRef="usd">22000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzUtMy0xLTEtMA_079d0ddb-2d82-4e73-ae4f-7fd9a2ee27a5"
      unitRef="usd">13000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzYtMS0xLTEtMA_5c8c362c-81a2-4caa-8dca-c184a4fd22d4"
      unitRef="usd">232000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzYtMy0xLTEtMA_54a28bcd-ee65-4ad5-be5d-ab39fe495c53"
      unitRef="usd">222000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzctMS0xLTEtMA_315dbfcf-c3d1-4222-a856-efde05eff9a3"
      unitRef="usd">75000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfMzctMy0xLTEtMA_3d5e7a6b-ceab-4950-8958-3ca5519e6119"
      unitRef="usd">34000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDAtMS0xLTEtMA_97425a00-ef54-4282-9c09-8d40a385af20"
      unitRef="usd">-38000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDAtMy0xLTEtMA_df7dd2ad-93ae-4c31-bb7c-2f65952dd0e4"
      unitRef="usd">6000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDEtMS0xLTEtMA_18f3a5a7-9d49-4302-a71f-c90e00fb7b0c"
      unitRef="usd">-2171000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDEtMy0xLTEtMA_029c87f1-6480-4c79-8bb5-83288e14b0dd"
      unitRef="usd">-447000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDMtMS0xLTEtMA_95aa486f-3634-474e-922e-447c0317a1cd"
      unitRef="usd">-171000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDMtMy0xLTEtMA_89cad99b-c55f-486c-b08b-c1ec96451113"
      unitRef="usd">413000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDUtMS0xLTEtMA_aee7ce01-3a7b-4516-9d34-20163b48dbca"
      unitRef="usd">1158000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i44797d3e9c614839926a9c2f3bb5be17_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDUtMy0xLTEtMA_5e185880-f443-4bef-a3b6-21adadb2db42"
      unitRef="usd">1192000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDYtMS0xLTEtMA_50af33cc-c818-4d70-9da7-34c29d75c955"
      unitRef="usd">987000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1f627c3af5db4299b234650d220eee56_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yMi9mcmFnOjdjNTljNjAwOTg4ODQ0NjM5YTU0NmU4YjMwNWE2NDhlL3RhYmxlOmU2NWFkNmY2ZTM3MTQ2NDRiY2ZlZTVhZTNhMjdkNzZiL3RhYmxlcmFuZ2U6ZTY1YWQ2ZjZlMzcxNDY0NGJjZmVlNWFlM2EyN2Q3NmJfNDYtMy0xLTEtMA_fc76e28a-0d71-402e-9c1b-b73eb0591dd7"
      unitRef="usd">1605000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia2e684a75e28400dbbfc768d86f47ec7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xLTEtMS0w_afcdc8dc-af3d-4448-820b-3323a2fa8746"
      unitRef="shares">122000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2e684a75e28400dbbfc768d86f47ec7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0zLTEtMS0w_86f91302-963d-4de0-9bbd-42ce82d513e5"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia69f34e8c6f742d4a439c6a90e6dbb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi01LTEtMS0w_22940d76-d044-4639-8d10-16562b063650"
      unitRef="usd">2555000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i60818a25d0774d728fc8875bec533fcb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi03LTEtMS0w_93537086-cfc0-4201-8948-99312ada67c3"
      unitRef="usd">10246000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i30536b78fd3e41639c5a631d6df42e38_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi05LTEtMS0w_fff974d3-50c4-4be1-a90b-8dea2f8631f1"
      unitRef="usd">-10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c26a3bcfeb74909a10ba5fbcc6ec947_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xMS0xLTEtMA_3616b30f-405f-4f12-b9c5-280e9947a16a"
      unitRef="usd">-6894000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf447d1f13b744eca3e676fb375b1f08_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xMy0xLTEtMA_f66b514e-78d2-4dbc-aa13-c0a00ad406ee"
      unitRef="usd">41000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c9436c528694ee1ac54e6f8ce941854_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xNS0xLTEtMA_dd84c7b4-8b2d-4b8c-b3b2-136d4deb0744"
      unitRef="usd">5940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i5c9436c528694ee1ac54e6f8ce941854_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMi0xOC0xLTEtMA_a064ce5e-7461-4028-9d10-51dc1785a354"
      unitRef="usd">78000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i6bcf39ba3ca3490ba9b723f846d97a93_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMy03LTEtMS0w_fef78ba1-7c56-4c57-9162-85eb152f9ce2"
      unitRef="usd">505000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i8d322c01404548d7bc8bcc50e7fc7e90_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMy0xMy0xLTEtMA_afdb15b1-b69f-4c6b-8fca-c74a0aa95d7f"
      unitRef="usd">19000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMy0xNS0xLTEtMA_76625519-af6a-4ac3-941b-7d2946fc9a0e"
      unitRef="usd">524000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMy0xOC0xLTEtMA_c10360e2-8ec9-4942-a8c7-245d5962bebe"
      unitRef="usd">3000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id6b3aa2d9a704d3890aa1d3b20c761cd_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNC05LTEtMS0w_0b83e23f-66d3-40be-9e61-f5251c4bd8dc"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNC0xNS0xLTEtMA_90bca51d-edf3-4b21-b151-adfaecfdacf0"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6bcf39ba3ca3490ba9b723f846d97a93_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNS03LTEtMS0w_5a858b1a-0149-479b-a136-a8fafefaf8da"
      unitRef="usd">76000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNS0xNS0xLTEtMA_bd7a5783-4ccb-4193-8b38-1424a3c7b892"
      unitRef="usd">76000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8d322c01404548d7bc8bcc50e7fc7e90_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNi0xMy0xLTEtMA_faa8245c-07f7-41d0-8278-ae3d9dede66b"
      unitRef="usd">20000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNi0xNS0xLTEtMA_0ee157e0-37ab-4280-aafb-dc51bd58974a"
      unitRef="usd">20000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNi0xOC0xLTEtMA_82d26123-79c1-4bcc-80db-16f76a7c6b00"
      unitRef="usd">2000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNy01LTEtMS0w_f30cf2fa-e921-4f4d-9171-1eee79f67eb6"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i61a8b1a97ea54a2cb0efda370034cf33_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNy0xMS0xLTEtMA_a1416fda-0dd8-4113-9fb6-4afdabc730fe"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfNy0xNS0xLTEtMA_23ff2d8d-dccf-4a9a-9b87-33614d4e79d6"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOC01LTEtMS0w_10ab8cf8-dfd0-4dab-9a8f-8b2d50f406b3"
      unitRef="usd">21000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOC0xNS0xLTEtMA_2915577a-fc26-43fb-8dee-3b9549a6ab81"
      unitRef="usd">21000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2c9526dd81d14acbb165fbdb21bc7d5b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOS0xLTEtMS0w_8b55fe96-afed-4ace-b58e-a98bfc535b84"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOS01LTEtMS0w_452a7674-4113-4e2a-bd32-9fa116aae06b"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i61a8b1a97ea54a2cb0efda370034cf33_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOS0xMS0xLTEtMA_884d961d-07d7-4586-b04e-5ef98522fe69"
      unitRef="usd">33000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfOS0xNS0xLTEtMA_24efd35d-8a66-4890-b995-4510e7bf7352"
      unitRef="usd">40000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i589fa93739b94d27a54926c93502ad8d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItNS0xLTEtMTc4NTM_9f35ce41-e2bb-45ef-bfef-7604b5e0afcd"
      unitRef="usd">649000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i6bcf39ba3ca3490ba9b723f846d97a93_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItNy0xLTEtMTc4NjE_4280cce2-82c7-48f6-8a43-22f16152b797"
      unitRef="usd">3342000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i61a8b1a97ea54a2cb0efda370034cf33_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTEtMS0xLTE3ODcx_e80e671f-30fa-4208-8267-c9e37191a466"
      unitRef="usd">-3991000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTUtMS0xLTE4ODc1_4be7a5e2-2fdb-47bb-b8c8-e3f2de5cc0d1"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia5469e4b199e4f6bba9dd760df124408_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMS0xLTEtMA_5aea562e-0ed8-4cde-af10-b754f3b6273e"
      unitRef="shares">123000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5469e4b199e4f6bba9dd760df124408_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMy0xLTEtMA_4d3d27e8-cd0c-4093-8c00-181dfa60a4b2"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1082d06815c4d1cbcdd4183ef7a7054_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItNS0xLTEtMA_8358e4fb-0811-4396-8276-259adf9e7ad9"
      unitRef="usd">1936000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90a31327e6d4444faef566d46a5e0076_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItNy0xLTEtMA_5e68d7f6-5f4b-473a-b20c-584ef30129d5"
      unitRef="usd">7333000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b159649f77f410ebe5d069195864be4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItOS0xLTEtMA_34ce62a8-eb83-45fc-a2c2-e112e39322b3"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39fbe907b9a04ba88fd377e9c3ee0c5b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTEtMS0xLTA_aec4192c-a8ca-4cd8-ab5f-15bd3ea7b085"
      unitRef="usd">-2866000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2de9bd88816b4b76a24f2e5e45391d53_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTMtMS0xLTA_bb17749c-603d-42fa-9033-470ec821c2fc"
      unitRef="usd">40000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTUtMS0xLTA_355968c5-2935-4292-8e42-86e168740359"
      unitRef="usd">6432000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTItMTgtMS0xLTA_be2a915d-858f-448b-bb0d-7a018ac54f62"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id7a7da46099a44378da1a233e2933299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMS0xLTEtMA_3ff940a4-c10b-42ea-9f11-ecf491464a39"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7a7da46099a44378da1a233e2933299_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMy0xLTEtMA_1b2aea89-141f-4bc2-bc11-1335d09185cf"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0bc8004207f6457d8e91cab661dc9d7d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtNS0xLTEtMA_c64f6da2-8011-4276-9bce-cefbe5892090"
      unitRef="usd">2841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i530936cdd95443c38a6ee1dac2f95b5d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtNy0xLTEtMA_4701ccd2-d361-407d-aef6-8078b0ba16fe"
      unitRef="usd">9303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd797ff06d5347448e67d12d0a112a21_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtOS0xLTEtMA_e4221de0-028b-4601-91b6-f285582ec5ea"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28ba8ee8faa74b07aa6d9f1fe6d24c42_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMTEtMS0xLTA_d7dd27f2-da6f-411f-9479-91eb3ad200ea"
      unitRef="usd">-5366000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6efac86a7154479b5393be974cf5b8e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMTMtMS0xLTA_88b0187b-3b87-4193-96bf-c6ed8276da53"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMTUtMS0xLTA_31851f9d-70da-4e0e-b6f0-63f227b7c42a"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTYtMTgtMS0xLTA_67027ecc-9733-49ae-8944-2187d67ea57f"
      unitRef="usd">82000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ic1ebeea55bd143e7a34428dfb1cb8d7b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTctNy0xLTEtMA_d994aa2e-39a6-4907-a9cd-f68c87af2db1"
      unitRef="usd">1605000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i462380c5fb3941a2be00f2507dfe4337_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTctMTMtMS0xLTA_1aa1eac0-5b3f-473c-80e6-fedcf09a41cb"
      unitRef="usd">53000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTctMTUtMS0xLTA_c5457694-ca1b-44c6-b61d-b94a235cdf5d"
      unitRef="usd">1658000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTctMTgtMS0xLTA_f33e949b-c3cf-4f16-8ece-87bfe220852c"
      unitRef="usd">9000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9be3cd77042747cfacd90361f64c7ca8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTgtOS0xLTEtMA_c02fe4ec-d87e-4166-82ec-1035058dd01e"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTgtMTUtMS0xLTA_57dcd666-edd3-4f8e-b2db-48ed67ac9fd8"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic1ebeea55bd143e7a34428dfb1cb8d7b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTktNy0xLTEtMA_8ff157de-57e5-4feb-be6a-f00e9046bad0"
      unitRef="usd">233000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMTktMTUtMS0xLTA_f8cc488f-4a10-4cb7-840f-a29b0720f0c6"
      unitRef="usd">233000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i462380c5fb3941a2be00f2507dfe4337_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjAtMTMtMS0xLTA_f294cbaa-fff7-401b-91f4-a92c68ca2c6f"
      unitRef="usd">63000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjAtMTUtMS0xLTA_d196f931-a724-4106-9809-9a43b23ba42f"
      unitRef="usd">63000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjAtMTgtMS0xLTA_f1e6b4e5-51ab-4750-81f4-31232903f930"
      unitRef="usd">12000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjEtNS0xLTEtMA_c2aa8b61-d64e-491e-a67e-ccd1db1ab0da"
      unitRef="usd">-25000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjEtMTEtMS0xLTA_50f9d7f2-6c4e-480f-bea2-c11266615985"
      unitRef="usd">42000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjEtMTUtMS0xLTA_fd8f99ea-b9e6-4775-9a9f-3b1614539744"
      unitRef="usd">17000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjItNS0xLTEtMA_047fa0ca-bf69-420d-bb73-062a79d9f877"
      unitRef="usd">60000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjItMTUtMS0xLTA_9ca25cd1-967b-410b-8b04-6785fbb3e5b7"
      unitRef="usd">60000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idf43e9ec0f474249909c8e64ca28aa9e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjMtMS0xLTEtMA_a0172a9a-659c-4ebf-92a7-79cb723954ef"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjMtNS0xLTEtMA_585d6e96-adce-40a8-bbef-c4cf4ac48a3e"
      unitRef="usd">19000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjMtMTEtMS0xLTA_32d319f0-2434-4c31-acdc-ad26f906a3e4"
      unitRef="usd">89000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjMtMTUtMS0xLTA_d8da1769-847e-45ae-b832-6b61c4b5b89b"
      unitRef="usd">108000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjQtNS0xLTEtMA_a59a944e-6187-4538-94bb-05ff58dacd32"
      unitRef="usd">10000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjQtMTEtMS0xLTA_62f5a387-dd5f-47ba-bd0b-dba3126ce97d"
      unitRef="usd">12000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjQtMTUtMS0xLTA_223c06b7-6ddd-4939-b66c-231cbc245430"
      unitRef="usd">22000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="idf43e9ec0f474249909c8e64ca28aa9e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjUtMS0xLTEtMA_5c0b1dcc-ae53-455a-872e-01d331504414"
      unitRef="shares">12000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjUtNS0xLTEtMA_4aea671e-8ea8-4906-8d9b-7c7b9b7208cf"
      unitRef="usd">300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjUtMTEtMS0xLTA_20dc3b1b-a076-431b-9e23-aa93d6ed0c11"
      unitRef="usd">1610000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjUtMTUtMS0xLTA_39579d33-dd5a-4b54-b44b-dc491af667a2"
      unitRef="usd">1910000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i446c705e4e9a4898b2061dff280fdc42_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjctNS0xLTEtMTc4Nzg_fe83390e-8918-4248-b32a-7aa10a360be9"
      unitRef="usd">649000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ic1ebeea55bd143e7a34428dfb1cb8d7b_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjctNy0xLTEtMTc4OTI_03771cfa-d111-4027-a9ba-b721e045fab7"
      unitRef="usd">3342000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjctMTEtMS0xLTE3ODk5_9f45baa9-7a95-4abc-a538-bcfc0ca8d748"
      unitRef="usd">-3991000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjctMTUtMS0xLTE5MjEw_ed51dd76-2a2a-446a-b11b-fac1b757b95a"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia5469e4b199e4f6bba9dd760df124408_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMS0xLTEtMA_82081f4d-38d7-4a83-bc58-ab1d119528fb"
      unitRef="shares">123000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5469e4b199e4f6bba9dd760df124408_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMy0xLTEtMA_adb17ec2-4cf1-4a72-8893-557f47021d74"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1082d06815c4d1cbcdd4183ef7a7054_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtNS0xLTEtMA_003c9ad4-6b43-48bc-be72-8ee3e849fbce"
      unitRef="usd">1936000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90a31327e6d4444faef566d46a5e0076_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtNy0xLTEtMA_d7781159-a09b-4637-ad8d-78cf49b58b8f"
      unitRef="usd">7333000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b159649f77f410ebe5d069195864be4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtOS0xLTEtMA_717b4cb0-f953-47d5-9024-3ab96480cd48"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39fbe907b9a04ba88fd377e9c3ee0c5b_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMTEtMS0xLTA_7a01a6f1-ed11-4531-8b90-d6dfe58cc4df"
      unitRef="usd">-2866000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2de9bd88816b4b76a24f2e5e45391d53_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMTMtMS0xLTA_2ca0374c-de42-42e3-99b6-d0842b15bd24"
      unitRef="usd">40000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMTUtMS0xLTA_153efc08-aee4-45b6-b19e-5c36ac53b627"
      unitRef="usd">6432000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjdjNGUxY2NmYWM5YTQzNjJhMTRjYzMyMjA3M2Q2OTMzL3RhYmxlcmFuZ2U6N2M0ZTFjY2ZhYzlhNDM2MmExNGNjMzIyMDczZDY5MzNfMjYtMTgtMS0xLTA_b03eeffa-1d6c-4262-b190-bda113191f0b"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1e728b108435425ca56aae502185c623_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xLTEtMS0w_9b9981de-7c16-4b75-ae68-23c7514ef877"
      unitRef="shares">134000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1e728b108435425ca56aae502185c623_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0zLTEtMS0w_0b5b3536-a3f8-4fdc-99b1-33f8a73ecb91"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44095c144c7847d1864cff543b26d594_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi01LTEtMS0w_c9a90890-bf8b-4e46-a91c-4dd0f6e06925"
      unitRef="usd">2764000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb2c2ba8e2984a5ebf8b1e80612267d0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi03LTEtMS0w_15a2b2d9-898f-41ab-9017-8accb53b62d7"
      unitRef="usd">8307000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2877089917b44598af747bd1c932cea2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi05LTEtMS0w_e0be0a7c-20b2-444f-b761-3d02daeb7551"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaec86bf908d1470cb320f0f36f8501f6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xMS0xLTEtMA_bc24966d-adad-4833-83ef-705c6d96b089"
      unitRef="usd">-5187000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie5469af2e4e646ff9485e5ea6fe72b27_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xMy0xLTEtMA_17e1df40-2e52-4bf2-b2be-00701ef9892f"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4291d6d468a544eda0577ac487a2c725_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xNS0xLTEtMA_b654d2f9-1adb-487d-90a4-9b3b28d698a6"
      unitRef="usd">5881000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i4291d6d468a544eda0577ac487a2c725_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMi0xOC0xLTEtMA_6850ffc7-4185-4ee9-8d50-be2d8a455880"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i6a95a06eb0f94af39dece3892ff96d29_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMy03LTEtMS0w_56dd2aed-dbcd-4946-a2d6-3c0a3c9aac4f"
      unitRef="usd">568000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ib2db14ecc4974269854d7acb2c998846_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMy0xMy0xLTEtMA_2e5ed972-b5f4-47e7-94af-83f7ab0cf575"
      unitRef="usd">18000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMy0xNS0xLTEtMA_514da99a-9713-4bbe-bfa9-0528a7c70356"
      unitRef="usd">586000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMy0xOC0xLTEtMA_1da50d86-d6ed-406a-b3ce-751fe5dfff94"
      unitRef="usd">5000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3eb4acc4683141d68c6b2262176ea057_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNC05LTEtMS0w_c6ed9364-7823-4357-91f2-78870bff2039"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNC0xNS0xLTEtMA_9efc9ae1-f1ee-4811-8f46-6bf8894da7ee"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6a95a06eb0f94af39dece3892ff96d29_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNS03LTEtMS0w_0beabbc5-116a-47dc-b541-d6b4d723c34c"
      unitRef="usd">75000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNS0xNS0xLTEtMA_a5a77923-7649-44c9-b9ca-d29fcf2cfa8a"
      unitRef="usd">75000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ib2db14ecc4974269854d7acb2c998846_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNi0xMy0xLTEtMA_c428f93e-7cf1-43ea-85a2-3b0debeb657d"
      unitRef="usd">22000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNi0xNS0xLTEtMA_07436d6b-0bd8-411a-b65b-381da4560d61"
      unitRef="usd">22000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNi0xOC0xLTEtMTY4_804bbc71-dade-40a7-8029-d41e0386c3be"
      unitRef="usd">2000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i496e5c6bce0145338271871a4b19a534_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNy0xLTEtMS0zNQ_895e2d04-36ea-4e60-8507-1f786804e32c"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7c7076b530f6444a947bc2cada186634_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNy01LTEtMS0w_a554311b-4ad5-4292-9c44-0d3f6dad6746"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8c4d3b899b3a4c27920b9a7a1c4341f5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNy0xMS0xLTEtMA_93d38f18-bd93-4b9e-81ee-7fb3641f4c6b"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfNy0xNS0xLTEtMA_7e2feb9b-4c50-4eef-a6d1-12b47edbd114"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7c7076b530f6444a947bc2cada186634_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOC01LTEtMS0w_9307926d-2b04-4c45-8b38-a05c927af537"
      unitRef="usd">32000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOC0xNS0xLTEtMA_68a80ff3-513e-4f3d-a714-a477b4d76eac"
      unitRef="usd">32000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7c7076b530f6444a947bc2cada186634_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOS01LTEtMS0w_855d7f37-f8e9-4fa0-aad8-27faa67fe5b6"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8c4d3b899b3a4c27920b9a7a1c4341f5_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOS0xMS0xLTEtMA_fe78a69a-b6c2-4715-bbc8-b34f3578e813"
      unitRef="usd">23000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfOS0xNS0xLTEtMA_485949c5-6049-4682-a456-43d3d6e253db"
      unitRef="usd">27000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMS0xLTEtMA_bc8e4fc6-3943-4e7e-94d8-47eeb963835a"
      unitRef="shares">135000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMy0xLTEtMA_0411ad32-de84-45da-9f01-ec5520fc6f55"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i854a56aad60640659955246cba8db3d1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItNS0xLTEtMA_6eb0d2aa-2f5b-4030-8a3d-c5f381cccdfd"
      unitRef="usd">2801000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ead955e97d24ea98107e5fdafbb5933_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItNy0xLTEtMA_490fc248-a808-4855-9bef-53d57ddd2db4"
      unitRef="usd">8800000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26471b06607740b18133552b7813a289_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItOS0xLTEtMA_fb8176dd-668a-4cce-a4c3-9aa6246d6d2b"
      unitRef="usd">-42000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81dfabce71384a93b5d745045e2c2b24_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMTEtMS0xLTA_c90fc230-54ea-4cd5-a3b9-dfd05c06c190"
      unitRef="usd">-5161000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1284835d8c794866b627a0391c20a3d7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMTMtMS0xLTA_480ef4d0-d927-47ad-a409-81559def530a"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f627c3af5db4299b234650d220eee56_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMTUtMS0xLTA_a6fa5e93-edb3-4d5e-8d2b-d451b1e66f5d"
      unitRef="usd">6446000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i1f627c3af5db4299b234650d220eee56_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTItMTgtMS0xLTA_5d9c902f-46ce-4da1-bc3c-ebb7f4d96270"
      unitRef="usd">80000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie2e7ae5dc9104f20a5ce0b4a9350ec65_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMS0xLTEtMA_7b5cf981-4f61-4614-918f-15ef78157e6b"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2e7ae5dc9104f20a5ce0b4a9350ec65_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMy0xLTEtMA_b8142176-1283-412c-ad62-ba94ccbbc18a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ied656b411f5c494fa95a8a47cdf2ea4b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtNS0xLTEtMA_6b07717f-3ba5-40aa-8b71-623d3d8e2d8a"
      unitRef="usd">2722000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id87c9e74f17947c78a11adfcb138af02_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtNy0xLTEtMA_7cac4ded-d195-431c-b415-5a49cc96c411"
      unitRef="usd">8174000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib217db8b923647049bb39b949b84c79e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtOS0xLTEtMA_c54aff99-46b5-4d8a-b8ba-93374db93e23"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if16bcecb1e6d4dd9afec8d10d7899999_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMTEtMS0xLTA_7860a44d-1acb-4691-913e-9bc7cb9dc1c5"
      unitRef="usd">-5218000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16a5de19f2d549a9a4351e241b197e97_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMTMtMS0xLTA_e5b462be-01a5-4cd6-a933-f5c805924ccd"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44797d3e9c614839926a9c2f3bb5be17_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMTUtMS0xLTA_ca19b8e0-15fa-4944-a9a0-1494a83a246e"
      unitRef="usd">5687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i44797d3e9c614839926a9c2f3bb5be17_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTYtMTgtMS0xLTA_43da6386-0beb-428a-a5ea-426ebc86e93a"
      unitRef="usd">76000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i8cb4bcbff08f44cdbccc42febe3b29cb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTctNy0xLTEtMA_3fd04836-232d-4cca-a6dd-efede4b567f0"
      unitRef="usd">852000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i9b4c9dc3e1504cc5ad275c05e942afdc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTctMTMtMS0xLTA_0334269c-77e9-4960-992e-80c06dfb9938"
      unitRef="usd">31000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTctMTUtMS0xLTA_9ace39c6-f9de-437b-8594-8c10c4aee390"
      unitRef="usd">883000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTctMTgtMS0xLTA_1ec59446-5421-4a10-a3ef-65523ffb66fa"
      unitRef="usd">7000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib05a9b6900b545f2b5c4580d8153e641_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTgtOS0xLTEtMA_c0f5bec9-085b-4431-83a2-90308eda3f82"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTgtMTUtMS0xLTA_8333bc2b-24d3-4ac8-a9ef-efd45e80c8e3"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i8cb4bcbff08f44cdbccc42febe3b29cb_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTktNy0xLTEtMA_35e9c0b4-2078-4088-b730-3ab50c4e8fb7"
      unitRef="usd">226000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMTktMTUtMS0xLTA_5d75c0f9-726a-4477-88c5-f5086f8c89fa"
      unitRef="usd">226000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9b4c9dc3e1504cc5ad275c05e942afdc_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjAtMTMtMS0xLTA_e0b6bef6-4b64-4a61-b3b2-b3e608f5c11a"
      unitRef="usd">31000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjAtMTUtMS0xLTA_9b219d34-3105-41de-9234-7d1a61bc797a"
      unitRef="usd">31000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjAtMTgtMS0xLTA_d2e80422-d201-42b2-9f0d-fd1cb4c092e0"
      unitRef="usd">3000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib54bc123a8304d1b95560ab37cf81299_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjEtMS0xLTEtNDQ_3f2ecc6d-3144-4f38-a723-78d90fc1a01d"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjEtNS0xLTEtMA_928781dd-d183-4762-8b4b-0689d72ce6bc"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjEtMTEtMS0xLTA_c47d7b6f-3eb4-4fdb-951f-4f99d0ed0c44"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjEtMTUtMS0xLTA_712929a0-fc11-482f-a674-38d2664c9b2a"
      unitRef="usd">17000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjItNS0xLTEtMA_8bccec9e-6df9-48aa-acdd-acf95f9e9979"
      unitRef="usd">63000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjItMTUtMS0xLTA_a862f0e4-a107-44e8-83db-b93a5eec7995"
      unitRef="usd">63000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib54bc123a8304d1b95560ab37cf81299_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjMtMS0xLTEtMA_1024e6b3-2982-4746-bccc-5b69f22131d5"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjMtNS0xLTEtMA_9613efee-446c-4e14-b054-44dde5d173d7"
      unitRef="usd">22000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjMtMTEtMS0xLTA_b85c10d5-db30-4c05-8e2b-096ac3a531fa"
      unitRef="usd">122000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjMtMTUtMS0xLTA_887b34e2-0458-41f5-a318-924e8af552db"
      unitRef="usd">144000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if8cb7ae7931945b8804c0aa52175e948_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjQtNS0xLTEtMA_c058a074-70ae-44a4-8f9b-276d95eeafe0"
      unitRef="usd">13000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjQtMTUtMS0xLTA_b1f4d14f-93d9-4c78-beec-498b8fc06ddd"
      unitRef="usd">13000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib54bc123a8304d1b95560ab37cf81299_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjUtMS0xLTEtMA_f7a8e67c-4010-41ca-acf8-73792d457385"
      unitRef="shares">1000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjUtMTEtMS0xLTA_4b9b2203-5d5e-4f0e-9b09-3cdb50d85113"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjUtMTUtMS0xLTA_8a424df9-0dde-4100-9c20-f7719a5040b4"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMS0xLTEtMA_0d98cda8-cf9d-40a6-a23c-5cd3e3269dc0"
      unitRef="shares">135000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ff0bbddb8b14c3aaa5b546a0c93cc0d_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMy0xLTEtMA_c89e05c1-fb37-421d-a954-2eaf1ece6423"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i854a56aad60640659955246cba8db3d1_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtNS0xLTEtMA_9d63af52-a0b5-4ea8-8e92-fad68fdfc388"
      unitRef="usd">2801000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ead955e97d24ea98107e5fdafbb5933_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtNy0xLTEtMA_11dc6ee7-e76b-4d66-98d5-1ba08de85620"
      unitRef="usd">8800000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26471b06607740b18133552b7813a289_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtOS0xLTEtMA_f3ea3331-cbdb-4aa7-9b0a-1bfef5f44e3d"
      unitRef="usd">-42000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81dfabce71384a93b5d745045e2c2b24_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMTEtMS0xLTA_1e3f594b-77d8-43d3-9990-b3e4d8f9c2c2"
      unitRef="usd">-5161000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1284835d8c794866b627a0391c20a3d7_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMTMtMS0xLTA_f08f1013-741f-412e-aef4-a13bf42a88f4"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f627c3af5db4299b234650d220eee56_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMTUtMS0xLTA_9f65edc7-4906-463d-9ae9-a5598ffb25f1"
      unitRef="usd">6446000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i1f627c3af5db4299b234650d220eee56_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8yNS9mcmFnOjA3YjU5ODM5YzI1NTQzNThiY2I3MDBiYTEzMmE0ZmMxL3RhYmxlOjE1NTE5MWJjN2RlNzQ3ODE5OWFlOWVjODFiOTFkNGFhL3RhYmxlcmFuZ2U6MTU1MTkxYmM3ZGU3NDc4MTk5YWU5ZWM4MWI5MWQ0YWFfMjYtMTgtMS0xLTA_5e8dfc81-026e-47f3-96f6-c26b4483645f"
      unitRef="usd">80000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NatureOfOperations
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zMS9mcmFnOmJkZTUwZjVmNTBiYTQ1Zjc4ZmNkYTRjMmJlMjc2NmQ1L3RleHRyZWdpb246YmRlNTBmNWY1MGJhNDVmNzhmY2RhNGMyYmUyNzY2ZDVfMTcwMg_1b36d651-e371-444d-aa36-6ce57311350d">DESCRIPTION OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDMzNg_2199a326-0c8a-46d2-b018-7630b0b88b7a">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#x201c;COVID-19&#x201d;) continues to impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three and nine months ended September&#160;30, 2021 may not be indicative of the results that may be expected for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDMzOQ_d468e629-1795-4706-ba8e-654ddafd81e4">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDMzMw_6976fb9d-2721-43e6-924f-b4981910a8fa">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDM0Mg_ce588c24-1b9a-47c7-ba9e-a4a04afdc8cb">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNC9mcmFnOjE0MjA1ZDBjMzc4MTRmZGJhZWU3MjJjNmEwYjdiODAzL3RleHRyZWdpb246MTQyMDVkMGMzNzgxNGZkYmFlZTcyMmM2YTBiN2I4MDNfNDM1Mg_d55da54e-9f05-4e51-8243-391e72551562">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RleHRyZWdpb246MTM5OTg5ZjVkNzQyNDZlN2I1ZjRiOThkY2U3N2E4YjJfODgx_8fda14fb-b74c-491a-bc08-4e2881e80732">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program.  See Note 9 for further details.  The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first three quarters of 2021 did not equal the total for the nine months ended September 30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of the ASRs.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RleHRyZWdpb246MTM5OTg5ZjVkNzQyNDZlN2I1ZjRiOThkY2U3N2E4YjJfODcz_acb2c679-f950-4bd9-9832-20b0d1625378">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfNy0xLTEtMS0w_b7244234-2ab1-49b4-b667-09528b61a1e9"
      unitRef="usd">505000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfNy0zLTEtMS0w_d0e39749-ee47-4d95-86f0-d789c6281a85"
      unitRef="usd">568000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfNy01LTEtMS0w_adbd9bd0-2464-4be0-8dbf-3d2ac7eae949"
      unitRef="usd">1605000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfNy03LTEtMS0w_5a75b1b5-54db-4569-9668-64e2ee588e86"
      unitRef="usd">852000000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOC0xLTEtMS0w_4d9a7aba-dc39-4198-9ac4-81db188841ad"
      unitRef="usd">2000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOC0zLTEtMS0w_011a3913-347d-4fad-a9d4-8be3448a80eb"
      unitRef="usd">2000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOC01LTEtMS0w_19af6867-2fae-4e54-8124-4475cfcaffea"
      unitRef="usd">6000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOC03LTEtMS0w_63a2aba2-d666-42d6-a2f5-91621c7770a7"
      unitRef="usd">3000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOS0xLTEtMS0w_cd95f6ce-9ef9-4377-bda4-660ecd6dc0a9"
      unitRef="usd">503000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOS0zLTEtMS0w_19daa1c3-951d-4249-bc9f-ea2dcbda8b5c"
      unitRef="usd">566000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOS01LTEtMS0w_c921dbae-2d44-4624-9bf3-260520da5dd8"
      unitRef="usd">1599000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfOS03LTEtMS0w_01030027-9ee4-4723-9a08-4455e4e07b8b"
      unitRef="usd">849000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTEtMS0xLTEtMA_b2f3161d-9f21-41c8-8dd3-0abf0eb00ab9"
      unitRef="shares">123000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTEtMy0xLTEtMA_fd15d5ad-d272-46bc-ab9a-aaf5578fee1e"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTEtNS0xLTEtMA_5d08dc81-58c6-45dc-9772-7cdbdfef14d0"
      unitRef="shares">127000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTEtNy0xLTEtMA_c697f6a5-e0dd-45a1-872b-b3d62bd74c69"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTMtMS0xLTEtMA_1be65da8-ac5b-419b-9cf3-a3f824480f81"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTMtMy0xLTEtMA_9aa90059-23bb-4ddc-a1a4-f29a8e2f4ae9"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTMtNS0xLTEtMA_cc7df161-9a3b-49bf-8884-2319f01b2cd7"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTMtNy0xLTEtMA_30f80c51-922f-45a3-aab6-f47aa6216255"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTQtMS0xLTEtMA_6db951db-f7d0-477d-ac49-0d12bd87d4b1"
      unitRef="shares">125000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTQtMy0xLTEtMA_931f7e2e-9deb-4741-86cd-3d3d6c8f5ad5"
      unitRef="shares">137000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTQtNS0xLTEtMA_5505b0f7-fb2a-4a9e-89df-121e14865a65"
      unitRef="shares">129000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTQtNy0xLTEtMA_c3d97b24-605f-41fa-aaa9-e74527e58e90"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTctMS0xLTEtMA_f9bf49f4-6879-4909-b377-eceff3ecbe2c"
      unitRef="usdPerShare">4.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTctMy0xLTEtMA_e6375ddc-d352-456f-a32b-dccc183be50a"
      unitRef="usdPerShare">4.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTctNS0xLTEtMA_c1b9a385-e2c2-41eb-9b10-faa1858e448d"
      unitRef="usdPerShare">12.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMTctNy0xLTEtMA_d24b1cec-ca69-405e-9c77-158b9de2e9c5"
      unitRef="usdPerShare">6.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMjItMS0xLTEtMA_0d6896e9-4b4c-4496-8565-c4dc90f5b212"
      unitRef="usdPerShare">4.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMjItMy0xLTEtMA_4f2ace29-f8b5-478a-be32-31fe87882795"
      unitRef="usdPerShare">4.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMjItNS0xLTEtMA_981ffd2a-ca14-4f22-8b65-bf07379ebd73"
      unitRef="usdPerShare">12.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOjAwOTZhNjMzOGEwMjRkYTY5ZDU2MDBhOWNkMzE0MWI0L3RhYmxlcmFuZ2U6MDA5NmE2MzM4YTAyNGRhNjlkNTYwMGE5Y2QzMTQxYjRfMjItNy0xLTEtMA_c24d52b4-93b2-48dc-9224-fb0e34e1cab8"
      unitRef="usdPerShare">6.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RleHRyZWdpb246MTM5OTg5ZjVkNzQyNDZlN2I1ZjRiOThkY2U3N2E4YjJfODcx_d4ef4108-4a3f-4226-9d8c-ea6b064eac00">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOmY5ZDM2NzNiNGJlOTQ4YzU4YmY4OGM0NWIzZjdiODNhL3RhYmxlcmFuZ2U6ZjlkMzY3M2I0YmU5NDhjNThiZjg4YzQ1YjNmN2I4M2FfMi0xLTEtMS0w_4076991c-f703-492a-a2a4-8690d5020691"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOmY5ZDM2NzNiNGJlOTQ4YzU4YmY4OGM0NWIzZjdiODNhL3RhYmxlcmFuZ2U6ZjlkMzY3M2I0YmU5NDhjNThiZjg4YzQ1YjNmN2I4M2FfMi0zLTEtMS0w_af0f0b1b-7518-4775-8a8d-1e89137f30aa"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOmY5ZDM2NzNiNGJlOTQ4YzU4YmY4OGM0NWIzZjdiODNhL3RhYmxlcmFuZ2U6ZjlkMzY3M2I0YmU5NDhjNThiZjg4YzQ1YjNmN2I4M2FfMi01LTEtMS0w_579df7f1-9c45-4d14-8e95-919151840d04"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RhYmxlOmY5ZDM2NzNiNGJlOTQ4YzU4YmY4OGM0NWIzZjdiODNhL3RhYmxlcmFuZ2U6ZjlkMzY3M2I0YmU5NDhjNThiZjg4YzQ1YjNmN2I4M2FfMi03LTEtMS0w_6e47869a-09a3-47e5-9ebb-2cbf820ea518"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <dgx:AcceleratedShareRepurchasesInitialPricePaid
      contextRef="i7a3f89fd967647879e6f70cc4eced07a_D20210401-20210430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8zNy9mcmFnOjEzOTk4OWY1ZDc0MjQ2ZTdiNWY0Yjk4ZGNlNzdhOGIyL3RleHRyZWdpb246MTM5OTg5ZjVkNzQyNDZlN2I1ZjRiOThkY2U3N2E4YjJfMzc2_add968ec-a6e8-45dd-aabe-2bec1338bc7e"
      unitRef="usd">1500000000</dgx:AcceleratedShareRepurchasesInitialPricePaid>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfMTYxNg_8e02efae-9a65-4f6e-aad4-10bbb7430ae5">BUSINESS ACQUISITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $54&#160;million of customer-related intangible assets and $171&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i5cc6b1efe84f4f65907f66036143af31_D20210601-20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfMjYx_895f715c-cbfd-43a5-8d97-d75580f8b7f8"
      unitRef="usd">225000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i666d9c35a6194943a43fbcf1f9c9b1df_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfNDU1_acf2a0de-d460-41d2-8939-8bbaff29d884"
      unitRef="usd">54000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i53b9c62c8412401893a2366a618ab917_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfNTAw_705ac188-c9c8-41da-a427-e6966ad2e8c0"
      unitRef="usd">171000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:Goodwill
      contextRef="i53b9c62c8412401893a2366a618ab917_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfNTAw_d09771df-c035-430f-94fd-d74b84ab9a8b"
      unitRef="usd">171000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iafd5f573146f490584b2d02d1a275200_D20210601-20210601"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80MC9mcmFnOjAyYzAyM2Y4NThkYTRlMTViYjc1MmI4NmZlMzcxOWJjL3RleHRyZWdpb246MDJjMDIzZjg1OGRhNGUxNWJiNzUyYjg2ZmUzNzE5YmNfNTk2_7d59ace5-9a29-4ec0-8ba6-14a25cdbfe49">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfMTMyMA_5c159baa-253b-4f12-bd20-cd711d228186">DISPOSITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; ("Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the nine months ended September 30, 2021, the Company recorded a $314&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the nine months ended September 30, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Solutions' clients, providing a range of lab testing capabilities to augment Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Solutions' core offerings and extend its industry leading suite of services.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i246ee08978dd4f9281e49cde4052adb5_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfNjE_d45f96b1-535d-4ddb-8dc8-bbff0c77336d"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross
      contextRef="i1f8b2bbcf7b442d5b60c4726c660f0b2_D20210401-20210401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfMjQ3_feb1d3a4-9da7-4f6d-9f44-880f7709492b"
      unitRef="usd">760000000</dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i62dc4fadac874b26b838080327833f3a_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfNTUz_1c4914e6-6e21-4e8c-980b-9209dd737025"
      unitRef="usd">-314000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id467bea9a9a042bd95d6970a12d3be15_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfNzI2_16da7478-8f61-4bcc-b04b-548457210858"
      unitRef="usd">20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfOTA2_4bb0b0c0-3f04-4a5b-a043-718ed471e78f"
      unitRef="usd">55000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfOTY2_9b35e8cd-d986-4caf-a7bc-bc0fc8152643"
      unitRef="usd">127000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80My9mcmFnOjFjMTJhZGIzNDA5ZDQxNjY4ZWQxOTBlMGFkNTJmYzI3L3RleHRyZWdpb246MWMxMmFkYjM0MDlkNDE2NjhlZDE5MGUwYWQ1MmZjMjdfMTAyMA_eb5bae41-3efb-4f50-98f3-1e151fadc362"
      unitRef="usd">72000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDgxOQ_03623b8c-3bd3-48e2-92f7-5e72e551ea7b">FAIR VALUE MEASUREMENTS  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed investment options that are classified as trading securities.  These trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  During the three months ended September 30, 2021, certain of the Company's equity investments became publicly-traded and, based on the readily determinable fair values, the Company recognized gains of $42&#160;million in other income, net in the Company's consolidated statement of operations.  Such equity investments are now classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of September&#160;30, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the nine months ended September&#160;30, 2021, the Company recorded an $8&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of September&#160;30, 2021 and December&#160;31, 2020, the fair value of the Company&#x2019;s debt was estimated at $4.5&#160;billion and $4.6 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDgyMw_077fcb10-a5bc-4bfa-a197-94f3987364ec">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:TradingSecurities
      contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNi0xLTEtMS0w_3bbb8cf6-40e3-4b95-848a-8052a6584b7a"
      unitRef="usd">75000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNi0zLTEtMS0w_7f396c89-068b-4959-96ad-f646fe0209d5"
      unitRef="usd">75000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNi01LTEtMS0w_6b479aa6-4eb6-4370-9fb1-f6125fc3646a"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNi03LTEtMS0w_f1addbe2-239f-4049-b262-c5d03e14a8a5"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNy0xLTEtMS0w_95f43da5-65d6-4103-b166-50db51202637"
      unitRef="usd">54000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNy0zLTEtMS0w_75cf5310-0ed5-4573-852c-ab223780ab6b"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNy01LTEtMS0w_d0a82985-ca27-49db-a536-f7a5db41158a"
      unitRef="usd">54000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfNy03LTEtMS0w_2ea503be-2467-437d-bcf1-0b7b1be053db"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOC0xLTEtMS0w_42755918-11cb-488e-a100-ee6501ac5373"
      unitRef="usd">49000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOC0zLTEtMS0w_e79985ea-ee4d-4f31-b8e2-84460fa79db2"
      unitRef="usd">49000000</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOC01LTEtMS0w_8b22f759-1960-4d98-9d23-78e369711ddd"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities
      contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOC03LTEtMS0w_c6d142fd-ffcf-47f9-8dce-ab1dfde607ad"
      unitRef="usd">0</dgx:EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOS0xLTEtMS0w_c13cc623-556b-41e7-9a44-d2ff5e2e85ca"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOS0zLTEtMS0w_4fa19bc5-5f06-4c50-a917-c1c10b2d1329"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOS01LTEtMS0w_9c36ae38-af72-48b3-b52e-8281a8647536"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfOS03LTEtMS0w_579794d0-efb2-47a0-8d3f-4dfdefcf9a54"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTItMS0xLTEtMA_3e2943ff-013b-4384-962d-0ec10531bb76"
      unitRef="usd">179000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTItMy0xLTEtMA_554ee431-4bf4-4783-8e46-799a7fcbf9ec"
      unitRef="usd">124000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTItNS0xLTEtMA_3a969568-0a95-446a-9ad3-0a2d9b8703a7"
      unitRef="usd">54000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTItNy0xLTEtMA_e82b1a0f-2cf9-478e-8a8d-b63235d0ee09"
      unitRef="usd">1000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTUtMS0xLTEtMA_3b8f640b-a11d-446d-977d-703402ade9b4"
      unitRef="usd">139000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTUtMy0xLTEtMA_e39f6ab7-bc8d-4c34-8d15-37ebe82d89c4"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i489cbc2ec2f54a06b5dcd00a3e10b195_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTUtNS0xLTEtMA_bb1d3c6f-9335-47a2-9816-8db9ddaaf231"
      unitRef="usd">139000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMTUtNy0xLTEtMA_d295a7c1-150e-4304-aa8f-6f133bd4facc"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMjItMS0xLTEtMA_4c83f1fe-55d4-4b25-b381-a6d43df228ae"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i86982bd9508a4400a05b7e7954cd17e4_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMjItMy0xLTEtMA_fb2a4e31-405e-4b74-b5d0-6ec06b045700"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i017ac5c7931e40dbb2e98f3e7c7b3333_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjNjMmVhNTk5MGRjMDQ5Y2JiNzgzYmRkZjY3OWQxZThmL3RhYmxlcmFuZ2U6M2MyZWE1OTkwZGMwNDljYmI3ODNiZGRmNjc5ZDFlOGZfMjItNy0xLTEtMA_3d163950-b1c5-42f0-9510-3b63a8fe9d2d"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:TradingSecurities
      contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMy0xLTEtMS0w_25fa838e-ad9c-4961-aa76-695bef7399d3"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i6717324b738441d5b2882980e7f96534_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMy0zLTEtMS0w_67b0e206-0bd2-47fd-8402-d95c09b7322f"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMy01LTEtMS0w_1d8850ea-c19a-4add-91e6-2640c17e329e"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMy03LTEtMS0w_cfc3f5d6-4338-436f-b600-4e585734ef59"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNC0xLTEtMS0w_ddf5bd1a-49ac-444a-ae65-45c2a5d33fef"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i6717324b738441d5b2882980e7f96534_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNC0zLTEtMS0w_90dea4a3-e9c9-4260-939e-838c9ebc6343"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNC01LTEtMS0w_d0d2ab83-6d7c-4958-b157-08d660a8decc"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNC03LTEtMS0w_03dfc24c-fb67-4945-a714-f2d15d925147"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNS0xLTEtMS0w_3d5624be-0c91-4b93-81c6-49a4c97ae75b"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6717324b738441d5b2882980e7f96534_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNS0zLTEtMS0w_fe688ddc-0414-4ca8-ba34-e15c53b609d6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNS01LTEtMS0w_4fa8d23d-7e5b-48b1-9831-644ae091810b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfNS03LTEtMS0w_70e7253e-858e-4786-bbeb-95ad9da588e5"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTAtMS0xLTEtMA_bea919a2-992b-47d6-8e87-709b8a8bd8cf"
      unitRef="usd">129000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6717324b738441d5b2882980e7f96534_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTAtMy0xLTEtMA_10915984-38f1-470b-b43d-296c9e530d13"
      unitRef="usd">67000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTAtNS0xLTEtMA_e97c58e9-e5d5-4708-a6a3-8a54e5f5d226"
      unitRef="usd">50000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTAtNy0xLTEtMA_2723b50a-382a-4b7c-9780-3b249a6229c8"
      unitRef="usd">12000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTMtMS0xLTEtMA_1ce96c34-28aa-41ac-8b45-d7943f1eb0f7"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i6717324b738441d5b2882980e7f96534_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTMtMy0xLTEtMA_471bdae9-785a-4ee0-bd5d-5850e2e22469"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i52ce18f6e3e3443e94f98d221b7e35f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTMtNS0xLTEtMA_67ddf948-6c2a-4d04-bdfe-a1f38c10847f"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMTMtNy0xLTEtMA_b14d8f3b-3199-42c3-8801-8aa1174183fe"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i19c606c4a927487086b61b79e8c8374b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMjEtMS0xLTEtMA_2c46c3f4-4859-4d8a-af50-cb2725675fbb"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i6717324b738441d5b2882980e7f96534_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMjEtMy0xLTEtMA_49fb57a3-9cdc-414b-a307-e1ca5ab30456"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i7f6dd2f1a61944b6948e0fcae9635ff4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RhYmxlOjBiYjQ0YzA4YmRhOTQ4OTA5ODY1M2FmZGM5NTUzM2ZkL3RhYmxlcmFuZ2U6MGJiNDRjMDhiZGE5NDg5MDk4NjUzYWZkYzk1NTMzZmRfMjEtNy0xLTEtMA_64ecb53b-fcd2-477e-8049-ac639d72aa54"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDk0NzgwMjMzNTUxMA_07e4efaf-ef18-40c6-9220-c00fd4a3d76d"
      unitRef="usd">42000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i36fc1b4d87cc4ef59463dc14ae3e0809_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfMjk0OQ_9391b487-0529-46ce-9df6-fa5dfa907156"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="i259a5f13f5bc45e7813aca65d4056271_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfMzcwMw_d29a31f1-08d9-49de-9c03-e01eb8ad050a"
      unitRef="usd">8000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDQ0OQ_d6047920-160e-4606-a9b6-d95f8d0eddaf"
      unitRef="usd">4500000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80Ni9mcmFnOmM4YjI4MmNhOTQyOTQ3ODE4ODdlYWJkMmEwOTUwYTVlL3RleHRyZWdpb246YzhiMjgyY2E5NDI5NDc4MTg4N2VhYmQyYTA5NTBhNWVfNDQ1Ng_838a904c-ed6d-4e24-9a44-d9d632c498ab"
      unitRef="usd">4600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfMTIxOQ_cfe60267-45b4-41f1-b272-0f825f302af3">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in goodwill for the nine months ended September&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Principally all of the Company&#x2019;s goodwill as of September&#160;30, 2021 and December&#160;31, 2020 was associated with its DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, goodwill acquired was principally associated with the acquisition of the outreach laboratory services businesses of Mercy Health and adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy; Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining 56% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets as of September&#160;30, 2021 and December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfMTIyOQ_83f87be7-77bf-46a2-bbee-6dc5d798f737">The changes in goodwill for the nine months ended September&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMS0xLTEtMS0w_811ac4b0-7564-4114-a544-eea29d652569"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i44797d3e9c614839926a9c2f3bb5be17_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMS0zLTEtMS0w_25fd348f-c34b-4056-91a5-c4a4f35594a3"
      unitRef="usd">6619000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMi0xLTEtMS0w_036ed037-8456-4ed4-b9bd-7f7b18f314f9"
      unitRef="usd">188000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i285e961758554fd5ac030b44fe9867ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMi0zLTEtMS0w_6d102805-8ff3-4fae-8e5b-ae38db09c34e"
      unitRef="usd">247000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMy0xLTEtMS0w_7e4cfada-8143-4f4b-96e5-93b9f8dea851"
      unitRef="usd">-4000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i285e961758554fd5ac030b44fe9867ff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfMy0zLTEtMS0w_d3a53b2e-937d-435f-bf2d-3d01cebc7a62"
      unitRef="usd">7000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfNy0xLTEtMS0w_362729a7-2b5b-46f5-919e-4c03f525c048"
      unitRef="usd">7057000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjhmODVlNjU0ZjhjODQyOWE5YTk0Y2I5ODQwODkzNGIzL3RhYmxlcmFuZ2U6OGY4NWU2NTRmOGM4NDI5YTlhOTRjYjk4NDA4OTM0YjNfNy0zLTEtMS0w_fe44a621-11cd-4e8f-8bf4-63b292fee78a"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="id248109e93494be5ab0649ef082cb608_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfNzE5_95dcb249-4755-4a24-a1d2-ec1bcb93dbc0"
      unitRef="number">0.56</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfMTI0MA_2d9c10ac-d0d5-4fb3-a0c6-d4c41f7139d2">Intangible assets as of September&#160;30, 2021 and December&#160;31, 2020 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibba5357fd8bf4d2f8cb494c4ee189328_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy0xLTEtMS0w_ca131be3-06a7-48cf-9924-40483e194b57">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if8117f4bb2f54d20ae84cf958f833fc9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy0zLTEtMS0w_ff3194ef-0b1d-4cb2-93bf-fd59eadfc285"
      unitRef="usd">1541000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if8117f4bb2f54d20ae84cf958f833fc9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy01LTEtMS0w_bb915713-66ca-4a75-b66c-091becf9b79f"
      unitRef="usd">704000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if8117f4bb2f54d20ae84cf958f833fc9_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy03LTEtMS0w_dfb52fcb-a4f0-485c-aaec-9828259cfd00"
      unitRef="usd">837000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3a5dcd0ab13e41d480cf6fd05837a2dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy05LTEtMS0w_1f3538d6-0c28-4a9f-9375-23de0c7844d1"
      unitRef="usd">1479000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3a5dcd0ab13e41d480cf6fd05837a2dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy0xMS0xLTEtMA_1e118b9a-d2eb-4d84-8a2b-6446a8cd1451"
      unitRef="usd">638000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3a5dcd0ab13e41d480cf6fd05837a2dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMy0xMy0xLTEtMA_10ccb0b2-2f7a-481a-a48d-9e844533591c"
      unitRef="usd">841000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8c1dfb7b00dd40caa23f7b20aa962872_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC0xLTEtMS0w_3856ab7b-a908-45c2-bc14-2a5107399fa8">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3b6c581188914f048902746e4d6c62a5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC0zLTEtMS0w_7bed5325-ef02-4490-bb88-4a3b2f718f65"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3b6c581188914f048902746e4d6c62a5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC01LTEtMS0w_f71ffbcb-f936-4917-b93b-8ea54b408d1d"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3b6c581188914f048902746e4d6c62a5_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC03LTEtMS0w_2e428f4a-fb50-48d0-a328-c5755721a715"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i53fde28f195345cdaa042f2d8f3d61df_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC05LTEtMS0w_474929c8-700a-49e5-92c5-722421f098b9"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i53fde28f195345cdaa042f2d8f3d61df_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC0xMS0xLTEtMA_c3085b8f-e69e-4937-a154-fb7537d01eb9"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i53fde28f195345cdaa042f2d8f3d61df_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNC0xMy0xLTEtMA_86267090-edec-4658-96b3-1f8b490b84cd"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8125b809d77340e4a919837e287c04be_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS0xLTEtMS0w_255d2987-5807-45c7-8771-c51c5b74a8e6">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i1aafd4a99f5b40e9855fa6aef485af35_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS0zLTEtMS0w_d3df4439-0128-4fe9-a915-fdbb50e47a73"
      unitRef="usd">142000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1aafd4a99f5b40e9855fa6aef485af35_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS01LTEtMS0w_fbec6dc9-b4f1-4ede-ac84-67a5b8fb9182"
      unitRef="usd">72000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1aafd4a99f5b40e9855fa6aef485af35_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS03LTEtMS0w_ee9721f5-fa6f-4ece-940b-f488c5ef5fe8"
      unitRef="usd">70000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i50c50c6fa9d5420593a7df593fbfd4b0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS05LTEtMS0w_c151a0e7-729b-475a-b68c-3452615fe6da"
      unitRef="usd">141000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i50c50c6fa9d5420593a7df593fbfd4b0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS0xMS0xLTEtMA_f08adfd6-a634-4475-b1e4-ceba95accea0"
      unitRef="usd">65000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i50c50c6fa9d5420593a7df593fbfd4b0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNS0xMy0xLTEtMA_1e83c0c3-9e4b-4022-a766-4d6471b8e4bd"
      unitRef="usd">76000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id699393e5c1e405cb9e349542a08565d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi0xLTEtMS0w_fbf8c502-9883-4a78-84e0-e9835560ab51">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i437864783a7b4db19f1011b84e670b30_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi0zLTEtMS0w_a586eaca-a1ea-4055-b2ff-37ce967f5102"
      unitRef="usd">108000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i437864783a7b4db19f1011b84e670b30_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi01LTEtMS0w_82761b13-7aa4-4f73-807e-ea3e38292863"
      unitRef="usd">100000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i437864783a7b4db19f1011b84e670b30_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi03LTEtMS0w_a5c40e3b-3e4f-45b2-8127-26e0b6605628"
      unitRef="usd">8000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i75d51148780249248ddb2e605bbe8abd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi05LTEtMS0w_ebb962f5-1c46-4344-8bcb-261c54be9cc7"
      unitRef="usd">108000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i75d51148780249248ddb2e605bbe8abd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi0xMS0xLTEtMA_24b6c308-9efb-4b74-9b8e-72687e9a7a7d"
      unitRef="usd">95000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i75d51148780249248ddb2e605bbe8abd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNi0xMy0xLTEtMA_f6ee57f0-85cd-47e4-a697-dd0d805bb4b3"
      unitRef="usd">13000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i748efa01b96341229310868eca941647_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy0xLTEtMS0w_738f07ad-be0c-4b8b-ad3d-c80a22c9c59e">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibb316df1367442cc90e4c2c5326acd80_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy0zLTEtMS0w_8c015134-4c05-4869-9a59-101a1e8fda9d"
      unitRef="usd">1794000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibb316df1367442cc90e4c2c5326acd80_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy01LTEtMS0w_15c7b5bf-46d5-4f04-87f2-40d4f2a2265d"
      unitRef="usd">878000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibb316df1367442cc90e4c2c5326acd80_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy03LTEtMS0w_39539d38-fb9c-4114-9ce5-6d8381ce7a9c"
      unitRef="usd">916000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i723c339a06ce4cf38176085ba130077e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy05LTEtMS0w_c209086a-110d-4a7e-82db-b08daaeba292"
      unitRef="usd">1731000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i723c339a06ce4cf38176085ba130077e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy0xMS0xLTEtMA_335c2ce8-dada-4d0f-aa86-b1212501fcea"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i723c339a06ce4cf38176085ba130077e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfNy0xMy0xLTEtMA_7fccef38-d07f-46ba-bce9-51366da0df0e"
      unitRef="usd">931000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib3d6d052e08a40f3aeb61f740e03dac2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTAtMy0xLTEtMA_622a5e7a-338d-429d-8fce-2b90e532f6cd"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib3d6d052e08a40f3aeb61f740e03dac2_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTAtNy0xLTEtMA_24b28335-5ec8-4152-8749-a9a31a52e81a"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i944e0f14985441db988806dbbf0e1725_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTAtOS0xLTEtMA_5f5484cd-5f06-46ed-9fcc-d97bd2000608"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i944e0f14985441db988806dbbf0e1725_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTAtMTMtMS0xLTA_0c5dc811-55c0-4f77-ae56-0061e03551d1"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ifa71f4cff13142c783bc54345c97e1b7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTItMy0xLTEtMA_2b2da0c3-632b-49b2-a5ee-bbd53e71972e"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ifa71f4cff13142c783bc54345c97e1b7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTItNy0xLTEtMA_1a6edada-1247-42bb-9796-2cccc180d4c4"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i386a526647e54047ad6392d22e224a8c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTItOS0xLTEtMA_5a058238-f2f8-4b22-b2cb-e167fb56ca70"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i386a526647e54047ad6392d22e224a8c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTItMTMtMS0xLTA_96f59563-2beb-416c-bf7d-d2f92c812473"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtMy0xLTEtMA_029619e2-ec24-4a6c-9ad2-ac61419a47e8"
      unitRef="usd">2030000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtNS0xLTEtMA_d1723379-9301-461e-84e1-7a206fea62a2"
      unitRef="usd">878000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtNy0xLTEtMA_e585a7ad-0310-4534-abd0-ab009d6798fd"
      unitRef="usd">1152000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtOS0xLTEtMA_41712cdd-840f-4ff5-9205-4d9d730d5a6e"
      unitRef="usd">1967000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtMTEtMS0xLTA_ebae6ec1-0d6f-4354-b3f7-ff2c08a79c48"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOmY2ZDQyMmIyNGRkNTRhNDQ5ZDlkYTIyZjBkMjYxMDQxL3RhYmxlcmFuZ2U6ZjZkNDIyYjI0ZGQ1NGE0NDlkOWRhMjJmMGQyNjEwNDFfMTMtMTMtMS0xLTA_0876a9d6-edff-4800-8670-e33c9b7424e2"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RleHRyZWdpb246YzQ5OTM1ZWQwNDBmNDA0ZjkzYWUxNGNlOWVmNGU2OTRfMTIzNw_699e59b0-38a9-4f69-b5fe-411df180bf84">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2021 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfMS0xLTEtMS0w_a63b90f8-bef6-4f4a-ae20-a7d55b6c69c7"
      unitRef="usd">26000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfMi0xLTEtMS0w_e4bd7d81-c444-44c4-8ebe-5298760c92b7"
      unitRef="usd">102000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfMy0xLTEtMS0w_9bb80ab8-6f5e-4a1d-bac4-6af0e6664f6d"
      unitRef="usd">100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfNC0xLTEtMS0w_5ca1e324-d45a-4fe4-9e7e-616bde5c6554"
      unitRef="usd">97000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfNS0xLTEtMS0w_729ac404-5919-4aca-aac0-51e229e0244a"
      unitRef="usd">96000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfNi0xLTEtMS0w_9699ac8f-2aea-4faa-af5f-440f9dfe9550"
      unitRef="usd">90000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfNy0xLTEtMS0w_33a2e5b0-9f25-418b-bf7b-c5f73f720ed0"
      unitRef="usd">405000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF80OS9mcmFnOmM0OTkzNWVkMDQwZjQwNGY5M2FlMTRjZTllZjRlNjk0L3RhYmxlOjQ0NGNjN2ZjODhkMTRlMWI4NmYyMmZjZDMwMDM3NWI1L3RhYmxlcmFuZ2U6NDQ0Y2M3ZmM4OGQxNGUxYjg2ZjIyZmNkMzAwMzc1YjVfOC0xLTEtMS0w_db360af6-5d55-47f2-b5c3-ba8752cfa343"
      unitRef="usd">916000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RleHRyZWdpb246NWUzYjM4NjY2NjU0NDUwMWE0MjlmY2E5ZDc4YWE1NmZfMzgzNQ_03a9908d-f5c5-4b51-aa55-d842e4fefa5c">FINANCIAL INSTRUMENTS &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Fair Value Hedges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of September&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both September&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and nine months ended September&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RleHRyZWdpb246NWUzYjM4NjY2NjU0NDUwMWE0MjlmY2E5ZDc4YWE1NmZfMzgyMA_e99b5eb0-c02b-41ed-94b3-02ce8beedb2f">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RleHRyZWdpb246NWUzYjM4NjY2NjU0NDUwMWE0MjlmY2E5ZDc4YWE1NmZfMzgyOA_12e656de-22e6-4c4c-97fd-bbff5ef892ce">As of September&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both September&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;</dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ic7399b9274664c749e91f89957ec71bc_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOmY4OGYxOWNkZjdjZTRkZmViMDU3M2U5OGQxYzFhYzNiL3RhYmxlcmFuZ2U6Zjg4ZjE5Y2RmN2NlNGRmZWIwNTczZTk4ZDFjMWFjM2JfMi01LTEtMS0w_e5df0bfd-f3eb-453b-8ebc-68fca1451645"
      unitRef="usd">41000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i34cc7bf29a7c44409c7e67bcd16c4a18_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOmY4OGYxOWNkZjdjZTRkZmViMDU3M2U5OGQxYzFhYzNiL3RhYmxlcmFuZ2U6Zjg4ZjE5Y2RmN2NlNGRmZWIwNTczZTk4ZDFjMWFjM2JfMi05LTEtMS0w_1017951e-06a0-4c42-862b-eb3d950733a5"
      unitRef="usd">51000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RleHRyZWdpb246NWUzYjM4NjY2NjU0NDUwMWE0MjlmY2E5ZDc4YWE1NmZfMzgyNA_c2765516-f6a1-4c78-af76-8dabf5df3c9f">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and nine months ended September&#160;30, 2021 and 2020:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfMy0zLTEtMS0w_a4a41410-d761-4624-b2e5-738e9e3d1eb6"
      unitRef="usd">40000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfMy01LTEtMS0w_3e9c486a-b434-4919-92b7-fd25131bc2a1"
      unitRef="usd">77000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfMy03LTEtMS0w_164375a8-30c1-425e-bab3-fef0b62aeb50"
      unitRef="usd">366000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfMy05LTEtMS0w_ae973255-2f1a-4eff-bb3e-ee07e1240c52"
      unitRef="usd">74000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="ia59678286edb47a683efe4ca31c9d152_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNi0zLTEtMS0w_90d81b52-b67c-4305-9911-d53cbeb27281"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="ib2cfcef6577746beaf2fc395bc84e9f4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNi01LTEtMS0w_6220f490-c361-4817-ab58-a9bb7853cbb6"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i091b01bda5c84720a769c37a5b845045_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNi03LTEtMS0w_ed8e8916-ce23-4cd2-86c5-012f6444248c"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="iec15589bf02e47779ded2be278cfe21a_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNi05LTEtMS0w_eda26ffa-9e38-4c6b-863e-c74107311c4b"
      unitRef="usd">-68000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i6c9fb4948c0446498ff2b9b1edc0349b_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNy0zLTEtMS0w_d0f1244e-de2d-4df8-af11-9417294a9510"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i93cec6591e0847ad8a42544b505883d4_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNy01LTEtMS0w_d0a46337-c858-4578-8d1a-3c477d57f553"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia65a33d49c0b41508f0b15bc06443452_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNy03LTEtMS0w_b2e5f060-6795-4648-9e7c-a544ab120f0d"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib938d748462e4324a82c390775ef95f0_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81Mi9mcmFnOjVlM2IzODY2NjY1NDQ1MDFhNDI5ZmNhOWQ3OGFhNTZmL3RhYmxlOjg1ZWI4ODkwMmVkZDQ2NmRhMmNiYTUwMzJjYTg3MGJjL3RhYmxlcmFuZ2U6ODVlYjg4OTAyZWRkNDY2ZGEyY2JhNTAzMmNhODcwYmNfNy05LTEtMS0w_581c9ab5-827e-4c9b-890c-137accc42203"
      unitRef="usd">68000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNTE5OQ_f6b92f57-a138-4d32-9718-b7c6d85e0e87">STOCKHOLDERS&#x2019; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Changes in Accumulated Other Comprehensive Loss by Component&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the nine months ended September&#160;30, 2021, $20&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income, net.  See Note 5 for further details. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During each of the first three quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of September&#160;30, 2021, $1.3 billion remained available under the Company&#x2019;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, the Company repurchased 12.5&#160;million shares of its common stock for a value of $1.6&#160;billion, including 9.1&#160;million shares repurchased under ASRs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The repurchases under the ASRs were initiated in April 2021 with the Company's entry into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract. For the nine months ended September&#160;30, 2021, the Company paid $1.5&#160;billion to the financial institutions and received 9.1&#160;million shares of its common stock, at an initial price of $132.27 per share for a value of $1.2&#160;billion, which represents 80% of the total value of shares to be repurchased under the ASRs. The ASR contracts will settle the remaining shares, based on the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, upon the completion of the ASRs during the fourth quarter of 2021. The Company recorded the transactions as an increase to treasury stock of $1.2&#160;billion and it recorded the remaining $300&#160;million as a decrease to additional paid-in capital in the Company&#x2019;s consolidated balance sheet.  The $300&#160;million recorded in additional paid-in capital will be included in treasury stock upon completion of the ASRs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2020, the Company repurchased 0.7 million shares of its common stock for $75 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shares Reissued from Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the nine months ended September&#160;30, 2021 and 2020, the Company reissued 1.7 million shares and 2.1 million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock Retirement &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended September 30, 2021, the Company retired 55&#160;million shares of treasury stock. In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of September&#160;30, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 6.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i246ee08978dd4f9281e49cde4052adb5_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTAxNg_d45f96b1-535d-4ddb-8dc8-bbff0c77336d"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id467bea9a9a042bd95d6970a12d3be15_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTIzMw_e3a61691-d672-4764-898d-f45b49ab4a0d"
      unitRef="usd">20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id96bc77fc8eb4e8e88dc16ca93868148_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTUzMg_1b92f9f2-a5a7-4b69-87b5-5db3fcf3021e"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i55bf2898a19d4ec4ada12d71732989e7_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTUzMg_67e9c76b-4491-444a-8c14-13f6d383e7aa"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTUzMg_9f18bf51-8097-411a-b047-756d94195ff4"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7e7d971b76454263a15f1169e211c2a2_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTY2NQ_21922d2e-9b0e-4580-8eaf-156bc08919ac"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i1ea29ec2e2ea47a79288bb5eb1c001b0_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTY2NQ_4140b7da-b6a2-4d0d-8e43-f6dbd70bbb7c"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5288d887a86f42969ff785028080679b_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTY2NQ_a279032a-2338-406a-837a-12f8077a0680"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTY2NQ_f0efa2e1-4443-4d6a-a135-c632e08e45a2"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i868f8637411d4f61887501630bc811b0_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTg0Ng_1898fb96-7cc6-42b5-825e-cb2ed21395ae"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i2d06b6e3f9dd4f56a49b29e3deefc334_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTg0Ng_f2e108d4-996c-4ad1-8b8b-3b23a31b923a"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTg2MA_d51c39d4-99bb-4241-9dc1-4cd0a635f0ca"
      unitRef="usd">1300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjA4OQ_9564f761-9cb4-4249-b631-210e022bb5ae"
      unitRef="shares">12500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7f6eafc6a2d540b0bc44d4a7d3db2c13_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjEyMw_7e284017-43c2-4bd4-8740-4ec92c7d1d85"
      unitRef="usd">1600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibfda32ff821e42f7b4ed59c5648a0dd6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMTA5OTUxMTYzMzA0Mg_ec4b8408-f9b8-47af-868e-c53b0c460ee4"
      unitRef="shares">9100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="icfcf88539a60445eb9be5a8700c50fb6_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjI3OQ_dd52c7ae-64f4-4484-9e85-8b95715628ca"
      unitRef="usd">1500000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="icfcf88539a60445eb9be5a8700c50fb6_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjc4Nw_dd52c7ae-64f4-4484-9e85-8b95715628ca"
      unitRef="usd">1500000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibfda32ff821e42f7b4ed59c5648a0dd6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjgzMw_9e241a91-4aea-4919-a523-40925c2ea613"
      unitRef="shares">9100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjg4Nw_ce95cd47-5579-4e64-bf6c-1cf66cbce185"
      unitRef="usdPerShare">132.27</us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare>
    <dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution
      contextRef="i4f600b81db564760a3990025b8fe7516_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjkxNQ_5aaf907c-7e4e-47ec-811e-957983282493"
      unitRef="usd">1200000000</dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution>
    <dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements
      contextRef="i4f600b81db564760a3990025b8fe7516_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMjkzNg_e400742a-35ed-426d-a557-d7ec5f003317"
      unitRef="number">0.80</dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="ibfda32ff821e42f7b4ed59c5648a0dd6_D20210101-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzMzMA_a3d8ea02-6291-4cd5-abbf-80eb285ebf02"
      unitRef="usd">1200000000</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="idf76d19dc0f440e89a7ca4bf2b2f2383_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzM2Mw_d6340d66-3679-4e67-acfb-1591bbb095de"
      unitRef="usd">-300000000</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <dgx:AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements
      contextRef="idf76d19dc0f440e89a7ca4bf2b2f2383_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzQ2MA_8bf78fb1-b627-472d-8f26-0ff504afebc0"
      unitRef="usd">300000000</dgx:AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzYyMA_782a0307-6f9a-4297-9a47-6bcd3b208d37"
      unitRef="shares">700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i922a9924d9ec4b7181384d39c1f648b9_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfMzY1NA_a71ffc48-4aef-4aa6-803f-9fc1354a1fe3"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNDE0NA_d52bd08f-ee08-4131-a8e8-12b119e38baa"
      unitRef="shares">1700000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNDE1OA_b9b69e6a-2de4-4359-a8f9-7f3b3a70045b"
      unitRef="shares">2100000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNDk0NzgwMjMzMDg2Mw_a44f06ee-6bbd-4f54-a946-6421a5115deb"
      unitRef="shares">55000000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i36fc1b4d87cc4ef59463dc14ae3e0809_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81NS9mcmFnOmRjZjkwOGY5YTcxNDRiODJhODAyYjQyMmEyNGUwODViL3RleHRyZWdpb246ZGNmOTA4ZjlhNzE0NGI4MmE4MDJiNDIyYTI0ZTA4NWJfNDQ2Mw_9391b487-0529-46ce-9df6-fa5dfa907156"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfMTMxMg_688965f7-39cc-47c4-91dc-0b2b54e1c52e">SUPPLEMENTAL CASH FLOW AND OTHER DATA&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration receivable/payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law.  In April 2020 and August 2020, the Company received approximately $65&#160;million and $73&#160;million, respectively, of funds that were distributed to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic under the CARES Act.  The Company accounted for the receipt of the funds under a gain contingency model. Accordingly, the amounts were recognized when the funds were received and the Company determined that it satisfied the associated terms and conditions. During the three months ended June 30, 2020, based on the terms and conditions that were in effect at such time, the Company concluded that it had satisfied such terms and conditions for the $65&#160;million of funds that were received in April 2020 and, therefore, the Company recognized such amount in other operating expense (income), net during the second quarter of 2020.  During the three months ended September 30, 2020, the Company reversed the $65&#160;million of funds that had previously been recognized and, during the three months ended December 31, 2020, the Company returned the entire $138&#160;million of funds.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfMTMwOQ_3fe063ce-95a1-4c33-ade1-8a2fe709e66c">Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2021 and 2020 was as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration receivable/payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:Depreciation
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMi0xLTEtMS0w_0612d3a3-aa44-4f7b-8055-a9af8fb8b0cb"
      unitRef="usd">76000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMi0zLTEtMS0w_7568419c-8276-4131-903a-3b61f8647dd6"
      unitRef="usd">62000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMi01LTEtMS0w_2885529d-02ed-49a1-b484-8bc05ee52ac1"
      unitRef="usd">225000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMi03LTEtMS0w_a8648d82-e8db-472a-b27c-9c2f01d25a9f"
      unitRef="usd">186000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMy0xLTEtMS0w_b0647898-4f1c-4161-a597-370ffced1845"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMy0zLTEtMS0w_64f51b29-a751-48c2-835f-99f89d2e2473"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMy01LTEtMS0w_40ed1f04-f0e3-4b0d-aaa3-df68fba7120e"
      unitRef="usd">77000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMy03LTEtMS0w_9b7d2de8-8f13-4e4d-b230-fca4bb164e82"
      unitRef="usd">77000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNC0xLTEtMS0w_3e1c85d9-59c9-40de-8885-b1a2b044caeb"
      unitRef="usd">101000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNC0zLTEtMS0w_535a2f11-a6e9-4a23-ab18-90abf5d0ee9a"
      unitRef="usd">89000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNC01LTEtMS0w_34cb24f3-e21a-43eb-9393-49793b626f2e"
      unitRef="usd">302000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNC03LTEtMS0w_d8af5a20-7131-4506-8fdc-e3517445d92c"
      unitRef="usd">263000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpense
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNi0xLTEtMS0w_98b55007-5705-492a-8dcd-d382492444cf"
      unitRef="usd">38000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNi0zLTEtMS0w_0f9930ef-82ad-4bbf-b518-ec7e1610254c"
      unitRef="usd">42000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNi01LTEtMS0w_fdc10582-44ac-4a3a-84dc-4561f1e5ba6d"
      unitRef="usd">114000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNi03LTEtMS0w_16692265-eb34-42c3-877f-56b5514bcdad"
      unitRef="usd">126000000</us-gaap:InterestExpense>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNy0xLTEtMS0w_98447fb8-f92b-4092-8a88-623a726949fc"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNy0zLTEtMS0w_5da82493-719b-45d8-a361-fc9eec02974f"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNy01LTEtMS0w_d23133e1-38d8-4082-b06c-de39efc89a3b"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfNy03LTEtMS0w_96e80936-248d-4856-a51f-06867aa0090e"
      unitRef="usd">2000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfOC0xLTEtMS0w_1bf29d3e-6dda-4f80-9c3f-7ccc78a1916c"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfOC0zLTEtMS0w_d2e2fe32-5234-4d3d-bd71-da032a6e5f52"
      unitRef="usd">-42000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfOC01LTEtMS0w_315c7699-7e66-4d6b-b434-f7a29dc23a19"
      unitRef="usd">-114000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfOC03LTEtMS0w_b2d9c719-4f78-4faa-88b6-b847ac13823e"
      unitRef="usd">-124000000</us-gaap:InterestIncomeExpenseNet>
    <dgx:InterestPaid1
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTAtMS0xLTEtMA_b0bed026-8c23-4cbd-8cac-6872d710c08a"
      unitRef="usd">33000000</dgx:InterestPaid1>
    <dgx:InterestPaid1
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTAtMy0xLTEtMA_4290a8e9-96ec-43e3-ac15-b6a8a62bc919"
      unitRef="usd">33000000</dgx:InterestPaid1>
    <dgx:InterestPaid1
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTAtNS0xLTEtMA_6aee1e4a-4c06-4186-8445-00f7e7f99ee8"
      unitRef="usd">111000000</dgx:InterestPaid1>
    <dgx:InterestPaid1
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTAtNy0xLTEtMA_4962f2a3-3f37-41a9-b21b-f2f518009559"
      unitRef="usd">136000000</dgx:InterestPaid1>
    <us-gaap:IncomeTaxesPaid
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTEtMS0xLTEtMA_6a54f5f7-eaae-44e2-95d1-2c3634c40023"
      unitRef="usd">187000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTEtMy0xLTEtMA_53ce9d3a-0eb9-486e-bd40-a3263cbb335b"
      unitRef="usd">148000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTEtNS0xLTEtMA_31149436-27a1-4174-ba67-43f8c1665297"
      unitRef="usd">522000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTEtNy0xLTEtMA_bb9ac73f-3305-48de-b2c9-88566b97bfe1"
      unitRef="usd">168000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTMtMS0xLTEtMA_ffa20d6c-8245-4245-9227-96b0bb896253"
      unitRef="usd">24000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTMtMy0xLTEtMA_87bd9226-166a-412d-b53a-e449c2c3f936"
      unitRef="usd">55000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTMtNS0xLTEtMA_6c327ef4-f3b6-41b4-8353-4878acfc2a14"
      unitRef="usd">24000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTMtNy0xLTEtMA_8c71d7c4-18bd-4295-9818-54385232b4c9"
      unitRef="usd">55000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTUtMS0xLTEtMA_def9ce84-e0bc-47ed-b661-97313181cc4f"
      unitRef="usd">77000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i1f627c3af5db4299b234650d220eee56_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTUtMy0xLTEtMA_430c30e9-c51d-4899-af40-aeea46731a6f"
      unitRef="usd">76000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTUtNS0xLTEtMA_7cbca707-dda3-4375-9064-2df717845c58"
      unitRef="usd">77000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i1f627c3af5db4299b234650d220eee56_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTUtNy0xLTEtMA_6bffa763-f642-4171-848b-ec9578326b31"
      unitRef="usd">76000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTgtMS0xLTEtMA_4cc3fe6f-3f95-4085-aa02-ddd2af7b203a"
      unitRef="usd">20000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTgtMy0xLTEtMA_08019cc9-5dd6-41d5-9426-6dd85aaee184"
      unitRef="usd">126000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTgtNS0xLTEtMA_053b5288-7275-411f-8d57-9f1a56813066"
      unitRef="usd">254000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTgtNy0xLTEtMA_2d4ccedf-8e5f-4aea-828d-1a7a5cdec868"
      unitRef="usd">377000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTktMS0xLTEtMA_ad6cd8ba-ff69-48bd-9be4-9ee862ddb0bd"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTktMy0xLTEtMA_1d4ba44e-b72b-4013-8fdf-40ee32fea240"
      unitRef="usd">9000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTktNS0xLTEtMA_426cc77b-2983-4df3-9d4a-199e99bf6460"
      unitRef="usd">3000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMTktNy0xLTEtMA_acd1c427-cbf3-4868-9d2e-857d40f21215"
      unitRef="usd">29000000</us-gaap:LiabilitiesAssumed1>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjAtMS0xLTEtMA_fb457b0e-f3e3-40ad-9b71-e986f292e797"
      unitRef="usd">20000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjAtMy0xLTEtMA_9443ba01-e8ac-48ba-9d65-3b95cadbc5eb"
      unitRef="usd">117000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjAtNS0xLTEtMA_3fc4b763-9e93-4524-82f6-2c14c88bc6fd"
      unitRef="usd">251000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjAtNy0xLTEtMA_5464e5bf-1b52-4508-b403-01420ac958a6"
      unitRef="usd">348000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjEtMS0xLTEtMA_98ce56f6-624b-4037-a15e-ec1daa49671b"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjEtMy0xLTEtMA_4dfabb4b-96c1-4e58-9f91-4b6e43b00458"
      unitRef="usd">2000000</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjEtNS0xLTEtMA_2accdcdf-5d79-4b09-b4c5-91e320cee156"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjEtNy0xLTEtMA_f34306cf-e4ee-4404-9130-9c223c27fd67"
      unitRef="usd">2000000</dgx:Mergerconsiderationpaidpayablenet>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjItMS0xLTEtMA_1e0993ce-1eea-4445-87a4-0937429d1391"
      unitRef="usd">20000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjItMy0xLTEtMA_d1fd6c36-79b9-436b-8a3f-f108315b95e9"
      unitRef="usd">119000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjItNS0xLTEtMA_549c79a0-4038-49db-868a-a59ad22461bb"
      unitRef="usd">251000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjItNy0xLTEtMA_60da7fb5-a730-4495-aedc-25bf3fab1702"
      unitRef="usd">350000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjMtMS0xLTEtMA_64485ff9-9a64-4807-88d9-fe02cd67b478"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjMtMy0xLTEtMA_44a70a3a-c61c-4ed8-b643-5cc6c0bd0c36"
      unitRef="usd">18000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjMtNS0xLTEtMA_80134ec4-e9d9-4109-a760-04b4e01e4d6c"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjMtNy0xLTEtMA_deed9c19-8a11-4984-941d-7c0f17cfe563"
      unitRef="usd">21000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjQtMS0xLTEtMA_f1c063c1-fb58-4c43-856b-87a2251c0830"
      unitRef="usd">20000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjQtMy0xLTEtMA_793b749d-f786-4145-96ad-bb0bf1f01ea3"
      unitRef="usd">101000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjQtNS0xLTEtMA_0aa2fcb2-9c33-4e90-b47c-d81af2010a6f"
      unitRef="usd">251000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMjQtNy0xLTEtMA_feed4f08-bc78-4809-bdd9-18ea0c3971b4"
      unitRef="usd">329000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMzEtMS0xLTEtMA_80205ff5-deaa-40bf-8d41-4fd7fa449462"
      unitRef="usd">46000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMzEtMy0xLTEtMA_23d71d21-c492-4236-9a35-de6b8133e0d0"
      unitRef="usd">40000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMzEtNS0xLTEtMA_86fc7f60-9961-4ef4-a020-07cee0bf57e6"
      unitRef="usd">115000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RhYmxlOjJkMWZmZTNmNDBhMzRkOWRhMTE3NjQwYmMyMDI5NWYxL3RhYmxlcmFuZ2U6MmQxZmZlM2Y0MGEzNGQ5ZGExMTc2NDBiYzIwMjk1ZjFfMzEtNy0xLTEtMA_190cce1a-63a8-4b4c-b9b3-ff5bd22653e6"
      unitRef="usd">119000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche
      contextRef="ib80fc1942e984fd5a7949043c3093362_D20200401-20200430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfMzM5_3b27933c-2fa9-42f2-85d1-f4f2ebebd030"
      unitRef="usd">65000000</dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche>
    <dgx:CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche
      contextRef="i7542d9b6daf04822b7c7295e9573a8a3_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfNDk0NzgwMjMyNjM3OQ_b24f8683-b85d-421f-b6d2-4314e0c0df01"
      unitRef="usd">73000000</dgx:CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche>
    <dgx:CARESActProceedsRecognizedInTheStatementOfOperations
      contextRef="ie051564f2e734da28d818b7a4efcf77c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfOTMy_d4a9dea1-ffa9-4790-87bd-2bb498acdd2b"
      unitRef="usd">65000000</dgx:CARESActProceedsRecognizedInTheStatementOfOperations>
    <dgx:ReversalOfRecognitionOfCARESActProceeds
      contextRef="id858b57b1f134c328d0f3870aff86791_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfMTE3MA_66bc9e60-a424-4ef5-9260-37fe9aa39b3a"
      unitRef="usd">65000000</dgx:ReversalOfRecognitionOfCARESActProceeds>
    <dgx:ReturnOfCashCARESAct
      contextRef="i5288d887a86f42969ff785028080679b_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF81OC9mcmFnOjI1OTM0YTkxZDZiMjQyYmViNmJmOWUxNmU2YWNjY2FiL3RleHRyZWdpb246MjU5MzRhOTFkNmIyNDJiZWI2YmY5ZTE2ZTZhY2NjYWJfNDk0NzgwMjMyNjQzOQ_30fd2bec-1c60-4b6a-8a96-6616b374a2e5"
      unitRef="usd">138000000</dgx:ReturnOfCashCARESAct>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfODQ4NQ_a564c6ba-a03f-46dc-b3e1-f321760a7f32">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  See Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of September&#160;30, 2021, providing collateral for current and future automobile liability and workers&#x2019; compensation loss payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Lease Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#x2019;s 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#x2019;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re: Quest Diagnostics ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;AMCA Data Security Incident&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#x201c;AMCA&#x201d;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018 and March 30, 2019 (the &#x201c;AMCA Data Security Incident&#x201d;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#x2019;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#x2019;s nor the Company&#x2019;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#x2019; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of September&#160;30, 2021, the Company does not believe that material losses related to legal matters are probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for legal matters totaled $6 million and $1 million as of September&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reserves for General and Professional Liability Claims&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $153 million and $138 million as of September&#160;30, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i01995b0930f44ae494baf9f00606c1be_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTEx_483c04ab-1438-4b6e-bbe3-67ee068c4ebe"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i71dae6d523044c6e86141e159ada5f54_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTI0_d4bb6860-b374-4cd6-9233-156774d5263d"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i23930df4ff5e47acbd2af40147c8310f_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTY3_e7e74e13-4019-4585-bf33-04e2217166bb"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3fa4a1c7a8cf4bde9e060da17dd6138d_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTgw_fc7b58fd-82ec-4e9a-891a-5d9935ceee1c"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i71dae6d523044c6e86141e159ada5f54_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMzgz_b67e614d-edf2-455c-b466-f9ecd26e1080"
      unitRef="usd">70000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMTcyNw_df7992db-c9d6-467e-9258-08f23cc6d887"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i27f9acec26b840b1a223ab39e755c0aa_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfMjI3NQ_527a211f-f368-4d6e-9ec0-4b4b3d5f2322"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationReserve
      contextRef="i182a2b075333465998d6cc5c986d8320_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfNzE5MQ_7bd8f3d9-b7e9-4d4c-b11f-39e302be3177"
      unitRef="usd">6000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i73ddab4100a944fea58ae374a6ff4845_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfNzE5OA_518febf3-e3e5-473c-b588-e06b883bff35"
      unitRef="usd">1000000</us-gaap:LitigationReserve>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfODMwNg_87839df2-cc7b-43d4-b8b0-dbfb09ea48ee"
      unitRef="usd">153000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82MS9mcmFnOjc5NTA2NzZkMWI3ZTRkOGNiMWJiM2NkYWJiNWI1MGFkL3RleHRyZWdpb246Nzk1MDY3NmQxYjdlNGQ4Y2IxYmIzY2RhYmI1YjUwYWRfODMxMw_bcd95c9c-05a6-4dc9-8367-9361585ebae5"
      unitRef="usd">138000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfMjQxNQ_8dcf857a-d1a9-4f4b-ad96-80973cb2c9b8">BUSINESS SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of September&#160;30, 2021, substantially all of the Company&#x2019;s services were provided within the United States, and substantially all of the Company&#x2019;s assets were located within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three and nine months ended September&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i58a1a67d34d240d7b603eb953adc9835_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfODA2_1cc95e9d-5f33-4acf-928d-96ac86e2f772"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i1952efe7be544fe591e6315daee82f95_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfODA2_cfe883ed-a5fa-4078-b5db-8e80fc84b9e6"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfMjQwOQ_8843cda6-dbe1-4e89-afe1-a9ef56e87bea">The following table is a summary of segment information for the three and nine months ended September&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(483)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida9a845517b14f2d85f82da38a53f275_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMy0xLTEtMS0w_03f7efdc-a7cc-4404-b35f-06f89f4d14ba"
      unitRef="usd">2703000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia12055ea11a54f1890616da76bad2b80_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMy0zLTEtMS0w_f8b6436a-9994-42e4-a2e3-4ba5cca9d625"
      unitRef="usd">2709000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad4b891b3a584530a9cf508df0670b51_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMy01LTEtMS0w_698628c9-f6a2-4ca8-b1a6-36203465eb03"
      unitRef="usd">7820000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88caa1b81b364b9fa199959abd7ed0d2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMy03LTEtMS0w_29a37968-7f21-47d9-983d-b86648142a2f"
      unitRef="usd">6217000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecf2cd09b04849daae0be004f7617d14_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNC0xLTEtMS0w_48b7b4a6-d8a3-40df-9456-3b5d2aeed0ac"
      unitRef="usd">71000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i537235110c194ee082108ce9a9ecc879_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNC0zLTEtMS0w_e583f179-6caa-40a6-b81b-18f14e1e349e"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9565fe343ad34611897d8c50225762c8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNC01LTEtMS0w_4c28f349-b9e9-4dd2-858d-35aa6c3c5eed"
      unitRef="usd">224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3be9f0b477af42a4a4c10b096f57639b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNC03LTEtMS0w_40d97aaf-6ec2-4d87-8f76-f48896109209"
      unitRef="usd">218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNS0xLTEtMS0w_e2c220f0-8c9c-4bf6-85f8-501aec36bd7c"
      unitRef="usd">2774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNS0zLTEtMS0w_4003186c-574c-4da1-a9d8-536b371aa88c"
      unitRef="usd">2786000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNS01LTEtMS0w_17bc90bf-115b-498d-a5ce-3de75e8e78ed"
      unitRef="usd">8044000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfNS03LTEtMS0w_0dd7c8b1-eb1a-43dd-a5ae-044e2659e58a"
      unitRef="usd">6435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida9a845517b14f2d85f82da38a53f275_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOC0xLTEtMS0w_429c0cda-e300-49e5-8e78-a00dbcf424bd"
      unitRef="usd">713000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia12055ea11a54f1890616da76bad2b80_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOC0zLTEtMS0w_400290fd-d4ce-4d30-ab1a-5fb7b7f8ffa6"
      unitRef="usd">840000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iad4b891b3a584530a9cf508df0670b51_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOC01LTEtMS0w_aad42e3f-97e4-465d-97f5-3c25278bdf2d"
      unitRef="usd">2026000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i88caa1b81b364b9fa199959abd7ed0d2_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOC03LTEtMS0w_48aebbc0-9c63-43ba-b5a0-40066080c411"
      unitRef="usd">1325000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iecf2cd09b04849daae0be004f7617d14_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOS0xLTEtMS0w_2e8bf432-60cf-4032-bd3d-38d4266c6765"
      unitRef="usd">8000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i537235110c194ee082108ce9a9ecc879_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOS0zLTEtMS0w_93e9c33d-bd80-4710-a437-4a19cdadeb29"
      unitRef="usd">16000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9565fe343ad34611897d8c50225762c8_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOS01LTEtMS0w_672c8619-d4de-4d38-91b4-e11ed9fdf0be"
      unitRef="usd">26000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3be9f0b477af42a4a4c10b096f57639b_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfOS03LTEtMS0w_28b6bf9d-0b2a-468c-9b95-a45c484d91fa"
      unitRef="usd">29000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i813b3cfd78584fa288cbfee1b07eba3a_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTAtMS0xLTEtMA_ae61645d-4f20-4ea0-868d-d0207c6510ff"
      unitRef="usd">-69000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1a59539f511c449187290980e118ba4d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTAtMy0xLTEtMA_b7c11d6d-d0c4-41db-b0c5-eaf62df94246"
      unitRef="usd">-138000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5acd767ddc8241cf9dfb969b29565a40_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTAtNS0xLTEtMA_7d40da68-0468-4dbf-b695-498bba7526b4"
      unitRef="usd">-207000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8a9fa386f73d4e2e82d8ed5c274ecabf_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTAtNy0xLTEtMA_a4d44098-5ef2-4142-8bed-7ecba7f305b0"
      unitRef="usd">-178000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTEtMS0xLTEtMA_0ffa319d-6a17-4f00-b2fc-bcf620d67fe1"
      unitRef="usd">652000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTEtMy0xLTEtMA_552f91fb-b6a3-4661-967f-2e13fec67d98"
      unitRef="usd">718000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTEtNS0xLTEtMA_0d4bc2a3-f0bd-41ca-ad55-198f8893dbae"
      unitRef="usd">1845000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTEtNy0xLTEtMA_4f02e8cd-8c80-4bd0-bbbc-4aeae5f171f4"
      unitRef="usd">1176000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTItMS0xLTEtMA_0b4330d0-328d-4ed6-8df7-0d5fe5c5c019"
      unitRef="usd">2000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTItMy0xLTEtMA_44b7ce3f-13e5-40f5-8f34-1673879923aa"
      unitRef="usd">35000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTItNS0xLTEtMA_5a604094-5eff-4222-9d14-d4badc17e310"
      unitRef="usd">252000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTItNy0xLTEtMA_2c2be0a4-9cd0-4699-a69a-f7d04e212a1a"
      unitRef="usd">-50000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTMtMS0xLTEtMA_61d538f1-4d8b-4e94-a27c-09bdc6e26bdd"
      unitRef="usd">654000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTMtMy0xLTEtMA_3f48ecd9-bb56-4c01-88f0-f1a3dbee98db"
      unitRef="usd">753000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTMtNS0xLTEtMA_6cd654b2-dbbe-4e2b-9c06-884591cca488"
      unitRef="usd">2097000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTMtNy0xLTEtMA_fe8ea494-fbd4-458a-a4cc-8e3da19a6e51"
      unitRef="usd">1126000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTQtMS0xLTEtMA_6a1ecee3-7bbf-4e31-81c2-4b694c2de61e"
      unitRef="usd">153000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTQtMy0xLTEtMA_7720c57a-1179-4bff-aa97-15df814d6367"
      unitRef="usd">177000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTQtNS0xLTEtMA_b31e6faa-26d7-4ec9-a623-04a2e13c2834"
      unitRef="usd">483000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTQtNy0xLTEtMA_d4f6832f-631d-4ca9-a631-e5a1e69ea675"
      unitRef="usd">269000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTUtMS0xLTEtMA_b4c8fd4a-c792-49d3-83e1-ed17cac15463"
      unitRef="usd">26000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTUtMy0xLTEtMA_7345adb9-3e31-4b7b-9213-c2ab6edb7e46"
      unitRef="usd">15000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTUtNS0xLTEtMA_07c66ae7-6954-451d-a306-210e81822f04"
      unitRef="usd">53000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTUtNy0xLTEtMA_96aee7be-7c7b-4f5c-b4a4-b3664143bd20"
      unitRef="usd">33000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTgtMS0xLTEtMA_9ce9442b-2cdf-4313-ac90-336178aea0cf"
      unitRef="usd">527000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTgtMy0xLTEtMA_52f6252d-c216-42d3-a9c3-4665155c5a0c"
      unitRef="usd">591000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTgtNS0xLTEtMA_2cc4cf4d-79b0-43ad-bedd-3f75c3242264"
      unitRef="usd">1667000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTgtNy0xLTEtMA_86083ccd-022c-42b4-8d21-6afa95583b8e"
      unitRef="usd">890000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTktMS0xLTEtMA_bafb0a19-5bcd-4fbc-a47e-79fbb1fc64be"
      unitRef="usd">22000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTktMy0xLTEtMA_78df581f-3fcd-49e4-8814-1b2e29cb9ae3"
      unitRef="usd">23000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTktNS0xLTEtMA_796ead94-7b39-406b-9979-7c31214e4294"
      unitRef="usd">62000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMTktNy0xLTEtMA_110eba59-8d09-48d7-bdd4-4c3c32eb2e99"
      unitRef="usd">38000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMjAtMS0xLTEtMA_796b8d7b-7529-4c6b-b870-76449e8d78a8"
      unitRef="usd">505000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMjAtMy0xLTEtMA_03e4f191-a790-480e-bb4a-0c3b2d48cacb"
      unitRef="usd">568000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMjAtNS0xLTEtMA_20365183-f8ad-4c01-898a-ac221495dde7"
      unitRef="usd">1605000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjBmMmVlM2Y4MzdiMDQ0MmRiN2ZkN2Q4NzM3NzM2OWFiL3RhYmxlcmFuZ2U6MGYyZWUzZjgzN2IwNDQyZGI3ZmQ3ZDg3Mzc3MzY5YWJfMjAtNy0xLTEtMA_b4b0ac81-e8df-4d00-ad93-4dd2b67dec04"
      unitRef="usd">852000000</us-gaap:NetIncomeLoss>
    <dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RleHRyZWdpb246MDIyMTRjMTBlNmE5NDUyOWE4YjU5ODA3ZmUyYzUyZTRfMjQyMA_dbabc2b8-17d5-491d-ba03-d288c24f334e">Net revenues by major service were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d8c3304c5b24c6698ca6cf99acb40f8_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfMy0xLTEtMS0w_d556b1cb-227c-4e6f-bab8-e1e7d6b97b60"
      unitRef="usd">1210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17915cdcfe1c4db0a3f41d20dcfb007b_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfMy0zLTEtMS0w_6884d84c-7ba3-430b-b741-28022f633a5d"
      unitRef="usd">1055000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d583a2157a4461d84a68397c4aa9749_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfMy01LTEtMS0w_a63bf10a-a548-4004-8441-418a1bd7bfc9"
      unitRef="usd">3392000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida3b6e41b6d84008a6bbdb8a925027f4_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfMy03LTEtMS0w_061dc26f-a97c-48ff-90b1-46f631de0f57"
      unitRef="usd">2812000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i534453e984bd4a6185b2140d89a55c40_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNC0xLTEtMS0w_14d2e2e0-2d80-442a-96c0-d4ade650bdf7"
      unitRef="usd">709000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02fec1695bc94fb4b799f16df36a277a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNC0zLTEtMS0w_78d8195d-28c1-426a-b285-6c2ee07db408"
      unitRef="usd">965000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e86467c36344bbf941f4c24f2436504_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNC01LTEtMS0w_cb9f060d-a688-430b-8b9e-067949ee9b02"
      unitRef="usd">2048000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe9af73476c6465093764838622b5110_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNC03LTEtMS0w_dae31153-c694-406e-9cd4-1dc5ff771c1e"
      unitRef="usd">1571000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2828a531f0ab4def88e14f6e27424f8c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNS0xLTEtMS0w_4b878580-61cc-4211-afea-2ed337719c69"
      unitRef="usd">646000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2adc13627b04c52868f7d8eaae852b7_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNS0zLTEtMS0w_53370cae-ceba-4e86-b2a7-a8e9140dce47"
      unitRef="usd">556000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1864ddab8bfd440b964803911e9124ec_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNS01LTEtMS0w_3c13bc17-1b0e-4afd-956b-4b59a331f144"
      unitRef="usd">1972000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd315ce487f94328842945669408cac6_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNS03LTEtMS0w_3826cdec-4f67-4254-8fe9-685040d35133"
      unitRef="usd">1491000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5e43ad9212f4e578d1fb6094dc932e7_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNi0xLTEtMS0w_bc8bdf6f-76c7-44b4-babb-653ba0988167"
      unitRef="usd">138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15f86920b99e47a8acf4dd4cfafd0615_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNi0zLTEtMS0w_790cbaf9-5a0f-4969-936f-a44671ea8073"
      unitRef="usd">133000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id771c1175b884bbca27eafcc9a648410_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNi01LTEtMS0w_aa84b43f-d46d-4155-84eb-0334100ea95c"
      unitRef="usd">408000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6af7c6063aec42389819aab63062e23e_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNi03LTEtMS0w_3df2b0a5-1461-4cd9-8e11-67532eb89211"
      unitRef="usd">343000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i048fe873cef04ee19ea2b9317513136c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNy0xLTEtMS0w_0ee5e938-4fc9-4f1d-8389-187610b7f222"
      unitRef="usd">71000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id44bc581e9ad4e67838ca4c123d65f5d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNy0zLTEtMS0w_bcd15b63-a5dc-4713-bdaf-c00965312b09"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b5cbcbc73384532a5dd309d11856852_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNy01LTEtMS0w_52b57de4-f492-40f1-8329-30c05963e13f"
      unitRef="usd">224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a06c98f38fb4642a99ba9b0eeb69e85_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfNy03LTEtMS0w_22ca373b-b1ef-4c45-9062-d35f82c5d72b"
      unitRef="usd">218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfOC0xLTEtMS0w_60b8dff2-40e4-490b-a79c-12d02d2fc48c"
      unitRef="usd">2774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfOC0zLTEtMS0w_7b611b3a-5316-4320-b11b-5c8c65e046da"
      unitRef="usd">2786000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfOC01LTEtMS0w_48180fa1-ac4c-4def-954a-22b871440fe9"
      unitRef="usd">8044000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82NC9mcmFnOjAyMjE0YzEwZTZhOTQ1MjlhOGI1OTgwN2ZlMmM1MmU0L3RhYmxlOjIxOGMyYjQ1MDMyZjQyYmJiYTdjMjM5NGNmODRkZmRjL3RhYmxlcmFuZ2U6MjE4YzJiNDUwMzJmNDJiYmJhN2MyMzk0Y2Y4NGRmZGNfOC03LTEtMS0w_9de88278-2f96-47af-8025-13bd71537078"
      unitRef="usd">6435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfMTU0OA_5af4f327-c5ef-489c-a585-9a9b6826a570">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DIS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues in the Company&#x2019;s DIS business accounted for over 95% of the Company&#x2019;s total net revenues for the three and nine months ended September&#160;30, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i1952efe7be544fe591e6315daee82f95_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfOTk_20db9a67-be49-456b-ab59-d364e28840da"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie5df9bb39dd94d1da9a87c3331dd1fc4_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfOTk_4ac88b5e-2b4b-471f-8ef2-6969bb19344a"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i21b8ec4029e44a988d269c3126940283_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfOTk_b3fcc3fb-536d-4b39-945d-8d6836cc9463"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i58a1a67d34d240d7b603eb953adc9835_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfOTk_c2ba5ea6-6802-46a1-bf05-00c534754c5a"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfMTU0NQ_d897a2fe-c1d8-4267-8e42-044579d5d533">The approximate percentage of net revenue by type of customer was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="ie3acee20262b40d6b10903fb4afbe132_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMy0xLTEtMS0w_de71c18b-d632-42f7-be70-0a63bb030915"
      unitRef="number">0.41</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia0e31adde43d46de97147148481af848_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMy0zLTEtMS0w_ea87d3cf-7e1e-435a-8b80-952301d6ff94"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia72c419b8ec64dba8571eec8d685eec3_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMy01LTEtMS0w_9d9b1d8d-d7ec-4abe-beb1-aba2ff5fe186"
      unitRef="number">0.39</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0a3d767b7d0c47bc9a4b5019b47e5bd9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMy03LTEtMS0w_90ade04a-4f79-483b-9407-1af34a22d3f1"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i4d3091cfcdc640a6a96229526a63c9f3_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNC0xLTEtMS0w_93486b4f-e53b-478c-a23c-f46d959ef5f8"
      unitRef="number">0.02</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iee01dc9e07e243b99354760cac0d4d32_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNC0zLTEtMS0w_4b67a934-4ba8-403e-b9cc-f0dea3e83a56"
      unitRef="number">0.02</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib3598a5751c24825831703722082a2cb_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNC01LTEtMS0w_229e1238-9238-4227-9a35-71f75d197e33"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i850f59cbde9f4344a88ebab6b1fc075b_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNC03LTEtMS0w_62cb17c4-2a74-4e1c-954f-c449539ba3c2"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i87cba5d430f245a68bd0315c18e62086_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNS0xLTEtMS0w_01162123-d5b6-47f9-a142-def909335946"
      unitRef="number">0.43</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ic42802853a4a454699bda9d6dbae93ab_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNS0zLTEtMS0w_646213d0-a8ec-4304-9072-9a8ff0724140"
      unitRef="number">0.35</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iddb27e7850474298b896873be1ac713d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNS01LTEtMS0w_65bb33c6-a15e-47c3-8198-f63a63e7c11b"
      unitRef="number">0.42</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i98c4699f13a94272b16b1d74570e68fc_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNS03LTEtMS0w_3a9233b9-1f8e-485e-91de-2f9a350c37bb"
      unitRef="number">0.36</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i1213d16766764ac4b9e354347e502602_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNi0xLTEtMS0w_02da4fff-388d-4855-bca4-4add16a5fd3a"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i90fe5caa0f59404680b57eb172b7feb0_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNi0zLTEtMS0w_ed4d6fcc-352a-41c4-b459-40b662bd55c7"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="if617a3f687c7470babc0347a121c9e4d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNi01LTEtMS0w_b817a9a3-f3ba-4451-ad2b-30fa1ede7186"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ic6c8d850bc0b470f9ed7d27f080d7d3e_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNi03LTEtMS0w_dbd0c2e1-2208-412d-9e92-cfbdbaea0f15"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia5bda4a72cc2448eb1edd6aaf8e616da_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNy0xLTEtMS0w_309270a2-30c4-41b5-b0e4-f6f0eef892b2"
      unitRef="number">0.31</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i5aa4bbd4b0f842faa92582711d35880e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNy0zLTEtMS0w_5303a538-fb99-4c4d-a6c6-03fc3f830601"
      unitRef="number">0.40</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i4f839de76b0f434eb190d581d2836010_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNy01LTEtMS0w_bc07ed6c-34d4-4ec6-a853-efa13dd3cdb9"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3f651cc6ea1b471f8b7f8940efacc318_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfNy03LTEtMS0w_31fd77b4-51a5-4c4a-a872-4e1925d9c392"
      unitRef="number">0.37</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i78617df876924999b6673b596d4ec4bc_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOC0xLTEtMS0w_fb709873-452f-4095-a00e-cbbc094a4916"
      unitRef="number">0.13</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ic7fa9139c7bb4f4499a1a4264ac05a1f_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOC0zLTEtMS0w_45cb033d-293b-456c-91d4-060e55d8c29a"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i37b7a8a12d95433386c13963200412ff_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOC01LTEtMS0w_0e699b5e-282f-4ada-b726-d8a3e986861b"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i7b51a1e39a2f490fa85b27203276ef0c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOC03LTEtMS0w_0a84ccd1-9467-4235-8b02-2716d4be158f"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ida9a845517b14f2d85f82da38a53f275_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOS0xLTEtMS0w_d0a43838-05e4-4718-9760-98f2ed069866"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia12055ea11a54f1890616da76bad2b80_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOS0zLTEtMS0w_1687a60e-166b-4758-8451-bf26128951b0"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iad4b891b3a584530a9cf508df0670b51_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOS01LTEtMS0w_7b86dbe6-91cd-4910-8bf9-8d712c538036"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i88caa1b81b364b9fa199959abd7ed0d2_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfOS03LTEtMS0w_93eda222-9cb7-4b3b-8179-317258c4a32f"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i86a46fb310654cc4b552d2896fa0e4ce_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTAtMS0xLTEtMA_10eacbf3-861a-49c7-ab18-90fdf801b42c"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia1e1c8f2d240445c9b8dcf6436139569_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTAtMy0xLTEtMA_d35cccc0-a767-47ab-9389-3a86e60c7a7c"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i40e0c746fc364568aca78621cf9fa220_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTAtNS0xLTEtMA_6d4c2d0c-a05d-485a-8a29-10613ebe9326"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iea67ec5cbe4542ba8a94aa5c96aa362d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTAtNy0xLTEtMA_0d3163cc-3997-48be-974e-a1236fbf15cc"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTEtMS0xLTEtMA_8030ed3e-e54c-40ae-8a58-00f9fea71d45"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTEtMy0xLTEtMA_ebad5262-5630-4d6c-b573-5e336cf8d3fe"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTEtNS0xLTEtMA_2a15981c-635a-4ed9-825a-c58118a5d270"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNhNzJjMDU5MzllNDRjMTQ4OWNlOTg2YzVlNzk0ZWQ5L3RhYmxlcmFuZ2U6M2E3MmMwNTkzOWU0NGMxNDg5Y2U5ODZjNWU3OTRlZDlfMTEtNy0xLTEtMA_74529a44-2f8d-4dd5-aa60-922ccc98fe9b"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:AccountsReceivableDisaggregationTableTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RleHRyZWdpb246N2E5ZTY3ZWE2ZjQ5NDMxNzkwNTZiNGVhZGZiN2M2Y2VfMTU1MQ_9ee5f490-0688-473f-b198-dd669b7b5338">The approximate percentage of net accounts receivable by type of customer was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:AccountsReceivableDisaggregationTableTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ieea0bd6309b146afa41000f43a995747_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfMi0xLTEtMS0w_83c75467-6b38-4a37-9b24-79c70777ff37"
      unitRef="number">0.35</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="if642e1ad2c084744ab7670f7a6352dfa_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfMi0zLTEtMS0w_5d9a03d5-6825-456b-aade-706fce209551"
      unitRef="number">0.34</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i104ac329ccf749b18a18c82c37f79955_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfMy0xLTEtMS0w_1ddd183f-f805-4926-adc5-6145b2e57a82"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i7b2258e70f904ecc8314266db2b2b0f9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfMy0zLTEtMS0w_f4be3356-60f8-4e94-a211-8f1178bfb65e"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="id6bb57ee8aae4e0bb388398be620f121_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNC0xLTEtMS0w_e75713e9-99f6-4029-a382-806477ce00e8"
      unitRef="number">0.36</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i22ec3dd09cf4437ea06fcdec19d1d6fd_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNC0zLTEtMS0w_d0636052-56b8-413d-ba1e-cdd13cefafa7"
      unitRef="number">0.46</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="iead44cad5e60407b9beab7d6f4ff0009_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNS0xLTEtMS0w_b54e9291-f34e-4af3-bd87-f3eeee2b323a"
      unitRef="number">0.20</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i68612d24937c4836b820313794721e70_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNS0zLTEtMS0w_b694ff06-43a4-49c9-874b-223ceda7f75d"
      unitRef="number">0.11</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i2caebe9557194cc5b637ac04007df5c4_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNi0xLTEtMS0w_7736d4d8-ac90-41fa-9045-90caa23fcd77"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i826e2caf620945adb4857cc3ca809c61_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNi0zLTEtMS0w_a291b0f2-d5af-4102-908c-ccd7a0658c26"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="if655a31fafc740b5b2318f68e86b82a3_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNy0xLTEtMS0w_57ab133a-c724-4039-982e-788b857479bf"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="if312089fa21e46d6b6f06ec4ba94bd10_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfNy0zLTEtMS0w_fb9263c9-d00e-4bdc-ab5c-6592e003a21f"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i240ccb0d73a24cda883d17698d2669f7_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfOC0xLTEtMS0w_dbd46398-d12f-4efe-8685-076a239eaeb2"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i6bc28e1736a04d9e9f222c1998dbf195_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF82Ny9mcmFnOjdhOWU2N2VhNmY0OTQzMTc5MDU2YjRlYWRmYjdjNmNlL3RhYmxlOjNmMGVlMmExZDFiZDQ4NGU5MTkzNGQwNjE4MTJhMjNlL3RhYmxlcmFuZ2U6M2YwZWUyYTFkMWJkNDg0ZTkxOTM0ZDA2MTgxMmEyM2VfOC0zLTEtMS0w_2877494d-58bf-4741-ad53-8394441e5c60"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMTAxNg_86c26f25-b43f-4f42-bc24-fd48f8a9cd0a">TAXES ON INCOME&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2021 and 2020, the effective income tax rate was 23.4% and 23.7%, respectively.  The effective income tax rate for the three months ended September&#160;30, 2021, benefited from a $6&#160;million income tax benefit associated with changes in reserves for uncertain tax positions, and $6 million of excess tax benefits associated with stock-based compensation.  The effective income tax rate for the three months ended September&#160;30, 2020, benefited from a lower effective income tax rate, 11.8%, associated with a $70&#160;million gain recognized as a result of the remeasurement of the Company's previously held equity interest in Mid America Clinical Laboratories, LLC ("MACL") to fair value, and $3 million of excess tax benefits associated with stock-based compensation.&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021 and 2020, the effective income tax rate was 23.1% and 23.9%, respectively.  For the nine months ended September&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions (see Note 5). For the nine months ended September&#160;30, 2020, the effective income tax rate benefited from a lower effective income tax rate, 11.8%, associated with a $70&#160;million gain recognized as a result of the remeasurement of the Company's previously held equity interest in MACL to fair value.  In addition, the effective income tax rate benefited from $15&#160;million of excess tax benefits associated with stock-based compensation arrangements for both the nine months ended September&#160;30, 2021 and 2020.&lt;/span&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTY_f2e41bce-f482-4f58-a36c-69161035ae7a"
      unitRef="number">0.234</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMTAz_e74d3a85-dc7a-4124-af15-d425e1b50048"
      unitRef="number">0.237</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTg4NA_cf3680cf-eeba-4e65-a412-3186aa4e952b"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i799f05ff39a24712b253c3e931752e30_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTM0NTg0ODgzODIxOQ_5b7be292-fcaa-409e-bd55-8b03b11f574a"
      unitRef="usd">-6000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <dgx:EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTk1MA_f456fd9c-fc67-4b52-bf47-4e8cd9c08fcc"
      unitRef="number">0.118</dgx:EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTM0NTg0ODgzNzc2MA_e7aa25fc-05de-424d-8782-5f2b216a86c2"
      unitRef="usd">70000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i27c71827889046b89c007c79c0fd8d7a_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTM0NTg0ODgzNzY5Mg_c141cafb-97e3-46bf-9be2-76c5a36cb849"
      unitRef="usd">-3000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfNTkz_5940246b-4ec9-4004-9129-5161d575c481"
      unitRef="number">0.231</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfNjAw_b0020e28-1c8d-4dbe-8d81-4e5225eddf27"
      unitRef="number">0.239</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i32feb78c82714f82a63f30aaa256b1fd_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfNzI3_15bb1350-34ff-42b9-910f-dab38c736762"
      unitRef="number">0.176</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i246ee08978dd4f9281e49cde4052adb5_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfNzcy_996e4619-c29b-427d-af3c-26c7dd292ba5"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <dgx:EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTk2Mw_c9761ae4-e7d4-49b4-b637-c8bd2c0ca04f"
      unitRef="number">0.118</dgx:EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfOTM0NTg0ODgzODUzNg_e7aa25fc-05de-424d-8782-5f2b216a86c2"
      unitRef="usd">70000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTk4OA_554827a1-5d18-4bbe-b5d9-e62c995faf7d"
      unitRef="usd">-15000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i0d4b0899e9e84aafafeaa969cd06372c_D20200101-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF83MC9mcmFnOjdmMjI4OGE3MTM2ZjQ0Mjc4NTNiZmJjZmMwY2Q5ZjM2L3RleHRyZWdpb246N2YyMjg4YTcxMzZmNDQyNzg1M2JmYmNmYzBjZDlmMzZfMzg0ODI5MDY5OTk4OA_a02ccdc3-8154-4289-94fb-79daf6e9fca3"
      unitRef="usd">-15000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="iae4f1e9e758948fca12122403d40b86e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF8zODQ4MjkwNjk4ODQ5_4644299d-9fd3-4212-a5eb-786c3967607f">SUBSEQUENT EVENT&#160;&#160;&#160;&#160;During October 2021, the Company amended its $600&#160;million secured receivables credit facility in order to extend the maturity dates for each underlying commitment by one year while maintaining the aggregate borrowing capacity under the secured receivables credit facility at $600&#160;million.  Under the secured receivables credit facility, the Company can borrow against a $250&#160;million loan commitment maturing October 2022 and a $250&#160;million loan commitment maturing October 2023.  Additionally, the Company can issue up to $100&#160;million of letters of credit through October 2023.  Borrowings under the secured receivables credit facility are collateralized by certain domestic receivables.  Interest on borrowings under the secured receivables credit facility are based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.725% to 0.80%.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9fb7b07b086a4309b9d46148ab2e12c2_I20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NDAy_8879b6c4-4261-4e6f-94dc-d28be15637e0"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9fb7b07b086a4309b9d46148ab2e12c2_I20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NDM0_8879b6c4-4261-4e6f-94dc-d28be15637e0"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id6f992896609491290214875ab35a9d6_I20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NDU0_75da8b42-54a5-408f-a9eb-bc53cf70a0e5"
      unitRef="usd">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i47405452b21d4961b150a63aba4933d5_I20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NTA4_7848acf0-c4d2-4385-8ec3-7eb8c445954c"
      unitRef="usd">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic3263481a80b4afdbad8e84b720b498c_I20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NTY2_0b1e984c-e867-42ed-8838-14f024c9844a"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia8f19a89fa884900aca21d4657c555f7_D20211022-20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NjM0_3f2599e4-416a-49c4-be6f-bc8b0ca1a63c"
      unitRef="number">0.00725</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2f807339735446ff8d0868243f7b30d8_D20211022-20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhZjZiMzIwYzNmNTRkNjY5MzdiNGI3NjczMDBhN2U0L3NlYzpkYWY2YjMyMGMzZjU0ZDY2OTM3YjRiNzY3MzAwYTdlNF8xMTEwL2ZyYWc6MDRhMmQxOTU4NTRlNDBjNjlkNDUwZTMyMTllMjE0NzgvdGV4dHJlZ2lvbjowNGEyZDE5NTg1NGU0MGM2OWQ0NTBlMzIxOWUyMTQ3OF80OTQ3ODAyMzI2NjU5_8d18b936-2642-4cad-b140-841fb3100092"
      unitRef="number">0.0080</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907942243048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Oct. 15, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Quest Diagnostics Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1387862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Secaucus,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,674,771<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908041531672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 2,774<span></span>
</td>
<td class="nump">$ 2,786<span></span>
</td>
<td class="nump">$ 8,044<span></span>
</td>
<td class="nump">$ 6,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating costs and expenses and other operating income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of services</a></td>
<td class="nump">1,670<span></span>
</td>
<td class="nump">1,580<span></span>
</td>
<td class="nump">4,861<span></span>
</td>
<td class="nump">4,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="nump">1,263<span></span>
</td>
<td class="nump">1,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense (income), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses, net</a></td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">2,068<span></span>
</td>
<td class="nump">6,199<span></span>
</td>
<td class="nump">5,259<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">652<span></span>
</td>
<td class="nump">718<span></span>
</td>
<td class="nump">1,845<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating income (expense), net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">654<span></span>
</td>
<td class="nump">753<span></span>
</td>
<td class="nump">2,097<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="num">(483)<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">527<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">$ 1,605<span></span>
</td>
<td class="nump">$ 852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic(in dollars per share)</a></td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 12.63<span></span>
</td>
<td class="nump">$ 6.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 12.41<span></span>
</td>
<td class="nump">$ 6.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in Shares)</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in Shares)</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022375144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 527<span></span>
</td>
<td class="nump">$ 591<span></span>
</td>
<td class="nump">$ 1,667<span></span>
</td>
<td class="nump">$ 890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in available-for-sale debt securities, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net deferred gain on cash flow hedges, net of taxes</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">1,675<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">$ 581<span></span>
</td>
<td class="nump">$ 1,613<span></span>
</td>
<td class="nump">$ 849<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907947004792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 987<span></span>
</td>
<td class="nump">$ 1,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $29 and $28 as of September&#160;30, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">1,473<span></span>
</td>
<td class="nump">1,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,854<span></span>
</td>
<td class="nump">3,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,634<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,057<span></span>
</td>
<td class="nump">6,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,152<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity method investees</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,572<span></span>
</td>
<td class="nump">14,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of long-term operating lease liabilities</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,759<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">4,006<span></span>
</td>
<td class="nump">4,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">495<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Quest Diagnostics stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2021 and December 31, 2020; 162 and 217 shares issued as of September 30, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,936<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">7,333<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 39 and 84 shares as of September&#160;30, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="num">(2,866)<span></span>
</td>
<td class="num">(5,366)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Quest Diagnostics stockholders' equity</a></td>
<td class="nump">6,392<span></span>
</td>
<td class="nump">6,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">6,432<span></span>
</td>
<td class="nump">6,809<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 13,572<span></span>
</td>
<td class="nump">$ 14,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022470392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907946584696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,667<span></span>
</td>
<td class="nump">$ 890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">302<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Provision for credit losses</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="num">(87)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_GainLossOnDispositionOfJointVenture', window );">Gain on disposition of joint venture</a></td>
<td class="num">(314)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">45<span></span>
</td>
<td class="num">(355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TerminationOfInterestRateSwapAgreements', window );">Termination of interest rate swap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities, net</a></td>
<td class="nump">39<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,752<span></span>
</td>
<td class="nump">1,464<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(251)<span></span>
</td>
<td class="num">(329)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(259)<span></span>
</td>
<td class="num">(256)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from disposition of joint venture</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Decrease (increase) in investments and other assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">248<span></span>
</td>
<td class="num">(604)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1,002)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(1,910)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(232)<span></span>
</td>
<td class="num">(222)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(2,171)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents and restricted cash</a></td>
<td class="num">(171)<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of period</a></td>
<td class="nump">$ 987<span></span>
</td>
<td class="nump">$ 1,605<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_GainLossOnDispositionOfJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Disposition of Joint Venture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_GainLossOnDispositionOfJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TerminationOfInterestRateSwapAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination of interest rate swap agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TerminationOfInterestRateSwapAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907945364536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock, at Cost</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 5,687<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,722<span></span>
</td>
<td class="nump">$ 8,174<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="num">$ (5,218)<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Sep. 30, 2020</a></td>
<td class="nump">6,446<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,801<span></span>
</td>
<td class="nump">8,800<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(5,161)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2019</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Sep. 30, 2020</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Jun. 30, 2020</a></td>
<td class="nump">5,881<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,764<span></span>
</td>
<td class="nump">8,307<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(5,187)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Sep. 30, 2020</a></td>
<td class="nump">6,446<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,801<span></span>
</td>
<td class="nump">8,800<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(5,161)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Jun. 30, 2020</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Sep. 30, 2020</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2020</a></td>
<td class="nump">6,809<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(5,366)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">1,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(233)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(1,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="num">(3,342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Sep. 30, 2021</a></td>
<td class="nump">6,432<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">1,936<span></span>
</td>
<td class="nump">7,333<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(2,866)<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2020</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Sep. 30, 2021</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Jun. 30, 2021</a></td>
<td class="nump">5,940<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,555<span></span>
</td>
<td class="nump">10,246<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(6,894)<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="num">(3,342)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Sep. 30, 2021</a></td>
<td class="nump">6,432<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1,936<span></span>
</td>
<td class="nump">$ 7,333<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (2,866)<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Jun. 30, 2021</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Sep. 30, 2021</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907939126088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DescriptionOfBusinessAbstract', window );"><strong>Description of Business (Abstract)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of Business (Abstract)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908031367848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#8220;COVID-19&#8221;) continues to impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three and nine months ended September&#160;30, 2021 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940952616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS (LOSS) PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.41&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program.  See Note 9 for further details.  The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first three quarters of 2021 did not equal the total for the nine months ended September 30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of the ASRs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908031690920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $54&#160;million of customer-related intangible assets and $171&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.</span></div>&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907941016664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISPOSITION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISPOSITION</a></td>
<td class="text">DISPOSITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the nine months ended September 30, 2021, the Company recorded a $314&#160;million pre-tax gain in other income, net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the nine months ended September 30, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940487880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed investment options that are classified as trading securities.  These trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in the Company's consolidated balance sheet.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  During the three months ended September 30, 2021, certain of the Company's equity investments became publicly-traded and, based on the readily determinable fair values, the Company recognized gains of $42&#160;million in other income, net in the Company's consolidated statement of operations.  Such equity investments are now classified within Level 1 of the fair value hierarchy because the changes in the fair values of the securities are measured using quoted prices in active markets based on the market price per share multiplied by the number of shares held, exclusive of any transaction costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of September&#160;30, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the nine months ended September&#160;30, 2021, the Company recorded an $8&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of September&#160;30, 2021 and December&#160;31, 2020, the fair value of the Company&#8217;s debt was estimated at $4.5&#160;billion and $4.6 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907943031144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in goodwill for the nine months ended September&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,057&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of September&#160;30, 2021 and December&#160;31, 2020 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, goodwill acquired was principally associated with the acquisition of the outreach laboratory services businesses of Mercy Health and adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy; Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining 56% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets as of September&#160;30, 2021 and December&#160;31, 2020 consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(878)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(878)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2021 is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940435112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both September&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and nine months ended September&#160;30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940516056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and nine months ended September&#160;30, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the nine months ended September&#160;30, 2021, $20&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income, net.  See Note 5 for further details. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the first three quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of September&#160;30, 2021, $1.3 billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021, the Company repurchased 12.5&#160;million shares of its common stock for a value of $1.6&#160;billion, including 9.1&#160;million shares repurchased under ASRs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The repurchases under the ASRs were initiated in April 2021 with the Company's entry into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract. For the nine months ended September&#160;30, 2021, the Company paid $1.5&#160;billion to the financial institutions and received 9.1&#160;million shares of its common stock, at an initial price of $132.27 per share for a value of $1.2&#160;billion, which represents 80% of the total value of shares to be repurchased under the ASRs. The ASR contracts will settle the remaining shares, based on the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, upon the completion of the ASRs during the fourth quarter of 2021. The Company recorded the transactions as an increase to treasury stock of $1.2&#160;billion and it recorded the remaining $300&#160;million as a decrease to additional paid-in capital in the Company&#8217;s consolidated balance sheet.  The $300&#160;million recorded in additional paid-in capital will be included in treasury stock upon completion of the ASRs.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2020, the Company repurchased 0.7 million shares of its common stock for $75 million.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the nine months ended September&#160;30, 2021 and 2020, the Company reissued 1.7 million shares and 2.1 million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock Retirement &#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended September 30, 2021, the Company retired 55&#160;million shares of treasury stock. In accordance with the Company's policy, the amount paid to repurchase the shares in excess of par value was allocated between retained earnings and additional paid-in capital based on a pro-rata allocation of additional paid-in capital at the time of the share retirement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of September&#160;30, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 6.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908032225864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW AND OTHER DATA<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:56.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration receivable/payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law.  In April 2020 and August 2020, the Company received approximately $65&#160;million and $73&#160;million, respectively, of funds that were distributed to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic under the CARES Act.  The Company accounted for the receipt of the funds under a gain contingency model. Accordingly, the amounts were recognized when the funds were received and the Company determined that it satisfied the associated terms and conditions. During the three months ended June 30, 2020, based on the terms and conditions that were in effect at such time, the Company concluded that it had satisfied such terms and conditions for the $65&#160;million of funds that were received in April 2020 and, therefore, the Company recognized such amount in other operating expense (income), net during the second quarter of 2020.  During the three months ended September 30, 2020, the Company reversed the $65&#160;million of funds that had previously been recognized and, during the three months ended December 31, 2020, the Company returned the entire $138&#160;million of funds.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940426472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  See Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of September&#160;30, 2021, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of September&#160;30, 2021, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $6 million and $1 million as of September&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div>&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $153 million and $138 million as of September&#160;30, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940327256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of September&#160;30, 2021, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three and nine months ended September&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(483)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.788%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907938954504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over 95% of the Company&#8217;s total net revenues for the three and nine months ended September&#160;30, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940411448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text">TAXES ON INCOME&#160;&#160;&#160;&#160;For the three months ended September&#160;30, 2021 and 2020, the effective income tax rate was 23.4% and 23.7%, respectively.  The effective income tax rate for the three months ended September&#160;30, 2021, benefited from a $6&#160;million income tax benefit associated with changes in reserves for uncertain tax positions, and $6 million of excess tax benefits associated with stock-based compensation.  The effective income tax rate for the three months ended September&#160;30, 2020, benefited from a lower effective income tax rate, 11.8%, associated with a $70&#160;million gain recognized as a result of the remeasurement of the Company's previously held equity interest in Mid America Clinical Laboratories, LLC ("MACL") to fair value, and $3 million of excess tax benefits associated with stock-based compensation.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the nine months ended September&#160;30, 2021 and 2020, the effective income tax rate was 23.1% and 23.9%, respectively.  For the nine months ended September&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions (see Note 5). For the nine months ended September&#160;30, 2020, the effective income tax rate benefited from a lower effective income tax rate, 11.8%, associated with a $70&#160;million gain recognized as a result of the remeasurement of the Company's previously held equity interest in MACL to fair value.  In addition, the effective income tax rate benefited from $15&#160;million of excess tax benefits associated with stock-based compensation arrangements for both the nine months ended September&#160;30, 2021 and 2020.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907938900936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENT&#160;&#160;&#160;&#160;During October 2021, the Company amended its $600&#160;million secured receivables credit facility in order to extend the maturity dates for each underlying commitment by one year while maintaining the aggregate borrowing capacity under the secured receivables credit facility at $600&#160;million.  Under the secured receivables credit facility, the Company can borrow against a $250&#160;million loan commitment maturing October 2022 and a $250&#160;million loan commitment maturing October 2023.  Additionally, the Company can issue up to $100&#160;million of letters of credit through October 2023.  Borrowings under the secured receivables credit facility are collateralized by certain domestic receivables.  Interest on borrowings under the secured receivables credit facility are based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.725% to 0.80%.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022997304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards to be Adopted</a></td>
<td class="text">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908031256168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.41&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940372152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value, Measurement Inputs</a></td>
<td class="text">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907938948312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill, Net</a></td>
<td class="text">The changes in goodwill for the nine months ended September&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,057&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Excluding Goodwill</a></td>
<td class="text">Intangible assets as of September&#160;30, 2021 and December&#160;31, 2020 consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,794&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(878)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(878)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense Intangible Assets</a></td>
<td class="text">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September&#160;30, 2021 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907942305384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock', window );">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</a></td>
<td class="text">As of September&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both September&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Fair Value Hedge Accounting on the Statement of Operations</a></td>
<td class="text">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and nine months ended September&#160;30, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907939029176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow and Other Data</a></td>
<td class="text">Supplemental cash flow and other data for the three and nine months ended September&#160;30, 2021 and 2020 was as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:56.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration receivable/payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907938850088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Segment Reporting Information by Segment</a></td>
<td class="text">The following table is a summary of segment information for the three and nine months ended September&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(483)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock', window );">Schedule of Revenues by Major Service</a></td>
<td class="text">Net revenues by major service were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.788%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,044&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,435&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Revenues by Major Service</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907940630120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The approximate percentage of net revenue by type of customer was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AccountsReceivableDisaggregationTableTextBlock', window );">Accounts Receivable Disaggregation</a></td>
<td class="text">The approximate percentage of net accounts receivable by type of customer was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableDisaggregationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disaggregation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableDisaggregationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022898680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">$ 1,605<span></span>
</td>
<td class="nump">$ 852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Less: Earnings allocated to participating securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">$ 566<span></span>
</td>
<td class="nump">$ 1,599<span></span>
</td>
<td class="nump">$ 849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic(in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 12.63<span></span>
</td>
<td class="nump">$ 6.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 12.41<span></span>
</td>
<td class="nump">$ 6.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options and performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember', window );">ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AcceleratedShareRepurchasesInitialPricePaid', window );">Accelerated share repurchases price paid</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AcceleratedShareRepurchasesInitialPricePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Initial Price Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AcceleratedShareRepurchasesInitialPricePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022389272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 251<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
<td class="nump">$ 6,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember', window );">Mercy Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="nump">$ 225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember', window );">Mercy Health | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022361320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISPOSITION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 483<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross', window );">Gross proceeds from disposition of joint venture</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Other Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on sale of investment, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Sale of Equity Method Investments, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907942238936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details) - Recurring Basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other Observable Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities', window );">Equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907937687112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Equity securities, gains</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=124268079&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022526808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at beginning of period</a></td>
<td class="nump">$ 6,873<span></span>
</td>
<td class="nump">$ 6,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Adjustments to goodwill</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at end of period</a></td>
<td class="nump">$ 7,057<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">MACL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907942433672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 2,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Intangible Assets Not Subject to Amortization - Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Intangible Assets Not Subject to Amortization - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer-related intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(704)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(704)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(638)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember', window );">Total Amortizing Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022241256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Balance Sheets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Hedge Accounting Basis Adjustment</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907947070968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Income Statement) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 366<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items (Long-term debt)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907946207256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="7">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized', window );">Additional amount authorized</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase authorization remaining available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,910,000,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare', window );">Accelerated share repurchase, initial purchase price, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Reissuance of shares for employee benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember', window );">ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution', window );">Value of shares to be received under accelerated share repurchase agreements at execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements', window );">Accelerated share repurchase, percent of total value to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,610,000,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost | ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stockholders' equity, period Increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stockholders' equity, period Increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements', window );">Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_StockRepurchaseProgramAdditionalAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907937639160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_InterestPaid1', window );">Interest paid</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">522<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable associated with capital expenditures</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FairValueOfNetAssetsAcquired', window );">Fair value of net assets acquired</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Mergerconsiderationpaidpayablenet', window );">Merger consideration receivable/payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: Cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_InterestPaid1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Paid1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_InterestPaid1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Mergerconsiderationpaidpayablenet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger consideration paid (payable), net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Mergerconsiderationpaidpayablenet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139907942469016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche', window );">CARES Act, amount received from initial tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche', window );">CARES Act, amount received from secondary tranche</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ReturnOfCashCARESAct', window );">Return of cash, CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other expense (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_CARESActProceedsRecognizedInTheStatementOfOperations', window );">CARES Act proceeds recognized in the statement of operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ReversalOfRecognitionOfCARESActProceeds', window );">Reversal of recognition of CARES Act proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_CARESActProceedsRecognizedInTheStatementOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act proceeds recognized in the statement of operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_CARESActProceedsRecognizedInTheStatementOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act, Related Expenses or Lost Revenues, Amount Received from Secondary Tranche</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ReturnOfCashCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Return of Cash, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ReturnOfCashCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ReversalOfRecognitionOfCARESActProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reversal of recognition of CARES Act proceeds</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ReversalOfRecognitionOfCARESActProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalCashFlowAndOtherDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Supplemental Cash Flow and Other Data [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalCashFlowAndOtherDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022900696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted', window );">Self-insurance reserves</a></td>
<td class="nump">$ 153,000,000<span></span>
</td>
<td class="nump">$ 138,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Class action lawsuits | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember', window );">Excludes general and professional liability claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserves</a></td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908027499256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,774<span></span>
</td>
<td class="nump">$ 2,786<span></span>
</td>
<td class="nump">$ 8,044<span></span>
</td>
<td class="nump">$ 6,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">652<span></span>
</td>
<td class="nump">718<span></span>
</td>
<td class="nump">1,845<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating income (expense), net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">654<span></span>
</td>
<td class="nump">753<span></span>
</td>
<td class="nump">2,097<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="num">(483)<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">527<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">568<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
<td class="nump">852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember', window );">Routine clinical testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">3,392<span></span>
</td>
<td class="nump">2,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember', window );">COVID-19 Testing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">965<span></span>
</td>
<td class="nump">2,048<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember', window );">Gene-based and esoteric testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">646<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">1,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember', window );">Anatomic pathology testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember', window );">All other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,703<span></span>
</td>
<td class="nump">$ 2,709<span></span>
</td>
<td class="nump">$ 7,820<span></span>
</td>
<td class="nump">$ 6,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">$ 713<span></span>
</td>
<td class="nump">$ 840<span></span>
</td>
<td class="nump">$ 2,026<span></span>
</td>
<td class="nump">$ 1,325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">General corporate activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="num">$ (69)<span></span>
</td>
<td class="num">$ (138)<span></span>
</td>
<td class="num">$ (207)<span></span>
</td>
<td class="num">$ (178)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AllotherservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908023039832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Fee-for-service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Capitated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Client Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments | DS Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_FeeforserviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_FeeforserviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_CapitatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_CapitatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022919256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">23.40%<span></span>
</td>
<td class="nump">23.70%<span></span>
</td>
<td class="nump">23.10%<span></span>
</td>
<td class="nump">23.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Changes in reserves for uncertain tax positions</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share-based compensation, excess tax benefit, amount</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest', window );">Effective tax rate on remeasurement in previously held interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by Sale | Q2 Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Tax Rate on Remeasurement of Previously Held Equity Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139908022641528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENT (Details) - Secured Receivables Credit Facility - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 22, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Commercial Paper or LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">0.725%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Commercial Paper or LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Loan commitment maturing October 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Loan commitment maturing October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dgx_CommercialPaperOrLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dgx_CommercialPaperOrLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>63
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M 4Z<J"X=54/Q35E5+[G"&KW\3/&B1H4&X/\5Y^JEH0/45[_Q/U!+ P04
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MJF.J64CX&7R#E]D83D_.0,6XHX"E<,\XQ\^ASN&D/NVY&N%,"#<L0:X*D.
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M/^M<T)-)/+0#G,2_@N_TP36Q2YE)^<?>?,O..I%%Q'.>&JLB@;\MG_ \MYH
MQ]^]TDXUIQUX>/VL_8M;/"QFEF@^D?DOD9GE66?4(1F?)YO<_)"[KWR_H+[5
ME\I<NU^RV\M&'9)NM)&K_6! L!)%^9\\[@UQ, #TX /8?@!K#NAY!L3[ ;%;
M:(G,+>LJ,<GYJ9([HJPT:+,7SC9N-*Q&%'8;IT;!6P'CS/GD[G9Z]_W;U<7#
M]169/L#?S?7MPY3<?2&3B^E7\N7[W:\I.28_IU?DZ,-'\H&(@MR(/(<]T*==
M Q"LHFZZG^ZRG(YYIAN3&UF8I2;71<:SE^.[ +W"SY[Q7[*@PBE??R9Q](FP
MB%$$S^3MPZ, G+@R9^STQ3YS)GI)YA ;FLR57!$(-Y4842Q*?Q5&<'T2F*=7
MS=-S\_0\\]Q"@(LBE2N.[4$Y=N#&VCC>GM/!8'C:W1X:IBTT&D>5S M4_0I5
M/[CZB^PW>"P$N='$2(CR5!:IR#DI*KCVN;U+K:'62FX%^ &9/;W;4H,*TR!H
MJ2L.Z2T529DTBHPD*ZF,^,\]P(Q7JNL?V"6.6,-V;1DVB'';#2N<PR#.>VL+
MEQPA-Y-4\4P8DDNM.1IFPS;*!L:V!!WA$$<5Q-$KIIQS!<"JK4P>R=&,%WPN
MS,=R,[7'J*,6F.-1TR';,I3A@,<5X'$0\-3(],^QS?(9 <1 ?;KT _YHK]'8
M&;=0#*(&4$3$L_DTJM-P%(3Z#S N 629T&NIA4,IY^2W%(4A6XBHC4+A[M6^
ML&Q,>PW$B)0GU.D!<= @XCNSY.J3#684%VWCZHV:L!"A@0\8JX&Q< Y>)L6"
M:TM4!TD% @FRDDT N4AF(G\UP= ZY],X:(F+-)4;F_,@T7"Q368YOE5Q:[6]
M?M,B;9GCN-_WF*1F"QJFBPKA.GFR\,I$F*9J Y&Q#P:<S7OM/#-H8F[+] \\
M\"7DFDIH/PCY6Y5C> 4;1=AO6W7<1-B6&?ML6O,*#1/+ U=0CR7/D0IQRA77
MAH##<:)WR9HD"\6Y8T,4>)M$FHD&$>GYPJ/F&1HF&A>WGGCPAS/"-RTKMV6.
MZ< #M^8<&B:=V[<6"RALA%.&_2:;8U*]@<^#:_*AXW?5@J+8@G^\O<)A-7FP
M,'E<;C0\T;"=Z=^-*-FCW$OKF<YZ[HUJEMS["AOA$-:G#2MA4C$;XU9B-8VP
M,(U,DK4P25YF(:AY@.?0K60(5[!^TP=Q*8\3LII2&'NM.$LYS_8;^5Z.WBL_
M!#7L-S,_(N0)=583$PL3TQ6'.A*J'W($%9N[^FA9L73$LDRW"4 >9 04?YN4
MFL4F(G),?;Y1TQ9[O<MIQ?[11KL2]",:4"C^-D&Q5BV""$$MXDD"K*8Q%FZ)
MFDE@#I0!/=';DT#-1RS,1R]]="85:(!Y<(N\SCV(R+#GV]&:?%B8?'YPH/+2
M\R!R,CY#V88A3-),VI@,C2)/Q\!JOF%AOKG?J'0)D>( &ALT&_5$M.TD4*A(
M9T/'M&5-1&SH*4%8S3 LW-]</W*5"HAO@.H0 C$:WX<9UFY;:-2* D2HYPF"
MN.:G.,Q/UZMU+I\XMW6<DGGN.L>=,,NES#/KH[;S*1<@M+8UZ:;(("5I7_^V
MSA-\D3%&94W7P82HIX.+:R*+PT1V)6R**C);K0J49V.,G.(6.DR*>?PZKBDL
M#E/8E=!&B=G&^8?["B.APBZ,W0^;CJKZ=9TH4W"%F[=-4H=NO%\ (A3[?.C@
MPUJ8R\JR%4N?WJ(UQIJIIL<C0IYR(:YY*WXC;^VI"H6-(D9(B-%ALQ3#Q'J]
MH0=VS55QN.5RL%WS;#&792.4!^Z"0_FX3?*J9K"NHD1J>/D>74R[ZSI&UH+T
M;]Y@K,DP#I/AY#W@/Y$97XBBL/L#F11Z"R'Q &YS(J7]ED=A4F-? -?4&8>I
M\YU+XK:P"RYFV/H /&Y]DT.$Z"!J$E?WX/QAQ=7"'<MHXKXYE)_RJZ?5T<^%
M._!H/+^D)Y/R *=64YXGW20*MDB3G,]!9?1Y".95Y1%->6/DVIURS*0Q<N4N
MESP!%K$"\'XNI7F^L1-4!V7G_P-02P,$%     @ Z()64\2W<S!M"@  "4
M !@   !X;"]W;W)K<VAE971S+W-H965T-RYX;6S%FVU/X[@6Q[^*A5:Z,]*4
M)K;CI"M &MI"N7=F8(&9U=7JO@BIH=&D23=)>?CVUTE#W=C';FF[S!MHX6_W
M^.G\SO%)CYZR_&<QX;Q$S],D+8X/)F4Y^[W;+:()GX;%83;CJ?C/?99/PU*\
MS1^ZQ2SGX;AN-$VZV'%8=QK&Z<')4?VWJ_SD*)N729SRJQP5\^DTS%].>9(]
M'1^X!Z]_N(X?)F7UA^[)T2Q\X#>\_#Z[RL6[[K*7<3SE:1%G*<KY_?'!9_?W
M48"K!K7B1\R?BI77J!K*79;]K-Y<C(\/G,HBGO"HK+H(Q:]'WN=)4O4D[/B[
MZ?1@^9E5P]77K[V?U8,7@[D+"][/DC_C<3DY/@@.T)C?A_.DO,Z>1KP9D%?U
M%V5)4?]$3XW6.4#1O"BS:=-86#"-T\7O\+F9B)4&+C$TP$T#O&D#TC0@2@/L
M&QK0I@%5/R$P-/":!I[2@)@^@34-F&H2-33PFP:^VH 9&@1-@Z!>W<5RU&LY
M",OPY"C/GE!>J45OU8MZ0]2MQ1+&:;5W;\I<_#<6[<J3_N6WF\LO%X//M\,!
MNKD5O[X.O]W>H,LS\>ZR_Y_1Y9?!\/KF7VCXQ_>+V_^B#OI^,T ??ON(BDF8
M\P+%*?H:)XG8A\4G]-OJVZ-N*0RL/J8;-<:<+HS!!F-NLS),@&9]>[-^-IV*
M8W!39M%/H/7 WOKS>!Q7QRA,T%48CSL7*>J'LQBV9&COZYJ7PEWP,1J&>1JG
M#] <G*TQ)XKFTWD2EJ*7RW+"<R2&)]S2I/(7CQQ]R0JHU_,U,RO\6C'/7Q:3
M] F%I>BV*(&.1O:.OF5I)\K2,L_$(J</Z"(MN=@&I6)35VS#Y5[$R[V(Z[ZI
MH>_3, G3B']ZW5K"R &/#A%Q/R'LN#UH9RQZ].H>*S_]>.(2<M1]!,P@2S/(
M9F8\ALF<;V+%Z:)#MF*%QP)_:<;"5%V$VXH!H/"Q(AKJHL#U:5MTIHLZI-?6
MG ,:#[M!6S72593!\TN7\TOK-L0POQ=I5.U&CCZ(>:U??:S<1KTS)UDRYGDA
MW,W?\[A\07]=BWV&!*6>PGS\/\L>\Y8?[ED7]YL(!^(TRJ8<6D=/VTU!0)3Y
M!S2>LD8C74-<>-+8TFYFM7OA"J*6*UB, WU(A$OX^ FE8FC9/2K#9P[Z7J89
MU5'&=F:5M.SVEW;[5KL'\6,\YNFX$ %%E(AC/89,\_7/Q9@I$[]&U#(O6)H7
MK#&O*//X;EX!H$!EAM(L775O<>/>T"S,RU3L3,CZ )@U5]D1=DW+]M[2]I[5
M]HNBF%>.JEKT:(' HCI#:)Z*,X3N>,KO8V&Y\&;%JT^%7&A/=Z&P8:XC@PIG
M;Z:!88*CVZ2XTP&@423G4#>.86PK 9-K'5OMISI5O#RNSZ,XC&$=AO/GZC7H
M5YHN5PUA1!V/5=,V5A+5M2-U^,SS*"[JA5BL0#8K%[&:>4.X.E2QP1#)5-<.
M5:,AX'01?=TH5>=+%ZFL/'=U>KG8-!;)+Y?:=\ B/!'>(LH>Q7;FTUF2O7 N
MG,1+Y3@J%RS"^')2T:R* M%R_\?B8(A]LS@&A6DGF<\%U=V(JVTDNZ@]:,E-
MUP[.JWD>382I1<V8UW"R6(23EKVDH[#CJJNTT 2K&N?0-U@LB>G:D6FQ&)Q;
M 'Z^IYK*]*!I1=2V5#+2M4,2"'QO^$R$G$X5<F('G%@=ARXQ62)QZ-IYJ,>^
MZPPY=76T,4H5>/<;E2WZ!3K"@:-LEB&@"@+'40(90-6AFG< 1)[+5'0#,E,(
M[$IVNW9X+R?ZQ\9)AJN#VC?8@26IL6,-QJ_YF/-I>)=P9$KMT%^?[T24%$:E
M+0#'$J#8#E!["(YU#!H\ 5[)*^T4W$N4AW4JFH)C++&(-\PU?VQ\WK#.O< 0
MU&")-&Q'&N"!_CU/[1X(ZYQQ"358(CF#[9S1/= Z0TZQSA@O")1CW&]4-@\$
M=(1]I@0>0T 5$$>)/<\ 5<=3<0**7/7F8 0-T+3D$H^8O7\:CB7SL)UY:[R
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MU+>3=)L[!!]XH-95AV/5M(V5;/6W?.K6EM/YP-.W!D,D7/T]%CQ]H)BI)C6
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MU_OM[OOV^0D]/Z#L)=\^;?(\#HPE=RE!,1)E U%T@>@K>I3"-!IM1 GEW_C
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M\4!DC0^V2LKPH-(F_I>/"8>>PKOQ'H5)4IBPW_$@]O)*!GE^ZNQ6.)*&-?K
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M6VM#A^#02AJT-\D(Z90P*E/>@P $*$5(L9+:[<R3 IQ$3['#(!_'WOHA/*O
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MM[O4L*BL5$'@84#\GOJ4T/> VI-3V!&$:K%:DI.D+\AIG!X*<JE)@Z2=U!1
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M-?8B@/.5 ]!V(0[Z[[_9/U!+ P04    " #H@E93$C=.2'T$  "^"0  &0
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M7:S8N]YXD9:9;Y3NBRA6-=<0,"THCLC&'F^V!=?.<&<"V7^0= ML">#126Z
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MT5K_;C78.0S.W?'U#2;O&+-[S@-F@[+;U=T.+DY>M[+O*&T/DU[]'.,Y;(]
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M>%#@%.+!]3MT/B'%'MRZUX2>>UNF<\?VD^;4AX@B.G4M5^D&%\? F>)\W%O
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MV@G0_D8I>U@X!^WE;_(74$L#!!0    ( .B"5E/&L$2+L ,  #P)   9
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;*U6;6\B-Q#^*Z/MJ6JENRPLD 0*
M2)!P:J302R%)/U3]8'9GP8K7WK.]<-=?W['W)8L2<FUU$O(+GGGFF6?\LN.#
MTD]FAVCA2R:DF00[:_-1&)IXAQDS9RI'22NITAFS--7;T.0:6>*=,A%&G<YY
MF#$N@^G8_W>GIV-56,$EWFDP198Q_76.0ATF03>H_UCQ[<ZZ/\+I.&=;7*-]
MR.\TS<(&)>$92L.5!(WI))AU1_.^L_<&CQP/IC4&E\E&J2<WN4DF0<<10H&Q
M=0B,NCU>H1 .B&A\KC"#)J1S;(]K](\^=\IEPPQ>*?$'3^QN$EP&D&#*"F%7
MZO K5OD,'%ZLA/$M'$K;7C^ N#!6994S,<BX+'OVI=*AY7#9.>$050Z1YUT&
M\BROF673L58'T,Z:T-S I^J]B1R7KBAKJVF5DY^=?IS=K.!Q=ONP@.5BMGY8
M+9:+W^[7\-,]VP@T/X]#2U&<;1A7B/,2,3J!.(2EDG9G8"$33([]0V+74(QJ
MBO/H3< UYF?0Z[R'J!-UW\#K-2GW/%[O5,J,:WADHD"XYB86RA0:#?PYVQBK
M:9?\]4:,?A.C[V/TOQGC/2R1N0BTDRW<R+RPYC51W\1S1W-D<A;C)*"S9U#O
M,9C>[Q!2)>A<<;D%ZPH&N59[GE ZK#YGH%*P9*DQ5EO)_\8$F#%HR40F(#C;
M<,$M)Q>[8Q:81LA*QF1H(769[+U:[A YF$)K%Y . S<CF+O.!6GIVDK9P.^%
MLH1UIWE,0;B$F3^)L&3ZR=&@FP5N$C+E,1,P\]S"VQ:O-2?>*:V2@)\H%0V?
M-DX"GW"IZ)'-@U0OUS&WF&W(M]Y)<*\LQ;O%/0KH5GU4];V*QPBN,47MM(A5
M1C>A8?XRH8V2. V,4Z-D^0XN!G7SXP^743?ZI36Z8F9'%2$D.A6-H"GIGR)I
M0BM,QE0^)7CLT ;]QK4U7'PNN/U*]GLTME2W/W2_VJ#N9WO&A<O_ ZG[P3 2
M(L&-;?/MOG"J)7D'W8NA:Z,^M0/7D#[/!3DE2GLOD4MO>*3$\7R%"=+SXBHD
ME8SIQM"TDYVD7%JD+6Z=EL-7M?0+W]QVUQA7!>_Z@G>^?\'/+^KF.Q2\\USP
MSG^J8_2RD-%S):-AS9%@W?Q_5#(Z/Z[DT?Q?5?(R.E%)6GCMN@U;+UJ&>NO?
M;4,D"VG+QZWYM_DTF)4OXK-Y^5U!U\R6] :!*;EVSBX& >CRK2XG5N7^?=PH
M2Z^M'^[H\P:U,Z#U5-']54U<@.:#:?H/4$L#!!0    ( .B"5E-*8$K4>@0
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M-$8<,8POK<^H"RD+-]MK[U<A=\XE4807UORN,U^,H[,(,LQ5;?R]7;W#-I\
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M2Z2=F$:SY?WM_6\K\! MP>KS;!F!\SD6B*3\ GP$CZLY.#^[ &?  7R#&.:
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M#V7 K+IU5P-!"WU+?*)"WCGUXP8CV:TH@'S_3*EX':@%FM\^IO\ 4$L#!!0
M   ( .B"5E,CCY<_:P,  %$-   9    >&PO=V]R:W-H965T<R]S:&5E=#,R
M+GAM;+5776_;-A3]*X30AQ9((U'6AU/8!F([B3TL;1HMZ\/0!]JB+:*4J))4
MG #[\2-I199G25/;Y<4FJ7O.X24/KZC1CO%O(L%8@J>49F)L)5+F'VQ;K!.<
M(G'.<IRI)QO&4R15EV]MD7.,8@-*J>TZ3F"GB&369&3&[OADQ I)28;O.!!%
MFB+^/,64[<86M%X&[LDVD7K GHQRM,41E@_Y'5<]NV*)28HS05@&.-Z,K4OX
M80$##3 1?Q*\$[4VT*FL&/NF.\MX;#EZ1ICBM=042/T]XAFF5#.I>7PO2:U*
M4P/K[1?V:Y.\2F:%!)XQ^H7$,AE;0PO$>(,**N_9;H'+A'S-MV94F%^PV\?Z
M@076A9 L+<%J!BG)]O_HJ5R(&@!Z+0"W!+A] 8,2,.@+\$J UQ?@EP"_+R H
M 4%?0%@"PKZ 80D8FMW=;X?9RSF2:#+B; >XCE9LNF$,8=!J"TFFO1M)KIX2
MA9.3Z4.T_'@51>!R]OEA&2W_6'[Z&(&W<RP1H>(=> \>HCEX^^8=> -(!FX)
MI<IR8F1+):XI['4I--T+N2U"OQ79.7#@&7 =%S; 9]WP".?G8."TPN?]X4X#
M_.K7U*]_3?VF&S[':P6'K?!%;SB\.(;;RBV59=S*,J[A&[19IA!J1 APN?Y>
M$$%,#?KK=S4&EA*GXFN'QJ#2&!@-KT5CAD0"<D1BH,HS6+THHH-BDP5G>]+
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M5!MLFHGZYL%<!ZCG&\;D2T=?,*NOJ,D_4$L#!!0    ( .B"5E,W1HLT_0,
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M%=XI0;L)^'VIE'U^<5>$ZI8Z_A=02P,$%     @ Z()64TYONXD>!0  51@
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M]O;$R&6V#3R5QL@X.UPP"@L[#8#[,PE?]_E)NK-<_"=A\#]02P,$%     @
MZ()64\V9HK%? P  8PH  !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
MS59M;QHY$/XK(]1*B91C7W@)5 2)!'*E"FT4CMR'TWTPRP!6O?;6]D+S[V_L
MW6RXZV8;Z;[T"_AEGF=F'GO',SHJ_=7L$2U\3X4T5ZV]M=F'(##)'E-FVBI#
M23M;I5-F::IW@<DTLHT'I2*(P[ ?I(S+UGCDU^[U>*1R*[C$>PTF3U.FGZY1
MJ.-5*VH]+SSPW=ZZA6 \RM@.EVA7V;VF65"Q;'B*TG E0>/VJC6)/LRBV &\
MQ2/'HSD9@TMEK=17-YEOKEJABP@%)M91,/H[X T*X9@HCF\E::ORZ8"GXV?V
M6Y\\);-F!F^4^)-O[/ZJ-6C!!K<L%_9!'3]BF5#/\25*&/\+Q\+VDHR3W%B5
MEF"*(.6R^&??2R%. ,13#XA+0/Q60*<$=/X+Z+X"Z): [EL!O1+@4P^*W+UP
M4V;9>*35$;2S)C8W\.I[-.G%I;LH2ZMIEQ/.CF\G\P=XG-RM9K"839:KA]EB
M]OF/)9Q]9EHS=XCG<#9%R[@PY_ ;K)93.'MW#N^ 2UAP(>BTS2BP%(HC#)+2
M[77A-G[%;0<62MJ]@9G<X*8&?].,'S;@ Y*@TB%^UN$Z;B1<8M:&3G@!<1A'
M=?'\/_BT&3[%A."1AX<U\%DS_%,NVA!Z>-1K$*-378J.Y^N\=BD8U_#(1(XP
MY281RN0:#?PU61NKZ=/^N\%'M_+1]3ZZK_B8?<NY?0*#2:ZYY6@N8$=UK?8N
M%4Q]S^0JWV'<C4?!H<9[K_+>>V.&%W#-!),)PM(7YM^URC,N=Q=PRR6M<R9@
M:9E%JHX6;ECFZAMI<4>,,*=ETZ1&OXJGWZB&C^?@%5=;*G1K6Z=#_T<=>F%8
M*5%<U+<836N,^B=&_\KALLKA\N<YE)K.999;.M([/*" 3H-"@XI]\$N<V+"*
M9]B8[3S-*"+O@DX,B]N<HMVK#97& QKK]NHJR? '[0?UPD?A2Q$/&X-9+9@Q
M\$EQBN:1W-+GVI!B=/(X1+^$Z%'\$E'<F.F7HT1M]CR##'5"OJB;@?432"43
M>A&THA=)[D!YL[I*^A/^:- >AN_K0@U.'MD4]<YW-P82E4M;O+?5:M5!37S?
M$+R8%^W7@ND=E3H0N"5HV+ZD8J6+CJ:86)7Y)WNM+#4 ?KBG+A"U,Z#]K5+V
M>>(<5'WE^!]02P,$%     @ Z()64Y6*%R@3 P  F@@  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S8N>&ULE5;;;MLX$/V5@= ""=!&%]N24]@&?$E3 TX:
MQ+T\%/O 2&.;K42Z)!VW?]\A):M.K&AW7R21G'/F<&;(T6 OU0^]033PJ\B%
M'GH;8[;O?%^G&RR8OI!;%+2RDJI@AH9J[>NM0I8Y4)'[41#$?L&X\$8#-W>G
M1@.Y,SD7>*= [XJ"J=\3S.5^Z(7>8>*>KS?&3OBCP9:M<8GF\_9.T<BO63)>
MH-!<"E"X&GKC\-TT#"S 67SAN-='WV"W\B#E#SN89T,OL(HPQ]18"D:O1YQB
MGELFTO&S(O5JGQ9X_'U@?^\V3YMY8!JG,O_*,[,9>GT/,ERQ76[NY?X#5AOJ
M6;Y4YMH]85_:)K$'Z4X;651@4E!P4;[9KRH01P#B:09$%2!Z#GC)0Z<"=-Q&
M2V5N6S-FV&B@Y!Z4M28V^^%BX]"T&RYL&I=&T2HGG!E=?_PX^SI?+&!\.X/Y
M[:?Q[?5\LKB"\7)Y]6D)9]=29GN>Y^=P-D/#>*[/X2U\7L[@[-4YO (NX(:6
M*2-ZX!L29&G]M'(^*9U'+SB_A!LIS$;#E<@P:\!/V_%AU$+@4R3J<$2'<$RB
M5L8E;B^@$[R!*(C")D'M\!FF! \=/&B1TZFSTW%\G9>R4T4?OMU+>E+A[IG*
M_FEA[M;,7<?<_1?F-S!A.1,I C/P@&LN!!=KD"O8HN*R*2F3DCEVS/::>!S%
M_:0S\!^/ ]5@%(>7M=$3T;U:=.\_B:;#_W/'%6:0[925:S;8HK<D[1U)"?O]
M9W)/;:)NTJPVKM7&K6K'V7<ZOW3E&0U&PKH2WZ0P/O'^MOM,X*G)"_*26E[R
M_RL 1=:>^^0DK4G02YYI/35Z4B!/Y/9KN?U6N3?CZ:*E[B]KFLO6$S79:9K1
M&L:VA#1WO>3;@N9@;K#0;6<K#/Y>JD&KV#M4*>6=^J"-)A<&%6HJ@T/=-EYU
M[92]^"((7C>I\X]N_P+5VC5%#:G<"5,V@GJV;KQCUV[\O^9EU[YABFX #3FN
M"!I<)%1OJFR$Y<#(K>LE#])09W*?&_IY0&4-:'TEI3D,K(/Z=V3T!U!+ P04
M    " #H@E93@R,#^-\&  #J)P  &0   'AL+W=O<FMS:&5E=',O<VAE970S
M-RYX;6S%6E%SFS@0_BL:3Q_:F;@&28"=23SCV*'GF23-U.EU;CKW0&S9Y@K(
M!W+2]->?  <9) 2DN<E+ OC;U:ZTVD]:Z>R1QC^2+2$,_ R#*#GO;1G;G0X&
MR7)+0B_Y2'<DXK^L:1QZC+_&FT&RBXFWRH3"8  -PQZ$GA_UQF?9M]MX?$;W
M+/ C<AN#9!^&7OQT00+Z>-XS>\\?OOB;+4L_#,9G.V]#%H1]W=W&_&U0:%GY
M(8D2GT8@)NOSWL0\=2V<"F2(/WWRF!P]@]25>TI_I"_SU7G/2"TB 5FR5(7'
M_SV0*0F"5!.WX]^#TE[19BIX_/RLW<V<Y\[<>PF9TN";OV+;\]ZP!U9D[>T#
M]H4^_D$.#EFIOB4-DNPO>#Q@C1Y8[A-&PX,PMR#TH_R_]_/0$4<"7(]: !X$
M8%4 UPB@@P!JVP(^"."V+5@' :NM@'T0L+.^SSLKZ^F9Q[SQ64P?09RBN;;T
M(1NN3)IWL!^ED;5@,?_5YW)L_.GSY]FW^=45F-S,P/SF;G+S:7YQ=0DFB\7E
MW0*\7_!07NT#DGP [V>$>7[ G_K@ZV(&WK_[ -X!/P+7?A#P*$G.!HQ;E.H=
M+ ^M7^2MPYK6$;BF$=LFX#):D95"?J:7'VGD![PGBNZ S]UQ ;4*%V3W$2#C
M!$ #F@I[INW%#94[O]?ZY>^U[NK%9V3)Q4V5>*DO41%:*-.':O2Y?N0STK_B
MF6,%O&@%YGR0UOG'(/LXCY@7;?S[@(!)DA"6@.]77 F8,Q(F?VM,P(4).#,!
MUYAPU("7-7 "IC1AJD#-%=F9HC0=/XRA@7@W/!P/7QN0*X/,D>T4H)(C5N&(
MU=61R7*Y#_>!QWA'3D(:,_^7ER9KE7.Y<NO(I/[0&5:<:P-R52##4#MG%\[9
M6N?N*/,"GD@D%V^(<JALR0;3M&#%FS8@5P6J&RJG\,;1>G,\%H#\Y$N A*B\
M<*2VH54V;^K(X>94W)2U.!7(I:S%J7%Q6+@X;#^SI4F<C=M)*2;!9=X/)\#U
MDR4?[+^(%X-KC^UCGSV![Y/[A,5\D:&;\Z/"N)&V_[^0=$&U(C&@Z[I$>C&2
M.]^N]*P64K+,- 39&EK;N#E0R9*&'(A&-:(;0&63COC?;#()*4TR%:U5\V$#
MJ&P2%";!)I.PTB0HM3:JS@<]IFR0(#(3-1ED*0U"<F/5,-)CR@8)6C/UO,8-
MLI4&8;DQ:<RTF+)!@IY,/3_=;0G?UZP9B95FR:R!#:MJEQY4-DQ0B]F"6Y0V
MR;E_9$J#IP>5;1($8>H90E[VW% &%OO[?_AV"S!:3IU]<!=[*Q)Y(4DTZ=$4
MR=OLD+U?=UUFBB1MZK-TAY69J<C$2(J>%B"W 53>,8BD#O5)O>OR!<IY7/:G
M#<AM )7]$8P ]8S0-3P_LVUUVI=;%HD?PK>*3"B2/=0G^PZ1">7<;E;'L1'B
M:B%E)P1!0#U!=(Y)F10D3Q3[FJHG.BUE3P2S0#VS3+,:"(G[,<GW.L(I73J$
M@B&@_69!)R@!ZBGA6U8!2W=R#R3V-J0\QVY)[%-E>:1!K>F )[[2UG:4X TX
M?+6),90#P<)21 WEB))0KDH7=D8U<24("'8FH"X[:BA32=\Q<-7#-BA7A;+1
M4.TA$KR$7I>7D,PF0U1=7Q] M@[DJC3AFDR !"\A/2_=T*B_I.&.,.[*)B8D
M)!'3A382Q(/>C'C04;E,3SPOS0$-:D>-*0 )6D&O5D]#,A>@:BS)C(*JD:33
M4G9", KZ7VMI2%$"JV[56V!</:;LFR S]+JE-*2H@%5]L1MY7ZNE[(E@1*2G
MKCNRW$8TH)LG7>0*\D)OMNE!@G.0GG->/,/U:DW<.,6Q8 VL9XTN)7-%00I7
MIP*6"4,"N4I--2&$!6'@UAN9ETQT+!>W^H[D7@N0JP+9-?LT+$@+Z\MD7><Z
MEDMCCG3  >5BL72^H=!34Q/!@ORPGJ6:-I'XZ,@'O]FQD^ 8K.>8E\[T!K56
M\T075('U5-%EHBORNU$]/L(*GJB"W 9-95<$5^#6!;47373Y$*4OU[I;H5P5
M:E0WU05[8?W6J_-4E_=,TG#)FR]IL!0[KYK5%Q8<B/5DE;MR&!(_VLBS41/=
MEJ QRWBK+& ) K+T!/32+-"@ML6NWA(L8NE9I$,:L.3$;SJCZI[7DBE$1KE*
M7:B&\BU!(U;GXEVG<W*Y%*<Z*&^#<I6HNL,Q2]";];J5/4O>9,GG'&U K@HD
MC=C@Z"I22.)-=FDL 4NZCUA^=:3X6EQ,FV37L2K?+\S3J:GX/C-/+_-K9T)]
M?@ONVHLW?I2 @*QY4\9'AW=]G%\LRU\8W647H>XI8S3,'K?$6Y$X!?#?UY2R
MYY>T@>)ZW_@_4$L#!!0    ( .B"5E/E*6>*0P(  -\$   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,X+GAM;(U4WT_;,!#^5TX1#T4:)$T*3*B-U!]#5((*
M$<H>ICVXR;7U<.S,=EN0]L?O[(2LTVBUE^3.ON^[[\YG]W=*OY@UHH774D@S
M"-;65M=A:/(UELR<JPHE[2R5+IDE5Z]"4VEDA0>5(HRCZ#(L&9=!VO=K#SKM
MJXT57.*#!K,I2Z;?1BC4;A!T@_>%1[Y:6[<0IOV*K3!#.Z\>-'EARU+P$J7A
M2H+&Y2 8=J_'/1?O YXY[LR>#:Z2A5(OSID6@R!R@E!@;AT#H]\6QRB$(R(9
M/QO.H$WI@/OV._N-KYUJ63"#8R6^\L*N!\'G  I<LHVPCVIWBTT]%XXO5\+X
M+^SJV*LD@'QCK"H;,"DHN:S_[+7IPQZ@VSL B!M _+^ I $DOM!:F2]KPBQ+
M^UKM0+MH8G.&[XU'4S5<NE/,K*9=3CB;WDQGP]EX.KR#Z2Q[>IS??YD]9= 9
M,<%DCI Y8G,*G0E:Q@599S#/)M Y.843X!+NN1!T'*8?6E+C.,.\R3RJ,\<'
M,F=8G4,2?8(XBKL?P,?'X1/,"=[U\.AO>$@]:!L1MXV(/5_O -^=DJLSB[J$
M"2XL_((;QC4\,[%!N,5BQ>7J2):DS9+X+,E!U9IOF9M<^'9'>S"U6)KO1YA[
M+7/OJ'ZG$6&8YVHC+8F%$3/<P+#X04-$U\Y^=$(UY:6G=/=]F_;H*+;[I_!O
MR,6?D%IIN#=^[NK?,TWM,B!P2:#H_.HB %U?I]JQJO(3N5"6YMN;:WJ!4+L
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M%WU325EUX-5$B[SL21="FPZW'*[-5PM(&V"NIT+HYXEM<YOOH/%_4$L#!!0
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M,0P%DFD44?'2A9"OVPYVM@,CME@J,^!V6@E=P!C4)!D*W7,+EAF+():,QTC
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MK%(-T@4@W9\(.?<C/PXPHC<8YU0#] ! [VR Z")E&N0E 'EYOJ;VZ8T&>05
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MTT]02P$"% ,4    " #H@E93!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .B"5E.3U""#[0   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( .B"5E.97)PC$ 8  )PG   3              "  <L!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ Z()64_KCR"@O!0  5Q4  !@
M         ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( .B"5E-B_2<]408  .8:   8              " @7$-  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #H@E93VA4@U@P$   &#@
M&               @('X$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ Z()64U0*_!"N!@  $!L  !@              ("!.A@  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( .B"5E-CN&DDPP(
M %\'   8              " @1X?  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    " #H@E93/SD=(;P&   T&P  &               @($7
M(@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ Z()64\2W
M<S!M"@  "4   !@              ("!"2D  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( .B"5E.@#DL)!0(  (D$   8
M  " @:PS  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #H
M@E93#>D%#FP(  "&%0  &               @('G-0  >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ Z()64RU(@P2&!   90L  !D
M         ("!B3X  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    " #H@E93ZO7L\*4$   +"@  &0              @(%&0P  >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( .B"5E,2-TY(?00  +X)
M   9              " @2)(  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ Z()64]=X3_5\"@  UR   !D              ("!UDP
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #H@E93%8,3
M0W(%   6#0  &0              @(&)5P  >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( .B"5E,Z! H7= <  *03   9
M  " @3)=  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
MZ()64[1N=U[@"0  WQL  !D              ("!W60  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    " #H@E93H2-EZ>\%   =#@  &0
M            @('T;@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( .B"5E.RUZ;FW P  $TA   9              " @1IU  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ Z()64VYF"\J?!P
M_!(  !D              ("!+8(  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    " #H@E93]+-R,UH%  "T#   &0              @($#
MB@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( .B"5E,0
M #"0E0,  +,*   9              " @92/  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ Z()64V1>Q[)$ P  Y <  !D
M     ("!8),  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .B"5E.V#7VF$00   P*   9              "
M@1"N  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ Z()6
M4S7C#_P)!   )PD  !D              ("!6+(  'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    " #H@E93!];9IOP%  !0#@  &0
M        @(&8M@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( .B"5E/&$MY92@,  .D'   9              " @<N\  !X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ Z()64X53/>*$!   !Q$
M !D              ("!3,   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    " #H@E93(X^7/VL#  !1#0  &0              @($'Q0
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( .B"5E,W1HLT
M_0,  +$.   9              " @:G(  !X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ Z()64TYONXD>!0  51@  !D
M ("!W<P  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " #H
M@E93S9FBL5\#  !C"@  &0              @($RT@  >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( .B"5E.5BA<H$P,  )H(   9
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M970T,"YX;6Q02P$"% ,4    " #H@E93$XAN+F0%   :%P  &0
M    @(%:[0  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M .B"5E/S1"ZW40,  /L)   9              " @?7R  !X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ Z()64T=.1K&6 P  $PT  !D
M             ("!??8  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    " #H@E93V[VL9\ &  #<(@  &0              @(%*^@  >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( .B"5E.@SY!-[00
M "LA   9              " @4$! 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ Z()64WHX:%_C P  (0T  !D              ("!
M908! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #H@E93
M]3J7&3P#  "\#0  &0              @(%_"@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( .B"5E,$C^ [#0,  &<0   -
M      "  ?(- 0!X;"]S='EL97,N>&UL4$L! A0#%     @ Z()64Y>*NQS
M    $P(   L              ( !*A$! %]R96QS+RYR96QS4$L! A0#%
M  @ Z()64Y)6^-<^!   C1\   \              ( !$Q(! 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( .B"5E.Y(]HWL@$  %0<   :
M  "  7X6 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M .B"5E-EX9FUMP$  &4<   3              "  6@8 0!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     W #< ^ X  % : 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>226</ContextCount>
  <ElementCount>318</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>54</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107104 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2109105 - Disclosure - DISPOSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISPOSITION</Role>
      <ShortName>DISPOSITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2111106 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2115107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2119108 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2123109 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2125110 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2129111 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2131112 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2134113 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2137114 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOME</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2139115 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENT</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2332306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2335307 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITION</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - DISPOSITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISPOSITIONDetails</Role>
      <ShortName>DISPOSITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DISPOSITION</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2417406 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2422409 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Income Statement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2424410 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2427411 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2428412 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2430413 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2433414 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2436415 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2438416 - Disclosure - TAXES ON INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOMEDetails</Role>
      <ShortName>TAXES ON INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/TAXESONINCOME</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="dgx-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2440417 - Disclosure - SUBSEQUENT EVENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails</Role>
      <ShortName>SUBSEQUENT EVENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUBSEQUENTEVENT</ParentRole>
      <Position>47</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="dgx-20210930.htm">dgx-20210930.htm</File>
    <File>dgx-20210930.xsd</File>
    <File>dgx-20210930_cal.xml</File>
    <File>dgx-20210930_def.xml</File>
    <File>dgx-20210930_lab.xml</File>
    <File>dgx-20210930_pre.xml</File>
    <File>dgx09302021ex101.htm</File>
    <File>dgx09302021ex102.htm</File>
    <File>dgx09302021ex22.htm</File>
    <File>dgx09302021ex311.htm</File>
    <File>dgx09302021ex312.htm</File>
    <File>dgx09302021ex321.htm</File>
    <File>dgx09302021ex322.htm</File>
    <File>dgx09302021ex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>68
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dgx-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "contextCount": 226,
   "dts": {
    "calculationLink": {
     "local": [
      "dgx-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dgx-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dgx-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dgx-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgx-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dgx-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 417,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 26,
   "keyStandard": 292,
   "memberCustom": 25,
   "memberStandard": 29,
   "nsprefix": "dgx",
   "nsuri": "http://questdiagnostics.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://questdiagnostics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - EARNINGS PER SHARE",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107104 - Disclosure - BUSINESS ACQUISITIONS",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109105 - Disclosure - DISPOSITION",
     "role": "http://questdiagnostics.com/role/DISPOSITION",
     "shortName": "DISPOSITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111106 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119108 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123109 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125110 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129111 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131112 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134113 - Disclosure - REVENUE RECOGNITION",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137114 - Disclosure - TAXES ON INCOME",
     "role": "http://questdiagnostics.com/role/TAXESONINCOME",
     "shortName": "TAXES ON INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139115 - Disclosure - SUBSEQUENT EVENT",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENT",
     "shortName": "SUBSEQUENT EVENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335307 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i5cc6b1efe84f4f65907f66036143af31_D20210601-20210601",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - DISPOSITION (Details)",
     "role": "http://questdiagnostics.com/role/DISPOSITIONDetails",
     "shortName": "DISPOSITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i1f8b2bbcf7b442d5b60c4726c660f0b2_D20210401-20210401",
      "decimals": "-6",
      "lang": "en-US",
      "name": "dgx:ProceedsFromSaleOfEquityMethodInvestmentsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ibf4a1ed2f3ea4d48aa675d2b867b318a_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i6bc28e1736a04d9e9f222c1998dbf195_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417406 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i240ccb0d73a24cda883d17698d2669f7_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i6bc28e1736a04d9e9f222c1998dbf195_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ic7399b9274664c749e91f89957ec71bc_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ic7399b9274664c749e91f89957ec71bc_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422409 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ia59678286edb47a683efe4ca31c9d152_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i240ccb0d73a24cda883d17698d2669f7_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i240ccb0d73a24cda883d17698d2669f7_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424410 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427411 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Schedule) (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ib80fc1942e984fd5a7949043c3093362_D20200401-20200430",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428412 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ib80fc1942e984fd5a7949043c3093362_D20200401-20200430",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i240ccb0d73a24cda883d17698d2669f7_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430413 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i240ccb0d73a24cda883d17698d2669f7_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433414 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i2d8c3304c5b24c6698ca6cf99acb40f8_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436415 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i6bc28e1736a04d9e9f222c1998dbf195_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dgx:PercentageofNetAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438416 - Disclosure - TAXES ON INCOME (Details)",
     "role": "http://questdiagnostics.com/role/TAXESONINCOMEDetails",
     "shortName": "TAXES ON INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i799f05ff39a24712b253c3e931752e30_D20210701-20210930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i71dae6d523044c6e86141e159ada5f54_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440417 - Disclosure - SUBSEQUENT EVENT (Details)",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails",
     "shortName": "SUBSEQUENT EVENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i9fb7b07b086a4309b9d46148ab2e12c2_I20211022",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i240ccb0d73a24cda883d17698d2669f7_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "i240ccb0d73a24cda883d17698d2669f7_I20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ie2e7ae5dc9104f20a5ce0b4a9350ec65_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "ie2e7ae5dc9104f20a5ce0b4a9350ec65_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210930.htm",
      "contextRef": "iae4f1e9e758948fca12122403d40b86e_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 54,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dgx_AcceleratedShareRepurchaseAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase Agreements",
        "label": "Accelerated Share Repurchase Agreements [Member]",
        "terseLabel": "ASRs"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseAgreementsMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AcceleratedShareRepurchasesInitialPricePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Initial Price Paid",
        "label": "Accelerated Share Repurchases, Initial Price Paid",
        "terseLabel": "Accelerated share repurchases price paid"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesInitialPricePaid",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_AccountsReceivableDisaggregationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Disaggregation [Table Text Block]",
        "label": "Accounts Receivable Disaggregation [Table Text Block]",
        "terseLabel": "Accounts Receivable Disaggregation"
       }
      }
     },
     "localname": "AccountsReceivableDisaggregationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AllotherservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other services [Member]",
        "label": "All other services [Member]",
        "terseLabel": "All other services"
       }
      }
     },
     "localname": "AllotherservicesMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements",
        "label": "Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements",
        "terseLabel": "Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements"
       }
      }
     },
     "localname": "AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_AnatomicpathologytestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anatomic pathology testing services [Member]",
        "label": "Anatomic pathology testing services [Member]",
        "terseLabel": "Anatomic pathology testing services"
       }
      }
     },
     "localname": "AnatomicpathologytestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CARESActProceedsRecognizedInTheStatementOfOperations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act proceeds recognized in the statement of operations",
        "label": "CARES Act proceeds recognized in the statement of operations",
        "terseLabel": "CARES Act proceeds recognized in the statement of operations"
       }
      }
     },
     "localname": "CARESActProceedsRecognizedInTheStatementOfOperations",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act, Related Expenses or Lost Revenues, Amount Received from Secondary Tranche",
        "label": "CARES Act, Related Expenses or Lost Revenues, Amount Received from Secondary Tranche",
        "terseLabel": "CARES Act, amount received from secondary tranche"
       }
      }
     },
     "localname": "CARESActRelatedExpensesOrLostRevenuesAmountReceivedFromSecondaryTranche",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche",
        "label": "CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche",
        "terseLabel": "CARES Act, amount received from initial tranche"
       }
      }
     },
     "localname": "CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_COVID19TestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing Services",
        "label": "COVID-19 Testing Services [Member]",
        "terseLabel": "COVID-19 Testing Services"
       }
      }
     },
     "localname": "COVID19TestingServicesMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapitatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitated [Member]",
        "label": "Capitated [Member]",
        "terseLabel": "Capitated"
       }
      }
     },
     "localname": "CapitatedMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ClientPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client Payers [Member]",
        "label": "Client Payers [Member]",
        "terseLabel": "Client Payers"
       }
      }
     },
     "localname": "ClientPayersMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CommercialPaperOrLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper or LIBOR",
        "label": "Commercial Paper or LIBOR [Member]",
        "terseLabel": "Commercial Paper or LIBOR"
       }
      }
     },
     "localname": "CommercialPaperOrLIBORMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DSBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Businesses [Member]",
        "label": "DS Businesses [Member]",
        "terseLabel": "DS Businesses"
       }
      }
     },
     "localname": "DSBusinessesMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DescriptionOfBusinessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business (Abstract)",
        "label": "Description of Business (Abstract)",
        "terseLabel": "Description of Business (Abstract)"
       }
      }
     },
     "localname": "DescriptionOfBusinessAbstract",
     "nsuri": "http://questdiagnostics.com/20210930",
     "xbrltype": "stringItemType"
    },
    "dgx_DiagnosticInformationServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Information Services Business [Member]",
        "label": "Diagnostic Information Services Business [Member]",
        "terseLabel": "DIS business"
       }
      }
     },
     "localname": "DiagnosticInformationServicesBusinessMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Tax Rate on Remeasurement of Previously Held Equity Interest",
        "label": "Effective Tax Rate on Remeasurement of Previously Held Equity Interest",
        "terseLabel": "Effective tax rate on remeasurement in previously held interest"
       }
      }
     },
     "localname": "EffectiveTaxRateOnRemeasurementOfPreviouslyHeldEquityInterest",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_EquityMethodInvestmentOwnershipPercentDisposedOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Ownership Percent Disposed Of",
        "label": "Equity Method Investment, Ownership Percent Disposed Of",
        "terseLabel": "Percent of ownership interest sold"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentDisposedOf",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities",
        "label": "Equity Securities, FV-NI, Excluding Deferred Compensation Trading Securities",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIExcludingDeferredCompensationTradingSecurities",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ExcludesgeneralandprofessionalliabilityclaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excludes general and professional liability claims [Member]",
        "label": "Excludes general and professional liability claims [Member]",
        "terseLabel": "Excludes general and professional liability claims"
       }
      }
     },
     "localname": "ExcludesgeneralandprofessionalliabilityclaimsMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired",
        "label": "Fair value of net assets acquired",
        "totalLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "FairValueOfNetAssetsAcquired",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FeeforserviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee-for-service [Member]",
        "label": "Fee-for-service [Member]",
        "terseLabel": "Fee-for-service"
       }
      }
     },
     "localname": "FeeforserviceMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ForeignCurrencyTranslationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation",
        "label": "Foreign Currency Translation [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GainLossOnDispositionOfJointVenture": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Disposition of Joint Venture",
        "label": "Gain (Loss) on Disposition of Joint Venture",
        "negatedTerseLabel": "Gain on disposition of joint venture"
       }
      }
     },
     "localname": "GainLossOnDispositionOfJointVenture",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_GenebasedandesoterictestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gene-based and esoteric testing services [Member]",
        "label": "Gene-based and esoteric testing services [Member]",
        "terseLabel": "Gene-based and esoteric testing services"
       }
      }
     },
     "localname": "GenebasedandesoterictestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GovernmentPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Payers [Member]",
        "label": "Government Payers [Member]",
        "terseLabel": "Government Payers"
       }
      }
     },
     "localname": "GovernmentPayersMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HealthcareInsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurers [Member]",
        "label": "Healthcare Insurers [Member]",
        "terseLabel": "Healthcare Insurers"
       }
      }
     },
     "localname": "HealthcareInsurersMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_InterestPaid1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Paid1",
        "label": "Interest Paid1",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid1",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LoanCommitmentMaturingOctober2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan commitment maturing October 2022",
        "label": "Loan commitment maturing October 2022 [Member]",
        "terseLabel": "Loan commitment maturing October 2022"
       }
      }
     },
     "localname": "LoanCommitmentMaturingOctober2022Member",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LoanCommitmentMaturingOctober2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan commitment maturing October 2023 [Member]",
        "label": "Loan commitment maturing October 2023 [Member]",
        "terseLabel": "Loan commitment maturing October 2023"
       }
      }
     },
     "localname": "LoanCommitmentMaturingOctober2023Member",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MercyHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mercy Health",
        "label": "Mercy Health [Member]",
        "terseLabel": "Mercy Health"
       }
      }
     },
     "localname": "MercyHealthMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_Mergerconsiderationpaidpayablenet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger consideration paid (payable), net",
        "label": "Merger consideration paid (payable), net",
        "terseLabel": "Merger consideration receivable/payable"
       }
      }
     },
     "localname": "Mergerconsiderationpaidpayablenet",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_MidAmericaClinicalLaboratoriesLLCMACLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mid America Clinical Laboratories, LLC (MACL)",
        "label": "Mid America Clinical Laboratories, LLC (MACL) [Member]",
        "terseLabel": "MACL"
       }
      }
     },
     "localname": "MidAmericaClinicalLaboratoriesLLCMACLMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_PatientsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patients [Member]",
        "label": "Patients [Member]",
        "terseLabel": "Patients"
       }
      }
     },
     "localname": "PatientsMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements",
        "label": "Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements",
        "terseLabel": "Accelerated share repurchase, percent of total value to be repurchased"
       }
      }
     },
     "localname": "PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Accounts Receivable",
        "label": "Percentage of Net Accounts Receivable",
        "terseLabel": "Net accounts receivable"
       }
      }
     },
     "localname": "PercentageofNetAccountsReceivable",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Revenues",
        "label": "Percentage of Net Revenues",
        "terseLabel": "Percentage of net revenues"
       }
      }
     },
     "localname": "PercentageofNetRevenues",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_ProceedsFromSaleOfEquityMethodInvestmentsGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Sale of Equity Method Investments, Gross",
        "label": "Proceeds from Sale of Equity Method Investments, Gross",
        "terseLabel": "Gross proceeds from disposition of joint venture"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestmentsGross",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_Q2SolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 Solutions",
        "label": "Q2 Solutions [Member]",
        "terseLabel": "Q2 Solutions"
       }
      }
     },
     "localname": "Q2SolutionsMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ReturnOfCashCARESAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return of Cash, CARES Act",
        "label": "Return of Cash, CARES Act",
        "terseLabel": "Return of cash, CARES Act"
       }
      }
     },
     "localname": "ReturnOfCashCARESAct",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ReversalOfRecognitionOfCARESActProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal of recognition of CARES Act proceeds",
        "label": "Reversal of recognition of CARES Act proceeds",
        "terseLabel": "Reversal of recognition of CARES Act proceeds"
       }
      }
     },
     "localname": "ReversalOfRecognitionOfCARESActProceeds",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_RoutineclinicaltestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Routine clinical testing services",
        "label": "Routine clinical testing services [Member]",
        "terseLabel": "Routine clinical testing services"
       }
      }
     },
     "localname": "RoutineclinicaltestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Revenues by Major Service",
        "label": "Schedule of Revenues by Major Service [Table Text Block]",
        "terseLabel": "Schedule of Revenues by Major Service"
       }
      }
     },
     "localname": "ScheduleOfRevenuesByMajorServiceTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "label": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt"
       }
      }
     },
     "localname": "ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SeniorunsecuredrevolvingcreditfacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving credit facility [Member]",
        "label": "Senior unsecured revolving credit facility [Member]",
        "terseLabel": "Senior Unsecured Revolving Credit Facility"
       }
      }
     },
     "localname": "SeniorunsecuredrevolvingcreditfacilityMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockRepurchaseProgramAdditionalAmountAuthorized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized",
        "label": "Stock Repurchase Program, Additional Amount Authorized",
        "terseLabel": "Additional amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorized",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Line Items]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Line Items]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataLineItems",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Table]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Table]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataTable",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TerminationOfInterestRateSwapAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of interest rate swap agreements",
        "label": "Termination of interest rate swap agreements",
        "terseLabel": "Termination of interest rate swap agreements"
       }
      }
     },
     "localname": "TerminationOfInterestRateSwapAgreements",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TotalAmortizingIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Amortizing Intangible Assets [Member]",
        "label": "Total Amortizing Intangible Assets [Member]",
        "terseLabel": "Total Amortizing Intangible Assets"
       }
      }
     },
     "localname": "TotalAmortizingIntangibleAssetsMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UMassJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UMass Joint Venture [Member]",
        "label": "UMass Joint Venture [Member]",
        "terseLabel": "UMass Joint Venture"
       }
      }
     },
     "localname": "UMassJointVentureMember",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution",
        "label": "Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution",
        "terseLabel": "Value of shares to be received under accelerated share repurchase agreements at execution"
       }
      }
     },
     "localname": "ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution",
     "nsuri": "http://questdiagnostics.com/20210930",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r273",
      "r297",
      "r345",
      "r347",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r527",
      "r529",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r273",
      "r297",
      "r345",
      "r347",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r527",
      "r529",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r196",
      "r331",
      "r333",
      "r483",
      "r526",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r196",
      "r331",
      "r333",
      "r483",
      "r526",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r273",
      "r297",
      "r335",
      "r345",
      "r347",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r527",
      "r529",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r273",
      "r297",
      "r335",
      "r345",
      "r347",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r527",
      "r529",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Initial Price Paid Per Share",
        "verboseLabel": "Accelerated share repurchase, initial purchase price, per share"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "terseLabel": "Accelerated share repurchases"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r18",
      "r29",
      "r201",
      "r202"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $29 and $28 as of September\u00a030, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r32",
      "r59",
      "r60",
      "r61",
      "r512",
      "r534",
      "r535"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r58",
      "r61",
      "r68",
      "r69",
      "r70",
      "r122",
      "r123",
      "r124",
      "r404",
      "r530",
      "r531",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r354",
      "r355",
      "r356",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r348",
      "r349",
      "r358",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r166",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All other operating segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r36",
      "r203",
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r103",
      "r221",
      "r228"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r115",
      "r178",
      "r185",
      "r192",
      "r210",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r399",
      "r405",
      "r447",
      "r467",
      "r469",
      "r487",
      "r510"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r19",
      "r20",
      "r53",
      "r115",
      "r210",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r399",
      "r405",
      "r447",
      "r467",
      "r469"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r205",
      "r206",
      "r214",
      "r493"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r416",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r344",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r344",
      "r346",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill, expected tax deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r385",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Equity interest in acquiree, remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable associated with capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "verboseLabel": "Less: Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r39",
      "r105"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r99",
      "r105",
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r99",
      "r448"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW &amp; OTHER DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash surrender value of life insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "terseLabel": "Hedged items (Long-term debt)"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r247",
      "r494",
      "r517"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r255",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r28",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r28",
      "r469"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2021 and December 31, 2020; 162 and 217 shares issued as of September 30, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r64",
      "r66",
      "r67",
      "r78",
      "r501",
      "r523"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r64",
      "r66",
      "r77",
      "r397",
      "r398",
      "r409",
      "r500",
      "r522"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r64",
      "r66",
      "r76",
      "r396",
      "r409",
      "r499",
      "r521"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r213",
      "r320",
      "r330"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "General corporate activities"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r83",
      "r115",
      "r210",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r447"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Operating costs and expenses and other operating income:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses, net"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r116",
      "r367",
      "r373",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current income tax expense (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer-related intangibles"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r114",
      "r120",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r461",
      "r488",
      "r490",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r279",
      "r288",
      "r289",
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45",
      "r114",
      "r120",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r45",
      "r114",
      "r120",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r310",
      "r311",
      "r312",
      "r313",
      "r458",
      "r459",
      "r461",
      "r462",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r116",
      "r368",
      "r373",
      "r374",
      "r375"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax (benefit) provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r103",
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r103",
      "r173"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r430",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r414",
      "r417",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r410",
      "r411",
      "r412",
      "r414",
      "r415",
      "r420",
      "r422",
      "r425",
      "r427",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r119",
      "r410",
      "r411",
      "r414",
      "r415",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r233",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by Sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "netLabel": "DISPOSITION"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r344",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r24",
      "r26",
      "r489",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r79",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r135",
      "r137",
      "r147",
      "r148",
      "r149",
      "r153",
      "r154",
      "r432",
      "r433",
      "r502",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic(in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r79",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r137",
      "r147",
      "r148",
      "r149",
      "r153",
      "r154",
      "r432",
      "r433",
      "r502",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r360",
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "negatedLabel": "Share-based compensation, excess tax benefit, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r68",
      "r69",
      "r70",
      "r122",
      "r123",
      "r124",
      "r126",
      "r132",
      "r134",
      "r156",
      "r211",
      "r309",
      "r314",
      "r354",
      "r355",
      "r356",
      "r369",
      "r370",
      "r431",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r530",
      "r531",
      "r532",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r80",
      "r81",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Loss on sale of investment, before tax",
        "verboseLabel": "Gain on sale of investment, before tax"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r40",
      "r179",
      "r209"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity method investees"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Equity securities, gains"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r435",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r279",
      "r288",
      "r289",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r436",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r279",
      "r336",
      "r337",
      "r342",
      "r343",
      "r436",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r279",
      "r288",
      "r289",
      "r336",
      "r337",
      "r342",
      "r343",
      "r436",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r279",
      "r288",
      "r289",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r436",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3",
        "verboseLabel": "Significant Unobservable Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value, Measurement Inputs"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r279",
      "r288",
      "r289",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r440",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets, useful life",
        "verboseLabel": "Weighted Average Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Intangible assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r222",
      "r224",
      "r227",
      "r231",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r222",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r227",
      "r484"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r215",
      "r216",
      "r469",
      "r486"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Balance at end of period",
        "periodStartLabel": "Goodwill, Balance at beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during the period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Hedge Accounting Basis Adjustment"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r178",
      "r184",
      "r188",
      "r191",
      "r194"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes and equity in earnings of equity method investees"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r73",
      "r103",
      "r175",
      "r209",
      "r496",
      "r518"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in earnings of equity method investees, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r344",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r14",
      "r238",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r236",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r363",
      "r365",
      "r366",
      "r371",
      "r376",
      "r378",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r133",
      "r134",
      "r176",
      "r361",
      "r372",
      "r377",
      "r525"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r100",
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Non-controlling Interest [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r149"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r223",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r223",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets Excluding Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible assets, Cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r220",
      "r225"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Total intangible assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r72",
      "r172",
      "r457",
      "r460",
      "r505"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r17",
      "r52",
      "r469"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "verboseLabel": "Leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r35",
      "r115",
      "r210",
      "r447",
      "r469",
      "r492",
      "r515"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r107",
      "r108",
      "r109"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedTerseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r115",
      "r210",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r400",
      "r405",
      "r406",
      "r447",
      "r467",
      "r468",
      "r469"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r47",
      "r247"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "terseLabel": "Self-insurance reserves"
       }
      }
     },
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r51",
      "r115",
      "r210",
      "r259",
      "r263",
      "r264",
      "r265",
      "r268",
      "r269",
      "r447",
      "r491",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r157",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r99",
      "r101",
      "r104"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r14",
      "r62",
      "r65",
      "r70",
      "r74",
      "r104",
      "r115",
      "r125",
      "r127",
      "r128",
      "r129",
      "r130",
      "r133",
      "r134",
      "r145",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r210",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r433",
      "r447",
      "r497",
      "r519"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Quest Diagnostics",
        "totalLabel": "Net income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r65",
      "r70",
      "r133",
      "r134",
      "r402",
      "r408"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r136",
      "r141",
      "r142",
      "r143",
      "r144",
      "r146",
      "r149"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings available to Quest Diagnostics\u2019 common stockholders \u2013 basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards to be Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r314",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating income (expense), net",
        "totalLabel": "Total non-operating income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r178",
      "r184",
      "r188",
      "r191",
      "r194"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Total operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r464"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r464"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r463"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r56",
      "r57",
      "r59"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net change in available-for-sale debt securities, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r55",
      "r59"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net deferred gain on cash flow hedges, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r63",
      "r66",
      "r68",
      "r69",
      "r71",
      "r75",
      "r309",
      "r449",
      "r454",
      "r455",
      "r498",
      "r520"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive (loss) income",
        "verboseLabel": "Other comprehensive income (loss), net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "verboseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "netLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating expense (income), net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "terseLabel": "Less: Earnings allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r88",
      "r91"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Decrease (increase) in investments and other assets"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r89",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid for business acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "terseLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r19",
      "r37",
      "r38"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r94",
      "r97"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from disposition of joint venture"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r92",
      "r353"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r14",
      "r62",
      "r65",
      "r70",
      "r98",
      "r115",
      "r125",
      "r133",
      "r134",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r210",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r396",
      "r401",
      "r403",
      "r408",
      "r409",
      "r433",
      "r447",
      "r506"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r21",
      "r22",
      "r235",
      "r469",
      "r507",
      "r516"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r61",
      "r68",
      "r69",
      "r71",
      "r449",
      "r453",
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r295"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r31",
      "r314",
      "r357",
      "r469",
      "r513",
      "r533",
      "r535"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r122",
      "r123",
      "r124",
      "r126",
      "r132",
      "r134",
      "r211",
      "r354",
      "r355",
      "r356",
      "r369",
      "r370",
      "r431",
      "r530",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r169",
      "r170",
      "r183",
      "r189",
      "r190",
      "r196",
      "r197",
      "r199",
      "r329",
      "r331",
      "r483"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Total net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r332",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow and Other Data"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Hedge Accounting on the Statement of Operations"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill, Net"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r178",
      "r181",
      "r187",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r178",
      "r181",
      "r187",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Segment Reporting Information by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Receivables Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r166",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r199",
      "r242",
      "r243",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r178",
      "r182",
      "r188",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r112",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r166",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r199",
      "r218",
      "r237",
      "r242",
      "r243",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r50",
      "r68",
      "r69",
      "r70",
      "r122",
      "r123",
      "r124",
      "r126",
      "r132",
      "r134",
      "r156",
      "r211",
      "r309",
      "r314",
      "r354",
      "r355",
      "r356",
      "r369",
      "r370",
      "r431",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r530",
      "r531",
      "r532",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r156",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r27",
      "r28",
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r27",
      "r28",
      "r309",
      "r314",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "auth_ref": [
      "r28",
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Reissuance of shares for employee benefit plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r27",
      "r28",
      "r314",
      "r350",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r309",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Share repurchase authorization remaining available"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r28",
      "r33",
      "r34",
      "r115",
      "r204",
      "r210",
      "r447",
      "r469"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Quest Diagnostics stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Quest Diagnostics stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r69",
      "r115",
      "r122",
      "r123",
      "r124",
      "r126",
      "r132",
      "r210",
      "r211",
      "r314",
      "r354",
      "r355",
      "r356",
      "r369",
      "r370",
      "r394",
      "r395",
      "r407",
      "r431",
      "r447",
      "r449",
      "r450",
      "r455",
      "r531",
      "r532",
      "r545"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r314",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Stockholders' equity, period Increase (decrease)"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r456",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r456",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r456",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r456",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r470",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r48",
      "r115",
      "r210",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance, Value",
        "periodStartLabel": "Balance, Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Intangible Assets Not Subject to Amortization - Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r49",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock, at Cost"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r28",
      "r309",
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Retirement of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r49",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r28",
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock, shares",
        "terseLabel": "Purchases of treasury stock- shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r28",
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "terseLabel": "Treasury stock retired (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r49",
      "r317",
      "r318"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 39 and 84 shares as of September\u00a030, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r309",
      "r314",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock, value"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-lived Intangible Assets [Member]",
        "terseLabel": "Intangible Assets Not Subject to Amortization - Other"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpatentedTechnologyMember": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based innovations or scientific advances that have not been patented.",
        "label": "Unpatented Technology [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "UnpatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Changes in reserves for uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r136",
      "r149"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in Shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r135",
      "r149"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in Shares)",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32787-111569"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r539": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r541": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r542": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r543": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r544": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0001022079-21-000144-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001022079-21-000144-xbrl.zip
M4$L#!!0    ( .B"5E,H$6U A \" #;M&0 0    9&=X+3(P,C$P.3,P+FAT
M;>R]:7>3Q](N_/W\"KW>SWE.LA8W]% ]D82S'&S8SL%R8IOPF"]9U1,6R)*W
M)(/M7_]6:_  !FR0-7%G %NZQZZJJZZJKJ[^]?^>'K4;[U.OW^IV?EOC#]E:
MX_\^^?7_JZK_^7WW16.C&TZ.4F?0>-I+.$BQ\:$U.&R\BJG_KI%[W:/&JV[O
M7>L]5M7PG*?=X[->Z\WAH"&8X!]]V7LL8PXR<55EAEB!]K&RF%(%+ $W.44
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M@5EZGSDOJYQ#W&E%*4GBF:&'F+*UB4/621@@T[1AZ7WE\]1)'OLI8B>F?G=
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M8= PX=>>\ ?:L+OQU-F'RS^<P<TV#5\;W'<8W&6"G>D$$)BJI%"9#,X(,CV
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M!M%S?Q=1O-QB0C,G\8E$QNMR&'=Z9V>][G%>D<(E<W')E09Z%*N( M9@K>#
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M<7T8+Z>Z^.GN2@UOK@:1):DKB .%<XY(+O"GO#/@<*)[%CTAGB6A3(M4;A+
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M<B)*1CPSC&HGC$9!)%I2[&8JFB.>OO#4*G@*7_(4(9HA+P5XQ!@P07-97XP
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M(Z1"586J'MRR(SYHZY526%AFI3"$11)X8)QJ[#DM+O"&<]#!)0=9BZ5DVH%
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M]<J.)NT\'-V/=K,2+=/J]YHQ-N-FJK^?^YJ><.,<]D>3F:/94+@!XR7]N*'
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M3G#G"656,\P#<48(B:UCRB=-J#%S*Q>U(RMW10Q;XT%>V0:UZ(=FW^_Z[Z_
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M=K]7-'LEXUMX;BB:[:+1Z<="%?U.^7T[",U^F7;;+BLE;/XE-=NV[9NV!:2
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ML'YY$7^ ?1U/,J!FO+'>=P;MTJ'5Z4[MWG#UQX#<G5 :XM6%F2U+R.J4AQ:
M&8QPX+%JT2/_V!1$#Z$\_K-"2#!?0B93B*"K ."6YWC"&1=\#W#[*:YI9H$3
M3VPS%/%'YL/ARY=JQNC< N+F]D2777'GO'?.MDH\[!W$V)]-I_+E0@?D8+\X
ML( Z-R[]CTJTY >!'+DH=ZK5#X&DA-G.\3'0J7< K]PK_4K \5G\CC?_GY>H
MD=T?H&>U!W _N*C9S?=>+IJEHV09> X^@.VIKACA>+5#>><N D@%EL/K@ QK
M8.0/)4\?C"%X-C#- 9QE.!>AV(9C$TOP9'@YNS;)\EBW&.[VA-PSCG_&NN,L
MZ@ X?>L,9>="18OE\U!^$Z67SPE:T DZ^VW@\U#LPU)*4O[W/%$>8Q(6*3%C
M*6AUU%'!/(N&$25H9/C;6GY5K#!!Y0^&X>OR!T"^H- I3<Q\Q<584'72)H,K
MWGUO--_#LC]T>L]^B$4K_N?3V=[7<.(HE[L_#YJ;A_MGNS0'<#;@'\\W=_9Y
M@WXYV#W^>+:[LRH:.[#&KU]28^T(-W[NGVX>;OYL['S^L;GZ#8.='9--*":B
M$<=>(@.J(?(8I\ M"TJ&I3?\JD#.T!;)7%?! ^!RYS@N%^W8OP$;QO[\?) Z
MH$F4>);98WL [#WC8&<N;7=.'])/VQO=XB'=M"447:LR#<%J#D?MRQ'\]L;!
MDM<)KS'EX=0 +I02=] ?=(>J9VIU3B=Q@*OB5-?IF>S:0V9[%S]K3IV&7A,
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M\G:F#PK(M$&VCV W2UJ7[K7\0SZ-L*W9>%H>G<3L$/.Q.=RE4F:-/CBQ9Z5
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MEM%ZBRR)%B2B &V3IH28\M%(E03!%,P[?+F,MC;OGMB\NR\6J\V[AV:W22!
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M*(PWH4C-MFW[9MF<=0QG.6<;#IC=CT43?HL_3DH<J_[</8K]HMOL'569V_X
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M<7*_8XSO[R"RBSMQ.2/UNCU8P",ZMMN+D<E^"]K?_/+UKOS2KDQW,BR=)7<
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M=@!%J9P/1'INB;[M?+<:R1X%R<08R0@FR@@2$986Y\ =15I2AZ)CP0BL&+.
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MR/GBG3(8WTHYN&%PW.F5?Z9ZX8M)Q4]%57FB*LQJ*[##A<GA2:073[+/%TA
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M!@3N# )G4Q#@5&.C@D9:!I=:9# $RJM 5AIE)+5.)Z.Y 8$&!%8EC:D!@>6
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MO=V"Y-E:, 5<OBGEF'9BQ[5,MQLFSP?X@ 7*W\![O#F&-U2WCGL5'"4Q/9R
M1OHN/<5,IF%:KFO*A<P?PG":AID()5^2/*#E?0ENTE7E,I^< /DG320G]O]2
M)2UVC?N2;IM?KI3-GU_<R_K**(%.>E$WLT1VK@[/Y:8F< 3X':?,91AY'S8N
M+6 NO,F@=@*O"JV?NIWC#(3P34D=O]81&T!U#)H6C/+G4K6I>/&DGV+0"2E=
M?S@J9UWK/3)-QBT7[L;]6A MSY49H50,^)K)285@!^1)K_SB_J*35X+8Y5C
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MKX???#^4"<))?TCI.3DMN$H[2E9Y3A2^XIF@_G2[E4Z0O@O96S 1.E4_SPL
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MXM:D3 [C9^W"IJ67=;7^!&XL<\U*8ZACDF\ =/V3Y+^&CSM;[?1%F:Z<.H7
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M\./7,!R%6Z4.OV"WV-(-UIG#:]*\MM,;P_I5'K%^;_A;WM7RNH.TI[N=7G\
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MD'(&#),;RWS+B')BF<LH3!S/B6WA!4'IY@NB4-F.YX<\5"J,'(K*M,,W4-?
MD.6]9!FI4"0^X[XG@3Q=(#O?XP$+/$HCEQ#'V+A;1I83&S<6BA'B,EMZ(<<2
M/\H.9<QML'S=)/%](G7G]7W77['XM+%QIZCM5P6?1 +0U1+]V%)%-M0Y!Z_3
M?H7.EHBO15_"@'A2>>2-L8GOQ!4$-! N(XDC(AZK) @4X8FGJ,]!40BDL8G;
MQF_.&S8QCP(_<,$<]HC$VKV$V)BZ9E,5,P;L)@0^M/<>I(Q1 EI&=XJ*6!+F
M43_"H!X:>$'BQX$20@4NC7QC$[>/[B8VL0O4Y4BA;*DB87.PL\ F%KXM A6B
M1U$J[N^]=UU#=VVC.P(F<1R+*(B2F',G"D'U=EA("!P<Y4H:FWC+B')B$S/@
MIY$DODTB1]E<)+$=NEYD\\@-!0,5AW#=4B+T6W];_>+(4L:,N, U S\).:-!
M@,5070^L* =K\'C&)MXRLIS8Q"R@GH2#L,&L\$%'=;D=)"JTO<!U0%0RES"&
M9,E7;<AD;.(I:COH"W@Y&,$#,;R"=U[>&FMWELTDKL)60R$E-.'*]8.8))'G
MA#R6(:/*-]9NVSA)VK!V(QE$<>(EMN])X"0\XA@H']F>RR+AA$% /"QGM(E2
MOD:\WZ]UNTG@A134[1 L(Q$(;/T5<YF DN9XQ#76;OOHKG$#'#HR$DEHN\))
M;!YZH1TR#.3BW/.)$H'CHP3?1,MN0W?WAU/J*P?BNQ%HU%$D!?652*0,!9B]
MG#@K-XPP=+=VNFN$7PLX-,X2.^9>;'/BNG; 560[C,'9.4J$KMQ[#Q:2H;N6
MT9TG$E]ZCL>$DIRR( Q(*$3D,<>CBC*U<CTY0W=KI[N&Q1HG-'*$:Q/N$9O+
M.+0#18CM^2XVC C ?"![[QG?@+S;)7NUV[6RX97*7[Q5ZO @48'/I$H<KA0)
ME:"1[FY &&&>N8-M';=HIF\[2KDJ9('-$QG"#Q+; 7!\FP2^1YS(3RBE>^\W
M$?!AA/3]RC'GD70#HD(1<^7Y<&I2<$DHBSTW<6-CE+:/[/YN.(-BXH)&90LW
MEC;W";.C6"2VA(/R7$9 @H= =BMV#S=DM_Z(H\B5$?S79RS@H%#!^<7,"6-"
M M<+7&ILTO:1W<0F=>'X_%AQ.^$AM;F3$)!V-+29(QTW])@B+,&6O=S07<OH
MSA>.)\,@84$2<8]3$8:1""-07R(O5(%K;-+VT=W$)J54"N:SR(Z(2L FY:X=
M.AZU8^8F 95N[-,(Z(ZTOHVA?H7?\=V6FZ<7V5!TK7ZCX/53EY(W+25VMI_$
M$W0L-.$LK6'$9\TT9,^)@CA)4/<!+8B'3H2]PZ1-:.S0F":2!Q(SKWQ_117H
M:6AH.QKJ&-:WLZSO"7H=&M;7)M;7B .(/$(B)FR7$<_FC#J@C9+(=F4@/5?!
M<<="L[Y@Q;CW'6-]+Y[OO3BF][S]$0W36SO3FSB\>$ ")Q'$%I)+&U,D[=#E
MPJ8T"GS"N9.H<.]]L._P)]3W#,<S'*_='.\).B8:CM<FCC=Q-8:Q"E"!MVD2
M@IKGB\0.'.K:A$6Q3USF.WZP]][;Y^P)N\:NF>,MU6[Q[N</=)LK=SF_25V)
M<R+Q(M"3)4M<'GM>R'PL?^7YS'&$K_A7#%A_OGZ.=QJ>Z'Z.A'6>N:7CDF3=
MFH:.MS4%QU=G?WRFI_3WJ]/>GPY0\-\G%](].?P,<WWJ_OG'I]Z?W^)OL(+N
M;$/'4WKD?KGXDWWYXX@"%;NGAR??3__^Z^;TX@NL\?>K+[_"O_2$_DE_3TXN
M/CMG!U]=D?"$4=^6+KK\P9*VA1NX=BC"R NH)US?F6WHZ$LJ/$5)1#V/.X$(
MX%@21XHHD7ZB2##;T/'3T>]'IY^/K$]''\Y^/3V^.#X[?;!KXV*\G]M]\>$E
M36\A O.1>%$8,X;UI&4H:)((*3CCCB1^O-?&UJ<5&-:T)CWCVW0([$<NL<K#
MX_,5#JUUP)QJ,IKVK>&5LCYD/5CA[7_](Z#$?U=8L$4K&A4P9U%80LIL!)PI
M1I7"RD 06 LU&5 T(N#=,^DIH4M5HOQ(N9PGR@V)\AAQ8Z%4 $+PH:M1VFQ5
M^Q^5HWP0ERI+8"=UO]JQ.F+3%\;-SB[^^DJ=. J%Y]N1XJ'-,2M;1&YHQ\SC
M"K-]'?0<K79HRHV3,(I8&,<ACTDL0A'XDC%&XI@DDC_@:#2']M"A<2&#('*5
M34%GP0@KT -50FT/U/PH(B&PYY4/#<1 H"1W:*C@Z3 (8@HV R,4,[UIP!ZX
M&#.']M"A12R1H&U&MLLP9P3(PPZY&]M![ 7,DS+D'EOUT-Q $"#>F/$8]+L8
M^Q$Q%84N$[$, ^8^X-TRA_;0H4D:"5<)S_; T+*Y)X@=)8YK.XYT&?==+EV@
MM/"NN?6(#WZRLF2N2!W>"7C0XA2'#G7?6ZRTUL?><KU,=WE5TUU>2^'-G'T+
MD4"/1KZK?Q&YL@8YX$,.:@0@5P_^P.)ML!1A78%.8%UG7= W\8-<=4%[O%8P
ML)O=V#$VWX9EY*!IE%LH.M8%+*JI NQ;-U>IO()W9-=I#"M?V/Y.+T>G'8P_
MVK<*>&&1I*AN# MKH'+MFNA+6$\$%I]69LLG<R6SRSXH.<4$2I.-C09 2[B[
MKM)D54&Z7@.L3J*^\OKF2O7A^6+4A=<A;'(UR')08-Y8 ''][7B]5^):69'2
M#P# <Q5W++W_ZOPLG+PGX!WZ7:*'JA"^&4BX %CDE2H^M-3W@9)#/&B8#TYO
MF Z[< ;P)^Q* <2M! PQ2U;6EW699Z.!UL#4=WDE^I=*(T0)XRF8XBE<ZM?C
M-A(PW3-+#&"@D%?ZL K56&99HT_I\2GL0=;+U0;@" Y-8/]XA'_1K.@W$+>P
MJECU4V K;_;U>0Q@=[ 3/ ,X+9@# 3S!D?%R"G@.;/8>8$M\[W)+L!7#^NS*
M7O8XO@('+K6"4/'6NE*B.[R2>(9IOQCE\.&^=8DJ:+^GUX5KAEV<J#C5HW#1
MY1]IC*"\S$4/-P,(VQC?V%K1F5;7'W92I( F_>%;YFDO[GT^BNJI2BOG&)(U
MR(H4IWU;D^&D9?U/>U-/56X<9_*(B J@XN'B1U;UH3SPV',;+)3.'$7CYU4^
M<:-?*CO*E?C+%@DL]JWHWHC;8N^?4WL"3*PG#] A/@NRA3M,DK7ML/2I@>#.
M2J;Q=H0,!T?!FD1KUF*!- *UY!\/>]?\O?<7Z/)#HD4'$Y+3__Q3M G3YKOD
M/GX^.K\ "7?PZ^G9^<7QAW/K^/3#V:?_G'TZN#@ZM Y.#ZWSSS^?'\.(3\='
M=ZW]MNWG].SBZ-RZ.+,^G)V>G_UV?*BW\<OQZ<'IA^.#WZSS"_C@Y.CTXMS2
M^@AYAR,OCD\_'QVV?G.O1WT!$@K%=_O7"M(<INVBB-P'M;^+^HA6AVY (0,9
MAI)I[DZ6<"#-^_(>Q^"#CKX9QV"HDL"C0BKF>5RX$L/PX*\X 7M4,"G:Z!C\
M!12F9)1K?1,T$)%V47&\%+G6:"H5LM8J2]!,.;S^NYC1<PM0Q$^SH;(8*FY:
MXRMQ3RLN>&DBM",L[8/^!(H2  (^0%UDUI<&4VO]_*#?1YWKDU9!+5@!K+EG
M$<?^W\[]Z+RTGM&N(VF9KW:K7;47\URS$W2=,HY*(^L643#-ES.R)C:6MHEB
MU06%-+\%FPB8EI2C/$<;,K_?6-IF^*[Y_NTP+<3E)?(C!/Y94GECM,[TDB_?
M3C]^C8/0!WFD;$GB +O>^':@.+4=SET_C-W896Q60''JD" )XT!)R2D1(A2@
M(P-5L)CY#G=F+]^0>K3=^5U;QD@3E6\,%=:&)\:*@&QN!ZII?%HW0 2BJ S4
MXNW]UW9S!?"#ZVTC12P22<!E+L&FPO@!5PLD?=D_$WH@T9DT*-3;^I=W<5H,
MNN+V;=K7:] /O:OFJBQ<-(MG@@NT_"N_GEAN':>TWJI4J.K-U=<=_=5,0$3Y
MG>MW7.HN_-KID(7?W3=MT/'"Q\UZ_W<N6_Q.L]:VK=5WEIYU3DA@31W 5]3J
M(Y=,#%R8F1LN4]>F-*<V%$9WQ\@J4P>UN_RD])(?37O)+>;L+RQX\P)@<XH7
M"#\$FG5@VF3HPC"T.9%H+0<U:GU+P'.I';\XR#E/0:2["AR#5NM$JV<1NML0
MB/^ONY=K;Y\1\YX:2<TK-X#@VU)NXA>E["3+[<J5]<)J(LX/\&-"*@5,TZ,1
M=V(O(D[HL"3B(HD48=3$BHVS1$ZO3O_^]S<8 ^OI=D\//WT[N?C(S_XX[9Y=
M7-(___Z]>_KW7\Z7/SZZ=[)$Z!$[Z9W<G%[\]3>\USG]]>3[Z>&E^R?][)X=
M?OEV^L=G=G;QJ?OEL)N<-,L>Q@I+2P>1'7N,VIPF&-SI.[8C/!9%#G-"XNZ]
MY\];]G 32/W34VB*+XBLA:,8@4TJSK"NM0I]PN%_ 0^(2."GB=M]?K*>Y/@K
M$?@QDXGM*Z)LSEQA!U'@V*%+F4-B+TE"OO?^F4O]&[+> K+VJ>0DQ/!NC\>1
M"%R?*"4Q[MB%?YD)$GY^LB:-G,XP(G$0V[&/G;A$I$!:1\06$09=N)B'Y0%9
MAX:L#5E/YWD+%ON>'_FQ([D?R5#PR'6 SKFOW"@.36K4\Y-U(U7;$;%RN+!Y
MXH<V#UADA]SQ;="D&!>4QBPA1EH;M\-"N'T0@Q0#Q&+C<-A+.=:A)C*1,:@P
M8,>*T*,4%%\/3%H9)B8Y[;EYW6FS\&+(>.!%/+&5RS =,9"VH$S:"1B1H1LJ
MT&*"O?>FM6\+"4LI,!UEJ!Q?4<ZB,&0N]SU'"NG$0'34F/S/3U@3DY]'GB^
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M!*--N$]H1%TF&8@5XKM4,><!J_7X]!?#IIZ<31TU[=; 88Z*F;*5RZ7-':%
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MH7?5;BI>CQN:X<QZ?^77[V[2>'B%3+/CE/I$Y3>OWEQ]W=%?S<B4\CN/=9R
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M+42L;-_Q$JFH$[HN6!^,OS"ZWB%]H]%;[3^FRGW=6\WA0C(:2IGX'#2.0)!
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M:OK]FC=R%$;X-'>G'<>91^U9J9D6HCO61[GSDY7= !LIKM*!)DTD6'S7Q[7
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MT:<Y-T7=9>=1K&"O':L..]Y?92?F#B)\N%);L%NGQ]TYCVKY9I <U]S4!II
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MS'$P1DM,5\C"!;7Q\1M)8CPYRY5/ LE+B,\0O>?#I23@8FQR'9A<Q.S0MU#
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M2ZORB[?A4]WSK[U?4YJ?8KYIV,QPDUR Q$4&57>):2H&X,F+R$42HO0A_AU
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MLC79\7A=_UF]PU4CXB.<)I+!R$@L6BB$P)6AX69=&P=+$)EXC>0LJDY9Q:^
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M!>Z64AE+O(F&*$HUE=XS+ZI9KD\BV]:-236F5%'!2[E5>6)0[_&'TU-!E[)
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MV03=*V)6Z\JH<*]?>IJEZQZ<Y 5B&+W[?N]OTT-<Z9CGI2Y.#JXD&'%*0F9
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M^'HT'ES"<%(KN:SQ%]VK6;1"R4'TWJ/1%Z(@DO)$@F&&1&G!J\2X]74NT9X
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M7_11_4I*';0AW!97F0= 9NVT&T!9Y:Q]-7WOX@1]0W4L4NH&LJRL7EOR+XU
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M5@2N4YUN%DW0[2+PMS6%KN0;KZ&-EW,[J9W)4 IPN!!+IJ'+Q.$&3;P-EL6
M>K-U<L5_[-O)36R8+6AJJ[>338#]O)UL5[^-+YK64<YV;R=SAB0<(RJ4@\72
M*RIXA?XD#39Q:;*)=3RE5W$[68<TJ^AD>[>321BN+.ZH,CI;KN "L;Y4:10
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MN#4 ?5@TYGN?AMT(GWPWS7R7CA>2>:HIH<HJ(B.$ AGMS^1 FY3!RCIIGFN
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MS7C\#K>I#,0%%TDHH6+.>TY3H]N01EW6;E_[VBWY]65<0]$W?&L"H_5^B?<
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M,98;D,F]%U5:2!4BI^W%^[V,>,TVM+B*V.K&:UJ9M F2X!*"@[':$%NJ3(I
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MPAW4/*;9S4(#5%4MA<6X=F,F;*ZW9XBP@= K; E+T&GGG$_.D6ARQG5* ['
M(M%"R)R]HC'5*>&Y32H\8QILBPFKR+I*KYMX/8140,U*>&5O@RYCE!Z(]+CW
ME0:9)!E#,TU2!%9G0W@$9?O&0!LZ>M3I9A,!5S^<G- ZTF224**<>DDB T>[
M1$6*W!8Q>OR%BGP+QY"OR@+84,P5DO\>(KIW&]@$5]T@DR7(=A2DO*'FGB3"
MAF*O$=*Q#)\L728U.BJXY^$ZY8Q":#@/#"A+501<PNJT0-HN'9X+/MX2&U:1
M=LL1$D<#W]\?7%YV)^EU'_WX>EBJG,3Q +<KU!&_V;@R*,8Y=<2FZ(A4JJ0P
MV4 $%5X&*V1,<Q<1"^,F&KYN!]$4K>AF4%>P+===>PZBF)7CS3;2H#@I>>I$
MBM( +*)$E'(Q4)\B\TT*$C1\W1O0_3J"K;#Z/[Q0GZ93.!%Q.4M$N1+KSARN
M;%:6+C4<O'<I\U#'&GR,Y=58@QN*N<6L^,6(;NL2/H^IJB6X"-5NK,!--?8D
M 380=_4UX 9;4$%+BPN1**G*DCI#K,'=28L@N/ .G*ASE;P]"CQC^6V# :M(
MN<;Y'XS',)R%5<WZBYDLE8^!A%()7H82TIDA$QL=HS%QBE_JG/XM0+-]2V!S
M/<T?_&TJY J'0/>CGJ8GFU"*PR$>X)X1Z8T@GE-)DDVEV4*T,M4Y]9M'\FJV
M_(U$7*$XR7T\LUN(!HBJ;O>/,>UFL]],5T\H?@-!5UCN%R 37@4!21! 7X;(
MI'!A2RD1'Q(7&OD?FS5 ?K&J?V:3KZWY5>3;=ILH]#YQ_>OZWB>/"^')\.CP
MW<GI;7L=GD0$A6YM+#6Y,JYL3I0C!Q L\:18H[.<I]ZQ_:U[4_D/*@BOQ<W[
M83=@(:W3V2<"5" (M$.(4PB':\]*KKJBII&;_H.T+F]K>UY?B(\UJ=MJ9MT$
MQFOM3;Z2"I9TM5Y'?BTWG+D/)R70D8$EQHARPVLT\8Y[7'0$8D'CWLA&-R<O
M0XV->I.WH<55Q-:R]AYVV,:M@7&C,V)@OJ0/(0;#!+&>2>#E4+Y93.2/U)M\
M)>$O[4V^BN1:WAEODL%N@!AA@V<L$)>E)5*@V+W0AN1H,D0OHC?M3<$'K_X!
M5;BVY%;M*7/SX_(E^!'\^[_\/U!+ P04    " #H@E93=P0;\E'#  #C\ <
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M+,J;\M/UNYO;UC,:\"#+,Z2^\"A(U.8O5MM 09#^_L<H"CAGU,C/=&J@L='
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MUW,RZIE"#9RTZ@?"W>163\]U[+;4^4#^(OB#&K<M"A&1*$"Q5-LM&280R4Q
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M8QR#2 2!"%,8DI1 M=@SB$.*84Q9H-9]D/# ZEQL=XBQK?NZC]]*1*=(T3U
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MW5_R':D*-DE$&F.6Q3"3"8(HR6-(TUPWJ!8QEC&/469)1'O'&1_SU&+]6,P
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MT1+:D<PYTV%&0@.!W#-)-5K 3WLW?A=U<1:FR]ZLJW0!Z@D!6AV@]?''91Y
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M7K,UHX+7^G1R,0=T_4*+CK.]3/IIJ_%[3V7/!+K6$[CY*C6GR.J?;<.=3DE
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M#S=L9=J3:N]4I3U]AQM5* /^>5Z1Z2_E_.7Y_91455V$7W\KZUH/.8^8I)C
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MQU%F5 KIT !C,YH:&<%*2*"E--]=[07Q].;J7&AZ7LR6J%CMK(ZI[K2QVOO
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M'(7&[W' _J&&/0$XJNZ.T__XU>>'#7R8/^GT82*EC,.4P@SI4J8\(3!GDB@
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MB,!8(<&3A.*<,=L#!DN;8WM>M]PV.Y_M$4%]J+#4K@.Z]MU^?]IV LZ?$/0
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MZS<\(EA"QDD,E<1IH9)<B<(IY7S[YF-[K;>^.7<]W4',=I?3#X?>MS8;MZZ
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M\5HU;Q6)E 6/4RCSA$.D8@X)-FE7/"=((8HQLEJ;6-H;&RDU6_L[/E_5FMK
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MG0F]P*[Z$DW2.,IXQB1$)*_V&P1D7%.(:1*>ZB5('.=.^PU.UL=&)'7++B.
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M>?U-SN1"KT!XZZ:W9N4^D+9/KS<\O3^_+2)-!4@/8G G1A_X8=ZU,?#C?'2
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M@W@U-HJO>Y"N-05H/<N&Z.?5P>5ZP&"Y'K'K06:(R;0]ZAQXBGH_#-V>@<V
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M<=R-4HYA;,<COI -0QY;WH'K,\ X4T7'T(/RPS$[@Y)"QT#WF:#KHP&4S>M
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M;&S/_,/U_W-S#^Z^@-LO[^\^W[@][YVHVCWZH;#JF06V!&$WCH(_;(IBG9G
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M Q]M]DX ,N)1-*&TN>(I$; F&(5Y!>@ZQP0O$-3O^4 ?@-I&$TU"ZDXZ4HJ
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MHI!$1H=LTB@)%SEXG4.*L<ZNPY8$_]G7Q^;8VR7LWQ((/9=N_BL_GY1N.,C
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MH;UCVEHEJ%ZK"@N?_ !-^--3)#U[=2,VJ3.M3KH0<2O8N.WA:TIO XPE1;1
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M:STU +W;533)F+T/YW \_ ;/Q/CQNAR+'UQ-IO/A?RWT>C,'8^&*[GGGP:G
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M]VOO^.YJH-!421\48662&6;$@@2#HHD>EU9PE@97!SPKB.GW5D,=K[>=I!L
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MP'DOMGOV[G]7NA3HQ(QF4I(4!*XV9C@)#(-1P<%B/IZ22'6&=/^4M%;\9C>
MZU83+1]2GE^<OO]??ST]_G!X=G[XK[\?7?S;P<F'L\,/AX>?#MX='YZ<GKP_
M/;DX.ST^/CKY[>CDXO#L\/QBB_/*[=[3V=%E!VQV=(IY/I_$__@R&>&"F!W^
MY_5P_N/N>"ESE8Q,I1>V0H=J().RBTL".*UDPH"^4C_\EVG:^:[HLR>?3.:P
MJJL ,KJX>[>,(:0OO5TX+JB<@A7X1YERG?L>:Y/8;US7$6Z>7;^LHJ _G<7;
MOE!CI]?U:_]J%G.\ F?[_[?W;<UMY,B:[_M?$('[Y64C9%G=XPW;\DCRS.X3
M Y>$S0V:I24I=_O\^DWP(ED4)1?) JOD.1W=:LF4JQ*97R8R@;P4!%-N2:#4
MH-<&JO2U$XBV$*P6D651IW=$]V;P<=. I\_WTW0%">!;B?8QR(K-=('RFJS&
MGP.*?-4K8(2_$R+/EFB:0ZFP#L1FNSP],HQ%YW3<KQ'$X;0,U@SN@YO=71U.
M)* !A!I;5WX_E_B<3=-92LL2>C]YV CF;W[@#[?-W$_^G#5WMW-\Q&HZ4?D=
M9,MX>@?I<G5*T$Q7\ZP5NMG<*DZ<*N,(0&9B%;K*D2?%D"\,/?%37.E76E]_
MTR5/C]F7$PB& * !J-5>"_QI '+00N02IG)#)9'H9A%/5T4!+E!AL^!UCI<.
M)'A0^0J#P-[V <()@-#S;.I_\NMF<K=<P/HJ*@>7&-)/7,+H0QK%B)<V$19E
MH%P;7MS&7SLI3Q[<\X'Z*439=,77H1G!\_5P]I_RUI#^+&V9&>"=(E(Y3T+T
MDF26%"T?)%ZI7\C+A/4WHK?WW;Q+D0T;@6OES"9'07D@*7%4*60-JI1"WDE@
MRF2IO3W!AKN+M $9NV.!T!YD!TAE:#!;_8![07[SX]H755WLWB+NC3HSJ)F>
MX,: VX,PB3@1&#(VEC:N&K@Z@17<D^K!@O,0 +T$SYK2' !R[WWGU1YSWGR[
M;:;+0IBED@-X*D,I3"YSV7E0Q&E<FPX&D+\.C*]U#_$"6?T-*.]]>^Y.7 /
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M\SDLYJ/@LO-, N$JIM*/SA&+WQ+ &%UZP6C<OH/I*NOI1;KZ[>U8'5 ="F4
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MD5>3S>KBQ(^_S=<7R$[K+)F0) )D(@T%$IPM53Y9!@L>4FISKGO JP<"R6$
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MZZ^?>8)=LFKSYN? 1Z-T60!Z9ER7Q/' B8-DRL%6U%E3%M(K\^#WL[7+BY!
M);J(5I$8A"-2&T4"9:@:4G+KG&="U,EB.(#8@6Z/^^#HR.UQ;Y$-X,CKOG/3
M9M#(>C'KDC?%+%N&+T;C#N 3+H8;W/:%CR8(SJ%27XT7R>H9:;5!L0W"SB0T
M!+BM:%]G"* S 4K92!24IL8Q*.*%C 05$ZQ2Q9FLDW3SB(R>X=2=>'>?3QS
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MYQ,_GX_S.*ZD78Y<*<O(7 W$<%H*A;,A@2M)!,;$BFH>LZA6P_\284, Z<#
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MUM;W_K[R*8?,5#(*C2"C1"HCB3,8@>N<1794I"1.4L7Q?J_606;P+D*GC!\
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M@L5UVNCNOLB/O='552JNV+#!H8]@T/C61T1W8-<$PKO TC+XZ'!XY"30RY9
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MI8]D,MG $7@]\LUGNZ"+PMX406-LQ^MR*D[I:KU[M:WD0%G(0C##H@.Y!EJ
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M4"/P@'(S:W 4U=E3R3Z[MK'V;CUO7#8O3:P_*R;P9GR%O6JJ\\?2&8Q^T3C
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M-Z"*X*];<K:>M5-8J3=27>.=X&6D!MW'SDXH40*M5913)'K\QY_C\<LXJ\Y
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M+!HVDP<\H$&&1RBOERWAPB0U.8CRW;G!)%RS-)[;C=TGU2Z<EG=%3 TTH E
M$Z4/!K#98_!AN2&UFB/MQI@QQH)_2G#B4".N,E")VXQF*<K-*8\JVB*R[F 9
M3+U'Y-:4C93<QE1'WGPYD0IS_D6*V2Q#392$ORJ2(FND^=*%%.2+N;B%Y)Y^
M4J]:&6 '_:PE]<N =[KP1A7ZUA]Y%RXCQFJ\BUSXP-'\6IH_>@XT7T'Y #MN
MFO/H'(U3:E%SZ9*4_>X*3[01++F&'NF(^S+-72BX9#>6;\/H8F9E'%D@%;'Y
MRES(W0JYOW(A]\<OFL8QQ-UI"&U69X^IDS:P_)RJNJ>J>M4]567%-%:TANN
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M:U,MPEI![O<@]8T,/ -RA)2TNI 8^5=6LMZ$$BM $O"@U@U.LX8L,^\QN6[
M?$7%3@T&*8)5"VO.W<O@F0X.SFAA&I+VC\<XY+_59.?&OL^&;$'8M^V\ZF*=
M5JSSM8MU/ME@GR<21]\OFJ,35'98I\S=".K5Q(F/IH#NN_[-HRH##<N#RVW2
M<G#J<WCA&>9V:"SXIN)K2\(I!\\FG,(08M,0Z>E4XB"XP,JCF>I?EDFIZVYI
M1[,&7(Q<=Y4U0 4(%_O :.H/7*&*73B@>2KPKL13&,!6N$S2NJ0.0:SM@?]%
M#S$NX;NU-NQ?PPD'>B&RB]Y:RT"B4U40]BUH#6IN7"8%5UKC7_:KH*>M)SD4
M,9!92A,H<;\(@4OA9J&4@RU9@DV&4F]>>@9Y/?9MY=BQK "YA(#_X6+]0BM#
MKFMK5;'V89]^.K$?9^YB2IZNTJ18,II5%,ZPF0*60^9^O?[)E[,;-'1 #?"
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MUXL\F7ZE"0@8^P8[91*:03,4HT;IO_KR9U\KUMGI0QMIVE+O==.(\^_9 O:
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MUD6>(>E6.=$;LZZ[A$RL4U>IW.:IY#9#!8R#UZ\C=!#(D.5F<BQY<>;CRQ0
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MI8<>!B.K"]D=7<OL4.Z<PYF)G1I5=U2_R7U_$&W1_-8[9#O@77%B[D*+[&\
M^I.^\5J#RS.MMMEY0LIDGC9+9NV,YO3H/=EN/72;/EV'VMA\X[MDN'-2'KTH
M1.VWFO%=^E3,>\J<J%; 9\,P4.3KY7*L/KP>ACJ[PN32[=HZ+AIM$??#E=O(
MXS9!1'O $&3W5ZRL$-2M/Z<OA%N>YC1!OHQ:'JJH$\!9VM1U(7FJ'O'O9"@
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M3?,%"8))/*5R.J+?2XW*HT"+UEX:-PCB_)^,ZH\<Q"766"7$4$J!MMDXVT3
MPAJPDH<JTHI,XBIQR#5M-8M"-!1_9/N5+?A/:4$*5G<NI7!HPC/(@^)+E/=>
M#XLZ'<S6T/GM^/:]ZN/VU14KW.(QFS(XA7CP5AR4:/,3ST;,Z6.T$84J%D4L
M&JG9<G)2N\^G-&7<+:C^Z*0_6/T-]5=O1); PE_;H-4;%;1"1_T X/]Z 'X6
MHC48OR1!+-.LDN<6>E@*AB"8YC!LD.H!!RWPB,&)C NV.G ];8MHO!?%),6N
MF% D5K1#Z5*[86M4TQDC8HGRK0BHA;7M"%>-&N X5:8>E6BHLMC!/L_Z-J0*
MT^5\@;US)<ZI7IN?(N85?ND]6MEQ[,<S;1U[?>04)#*#",J<=54T1>H5^#+%
M>C!5!:J8=*M#]-.++8SRO79\%0'6 V/(UI3B^\]LO(+"+D]XJ1_N8I,;VKB$
M 1'<H#N.XG229X0OO9=X6?U]F>>(6_$:=@6D0BTQ*Y:4=ZKIF!BB/+]CKZFU
MCZ&H5T'R;ECA'-UD]W!K6J=?%Y);$U*>:Y-(FT<?>,NO09B&UI5A'.]?:QW]
MU UY&NY('MT2-#B3:D/OJ>C&.R3A6%G:IMZDA3,AYQ;HXQB^.#,0?FO:$"XF
M@UU1EDTVO;/CT8B C7XLM DQU2FM1C"5]YJ-DOJ>9\VRHH(;JCJAS"QENPZQ
M3A7K/#O$.K]2K+/'MD /"YBV-@9BL066"RK&T.HH_AA/B#Q$M'S]"JJW82D1
MH>28@5P'2[U4=P7Y0U]CU4I81A/:4KPGJ@</FOL?XAA<U=8ROK5?8%&\2*.)
M6 IC\(\YW('9SR(1Q;#(LTYF/9'MHE_+2;X0CIDE6[L:H]A^>ZOK5!G'>*4]
M>7+MV^H4&>U.J50I.EP*)Q5^D.6PE.A%PSVC*@?MP&&ZQ_@Y/3Y$DSX=HF>"
M6?-M.#8)XI#6)C,FG[_.]2TKRCF9HVF#*'VZPM@9730FY7+\+XGXK['?<%?(
M#6TEB35.$@(XA9Y9!A>+W6%,YTU&.#T(3L,[W//\^J7;XN:M=""J'QN]UP[]
M:&<<^M_!$,LJM$2E#/^]0.SVHPS_NG[VP#QFC!R[A554+;'@NL2MG]T2!\GQ
M[3$JHB)?WMY9Q*'@BJ]GLR0E]\TK4K36-I;QY/P99?],"]F$H4K&>^C"1N@:
M143X4/\8.)?L=B2$LI1SBZ'=,HXI[CM;(B%;Z%>-D7M2L),9-PK;I-^$$5/@
MDS)6CB-]]W'!5&@($WP7@W\!OQ =FT0"4++ 5%#@EEQ?\LK*.G. D2OF,2(K
M/=XRJFIJG6TV9R91230VTUB GU%1X%+1 G94S7ZHPUP5;*00O*Q;2KY).W75
M9 G/I-KFI.0"V)RJ+DD\AIX_N#!?L\QRUA*3OB2&S?]B<#<4&<M-%V3:T TF
M/VX"LGR9QM86,?,2"[J7FS20AHJSJ8G(==U"HV+?&'3GVOR"# YL(U(YY'":
MAB>X>JPGC(ZY7BSB*.6RT:2BPG7\,[O?\*AKI6/SK/,RYLFO?ZR" [5/:MH&
M;V&7.,DTLM9-P+XHF-.=43!OG>5,U<8_Q@4>RT!3?W?KFOYJEA[&AZ\%)<^$
M$JP%HG5.4 /LSGD6DI _1M7D[FBY"-X4\='[Z*-??8M7V,/V"UZ*0L>_Q%2_
M6FG/.4JC:2@F%16(*K6X51<W128PQJ +L)U_7Z A7BF3DT0_"G2T-2?T!)4L
M.K0\><H0!$I5 2Z4OLG@3*S0PE%+466P@FRHS%2WMA8-CBV+_CH<),/!S3 8
M,-Z9; _8*P]WL?&*.I[+Q.5P$(9A\)[8'E!'O(&'1QE^#.(G$H.*;(NHNB."
M@D/L4\4^SP^QST-#D1[6&MYQG1:8$1;8 M;HQ7.FK5Q_CG=J[GM8G8-SCWX-
M"&!,*&:3)$H=)5$])W?*K"]Y=Z/T'4?K]+ HQ*3T,+96RP)8NB$RODS<D ]1
MP2YSG.F6K)T^,R<03'21F*8ZB0U\/MN.!@H?AD>CP70X@!D%G4])T%9N)46N
M8YH98F#TMH@6=P%\F4EF3:<2"PLX0EC 7H2T=B49U8Y)J4>(ZL!HH;H#JVPA
M]0,4-89;&/BS6GNZ(;L$#:X'S\]H\X%8@=!H07E<GH8*/1N:+D:;3<=UP3)J
MSVC&P6_OSB4',3I?TX06[Z,D);>F7BX\-G&3NA,7E66,!'U^NR P0*LC&U\#
MQXN9)0E-EV>,T8.C32^66'10$?O,(8I+6L@I<<PUBNKS03H,O;B+J96>YUF\
MPJC3Y XIVQ%U8:5$7BAV%#,+](FKA^\DR0L&["82FUN-<:2BJ*\N'9<9JK]R
M8R(MR].]C9*_;.=[LNPN'$2GXO@ZGZC^QH$S9"UG"&P]LX!8=$[$,"YAUJ20
M*72020%;9,T1>B1;;,-WA=,\QN>"4IO6I<VC8,<]UB']R\6""J$8$DF71B0:
M&0^QD'6[P#*+&P,9:V$*T!'^+4@ZFPG@S4-@QCD']"*H-'%F.H:/222<AS/\
M<PL:FC6E)?-4F5?2>B6C#=V&?_GFQ[?O#%$'2T0GNBB G]#-X49@,*TQB+['
M:,?%(=KQ%9!>+E_P55?]6>N$7K]]?_/CJY?![S=?1QRVC:*63CD^.2>U@/,*
M_W_UZ_7K=\'UZQ?!/V_>__SB[?4_KU^]VXLLUN5QCU 2&UH4O,J1; 2->*<X
M=C%IU8!#,$)<@OB83B5\@:$34;%[Y<"_?'OS[MI!E@<C=+HC\.3&*P73;H&Z
MAP:.@#YY[CB;!(T?_ 0S+IESEP@R["U8 +U,+3:)\N;KTSL[99#U+YO(>]XB
MP;@=H/5&T8R"#RS^01\,3/.JND3BD$_ND50;F^R52<E!P8,'M-X#JF$<3*$,
M9<_9Q7T0I,R" K*<R)K@[<P!0P\7,3=P+&-=*(H&;I*)SS.FSHH$FN7,\0.X
M7G=8(H2(%S(B\S&LLT$FSNHAE5 (W=+HH418$$H&.+F+:(6^+XQINI1'$2K0
MFJ:S:%+EA80:<)C1%/N_$/DSW<4+0;K C01?L'2';LWO6L26N4RB#6U1'[AF
M3URX'H8!7W*M2SU2!<[;4?PQ86!2RJK4[X^)P>>XN#6L?BYN)"SJJK'W!^'K
M -$44U41D6303J&VJB7:D^CCF*BC_C+S*VH=B-N.G'["H2&OPF TY V5+RL7
MT'0]UX[;.[HT'T,W,6'K)#-]#UK>*1[6NL>I1Q^C/BQB&]9VG>?AR;-\6508
MK2 E/ 7[GIB45'FUE(2O@S /X;;50RP9=3@@^6QF2"9H$:PH(:JQ$A%C$^D:
MDL%NPH\/\:QMI+FLW!$LE%=1(+!(+^2D?'T-\&ZL'AA,]>B[@8?>YO!;J'L$
MRFX@^?A+5, N.7T6!J<GIR<.\?KW*%MBN.!L1)^,VDZ,*]>DO6':]M7!DU$*
M6WJZ(GQMU#A4H=U3\^@C[>AL28WD86>EOO'A&A>C='C(B9B.Z+L888MG9IR;
M\G'^,L:N]3G:07.]AV&Z]VX;V\-OZB3L<OUQ%,+(A(.U50W?,RBYUKJ;!66Y
MG&'5IH!:R^4"0\'Z_'@/I9]-OP:Q3;R0+O7."AF+K2M5T: 5;\/L/[\=-LLU
M@AK!3+B")JT7S,#E*YZ6JU'2AN[1I*S O.*]C@H'V]"?#@]PM:>T3OYX<8+;
M$KU0L!J=+,4*W=+:M7=P&T(DMJ\RRQ;KN))^5 (6=.81]58522NM6*6&9TIR
MGDA9^-=*]@+N%I/;YFXLW?NL;03V_BTWW(C V*E]U4,TTJ]X%99<#1A_9'DJ
ML?EZ+%R:UOSR$3+GQZ?N<I:)M69QZ^"[ZY;]$-O7L?W+0VS_NZ_B;G7;J(MI
M&$A=L0MO6."3*2VQT*>RE>P"G:4%E]AL= \G6[B'S@7.';L[TS*7-<)+K2?8
M9N'FJ4()'4TFQ9)+0ZUU')0)F5L5I=>E9DR- 9ZAW@U=#3,O'4K)WGE/@BO3
M_JF9]S7GB@("U#F!&KECKS\T0G+8)?'TEDV1=6H)VZJ!S\9V*(.1QGE1Y ^X
ML<@07J.9=.V@1%_>"-1/&@^Z+D*T+8+@&LY,S:VCD%TDC8/\MJ,I^)2IZD4P
M0R!5AJ^>>ML[##K[D/X;W%BX*,6^GO?$D^/X\?!+<[;#T%!'7W9P,>3VGK6V
MJ]*ELG0&8PT]$$V(404/*AZ:JL"0)/6&?(C3%!=EF>%)H_K"AQ;:/B+K2TRO
M>WJ2;A&IVR+7M?R0:_/<W,"<8&?'2=QB/[1-_(:9J2BV="(S<]Q-(MOCLQSW
MZ2P+[\"JQ1FM49[CB<;IUPM(7Q+P!N')(I.4BQQ!@/GB-)\L&<QH.VQA)'&\
MHNY<H)\*T^W*,GM(PH"H'K74E^)1JN7M'(]$L>;YE,%ZU+>%>0*5@&+'A?9R
M+C25VT)J-'B9@36FZ\P\-I$OCR/SG=5W9HQ4N"ND^$SOE,7QU+ [D3% CGZM
M,??!,7]JP#H*K4J64R*599YQ'R'V-T#.+6']"^J!BR=$MHFA(>O8EGM4#=)#
MW[>Z4Z@T;M6$B7DZZ-CJ&_7]'JU #^MQR&[#I'I@6RFRE64(5R4[/.7T< :2
M>8\6I(?E-Z1$#)V[X>B12$VU6L22!9=:;1O0RV>H@_=I;7I(S-\45\;.9J2P
M,LH+J7)R6*B]69@>,N W%\;".8Q%P*$-9N<QC"W@&DV2 LQ<]!R1F,Y]"QG9
MZ@ 44U1C.3"9?B<6VCS[W<%LB>PG!5.Z1"FEYRWUP![MA!Y2Y7/=1AQ59NU9
M/$J.)8VC>XZJ1>/2>BQ,^.>7/#HJ $Z P'7[6H/:0\9XRJLQ90?%1))J2=Z?
M"3":S#^8[PL!@-EV)=&'.!/8$ SIWD:6L&;KD-7068UGAZS&=Y_5&,SZ<_K/
MCT_.3*C:82ELS-)&NS"0,RVB!X4 3RS-%R5#:O'EUBX1FH>R;$?+VBBJ9C[K
MC"4'$3+N.7BZR_,H0J6O,=C]R*'<]F=CKJE3]ZL.VTO4DSJ)JZ@Q0;K39EG+
MIQ>Z0V TH'7/:_Q8I#7KW<):6:]JC5'V9-?<]6_7O&\[K4+<V&!Y](I7MV:^
M#32=*(;GLQ)#FYF J77_&R;-.+VX.#D^/[D:'XWV9.&3_BS\^?'E<^[+!C-8
M8"[#*YO"%7'Y$5SO&IRQ3B2 N^2WO[^[#MY(!A53)91HP[H,DV%LMLJZ/!ZQ
MAF05@@]D_E4/U#NZ.B%$<0?DK(I=9%"G#RE/BYP.!$_@SA$(U)TE*='%FC02
M[D6+Q33Y%%N=K)FP^1GF>JL]X44CCMIC6Y&DPL(2%F48<"$K/ZN80R:O]ZMA
M+(.<N,F'+'_@Y#8)1ZX1418&]_O&WXQW2(U&X-5 T\NX0C69[:OG^-V3DFGG
MI FCU[[$PW,,3O>%&.!?_3F%5\?/GV^EM,UQ:>AM#AVP9C8T+ ;>3NCVT:5;
M;44P81B42IW_I,J**/B%ZU08T8O)=TL\.;1>K9=RA%'*3M6)?'64HDV O1YO
MEP_]V2Z7QV>?U!AC/R)Y/4SKHLALEH52!$\'\/"RWRS#SR]8VX?G4XB4PD9Q
MGS&<RV6Y8'1!K1=5I&EBVQB#1N>#Y1"IPKSS:KU :YE/<9$99M?>EE*1SJ;1
MP]['&7N8?VY4?K;M.4%/8O*--IY)B#:VHJRRVUD&PN;@4?R=P7+!()WJ(4[O
MXZ,YC/XN '$_,=<.#Q5QVU3$(>BCB%L*;VR](RYN,M7$8WF1W%(K.Y>PD?51
MYU&T.%<*E>Q(3]':)<P/P7U6>:W\3.Y2%QY64QCOV^T&WBFH4O;$_$O[<\2-
M$R86/<=%J.C4@M>XC#BROC98?ID(>7)0K--3Q$QT,8LFI%]P<>=163IR-M,N
MAWT #A)J.6)J[@F1;<C*J4=?['H.Z-+EL!LK^3VF*JX.J8IOEJKX1L)D44/D
MJ:(U</JG!. TS'Q, 1''K!5J3;G$ZK+1>\L8@S2,5/UI()W3P'3,,0<; _]-
M^@'\%.,1]TR@T4D_8#@WYMR)1SN(22$NHO;J3"6$$RMRY\)BRFO-.$'SP2S]
MKZ2MD;.^#(.HC7).!T6F2V9@40J(6YY80\@K^D:],K'0RN;@L!R%^Q_A70QL
M0O#T$Z(Y+1/8(5'AP2VH>>S*O7$\/?+N.]5(-('8ZKYGJ.H=6 I--;[>-!VC
M%S=+8?2V-<'A4S"Z6:$;DUT5K5 UB\/V&)1''2J*^Z?B*!R%=*B"H*U\=T\4
M_+PW"GYT)0J^C;X ^1YC^JT[NN[B.RNSNRC4XQ^Q-7TBN>Y*@C-^728V91^,
M'Q74ZS/36H_:!6U@6OO9,,G_4W+$4;H?G>AZR/#UCP6E(M8RMA%"S@3[V7,&
MSZL1IP\(L>=:M=9)0VR4-<**"LZD&Q0 %5\*V,ZO4:L5FH$YGR)D"(6]6-V-
MYFZ@D_YIT04&9*LDA+B3(B,\WCFUXU3JGSJ=32TT@*;!LJ"!RCBR+H-R414:
M@+EXN)MG(_&/ ],8A7_R+>)H<J?O'=JYVC@V6P74TE3=$ ]M@B/XH]J/T]=#
MMJSK!JV.I /=8K<G!4^9K$H(=]35B>M '[G^L_CE9#X'=6HXZ>_BZ'ZEVG=@
M#53=ZFRR5$V&@]%0BHM+G]FX!#E>SL04W/INIT/A7S$7>OTJR&0W2;R65B,F
M>"NQ(V\\'L9(C8_ .W8J_ E E$^D,!;V07Z17K/5[=9)_K"+XIE,'WP<?=UC
MK_%(SOSYHQX9>@L)NR9#V=6VP/@'+T ]C$TYW?&<JE/AW=%X-U6#D73=\%X5
M*\5K2V_)J9J+%GW)95NW1-TR:IOX^H'<R1@$<+X177+R0_.__0QFWVP4:]\R
MS$T'5)W#%B^5-WV+T,:$U,:7:ZOQ7@=4& ^MYN .(W#Q^M+6[S%4^?P0JGSZ
MKG?/3OMM+U[W1CB/GA_S1+S\B*$^/M5WR5P#MT+P!9)T6L095WERR ^; /G4
MW5X>?'1Q:DOJ&>>$XDA?4N(U(#7([L-_3SEG/I@.1]B<DSD8$1?CJ?%\C+P$
MPP#%UP215U$A_=(?\F4Z)6@5EV2Y[A7>R$Y'9_ (CP2C.5 =T8O-U&"4%:Y^
M=GSQ)Y*B)H5_6^1E2<#*>3Q\1 %7W[?I7WNS34]/Q*WY,2\Q_DS-CU+DED@C
M!9VWO9\T6XHBE6EC,AG JDHG*XR6WV*_+A/HWJ?%_+%_B_E&U6 N$XZZFA7%
M(QR9[F6QU#47><Y.T#C'<VH/)@H*!DVP,?^Q$NQ$,!B!5"$ !6==L4\96"PY
M>D0K]Q"Z0Z?8"[^NW-NC3?>B-YO.*CI;J>-IE47!$ !<_OA>0OB4H^F2&[ E
MD&MSDN8E5A6+.VM%2+?$V:/E?=F;Y069POF>-QJL-5X6Z,W@4BVSN( ?/9%Q
M1]VW)LS]O  [@@#<3WKXZ>Q/\>S;D]X-Y?!CH&?U-%#?=\=/_=D=H^.S"\_*
M-=@[BM@30&<:S?'<PGIUG7AE9'*+-<="-XE*^$NU4FP +9;GZ/)B@]E9OWQP
M-T3F.,TDP,"STEBCH$U._F2DS1J+=/LNR3NWS_[6FWW6]*:H"RBL1>RU3*7U
M(_H/6B#\=UD([ "LD'JT!I/,$7%180>6J' QRI_B*8FUEP2)0#3%+U$&VYC,
MJFO^R^"GE[]<#Q7<\&T^CHLJ>'\<O*NB&6SA*76=I0>\C=,DGM&PW3VO2ZP7
MHZCR]01$Y)OE^#AX=0P[[^3HV<FS,#"P3SXB:S2F^_,BC3B.ZZ@4ZF 7JC R
M \-"AC2?D&V(@>X,*?BQI6L)6]*$;?%-Z4QB?U08T1)K<-W@ZZU#] .VS43M
MW.GXN<>GHYZX@4-RC4;QCV(1OX1_Q]A\"!8_J<0W*(V,-HW%BF2.5AQ3_$T2
M^-FT%I.$:1G-8U,*27!=I00B4YT&/S.2V^IZC&12SLE^P:0,,&7#VJ..'?,8
M G_*);LF(=-0=4-;,VCBW54[.(OF0L>K+Z<&:W=,TKO$FD[7R0SGW_30HE=\
M!.LWL9VP8115=P=&#!6[O3PYQ&Z?/G9[J%-Y9*Y_70KKNB4/6L][[D022U3^
MFM=I;P5#B2SI>105T6T1+>ZH)\IVF:Q'4+/VW0[H8<[AI@JF><RT!!);5\E[
M459=*[A'890>QME_YG)]3K:@]4$@:] %!FFANY@C]3.:+;9?)\5CN8@Q6QD,
MOFI[0%T'7-,#0HZ &98A8E^Y218>O6&Q-\!E^[[\/8S,R_([ORZO@W5\=@6N
M$# LW&H)P2E;E@(!C5,0L$6>)1-*WF%++"^4YGA(A(:$P2&CX_.3T2 :'IV.
M!O%P<$;]K.!RMM;)0&=PE"VDQ7%-8'-J2ILY-;3/,Z[&ND%#$FWEMQCV74IL
MYX[?VFL2-HG*.^<;I D8_%.AB]--:+W>M0UDD8$E:;"3$7S4'S*:5&CI*PH*
MGVW 5O]N&RS<N4/0PTQ!O70 3 2K@<A3)6=N!"X;'&'.'"E31O;B)UDRG58+
M8VOXP@3#2W"2JCLL*W5;GK_7.$Q\C#X,CT88?SX=#I+[(8P;++#]P.#VL*G*
M368;C)L#W;;NMC+ML>#1L('/BM(RIYWGX._M>VV!#9%!-\\X@&B:+!.K.J(J
M.#(95-%'-(^QXQQ(RRJ)?:&7\8,E P];$+G';!V>-A'V!.C=PVX?/GN4Q(0$
MK$M42]9D4\*)$PHF?K3J;KXC[$422/L-;QJ\2*+;+(>%F92@2%6SCW=5/OE
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M'/+3=II++TI_OHO=SFXR3$HQ"XFT),Q6#5/BT5X/!?^E\8 ._]OXT9ILQWF
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M@"'USJ"UW]^26[:H'I?)''DQILUH.&U2+Y=,&ZDMV$[V8TUA/M+\;%PJTQ7
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M1P +K %)4><.6FI?OA5^:H-"6M9D%>:41A3N8-,]H?& P(_[!)X0R?[RBQ7
M$N= #C;UP_0.&_ PE?#+@;;Y2=>&&HNRPYW)\H2>OQ:T6.0;K+T9%2Z+EO A
M)IMMO1WGU.NA]4?'K\S3^SAH66UNEY-42];BW[.E5S=XY)4;2O&+&3A[DI^+
M^[3GGVVB<MW>&FHO2/K&!M$!KJ^R%,].#EF*K]SD=2>T< \-+45!2#PMEL^
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M@Y^7TY)H<4#N@Y;!F?A[#([%RG#C>W3(&B"EZ24-*[X8EN3$Z&Q<274NW@A
M'11,PCW[XF/'^3#5J5)NHPY58R$^\56I-S&3_)CF(:6T:[B30EA=([MI%)C;
M!P<-&P@6W(TR18>L6A:N/EGR8+& 7H2FDX<WCR/LU(R&.N$5\';+E&P+[&>Z
M)U;[Z*0_9OOI>K/]+:<9]T*RBACC\^VY@V5GRN2Q3.WKFNUB @?!F!R@<!A8
MUVG$UKX+I=]__L?H\N2'S__O(86C4CB7AQ3.]T9PPRVR6)1A7_I;#AR2=E.$
MP19>H0B"7?UJDADS/9%V9TQ95S/M0W?:"6A=W*MX)\Q"/B5R&WJL/?F.]HY
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M8'*G5'P_0Y4F>J?H5XRBT?%&\K*2BCJ_(S..7$/(>2DUC<IR.6<VG8B],7
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M$^K?;H!_^"]A*QF*?[I0_JF$V]5 @V2.M=D1AAK\R.\ALJLBN\\/D=WOK:A
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MKT9540V4/S3EP_1S<RAD;$$^"6-NN#/(B-H#HBH0GH#QNI2)J0!^7 R3\5"
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M\,>92*:$>-:<T]WY@D!47,I[0>6WL:)-V;Z<@ML6B50U?A5C6.\I/-OKPF7
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M ATV-)7H\^AJNE?-N%.(_<RL18 < ^'*[6J;>'59 +V(&!W@KT3\S.!UXKZ
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M88[:2A-=D:S&4.",)[ 6P5;>:NQN<\.I@1FX&1)B"CB;VAV>, ;6^A"E1\Z
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M;BM]"&E?TC:"%3V" CR0"-D[T@OEJ#%S51JC $$OHP@'&*ISJ6R P(Q=1]F
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MRSHU-?(X=V_7BX&7@#UI9CC7A/(DMTL,H3M-YY<HC&.@7R]27V_E 5051Q!
MY##T@36Q*%EC4KB,24&((6G9,_RJT62T[C@#C<P!$33A?[<\($<,_!?W"*58
MG08%MMV38/<I;.8X0>/0%T]<]1%EF*YF>2P#IYJUT1K+6Z&=Z^1!T?89.Q<&
ML5O(ENDO&B?'QS6#6VMJ!3Z];6XE6/D=T4H(&!PG7D7.GV''<4<(PTPOS P
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MI=#7O\?Y;YW0'<-_^LG _\?_!U!+ P04    " #H@E93PKDA?JM/  !?I (
M%    &1G># Y,S R,#(Q97@Q,#(N:'1M[7U9<]M(MN;[_ J,:Z9:C*!H4;OL
MZHJ0);I+?6W9+<E5MYXFDF121!L$>+%(9O_Z.4MF(A,+1;DD$[!Y^T:W18*)
M7$Z>_7SGE_]]_N'LYL^/ V^:S@+OXZ<W[R[.O!?;+U_^L7?V\N7YS;GWV\W[
M=]Y^;Z?OW<0B3/S4CT(1O'PYN'SAO9BFZ?S5RY?W]_>]^[U>%-^^O+EZB4/M
MOPRB*)&]<3I^\>LO^ G\MQ3C7__7+_][>]L[CT;93(:I-XJE2.78RQ(_O/7^
M&,ODL[>]K9XZB^:+V+^=IM[NSF[?^R.*/_MW@K]/_320O^IQ?GG)?__RDE[R
MRS :+W[]9>S?>?[X[R_\G>%!7TR.#_;EN+^_>[QSO-O?&8[$OAP>G!R/A\/_
MUX=)OH3'^3=)N@CDWU_,_'![*O']KXYVY^GK>W^<3E_U=W;^[POGN51^2;=%
MX-^&KVBV\.TD@K6IKT=1$,6O?MJA_WN-WVQ/Q,P/%J_^=N//9.)=RGOO*IJ)
M\&_=!'9X.Y&Q/^$'$_\_\E4?7TY_WJO9P#B!'TH]N_XN3FGP9>H/_=3K[_1V
M?WF)S^LUE5<FXEM8W#!*TVC&XUN+&,&&RGA-J_C7I\'UC7=^<?J/RP_7-Q=G
MUYZ[EG:LXOK3QX_O!N\'ES>G[[SSP=O!U=7@W#O[\/[CX/+Z].;BPZ7W\=WI
M91N7MO41SL7[^2>X0_W7<#%W]CNURVC*G$_A),[A $XOS[TKH*_3&_CC?' V
M>/]F<.7UN\A?=FI78?. ><0<\%4L Y'Z=[*6*ZBSV\E_(H9)%&1I^2>\*<"U
MXE]+DZC]KGBU5V-T^X;136,]T[FXE=M#8,2?M\4$#NF5".[%(GGQ*&;XP#R7
MTO::J.+CU>#T_9MW@Z^\A?_.DM2?+)Y]\OO5W'XRD2,D0$\D7C3Q_BG"3,2+
MGW_J'^Z\!HKNGYR<=+U_93))O7-?W(81S':4>&(<S5'@IE-9\>UU-I\'$B6J
M"+QS.9%Q#,^>1;.Y#!.!5.Q]#$3H3:*81AC*4$Y YL $1C).A1_B/_TT\0:S
M>1 MI$QZGG<*K_5BF60!/8D_E*$8I:0!P$^0B> 7U[@B>,7^SLFI?O "V08H
M'-Z5O)-A)F$R8XE?]D^.#[NX> '#C.6X:K%382_83[RQTA>Z?W']6Q_A!RX3
MA"$C6.0D@$70Z##O60+_$JEW[P>!=QO=P4I@NE$6INH+$4MOK%^S=>_#)$/Z
M\4R*$#4B6.@-W$S8Q2MYV_/P>(]>]WNX0]N'6Z*SU>]TO S6S^=!D\,AQ!<Q
M#*2WD").X)2 C'DX>'\X]NB::Y)A_K=S  =U8Z:M=I_&@TV$(241'([P891&
M0_C]7I=/CE8W HKU\7Q@%PHK+4R/=T0^R<K'68S/UBUW'OM(J%'%4M\R!2?2
MFV<QL&B9 #'I.7M *K"@Q(>)P_3,/(<2"%\61^MZ_D1_E62CJ3<&E98I[*.(
M@:[\N8 QIP(VW@ODK0B"A3?TPS%.D?5;F.(09B)\OIAJ%H_=EO[6D+:E2X>,
MOS*C6Z/>PWG"/H6P'GSL#N[ 5QY!1Y&,VD&':& 'X;7S.+J#381ML>Y5+%,_
MENKRCZ*9Y.G"TT!ZP$PDL%<?C]/P$!H6KC'>/WB.S@.&&4E_3AS%OJ!=G$Z2
MX8ZK=9<H6DU;S],'%H,<1)T"?)B%DXP^,2<_LEG ''\X V:'# ^^K."&PDLD
M<8+;.,KF^ EP?)"SM&IX? H' U1@AH51I%DM7QC%#1-FZ;L[_:U=.-D]^%\@
M_KT.;=H^_]7OX!L&5Q?7I_KH8Z9'7I+\ H.GWB2.9D22B;<+(_$(Q'BS(=E/
MWALZ<_KG13ZDVL>9^.+/LAF,EN(JZ+22A$XJO^)TX@G.FV<136"W5U$077%:
MK0P]^+/U2>%SH,89<D6E3?+]3^:P$7#<A9M1%CQG,+8_@LOQ3@RC6*11["-'
MN@A'O1]"+SUJHE[:&)OKYA345._#6[ @+V_ J+Q^M,6U_#ZY2S\DC3PEB6J(
M)H8+O@WK#<0\D:_T/UZ/_02XX>*5']*LZ4>OW>$.8(F@#Z1(WFIJ-$O^.C^P
MW@X?6@H33<?ZS>KK'GWU,AV7OSO9Z_7WZ[_>Z?5KOULV['[O\'"U45_2C'G6
ML#$)2/N_O]A[D9/Q&"7]J]WY%Z\/7!C_=Z]W=.325R GI6V:^>-Q(-=E,^-4
M@ +Z/19 Y?\&_1B8%LFHG$FIS7IX'U9>O$6G:HAM?/[5;N\(24M_1JJ.^G M
M6\8+&LL1\F_DJR04\2F8CO"F()'__N*G%7R1.R^:,_'^+R]%D7$^*\VGT7Q-
MLKS?ZZ] Z4]/Z+SB)E)YU3ZU@LH?._%O3N6-X.R[M9S=F*VX41O>WA*J?^S$
M]W\<WKY;S]O/HAD8Y2-EF4\\A_8WW+X%=/_8B?]0=+];1_=7,LEF[%(K4KWW
M%LR[Z!Y=@%>2W5(<9-]<ALUE:/-EV*L5 E,1WDH,<PP,N7O7J4BSC<*_H?KO
M1>'?JU7XSV",V!]F&V=.FZC^L1,_^'%X_=Y29XZ,8Q%XSTWT&SZ_]HG_4!1?
MJ^I;RCVH]"JJ'F_H__NG_\,?B?YKM7M*7,>4$3!TW\+N;'3Z[Y'6CWY(G7[_
M82=^F":4J7CTVCL=C2@G;Z/BM^02/';BQS\.P]^O5_$O0EBY/\Y R=<4OV'Y
M+:#VQT[\AZ+V6O5>D3CJ]IB)^E&0^W)#\1N*_UZ4G(-:)><BQ/QU';O=N#';
M> <>._&3'X?K']3K..]%&+))F]^!#<MO ;D_=N(_%+G7*CD6HS^7(ZXPV9#[
MAMR_$PWG<(D;9Z'5&Z7H;Q2;EI#^HY/M=WX<5G]8K]D8B@^]ZSGP^HDOQ]ZY
M2.6&W[> Z!^=>_]#$7VM?G/N)\9T15[_.Y=E*Y;O97/X^ 8K;D.A'QEL,C,W
M%^-[N1BUP5OG8M U.)<BG?[\T\'):^\-5=R/?('ETIM;L+D%+;\%^P_I1.>,
ML")"[U.(  ^)E)BS+.-;&8X6FQOP/=Z 'Z@&][!W4!OE&B/4!UT"C')9_J#!
MESF\#6NXX'H0'M!%F*0B".A;Q-S8W(O-O6CYO3BLNQ<.:!HB^AA1 1;S1B?:
M4'[;*?_H(9U(H98-[I2;]$9\V13O;FC_>Z#]XSK:_UT$F=@ DGRW5+[[(U'Y
M2:UN,Y?A.)W"L*#':V#!#<%O"+[E!-_?J:/XMV+D!WZZ8$R&C7-_0^_?!;W7
M%^/ZR6@JXEL"#_XPA)ENM)H-T7\?1%\;ZP4#=>.9V5#X]Y.]=E2;O7:*S1G(
M2X.N22N!89/$UI(K\.@DMA\(4>JH/HDM)_SAHHSWOF'^+:#\1S/_'XKREP +
MIG$DN"N"N04;BM]0?-LIOC9%C=IZ6+K-AM9_.%I_29TO].??LDF+_HE%0=^H
M5TGU/=GVM[^N64Q#&K]LNI\TI/O).EG]@WF85?GXNL/3AOW_<.S_N_7L'-=Z
M=K"#WDV<)<\0G]HX<IHP\?X/!)YY7._(&20HUOUDJJMPGXGH-SQ^[1/_]A3?
M"!Y_4LOCW_O)2(*N&\HHV^#IM(7L'\WH?R"4V)-Z1O_.G_FI4>:O\$<;KV4;
MZ/W1;/Z'HO=:/_W;+ Y!K>%ZJ4D4SS:^RPW%?P\47^NGM\C<&\KT'FMGT6ES
M.I[Y(9:98]]M3E1 '5]N $<VEZ'MEZ'6DWD9P10W:6@;$F\]B=>6C/\1^XB*
MG!!+'P1RE,91Z(\\;/F9P3\VJ<:;&_!=W(#:XO!_1##+$%7\=^)^0^@;0F\Y
MH=?6@I\!(T_C;+0Q83=T_AW0>6W=MX/V 7K,//!%.-H8JM\ER?^8':WZ._58
MR)AH:7EK-G4D[:'^1T>E?B#<>R#Y>C3DZ%[&;,)>R60.>HX_Q!)Q'UZODLX<
M_^5&%+3@,CQ:%/Q8EZ$V9G46"'^F+\.=#R_\&$<C.<YBN>E@NZ'\]E/^TAH3
MU<4S<52@.PEV0/(L+3TWY+_VB>\NA3^NK3JQ#A914_W)XD5M/<2/7:SRM=4J
MN!A__/<7*]%3PTI<:'-J261M=I_A8&NPH%S.MM\[VD,N=BXGP&<+W03;M+?]
M7K\QFVH$3C6GL_;ZVTRYFB/T/%0IPR@+$R]+Y%BCBY+K0<12_ST3R2C#GWNW
M$A?A#3-$(AT%V5C2 Q.),CK_/@L#F23TU0AF 1OA =6+.%C S\88C$2##KZ.
M[_U$PC3^@'_*._PE3@/_\,,N#QT%072/41W@'* .3\4=OW,F14@!ST022G8Z
M]882'NWJMPMO[$\F,!1LK'K8\Q,SD5C^3^;'\+;API[HSS\='+]N./U7G^:6
MZ#2&_D$U0IZ"2MRN:=I+?_5?KY/BB1#0IO*$:C8C=<D#4$+$Y#Z,HL_D;Q">
MU5?>**3<B@9H%:'9\?EY%H,V0*A>,5YWW </KKB,8Q&X?5J[^:^=S\G*N\[F
M\T!BZ47Q9]X("-5/>8I#.17!I#0_O*Q@&<[EB"HW1M%L+L.$$\!PIK!C=Y@$
M@RT5DFPTS6>"[Q;AP@LC?!C>#5<[FLFN)[_@$/"3+;[LN"[AJN,C5,?M@D#8
MO1@8@;I4 E8$UQWK2^VIPHXE&?X#YJ*]_&@0=+K>K?!AO3#?($KPU:21P<*1
M6<@T E[Q%KY46Z[>#+>:7CV.1AEN7]>K)#PO@8T+#..*0N "8D8=TV$0D1++
M&].YP0OO?1@XM%D-%\1(D?3 (+_M>6BL'+WN]S ^L7T(UV^KW^EX8X;E3\47
M6O8"N$T"9P9L@\<(>;]1$?+^*<),Q NOW_5V=W8.8'$WI12]F5CD1,HGEV1#
M1;Y .(GGIS!KB:Z"^3R.YK$/&V:(4S@>9/NDFB[E:[C<L$E<;F?79G/VN36'
MV>%YET!Y5#>A-"F$&"A?R$]3*0U;F,LX0<HQ+,2;(SPMRGFXOO?3:$:O>'C
M*=#J6 ;REBZTR-)I%/OI JB^G90X:A(E.O)V/I<B2/*M;SHQEB;<:RE)C)M$
M$@YSRKN'+9I%#3E[X7\E'DAP/PV 19#%I!4$=@T>]O:0ZX">)5']&&JFPX\:
M)80@"_"O,?9/*^E*+15]LDG493.<-U&8)<TBJY$ ;6F(\V+=#G3$N5B02B8%
MZ%#O10S_O>5/4.W-M;X*S90);Z_7[UA4=BU#'TCVO0C%+:GLWD6(WCTD2J)
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M&IB&*=DZ0JN4T(HTL82N+08%.L0YU5^[G6\4W*_S][TE<56L/N5$T;(\3Z(
M_6YL"9D%=?,+8=*4^,(@"],I-4KP;/)EK'R9@^\@7V85QK*F_55*3@CS*6BP
M!37(46.KZDY=3775^&]%IFSUB!.^A48#6#W"'(4F_ H73865\9^L@:KT6^>"
M3X5B4U4WO()UY;P*_3(R?,QM5_L[BOQPY*-8R4WR94?@!(-[?REDU@!1]TAA
M4B?\UBDH&NB\?X3,W5NWE,WG"O?#R3=X8-YY*HBV!1^Z.N[H>0,O=G!2C^:A
MA$M,-ZN=ML.W*GM]"D_2&974* /X=/V )^P[,AG8BH'3)'644J>&6R F#EZ)
MJRY2?;7),S][L,$V6=Q5 M&((-8N7>'S2&.G.;0Z:0ZM<I^!9<3Z\T\G_=<7
M" ;#U<SH3:)6-&/X9N]U2X_@MCE'\+"K8:!O 3J+UNU?. 7>8-_U/!O"!=G
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MR^ED+[8JU:N_T]OK=#T$7N2U!!'U"\WGC5B.J'P7E'%\CQ^BDHWK3A[.J+,
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MY3"4J0,;D$Q &X_BNO S&4-L.L -])4MA1>BE+9?YE1^.!)STO/15(&;%*!
MQ?LK)A/APPUWJAGAQ5$,NP^W-PA@293;./'1(;S(9\^#CNBY\H:@9"9 7QM0
M+6&32^7019Q_CJ%CDO=.:BSF>V:Q1J9$*_#?6>PGL)/,.^XHWY-2H<Q^Q+5C
MYW[MJ;C3RD0@;S'RFZ536JVN?J1$1V1,:+FR8SJ6Q'XPYA5'@=%5S*L5'J<R
MD$WOA)JY\+$5]@6S2#&8G#,Z^X&"JY&>CB9=Q:$0SY$P[WA9Q@(L(,CD79$)
M2-FLS[+-%2TE'KY T5%47&Q;N5]CH"\>XG[GYCSA2#X,8?<:80A\=&O\<H]3
M6'(OY5YJ<R.'$G2@.W8<W$81:.H"?0:5SG@=((!7^&Z2-!,\=S;@*PG$+<FK
MX]Z"G.@Y]85^Q44O4;ZC)7\8^3%4<GN%,PP1FI264YXU,,V*+DUY4TA\+4<_
M$BGBT32'^7#U*GN]0[F(U*5-)#>C(@LKEK<8K4"=!):?RJ50F34J;H!8K)_#
MZ#[$3!A8=)+[F(HK2S% DSPT6_;883:\AZU4TT"!4!F?6H$^JKJT%X8$*@E(
M;(P"X<^<''>2,B!A\/ P(8>X*Z^GL@I#19.PVH%"C,1%R2/"\1RC"8K*NG76
M_2C22&Q6OQ'. X?$V6 ZNKH=(5QO_/=GOZHV#G>H?J9U\I2ARFQ^;6^':NOC
MS,4DF=&#UIQ8S&@ 852XV;&9Z)J/.O4F)Q%[ T)Z*W^.4NPV0DKEFY^   U=
M*[T>SH8JV$C-T0J]6K31?]1J81-(H:FN2#"%= H,636S*T"\)6X^(,7!HB
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M,=ZD@N4)S428R6P1TN/$<D]T-5M:Z94*,@BE,O*VBEH1C7;0<=75+07^/LY
MS3"N*0ROS<$N8YB[.]DASF7T J7?ZE5ICI:KM_.Y1/P'!"'$1Q064('A.1M
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MA8ENU-S<B#J)N+8B7A";4/OLX/#H^'.'MF75/:&1XYPR!IS3D#RV@\,>O'$
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M>F!;M[C6'! =QOPRV3!=$[8NM]R6 \H+V#@9F 74+Q%LHYASP$G<*<] EDB
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M@V@M-2Y4 <B!%*U[Q6! +I@B!7A E-Q@RH2S]<3NAU8#^[?%PJ0?:^"5.L"
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M]GO!-99/,L?[7&G+5,8NE$Y9T*S]PE3,?BF$L>Q<\G&FC)6A88,L5!JVQ/7
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M;B,P)N?9RTJ[LJA0KIEN*[]EP8)(?!QH&=V-C0_+EP>-NW/R:KX$2#GJ;WQ
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M_,W]5&MI[G-4\\:@UA$WVEB&<4N)VL!6A.G4L.S^@,>$Z54NJ-1@=S4C21)
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ME_=3;4$3HJONSH7-]4@W&)QK$3+'N5ZHAT6><(B^\2SOHLRMV.%?4$L#!!0
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M5;Q!5V+B<*L\R;0-!"%WBX32A1>BX0$8JHOS0#M^>(N_:"0!H#'TN3\WY@K
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MX>EHJP-V :.:8R WK 9#WB'<**@;)HHR5DU'E]E3TFTR'3HRN!6!>BZ-,,>
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M7,0Y>P0"MV 3#ZJ]B:? 0>>L3\%G]6:NVLS#:F\F<5#-R446]!'G1H XQ$2
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MOYI,@^E'P6=#LMG1K?C(( Q4W5BA;\3JM"[( ]/"![M$2'>J%#M7=;QK),H
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M9W@M,C R,3 Y,S N:'1M4$L! A0#%     @ Z()64WN['R$K#P  RY$  !
M             ( !L@\" &1G>"TR,#(Q,#DS,"YX<V102P$"% ,4    " #H
M@E93(@+/ &X<  "6# $ %               @ $+'P( 9&=X+3(P,C$P.3,P
M7V-A;"YX;6Q02P$"% ,4    " #H@E93@Y[Q(\U(  #N"@, %
M    @ &K.P( 9&=X+3(P,C$P.3,P7V1E9BYX;6Q02P$"% ,4    " #H@E93
M=P0;\E'#  #C\ < %               @ &JA ( 9&=X+3(P,C$P.3,P7VQA
M8BYX;6Q02P$"% ,4    " #H@E93(5J,ZK%Y  "$3P4 %
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M              "  9F'!0!D9W@P.3,P,C R,65X,S(R+FAT;5!+ 0(4 Q0
M   ( .B"5E.\$QAN$"L   ^W 0 4              "  7>,!0!D9W@P.3,P
C,C R,65X.3DQ+FAT;5!+!08     #@ . ),#  "YMP4    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
